Citrus Sinensis ID: 010768
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCU5 | 549 | Probable serine/threonine | yes | no | 0.635 | 0.581 | 0.719 | 1e-135 | |
| Q9LVL5 | 571 | Probable serine/threonine | no | no | 0.928 | 0.816 | 0.508 | 1e-126 | |
| Q2RBE3 | 622 | Probable serine/threonine | yes | no | 0.633 | 0.511 | 0.594 | 6e-96 | |
| Q2QYL8 | 619 | Probable serine/threonine | yes | no | 0.633 | 0.513 | 0.599 | 7e-95 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.589 | 0.521 | 0.536 | 2e-93 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.603 | 0.430 | 0.525 | 3e-93 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.603 | 0.430 | 0.525 | 3e-93 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.581 | 0.470 | 0.513 | 3e-91 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.585 | 0.597 | 0.537 | 7e-91 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.567 | 0.552 | 0.573 | 3e-90 |
| >sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 483 bits (1244), Expect = e-135, Method: Compositional matrix adjust.
Identities = 236/328 (71%), Positives = 266/328 (81%), Gaps = 9/328 (2%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLREYR+KY +VDIRA+K+WARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 107 LFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 166
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQ+AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT EYP
Sbjct: 167 QVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYP 226
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS- 179
YSEC+NPAQIYKKVTSGKLP +FH IQ EA+RFVGKCLE VS+RLPAKELL DPFLA+
Sbjct: 227 YSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAAT 286
Query: 180 ---DAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
D +P+ + QNL NG V E +P +D ++TDM+ITG MN ED TIFL
Sbjct: 287 DERDLAPLFRLPQQLAIQNLAANGTVVEHLPS---TTDPTRTTDMSITGKMNSEDHTIFL 343
Query: 237 KVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
+VQI D DG RNI FP++I +DT EVALEMVKELEITDW+PLEIA MIE EIS LVPN
Sbjct: 344 QVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPN 403
Query: 297 WKECGSPQFCHQHSFSYEDEDDDNDDYG 324
W+ S SF +ED++D+ D G
Sbjct: 404 WRANDSS--IRHESFGHEDDEDNGDTEG 429
|
Regulates flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVL5|WNK4_ARATH Probable serine/threonine-protein kinase WNK4 OS=Arabidopsis thaliana GN=WNK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 257/505 (50%), Positives = 330/505 (65%), Gaps = 39/505 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLR+Y+ KY R+DIRA+K+WARQIL G+ YLH HDPPVIHRDLKCDNIFVNGHLG
Sbjct: 101 LFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLG 160
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLA +LR AHS+IGTPEFMAPELYEE+YNEL+D+YSFGMC LEM+TSE+P
Sbjct: 161 QVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFP 220
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++PAQIYKKV GKLPGAF+R+ D EA+RF+GKCL + SKR+ AKELL DPFLASD
Sbjct: 221 YSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
+ NP + E D T+M+I G + ED+ I L+VQI
Sbjct: 281 ESWMVYTSGAG-----NPKPFLNENEMDTLKLEDDELRTEMSIAGKLGAEDNKIDLEVQI 335
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
+G A N++FP+DI NDT+ +VA EMVKELEI DWEP+EIA+MI+ ISSLV +WK
Sbjct: 336 AYDNGLANNVFFPFDIMNDTSIDVAKEMVKELEIIDWEPVEIAKMIDGAISSLVSDWK-- 393
Query: 301 GSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQE 360
YE++D+ D+ + +SS S + +S + A W+ Q+
Sbjct: 394 ------------YEEDDETPHDHHRHRTDSFHSSSSHASSSQASLSNYMARGLQDWV-QD 440
Query: 361 DLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTRFCPEAAM 420
DL +D+ S S +S YS+ +Y + +E + + P + T TRFCPE +
Sbjct: 441 DL--HDETYSQSSSHSGSYSNLNYIAVDE------YSSQSP--VMSRTHNMTRFCPEES- 489
Query: 421 NNDRCNSEDVNSWKACSTN----SNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKT 476
S N++ A S+ ++++R L+R RSLVDV+ QLLHRS EE KRRLFKT
Sbjct: 490 --SHLQSGQANAYAASSSTNRSLASDNRTLTRNRSLVDVQRQLLHRSPGEEARKRRLFKT 547
Query: 477 VGAIENIGFHEPANCAAYGRCPVSR 501
VG +E +GF P A + P SR
Sbjct: 548 VGDVETVGFQSP--YAVSRKPPSSR 570
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBE3|WNK7_ORYSJ Probable serine/threonine-protein kinase WNK7 OS=Oryza sativa subsp. japonica GN=WNK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 198/333 (59%), Positives = 235/333 (70%), Gaps = 15/333 (4%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+F+SGTLR YR +Y RV RAV WAR ILRG+AYLH VIHRDLKCDNIFVNGHLG
Sbjct: 117 LFSSGTLRSYRLRYPRVSRRAVAAWARAILRGLAYLHARG--VIHRDLKCDNIFVNGHLG 174
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAA+LRG A SVIGTPEFMAPE+Y+E Y VD+YSFGMC+LEMLT+EYP
Sbjct: 175 QVKIGDLGLAAVLRGCASARSVIGTPEFMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYP 234
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC NPAQIYKKVT+GKLP AF+R+ DA+ARRF+G+CL + + R A+ELLLDPFL+
Sbjct: 235 YSECDNPAQIYKKVTAGKLPDAFYRLTDADARRFIGRCLVDAAHRPSAEELLLDPFLSPS 294
Query: 181 AGEP---LLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLK 237
++ L + + + A + K+TDM ITG +N E DTIFLK
Sbjct: 295 QNHDDHNIIAHATAPPPPLPLACSNSSEEQEEAAPAPAAKTTDMAITGKLNKEHDTIFLK 354
Query: 238 VQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
VQI RNIYFP+D+ NDTA EVA EMVKEL+I D EP EIA MIEQEI LVP +
Sbjct: 355 VQIGGGR-NVRNIYFPFDVANDTAMEVATEMVKELDIADREPTEIAAMIEQEIVRLVPGY 413
Query: 298 KECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFY 330
K QH +SY D++DD+D G +PFY
Sbjct: 414 K---------QHEYSYADDNDDDDVSGHPNPFY 437
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYL8|WNK8_ORYSJ Probable serine/threonine-protein kinase WNK8 OS=Oryza sativa subsp. japonica GN=WNK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 7e-95, Method: Compositional matrix adjust.
Identities = 199/332 (59%), Positives = 234/332 (70%), Gaps = 14/332 (4%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+F+SGTLR YR +Y RV RAV WAR ILRG+AYLH VIHRDLKCDNIFVNGHLG
Sbjct: 117 LFSSGTLRSYRLRYPRVSRRAVAAWARAILRGLAYLHSRG--VIHRDLKCDNIFVNGHLG 174
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAA+LRG A SVIGTPEFMAPE+Y+E Y VD+YSFGMC+LEMLT+EYP
Sbjct: 175 QVKIGDLGLAAVLRGCTSARSVIGTPEFMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYP 234
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLA-- 178
YSEC NPAQIYKKVT+GKLP AF+ + DA+ARRF+G+CL + + R A+ELLLDPFL+
Sbjct: 235 YSECDNPAQIYKKVTAGKLPDAFYLLTDADARRFIGRCLVDAAHRPSAEELLLDPFLSPP 294
Query: 179 SDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
+ + I + P Q ++ K+T M ITG +N E DTIFLKV
Sbjct: 295 QNHDDHNTIAHATAPPPPLPLACSNSSEEQEEEEAPAAKTTGMAITGKLNKEHDTIFLKV 354
Query: 239 QITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK 298
QI G RNIYFP+D+ NDTA EVA EMVKEL+I D EP EIA MIEQEI LVP +K
Sbjct: 355 QI-GGGGNVRNIYFPFDVANDTAMEVATEMVKELDIADREPTEIAAMIEQEIVRLVPGYK 413
Query: 299 ECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFY 330
QH +SY D+DDD+D G +PFY
Sbjct: 414 ---------QHEYSYADDDDDDDVNGQPNPFY 436
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 169/315 (53%), Positives = 224/315 (71%), Gaps = 19/315 (6%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLR+YR ++ RV+IRAVK W +QIL+G+ YLH PP+IHRDLKCDNIF+NG+ G
Sbjct: 106 LFTSGTLRQYRLRHRRVNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQG 165
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAILR S HA +GTPEFMAPE+Y+E+YNELVD+Y+FGMCVLEM+T +YP
Sbjct: 166 EVKIGDLGLAAILRKS-HAVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYP 224
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++PAQIYKKVTSGK P AF+ ++D E R FV KCL NV+ RL A ELL DPFL D
Sbjct: 225 YSECTHPAQIYKKVTSGKKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDD 284
Query: 181 AGEPLLIPKVPSFQNLNPNGAV-----------------TELVPQFAVDSDRRKSTDMTI 223
+ ++ + + + G +++ +D D++I
Sbjct: 285 NMDGFVMRPIDYYNGYDETGVFLRHPLIDDPLYHDQFESSQICEIDLFANDDEDHVDISI 344
Query: 224 TGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIA 283
G N DD IFL+++I+D +G+ RNIYFP++ DTA VA+EMV EL+IT+ + +IA
Sbjct: 345 KGKRNG-DDGIFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIA 403
Query: 284 EMIEQEISSLVPNWK 298
EMI+ EI++LVP+WK
Sbjct: 404 EMIDAEIAALVPDWK 418
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 185/352 (52%), Positives = 231/352 (65%), Gaps = 49/352 (13%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR+YR+K+ RV+I AVK+W RQIL G+ YLH HDPP+IHRDLKCDNIFVNG+ G
Sbjct: 109 MFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQG 168
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAILR S HA +GTPEFMAPE+YEE+YNELVDIYSFGMCVLEM+T EYP
Sbjct: 169 EVKIGDLGLAAILRKS-HAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYP 227
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++P QIYKKV SG P A ++++D R+FV KCL S+RL A+ELL DPFL D
Sbjct: 228 YSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD 287
Query: 181 AGEPLLIPKVPSFQNLN-----------------PNG---AVTELVP---QFAVDSDRRK 217
+ + P + +N NG ++ E P ++ + D K
Sbjct: 288 --DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIK 345
Query: 218 S----------------TDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDTA 261
+ D+TI G + ED +IFL+++I D DG RNIYFP+DI DTA
Sbjct: 346 ADGIDLFNGHEDEPLGNVDITIKGRKS-EDGSIFLRLRIADNDGHVRNIYFPFDIEADTA 404
Query: 262 TEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK------ECGSPQFCH 307
VA EMV EL+ITD E IAEMI+ E+S+LVP+W+ E +CH
Sbjct: 405 LSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCH 456
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 185/352 (52%), Positives = 231/352 (65%), Gaps = 49/352 (13%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR+YR+K+ RV+I AVK+W RQIL G+ YLH HDPP+IHRDLKCDNIFVNG+ G
Sbjct: 109 MFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQG 168
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAILR S HA +GTPEFMAPE+YEE+YNELVDIYSFGMCVLEM+T EYP
Sbjct: 169 EVKIGDLGLAAILRKS-HAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYP 227
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++P QIYKKV SG P A ++++D R+FV KCL S+RL A+ELL DPFL D
Sbjct: 228 YSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD 287
Query: 181 AGEPLLIPKVPSFQNLN-----------------PNG---AVTELVP---QFAVDSDRRK 217
+ + P + +N NG ++ E P ++ + D K
Sbjct: 288 --DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIK 345
Query: 218 S----------------TDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDTA 261
+ D+TI G + ED +IFL+++I D DG RNIYFP+DI DTA
Sbjct: 346 ADGIDLFNGHEDEPLGNVDITIKGRKS-EDGSIFLRLRIADNDGHVRNIYFPFDIEADTA 404
Query: 262 TEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK------ECGSPQFCH 307
VA EMV EL+ITD E IAEMI+ E+S+LVP+W+ E +CH
Sbjct: 405 LSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCH 456
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 169/329 (51%), Positives = 221/329 (67%), Gaps = 37/329 (11%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLR+YR K+ +VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIFVNG+ G
Sbjct: 110 VFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQG 169
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLA IL ++ AHS+IGTPEFMAPELY+E+YNELVDIY+FGMC+LE++T EYP
Sbjct: 170 EVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYP 229
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y ECSN AQIYKKV+ G+ P + +I+D E R F+ KC+ S+RL A+ELL+DPFL D
Sbjct: 230 YCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDD 289
Query: 181 AGEPLLIPKVPSFQNLNPNG-----------------AVTELVPQFAVDSDRRKSTDMTI 223
GE + P + + + G A+ E FA +D I
Sbjct: 290 -GEKIFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFA----EEHPSDRYI 344
Query: 224 TGTMNPED---------------DTIFLKVQITDKDGQARNIYFPYDIFNDTATEVALEM 268
TM+P+ +TIFLK++I D G A+NI+FP+DI DT+ VA EM
Sbjct: 345 HSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEM 404
Query: 269 VKELEITDWEPLEIAEMIEQEISSLVPNW 297
V +L++TD + IAEMI+ EI + +P+W
Sbjct: 405 VVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 181/337 (53%), Positives = 220/337 (65%), Gaps = 43/337 (12%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR+YR K+ RV+IRAVKNW RQILRG+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 107 MFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQG 166
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAA L+ S AH V GTPEFMAPE+Y+E+YN+LVDIYSFGMCVLEM+T +YP
Sbjct: 167 EVKIGDLGLAACLQHSHAAHCV-GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYP 225
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECS+PAQIYK+V SGK P +++D E R F+ KCL VS RL A ELL D FL D
Sbjct: 226 YSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID 285
Query: 181 ----------------AGEPLLIP-KVPSFQN----------LNPNGAVTELVPQFAVD- 212
AG PL +P + N + NG E V +D
Sbjct: 286 ESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNG--DETVESHEIDL 343
Query: 213 ------------SDRRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDT 260
R S D++I G D +FL+++ +K+G RNIYFP+DI DT
Sbjct: 344 LEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDT 403
Query: 261 ATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
A VA EMV+ELE+ D + +IA MI+ EI+SLVPNW
Sbjct: 404 AISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 172/300 (57%), Positives = 219/300 (73%), Gaps = 15/300 (5%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG LR+YRKK+ VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 104 VFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQG 163
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAIL ++ AHSVIGTPEFMAPELYEEDYN LVDIY+FGMC+LE++T EYP
Sbjct: 164 EVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYP 223
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLA-- 178
YSEC+N AQIY+KVTSG P A + D + R F+ KC+ VS+RL AKELL DPFL
Sbjct: 224 YSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCY 283
Query: 179 SDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
+ E + K + N NG V +L SD +T+ G + +TIFLK+
Sbjct: 284 KENTENVSSHKENGY---NGNGIVDKL-------SDSEVGL-LTVEG-QRKDLNTIFLKL 331
Query: 239 QITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLE-IAEMIEQEISSLVPNW 297
+ITD GQ RNI+FP++I DT+ VA+EMV+EL++TD + + IA+MI+ EI S +P+W
Sbjct: 332 RITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | ||||||
| 224140589 | 601 | predicted protein [Populus trichocarpa] | 0.952 | 0.795 | 0.679 | 0.0 | |
| 359481240 | 626 | PREDICTED: probable serine/threonine-pro | 0.944 | 0.757 | 0.658 | 1e-169 | |
| 255584247 | 617 | kinase, putative [Ricinus communis] gi|2 | 0.946 | 0.769 | 0.668 | 1e-168 | |
| 225434355 | 631 | PREDICTED: probable serine/threonine-pro | 0.948 | 0.754 | 0.637 | 1e-166 | |
| 224124748 | 608 | predicted protein [Populus trichocarpa] | 0.930 | 0.768 | 0.620 | 1e-159 | |
| 356496301 | 609 | PREDICTED: probable serine/threonine-pro | 0.956 | 0.788 | 0.611 | 1e-154 | |
| 148469851 | 610 | WNK1 [Glycine max] | 0.956 | 0.786 | 0.606 | 1e-151 | |
| 351721696 | 607 | with no lysine kinase 5 [Glycine max] gi | 0.950 | 0.785 | 0.606 | 1e-150 | |
| 224145457 | 606 | predicted protein [Populus trichocarpa] | 0.926 | 0.767 | 0.585 | 1e-150 | |
| 449531499 | 579 | PREDICTED: probable serine/threonine-pro | 0.946 | 0.820 | 0.556 | 1e-148 |
| >gi|224140589|ref|XP_002323664.1| predicted protein [Populus trichocarpa] gi|222868294|gb|EEF05425.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/490 (67%), Positives = 391/490 (79%), Gaps = 12/490 (2%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR YRKKY RVDIRA+KNW+RQILRG+A+LHGHDPPVIHRDLKCDNIF+NGHLG
Sbjct: 111 MFTSGTLRAYRKKYQRVDIRAIKNWSRQILRGLAFLHGHDPPVIHRDLKCDNIFINGHLG 170
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
VKIGDLGLAA+L+GSQHAHSVIGTPEFMAPELYEEDY+ELVDIYSFGMCVLEMLT EYP
Sbjct: 171 HVKIGDLGLAAVLQGSQHAHSVIGTPEFMAPELYEEDYDELVDIYSFGMCVLEMLTFEYP 230
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP AF+RI+D EA+ F+GKCL SKRLPA+ELLLDPFLASD
Sbjct: 231 YSECSNPAQIYKKVTSGKLPEAFYRIEDVEAQEFIGKCLATASKRLPARELLLDPFLASD 290
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
E IPKVPS + +P +++P D K+T+MT+TGTMNP+DDTIFLKV+I
Sbjct: 291 EAELGTIPKVPSPWS-SPKVTEEKIMPSLLADPT--KATEMTVTGTMNPQDDTIFLKVKI 347
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
++KDGQ RNIYFP+DI NDTA +VA+EMVKELEITDWEP EIA+MIE++ISSL+P WK+C
Sbjct: 348 SEKDGQTRNIYFPFDIMNDTAIDVAMEMVKELEITDWEPFEIADMIEEQISSLIPGWKQC 407
Query: 301 GSPQFCH-QHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQ 359
S Q H QH FSYED+DDD+ + G HPF+++SSHSSS ASL AF + P
Sbjct: 408 SSSQIHHPQHCFSYEDDDDDDHNDGPRHPFFASSSHSSSQASLLAFNCSFQTKPC----- 462
Query: 360 EDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTRFCPEAA 419
+L +DDASS S+NSFKYS+ +Y SGNEDDY+ S R PL + KSTRFCP +
Sbjct: 463 -ELFIDDDASSQSSLNSFKYSTLNYSSGNEDDYDASLRE-VPLGFGK-IHKSTRFCPADS 519
Query: 420 MNNDRCNSEDVNSWKACSTNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGA 479
++ + + +SN RKLSRIRS VDVR+QLLHRSL+EEI+KRRLFKTVGA
Sbjct: 520 LSAKQYKHRNARLDSGGCCSSNPQRKLSRIRSQVDVRNQLLHRSLLEEINKRRLFKTVGA 579
Query: 480 IENIGFHEPA 489
+ENIG+HEP
Sbjct: 580 VENIGYHEPG 589
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481240|ref|XP_002266913.2| PREDICTED: probable serine/threonine-protein kinase WNK5-like [Vitis vinifera] gi|297735557|emb|CBI18051.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 332/504 (65%), Positives = 389/504 (77%), Gaps = 30/504 (5%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLREYR+KY RVDI AVKNWARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 111 MFTSGTLREYRQKYKRVDIGAVKNWARQILHGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 170
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE+Y+ELVD+YSFGMCVLEMLTSEYP
Sbjct: 171 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYDELVDVYSFGMCVLEMLTSEYP 230
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y ECSNPAQIYKKVTSGKLP AF+RI+D EAR FVG+CLE+V+KRLPAKELL+DPFLA D
Sbjct: 231 YCECSNPAQIYKKVTSGKLPEAFYRIEDVEAREFVGRCLEHVAKRLPAKELLMDPFLAVD 290
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
GE +L S Q +PNG V E +P F + R++STDMTITGT+NP+D TIFLKV I
Sbjct: 291 HGEQMLPMLKISSQKPSPNGTV-EKIPSFQTNP-RKRSTDMTITGTINPDDYTIFLKVAI 348
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
+DKDG +RNIYFP+DI +DT +VA EMV+ELEITDWEP EIA+MIE+EI +LVP+WK+C
Sbjct: 349 SDKDGLSRNIYFPFDIGSDTPIDVAAEMVRELEITDWEPFEIAKMIEEEIFALVPSWKQC 408
Query: 301 GSPQFCHQHSF-SYEDEDDDNDDYGIYHPFYSNSSHSSSHA--------SLPAFFTNNAN 351
SP+ HQHSF E+E++++DD YHPFY +S SS A + + N+
Sbjct: 409 TSPE-NHQHSFEYEEEEEEEDDDDETYHPFYCYASESSRVALQDLSISCEIQSQHRNHMI 467
Query: 352 SPPSWLQQEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYE-FSHRAGEPLCIARATQK 410
S W QE LL NDDASS S+NS KYS+ Y S E+D + + + EP+ A +T K
Sbjct: 468 SGEDWF-QEGLLINDDASSQSSLNSDKYSTLVYCSVTENDIDHLAPKRVEPIFTA-STHK 525
Query: 411 STRFCPEAAMNNDRCNSEDVNSWKACST-----NSNNHRKLSRIRSLVDVRSQLLHRSLV 465
STRFCPE E +SW C+ +SN HRKLSRI+S VDVRSQLL RSL+
Sbjct: 526 STRFCPE----------EGTSSWNQCNGSRRPYDSNCHRKLSRIKSFVDVRSQLLRRSLM 575
Query: 466 EEIHKRRLFKTVGAIENIGFHEPA 489
E I+KRRLFKT+GA+ENIG+ EP
Sbjct: 576 EMINKRRLFKTIGAVENIGYQEPG 599
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584247|ref|XP_002532861.1| kinase, putative [Ricinus communis] gi|223527373|gb|EEF29515.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1543), Expect = e-168, Method: Compositional matrix adjust.
Identities = 339/507 (66%), Positives = 394/507 (77%), Gaps = 32/507 (6%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLREYRKKY VDIRAVKNWARQIL+G+AYLHGHDPPVIHRDLKCDNIF+NGHLG
Sbjct: 113 MFTSGTLREYRKKYQHVDIRAVKNWARQILQGLAYLHGHDPPVIHRDLKCDNIFINGHLG 172
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQHA SVIGTPEFMAPELYEE+YNELVDIYSFGMCVLEM TSEYP
Sbjct: 173 QVKIGDLGLAAILRGSQHARSVIGTPEFMAPELYEEEYNELVDIYSFGMCVLEMFTSEYP 232
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP AF++I+D EA++FVGKCLE+ SKRLPA+ELLLDPFL+SD
Sbjct: 233 YSECSNPAQIYKKVTSGKLPEAFYKIKDTEAQKFVGKCLESASKRLPARELLLDPFLSSD 292
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
G+ L + K+P Q + N A E++P D K T+MTITGTMNP+DDT+FLKVQI
Sbjct: 293 EGKLLPVTKIP-IQRSSSN-ASEEIIPSLLADP--TKDTEMTITGTMNPDDDTVFLKVQI 348
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
+DKDG RNIYFPYD NDTA +VA+EMVKELEITDWE L+IAEMIE++I+SL+P+ KE
Sbjct: 349 SDKDGHTRNIYFPYDTMNDTAIDVAVEMVKELEITDWESLDIAEMIEEQIASLIPSSKEW 408
Query: 301 GSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFT------------N 348
G F QHSF+ D+DD+ D+ G +HPF+S SS SSS ASL A +
Sbjct: 409 G--LFQQQHSFN-YDDDDEYDNDGNHHPFHSFSSRSSSQASLLALSSPYENPHLHGGSNT 465
Query: 349 NANSPPSWLQQEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARAT 408
N WLQ E L NDD SS S NS KYS+ +Y SGNED E S R GE L A+A
Sbjct: 466 NVTCSLDWLQGE-LFTNDDTSSQSSFNSIKYSNLNYCSGNEDSCETSTRGGEHLSFAKA- 523
Query: 409 QKSTRFCPEAAMNNDRCNSE------DVNSWKACSTNSNNHRKLSRIRSLVDVRSQLLHR 462
KSTRFCP +++ C+ + + SW+ ++S++ KLSR RSLVDVRSQLLH+
Sbjct: 524 HKSTRFCP---ADSNLCSKQHKQRNAQLGSWEC--SSSSSQPKLSRHRSLVDVRSQLLHK 578
Query: 463 SLVEEIHKRRLFKTVGAIENIGFHEPA 489
SL+E+IHKRRLFKTVGA+ENIGFHEP
Sbjct: 579 SLLEQIHKRRLFKTVGAVENIGFHEPG 605
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225434355|ref|XP_002268300.1| PREDICTED: probable serine/threonine-protein kinase WNK4 [Vitis vinifera] gi|297745773|emb|CBI15829.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 325/510 (63%), Positives = 371/510 (72%), Gaps = 34/510 (6%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
FTSGTLREYRKKY RVDIRA+K WARQILRG+ YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 111 FFTSGTLREYRKKYKRVDIRAIKCWARQILRGLVYLHGHDPPVIHRDLKCDNIFVNGHLG 170
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVD+YSFGMCVLEMLTSEYP
Sbjct: 171 EVKIGDLGLAAILRGSQSAHSVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYP 230
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLPGAF+RIQD EA+RF+GKCL SKRLPAKELLLDPFLASD
Sbjct: 231 YSECSNPAQIYKKVTSGKLPGAFYRIQDLEAQRFIGKCLVTASKRLPAKELLLDPFLASD 290
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
+ L PK+ S + + + +L SD R T+MTITGT+NP+DDTIFLKVQ
Sbjct: 291 EAKRLPKPKLGSQKPFLNDIRIEKLRL-----SDDRVRTNMTITGTLNPDDDTIFLKVQT 345
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
DKDG ARNIYFP+DI DT +VA+EMVKELEITDWEP EIA+MI+ EIS+LVP WK+
Sbjct: 346 ADKDGSARNIYFPFDIVTDTPIDVAMEMVKELEITDWEPFEIADMIDGEISALVPQWKKW 405
Query: 301 GSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFT----NNANSPPSW 356
PQ H ++F Y++ED+ G HPF S SS SSS AS P T + W
Sbjct: 406 DMPQ-QHHYAFDYQEEDE-----GHNHPFRSFSSCSSSQASFPCLSTSHRLDTMAQGGDW 459
Query: 357 LQQEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTRFCP 416
L ++DL DD SS S +S KYS+ +Y SGNE E S E A+ TQKSTRFCP
Sbjct: 460 L-KDDLF--DDTSSESSAHSGKYSNLNYFSGNEHCSETSTLRREQHPGAK-TQKSTRFCP 515
Query: 417 EAAMNNDRCNSEDVNSWKACSTNSNNHR-------------KLSRIRSLVDVRSQLLHRS 463
E N+ + S+K + R +L+R RSLVDVRSQLLHR+
Sbjct: 516 EE--NSSTRKALPGKSYKQGKVLQESQRAPGSKDKFAMETIRLTRNRSLVDVRSQLLHRT 573
Query: 464 LVEEIHKRRLFKTVGAIENIGFHEPANCAA 493
LVEE+HKRRL KTVGA+ENIGF P N +
Sbjct: 574 LVEEVHKRRLSKTVGAVENIGFQAPCNVSG 603
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124748|ref|XP_002319412.1| predicted protein [Populus trichocarpa] gi|222857788|gb|EEE95335.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 312/503 (62%), Positives = 363/503 (72%), Gaps = 36/503 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLREYRKKYTRV+IRA+K WARQIL GI YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 113 MFTSGTLREYRKKYTRVNIRAIKKWARQILEGIVYLHGHDPPVIHRDLKCDNIFVNGHLG 172
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQ AHSVIGTPEFMAPELYEE+YNELVD+YSFGMCVLEMLTSEYP
Sbjct: 173 QVKIGDLGLAAILRGSQSAHSVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYP 232
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC+NPAQIYKKVTSGKLP FHRIQD EA+RF+GKCL +KRL AKELLLDPFLASD
Sbjct: 233 YSECTNPAQIYKKVTSGKLPAVFHRIQDLEAQRFIGKCLVTAAKRLSAKELLLDPFLASD 292
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
E +P VP F+ P E+ D R TDMTITG +NPEDDTIFLKVQI
Sbjct: 293 EAE---LPHVPRFRKQKPFLNDREMEKLQLNDHPPR--TDMTITGKLNPEDDTIFLKVQI 347
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKEC 300
++DG RNI+FP+DI +DT +VA+EMVKELEI DWEP EIA+MI+ IS+LVPNWK+
Sbjct: 348 ANEDGTLRNIFFPFDILHDTPIDVAMEMVKELEIDDWEPFEIADMIDGAISALVPNWKKW 407
Query: 301 GSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQE 360
P H+F Y+ EDD +D HPF+S+SS SSS ASL + L Q+
Sbjct: 408 DLPHIESHHTFDYQ-EDDGHD-----HPFHSSSSCSSSPASLSGLMPH--------LLQD 453
Query: 361 DLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTRFCPEAAM 420
DL DD SS S +S YS +Y SG+E ++ S + I R TQ STRFCP+
Sbjct: 454 DLF--DDTSSQSSSHSGSYSCLNYISGDEHKFDLSSTRRDKHLITR-TQNSTRFCPQENS 510
Query: 421 NNDRCNSEDVNSWKAC--------------STNSNNHRKLSRIRSLVDVRSQLLHRSLVE 466
N++ + N++ C S + R+L+R RSLVD+RSQLLHRSLVE
Sbjct: 511 NSNIGQALATNAYNHCKVLLESQTRASSSKSKRMMDSRRLTRNRSLVDIRSQLLHRSLVE 570
Query: 467 EIHKRRLFKTVGAIENIGFHEPA 489
E+HKRRL KTVG +E++GF +P
Sbjct: 571 EVHKRRLSKTVGDVEDVGFQKPT 593
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496301|ref|XP_003517007.1| PREDICTED: probable serine/threonine-protein kinase WNK5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1422), Expect = e-154, Method: Compositional matrix adjust.
Identities = 317/518 (61%), Positives = 385/518 (74%), Gaps = 38/518 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 225
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP A++RI D EA+RFVGKCL NVS+RL AKELLLDPFLA +
Sbjct: 226 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQRFVGKCLANVSERLSAKELLLDPFLAKE 285
Query: 181 AGE-PLLIPKVPSFQ--NLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLK 237
+ PL P +P Q LN ++ + + Q S++ K + MTITG++N EDDT+FLK
Sbjct: 286 QLDSPLPSPTLPKKQAPTLNFTASLAKELSQ--PKSNQTKDSHMTITGSINEEDDTVFLK 343
Query: 238 VQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
VQI++KDGQ RNI+FP+D DTA +VA+EMVKELEI+D EPLEIA+MIE+EIS+LVP W
Sbjct: 344 VQISNKDGQKRNIFFPFDTIYDTAIDVAMEMVKELEISDLEPLEIAKMIEEEISALVPKW 403
Query: 298 KECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAF---FTNNA---- 350
++ GS ++ QHSFSYE+E D ++ +HPF+S SS SSSHASLP F + NN+
Sbjct: 404 RDWGSAEYQKQHSFSYEEEYDMSN----HHPFFSTSSRSSSHASLPVFGSSYKNNSHYRG 459
Query: 351 NSPP---SWLQQEDLLGNDDASSNGSVNSFKYSSWD-YHSGNEDDYEFSHRAGEP--LCI 404
N P W Q E L NDDASS S+NSFK +++ GNED+++ + G
Sbjct: 460 NHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNFNCCDPGNEDEHDPTLVLGAEHLYYT 518
Query: 405 ARATQKSTRFCP-EAAMNNDRCNSEDVNSWKACSTNSNNHR-----KLSRIRSLVDVRSQ 458
+ +K RFCP E M+ D + C+ ++HR +L+RIRS VD+R Q
Sbjct: 519 PKGNEKCIRFCPREEVMDADFTK-------QLCNMRMDSHRCHGMHRLTRIRSFVDLRRQ 571
Query: 459 LLHRSLVEEIHKRRLFKTVGAIENIGFHEP--ANCAAY 494
L RSL+EEIHKRR+FKTVGA+ENIGF P C +Y
Sbjct: 572 QLQRSLMEEIHKRRMFKTVGAVENIGFQNPEGGGCFSY 609
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|148469851|gb|ABQ65855.1| WNK1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1394), Expect = e-151, Method: Compositional matrix adjust.
Identities = 315/519 (60%), Positives = 382/519 (73%), Gaps = 39/519 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 225
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP A++RI D EA++FVGKC NVS+RL AKELLLDPFLA++
Sbjct: 226 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQKFVGKCSANVSERLSAKELLLDPFLATE 285
Query: 181 A-GEPLLIPKVPSFQ--NLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLK 237
PL P +P Q LN + + +P S++ K T MTITG+ N E+DT+FLK
Sbjct: 286 QLDSPLPSPTLPKKQTPTLNFTALLAKELP--PPKSNQTKDTHMTITGSTNEENDTVFLK 343
Query: 238 VQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
VQI++K+GQ RNI+FP+D NDTA +VA+EMVKELEI+D EPLEIAEMIE+EIS+LVP W
Sbjct: 344 VQISNKNGQKRNIFFPFDTINDTAIDVAMEMVKELEISDLEPLEIAEMIEEEISALVPTW 403
Query: 298 KECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAF----FTNNA--- 350
++ GS ++ QHSFSYE+ D ++ +HPF+S +S SSSHASLP F + N++
Sbjct: 404 RDWGSAKYQKQHSFSYEEAYDMSN----HHPFFSPTSRSSSHASLPVFGSSSYKNSSHHR 459
Query: 351 -NSPP---SWLQQEDLLGNDDASSNGSVNSFKYSSWD-YHSGNEDDYE--FSHRAGEPLC 403
N P W Q E L NDDASS S+NSFK + + GNED+++ + A
Sbjct: 460 ENHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNLNCCDPGNEDEHDPTLALGAEHLFY 518
Query: 404 IARATQKSTRFCP-EAAMNNDRCNSEDVNSWKACSTNSNNHR-----KLSRIRSLVDVRS 457
+ +K TRFCP E M +D + C+ ++HR +L+RIRS VD+R
Sbjct: 519 TPKGNEKYTRFCPREEVMESDFTK-------QFCNMRMDSHRCHGMHRLTRIRSFVDLRR 571
Query: 458 QLLHRSLVEEIHKRRLFKTVGAIENIGFHEPA--NCAAY 494
Q RSLVEEIHKRR+FKTVGAIENIGF +P C +Y
Sbjct: 572 QQQQRSLVEEIHKRRMFKTVGAIENIGFQDPEGDGCFSY 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721696|ref|NP_001237474.1| with no lysine kinase 5 [Glycine max] gi|225348639|gb|ACN87281.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1385), Expect = e-150, Method: Compositional matrix adjust.
Identities = 315/519 (60%), Positives = 382/519 (73%), Gaps = 42/519 (8%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLREYRKKY RVDIRAVKNWARQIL G+ YLH HDPPVIHRDLKCDNIF+NGHLG
Sbjct: 106 LFTSGTLREYRKKYQRVDIRAVKNWARQILSGLEYLHSHDPPVIHRDLKCDNIFINGHLG 165
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQHAHS TPEFMAPELYEE+YNELVDIYSFGMC++E+ TSE+P
Sbjct: 166 QVKIGDLGLAAILRGSQHAHS---TPEFMAPELYEEEYNELVDIYSFGMCMIEIFTSEFP 222
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP A++RI D EA++FVGKCL NVS+RL AKELLLDPFLA++
Sbjct: 223 YSECSNPAQIYKKVTSGKLPEAYYRIHDLEAQKFVGKCLANVSERLSAKELLLDPFLATE 282
Query: 181 A-GEPLLIPKVPSFQ--NLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLK 237
PL P +P Q LN + + +P S++ K T MTITG+MN E+DT+FLK
Sbjct: 283 QLDSPLPSPTLPKKQTPTLNFTALLAKELP--PPKSNQTKDTHMTITGSMNEENDTVFLK 340
Query: 238 VQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNW 297
VQI++K+GQ RNI+FP+D NDTA +VA+EMVKELEI+D EPLEIAEMIE+EIS+LVP W
Sbjct: 341 VQISNKNGQKRNIFFPFDTINDTAIDVAMEMVKELEISDLEPLEIAEMIEEEISALVPTW 400
Query: 298 KECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAF----FTNNA--- 350
++ GS ++ QHSFSYE+E D ++ +HPF+S +S SSSHASLP F + N++
Sbjct: 401 RDWGSAKYQKQHSFSYEEEYDMSN----HHPFFSPTSRSSSHASLPVFGSSSYKNSSHHR 456
Query: 351 -NSPP---SWLQQEDLLGNDDASSNGSVNSFKYSSWD-YHSGNEDDYEFSHRAGEP--LC 403
N P W Q E L NDDASS S+NSFK + + GNED+++ + G
Sbjct: 457 ENHYPFAQDWPQDE-LFMNDDASSQSSMNSFKCFNLNCCDPGNEDEHDPTLALGAEHLFY 515
Query: 404 IARATQKSTRFCP-EAAMNNDRCNSEDVNSWKACSTNSNNHR-----KLSRIRSLVDVRS 457
+ +K TRFCP E M +D + C+ ++HR +L+RIRS VD+R
Sbjct: 516 TPKGNEKYTRFCPREEVMESDFTK-------QFCNMRMDSHRCHGMHRLTRIRSFVDLRR 568
Query: 458 QLLHRSLVEEIHKRRLFKTVGAIENIGFHEPA--NCAAY 494
Q RSLVEEIHKRR+FKTVGAIENIGF +P C +Y
Sbjct: 569 QQQQRSLVEEIHKRRMFKTVGAIENIGFQDPEGDGCFSY 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145457|ref|XP_002325649.1| predicted protein [Populus trichocarpa] gi|222862524|gb|EEF00031.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1384), Expect = e-150, Method: Compositional matrix adjust.
Identities = 295/504 (58%), Positives = 352/504 (69%), Gaps = 39/504 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR+YR+KYTRV+IRA+K WARQIL GI YLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 112 MFTSGTLRQYRQKYTRVNIRAIKKWARQILEGIEYLHGHDPPVIHRDLKCDNIFVNGHLG 171
Query: 61 QVKIGDLGLAAILRGSQHAHSVIG-TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEY 119
QVKIGDLGLAAILRGSQ AHSVIG TPEFMAPELYEE+YNELVD+YSFGMCVLEMLT+EY
Sbjct: 172 QVKIGDLGLAAILRGSQSAHSVIGSTPEFMAPELYEENYNELVDVYSFGMCVLEMLTAEY 231
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS 179
PYSEC+NPAQIYKKVTSGKLP F+RIQD EA+RF+GKCLE SKRLPAKELLLDPFLAS
Sbjct: 232 PYSECTNPAQIYKKVTSGKLPAVFYRIQDLEAQRFIGKCLETASKRLPAKELLLDPFLAS 291
Query: 180 DAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQ 239
D E +P++ + ++ + + +L Q +D TDM ITG +N DDTIFLKVQ
Sbjct: 292 DEAELSRVPRIRNQKSFLNDREMEKL--QL---NDHPPRTDMIITGKLN-RDDTIFLKVQ 345
Query: 240 ITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKE 299
I ++DG RNI+FP+DI +DT +VA+EMVKELEI DWEP EIA+MI+ IS LVPNWK+
Sbjct: 346 IANEDGTPRNIFFPFDILHDTPIDVAMEMVKELEIGDWEPFEIADMIDGAISDLVPNWKK 405
Query: 300 CGSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFTNNANSPPSWLQQ 359
P +H F Y+++D N HPF H+S + ++ + L Q
Sbjct: 406 WDLPHTEPRHIFDYQEDDGHN------HPF---------HSSSYSSSHSSLSGSTPHLLQ 450
Query: 360 EDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTRFCPEAA 419
+DL DD SS S +S YS +Y SG E + S E R TQ STRFCP
Sbjct: 451 DDLF--DDTSSQSSSHSGSYSCLNYISGYEHKLDLSTTRREKHLDTR-TQNSTRFCPREN 507
Query: 420 MNNDRCNSEDVNSWKACST--------------NSNNHRKLSRIRSLVDVRSQLLHRSLV 465
N++ N++ C + R+L+R RSLVD+RSQLLHRSLV
Sbjct: 508 SNSNIGQVLATNAYNNCKVLLESKSRVSSSKSKRMMDSRRLTRNRSLVDIRSQLLHRSLV 567
Query: 466 EEIHKRRLFKTVGAIENIGFHEPA 489
EE+HKRRL KTVG +E++GF PA
Sbjct: 568 EEVHKRRLSKTVGDVEDVGFQAPA 591
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531499|ref|XP_004172723.1| PREDICTED: probable serine/threonine-protein kinase WNK5-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-148, Method: Compositional matrix adjust.
Identities = 285/512 (55%), Positives = 366/512 (71%), Gaps = 37/512 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLREYR+KY +DI A+KNWARQIL G+ YLHGHDPP+IHRDLKCDN+F+NGHLG
Sbjct: 81 MFTSGTLREYRQKYRNIDIEAIKNWARQILHGLVYLHGHDPPIIHRDLKCDNVFINGHLG 140
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAIL SQHAHSVIGTPEFMAPELY+E+YNELVD+YSFGMC++EMLT EYP
Sbjct: 141 QVKIGDLGLAAILHDSQHAHSVIGTPEFMAPELYDEEYNELVDVYSFGMCMIEMLTLEYP 200
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECSNPAQIYKKVTSGKLP AF+ I+D EA+RFV KCLENVSKR+ A+ELLLDPFLA
Sbjct: 201 YSECSNPAQIYKKVTSGKLPNAFYEIKDLEAQRFVRKCLENVSKRVSARELLLDPFLA-- 258
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
P + + N + L P+ ++ + R TD+ I+G++NP+DD+IFLKVQI
Sbjct: 259 -------PSNANHASHNEELLSSSLSPEKSIMARR---TDLAISGSINPKDDSIFLKVQI 308
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEMVKELE-ITDWEPLEIAEMIEQEISSLVPNWKE 299
K+G+++N+YF +DI NDT +VA EMVKELE I+DW+PLEIA MIE+EISSL+P+W+E
Sbjct: 309 KVKNGKSKNVYFAFDILNDTTIDVATEMVKELEIISDWDPLEIAVMIEKEISSLIPDWEE 368
Query: 300 CGSPQFCHQHSFSYED---------EDDDNDDYGIYHPF-YSNSSHSSSHASLPAFFTNN 349
P+ HQ SF+YE DDD+++Y HPF Y SSH SS SL AF+++
Sbjct: 369 WKLPKIQHQDSFNYEQDHDGDNDNDNDDDDENYATPHPFYYCGSSHGSSSDSLHAFYSSR 428
Query: 350 ANSPPSWLQQEDL------LGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSH--RAGEP 401
N + +D DD SS S+NSF YS ++S NED+YE+ + EP
Sbjct: 429 ENPNHYFGGMKDTSNTTEWFREDDTSSCCSLNSFNYSDLSFYSNNEDEYEYDSNIKGREP 488
Query: 402 LCIARATQKSTRFCPEAAMNNDRCNSEDVN-----SWKACSTNSNNHRKLSRIRSLVDVR 456
++ T++ TRFCP +++ +D + SNN +L+R++S+V++R
Sbjct: 489 QYVS-TTKQPTRFCPTMKIDSHHLRHKDNKIIPNREVFESRSRSNNSPRLTRVKSMVNLR 547
Query: 457 SQLLHRSLVEEIHKRRLFKTVGAIENIGFHEP 488
S+ LHR LVE + K+RLF TVGA+ENIG+ +P
Sbjct: 548 SETLHRYLVEMLLKKRLFNTVGAMENIGYQKP 579
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 502 | ||||||
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.762 | 0.697 | 0.630 | 1.5e-127 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.603 | 0.530 | 0.625 | 1.4e-120 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.362 | 0.26 | 0.710 | 8e-89 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.362 | 0.369 | 0.699 | 1.7e-86 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.567 | 0.552 | 0.573 | 4.4e-84 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.376 | 0.333 | 0.632 | 2e-77 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.376 | 0.339 | 0.611 | 2.5e-75 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.426 | 0.380 | 0.6 | 3.7e-74 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.525 | 0.503 | 0.481 | 2.7e-61 | |
| ZFIN|ZDB-GENE-030131-2656 | 1909 | wnk1b "WNK lysine deficient pr | 0.360 | 0.094 | 0.551 | 6.3e-60 |
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1186 (422.6 bits), Expect = 1.5e-127, Sum P(2) = 1.5e-127
Identities = 253/401 (63%), Positives = 288/401 (71%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLREYR+KY +VDIRA+K+WARQIL G+AYLHGHDPPVIHRDLKCDNIFVNGHLG
Sbjct: 107 LFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLG 166
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLAAILRGSQ+AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLT EYP
Sbjct: 167 QVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYP 226
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLAS- 179
YSEC+NPAQIYKKVTSGKLP +FH IQ EA+RFVGKCLE VS+RLPAKELL DPFLA+
Sbjct: 227 YSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAAT 286
Query: 180 DAGE--PLL-IPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
D + PL +P+ + QNL NG V E +P +D ++TDM+ITG MN ED TIFL
Sbjct: 287 DERDLAPLFRLPQQLAIQNLAANGTVVEHLPS---TTDPTRTTDMSITGKMNSEDHTIFL 343
Query: 237 KVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPN 296
+VQI D DG RNI FP++I +DT EVALEMVKELEITDW+PLEIA MIE EIS LVPN
Sbjct: 344 QVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPN 403
Query: 297 WKECGSPQFCHQHSFSYXXXXXXXXXYGIYHPFYXXXXXXXXXXXLPAFFTNNANSPPSW 356
W+ S H+ SF + G F A NN +S
Sbjct: 404 WRANDS-SIRHE-SFGHEDDEDNGDTEGRTRLFSSASSSHDSPV---AVRENNDDSSNDV 458
Query: 357 LQQEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHR 397
+ D GN SSN +NS S++ Y +DD R
Sbjct: 459 IPDMDD-GN--RSSNRLLNS---STYHYSPAIDDDQNQQQR 493
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 194/310 (62%), Positives = 239/310 (77%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLR+Y+ KY R+DIRA+K+WARQIL G+ YLH HDPPVIHRDLKCDNIFVNGHLG
Sbjct: 101 LFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLG 160
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
QVKIGDLGLA +LR AHS+IGTPEFMAPELYEE+YNEL+D+YSFGMC LEM+TSE+P
Sbjct: 161 QVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFP 220
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++PAQIYKKV GKLPGAF+R+ D EA+RF+GKCL + SKR+ AKELL DPFLASD
Sbjct: 221 YSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTEL-VPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQ 239
E ++ S NP + E + ++ D + T+M+I G + ED+ I L+VQ
Sbjct: 281 --ESWMV--YTSGAG-NPKPFLNENEMDTLKLEDDELR-TEMSIAGKLGAEDNKIDLEVQ 334
Query: 240 ITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWKE 299
I +G A N++FP+DI NDT+ +VA EMVKELEI DWEP+EIA+MI+ ISSLV +WK
Sbjct: 335 IAYDNGLANNVFFPFDIMNDTSIDVAKEMVKELEIIDWEPVEIAKMIDGAISSLVSDWKY 394
Query: 300 CGSPQFCHQH 309
+ H H
Sbjct: 395 EEDDETPHDH 404
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 8.0e-89, Sum P(2) = 8.0e-89
Identities = 130/183 (71%), Positives = 154/183 (84%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSGTLR+YR ++ RV+IRA+K+W RQILRG+ YLH HDPPVIHRDLKCDNIFVNG+ G
Sbjct: 106 LFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQG 165
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAILR S AH V GTPEFMAPE+YEE YNELVDIYSFGMC+LEM+T +YP
Sbjct: 166 EVKIGDLGLAAILRKSHAAHCV-GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYP 224
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSEC++PAQIYKKV SGK P A ++++D E + F+ KCL VS R+ A+ELL DPFL D
Sbjct: 225 YSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRID 284
Query: 181 AGE 183
GE
Sbjct: 285 DGE 287
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 1.7e-86, Sum P(2) = 1.7e-86
Identities = 128/183 (69%), Positives = 149/183 (81%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFTSGTLR+YR K+ RV+IRAVKNW RQILRG+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 107 MFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQG 166
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAA L+ S AH V GTPEFMAPE+Y+E+YN+LVDIYSFGMCVLEM+T +YP
Sbjct: 167 EVKIGDLGLAACLQHSHAAHCV-GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYP 225
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
YSECS+PAQIYK+V SGK P +++D E R F+ KCL VS RL A ELL D FL D
Sbjct: 226 YSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID 285
Query: 181 AGE 183
+
Sbjct: 286 ESD 288
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 4.4e-84, P = 4.4e-84
Identities = 172/300 (57%), Positives = 219/300 (73%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG LR+YRKK+ VD+RA+K W+RQIL G+ YLH HDPPVIHRDLKCDNIF+NG+ G
Sbjct: 104 VFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQG 163
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAAIL ++ AHSVIGTPEFMAPELYEEDYN LVDIY+FGMC+LE++T EYP
Sbjct: 164 EVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYP 223
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLA-- 178
YSEC+N AQIY+KVTSG P A + D + R F+ KC+ VS+RL AKELL DPFL
Sbjct: 224 YSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCY 283
Query: 179 SDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKV 238
+ E + K + N NG V +L SD +T+ G + +TIFLK+
Sbjct: 284 KENTENVSSHKENGY---NGNGIVDKL-------SDSEVGL-LTVEG-QRKDLNTIFLKL 331
Query: 239 QITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLE-IAEMIEQEISSLVPNW 297
+ITD GQ RNI+FP++I DT+ VA+EMV+EL++TD + + IA+MI+ EI S +P+W
Sbjct: 332 RITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 2.0e-77, Sum P(2) = 2.0e-77
Identities = 122/193 (63%), Positives = 155/193 (80%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG+LR YRKK+ +V+++AVKNWARQIL G+ YLHG +PP+IHRDLKCDNIF+NG+ G
Sbjct: 110 LFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHG 169
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLA ++ + +A SVIGTPEFMAPELY+E+YNEL DIYSFGMC+LEM+T +YP
Sbjct: 170 EVKIGDLGLATVMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYP 228
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y EC N AQIYKKV+SG P + R++D E ++F+ KCL S+RL AKELLLDPFL +
Sbjct: 229 YCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLN 288
Query: 181 A---GEPLLIPKV 190
PL +P +
Sbjct: 289 GLTMNNPLPLPDI 301
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 2.5e-75, Sum P(2) = 2.5e-75
Identities = 118/193 (61%), Positives = 152/193 (78%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG+LR+YRKK+ +V+++AVK WARQIL G+ YLH DPP+IHRD+KCDNIF+NG+ G
Sbjct: 110 LFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHG 169
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLA ++ + +A SVIGTPEFMAPELY+E+YNEL DIYSFGMC+LEM+T EYP
Sbjct: 170 EVKIGDLGLATVMEQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYP 228
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y EC N AQIYKKV+SG P + +++D E +F+ KCL S+RL A+ELLLD FL +
Sbjct: 229 YCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVN 288
Query: 181 A---GEPLLIPKV 190
PL +P +
Sbjct: 289 GLVMNNPLPLPDI 301
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 649 (233.5 bits), Expect = 3.7e-74, Sum P(2) = 3.7e-74
Identities = 132/220 (60%), Positives = 160/220 (72%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG+LR YRKK+ +VD +A+KNWARQIL+G+ YLH +PPVIHRDLKCDNIFVNG+ G
Sbjct: 111 LFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTG 170
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLA +L+ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYP
Sbjct: 171 EVKIGDLGLATVLQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYP 229
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y+EC N AQIYKKVTS P + ++ D + R+F+ KCL S R A EL DPFLA D
Sbjct: 230 YNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARD 289
Query: 181 AGEP--LLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKS 218
G+ LL S + + P E +P VD + KS
Sbjct: 290 GGKDSALLASSSTSSKYVRP--PQLEHLPM-DVDHNENKS 326
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 2.7e-61, P = 2.7e-61
Identities = 129/268 (48%), Positives = 171/268 (63%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+FTSG+L YRKK+ +VD +A+ NWARQIL+G+ YLH PPVIHRDLKCDNIFVNG+ G
Sbjct: 98 LFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTG 157
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+VKIGDLGLAA+++ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYP
Sbjct: 158 KVKIGDLGLAAVMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYP 216
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASD 180
Y EC N AQIYKKVTSG P + ++ D + ++F+ KCL R A ELL D LA D
Sbjct: 217 YRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVD 276
Query: 181 AGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI 240
+ + S P A+ +D + +K+T ++I + + L+
Sbjct: 277 GAKDSTLT-ASSNTTFKP--AMPPQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTME 333
Query: 241 TDKDGQARNIYFPYDIFNDTATEVALEM 268
+ ++ + +D A +AL +
Sbjct: 334 VQRVAESTEFKLSGERRDDVAASMALRI 361
|
|
| ZFIN|ZDB-GENE-030131-2656 wnk1b "WNK lysine deficient protein kinase 1b" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 6.3e-60, Sum P(4) = 6.3e-60
Identities = 101/183 (55%), Positives = 133/183 (72%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ TSGTL+ Y K++ + I+ +++W RQIL+G+ +LH PP+IHRDLKCDNIF+ G G
Sbjct: 296 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLHFLHTRAPPIIHRDLKCDNIFITGPTG 355
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP 120
VKIGDLGLA + R S A SVIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYP
Sbjct: 356 SVKIGDLGLATLKRSS-FAKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 414
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLAS 179
YSEC NPAQIY++VTSG PG+F ++ E + + C+ +N +R K+LL F
Sbjct: 415 YSECQNPAQIYRRVTSGVKPGSFDKVAIPEVKEIIEGCIRQNKDERYAIKDLLNHAFFQE 474
Query: 180 DAG 182
+ G
Sbjct: 475 ETG 477
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCU5 | WNK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7195 | 0.6354 | 0.5810 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVI.263.1 | hypothetical protein (570 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 502 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-19 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 7e-50
Identities = 63/177 (35%), Positives = 93/177 (52%), Gaps = 8/177 (4%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + KK R+ + + RQIL + YLH ++HRDLK +NI ++ G VK+
Sbjct: 82 GDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENILLDED-GHVKL 138
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPYS 122
D GLA L + + +GTPE+MAPE L + Y + VDI+S G +L E+LT + P+
Sbjct: 139 ADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFP 197
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+++KK+ K P EA+ + K L + KRL A+E L PF
Sbjct: 198 GDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 69/178 (38%), Positives = 94/178 (52%), Gaps = 8/178 (4%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L KK+ ++ ++ + RQIL G+AYLH + ++HRD+K NI V G VK+
Sbjct: 86 GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV-DSDGVVKL 142
Query: 65 GDLGLAAILRGSQHA---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP 120
D G A L + SV GTP +MAPE+ E+Y DI+S G V+EM T + P
Sbjct: 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+SE NP K+ S P EA+ F+ KCL + KR A ELL PFL
Sbjct: 203 WSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 63/181 (34%), Positives = 95/181 (52%), Gaps = 11/181 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y + + K A QILRG+ YLH + +IHRDLK +NI ++ + G VKI
Sbjct: 83 GDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLDEN-GVVKI 139
Query: 65 GDLGLAA-ILRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
D GLA +L+ S + +GTP +MAPE L Y VD++S G+ + E+LT + P+
Sbjct: 140 ADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF 199
Query: 122 SECSNPAQIYK--KVTSGKLPGAF--HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
S + Q+ ++ L EA+ + KCL + SKR A+E+L P+
Sbjct: 200 SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
Query: 177 L 177
Sbjct: 260 F 260
|
Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 61/161 (37%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHAHSVIG 84
R++L+G+ YLH VIHRD+K DNI ++ G VK+ D G AA L + +SV+G
Sbjct: 122 CREVLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178
Query: 85 TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TP +MAPE+ + +DY VDI+S G+ +EM E PY P + +T+ +P
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP--- 234
Query: 144 HRIQDA-----EARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
+++ E + F+ KCL + KR A+ELL PFL
Sbjct: 235 -PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-35
Identities = 67/181 (37%), Positives = 97/181 (53%), Gaps = 13/181 (7%)
Query: 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L + KKY ++ + RQIL G+ YLH + +HRD+K NI V+ + G V
Sbjct: 85 PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVV 141
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYP 120
K+ D G+A + A S G+P +MAPE+ + Y DI+S G VLEM T + P
Sbjct: 142 KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELLLDPF 176
+S+ A ++K S +LP I D EA+ F+ KCL+ + S R A ELL PF
Sbjct: 202 WSQLEGVAAVFKIGRSKELP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
Query: 177 L 177
+
Sbjct: 258 V 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 54/156 (34%), Positives = 89/156 (57%), Gaps = 11/156 (7%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
+++L+G+ YLH + +IHRD+K NI + G+VK+ D GL+A L ++ ++++GT
Sbjct: 104 CKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGT 160
Query: 86 PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP-G 141
P +MAPE + + Y+ DI+S G+ +E+ + PYSE ++K T+G L
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
E + F+ KCL+ N KR A++LL PF
Sbjct: 221 EKW---SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 39/114 (34%), Positives = 66/114 (57%), Gaps = 6/114 (5%)
Query: 5 GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L++ K+ ++ + QIL G+ YLH + +IHRDLK +NI ++ G+VK
Sbjct: 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVK 133
Query: 64 IGDLGLAAILR-GSQHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEM 114
+ D GL+ +L +++GTP +MAPE+ Y+E DI+S G+ + E+
Sbjct: 134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 68/184 (36%), Positives = 96/184 (52%), Gaps = 14/184 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
GTL E + +D ++ + Q+L G+AYLH H ++HRD+K NIF+ H G +K+
Sbjct: 84 GTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL-DHNGVIKL 140
Query: 65 GDLGLAAIL-RGSQHAH----SVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEML 115
GD G A L + S+ GTP +MAPE+ + DI+S G VLEM
Sbjct: 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200
Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLL 173
T + P+SE N QI V +G P +Q E + F+ +CLE + KR A ELL
Sbjct: 201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
Query: 174 DPFL 177
PF+
Sbjct: 261 HPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 56/178 (31%), Positives = 93/178 (52%), Gaps = 7/178 (3%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + KK ++ + ARQIL+G+ YLH +IHRD+K N+ +N G+VKI
Sbjct: 84 GSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLIN-SKGEVKI 141
Query: 65 GDLGLAAIL-RGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
D G++ +L ++ +GT +M+PE + E Y+ DI+S G+ +LE ++P+
Sbjct: 142 ADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201
Query: 123 --ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ ++ + + G P E R F+ CL+ + KR A ELL PF+
Sbjct: 202 PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 9/165 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + K R + +A +I+ + YLH +I+RDLK +NI ++ G +K+
Sbjct: 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKL 134
Query: 65 GDLGLAAIL-RGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
D GLA L ++ GTPE++APE L + Y + VD +S G+ + EMLT + P+
Sbjct: 135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF- 193
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ +IY+K+ L F EAR + L+ + +KRL
Sbjct: 194 YAEDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKRL 236
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 55/164 (33%), Positives = 80/164 (48%), Gaps = 26/164 (15%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
Q L+G+ YLH + IHRD+K NI +N GQ K+ D G++ L + ++VIGT
Sbjct: 106 YQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 86 PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC----------SNPAQIYKKV 134
P +MAPE + E YN DI+S G+ +EM + PYS+ + P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD- 221
Query: 135 TSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
P + E FV KCL ++ +R A +LL PF+
Sbjct: 222 -----PEKWSP----EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 10/158 (6%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSV 82
+W Q+ + YLH ++HRD+K NIF+ G VK+GD G++ +L + A +V
Sbjct: 107 DWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTV 163
Query: 83 IGTPEFMAPELYEED-YNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGKLP 140
+GTP +++PEL + YN DI+S G CVL E+ T ++P+ E N ++ K+ G+ P
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLG-CVLYELCTLKHPF-EGENLLELALKILKGQYP 221
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+E R V L+ + +R ++L PF+
Sbjct: 222 -PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 65/188 (34%), Positives = 94/188 (50%), Gaps = 30/188 (15%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+G+LR+ KK+ V + Q+L+G+AYLH VIHRD+K NI G VK
Sbjct: 83 NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVK 139
Query: 64 IGDLGLAAILRG-SQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
+ D G+A L S+ SV+GTP +MAPE+ E + DI+S G V+E+LT PY
Sbjct: 140 LADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRI-QD----------AEARRFVGKCLE-NVSKRLPAK 169
+ NP A RI QD E + F+ +C + + + R AK
Sbjct: 200 YDL-NPMA------------ALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAK 246
Query: 170 ELLLDPFL 177
+LL P++
Sbjct: 247 QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 30/169 (17%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-----RGSQHAHS 81
+++L+G+ YLH + IHRD+K NI + G VKI D G++A L R + +
Sbjct: 109 KEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 82 VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSEC-----------SNPA 128
+GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PYS+ ++P
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225
Query: 129 QIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
+ K +F R+ + CL+ + SKR A+ELL F
Sbjct: 226 SLETGADYKKYSKSF--------RKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/162 (36%), Positives = 87/162 (53%), Gaps = 7/162 (4%)
Query: 21 AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79
+ + +QIL G+ YLH D ++HRD+K DN+ VN + G VKI D G + L G +
Sbjct: 109 TIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166
Query: 80 HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
+ GT ++MAPE+ ++ Y DI+S G ++EM T + P+ E P KV
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226
Query: 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
K+ AEA+ F+ +C E + KR A +LL DPFL
Sbjct: 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 63/183 (34%), Positives = 94/183 (51%), Gaps = 16/183 (8%)
Query: 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G++++ K Y + + + RQIL G+ YLH + ++HRD+K NI + G V
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNV 143
Query: 63 KIGDLG----LAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS 117
K+GD G L I SV GTP +M+PE+ E Y D++S G V+EMLT
Sbjct: 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203
Query: 118 EYPYSECSNPAQIYK---KVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLL 173
+ P++E A I+K + T+ +LP +AR F+ + EN KR A+ELL
Sbjct: 204 KPPWAEFEAMAAIFKIATQPTNPQLPSHV----SPDARNFLRRTFVENAKKRPSAEELLR 259
Query: 174 DPF 176
F
Sbjct: 260 HFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 9/180 (5%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPP---VIHRDLKCDNIFVNGHLG 60
+ +++ +K+ ++ + Q+L + H P V+HRDLK NIF++ +
Sbjct: 89 AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-N 147
Query: 61 QVKIGDLGLAAIL-RGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
VK+GD GLA IL S A + +GTP +M+PE L Y+E DI+S G + E+
Sbjct: 148 NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
P+ N Q+ K+ GK +R E + L + KR +ELL P +
Sbjct: 208 PPF-TARNQLQLASKIKEGKFRRIPYRYSS-ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 16/180 (8%)
Query: 9 EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 68
E + T IR V RQ+L + +LH H VIHRDLK NI + G VK+ D G
Sbjct: 95 ELERGLTEPQIRYV---CRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFG 148
Query: 69 LAAILRGS-QHAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLTSEYPY 121
++A + + Q + IGTP +MAPE+ + Y+ DI+S G+ ++E+ E P+
Sbjct: 149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
Query: 122 SECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
E NP ++ K+ + P + F+ CL + R A ELL PF++
Sbjct: 209 HE-LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 15 TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-IL 73
TR++ + +L+ +++LH VIHRD+K D+I + G+VK+ D G A +
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVS 166
Query: 74 RGSQHAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
+ S++GTP +MAPE+ Y VDI+S G+ V+EM+ E PY P Q K
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMK 225
Query: 133 KVTSGKLPGAFHRIQ-DAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLI 187
++ P + + R F+ + L + ++R A ELL PFLA AG P I
Sbjct: 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK-AGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 59/165 (35%), Positives = 87/165 (52%), Gaps = 14/165 (8%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL-----AAILRGS 76
V+N+ RQIL+G+ YLH +IHRD+K NI V+ G +KI D G+ A L
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTK 164
Query: 77 QHAH--SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
+ S+ G+ +MAPE+ ++ Y DI+S G V+EMLT ++P+ +C+ I+K
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK- 223
Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+EA F+ K E + +KR A ELL PFL
Sbjct: 224 -IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
R++L G+ YLH IHRD+K NI ++ G VK+ D G++ L + ++ +GT
Sbjct: 105 REVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGT 161
Query: 86 PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ + Y+E DI+S G+ +E+ E P S+ P ++ + P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEG 220
Query: 145 RIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
+ FV CL ++ +R AKELL F+
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 9e-23
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G++ KY + N+ Q+LRG++YLH + +IHRD+K N+ ++ +++I
Sbjct: 88 GSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRI 145
Query: 65 GDLGLAA-----ILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
D G AA + ++GT FMAPE L E Y D++S G ++EM T++
Sbjct: 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
Query: 119 YPYS--ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
P++ + SN + K+ S + R +CLE R P++ELL P
Sbjct: 206 PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-22
Identities = 62/177 (35%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G++++ K Y + + + RQIL G++YLH + ++HRD+K NI + G VK+
Sbjct: 91 GSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDS-AGNVKL 147
Query: 65 GDLG----LAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
GD G L I SV GTP +M+PE+ E Y D++S G V+EMLT +
Sbjct: 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPF 176
P++E A I+K T P I + AR F+G R A+ELL PF
Sbjct: 208 PWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.3 bits (243), Expect = 3e-22
Identities = 51/203 (25%), Positives = 78/203 (38%), Gaps = 27/203 (13%)
Query: 2 FTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
G+L + KK + QIL + YLH +IHRD+K +NI ++
Sbjct: 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRD 137
Query: 59 LGQVKIGDLGLAAILRGS-------QHAHSVIGTPEFMAPELY----EEDYNELVDIYSF 107
VK+ D GLA +L + +GTP +MAPE+ + DI+S
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197
Query: 108 GMCVLEMLTSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQ-------DAEARRFVGK 157
G+ + E+LT P+ S +Q K + P + A + K
Sbjct: 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKK 257
Query: 158 CLE-NVSKRLPAKELLLDPFLAS 179
L + RL + L LA
Sbjct: 258 LLAKDPKNRLSSSSDLSHDLLAH 280
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 60/171 (35%), Positives = 90/171 (52%), Gaps = 16/171 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHAHSVIGT 85
R++L + Y+H VIHRD+K NI V G VK+ D G+AA+L + S + +GT
Sbjct: 108 REVLVALKYIH-KVG-VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGT 164
Query: 86 PEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
P +MAPE+ E Y+ DI+S G+ + EM T PYS+ + + + K P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKPP--- 220
Query: 144 HRIQD----AEARRFVGKCLENVSK-RLPAKELLLDPFLASDAGEPLLIPK 189
R++D R FV CL+ K RL A+ELL ++ + + P+ I K
Sbjct: 221 -RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 62/155 (40%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-VIGT 85
R+ L+ + +LH + VIHRD+K DNI + G G VK+ D G A + Q S ++GT
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 86 PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ-IYKKVTSGKLPGAF 143
P +MAPE+ + Y VDI+S G+ +EM+ E PY NP + +Y T+G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQN 237
Query: 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
A R F+ +CLE +V KR AKELL PFL
Sbjct: 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQV 62
G L +Y +KY +D + + +A +IL + YLH +IHRDLK +NI + + H+
Sbjct: 87 GELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHI--- 141
Query: 63 KIGDLGLAAIL---------------------RGSQHAHSVIGTPEFMAPELYEE-DYNE 100
KI D G A +L + + S +GT E+++PEL E +
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 101 LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160
D+++ G + +MLT + P+ SN ++K+ + F +A+ + K L
Sbjct: 202 SSDLWALGCIIYQMLTGKPPFR-GSNEYLTFQKILKLEYS--FPPNFPPDAKDLIEKLLV 258
Query: 161 -NVSKRL----PAKELLLDPF 176
+ RL EL PF
Sbjct: 259 LDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 62/178 (34%), Positives = 94/178 (52%), Gaps = 14/178 (7%)
Query: 5 GTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
GTL EY +K +D + ++ QIL +A H H ++HRDLK NI ++ H V
Sbjct: 84 GTLAEYIQKRCNSLLDEDTILHFFVQIL--LALHHVHTKLILHRDLKTQNILLDKHKMVV 141
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
KIGD G++ IL A++V+GTP +++PEL E + YN+ DI++ G CVL L S
Sbjct: 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALG-CVLYELASLKRA 200
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELLLDP 175
E +N + K+ SG F I D + R+ + L + SKR +++ P
Sbjct: 201 FEAANLPALVLKIMSGT----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 13/182 (7%)
Query: 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G LR + + + VK W +I+ + YLH +IHRD+K DNI ++ G V
Sbjct: 83 LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHV 139
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
I D +A + S GTP +MAPE+ + Y+ VD +S G+ E L + PY
Sbjct: 140 HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 122 ---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL--PAKELLLDP 175
S K+ T+ L A EA + K LE + KRL K+L P
Sbjct: 200 RGHSRTIRDQIRAKQETADVLYPATWST---EAIDAINKLLERDPQKRLGDNLKDLKNHP 256
Query: 176 FL 177
+
Sbjct: 257 YF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 52/166 (31%), Positives = 92/166 (55%), Gaps = 14/166 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + +K R + +A Q++ + YLH D +++RDLK +N+ + G +KI
Sbjct: 86 GELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKI 142
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
D G A ++G +++ GTPE++APE + + Y + VD ++ G+ + EML YP +
Sbjct: 143 TDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG-YPPFF 199
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ NP QIY+K+ GK+ F +A+ + L+ +++KRL
Sbjct: 200 DD--NPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 17/178 (9%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
++ R+ R + A +L+G+ YLH +IHRD+K NI VN GQ+K+ D G+
Sbjct: 90 LKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGV 147
Query: 70 AAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
+ L S A + +GT +MAPE + DY+ DI+S G+ ++E+ T +PY ++P
Sbjct: 148 SGQLVNSL-AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206
Query: 129 ----QIYKKVTSG---KLP-GAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
++ + + + +LP G F + + FV CL ++ +R KELL PF+
Sbjct: 207 DGIFELLQYIVNEPPPRLPSGKF----SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 55/180 (30%), Positives = 99/180 (55%), Gaps = 14/180 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWAR--QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G L + K + + W QIL G+A+LH ++HRD+K N+F++ + V
Sbjct: 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NV 140
Query: 63 KIGDLGLAAILRGSQH-AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
KIGDLG+A +L + + A++++GTP +++PEL E+ YNE D+++ G+ + E T ++P
Sbjct: 141 KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
Query: 121 YSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFL 177
+ + +N + K+ G P + Q A+ + +CL ++ P +LL +P L
Sbjct: 201 F-DANNQGALILKIIRGVFPPVSQMYSQQLAQ---LIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 38/204 (18%)
Query: 7 LREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
L++Y K+ + +K+ Q+LRG+AY H H ++HRDLK NI +N G +K+
Sbjct: 84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLA 140
Query: 66 DLGLAAILR--GSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT----- 116
D GLA + H V+ T + APE+ + Y+ VDI+S G EM+T
Sbjct: 141 DFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
Query: 117 ---------------------SEYP-YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
+P ++ + + K L R+ D E
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRL-DPEGIDL 258
Query: 155 VGKCLE-NVSKRLPAKELLLDPFL 177
+ K L+ N +KR+ AKE L P+
Sbjct: 259 LSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 44/142 (30%), Positives = 72/142 (50%), Gaps = 6/142 (4%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
++ YLH +I+RDLK +N+ ++ G VK+ D G A L+ Q + GTPE
Sbjct: 101 CVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157
Query: 88 FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC-SNPAQIYKKVTSGKLPGAFHR 145
++APE+ + Y+ VD +S G+ + E+LT P+ E +P +IY + G F
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 146 IQDAEARRFVGK-CLENVSKRL 166
D A+ + + N +RL
Sbjct: 218 YIDKAAKDLIKQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 26/179 (14%)
Query: 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA------- 70
D + + +I+ + YLH + +IHRDLK DNI ++ + G +K+ D GL+
Sbjct: 91 DEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRR 147
Query: 71 --AILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
+ + ++GTP+++APE + + +++ VD +S G + E L P+ P
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETP 206
Query: 128 AQIYKKVTSGKLPGAFHRIQDA----EARRFVGKCLE-NVSKRLPAK---ELLLDPFLA 178
+I++ + +GK+ +D EA + K L + KRL AK E+ PF
Sbjct: 207 EEIFQNILNGKIE----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 60/178 (33%), Positives = 89/178 (50%), Gaps = 9/178 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G++++ K Y + + + RQIL G++YLH + ++HRD+K NI + +G VK+
Sbjct: 91 GSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDS-VGNVKL 147
Query: 65 GDLG----LAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
GD G L I SV GTP +M+PE+ E Y DI+S G V+EMLT +
Sbjct: 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
P++E A I+K T P + D R F+ + R A ELL F+
Sbjct: 208 PWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
++ ++K+ + R + + Q+ + ++H ++HRD+K N+F+ G VK+GD
Sbjct: 93 IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGD 149
Query: 67 LGLAAILRG-SQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSE 123
LGL + AHS++GTP +M+PE ++E YN DI+S G + EM + P Y +
Sbjct: 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159
N + KK+ P E R V +C+
Sbjct: 210 KMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G++ + Y R + + V+ + Q+L G+AYLH ++HRDLK DN+ V+ G KI
Sbjct: 93 GSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKI 149
Query: 65 GDLGLA---AILRGSQHAHSVIGTPEFMAPE---LYEEDYNELVDIYSFGMCVLEMLTSE 118
D G++ + + S+ G+ +MAPE Y + Y+ VDI+S G VLEM
Sbjct: 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
Query: 119 YPYSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
P+S+ A ++K +P A F+ C N R A+ELL
Sbjct: 210 RPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269
Query: 175 PF 176
PF
Sbjct: 270 PF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 9e-20
Identities = 60/159 (37%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-VIGT 85
R+ L+ + +LH + VIHRD+K DN+ + G G VK+ D G A + Q S ++GT
Sbjct: 122 RECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 86 PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ + Y VDI+S G+ +EM+ E PY NP + + + P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP---- 233
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
+Q+ E R F+ +CLE +V KR AKELL PFL
Sbjct: 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSVIGT 85
R+ L+G+AYLH IHRD+K NI + G VK+ D G++A L + S IGT
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGT 164
Query: 86 PEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
P +MAPE+ Y+ DI++ G+ +E+ + P + +P + ++ P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPP 223
Query: 142 AFHRIQDAEA-----RRFVGKCL-ENVSKRLPAKELLLDPF 176
+++D E F+ KCL ++ KR A +LL PF
Sbjct: 224 P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G++++ K Y + + + RQIL+G++YLH + ++HRD+K NI + G VK+
Sbjct: 91 GSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSA-GNVKL 147
Query: 65 GDLG----LAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
GD G + I SV GTP +M+PE+ E Y D++S V+EMLT +
Sbjct: 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPF 176
P++E A I+K T P + DA R F+ + +R A+ LL PF
Sbjct: 208 PWAEYEAMAAIFKIATQPTKPMLPDGVSDA-CRDFLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 61/186 (32%), Positives = 94/186 (50%), Gaps = 16/186 (8%)
Query: 9 EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 68
E + T IR V +Q L + YLH + +IHRDLK NI G +K+ D G
Sbjct: 95 ELERPLTEPQIRVV---CKQTLEALNYLH--ENKIIHRDLKAGNILFTLD-GDIKLADFG 148
Query: 69 LAAI-LRGSQHAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLTSEYPY 121
++A R Q S IGTP +MAPE+ + Y+ D++S G+ ++EM E P+
Sbjct: 149 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
E NP ++ K+ + P + +E + F+ KCLE NV R +LL PF+
Sbjct: 209 HEL-NPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267
Query: 180 DAGEPL 185
++ +P+
Sbjct: 268 NSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+LRG+ LH + ++HRDLK NI + + VKIGDLG++ +L+ + A + IGTP
Sbjct: 111 QLLRGLQALH--EQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNM-AKTQIGTPH 166
Query: 88 FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146
+MAPE+++ Y+ DI+S G + EM T P+ E + + KV GK P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIY 225
Query: 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ + F+ L+ R ++L P +
Sbjct: 226 SQ-DLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 6e-19
Identities = 60/159 (37%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-VIGT 85
R+ L+ + +LH + VIHRD+K DNI + G G VK+ D G A + Q S ++GT
Sbjct: 122 RECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 86 PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ + Y VDI+S G+ +EM+ E PY NP + + + P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP---- 233
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
+Q+ E R F+ +CLE +V +R AKELL PFL
Sbjct: 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 46/141 (32%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G L +Y +K ++ ++A QI RG+ YL IHRDL N V +L V
Sbjct: 86 GDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL-VV 142
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPE---FMAPELYEED-YNELVDIYSFGMCVLEMLTS- 117
KI D GL+ L + + V G +MAPE +E + D++SFG+ + E+ T
Sbjct: 143 KISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 118 EYPYSECSNPAQIYKKVTSGK 138
E PY SN A++ + + G
Sbjct: 202 EEPYPGMSN-AEVLEYLKKGY 221
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 13/141 (9%)
Query: 5 GTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y +K ++ + + ++A QI RG+ YL IHRDL N V +L VK
Sbjct: 86 GDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL-VVK 142
Query: 64 IGDLGLA-AILRGSQHAHSVIGTPE---FMAPELYEED-YNELVDIYSFGMCVLEMLTS- 117
I D GL+ + + G +MAPE +E + D++SFG+ + E+ T
Sbjct: 143 ISDFGLSRDLYDDDYYRKR--GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 200
Query: 118 EYPYSECSNPAQIYKKVTSGK 138
E PY SN ++ + + +G
Sbjct: 201 EQPYPGMSN-EEVLEYLKNGY 220
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA-HSVIGT 85
R+ LRG+AYLH + VIHRD+K NI + +VK+ D G++A L + ++ IGT
Sbjct: 120 RETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176
Query: 86 PEFMAPEL------YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
P +MAPE+ + Y+ D++S G+ +E+ + P + +P + K+
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPP 235
Query: 140 PGAFH-RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
P + F+ +CL N +R +ELL PF+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 18/158 (11%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--HAHSVIGT 85
QI+ ++Y+H ++HRD+K NIF+ G +K+GD G++ IL GS+ A +V+GT
Sbjct: 109 QIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKIL-GSEYSMAETVVGT 164
Query: 86 PEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGK---LP 140
P +M+PEL + YN DI++ G CVL E+LT + + + +NP + K+ G +
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALG-CVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVV 222
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ +E V L+ + KR A E+L P L
Sbjct: 223 SVY----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 60/179 (33%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 14 YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-I 72
+TR++ + +L+ ++ LH VIHRD+K D+I + H G+VK+ D G A +
Sbjct: 110 HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 166
Query: 73 LRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
+ S++GTP +MAPEL Y VDI+S G+ V+EM+ E PY + P
Sbjct: 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKA 224
Query: 132 KKVTSGKLPGAFHRIQDAEA--RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLI 187
K+ LP + + F+ + L + ++R A ELL PFLA AG P I
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK-AGPPSCI 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-18
Identities = 59/159 (37%), Positives = 86/159 (54%), Gaps = 16/159 (10%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-VIGT 85
R+ L+ + +LH + VIHRD+K DNI + G G VK+ D G A + Q S ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 86 PEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ + Y VDI+S G+ +EM+ E PY NP + + + P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFL 177
+Q+ E R F+ +CL+ +V KR AKELL FL
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 55/175 (31%), Positives = 80/175 (45%), Gaps = 16/175 (9%)
Query: 29 ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEF 88
I++ + YLH VIHRD+K N+ +N GQVK+ D G++ L S G +
Sbjct: 112 IVKALEYLH-SKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 89 MAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV---TSGKLP 140
MAPE + Y+ D++S G+ ++E+ T +PY P Q K+V S +LP
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229
Query: 141 -GAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLASDAGEPLLIPKVPSF 193
F E + FV KCL+ K P ELL PF + + S
Sbjct: 230 AEKF----SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 10/185 (5%)
Query: 15 TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-IL 73
TR++ + +L+ + YLH VIHRD+K D+I + G+VK+ D G A I
Sbjct: 112 TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQIS 168
Query: 74 RGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
+ S++GTP +MAPE+ Y VDI+S G+ V+EM+ E PY +P Q K
Sbjct: 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMK 227
Query: 133 KVTSGKLPGA--FHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPLLIPK 189
++ P H+I R F+ + L +R A+ELL PFL L+P
Sbjct: 228 RLRDSPPPKLKNAHKISPV-LRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPL 286
Query: 190 VPSFQ 194
+ ++
Sbjct: 287 IQQYR 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 10/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ RK ++ ++ + A QI +G+ YL +HRDL N V VK
Sbjct: 86 GDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK--NFVHRDLAARNCLV-TENLVVK 142
Query: 64 IGDLGLA-AILRGSQHAHSVIG-TPEF-MAPELYEED-YNELVDIYSFGMCVLEMLT-SE 118
I D GL+ I + G P MAPE ++ + D++SFG+ + E+ T E
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 119 YPYSECSNPAQIYKKVTSGK 138
PY SN ++ + + G
Sbjct: 203 QPYPGMSN-EEVLELLEDGY 221
|
Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 13/176 (7%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
L E + + V W Q+L G+ Y+H ++HRDLK NIF+ +L +KIGD
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGD 148
Query: 67 LGLAAILRGS-QHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
G++ +L GS A + GTP +M+PE L + Y+ DI+S G + EM + + E
Sbjct: 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EG 207
Query: 125 SNPAQIYKKVTSG---KLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFL 177
N + ++ G LP + R ++ + + K + S R A E+L +PF+
Sbjct: 208 QNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNK---DPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 44/123 (35%), Positives = 71/123 (57%), Gaps = 6/123 (4%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78
V W QI + YLH + ++HRDLK N+F+ +K+GDLG+A +L
Sbjct: 102 NQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDM 158
Query: 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
A ++IGTP +M+PEL+ + YN D+++ G CV EM T ++ ++ + +Y ++ G
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEG 217
Query: 138 KLP 140
KLP
Sbjct: 218 KLP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 39/141 (27%), Positives = 66/141 (46%), Gaps = 14/141 (9%)
Query: 7 LREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
LR+ R + + + ++ + ++A QI +G+ YL +HRDL N V L
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDL-V 143
Query: 62 VKIGDLGLAAILRGSQHAHSVIGTPE---FMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
VKI D GL+ + + G +MAPE L + + D++SFG+ + E+ T
Sbjct: 144 VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
Query: 117 SEYPYSECSNPAQIYKKVTSG 137
PY SN ++ + + G
Sbjct: 204 GATPYPGLSN-EEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 64/217 (29%), Positives = 82/217 (37%), Gaps = 65/217 (29%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
QILRG+ YLH + VIHRDLK NI VN + +KI D GLA RG
Sbjct: 111 QILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLA---RGVDPDED---EKG 161
Query: 88 FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT-------SEY-------- 119
F+ APE L Y + +DI+S G C+ E+LT +Y
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIV 220
Query: 120 -----PYSE----CSNPA--------QIYKKVT-SGKLPGAFHRIQDAEARRFVGKCLE- 160
P E ++ K S PGA EA + K L
Sbjct: 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-----SPEAIDLLEKMLVF 275
Query: 161 NVSKRLPAKELLLDPFLAS---DAGEPLLIPKVPSFQ 194
+ KR+ A E L P+LA EP+ P
Sbjct: 276 DPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF 312
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 14/121 (11%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+G L K+T +K + +Q+L G+ YLH + ++HRD+K NI +N G +K
Sbjct: 87 TGLLDSPEVKFT---ESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLK 140
Query: 64 IGDLGLAAILRGSQHA---HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTS 117
+ D GLA A + VI T + PEL Y VD++S G C+L E+
Sbjct: 141 LADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFLG 198
Query: 118 E 118
+
Sbjct: 199 K 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S L ++K V+I A+ L+G+AYLH H+ IHRD+K NI + G VK
Sbjct: 102 SDILEVHKKPLQEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVK 155
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
+ D G A+++ A+S +GTP +MAPE+ E Y+ VD++S G+ +E+ +
Sbjct: 156 LADFGSASLV---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENV-SKRLPAKELLLDPFLA 178
P + + +Y + P R FV CL+ + R ++ELL F+
Sbjct: 213 PLFNMNAMSALY-HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
Query: 179 SDAGEPLLI 187
+ ++I
Sbjct: 272 RERPPTVII 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S L ++K V+I AV + A L+G+AYLH H+ +IHRD+K NI ++ G VK
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVK 155
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
+GD G A+I+ A+ +GTP +MAPE+ E Y+ VD++S G+ +E+ +
Sbjct: 156 LGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD 174
P + + +Y + + P R FV CL+ + + P E+LL
Sbjct: 213 PLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 14 YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-I 72
+TR++ + +LR ++YLH VIHRD+K D+I + G++K+ D G A +
Sbjct: 112 HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQV 168
Query: 73 LRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
+ S++GTP +MAPE+ Y VDI+S G+ V+EM+ E PY P Q
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAM 227
Query: 132 KKVTSGKLPGAFHRIQDAEA-----RRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEPL 185
+++ P R++D+ R F+ L S+R A+ELL PFL AG P
Sbjct: 228 RRIRDNLPP----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL-AGPPS 282
Query: 186 LI 187
I
Sbjct: 283 CI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S L ++K V+I A+ + A L+G+AYLH H+ +IHRD+K NI + GQVK
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 161
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
+ D G A+ S A+S +GTP +MAPE+ E Y+ VD++S G+ +E+ +
Sbjct: 162 LADFGSASK---SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAK-ELLLDPFLA 178
P + + +Y + P R FV CL+ + + PA ELL F+
Sbjct: 219 PLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
Query: 179 SDAGEPLLI 187
D +LI
Sbjct: 278 RDRPARVLI 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 8/158 (5%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
R+IL+G+ YLH IHRD+K N+ ++ H G+VK+ D G+A L +Q ++ +GT
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 86 PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P ++ + P
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLE 222
Query: 145 RIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
+ FV CL + S R AKELL F+ A
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 37/115 (32%), Positives = 62/115 (53%), Gaps = 14/115 (12%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
LR+ + VK++ R +L+G+AY+H + ++HRDLK N+ ++ G +KI D
Sbjct: 89 LRDEERPLPE---AQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIAD 142
Query: 67 LGLAAIL---RGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EML 115
GLA + ++H V T + APEL Y+ VD+++ G C+ E+L
Sbjct: 143 FGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVG-CIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 15/189 (7%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S L ++K V+I A+ + A L+G+AYLH H+ +IHRD+K NI + GQVK
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 165
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEY 119
+ D G A+I + A+S +GTP +MAPE+ E Y+ VD++S G+ +E+ +
Sbjct: 166 LADFGSASI---ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFLA 178
P + + +Y + + P R FV CL+ + + P ++ELL F+
Sbjct: 223 PLFNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281
Query: 179 SDAGEPLLI 187
+ E +LI
Sbjct: 282 RERPETVLI 290
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78
+ +W QI +A H HD ++HRD+K NIF+ G +K+GD G+A +L + +
Sbjct: 101 DQILDWFVQIC--LALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVEL 157
Query: 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
A + IGTP +++PE+ E YN DI++ G + EM T ++ + E N + K+ G
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRG 216
Query: 138 KLP 140
P
Sbjct: 217 SYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 45/117 (38%), Positives = 62/117 (52%), Gaps = 6/117 (5%)
Query: 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71
K+ + I +QIL G+ YLH +IHRD+K +NIF+N + QV IGDLG A
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIND-VDQVCIGDLGAAQ 205
Query: 72 ILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNP 127
+ + GT E APE+ D YN DI+S G+ + EML YP + +P
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSQHA 79
K + +++ G+ LH +IHRD+K +N+ + GHL K+ D GL+ R
Sbjct: 99 AKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHL---KLTDFGLS---RNGLEN 150
Query: 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
+GTP+++APE +++ D +S G + E L YP P ++ + S +
Sbjct: 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPPFHAETPDAVFDNILSRR 209
Query: 139 L--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLAS 179
+ P EA + + L + +KRL A E+ PF S
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 47/138 (34%), Positives = 79/138 (57%), Gaps = 9/138 (6%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A +I+ + YLH + +++RDLK +NI ++ G +K+ D G A LR ++ G
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLR--DRTWTLCG 160
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TPE++APE + + +N+ VD ++ G+ + EML P+ + NP IY+K+ +GKL F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EF 217
Query: 144 HRIQDAEARRFVGKCLEN 161
R D A+ + K L
Sbjct: 218 PRHLDLYAKDLIKKLLVV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIG 84
ARQIL GIAYLH ++HRD+K N+ +N VKI D G++ IL + +S +G
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVG 230
Query: 85 TPEFMAPELYEEDYNELV------DIYSFGMCVLEMLTSEYPY--SECSNPAQIYKKVTS 136
T +M+PE D N DI+S G+ +LE +P+ + A + +
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290
Query: 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
+ P A E R F+ CL+ +KR A +LL PF+
Sbjct: 291 SQPPEA-PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336
|
Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 36/179 (20%)
Query: 29 ILRGIAY--LHG-----HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+LR I Y + G + +IHRD+K N+ VNG+ GQVK+ D G++ L S A +
Sbjct: 103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASL-AKT 160
Query: 82 VIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
IG +MAPE + Y D++S G+ +LEM YPY P + Y +
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANI 215
Query: 135 TSG----------KLPGAFHRIQDAEARRFVGKCLENVSKRLPA-KELLLDPFLASDAG 182
+ LP + +A+ FV KCL + R P +LL P+L
Sbjct: 216 FAQLSAIVDGDPPTLPSGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 53/161 (32%), Positives = 87/161 (54%), Gaps = 14/161 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
++IL+G+ YLH IHRD+K N+ ++ G VK+ D G+A L +Q ++ +GT
Sbjct: 108 KEILKGLDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 86 PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY---KKVTSGKLPG 141
P +MAPE+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ K L G
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNNPPTLTG 223
Query: 142 AFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDA 181
F + + F+ CL ++ S R AKELL F+ +A
Sbjct: 224 EFSK----PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVIGT 85
RQ+L + YLH +IHRDLK N+ + G +K+ D G++A ++ Q S IGT
Sbjct: 117 RQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 86 PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
P +MAPE + + Y+ DI+S G+ ++EM E P+ E NP ++ K+ +
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEP 232
Query: 140 PGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
P + E R F+ L+ + R A +LL PF++S
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 58/165 (35%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSQHAHSV 82
+ +QIL G+AYLH + V+HRD+K +N+ + + G +K+ D G A L G HS
Sbjct: 107 YTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 83 I-----GTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136
+ GTP +MAPE+ E Y DI+S G V EM T + P + A ++
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YI 220
Query: 137 GKLPGAFHRIQD---AEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
G G R+ D A A FV CL + +R A +LL FL
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 15/159 (9%)
Query: 33 IAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--HAHSVIGTPEFMA 90
+A H H +I+RD+K +NI ++ G V + D GL+ + A+S GT E+MA
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 91 PELY---EEDYNELVDIYSFGMCVLEMLTSEYPYS---ECSNPAQIYKKVTSGKLPGAFH 144
PE+ +++ VD +S G+ E+LT P++ E ++ ++I +++ K P F
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FP 232
Query: 145 RIQDAEARRFVGKCLE-NVSKRL---PAKELLLDPFLAS 179
+ AEAR F+ K LE + KRL A E+ PF
Sbjct: 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 6/167 (3%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S ++ ++K+ + + V + Q+ + ++H V+HRD+K N+F+ G VK
Sbjct: 90 SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVK 146
Query: 64 IGDLGLAAILRG-SQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
+GDLGL + AHS++GTP +M+PE ++E YN DI+S G + EM + P
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLENVSKRLP 167
Y + N + KK+ P E R+ V C+ ++ P
Sbjct: 207 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 32/202 (15%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L KK + + + A ++ G+ YL+ + ++HRD+K NI VN GQ+K+
Sbjct: 88 GSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY-NVHRIMHRDIKPSNILVNSR-GQIKL 145
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
D G++ L S A + +GT +M+PE + Y D++S G+ ++E+ ++P++
Sbjct: 146 CDFGVSGELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
Query: 124 -------CSNPAQIYK-----------KVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSK 164
+P I ++ S P + R FV CL ++ ++
Sbjct: 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP--------EDLRDFVDACLLKDPTE 256
Query: 165 RLPAKELL-LDPFLASDAGEPL 185
R ++L + PF+ + +
Sbjct: 257 RPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 38/98 (38%), Positives = 58/98 (59%), Gaps = 4/98 (4%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A QI+ G+ H H +++RDLK +N+ ++ H G V+I DLGLA L+G + G
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG 156
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
TP +MAPE L E Y+ VD ++ G + EM+ P+
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 29 ILRGIAYL---HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-VIG 84
I++ + YL HG VIHRD+K NI ++ G VK+ D G++ L S+ A + G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSK-AKTRSAG 176
Query: 85 TPEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
+MAPE + Y+ D++S G+ ++E+ T ++PY C ++ K+ +
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236
Query: 140 PGAFHRIQ-DAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
P + FV CL ++ KR +ELL PF+
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 46/119 (38%), Positives = 62/119 (52%), Gaps = 13/119 (10%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGD 66
+ K + VK+ QIL G+ YLH + V+HRDLK NI V G G VKIGD
Sbjct: 98 RQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGD 155
Query: 67 LGLAAI----LRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
LGLA + L+ V+ T + APEL Y + +DI++ G C+ E+LT E
Sbjct: 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 39/111 (35%), Positives = 65/111 (58%), Gaps = 5/111 (4%)
Query: 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LR 74
R D + +A +I+ G+ +LH +I+RDLK DN+ ++ G +KI D G+ +
Sbjct: 92 RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMN 148
Query: 75 GSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
G A + GTP+++APE+ + + YNE VD +SFG+ + EML + P+
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A +I+ G+ +LH +I+RDLK DN+ ++ G +KI D G+ + G +
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP+++APE L + Y VD ++ G+ + EML + P+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHAHSVI 83
+A ++ G+ YLH + +++RDLK DN+ ++ G VKI D GL G +
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
GTPEF+APE L E Y VD + G+ + EML E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 41/117 (35%), Positives = 68/117 (58%), Gaps = 5/117 (4%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSVI 83
W QI G+ H HD ++HRD+K NIF++ + K+GD G+A L S + A++ +
Sbjct: 106 WFVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV 163
Query: 84 GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
GTP +++PE+ + YN DI+S G + E+ T ++P+ E +N Q+ K+ G
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYF 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 38/99 (38%), Positives = 60/99 (60%), Gaps = 5/99 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHAHSVI 83
+ QI+ G+ +LH +I+RDLK +N+ ++ G V+I DLGLA L+ G
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYA 158
Query: 84 GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP FMAPEL + E+Y+ VD ++ G+ + EM+ + P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 44/146 (30%), Positives = 81/146 (55%), Gaps = 10/146 (6%)
Query: 23 KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82
K + +++ YLH D +I+RDLK +N+ ++ G VK+ D G A + ++
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAK--KVPDRTFTL 175
Query: 83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
GTPE++APE+ + + + + VD ++ G+ + E + P+ + + P +IY+K+ +G+L
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGRL-- 232
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRL 166
F D AR V L+ + +KRL
Sbjct: 233 KFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
R+IL+G+ YLH IHRD+K N+ ++ G VK+ D G+A L +Q ++ +GT
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 86 PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ + P
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLE 222
Query: 145 RIQDAEARRFVGKCLENVSKRLP-AKELLLDPFL 177
+ FV CL + P AKELL F+
Sbjct: 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 6/159 (3%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
S ++ ++K+ + R V + Q+ + ++H V+HRD+K N+F+ G VK
Sbjct: 90 SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVK 146
Query: 64 IGDLGLAAILRG-SQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
+GDLGL + AHS++GTP +M+PE ++E YN DI+S G + EM + P
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159
Y + N + +K+ P + R V C+
Sbjct: 207 YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+K++ Q+L+G+A+ H H ++HRDLK +N+ +N G +K+ D GLA ++
Sbjct: 100 IKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYT 156
Query: 82 -VIGTPEFMAPELYEED--YNELVDIYSFGMCVL-EMLT 116
+ T + APEL D Y+ VDI+S G C+ E+L+
Sbjct: 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH--- 78
+K++ LRG+ YLH + ++HRDLK +N+ + G +K+ D GLA GS +
Sbjct: 104 IKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSF-GSPNRKM 159
Query: 79 AHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPY 121
H V+ T + APEL Y VD++S G C+ L P+
Sbjct: 160 THQVV-TRWYRAPELLFGARHYGVGVDMWSVG-CIFAELLLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 17/142 (11%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEED 97
H+ IHRDLK +N F+ G +K+ D GL+ +A+SV+G+P++MAPE L +
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 98 YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY------KKV---TSGKLPGAFHRIQD 148
Y+ VD +S G + E L P+S S P + + K+ P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSD-- 231
Query: 149 AEARRFVGKCLENVSKRLPAKE 170
EA + K + + S+R + E
Sbjct: 232 -EAWDLITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 54/191 (28%), Positives = 80/191 (41%), Gaps = 48/191 (25%)
Query: 29 ILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
+LRG+ YL H ++HRD+K NI VN G++K+ D G++ L S A+S +GT
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRS 163
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP---------------YSECSNPAQIY 131
+M+PE L Y DI+S G+ ++EM YP + +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 132 KKVTSG-----------------------KLPGAFHRIQDAEARRFVGKCL-ENVSKRLP 167
+ V+ KLP E + FV KCL +N +R
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERAD 280
Query: 168 AKELLLDPFLA 178
KEL PF+
Sbjct: 281 LKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 56/185 (30%), Positives = 75/185 (40%), Gaps = 31/185 (16%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79
+K+ RQ+LRG+ +LH H ++HRDLK NI V GQVKI D GLA I
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMAL 163
Query: 80 HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP----YSECSNPAQIYKK- 133
SV+ T + APE L + Y VD++S G C+ L P SE +I+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVI 222
Query: 134 ---------VTSGKLPGAFHRIQ-----------DAEARRFVGKCLE-NVSKRLPAKELL 172
+F E + K L N KR+ A E L
Sbjct: 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282
Query: 173 LDPFL 177
P+
Sbjct: 283 QHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76
+D V+ + QILRGI + H H+ +IHRD+K +NI V+ G VK+ D G A L
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP 153
Query: 77 QHAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
++ + T + APEL D Y VDI++ G V EMLT E + S+ Q+Y
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213
Query: 134 VT-----SGKLPGAFHRIQDAEARRFVG------KCLENVSKRLP 167
+ + F + F G K +E + KR P
Sbjct: 214 IKCLGNLIPRHQEIFQK-----NPLFAGMRLPEVKEIEPLEKRFP 253
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 35/202 (17%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
L E K V +K Q L+ + + H H+ IHRD+K +NI + GQ+K+ D
Sbjct: 87 LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCD 143
Query: 67 LGLAAILRGSQHAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
G A IL G ++ + T + APEL D Y VD+++ G E+LT + +
Sbjct: 144 FGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203
Query: 124 CSNPAQIYK-KVTSGKL----------PGAFHRIQDAEARR-----------------FV 155
S+ Q+Y + T G L F + E F+
Sbjct: 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFL 263
Query: 156 GKCLE-NVSKRLPAKELLLDPF 176
CL+ + ++RL +ELL P+
Sbjct: 264 KGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 24/185 (12%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L YRK V R A +++G+ YL ++HRD+K N+ VN GQVK+
Sbjct: 84 GSLDVYRKIPEHVLGRI----AVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKL 136
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-- 121
D G++ L S A + +GT +MAPE + E Y D++S G+ +E+ +PY
Sbjct: 137 CDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195
Query: 122 ---SECS-NPAQIYKKVTSGKLPGAFHRIQDAEAR----RFVGKCLENVSKRLPAKELLL 173
++ S P Q+ + + P + + F+ +C+ K PA E L+
Sbjct: 196 IQKNQGSLMPLQLLQCIVDEDPP----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
Query: 174 D-PFL 177
D PF+
Sbjct: 252 DHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 38/104 (36%), Positives = 61/104 (58%), Gaps = 5/104 (4%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSV 82
W Q+ G+ H H+ V+HRD+K NIF+ + G+VK+GD G A +L +A +
Sbjct: 104 QWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTY 160
Query: 83 IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS 125
+GTP ++ PE++E YN DI+S G + E+ T ++P+ S
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 70/214 (32%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 33 IAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSQHAHSVIGTPEFMA 90
+A H H +I+RDLK +NI ++ G VK+ D GL +I G+ H+ GT E+MA
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV-THTFCGTIEYMA 168
Query: 91 PE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149
PE L + + VD +S G + +MLT P++ N + K+ GKL
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKL--NLPPYLTP 225
Query: 150 EARRFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEPLLIPKV-PSFQNLNPNGAV 202
EAR + K L+ N S RL A E+ PF + LL KV P F+ P
Sbjct: 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK---PLLQS 282
Query: 203 TELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
E V QF R+ D T++ + IFL
Sbjct: 283 EEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFL 316
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 38/103 (36%), Positives = 59/103 (57%), Gaps = 12/103 (11%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GS--Q 77
VK Q+L G+A+LH D ++HRDLK N+ +N + G +KI D GLA R GS +
Sbjct: 108 VKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLK 161
Query: 78 HAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
++ T + APEL ++Y+ +D++S G E+LT +
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
++ +K+ R+ + + A +L+G++YLH +IHRD+K NI + GQVK+
Sbjct: 91 IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRK-GQVKLC 147
Query: 66 DLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY--- 121
D G++ L S A + GT +MAPE + + Y+ D++S G+ +LE+ + +P+
Sbjct: 148 DFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
Query: 122 -SECSNPAQIYKKVTSGKLPGAFHRIQDAEA---------RRFVGKCLENVSKRLPA-KE 170
P ++ + + P ++D + F+ +CLE R P +
Sbjct: 207 GEPPLGPIELLSYIVNMPNP----ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262
Query: 171 LLLDPFL 177
+L P++
Sbjct: 263 MLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHAHSVIGT 85
R+ILRG+++LH H VIHRD+K N+ + + +VK+ D G++A L R ++ IGT
Sbjct: 118 REILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 86 PEFMAPELYEED------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
P +MAPE+ D Y+ D++S G+ +EM P + +P + +
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 233
Query: 140 PGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
P + + + F+ CL +N S+R ++L+ PF+
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 6 TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
TL E + + AV+++ Q+L+ IAY H H+ +IHRD+K +NI V+ G +K+
Sbjct: 85 TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKL 141
Query: 65 GDLGLAAILRGSQHAH--SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYP 120
D G A LR + + T + APEL D Y + VD+++ G + E+L E
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201
Query: 121 YSECSNPAQIYK-KVTSGKLPGA----------FHRIQ-------DAEARR--------- 153
+ S+ Q+Y + G LP + F + ++ RR
Sbjct: 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA 261
Query: 154 --FVGKCLE-NVSKRLPAKELLLDPFL 177
F+ CL + +RL ELL P+
Sbjct: 262 LDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHAHSVIGT 85
R+ILRG+A+LH H VIHRD+K N+ + + +VK+ D G++A L R ++ IGT
Sbjct: 128 REILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 86 PEFMAPELYEED------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
P +MAPE+ D Y+ DI+S G+ +EM P + +P + +
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPP 243
Query: 140 PGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
P + + F+ CL +N R ++LL PF+
Sbjct: 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+++ QIL+G+A++H H HRDLK +N+ V+G VKI D GLA +R
Sbjct: 101 IRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTD 157
Query: 82 VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT 116
+ T + APE L Y+ VDI++ G C++ E+ T
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R + + + NW QI +G++YL ++HRDL N+ V VK
Sbjct: 93 GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVK 149
Query: 64 IGDLGLAAIL-RGSQHAHSVIG-TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
I D GLA +L + H+ G P ++MA E + Y D++S+G+ V E++T
Sbjct: 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 45/158 (28%), Positives = 84/158 (53%), Gaps = 24/158 (15%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPP----VIHRDLKCDNIFVNG- 57
S +++ K + +++ A+ + RQ+L +AY H D P V+HRDLK NIF++
Sbjct: 102 SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161
Query: 58 --HLGQV-------------KIGDLGLAAILRGSQHAHSVIGTPEFMAPELY---EEDYN 99
H+G++ KIGD GL+ + AHS +GTP + +PEL + Y+
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221
Query: 100 ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
+ D+++ G + E+ + + P+ + +N +Q+ ++ G
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/195 (23%), Positives = 75/195 (38%), Gaps = 50/195 (25%)
Query: 24 NWAR----QILRGIAYLH--GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS- 76
AR +++ + +H G IHRD+K DNI ++ G +K+ D GL + +
Sbjct: 101 ETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155
Query: 77 -----------------------------QHAHSVIGTPEFMAPE-LYEEDYNELVDIYS 106
A+S +GTP+++APE L Y D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLENV 162
G+ + EML P+ + Y K+ + K P EA + + L +
Sbjct: 216 LGVILYEMLYGFPPFYS-DTLQETYNKIINWKESLRFP--PDPPVSPEAIDLICRLLCDP 272
Query: 163 SKRL-PAKELLLDPF 176
RL +E+ PF
Sbjct: 273 EDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 44/203 (21%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV----- 82
Q+LRG+ Y+H + VIHRDLK N+ VN +++IGD G+A L S H
Sbjct: 115 QLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 83 IGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE--YPYSECSN----------- 126
+ T + APEL +Y +D++S G C+ EML +P +
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 127 -PAQIYKKVTS-----------GKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKE 170
++ ++ S K P + +I EA + + L+ + +R+ ++
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 171 LLLDPFLA---SDAGEPLLIPKV 190
L PFLA EP P
Sbjct: 291 ALQHPFLAQYHDPDDEPTCPPPF 313
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 56/189 (29%), Positives = 80/189 (42%), Gaps = 48/189 (25%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS----VI 83
QILRG+ Y+H +IHRDLK NI VN ++KI D GLA +H +
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA------RHTDDEMTGYV 176
Query: 84 GTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTS--GK 138
T + APE L YN+ VDI+S G C++ E+LT + S+ K++ + G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGK-TLFPGSDHIDQLKRIMNLVGT 234
Query: 139 LPGAF-HRIQDAEARRFV--------------------------GKCLE-NVSKRLPAKE 170
+I AR ++ K L + KR+ A E
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294
Query: 171 LLLDPFLAS 179
L P+LA
Sbjct: 295 ALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILR 74
+ D+ +A +I+ G+ +LH +++RDLK DNI ++ G +KI D G+ +
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENML 148
Query: 75 GSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
G + GTP+++APE L + YN VD +SFG+ + EML + P+
Sbjct: 149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LR 74
R D+ +A +I+ G+ +LH +I+RDLK DN+ ++ G +KI D G+ +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVF 148
Query: 75 GSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
G A + GTP+++APE+ + Y VD +SFG+ + EML + P+
Sbjct: 149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 7/113 (6%)
Query: 8 REYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDL 67
R + + +K++ Q+L+G+A+ H H V+HRDLK N+ V+ G +KI DL
Sbjct: 98 SNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155
Query: 68 GL--AAILRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
GL A + + H ++ T + APE L Y+ VDI+S G EM
Sbjct: 156 GLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 17/216 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + +K R K + +++ + +LH +D +++RDLK +NI ++ G + +
Sbjct: 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIAL 137
Query: 65 GDLGLA-AILRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYP- 120
D GL+ A L ++ ++ GT E++APE L E+ Y + VD +S G+ V EM P
Sbjct: 138 CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL----PAKELLLDP 175
Y+E + Q+Y+ + GK+ + + D E R+FV L N RL A EL P
Sbjct: 198 YAE--DTQQMYRNIAFGKVRFPKNVLSD-EGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254
Query: 176 FLASDAGEPLLIPKV-PSFQ-NLNPNGAVTELVPQF 209
F A + L ++ P F+ ++ + V+ P+F
Sbjct: 255 FFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEF 290
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/199 (27%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + ++ R D+ + + ++L + LH + VI+RDLK +NI ++ + G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 65 GDLGLAAI-LRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
D GL + ++ ++ GTPE++APEL Y + VD ++ G+ + EMLT P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 123 ECSNPAQIYKKVTSGKL--PGAFHRIQDAEARR-FVGKCLENVSKRL---PAKELLLDPF 176
+ N ++Y+K+ L P F D +A+ +G + ++RL A+E+ PF
Sbjct: 195 D-ENVNEMYRKILQEPLRFPDGF----DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249
Query: 177 LASDAGEPLLIPKV-PSFQ 194
+ + + LL+ + P F+
Sbjct: 250 FSQLSWKKLLMKGIQPPFK 268
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 18/172 (10%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + +K R D + +A +I + +LH D +I+RDLK DN+ ++ H G K+
Sbjct: 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLD-HEGHCKL 137
Query: 65 GDLGLA--AILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
D G+ I G + + GTP+++APE L E Y VD ++ G+ + EML P+
Sbjct: 138 ADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
Query: 122 SECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLENVSKRLPAKEL 171
E N +++ + + ++ P QDA L+ + P L
Sbjct: 197 -EAENEDDLFEAILNDEVVYPTWLS--QDAVD------ILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 30/230 (13%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A +I + YLH + +I+RDLK +NI ++ G V + D GL + S+ +
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-------T 135
GTPE++APE L ++ Y+ VD + G + EML P+ + A++Y +
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLK 216
Query: 136 SGKLPGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD----PFLASDAGEPLLIPKVP 191
A H ++ G ++ +KRL AK+ L+ F +S + L+ K+
Sbjct: 217 PNISVSARHLLE--------GLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKIT 268
Query: 192 SFQNLNPNGA--VTELVPQF---AVDSDRRKSTDMTITGTMNPEDDTIFL 236
N N +G + P+F V + KS D + E D FL
Sbjct: 269 PPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFL 318
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + KK ++ VK RQ++ + LH H+ +IH D+K +N+ + ++ +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY-- 121
D GL I G+ + GT ++ +PE + +Y+ D ++ G+ E+LT ++P+
Sbjct: 152 CDYGLCKI-IGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
Query: 122 --SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
E + + K KLP F + A FV L+ N++ RL
Sbjct: 209 DEDEELDLESL-LKRQQKKLP--FIKNVSKNANDFVQSMLKYNINYRL 253
|
Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSVIGT 85
R+ L+G+AYLH +HRD+K NI + + G VK+ D G+AA + + S IGT
Sbjct: 113 RETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 86 PEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYP 120
P +MAPE+ + YN+L DI++ G+ +E+ + P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 37 HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGTPEFMAPEL-- 93
H H+ +IHRD+K +NI + G VK+ D G++A L ++ ++ +GTP +MAPE+
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 94 ----YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149
Y+ Y+ D++S G+ +E+ + P + +P + K+ P H +
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRNPPPTLLHPEKWC 260
Query: 150 EA-RRFVGKCL-ENVSKRLPAKELLLDPFL 177
+ F+ +CL ++ R LL PF+
Sbjct: 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 43/117 (36%), Positives = 62/117 (52%), Gaps = 18/117 (15%)
Query: 12 KKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
KKY T +D +K++ Q+L+GIAY H H V+HRDLK N+ ++ G +K+
Sbjct: 85 KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLA 141
Query: 66 DLGLAAI----LRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
D GLA +R + H V+ T + APE L Y+ VDI+S G EM+
Sbjct: 142 DFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 35/108 (32%), Positives = 61/108 (56%), Gaps = 4/108 (3%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76
+++ V +++ QI GI LH H +++RD+K +N+ ++ G ++ DLGLA L+
Sbjct: 92 LEMERVIHYSAQITCGI--LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDG 148
Query: 77 QHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
+ GT +MAPE L EE Y+ VD ++ G + EM+ P+ +
Sbjct: 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+ + Q+LRG+ Y+H + V+HRDLK N+F+N +KIGD GLA I+ ++H
Sbjct: 116 ARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHK 172
Query: 82 -----VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
+ T + +P L +Y + +D+++ G EMLT
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 43/128 (33%), Positives = 58/128 (45%), Gaps = 22/128 (17%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
SG L K T I K + Q+L GI YLH + ++HRD+K NI ++ G +K
Sbjct: 102 SGLLENPSVKLTESQI---KCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQ-GILK 155
Query: 64 IGDLGLAAILRGS----QHAH--------SVIGTPEFMAPELY--EEDYNELVDIYSFGM 109
I D GLA G + +++ T + PEL E Y VDI+ G
Sbjct: 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG- 214
Query: 110 CVL-EMLT 116
CV EM T
Sbjct: 215 CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 40/117 (34%), Positives = 66/117 (56%), Gaps = 4/117 (3%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + K+ R+ + + +LRG+AYL ++HRD+K NI VN G++K+
Sbjct: 88 GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSR-GEIKL 145
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
D G++ L S A+S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 146 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 13/144 (9%)
Query: 4 SGTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
SG+L+EY + +++++ +A QI +G+ YL +HRDL N+ V QV
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQV 148
Query: 63 KIGDLGLAAILRGSQHAHSV---IGTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
KIGD GL + + ++V + +P F APE L + + D++SFG+ + E+LT
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT- 207
Query: 118 EYPYSECSNPAQIYKKV--TSGKL 139
Y SE S K + T G++
Sbjct: 208 -YCDSESSPMTLFLKMIGPTHGQM 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 12/101 (11%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI----LRGSQ 77
+K++ Q+L+G+A+ H H V+HRDLK N+ +N G +K+ D GLA +R
Sbjct: 102 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVR--T 156
Query: 78 HAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
+ H V+ T + APE L + Y+ VDI+S G EM+T
Sbjct: 157 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 40/100 (40%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76
V +K+ Q+LRG+ +LH H V+HRDLK NI V GQ+K+ D GLA I
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQ 163
Query: 77 QHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
SV+ T + APE L + Y VD++S G EM
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA---HSV 82
ARQ+L I Y+HG +IHRD+K +N+ VNG + +GD G A RGS + +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGI 322
Query: 83 IGTPEFMAPELYEED-YNELVDIYSFGMCVLE 113
GT + APE+ D Y VDI+S G+ + E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 33/170 (19%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSVIG 84
+R+ L+G+ YLH +HRD+K NI + + G VK+ D G++A + + S IG
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIG 168
Query: 85 TPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECS-------------NP 127
TP +MAPE+ + YN+L DI++ G+ +E+ + P + P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
Query: 128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPF 176
++ K+ K +FH FV L +N KR A++LL PF
Sbjct: 229 PKLKDKM---KWSNSFH--------HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+K+ RQ LRG+ +LH + ++HRDLK +NI V GQVK+ D GLA I
Sbjct: 110 IKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTP 166
Query: 82 VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
V+ T + APE L + Y VD++S G EM
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 14/117 (11%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLAAILRGSQHA------ 79
Q+L +A H+ ++HRDLK NI V+ G K+ D G+ +L G + A
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 80 --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133
V+GTP + APE L E D+Y++G+ LE LT + + ++ A+I +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 21 AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80
VK Q+LRG+ YLH + +IHRDLK N+ + G +KI D GLA A
Sbjct: 109 QVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAK 163
Query: 81 SVIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
+ TP+ + APEL Y +D+++ G C+L E+L +
Sbjct: 164 PM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 11/133 (8%)
Query: 4 SGTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
SG+LR+Y ++ +++++ + ++ QI +G+ YL IHRDL NI V V
Sbjct: 92 SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVE-SEDLV 148
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
KI D GLA +L + + V E APE L ++ D++SFG+ + E+ T
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT- 207
Query: 118 EYPYSECSNPAQI 130
Y S PA+
Sbjct: 208 -YGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 41/119 (34%), Positives = 61/119 (51%), Gaps = 7/119 (5%)
Query: 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI--LRG 75
+ R +K + QILRGIAY H H V+HRDLK N+ ++ +K+ D GLA +
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157
Query: 76 SQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132
H V+ T + APE L Y+ VDI+S G EM+ + + S +++K
Sbjct: 158 RTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 53/183 (28%), Positives = 94/183 (51%), Gaps = 21/183 (11%)
Query: 33 IAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA--ILRGSQHAHSVIGTPEFMA 90
+A H H +I+RD+K +NI ++ + G V + D GL+ + A+S GT E+MA
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 91 PELY---EEDYNELVDIYSFGMCVLEMLTSEYPYS---ECSNPAQIYKKVTSGKLPGAFH 144
P++ + +++ VD +S G+ + E+LT P++ E ++ A+I +++ + P +
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YP 232
Query: 145 RIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVTE 204
+ A A+ + + L + P K L P SDA E I K P FQ +N + +
Sbjct: 233 QEMSALAKDIIQRLL----MKDPKKRLGCGP---SDADE---IKKHPFFQKINWDDLAAK 282
Query: 205 LVP 207
VP
Sbjct: 283 KVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIF-VNGHLGQVK 63
G L +Y KK + + +K A Q+ G+AYL +HRDL N+ VN H Q K
Sbjct: 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRH--QAK 135
Query: 64 IGDLGLAAILR-GSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
I D G++ L GS + + P ++ APE + ++ D++S+G+ + E +
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG 195
Query: 118 EYPYSECSNPAQIYKKVTSGK 138
PY E ++ + SG+
Sbjct: 196 AKPYGEMKGA-EVIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 42/111 (37%), Positives = 59/111 (53%), Gaps = 9/111 (8%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70
++ DI A++ R +LR I YLH + +IHRD+K +NIF+N H G V +GD G A
Sbjct: 176 KRNIAICDILAIE---RSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAA 229
Query: 71 A--ILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSE 118
+ + + GT APEL D Y VDI+S G+ + EM T
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 41/132 (31%), Positives = 65/132 (49%), Gaps = 9/132 (6%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
QILRG+ Y+H D +IHRDLK N+ VN ++KI D GLA + T
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 88 FMAPELYEE--DYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
+ APE+ YN+ VDI+S G + E+LT +P ++ + ++ ++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242
Query: 144 HRIQDAEARRFV 155
+I AR ++
Sbjct: 243 KKISSESARNYI 254
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 39/117 (33%), Positives = 66/117 (56%), Gaps = 4/117 (3%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + KK R+ + + + +++G+ YL ++HRD+K NI VN G++K+
Sbjct: 88 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKL 145
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
D G++ L S A+S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 146 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75
++ + ++ + QILRG+ Y+H V+HRDLK NI +N + +KI D GLA I
Sbjct: 104 PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENC-DLKICDFGLARI--Q 158
Query: 76 SQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSE 118
+ T + APE L + Y+ VDI+S G EML +
Sbjct: 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 39/114 (34%), Positives = 56/114 (49%), Gaps = 23/114 (20%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--------------AIL 73
+I I Y+H V+HRDLK DNI + G G+V I D G A
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 74 RGSQHAH-----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
R ++ ++GTP++MAPE L +E DIY+ G+ + +MLT +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 49/133 (36%), Positives = 72/133 (54%), Gaps = 15/133 (11%)
Query: 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+LR+Y +K+ R+D R + +A QI +G+ YL +HRDL NI V +V
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRV 147
Query: 63 KIGDLGLAAILRGSQHAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
KIGD GL +L + + V +P F APE L E ++ D++SFG+ + E+ T
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT- 206
Query: 118 EYPYSE--CSNPA 128
YS+ CS PA
Sbjct: 207 ---YSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 8/113 (7%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSQHAHSV 82
+A ++ + +LH H VI+RDLK DNI ++ G K+ D G+ IL G +
Sbjct: 101 YAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVT-TTTF 156
Query: 83 IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV 134
GTP+++APE L E +Y VD ++ G+ + EM+ + P+ E N +++ +
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+ +I+ + YLH + V++RDLK +N+ ++ G +KI D GL ++ +
Sbjct: 100 YGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
GTPE++APE+ E+ DY VD + G+ + EM+ P+ + ++++ + ++
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--R 214
Query: 143 FHRIQDAEARRFVGKCL-ENVSKRL-----PAKELLLDPFLASDAGEPLLIPK-VPSFQN 195
F R EA+ + L ++ +RL AKE++ F A + + K VP F+
Sbjct: 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFK- 273
Query: 196 LNPNGAVTELVPQFAVDSDRR----KSTDMTITGTMNPEDDT 233
PQ ++D R + T IT T +DD+
Sbjct: 274 -----------PQVTSETDTRYFDEEFTAQMITITPPDQDDS 304
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 37/101 (36%), Positives = 58/101 (57%), Gaps = 11/101 (10%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---H 78
+K++ +Q+L G+ Y H +HRD+KC NI +N GQ+K+ D GLA + + +
Sbjct: 118 IKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPY 174
Query: 79 AHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
+ VI T + PEL EE Y +D++S G C+L E+ T
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 37 HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSQHAHSVIGTPEFMAPELY- 94
H H +I+RDLK +NI ++ G +K+ D GL+ + + A+S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 95 EEDYNELVDIYSFGMCVLEMLTSEYPY 121
+ + D +SFG+ + EMLT P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI--LRGSQHA 79
VK + QILRG+ YLH ++HRD+K N+ VN + +KI D GLA + S+H
Sbjct: 105 VKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHM 161
Query: 80 HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEML 115
+ T + APE+ Y VDI+S G E+L
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 39/97 (40%), Positives = 57/97 (58%), Gaps = 13/97 (13%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS-----V 82
QILRG+ Y+H + V+HRDLK N+ +N + +KI D GLA I +H H+
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIA-DPEHDHTGFLTEY 169
Query: 83 IGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT 116
+ T + APE L + Y + +DI+S G C+L EML+
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 31/200 (15%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSQHAHSVIGT 85
+I+ + YLH D V++RDLK +N+ ++ G +KI D GL I G+ + GT
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGAT-MKTFCGT 158
Query: 86 PEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGAF 143
PE++APE+ E+ DY VD + G+ + EM+ P Y++ ++++ + ++ F
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEI--RF 214
Query: 144 HRIQDAEARRFV-GKCLENVSKRL-----PAKELLLDPFLASDAGEPLLIPKV-PSFQNL 196
R EA+ + G ++ +RL AKE++ F AS + ++ K+ P F+
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFK-- 272
Query: 197 NPNGAVTELVPQFAVDSDRR 216
PQ ++D R
Sbjct: 273 ----------PQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A +I G+ +LH +I+RDLK DN+ ++ G +KI D G+ + G + +
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162
Query: 84 GTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP+++APE Y+ Y + VD ++FG+ + EML + P+
Sbjct: 163 GTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSQHAHSV 82
+ +I+ + YLH D V++RD+K +N+ ++ G +KI D GL I G+ +
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGAT-MKTF 155
Query: 83 IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPY 121
GTPE++APE+ E+ DY VD + G+ + EM+ P+
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A +I G+ LH +++RDLK +NI ++ + G ++I DLGLA + + +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVG 163
Query: 85 TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
T +MAPE+ + E Y D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 56/212 (26%), Positives = 82/212 (38%), Gaps = 60/212 (28%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV----- 82
Q+L+ + Y+H + VIHRDLK NI +N +VK+ D GLA L +
Sbjct: 115 QLLKALKYIHSGN--VIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTD 171
Query: 83 -IGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT---------------------- 116
+ T + APE L Y + VD++S G C+L EML
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230
Query: 117 -----------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSK 164
S + + + +K LP A +A + K L N +K
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-----SDDALDLLKKLLVFNPNK 285
Query: 165 RLPAKELLLDPFLA--------SDAGEPLLIP 188
RL A+E L P++A P+ IP
Sbjct: 286 RLTAEEALEHPYVAQFHNPSDEPVLPYPITIP 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A +I G+ LH +++RDLK +NI ++ H G ++I DLGLA + Q +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 85 TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
T +MAPE+ + E Y D ++ G + EM+ + P+ Q KK
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKK---------- 206
Query: 144 HRIQDAEARRFVGKCLENVSKRL-PAKELLLDPFLASDAGEPL 185
+I+ E R V + E S++ P L L D E L
Sbjct: 207 -KIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 34/96 (35%), Positives = 58/96 (60%), Gaps = 6/96 (6%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA--HSVIG 84
+Q+L + Y+H D +IHRD+K +NIF+N G++ +GD G A + A + +G
Sbjct: 274 KQLLCAVEYIH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 85 TPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEY 119
T +PE+ D Y E+ DI+S G+ +L+ML+ ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 2 FTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
+ L++Y + +D VK++ Q+L+GIA+ H + V+HRDLK N+ +N
Sbjct: 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR 136
Query: 59 LGQVKIGDLGLA-AILRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
G++K+ D GLA A + + T + AP+ L Y+ +DI+S G + EM+
Sbjct: 137 -GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
Query: 116 T 116
T
Sbjct: 196 T 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/187 (29%), Positives = 83/187 (44%), Gaps = 25/187 (13%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L+G+ Y+H +IHRDLK N+ VN ++KI D GLA + V T
Sbjct: 126 QMLKGLKYIHAAG--IIHRDLKPGNLAVNEDC-ELKILDFGLARQTDSEMTGYVV--TRW 180
Query: 88 FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--KVTSGKLPGAF 143
+ APE L Y + VDI+S G + EMLT + + + Q+ + KVT G F
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT-GTPSKEF 239
Query: 144 -HRIQDAEARRFV-----------GKCLENVSK---RLPAKELLLDPFLASDAGEPLLIP 188
++Q +A+ +V L N + + K L+LD A E L P
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299
Query: 189 KVPSFQN 195
F +
Sbjct: 300 YFEEFHD 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 37 HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGTPEFMAPEL-- 93
H H IHRD+K +NI + G VK+ D G++A L ++ ++ +GTP +MAPE+
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 94 ----YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQ 147
+ Y+ D++S G+ +E+ + P ++ +P + K+ P H+ +
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNP-PPTLHQPELW 255
Query: 148 DAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
E F+ KCL ++ KR +LL F+
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/124 (33%), Positives = 58/124 (46%), Gaps = 17/124 (13%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-------RGS 76
A +I G+AYL +HRDL N V L VKIGD G+ + +G
Sbjct: 123 QMAAEIADGMAYL--AAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGG 179
Query: 77 QHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKV 134
+ V +MAPE L + + D++SFG+ + EM T +E PY SN ++ K V
Sbjct: 180 KGLLPV----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFV 234
Query: 135 TSGK 138
G
Sbjct: 235 IDGG 238
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/109 (35%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQHAHSVIGTP 86
Q+LRG+AY+HG ++HRDLK N+ ++ +LG++K+ D GLA A SQ S + T
Sbjct: 111 QLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTL 167
Query: 87 EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN-PAQIYK 132
+ P+ L DY+ +DI+ G +EML + + S+ Q+ K
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 36/125 (28%), Positives = 67/125 (53%), Gaps = 6/125 (4%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ G L + ++ + ++ +A +I+ G+ H H+ V++RDLK NI ++ H G
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLDEH-G 134
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSE 118
V+I DLGLA + H+ +GT +MAPE+ ++ Y+ D +S G + ++L
Sbjct: 135 HVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
Query: 119 YPYSE 123
P+ +
Sbjct: 194 SPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q++ + YLH + ++HRDL +NI + G +V I D GLA + SV+GT
Sbjct: 121 QMVLALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 88 FMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
+ PE+ + E Y E D+++FG + +M T + P+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPEL----YEEDY 98
+IHRD+K NI ++ + G +K+ D G++ L S G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 99 NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---KLPGAFHRIQDAEARRFV 155
+ D++S G+ + E+ T ++PY + ++ +V G L + R F+
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 156 GKCL-ENVSKRLPAKELLLDPF 176
CL ++ SKR KELL PF
Sbjct: 248 NLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 50/132 (37%), Positives = 66/132 (50%), Gaps = 19/132 (14%)
Query: 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQVKIGDLG 68
KK ++ VK+ QIL GI YLH + V+HRDLK NI V G G+VKI D+G
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 69 LAAI----LRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
A + L+ V+ T + APEL Y + +DI++ G E+LTSE P
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 216
Query: 123 EC-------SNP 127
C SNP
Sbjct: 217 HCRQEDIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 6/104 (5%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
++ +A +I+ G+ H H+ V++RDLK NI ++ H G V+I DLGLA + H+
Sbjct: 99 MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF-SKKKPHA 154
Query: 82 VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
+GT +MAPE+ ++ Y+ D +S G + ++L P+ +
Sbjct: 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 50/132 (37%), Positives = 66/132 (50%), Gaps = 19/132 (14%)
Query: 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQVKIGDLG 68
KK ++ VK+ QIL GI YLH + V+HRDLK NI V G G+VKI D+G
Sbjct: 100 KKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 69 LAAI----LRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
A + L+ V+ T + APEL Y + +DI++ G E+LTSE P
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF 216
Query: 123 EC-------SNP 127
C SNP
Sbjct: 217 HCRQEDIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+ +I+ + YLH +++RDLK +N+ ++ G +KI D GL + + +
Sbjct: 100 YGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156
Query: 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
GTPE++APE+ E+ DY VD + G+ + EM+ P+ + ++++ + +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--K 213
Query: 143 FHRIQDAEARRFV-GKCLENVSKRL-----PAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
F R A+A+ + G +++ +KRL AKE++ F ++Q++
Sbjct: 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG-----------VNWQDV 262
Query: 197 NPNGAVTELVPQFAVDSDRR------KSTDMTITGTMNPEDD 232
V PQ ++D R + +TIT ++D
Sbjct: 263 YDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDED 304
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 41/138 (29%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---------------------- 76
H IHRD+K DN+ ++ G VK+ D GL L+ +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 77 --------------QHAHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPY 121
Q A+S +GTP+++APE++ + YN+L D +S G+ + EML P+
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 122 SECS-NPAQIYKKVTSGK 138
CS P + Y+KV + K
Sbjct: 237 --CSETPQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 7/100 (7%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA--ILRGSQHAHSV 82
+A +I G+ +LH +I+RDLK DN+ ++ G +KI D G+ + G +
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT-TKTF 161
Query: 83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP+++APE+ + Y + VD ++FG+ + EML + P+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 15/145 (10%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L EY + + + + A Q+ G+AYL + IHRDL N+ V +
Sbjct: 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NIC 142
Query: 63 KIGDLGLAAILRGSQH-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
K+ D GLA +++ + A P ++ APE YN D++SFG+ + E++T
Sbjct: 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTY 200
Query: 117 SEYPYSECSNPAQIYKKVTSG-KLP 140
PY +N A++ ++V G ++P
Sbjct: 201 GRMPYPGMTN-AEVLQQVDQGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 42/138 (30%), Positives = 63/138 (45%), Gaps = 41/138 (29%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---------------------- 76
H IHRD+K DN+ ++ G VK+ D GL L+ +
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 77 --------------QHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
Q A S +GTP+++APE++ + YN+L D +S G+ + EML P+
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 122 SECS-NPAQIYKKVTSGK 138
CS P + YKKV + K
Sbjct: 237 --CSETPQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 2 FTSGTLREYRKKYTR----VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57
F T+ +Y K Y R + + VK ++ Q+ R +AY+H + HRDLK N+ ++
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDP 205
Query: 58 HLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEML 115
+ +K+ D G A L Q + S I + + APEL +Y +D++S G + EM+
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
Query: 116 TSEYPYSECSNPAQI--------------------------YKKVTSGKLPGAFHRIQDA 149
+S S+ Q+ + V L F +
Sbjct: 266 LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD 325
Query: 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLL-----IPKVPSFQNL 196
+A F+ + L+ KRL E L DPF D +P + I K+P N
Sbjct: 326 DAINFISQFLKYEPLKRLNPIEALADPFF-DDLRDPCIKLPKYIDKLPDLFNF 377
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 18/99 (18%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--------SQHA 79
QIL G+ Y+H + V+HRDLK N+ VN ++KI D GLA RG +
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLA---RGFSENPGENAGFM 166
Query: 80 HSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVL-EML 115
+ T + APE L + Y + +D++S G C+L E+L
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
MFT R+ + V+ ++ +I+ +A H H +++RD+K +NI ++ G
Sbjct: 92 MFTHLYQRDNFSE------DEVRFYSGEII--LALEHLHKLGIVYRDIKLENILLDSE-G 142
Query: 61 QVKIGDLGLAA--ILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
V + D GL+ + + +S GT E+MAPE+ + + + VD +S G+ + E+LT
Sbjct: 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 117 SEYPYS---ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL-----P 167
P++ E + +++ +++ K F EA+ + K L ++ KRL
Sbjct: 203 GASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260
Query: 168 AKELLLDPFLASDAGEPLLIPKVPS 192
A E+ PF E L + KV
Sbjct: 261 ASEIKEHPFFKGLDWEALALRKVNP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 21/187 (11%)
Query: 23 KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHS 81
+ +A +I + YLH + +++RDLK +NI ++ G V + D GL + S +
Sbjct: 99 RFYAAEIASALGYLHSIN--IVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQSDTTTT 155
Query: 82 VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL- 139
GTPE++APE + ++ Y+ VD + G + EML P+ C + A++Y + L
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHKPLV 214
Query: 140 --PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD----PFLASDAGEPLLIPKVPS 192
PGA A + + LE + +RL AKE L+ PF S + L K+P
Sbjct: 215 LRPGA-----SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
Query: 193 FQNLNPN 199
NPN
Sbjct: 270 --PFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/223 (24%), Positives = 103/223 (46%), Gaps = 32/223 (14%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A QI+ YL + +++RDLK +N+ ++ G +K+ D G A ++ +++ G
Sbjct: 136 YAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV--DTRTYTLCG 190
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TPE++APE L + + D ++ G+ + E+L P+ + P IY+K+ G + F
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGII--YF 247
Query: 144 HRIQDAEARRFVGKCL-ENVSKRL-----PAKELLLDPFLASDAGEPLL-----IPKVPS 192
+ D + + K L +++KR A+ + P+ + LL +P P
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307
Query: 193 FQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIF 235
++N+ F + R D+TI + E+D F
Sbjct: 308 YKNV------------FDSSNFERVQEDLTIADKITNENDPFF 338
|
Length = 340 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA---HSVI 83
R++L +AYLHG +IHRD+K +NIF++ +GD G A L +
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 84 GTPEFMAPELYEED-YNELVDIYSFGMCVLEML 115
GT E +PEL D Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE 95
H ++HRDLK NIF+ G +K+GD G + S A S GTP ++APEL+E
Sbjct: 186 HSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
Query: 96 ED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--IYKKVTSGK 138
Y++ D++S G+ + E+LT P+ P+Q I ++V GK
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQH---- 78
++A QI G+ YL IHRDL NI + +VKIGD GL A+ + H
Sbjct: 101 DYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVME 157
Query: 79 AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKV 134
H + + APE L ++ D++ FG+ + EM T E P++ S +QI KK+
Sbjct: 158 EHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/130 (28%), Positives = 66/130 (50%), Gaps = 8/130 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + ++ ++ + ++ +I + YLH + +I+RDLK DN+ ++ G +K+
Sbjct: 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSE-GHIKL 137
Query: 65 GDLGLAAI-LRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYS 122
D G+ LR + GTP ++APE+ EDY VD ++ G+ + EM+ P+
Sbjct: 138 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
Query: 123 ---ECSNPAQ 129
NP Q
Sbjct: 198 IVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIG 84
Q+L +A H H +IHRD+K NI + + G VK+GD G + + + + G
Sbjct: 151 QVL--LAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 85 TPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK---LP 140
TP ++APE++ Y++ D++S G+ + E+LT + P+ + N ++ K +G+ LP
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYDPLP 266
Query: 141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLLD 174
+ E + V L + KR P+ LL+
Sbjct: 267 PSI----SPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 26/142 (18%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+LRG+ Y+H + V+HRDLK N+ +N + +KI D GLA R + +
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGLA---RTTS------EKGD 163
Query: 88 FM----------APELY--EEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKK 133
FM APEL +Y +D++S G E+L + +P + + ++ +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 134 VTSGKLPGAFHRIQDAEARRFV 155
+ I++ +ARR++
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYI 245
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R+ + + + NW QI +G+ YL + ++HRDL N+ V VK
Sbjct: 93 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EERRLVHRDLAARNVLVKTP-QHVK 149
Query: 64 IGDLGLAAILRGSQHAHSVIG--TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
I D GLA +L + + G P ++MA E + Y D++S+G+ V E++T
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L G+ Y+H +IHRDLK N+ VN ++KI D GLA + V T
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGYVV--TRW 179
Query: 88 FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--KVTSGKLPGAF 143
+ APE L YN+ VDI+S G + EMLT + + Q+ + KVT P
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239
Query: 144 HRIQDAEARRFVGKCLENVSKRLPAKEL-LLDPFLASDAGEPLL 186
+++D A+ ++ K L + P K+ L P AS LL
Sbjct: 240 QKLEDKAAKSYI-KSL----PKYPRKDFSTLFP-KASPQAVDLL 277
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 48/134 (35%)
Query: 44 IHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGS------------------------- 76
IHRD+K DN+ + GH +K+ D GL L+ S
Sbjct: 123 IHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 77 --------------QHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
A+S +GTP+++APE++ + YN+ D +S G+ + EML P+
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 122 SECS-NPAQIYKKV 134
CS NP + Y+K+
Sbjct: 240 --CSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 19/155 (12%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV--IGTPEFMAPELYEE 96
H +HRD+K +N+ ++ G +K+ D G AA L ++ +S +GTP+++APE+
Sbjct: 119 HQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 97 -------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD- 148
Y D +S G+ EM+ P+ E A+ Y + + + F + +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQ---RFLKFPED 233
Query: 149 ----AEARRFVGKCLENVSKRLPAKELLLDPFLAS 179
++ + L +RL + L PF +
Sbjct: 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 32/100 (32%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSQHAHSV 82
+A +I G+ +LH +I+RDLK DN+ ++ G +KI D G+ ++ G +
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT-TRTF 161
Query: 83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP+++APE+ + Y + VD +++G+ + EML + P+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 43/123 (34%), Positives = 66/123 (53%), Gaps = 11/123 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQVK 63
G+LR+Y K+ ++++ + +A+QI G+AYLH IHRDL N+ + N L VK
Sbjct: 93 GSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRL--VK 147
Query: 64 IGDLGLAAILRGSQHAHSVI---GTPEF-MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
IGD GLA + + V +P F A E L E ++ D++SFG+ + E+LT
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207
Query: 119 YPY 121
Sbjct: 208 DSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
++ +I + +LH + +I+RDLK DN+ ++ G +K+ D G+ +R +
Sbjct: 101 YSAEISLALNFLH--ERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFC 157
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP ++APE L EDY VD ++ G+ + EM+ P+
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 38/124 (30%), Positives = 67/124 (54%), Gaps = 9/124 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L ++ R+ +D + + NW QI +G+ YL H ++HR+L NI + V+
Sbjct: 93 GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDS-IVQ 149
Query: 64 IGDLGLAAIL--RGSQHAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
I D G+A +L ++ +S TP ++MA E + Y D++S+G+ V EM++
Sbjct: 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209
Query: 119 YPYS 122
PY+
Sbjct: 210 EPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 39/122 (31%), Positives = 64/122 (52%), Gaps = 8/122 (6%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A ++ I YLH + +I+RDLK +NI ++ G V + D GL + + +
Sbjct: 101 YAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP 140
GTPE++APE L +E Y+ VD + G + EML P+ + +Q+Y + +LP
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPLQLP 216
Query: 141 GA 142
G
Sbjct: 217 GG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 46/128 (35%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR----------GSQH---------- 78
H IHRD+K DNI ++ G +K+ D GL R G H
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 79 ------------------------AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLE 113
AHS++GTP ++APE L Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 114 MLTSEYPY 121
ML + P+
Sbjct: 237 MLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
VK++ Q+L+ + ++H + + HRD+K +NI + + +K+ D G +
Sbjct: 102 VKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTE 157
Query: 82 VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
I T + APE L + Y +DI++ G E+L+
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83
+ A Q+ G+AYL + IHRDL NI V L K+ D GLA +++ + S
Sbjct: 108 DMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDK 164
Query: 84 GTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG--- 137
P ++ APE ++ D++SFG+ + EM T + PY +N ++Y ++T+G
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRM 223
Query: 138 ----KLPGAFHRI 146
K P ++I
Sbjct: 224 PCPAKCPQEIYKI 236
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 38/119 (31%), Positives = 50/119 (42%), Gaps = 20/119 (16%)
Query: 15 TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA---- 70
R+ VK QIL G+ LH +HRDL NIF+N G KI D GLA
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIADFGLARRYG 170
Query: 71 ------AILRGSQHAHSVIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
+ + T + + APEL E Y+ VD++S G E+LT
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 35/117 (29%), Positives = 63/117 (53%), Gaps = 6/117 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A +I + YLH + +++RDLK +NI ++ G + + D GL + + +
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
GTPE++APE L+++ Y+ VD + G + EML P+ N A++Y + + L
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A +IL G+ LH + ++RDLK +NI ++ + G ++I DLGLA + + +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIRGRVG 163
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
T +MAPE L + Y D + G + EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 39 HDPPVIHRDLKCDNIF--VNGHLGQVKIGDLG--LAAILRGSQHAHSVIGTPEFMAPELY 94
H +HRD+K DN+ +NGH +++ D G L G+ + +GTP++++PE+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 95 E--ED----YNELVDIYSFGMCVLEMLTSEYPY 121
+ ED Y D +S G+C+ EML E P+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHAHSVI 83
+A +I + +LH + +I+RDLK DN+ ++ G +K+ D G+ L +
Sbjct: 101 YAAEICIALNFLH--ERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC 157
Query: 84 GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
GTP ++APE+ E+Y VD ++ G+ + EM+ P+
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLG--LAAILRGSQHAHSVIGTPEFMAPELYE- 95
H +HRD+K DNI ++ + G +++ D G L + G+ + +GTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 96 -ED----YNELVDIYSFGMCVLEMLTSEYPY 121
ED Y D +S G+C+ EML E P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 26/64 (40%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 12 KKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
KKY +D VK++ Q+L+G+A+ H H+ V+HRDLK N+ +N + G++K+ D
Sbjct: 86 KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLAD 142
Query: 67 LGLA 70
GLA
Sbjct: 143 FGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 8/118 (6%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH--SVI 83
QI G+ +L +HRDL N V+ +VK+ L L+ + S++ + +
Sbjct: 123 CTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKL 139
++APE + E+D++ D++SFG+ + E+ T E P+ S+ ++ ++ +GKL
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKL 236
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 12/106 (11%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AI--- 72
+D VK++ QIL+GI + H V+HRDLK N+ ++ G +K+ D GLA A
Sbjct: 98 MDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP 154
Query: 73 LRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
+R + H V+ T + APE L Y+ VDI+S G EM T
Sbjct: 155 VR--VYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 34/121 (28%), Positives = 63/121 (52%), Gaps = 8/121 (6%)
Query: 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
+ G L +Y ++ + + + NW QI +G+ YL + ++HRDL N+ V
Sbjct: 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSP- 145
Query: 60 GQVKIGDLGLAAILRGSQHAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
VKI D GLA +L G + ++ G ++MA E ++ + D++S+G+ + E++
Sbjct: 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
Query: 116 T 116
T
Sbjct: 206 T 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 16/143 (11%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQ 61
G L + RK+ + + + + +++ Q+ +G+A+L + IHRDL N+ + +G +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKI-- 179
Query: 62 VKIGDLGLAA-ILRGSQHAHSVIGTP----EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
VKI D GLA I+ S + V G ++MAPE ++ Y D++S+G+ + E+
Sbjct: 180 VKICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 116 T-SEYPYSECSNPAQIYKKVTSG 137
+ PY ++ YK + G
Sbjct: 238 SLGSNPYPGMPVDSKFYKLIKEG 260
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R+ R+ + + NW QI +G++YL + ++HRDL N+ V VK
Sbjct: 93 GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARNVLVKSP-NHVK 149
Query: 64 IGDLGLAAILRGSQHAHSVIG--TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
I D GLA +L + + G P ++MA E + + D++S+G+ V E++T
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+LRG+ Y+H +IHRDLK N+ VN +++I D GLA + + T
Sbjct: 126 QLLRGLKYIH--SAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180
Query: 88 FMAPE--LYEEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAF 143
+ APE L YN+ VDI+S G + E+L + +P ++ + + +V P
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240
Query: 144 HRIQDAEARRFV 155
+I AR+++
Sbjct: 241 KKISSEHARKYI 252
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL----RGSQHAHSVI 83
Q+LR + Y+H + V HRDLK NI N ++KI D GLA + + +
Sbjct: 111 QLLRALKYIHTAN--VFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 84 GTPEFMAPEL---YEEDYNELVDIYSFGMCVLEMLTSE--YPYSECSNPAQIYKKVTSGK 138
T + APEL + Y +DI+S G E+LT + +P + + +
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 139 LPGAFHRIQDAEARRFVGKCLENVSKRLP 167
P R+++ +ARR+ L ++ K+ P
Sbjct: 228 SPETISRVRNEKARRY----LSSMRKKQP 252
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL--RGSQHAHSVIGTPEFMAPELYEE 96
H +IHRD+K DN+ ++ H G +K+ D G + G + +GTP++++PE+ +
Sbjct: 159 HSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 97 D-----YNELVDIYSFGMCVLEMLTSEYPY 121
Y D +S G+ + EML + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 33 IAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI----LRGSQHAHS------- 81
+ YLH + ++HRDLK DN+ + +G +K+ D GL+ I L + +
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 82 -----VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
V GTPE++APE + + Y + VD ++ G+ + E L P+ P +++ +V
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVI 229
Query: 136 SGKL--PGAFHRIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPKVPSF 193
S + P + A+A+ + + L +P G + + F
Sbjct: 230 SDDIEWPEGDEALP-ADAQDLISRLLRQ------------NPLERLGTGGAFEVKQHRFF 276
Query: 194 QNLNPNGAV---TELVPQFAVDSD 214
L+ NG + E +PQ + D
Sbjct: 277 LGLDWNGLLRQKAEFIPQLESEDD 300
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 33/104 (31%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 44 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSQHAHSVIGTPEFMAPELYE--ED-- 97
+HRD+K DN+ ++ + G +++ D G L G+ ++ +GTP++++PE+ + ED
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 98 --YNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGK 138
Y D +S G+C+ EML E P Y+E + + Y K+ + K
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 42/122 (34%), Positives = 64/122 (52%), Gaps = 14/122 (11%)
Query: 29 ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+LRGIA YL + +HRDL NI VN +L K+ D GL+ L S+ ++ G
Sbjct: 111 MLRGIASGMKYLSEMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKG 167
Query: 85 --TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG-K 138
P + APE + + D++SFG+ + E+++ E PY + SN + K V G +
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYR 226
Query: 139 LP 140
LP
Sbjct: 227 LP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 14/143 (9%)
Query: 3 TSGTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
T G L +Y ++ R ++ AV A QI + YL + IHRDL N V +
Sbjct: 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-H 141
Query: 61 QVKIGDLGLAAILRGSQH-AHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
VK+ D GL+ ++ G + AH+ P ++ APE L ++ D+++FG+ + E+ T
Sbjct: 142 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201
Query: 117 --SEYPYSECSNPAQIYKKVTSG 137
S YP + S Q+Y+ + G
Sbjct: 202 GMSPYPGIDLS---QVYELLEKG 221
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 15/118 (12%)
Query: 7 LREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
L++Y + + V+ + Q+LRG+AY H V+HRDLK N+ ++ G++K+
Sbjct: 89 LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLA 145
Query: 66 DLGLAAILRGSQ-----HAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
D GLA R +++ V+ T + P+ L +Y+ +D++ G EM T
Sbjct: 146 DFGLA---RAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNEL 101
+++RDLK +NI ++ G ++I DLGLA + + +GT +MAPE + E Y
Sbjct: 123 IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 102 VDIYSFGMCVLEMLTSEYPY 121
D + G + EM+ + P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 13/135 (9%)
Query: 4 SGTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
+G+L ++ K + + K + A QI G+A++ + IHRDL+ NI V+ L
Sbjct: 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETL-C 140
Query: 62 VKIGDLGLAAILRGSQH-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT 116
KI D GLA ++ +++ A P ++ APE +Y D++SFG+ + E++T
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVT 198
Query: 117 -SEYPYSECSNPAQI 130
PY +NP I
Sbjct: 199 YGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 39/134 (29%), Positives = 72/134 (53%), Gaps = 13/134 (9%)
Query: 5 GTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K + ++ + + +++ QI G+A++ + IHRDL+ NI V+ L
Sbjct: 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VC 141
Query: 63 KIGDLGLAAILRGSQH-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
KI D GLA ++ +++ A P ++ APE ++ D++SFG+ ++E++T
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTY 199
Query: 117 SEYPYSECSNPAQI 130
PY SNP I
Sbjct: 200 GRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
LRE+ K++ + + + + G+AYL IHRDL N V+ G VK+ D
Sbjct: 90 LREHGKRFQPSQLLEM---CKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSD 143
Query: 67 LGLAAILRGSQHAHSVIGTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPY 121
GL+ + ++ SV G+ + PE L ++ D+++FG+ + E+ + + PY
Sbjct: 144 FGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
Query: 122 SECSNPAQIYKKVTSG 137
+N ++ +KV+ G
Sbjct: 203 ERFNN-SETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 40/123 (32%), Positives = 64/123 (52%), Gaps = 15/123 (12%)
Query: 29 ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA-HSVI 83
+LRGIA YL D +HRDL NI VN +L + K+ D GL+ +L ++
Sbjct: 112 MLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTS 168
Query: 84 GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG- 137
G + APE + + D++SFG+ + E+++ E PY + SN ++ K + G
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGF 227
Query: 138 KLP 140
+LP
Sbjct: 228 RLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI--LR 74
+++ VK + Q+LRG+ Y H V+HRDLK N+ +N G++K+ D GLA +
Sbjct: 101 INMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157
Query: 75 GSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
+++ V+ T + P+ L DY+ +D++ G EM T
Sbjct: 158 TKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 14/105 (13%)
Query: 30 LRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLG-LAAILRGSQHAHSVIGTPEF 88
LRG+ YLH + IHR++K +I ++G G V + L L +++R Q A V P+F
Sbjct: 111 LRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 89 -------MAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSE 123
++PEL +D YN DIYS G+ E+ T P+ +
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A Q+ RG+ YL IHRDL N+ V +KI D GLA RG T
Sbjct: 140 AYQVARGMEYLESRR--CIHRDLAARNVLVTED-NVMKIADFGLA---RGVHDIDYYKKT 193
Query: 86 P------EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
++MAPE L++ Y D++SFG+ + E+ T S YP
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 38/119 (31%), Positives = 58/119 (48%), Gaps = 14/119 (11%)
Query: 29 ILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ----VKIGDLGLAAILRGSQHAHSVIG 84
+ +G YL IHRDL N V+ VKIGD GLA + S + + G
Sbjct: 115 VAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEG 171
Query: 85 TP----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
+MAPE L + + D++SFG+ + E+LT + PY +N ++ + VT+G
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA S + T
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
+ APE + Y E VDI+S G + EM+
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 25 WAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAIL--RGS 76
WAR +++ + +H IHRD+K DN+ + +GHL K+ D G + G
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHL---KLADFGTCMKMDANGM 197
Query: 77 QHAHSVIGTPEFMAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPY 121
+ +GTP++++PE+ + Y D +S G+ + EML + P+
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 12/105 (11%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A QI G++YLH VIH+D+ N ++ L QVKI D L+ L + H +G
Sbjct: 123 AIQIACGMSYLHKRG--VIHKDIAARNCVIDEEL-QVKITDNALSRDLFPMDY-HC-LGD 177
Query: 86 PE-----FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSE 123
E +MA E L ++Y+ D++SFG+ + E++T + PY E
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 50/132 (37%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---------------------- 76
H IHRD+K DNI ++ G +K+ D GL R +
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 77 ----------------------QH----AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGM 109
QH AHS++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 110 CVLEMLTSEYPY 121
+ EML + P+
Sbjct: 237 ILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/115 (28%), Positives = 59/115 (51%), Gaps = 7/115 (6%)
Query: 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR Y + +D+ ++ ++ Q+ +AYL +HRD+ N+ V+ VK
Sbjct: 91 GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVK 147
Query: 64 IGDLGLAAILRGSQHAHSVIGT-P-EFMAPE-LYEEDYNELVDIYSFGMCVLEML 115
+GD GL+ L + + G P ++MAPE + + D++ FG+C+ E+L
Sbjct: 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAA-ILRGSQHAH--SVI 83
Q+ G+ +L + +HRDL N+ + G L VKI D GLA I+R S + S
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTF 302
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 36/132 (27%), Positives = 51/132 (38%), Gaps = 50/132 (37%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR------------------------ 74
H IHRD+K DNI ++ G +K+ D GL R
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 75 --------------------GSQH----AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGM 109
QH AHS++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 110 CVLEMLTSEYPY 121
+ EML + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76
+ + VK + QILRG+AY H V+HRDLK N+ +N G++K+ D GLA
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVP 157
Query: 77 QHAHS-VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
+S + T + P+ L +Y+ +D++ G EM
Sbjct: 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 15/123 (12%)
Query: 29 ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSVI 83
+LRGIA YL D +HRDL NI VN +L K+ D GL+ +L + A++
Sbjct: 111 MLRGIASGMKYLS--DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 84 GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG- 137
G + APE + + D++S+G+ + E+++ E PY E SN + K + G
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGY 226
Query: 138 KLP 140
+LP
Sbjct: 227 RLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K +R + + A QI G+AYL + IHRDL NI V +L
Sbjct: 86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENL-VC 142
Query: 63 KIGDLGLAAILRGSQH-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
KI D GLA ++ ++ A P ++ APE +Y D++SFG+ + E++T
Sbjct: 143 KIADFGLARLIEDDEYTAREGAKFPIKWTAPE--AANYGRFTIKSDVWSFGILLTEIVTY 200
Query: 117 SEYPYSECSNP 127
PY +N
Sbjct: 201 GRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 20/116 (17%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLA----- 70
+ + + ++A QI RG+ YL + ++HRDL N+ V G ++KI D GL+
Sbjct: 124 LTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYE 179
Query: 71 --AILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
+ ++ S+ V ++MA E L++ Y D++SFG+ + E++T + YP
Sbjct: 180 EDSYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 24/133 (18%)
Query: 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77
++ A ++ G+ +LH D IH DL N + L VKIGD GLA Q
Sbjct: 98 QKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADL-SVKIGDYGLAL----EQ 150
Query: 78 HAHSVIGTPE-------FMAPELYEEDYNELV--------DIYSFGMCVLEMLT-SEYPY 121
+ T + ++APEL E +L+ +I+S G+ + E+ T ++ PY
Sbjct: 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210
Query: 122 SECSNPAQIYKKV 134
+ S+ Q+ K+V
Sbjct: 211 PDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 12/112 (10%)
Query: 13 KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-- 70
K + + +K + +L G+ Y+H + ++HRD+K NI + G +K+ D GLA
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARA 168
Query: 71 -AILRGSQ---HAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLT 116
++ + S+ + + V+ T + PEL E DY +D++ G + EM T
Sbjct: 169 FSLSKNSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSQHAHSVIGTPEFMAPELYEE 96
H IHRD+K DN+ ++ G +K+ D G + G + +GTP++++PE+ +
Sbjct: 159 HSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 97 D-----YNELVDIYSFGMCVLEMLTSEYPY 121
Y D +S G+ + EML + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
VK + Q+LRG++Y+H ++HRDLK N+ ++ G++K+ D GLA H +S
Sbjct: 105 VKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYS 161
Query: 82 -VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEML 115
+ T + P+ L +Y+ +D++ G +EM+
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 38/130 (29%), Positives = 70/130 (53%), Gaps = 13/130 (10%)
Query: 5 GTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K + +V + + +++ QI G+AY+ + IHRDL+ N+ V+ L
Sbjct: 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESL-MC 142
Query: 63 KIGDLGLAAILRGSQH-AHSVIGTP-EFMAPELYEEDYNELV---DIYSFGMCVLEMLT- 116
KI D GLA ++ +++ A P ++ APE ++ D++SFG+ + E++T
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTY 200
Query: 117 SEYPYSECSN 126
+ PY SN
Sbjct: 201 GKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI--LRGSQHA 79
VK + Q+LRG++Y H ++HRDLK N+ +N G++K+ D GLA + ++
Sbjct: 105 VKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYS 161
Query: 80 HSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
+ V+ T + P+ L +Y+ +D++ G + EM T
Sbjct: 162 NEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 15/121 (12%)
Query: 26 ARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
A QI G+ YL H +HRDL N V L VKIGD G++ + + + + V G
Sbjct: 128 ASQIASGMVYLASLH---FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDY-YRVGG 182
Query: 85 TP----EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
+M PE LY + E DI+SFG+ + E+ T + P+ + SN I + +T G
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-ECITQG 240
Query: 138 K 138
+
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A Q+ RG+ YL IHRDL N+ V +KI D GLA R H T
Sbjct: 146 AYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLA---RDIHHIDYYKKT 199
Query: 86 P------EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
++MAPE L++ Y D++SFG+ + E+ T S YP
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSQHAH--SVIG 84
Q+ RG+ +L + +HRDL N+ + VKI D GLA I+ S + S
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG--- 84
Q+ RG+ YL IHRDL N+ V + +KI D GLA + +
Sbjct: 145 QVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
++MAPE L++ Y D++SFG+ + E+ T S YP
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 40/125 (32%), Positives = 60/125 (48%), Gaps = 21/125 (16%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQVKIG 65
R + T+ D+ + +A Q+ RG+ +L IHRDL N+ V H+ +KI
Sbjct: 122 PRPPEETLTQKDLVS---FAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHV--MKIA 174
Query: 66 DLGLAAILRGSQHAHSVIGTP------EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-- 116
D GLA R H T ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 175 DFGLA---RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231
Query: 117 -SEYP 120
S YP
Sbjct: 232 GSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 3 TSGTLREYRKKYTRVDIR--AVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ G+L ++ K +R + + A QI G+AY+ + +HRDL+ NI V +L
Sbjct: 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL- 139
Query: 61 QVKIGDLGLAAILRGSQH-AHSVIGTP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT 116
K+ D GLA ++ +++ A P ++ APE LY + D++SFG+ + E+ T
Sbjct: 140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT 198
Query: 117 S-EYPY 121
PY
Sbjct: 199 KGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R + + + + G+AYL + VIHRDL N V G VK
Sbjct: 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVK 140
Query: 64 IGDLGLAAILRGSQHAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-E 118
+ D G+ + Q+ S GT ++ +PE++ Y+ D++SFG+ + E+ + +
Sbjct: 141 VSDFGMTRFVLDDQYTSST-GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY SN +++ + + +G
Sbjct: 200 TPYENRSN-SEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 14/114 (12%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL------AAILRGSQHA 79
A+Q+ G+AYL + +HRDL N V ++ VKI D GL A + S++
Sbjct: 136 AKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASEND 192
Query: 80 HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131
I +M PE ++ Y D++++G+ + E+ + PY ++ IY
Sbjct: 193 AIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG- 84
A Q+ RG+ YL IHRDL N+ V +KI D GLA + +
Sbjct: 140 AYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 85 --TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
++MAPE L++ Y D++SFG+ + E+ T S YP
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/117 (32%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIG 84
A Q+ G+AY+ + IHRDL+ NI V L KI D GLA ++ +++ A
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAK 164
Query: 85 TP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSG 137
P ++ APE LY + D++SFG+ + E++T PY +N ++ ++V G
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 29/125 (23%), Positives = 59/125 (47%), Gaps = 15/125 (12%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQHAHSVIGT 85
+ +L + Y+H IHR +K +I ++G G+V + L + ++++ + V
Sbjct: 108 KDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF 164
Query: 86 PEF-------MAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT 135
P+ ++PE+ +++ YNE DIYS G+ E+ P+ + Q+ +
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD-MPATQMLLEKV 223
Query: 136 SGKLP 140
G +P
Sbjct: 224 RGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/94 (34%), Positives = 45/94 (47%), Gaps = 9/94 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSV 82
A QI G+ YL H +HRDL N V L VKI D GL+ + + +
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKS 186
Query: 83 IGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
+ +M PE LY + E DI+SFG+ + E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA S + T
Sbjct: 134 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
+ APE + Y E VDI+S G + EM+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 35/113 (30%), Positives = 49/113 (43%), Gaps = 27/113 (23%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA-HSVIG 84
RQIL + LH ++HRD+K NI + G KI DLG AA LR G + +
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319
Query: 85 TPEFMAPE-----------------------LYEEDYNELVDIYSFGMCVLEM 114
P + APE L++ + + DIYS G+ L+M
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA + + T
Sbjct: 131 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
+ APE + Y E VDI+S G + E++
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
LRE + K + + + + YL + IHRDL N V G VK+ D
Sbjct: 90 LRERKGKLGTEWLLDM---CSDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSD 143
Query: 67 LGLAAILRGSQHAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPY 121
GLA + Q+ S GT ++ PE+++ ++ D++SFG+ + E+ + + PY
Sbjct: 144 FGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202
Query: 122 SECSNPAQIYKKVTSG 137
SN +++ + V++G
Sbjct: 203 ERFSN-SEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 35/89 (39%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA S + T
Sbjct: 127 QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVLEML 115
+ APE + Y E VDI+S G + EM+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 13/121 (10%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A QI G+ YL +HRDL N V G+ VKIGD G++ + + + + V G
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDY-YRVGGH 183
Query: 86 P----EFMAPE--LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK 138
+M PE +Y + E D++SFG+ + E+ T + P+ SN ++ + +T G+
Sbjct: 184 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQGR 241
Query: 139 L 139
L
Sbjct: 242 L 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 34/139 (24%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y R++ ++ + + + + G+ YL + IHRDL N V+ G VK
Sbjct: 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSS-TGVVK 140
Query: 64 IGDLGLAAILRGSQHAHSVIGTP---EFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-E 118
+ D G+ + ++ S G ++ PE++ Y+ D++SFG+ + E+ T +
Sbjct: 141 VSDFGMTRYVLDDEYTSSS-GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
Query: 119 YPYSECSNPAQIYKKVTSG 137
P+ + SN ++ + ++ G
Sbjct: 200 MPFEKKSN-YEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 13/140 (9%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
L+E KY + + + + A QI G+AY+ + IHRDL+ NI V +L KI D
Sbjct: 91 LKEGDGKYLK--LPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIAD 145
Query: 67 LGLAAILRGSQH-AHSVIGTP-EFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS-EYPY 121
GLA ++ +++ A P ++ APE LY + D++SFG+ + E++T PY
Sbjct: 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY 204
Query: 122 SECSNPAQIYKKVTSG-KLP 140
N ++ ++V G ++P
Sbjct: 205 PGMVN-REVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 29/102 (28%), Positives = 37/102 (36%), Gaps = 18/102 (17%)
Query: 25 WA--RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82
WA Q L + LH L + + G A Q
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQS---- 64
Query: 83 IGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE 123
P FMAPE+ + Y E DIYS G+ + E L E PY+E
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 79 AHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTS 136
A+S +GTP+++APE++ ++ Y + D +S G + E L P+ CS N + Y+K+ +
Sbjct: 205 AYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF--CSENSHETYRKIIN 262
Query: 137 GK----LPGAFHRIQDAEARRFVGKCLENVSKRL---PAKELLLDPFLA 178
+ P H EA + + + N RL A E+ PF
Sbjct: 263 WRETLYFPDDIH--LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 30/102 (29%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH- 80
V+++ Q+++ I + H +D ++HRD+K +N+ ++ H +K+ D G A L +A+
Sbjct: 102 VRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANY 158
Query: 81 -SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+ T + +PE L Y + VD++S G C+L L+ P
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVG-CILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 35/127 (27%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76
+D + +++ Q+ +G+++L + IHRDL NI + H KI D GLA +R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRND 267
Query: 77 QHAHSVIGTP----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
+ + V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 268 SN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 131 YKKVTSG 137
YK + G
Sbjct: 327 YKMIKEG 333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 44/212 (20%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--GHDPPVIHRDLKCDNIFV--NGHL- 59
L+ K ++ + +A ++L + YLH G +++RDLK +NI + +GH+
Sbjct: 90 RLLQRQPGKCLSEEV--ARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIM 143
Query: 60 -------------GQVKIGDLG-------------LAAILRGSQHAHSVIGTPEFMAPEL 93
L S ++S +GT E++APE+
Sbjct: 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 94 YEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152
D + VD ++ G+ + EML P+ + SN + + + ++ + AR
Sbjct: 204 ISGDGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETFSNILKKEVTFPGSPPVSSSAR 262
Query: 153 RFVGKCLE-NVSKRL----PAKELLLDPFLAS 179
+ K L + SKRL A E+ PF
Sbjct: 263 DLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 14/102 (13%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSQHAHSVIGTP 86
Q+ RG+ +L IHRDL NI ++ + VKI D GLA I + + G
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRK--GDA 235
Query: 87 ----EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT---SEYP 120
++MAPE ++++ Y D++SFG+ + E+ + S YP
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77
DI +K RQ+L G+ LH ++HRD+K +N+ V GQVKI D G A +
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGI 363
Query: 78 HAHSVIGT--PEFMAPE 92
+ + + G P + PE
Sbjct: 364 NFNPLYGMLDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 29 ILRGIA----YLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+LRGIA YL + +HRDL NI VN +L K+ D GL+ L +
Sbjct: 111 MLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 85 T-----P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSN 126
+ P + APE + + D++S+G+ + E+++ E PY + SN
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.87 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.86 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.84 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.82 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.82 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.81 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.81 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.75 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.75 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.55 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.53 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.33 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.31 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.28 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.27 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.22 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.18 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.14 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.86 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.8 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.79 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 96.9 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.29 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 96.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 95.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 94.25 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 93.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 92.13 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 91.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 91.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 91.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 90.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 90.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.27 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 89.65 | |
| PLN02236 | 344 | choline kinase | 88.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 88.4 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 87.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 87.61 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 86.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 85.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 85.77 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 85.75 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 84.46 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 84.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 83.51 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 82.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 82.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 82.15 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 81.91 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 81.04 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-61 Score=507.70 Aligned_cols=452 Identities=46% Similarity=0.670 Sum_probs=323.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
+|++|||++|++++++++.+.++.|++||++||.|||++.|||||||||++||||+++.|.|||+|+|+|+..... ...
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-~ak 202 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-HAK 202 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-ccc
Confidence 6899999999999999999999999999999999999999999999999999999999999999999999987654 344
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
.++|||.|||||++...|++.+|||||||||+||+|+.+||.+|.++++||++|..|..|..+.++.++++++||.+||.
T Consensus 203 svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCccccCCCCCC-------CCCCCC--------CC----cCCC------CCCCCcccc----ccccc-
Q 010768 161 NVSKRLPAKELLLDPFLASDAGEP-------LLIPKV--------PS----FQNL------NPNGAVTEL----VPQFA- 210 (502)
Q Consensus 161 dP~kRpsa~ElL~hpf~~~~~~~~-------l~~p~~--------P~----~~~~------~~~~~~~~~----~~~~~- 210 (502)
..++|+++.|||.||||..+.... ...+.+ +. +... +.+....+. +-...
T Consensus 283 ~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~ 362 (632)
T KOG0584|consen 283 TKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEI 362 (632)
T ss_pred CchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhcc
Confidence 999999999999999999863310 000000 00 0000 000000000 00000
Q ss_pred -cccc------cccccccccccCCCCCCCceEEEEEEEcCCCCeeeeecCCCCCcccHHHHHHHHHhccCCCCCCHHHHH
Q 010768 211 -VDSD------RRKSTDMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIA 283 (502)
Q Consensus 211 -~~~~------~~k~~~~~i~g~~n~e~~~i~L~l~i~d~~g~~r~i~f~f~~~~Dt~~~Va~EMV~~~~i~~~d~~~ia 283 (502)
.+.+ ..+.+.+.++|+.+.+...++|.|+|.+++|..++|+|+|++..|||.+||.|||++++++++++..||
T Consensus 363 ~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia 442 (632)
T KOG0584|consen 363 VSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIA 442 (632)
T ss_pred CCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHH
Confidence 0111 124478899999987777999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCccCCCC--CccccccccccCCCCCCCCCCCCCCcccCCC--CCCCCCCccccccCCCC-CCCCCcc
Q 010768 284 EMIEQEISSLVPNWKECGSP--QFCHQHSFSYEDEDDDNDDYGIYHPFYSNSS--HSSSHASLPAFFTNNAN-SPPSWLQ 358 (502)
Q Consensus 284 ~~I~~~i~~l~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~ 358 (502)
+||+.+|.+|+|.|+....- ..+.||..+ +.|. ++++.....+.+..+.+ ....|-+
T Consensus 443 ~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~------------------~~s~~~~~~s~~~~~~~~~~~~~~~~~~~~~ 504 (632)
T KOG0584|consen 443 EMIDGEISALVPNWKASTPNDESPHEQHTDN------------------SVSIQRSSESATQSQKSFSSADPQQVAPFVQ 504 (632)
T ss_pred HHHhchhhhcCCccCCCCCccccchhccCcc------------------cccccCCCccccccccccccccccccccccc
Confidence 99999999999999865411 222222221 1222 11111111111111111 3444655
Q ss_pred cCccCCCCCCCCCCCCCCcccccccccCCCCCcccccccCCCchhhhcccc-c--ccccccccccC-CcCCCcccccccc
Q 010768 359 QEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQ-K--STRFCPEAAMN-NDRCNSEDVNSWK 434 (502)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~-~~~~~~~~~~~~~ 434 (502)
+. +.|..++....+..+.....+....+.+. .+..+..++ + +-.|+...... ..+. .+..+.
T Consensus 505 ~~---~~~~~~~~~~~r~~~~~~~~~~~~~~~~~--------~~~~q~~t~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 570 (632)
T KOG0584|consen 505 QS---MEDPLSSDVESRFSKNELVQTQVSPLGER--------LVQCQLETHHKQETFEFDQPLSSPEEIAK---AMSEQE 570 (632)
T ss_pred cc---ccCCCccccccccccccccccccccchhh--------hhhhhhccccceeeecccccCCchhhhhh---hhhccc
Confidence 53 44442222212222223322222111111 010111122 2 44555544431 0000 011111
Q ss_pred ccCCCCCCCCcccccchhhhhhhhHhhhhHHHHHhhhhcccccccccccccC
Q 010768 435 ACSTNSNNHRKLSRIRSLVDVRSQLLHRSLVEEIHKRRLFKTVGAIENIGFH 486 (502)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 486 (502)
+ .-.....+-.++.|++++...++||+...+...|+..+|+....+-.|++
T Consensus 571 ~-~l~~e~~~~~~q~r~~~q~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (632)
T KOG0584|consen 571 E-QLKTELERIESQLRSLVQDALELLSRAVEEAKDKVIATKQKSVNSAHPAQ 621 (632)
T ss_pred h-hhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHhhhhhccccccccccCCC
Confidence 1 00234567788999999999999999999999999999998888888777
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.51 Aligned_cols=177 Identities=33% Similarity=0.568 Sum_probs=162.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
||.||+|.+++++.++++|..+..++.+|++||.|||. ++ ||||||||+||||+.. |+|||||||.++.+... ..
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hc
Confidence 79999999999999999999999999999999999995 77 9999999999999997 89999999999988765 67
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC----CChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.+++||..|||||.+.+ .|+.++||||||+.++|+++|++||... ....+++..|..+..|.......+++++.|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 89999999999998886 5999999999999999999999999763 467788888888877766666789999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|..||+ ||.+|++++|++.|||++...
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999 999999999999999998643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.44 Aligned_cols=178 Identities=26% Similarity=0.389 Sum_probs=161.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++-.++.+.+...+.+++||+.||.|||++| |+||||||+|||+..+ .-.+||+|||+|+.......
T Consensus 257 ~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf 334 (475)
T KOG0615|consen 257 YVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF 334 (475)
T ss_pred EecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence 6899999999999999999999999999999999999999 9999999999999765 24799999999999988888
Q ss_pred cccccCCCcccCccccccc----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~ 152 (502)
+.+.+|||.|.|||++... +..++||||+||+||-+|+|.+||.+......+.+.|..|.++. ..+...+.++.
T Consensus 335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~ 414 (475)
T KOG0615|consen 335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEAL 414 (475)
T ss_pred hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHH
Confidence 9999999999999998643 45599999999999999999999999777777899999998753 34455699999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||.+||. ||++||++.|+|+||||+..
T Consensus 415 dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 415 DLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred HHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999 99999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=313.35 Aligned_cols=180 Identities=32% Similarity=0.535 Sum_probs=161.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+||++.+.|++..++.++.||+.||+|||++| ||||||||+||||+++ +++||+|||.|+.+.....
T Consensus 155 ~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred ecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhccc
Confidence 6899999999999999999999999999999999999999 9999999999999998 7999999999998743211
Q ss_pred ------------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 79 ------------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 79 ------------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
..+++||..|.+||++.. ..+..+|||+||||+|.|+.|.+||.+ .+.-.++++|..-.+ .++.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y--~fp~ 308 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDY--EFPE 308 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhcc--cCCC
Confidence 145899999999999975 588999999999999999999999988 677788888887655 5666
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCCCC
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~l~ 186 (502)
..++.+++||+++|. ||.+|+++.+|.+||||.+..|+.+-
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 678999999999999 99999999999999999998886643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.45 Aligned_cols=178 Identities=27% Similarity=0.513 Sum_probs=165.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||.|++|+.++++|++.++.++++||+.||.|||..+ |+||||||+|+|++.+ +++||+|||+|..-..+....
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCCcccc
Confidence 6899999999999999999999999999999999999999 9999999999999998 579999999999888888889
Q ss_pred cccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
+.||+|.|+|||++.|. -+.++||||+|||||.||||+.||.+ .|...++.+|..|.+ ..+...++++++||++|
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRM 246 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHH
Confidence 99999999999998764 47799999999999999999999986 899999999999988 45577899999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
|. ||.+|+|.+||++|||+.+....+
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCCCC
Confidence 99 999999999999999999876544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.66 Aligned_cols=185 Identities=32% Similarity=0.543 Sum_probs=165.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~-~~~~~~~ 79 (502)
|+.||.|+..|++.+.+++..++.|+.+|+.||.|||++| ||||||||+|||++.+ |+++|+|||+++. ...+...
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhcccCCCcc
Confidence 6889999999999999999999999999999999999999 9999999999999988 8999999999985 4445566
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++||+.|||||++. ..|+..+|.||||+++|+|++|.+||.+ .+...++++|..++.+ ..+...+.++++||+++
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARDLLKKL 260 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHHHHHHH
Confidence 7889999999999876 5699999999999999999999999987 7788899999998854 34555799999999999
Q ss_pred hc-CcCCCC----CHHHHhcCccccCCCCCCCCCCCC
Q 010768 159 LE-NVSKRL----PAKELLLDPFLASDAGEPLLIPKV 190 (502)
Q Consensus 159 L~-dP~kRp----sa~ElL~hpf~~~~~~~~l~~p~~ 190 (502)
|. +|.+|. .+.++-.||||..-.|+.+..-.+
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 99 999995 799999999999998876544433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.29 Aligned_cols=175 Identities=33% Similarity=0.546 Sum_probs=160.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
+|..|+|.+++++.+.++|.+++.+++||+.||.|||+++ |||||||..|||++.+ -+|||+|||+|..+... ...
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecccceeeeecCccccc
Confidence 6899999999999999999999999999999999999999 9999999999999998 49999999999988744 667
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+.+|||.|+|||++.+ ..+..+||||+||+||.||+|++||.. ....+++.+|..... .++...+.++++||.+|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL 252 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence 78999999999998874 589999999999999999999999977 678889999988876 44557899999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+|||+.++|.|+||+...
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred hcCCcccCCCHHHHhcCHhhhCCC
Confidence 99 999999999999999995543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=289.65 Aligned_cols=182 Identities=32% Similarity=0.608 Sum_probs=166.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|..||.|..|+++.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+ |.+||+|||+|+...+. ..
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r--T~ 199 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR--TW 199 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc--EE
Confidence 6789999999999999999999999999999999999999 9999999999999998 89999999999987654 67
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
+.+|||.|+|||++. ..|+.++|.||||+++|||+.|.+||.. .++.+++.+|..+++ .++...++.+++||.++|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence 889999999999886 5699999999999999999999999987 677999999999988 667788999999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCCCCCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGEPLLIPKV 190 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~~l~~p~~ 190 (502)
+ |-.+|. ...+|..||||+...|..+....+
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 9 999983 578899999999999877554443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.28 Aligned_cols=175 Identities=29% Similarity=0.585 Sum_probs=159.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~-~~~~~~ 79 (502)
||.||+|.+++.+.+++.+.+++.+++||+.||+|||++| |+||||||+|||++.+.+++||+|||++... ......
T Consensus 101 y~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l 178 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLL 178 (370)
T ss_pred ecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcc
Confidence 7899999999999999999999999999999999999999 9999999999999987569999999999988 455677
Q ss_pred ccccCCCcccCccccccc--C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccC-CHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEED--Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFV 155 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~~--~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~-s~~l~~LI 155 (502)
.+.+||+.|+|||++.+. | +.++||||+|++||.|++|+.||.. .+...++.++..+.+. ++... +++++.||
T Consensus 179 ~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~~~Li 255 (370)
T KOG0583|consen 179 KTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEARSLI 255 (370)
T ss_pred cCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHHHHHH
Confidence 889999999999999763 5 5799999999999999999999988 7777888888888773 34444 99999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. +|.+|+++.+++.||||+..
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999 99999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.47 Aligned_cols=179 Identities=36% Similarity=0.596 Sum_probs=152.7
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC----
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---- 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~---- 75 (502)
|+.||+|.+++++++ +|++..++.+.+||++||+|||++| ||||||||+|||++...+.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 789999999999987 8999999999999999999999999 999999999999998337999999999987653
Q ss_pred CCCcccccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCC-CCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 76 SQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE-CSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~-~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
........||+.|||||++... ...++|||||||++.||+||+.||.+ ......++........| .++...+++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~ 253 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAK 253 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHH
Confidence 1224467899999999988743 33499999999999999999999987 33444445544455445 66677899999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+||.+|+. +|.+||||.++|.|||++....
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999 9999999999999999987654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.24 Aligned_cols=176 Identities=34% Similarity=0.587 Sum_probs=157.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|++||+|.+.+.+. .++|.++..|+++++.||+|||.+| |||||||.+|||++.+ |.+||+|||+|..+.... ..
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeeeeeccccccCcc
Confidence 78999999998774 5999999999999999999999999 9999999999999987 899999999998876544 66
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+.+|||.|||||++.. .|++++||||||++++||+-|++||-.......++.....|......+...++.+++|+.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 78999999999998875 59999999999999999999999998855555566666667666677778899999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. |+.+|++|.|||.||||+..
T Consensus 507 L~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hhcchhcCCCHHHHhcChhhhhc
Confidence 99 99999999999999999543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=271.55 Aligned_cols=179 Identities=27% Similarity=0.494 Sum_probs=160.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
+++||+|..-|-+.-.+++..+-.+++||+.||.|||.+| |||||+||+|+++... ..-+||+|||+|..+.++..
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 5789999988877777899999999999999999999999 9999999999999643 35799999999999887777
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI 155 (502)
....+|||.|||||++. ..|+..+|||+.|+|||-||.|++||.+ .....+++.|..+.. +...+...++.+++||
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 78899999999999887 4699999999999999999999999987 567889999999875 4445667799999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
++||. ||.+|+|+.|+|+|||+.....
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcchHH
Confidence 99999 9999999999999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=275.19 Aligned_cols=175 Identities=26% Similarity=0.519 Sum_probs=157.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
+|..|.|.+||...-.+++++.+.|++||+.|++|||.++ ||||||||+|||++.+ -++||.|||++..+..+....
T Consensus 104 l~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~GekLr 180 (411)
T KOG0599|consen 104 LMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEPGEKLR 180 (411)
T ss_pred hcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCCchhHH
Confidence 4778999999999999999999999999999999999999 9999999999999998 599999999999999988889
Q ss_pred cccCCCcccCccccc-------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHH
Q 010768 81 SVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEA 151 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l 151 (502)
..+|||+|+|||.+. ..|+..+|+|++|+|||.||.|.+||.. ....-+.+.|..|++. .+.+...+...
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadis~~~ 259 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADISATV 259 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhccccH
Confidence 999999999999774 2489999999999999999999999966 4445567888888864 33445568899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
++||.+||+ ||.+|+|++|+|.||||..
T Consensus 260 KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 260 KDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999 9999999999999999964
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.83 Aligned_cols=181 Identities=25% Similarity=0.429 Sum_probs=157.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.||++..+|.+.+.|++..++.++.+++.|++.||++| +|||||||+|+||+.. |++||.|||++..+...
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhhhhhhhh
Confidence 7899999999999999999999999999999999999999 9999999999999998 89999999998543110
Q ss_pred --------------------C------------------------CcccccCCCcccCcccccc-cCCcccchhhhhHHH
Q 010768 77 --------------------Q------------------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV 111 (502)
Q Consensus 77 --------------------~------------------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iL 111 (502)
. ...+.+|||.|||||++.+ .|+..+|+||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0 0012689999999998865 499999999999999
Q ss_pred HHHhhccCCCCCCCChHHHHHHHHcCC--CCCCccccCCHHHHHHHHHhhcCcCCCCC---HHHHhcCccccCCCCCCC
Q 010768 112 LEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEPL 185 (502)
Q Consensus 112 yeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~dP~kRps---a~ElL~hpf~~~~~~~~l 185 (502)
||||.|.+||.. .++.+.+++|.... +..+.....++++++||.+||.||.+|.. +.||..||||+...|..+
T Consensus 379 yEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 379 YEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchh
Confidence 999999999987 78899999998765 33333445579999999999999999985 999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=271.81 Aligned_cols=166 Identities=30% Similarity=0.517 Sum_probs=150.4
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPP--VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~--IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
||.+|+|.+.++. ++.++++.+|+++.|++.||..||+.-+. |+||||||.|||++.+ |.|||+|||+++.+.
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRFLS 179 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhHhc
Confidence 6889999999874 35699999999999999999999994333 9999999999999988 899999999999886
Q ss_pred CCC-CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 75 GSQ-HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 75 ~~~-~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
... ...+.+|||.||+||++. ..|+.++||||+||++|||+.-++||.+ .+..++.++|..|.+|+.+....+..+.
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 543 457889999999999886 4699999999999999999999999988 5899999999999998777788899999
Q ss_pred HHHHHhhc-CcCCCCCH
Q 010768 153 RFVGKCLE-NVSKRLPA 168 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa 168 (502)
.+|..|+. ||..||+.
T Consensus 259 ~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHccCCcccCCCc
Confidence 99999999 99999987
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=276.13 Aligned_cols=178 Identities=27% Similarity=0.488 Sum_probs=152.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcc
Confidence 6889999999999899999999999999999999999999 9999999999999887 799999999987532 22233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+...+..+.. .++...++.+.+||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999976 455666666665543 34455789999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|. ||.+|| ++.++++||||....+..
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 999999 899999999998865543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=279.36 Aligned_cols=178 Identities=25% Similarity=0.500 Sum_probs=158.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC-----CcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-----GQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~-----g~vKL~DFGlA~~~~~ 75 (502)
||.||+|.+||++++.+++..++.++.||+.||++||+++ ||||||||+||||+... ..+||+|||+|+.+..
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 8999999999999999999999999999999999999999 99999999999998641 3689999999999998
Q ss_pred CCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-CCCccccCCHHHHH
Q 010768 76 SQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARR 153 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~ 153 (502)
.....+.+|+|.|||||++. .+|+.|+|+||+|+|+|+|++|+.||.. .+..++...+..+.. ...++...+..+.+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhh
Confidence 88888999999999999884 7899999999999999999999999987 566677777776643 34455566777778
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
++..+|. ++..|.+..+-+.|+++....
T Consensus 247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8888888 999999999999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=268.26 Aligned_cols=176 Identities=31% Similarity=0.544 Sum_probs=152.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC--cc
Confidence 6889999999999899999999999999999999999999 9999999999999877 79999999999765432 23
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+++.+..+.. .++...++.+++||.+||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHc
Confidence 4579999999998864 488999999999999999999999977 556677777777654 344456889999999999
Q ss_pred c-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 160 E-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 160 ~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
. ||.+|++ +.+++.||||....+..
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9 9999995 99999999998755543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=272.31 Aligned_cols=176 Identities=28% Similarity=0.523 Sum_probs=153.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~--~~ 173 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR--TF 173 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCCC--cc
Confidence 6789999999999999999999999999999999999999 9999999999999987 79999999999876432 23
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ ....++++.+..+..+ ++...+..+++||.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDLVKGLL 250 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHHHHHHh
Confidence 4679999999998864 488999999999999999999999976 5566777777777553 34557889999999999
Q ss_pred c-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 160 E-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 160 ~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
. ||.+|++ +++++.||||....+..
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 9 9999997 79999999998765543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=268.64 Aligned_cols=176 Identities=28% Similarity=0.498 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 74 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~ 150 (312)
T cd05585 74 FINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKT 150 (312)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999887 7999999999875422 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ ....++++.+..+.. .++...++.+++||.+|
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 227 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGL 227 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999977 455666666666543 34456789999999999
Q ss_pred hc-CcCCCC---CHHHHhcCccccCCCC
Q 010768 159 LE-NVSKRL---PAKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRp---sa~ElL~hpf~~~~~~ 182 (502)
|. +|.+|| ++.++|.||||....+
T Consensus 228 L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 228 LSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred cCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99 999997 5899999999987543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=272.65 Aligned_cols=176 Identities=24% Similarity=0.467 Sum_probs=153.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~--~~~ 186 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT--RTY 186 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeecCC--Ccc
Confidence 6889999999999999999999999999999999999999 9999999999999877 7999999999987643 234
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+++.+..+.. .++...++.++++|++||
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l 263 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLL 263 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 488999999999999999999999987 456667777777654 234556889999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
. +|.+|+ ++++++.||||....+..
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9 999995 899999999998766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=275.79 Aligned_cols=171 Identities=32% Similarity=0.501 Sum_probs=147.7
Q ss_pred CCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.+|+|.+++.+ ...++...+..|+.||+.|++|||++++ ||||||||+||||+.+.-.+||+|||+++..... .
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 7899999999988 6789999999999999999999999986 9999999999999988339999999999877654 3
Q ss_pred CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
......||+.|||||++.+ .|+.|+||||||+++|||+||+.||.+... .++...+..+...+.++...++.+..+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 3444789999999999985 399999999999999999999999999766 555555554444444555589999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|..||. +|.+||++.+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 999999 9999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.26 Aligned_cols=176 Identities=24% Similarity=0.399 Sum_probs=148.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc--ccC
Confidence 6889999999999889999999999999999999999999 9999999999999887 7999999999976543 334
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC----CCCc--cccCCHHHHH
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----PGAF--HRIQDAEARR 153 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~----p~~~--~~~~s~~l~~ 153 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+..... +... ....+..+.+
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 5679999999998764 589999999999999999999999977 455555555543221 1111 1234789999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
||.+||. +|.+||++.+++.||||....+
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 9999999 8999999999999999987544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=269.16 Aligned_cols=177 Identities=25% Similarity=0.469 Sum_probs=152.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcc
Confidence 6889999999999899999999999999999999999999 9999999999999887 799999999987542 22233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...+..+++||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAF 230 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999977 556667777766554 23445688999999999
Q ss_pred hc-CcCCCCCH------HHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPA------KELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa------~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+++ ++++.||||....+.
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99 99999998 999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=269.33 Aligned_cols=179 Identities=25% Similarity=0.405 Sum_probs=150.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCcccCccc
Confidence 6789999999999889999999999999999999999999 9999999999999987 799999999997654332
Q ss_pred ---------------------------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH
Q 010768 78 ---------------------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129 (502)
Q Consensus 78 ---------------------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~ 129 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-HHH
Confidence 2334679999999998864 58999999999999999999999998743 455
Q ss_pred HHHHHHc--CCCCCCccccCCHHHHHHHHHhhcCcCCCCC-HHHHhcCccccCCCCC
Q 010768 130 IYKKVTS--GKLPGAFHRIQDAEARRFVGKCLENVSKRLP-AKELLLDPFLASDAGE 183 (502)
Q Consensus 130 i~~~i~~--~~~p~~~~~~~s~~l~~LI~kcL~dP~kRps-a~ElL~hpf~~~~~~~ 183 (502)
.+..+.. ...........++.+.+||.+||.+|.+|++ +.+++.||||+...+.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 5555555 2222222223589999999999999999999 9999999999876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=264.20 Aligned_cols=181 Identities=22% Similarity=0.372 Sum_probs=157.3
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~ 76 (502)
.++||.|+..++.++. ++++++..|++||..|+.|||+.+ |.||||||+|+|...+ +..+||+|||+|+.....
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 4789999999998765 999999999999999999999999 9999999999999754 357999999999987766
Q ss_pred CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCC---hHHHHHHHHcCCC--CCCccccCCHH
Q 010768 77 QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKL--PGAFHRIQDAE 150 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---~~~i~~~i~~~~~--p~~~~~~~s~~ 150 (502)
....+.+.||.|.|||++. .+|+..+|+||+||++|-||+|.+||..... ...+..+|..|.+ |...+...++.
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~ 297 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEA 297 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHH
Confidence 6777888999999999997 5699999999999999999999999965322 2345667777754 55566677999
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
++++|+++|. +|.+|.|+.+++.|||+......
T Consensus 298 aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 298 AKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred HHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 9999999999 99999999999999999876543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=289.35 Aligned_cols=182 Identities=29% Similarity=0.511 Sum_probs=160.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||++..+ ++.+.|++..++.|+..|+.||+|||++| |||||||.+|||+|.+ |.+||+|||+++..- .+...
T Consensus 450 y~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 450 YVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred ecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccCCCCCcc
Confidence 7889994443 45578999999999999999999999999 9999999999999998 899999999998743 55677
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++|||.|||||++.+ .|+.++|.|||||+|||||.|+.||.+ .+.++++..|..... .++...+.++..+++++
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~--~yP~~ls~ea~~il~~l 602 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSKEAIAIMRRL 602 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--CCCCcccHHHHHHHHHH
Confidence 89999999999999875 599999999999999999999999998 678889998887665 45667799999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCCCCCCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAGEPLLIPK 189 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~~~l~~p~ 189 (502)
|. +|.+|.. +.+|..||||+.-.|..+....
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 99 9999985 5889999999998887654433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=275.65 Aligned_cols=177 Identities=28% Similarity=0.404 Sum_probs=152.2
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 3 ~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
...+|.++++.+ +.|++..++.|+.||++||+|+|.+| +.||||||+|||+.++ ..|||+|||+|+.+......+.
T Consensus 92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPYTe 168 (538)
T KOG0661|consen 92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRSKPPYTE 168 (538)
T ss_pred hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccccCCCcch
Confidence 345899999866 45999999999999999999999999 9999999999999976 5899999999999988888889
Q ss_pred ccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC------------------
Q 010768 82 VIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG------------------ 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~------------------ 141 (502)
++.|.+|.|||++- +.|+.++||||+|||++|+.+-++.|.+..+.+++++...--..|.
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 99999999999764 5699999999999999999999999999888888887644211110
Q ss_pred --C-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 --A-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 --~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
. +-...++++.++|.+||. ||.+||||.|+|+||||+....
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0 011247889999999999 9999999999999999986543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=262.72 Aligned_cols=179 Identities=22% Similarity=0.392 Sum_probs=147.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe
Confidence 67899999988653 46999999999999999999999999 9999999999999877 7999999999987654444
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ..+...+.... ..+....+..+.+|
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~l 235 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--EEYSEKFSEDAKSI 235 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--ccCCccCCHHHHHH
Confidence 45567999999999886 46899999999999999999999999764322 22333332222 23444568899999
Q ss_pred HHHhhc-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
|.+||. +|.+||+ +++++.||||....+..
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 999999 9999997 89999999998866544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=269.09 Aligned_cols=177 Identities=25% Similarity=0.479 Sum_probs=150.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.+|+|..++...+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccc
Confidence 6889999999998889999999999999999999999999 9999999999999987 7999999999875322 2233
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .....+.+.+..+.. .++...++.+.+||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGL 229 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHH
Confidence 4567999999999886 4589999999999999999999999976 444555555554443 34456789999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+ ++.+++.||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99 999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=271.60 Aligned_cols=180 Identities=27% Similarity=0.441 Sum_probs=147.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCccccccccccc
Confidence 6889999999999899999999999999999999999999 9999999999999887 799999999987543210
Q ss_pred ---------------------------------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCC
Q 010768 78 ---------------------------------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123 (502)
Q Consensus 78 ---------------------------------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~ 123 (502)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 012457999999999876 4589999999999999999999999977
Q ss_pred CCChHHHHHHHHcCCCCCCcc--ccCCHHHHHHHHHhhcCc---CCCCCHHHHhcCccccCCCCCC
Q 010768 124 CSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVGKCLENV---SKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 124 ~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~dP---~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
......++++........++ ...++.+++||.+|+.+| ..||++.|++.||||+...+..
T Consensus 239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 239 -ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred -CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 45566677776533221122 235789999999977643 4578999999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=272.74 Aligned_cols=181 Identities=28% Similarity=0.490 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.+|++.+.++.. ..++|..|..|++++++||.|||.+| .||||||+.||||+.+ |.|||+|||....+-....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCceeeeeecccCc
Confidence 68999999999875 34999999999999999999999999 9999999999999998 8999999999866533211
Q ss_pred -----cccccCCCcccCccccc---ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-------CCCc
Q 010768 79 -----AHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-------PGAF 143 (502)
Q Consensus 79 -----~~~~~GT~~Y~APEvl~---~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-------p~~~ 143 (502)
..+++||++|||||++. ..|+.|+||||||++..||.+|..||........+..++..... +...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 15678999999999964 34999999999999999999999999986666666655554332 1122
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
.+..+..++.+|..||. ||.+|||++++|+|+||+......
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 33456789999999999 999999999999999999866544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=266.20 Aligned_cols=178 Identities=27% Similarity=0.430 Sum_probs=151.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999887 7999999999875322 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.. ......+..+.++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEGL 230 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998764 589999999999999999999999976 556667777766544 23344588999999999
Q ss_pred hc-CcCCCCCH----HHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPA----KELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa----~ElL~hpf~~~~~~~~ 184 (502)
|+ +|.+||++ .+++.||||....+..
T Consensus 231 l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 99999987 6999999998765533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.14 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=148.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~ 78 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 86 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~~~~~ 162 (332)
T cd05614 86 YVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKER 162 (332)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCccccccCCCc
Confidence 6889999999999889999999999999999999999999 9999999999999987 79999999999764322 22
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCC---CChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+..... .++...++.+++
T Consensus 163 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 240 (332)
T cd05614 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEAQD 240 (332)
T ss_pred cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 335679999999998864 3788999999999999999999999642 223344444443332 344557899999
Q ss_pred HHHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 154 FVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 154 LI~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
||.+||. +|.+|| ++++++.||||+...+..
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9999999 999999 889999999998765433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=268.17 Aligned_cols=176 Identities=26% Similarity=0.486 Sum_probs=150.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~ 78 (502)
|+.+|+|..++.+.+.+++..++.++.||+.||+|||+ +| |+||||||+|||++.+ +.+||+|||++.... ....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcc
Confidence 68899999999988899999999999999999999997 68 9999999999999987 799999999987543 2223
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+...+.+.+..... .++...++.+.+||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 229 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSG 229 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHH
Confidence 34567999999999886 4589999999999999999999999977 445566666655443 3445578999999999
Q ss_pred hhc-CcCCCC-----CHHHHhcCccccCCCC
Q 010768 158 CLE-NVSKRL-----PAKELLLDPFLASDAG 182 (502)
Q Consensus 158 cL~-dP~kRp-----sa~ElL~hpf~~~~~~ 182 (502)
||. +|.+|+ ++.+++.||||....+
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 999 999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.68 Aligned_cols=177 Identities=24% Similarity=0.444 Sum_probs=152.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCccc
Confidence 6889999999999899999999999999999999999999 9999999999999987 7999999999875432 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+++.+..+.. .++...+..+.++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAF 230 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999987 456667777776554 23345688999999999
Q ss_pred hc-CcCCCC-------CHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRL-------PAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRp-------sa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+ ++.+++.||||....+.
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 99 999999 99999999999875554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=266.46 Aligned_cols=178 Identities=24% Similarity=0.446 Sum_probs=152.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999987 7999999999975432 2233
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+ .+...+...+..... .++...+..+.++|.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL 235 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHH
Confidence 4567999999999876 4589999999999999999999999977 455667777766554 34455789999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+|++ ..+++.||||+...+..
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred cccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 99 9999997 48999999998766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=268.68 Aligned_cols=177 Identities=29% Similarity=0.457 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCc
Confidence 6889999999999899999999999999999999999999 9999999999999987 799999999987532 22334
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.... .....++.+++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~ 231 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKG 231 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHH
Confidence 45679999999998754 478999999999999999999999976 55666777777665432 223468899999999
Q ss_pred hhc-CcCCCC----CHHHHhcCccccCCCC
Q 010768 158 CLE-NVSKRL----PAKELLLDPFLASDAG 182 (502)
Q Consensus 158 cL~-dP~kRp----sa~ElL~hpf~~~~~~ 182 (502)
||. +|.+|| ++.+++.||||....+
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 999 999998 7999999999987554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=265.62 Aligned_cols=177 Identities=24% Similarity=0.464 Sum_probs=151.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCce
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999987532 22233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .....++..+..... .++...+..+.++|.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999976 455666777766543 34456788999999999
Q ss_pred hc-CcCCCCCH-----HHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPA-----KELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa-----~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+++ .+++.||||....+.
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99 99999976 899999999876553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.38 Aligned_cols=177 Identities=26% Similarity=0.482 Sum_probs=150.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.+|+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcc
Confidence 6899999999998889999999999999999999999999 9999999999999987 7999999999875322 2233
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++. +.++.++|||||||++|+|++|..||.. .+.......+..... .++...++.+++||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 4567999999999886 4589999999999999999999999976 444555555554443 23456689999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+ ++.+++.||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99 999998 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.71 Aligned_cols=180 Identities=23% Similarity=0.397 Sum_probs=148.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCCCce
Confidence 68899999999886 77999999999999999999999999 9999999999999987 7999999999987643322
Q ss_pred -cccccCCCcccCccccc-------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCC
Q 010768 79 -AHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQD 148 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s 148 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+..+........+ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCC
Confidence 23347899999999874 34788999999999999999999999774 444455555543321112 22458
Q ss_pred HHHHHHHHHhhcCcCCCCCHHHHhcCccccCCCCCC
Q 010768 149 AEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 149 ~~l~~LI~kcL~dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
..+.+||.+||.+|.+||++.+++.||||....+..
T Consensus 238 ~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred HHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence 899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.28 Aligned_cols=176 Identities=27% Similarity=0.514 Sum_probs=149.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCce
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999987532 12233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+.+.+..+.. .++...+..+++||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 230 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKL 230 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999976 455566666654432 33445688999999999
Q ss_pred hc-CcCCCCCH-HHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPA-KELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa-~ElL~hpf~~~~~~ 182 (502)
|. +|.+|+++ .+++.||||....+
T Consensus 231 l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 231 FERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred ccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 99 99999997 58889999987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=264.07 Aligned_cols=177 Identities=29% Similarity=0.415 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|.+++.+.+.+.+..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence 6889999999999899999999999999999999999999 9999999999999887 7999999999875432 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..+.. .++...++.+.+||.+|
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKKL 234 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999977 445555666666554 33445688999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|| ++.+++.||||....+.
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99 999999 89999999999876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.36 Aligned_cols=176 Identities=29% Similarity=0.529 Sum_probs=150.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999887 7999999999976432 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++...+..... .++...+..+.+||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKL 230 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999987 455666666654432 34456788999999999
Q ss_pred hc-CcCCCCCH-HHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPA-KELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa-~ElL~hpf~~~~~~ 182 (502)
|. +|.+||++ .+++.||||....+
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 231 FERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ccCCHHHcCCChHHHHcCcccCCCCH
Confidence 99 99999986 58889999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=268.13 Aligned_cols=179 Identities=27% Similarity=0.448 Sum_probs=148.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceecccccccc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999987543211
Q ss_pred ------------------------------------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCC
Q 010768 78 ------------------------------------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP 120 (502)
Q Consensus 78 ------------------------------------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~P 120 (502)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 112346999999999875 4589999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCCCCC--ccccCCHHHHHHHHHhhcCcCCCCC---HHHHhcCccccCCCCC
Q 010768 121 YSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGE 183 (502)
Q Consensus 121 f~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~dP~kRps---a~ElL~hpf~~~~~~~ 183 (502)
|... ........+........ .....++.+++||.+||.+|.+|++ +.+++.||||+...+.
T Consensus 239 f~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 239 FCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 9874 45555555554332211 2224588999999999999999997 9999999999876553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=264.95 Aligned_cols=177 Identities=21% Similarity=0.434 Sum_probs=147.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~-~~~~~~ 79 (502)
|+.||+|.+++.+.+++++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.. ......
T Consensus 77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCcc
Confidence 6899999999998889999999999999999999999999 9999999999999887 79999999998753 222334
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--------CChHHHHHHHHcCCCCCCccccCCHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+.+.+..... ..+...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~ 231 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK 231 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHH
Confidence 45689999999998864 5899999999999999999999999631 112234444554433 334556889
Q ss_pred HHHHHHHhhc-CcCCCCC------HHHHhcCccccCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLP------AKELLLDPFLASDAG 182 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRps------a~ElL~hpf~~~~~~ 182 (502)
+.++|.+||. +|.+|++ +.+++.||||....+
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999 9999987 789999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.01 Aligned_cols=177 Identities=30% Similarity=0.523 Sum_probs=157.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~---g~vKL~DFGlA~~~~~~~ 77 (502)
||.||.|.+.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+.... +.+|++|||++.......
T Consensus 117 L~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred ecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 68999999999887 5999999999999999999999999 99999999999997542 479999999999988766
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~L 154 (502)
.....+||+.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .........+..+.+ +...+...+..+++|
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 788899999999999998 6799999999999999999999999988 444556667777765 344555669999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|.+||. ||.+|+++.++|.|||++...
T Consensus 273 i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999 999999999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=255.83 Aligned_cols=171 Identities=34% Similarity=0.493 Sum_probs=139.3
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...........
T Consensus 92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 168 (290)
T cd07862 92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS 168 (290)
T ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccccceEeccCCccccc
Confidence 47899999764 45899999999999999999999999 9999999999999887 7999999999987655444456
Q ss_pred ccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CC----------------
Q 010768 82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GA---------------- 142 (502)
Q Consensus 82 ~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~---------------- 142 (502)
..||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+.+.+.....+ ..
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (290)
T cd07862 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 248 (290)
T ss_pred ccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCC
Confidence 67999999999875 468999999999999999999999998754444333322211110 00
Q ss_pred ------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 ------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 ------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.....++.+++||.+||. +|++||++.|+|+||||
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 249 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012346788999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=261.86 Aligned_cols=176 Identities=26% Similarity=0.502 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999987532 22233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..... .++...+..+.+||.+|
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSF 230 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence 44679999999998864 589999999999999999999999976 455666666665543 33455688999999999
Q ss_pred hc-CcCCCCCH-----HHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPA-----KELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa-----~ElL~hpf~~~~~~ 182 (502)
|. +|.+||++ .+++.||||+...+
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99 99999999 99999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.39 Aligned_cols=180 Identities=27% Similarity=0.473 Sum_probs=148.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCcccccccccc
Confidence 6889999999999889999999999999999999999999 9999999999999887 799999999986542210
Q ss_pred ---------------------------------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCC
Q 010768 78 ---------------------------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE 123 (502)
Q Consensus 78 ---------------------------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~ 123 (502)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 0124579999999998764 589999999999999999999999977
Q ss_pred CCChHHHHHHHHcCCCCCCc--cccCCHHHHHHHHHhhcCcCCCC---CHHHHhcCccccCCCCCC
Q 010768 124 CSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFVGKCLENVSKRL---PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 124 ~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~dP~kRp---sa~ElL~hpf~~~~~~~~ 184 (502)
......+..+........+ ....++.+++||.+|+.+|.+|+ ++.+++.||||....+..
T Consensus 239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 239 -ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred -CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 4555666666543221111 22358899999999877999888 589999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=262.79 Aligned_cols=179 Identities=21% Similarity=0.404 Sum_probs=149.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCce
Confidence 6889999999998889999999999999999999999999 9999999999999987 799999999987532 22334
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCC------CChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~------~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+.+.+..... .++...+..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~ 231 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKAS 231 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHH
Confidence 4567999999999876 45899999999999999999999999532 222344555544433 34556788999
Q ss_pred HHHHHhhc-CcCCCCC------HHHHhcCccccCCCCCC
Q 010768 153 RFVGKCLE-NVSKRLP------AKELLLDPFLASDAGEP 184 (502)
Q Consensus 153 ~LI~kcL~-dP~kRps------a~ElL~hpf~~~~~~~~ 184 (502)
++|.+||. +|.+|++ +.+++.||||....+..
T Consensus 232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 99999999 9999997 57999999998866543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=263.58 Aligned_cols=176 Identities=27% Similarity=0.424 Sum_probs=149.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCc
Confidence 6889999999999899999999999999999999999999 9999999999999887 7999999999875322 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+++.+...... .....+..+.++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~l 230 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEEL 230 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999976 4556667777665442 2334678899999999
Q ss_pred hc-CcCCCCCH----HHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPA----KELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa----~ElL~hpf~~~~~~ 182 (502)
|. +|.+||++ .+++.||||....+
T Consensus 231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred hccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 99 99999976 59999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=261.65 Aligned_cols=177 Identities=26% Similarity=0.490 Sum_probs=150.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCce
Confidence 6889999999998888999999999999999999999999 9999999999999987 7999999999875322 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++.+.+..... .++...+..+++||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKL 230 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999977 455666666655433 23445688999999999
Q ss_pred hc-CcCCCCCHH-HHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPAK-ELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa~-ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+++. +++.||||....+.
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 231 FVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred hccCHhhcCCChHHHHcCcccCCCCHH
Confidence 99 999999996 89999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=262.12 Aligned_cols=178 Identities=26% Similarity=0.424 Sum_probs=151.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|.+++.+.+.+.+..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCc
Confidence 6889999999999888999999999999999999999999 9999999999999887 7999999999875422 2234
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....++.+..... ......+..++++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGL 230 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999976 455666666665443 23345688999999999
Q ss_pred hc-CcCCCCCHH----HHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPAK----ELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa~----ElL~hpf~~~~~~~~ 184 (502)
|. +|.+|+++. ++++|+||....+..
T Consensus 231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred cccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 99 999999876 899999998765544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=262.20 Aligned_cols=177 Identities=21% Similarity=0.415 Sum_probs=147.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.+|+|..++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcc
Confidence 6889999999998889999999999999999999999999 9999999999999987 799999999987532 22233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--------CChHHHHHHHHcCCCCCCccccCCHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... .++...+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~ 231 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK 231 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHH
Confidence 45679999999998864 5889999999999999999999999521 112234444444433 344566889
Q ss_pred HHHHHHHhhc-CcCCCCC------HHHHhcCccccCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLP------AKELLLDPFLASDAG 182 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRps------a~ElL~hpf~~~~~~ 182 (502)
+.++|.+||. +|.+|++ +.+++.||||+...+
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999 9999998 589999999987655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=261.73 Aligned_cols=180 Identities=28% Similarity=0.434 Sum_probs=151.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC---
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--- 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~--- 75 (502)
||.||+|...++++ +.+++..++.|+.+|+.||+|||..| ||+|||||+||||..+ |+|.|.||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCCCCCe
Confidence 89999999999876 56999999999999999999999999 9999999999999988 8999999998743200
Q ss_pred ------------------------------C-C-----------------------CcccccCCCcccCccccccc-CCc
Q 010768 76 ------------------------------S-Q-----------------------HAHSVIGTPEFMAPELYEED-YNE 100 (502)
Q Consensus 76 ------------------------------~-~-----------------------~~~~~~GT~~Y~APEvl~~~-~s~ 100 (502)
. . ...+++||-.|+|||++.|. .+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 01246899999999999875 889
Q ss_pred ccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCC----HHHHhcCc
Q 010768 101 LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP----AKELLLDP 175 (502)
Q Consensus 101 ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRps----a~ElL~hp 175 (502)
++|+|+||+++||||.|..||.+..+.+- ...|....+..+.....+..+++||+++|. ||.+|.. |.||-+||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 99999999999999999999999655544 445554444333333567899999999999 9999998 99999999
Q ss_pred cccCCCCCC
Q 010768 176 FLASDAGEP 184 (502)
Q Consensus 176 f~~~~~~~~ 184 (502)
||++..|..
T Consensus 394 FF~gVnWaL 402 (459)
T KOG0610|consen 394 FFEGVNWAL 402 (459)
T ss_pred cccCCChhh
Confidence 999999975
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=266.50 Aligned_cols=178 Identities=26% Similarity=0.442 Sum_probs=144.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeecccccccccccccc
Confidence 6889999999999899999999999999999999999999 9999999999999877 799999999986321100
Q ss_pred ---------------------------------------------CcccccCCCcccCcccccc-cCCcccchhhhhHHH
Q 010768 78 ---------------------------------------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV 111 (502)
Q Consensus 78 ---------------------------------------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iL 111 (502)
.....+||+.|+|||++.+ .++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0012469999999998764 589999999999999
Q ss_pred HHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHHHHHHHHHhhcCcCC---CCCHHHHhcCccccCCCC
Q 010768 112 LEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVGKCLENVSK---RLPAKELLLDPFLASDAG 182 (502)
Q Consensus 112 yeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~dP~k---Rpsa~ElL~hpf~~~~~~ 182 (502)
|+|++|..||.. ......+..+........++ ...+..+++||.+||.+|.+ |+++.+++.||||+...+
T Consensus 239 ~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 239 FECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999999999977 34455555555432211222 24578999999999996655 569999999999987554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=258.52 Aligned_cols=171 Identities=30% Similarity=0.500 Sum_probs=143.1
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCccccc
Q 010768 6 TLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHAHSVI 83 (502)
Q Consensus 6 sL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~~~~~ 83 (502)
|+.+-|.++ ..++.+.++.++.|++.|+.|||+++ +|||||||+||||+.+ |.+||||||+|+.+. .+...+.++
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~YTDYV 162 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNYTDYV 162 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcCCcchhhhhh
Confidence 344444444 55999999999999999999999999 9999999999999988 899999999999887 445567789
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC-------------------CC
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-------------------PG 141 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~-------------------p~ 141 (502)
.|.+|.|||++-+ +|+..+||||+||++.||++|++.|++.++.++++..+.. |.+ |.
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~ 242 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE 242 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence 9999999998865 5999999999999999999999999999999988765432 221 11
Q ss_pred C-----cc---ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 142 A-----FH---RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 142 ~-----~~---~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
. +. ...+..+.+|+++||. ||.+|++.+++|.||||..
T Consensus 243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1 00 1235678899999999 9999999999999999943
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=273.42 Aligned_cols=176 Identities=30% Similarity=0.506 Sum_probs=153.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
||.||++.+.++..+.+++.++..++++++.||.|||.++ .+|||||+.|||+..+ |.+||+|||++.++.... ..
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeechhhcc
Confidence 6899999999998888899999999999999999999999 9999999999999998 899999999998876543 34
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++|||.|||||++.+ .|+.++||||||++.+||++|.+|+..... ......|.+ ..|+.+....++.+++||..|
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk-~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPK-SAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccC-CCCCccccccCHHHHHHHHHH
Confidence 78999999999999886 699999999999999999999999988543 222222222 334455667799999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|+.||+|.+||+|+|++...
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcC
Confidence 99 999999999999999998743
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=259.91 Aligned_cols=177 Identities=25% Similarity=0.386 Sum_probs=150.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|..++.+...+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCcc
Confidence 6889999999998888999999999999999999999999 9999999999999987 7999999999875322 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..... .++...+..+.++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGL 230 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 589999999999999999999999977 455667777766543 34445688999999999
Q ss_pred hc-CcCCCCCH----HHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPA----KELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa----~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|+++ .+++.|+||....+.
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 99 99999875 599999999875543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=266.42 Aligned_cols=179 Identities=26% Similarity=0.402 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCcccccccccc
Confidence 6889999999998888999999999999999999999999 9999999999999887 79999999997532100
Q ss_pred --------------------------------------------CCcccccCCCcccCccccc-ccCCcccchhhhhHHH
Q 010768 77 --------------------------------------------QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCV 111 (502)
Q Consensus 77 --------------------------------------------~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iL 111 (502)
......+||+.|+|||++. ..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0012357999999999876 4599999999999999
Q ss_pred HHHhhccCCCCCCCChHHHHHHHHcCC--CCCCccccCCHHHHHHHHHhhcCcCCCCC---HHHHhcCccccCCCCC
Q 010768 112 LEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGE 183 (502)
Q Consensus 112 yeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~dP~kRps---a~ElL~hpf~~~~~~~ 183 (502)
|+|++|+.||... +..+....+.... .+.......++.+.++|.+|+.+|.+|++ +.+++.||||+...+.
T Consensus 239 ~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 239 YEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999874 4444444444322 22222334688999999998889999987 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=261.62 Aligned_cols=176 Identities=27% Similarity=0.422 Sum_probs=150.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+|+|.+++.+...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCce
Confidence 6889999999998888999999999999999999999999 9999999999999887 79999999998765433 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .........+..... ..+...++.+++||.+|
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRAL 232 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999977 445556666665544 23445688999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~ 182 (502)
|. +|.+||+ +.+++.||||....+
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 99 9999999 788999999987544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.78 Aligned_cols=178 Identities=26% Similarity=0.402 Sum_probs=144.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccccc
Confidence 6889999999999889999999999999999999999999 9999999999999887 79999999997532100
Q ss_pred ----------------------------------------CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHh
Q 010768 77 ----------------------------------------QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEML 115 (502)
Q Consensus 77 ----------------------------------------~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLL 115 (502)
......+||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00123579999999998864 5899999999999999999
Q ss_pred hccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHHHHHhhcCcCCCC---CHHHHhcCccccCCCC
Q 010768 116 TSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLENVSKRL---PAKELLLDPFLASDAG 182 (502)
Q Consensus 116 tG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~dP~kRp---sa~ElL~hpf~~~~~~ 182 (502)
+|+.||.+. ........+..... ........++.+.++|.+|+.+|.+|+ ++.+++.||||+....
T Consensus 239 ~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 239 VGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred hCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 999999874 34444444443221 222223468899999999888999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=265.09 Aligned_cols=178 Identities=22% Similarity=0.438 Sum_probs=148.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.||+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeeccCCCccc
Confidence 68899999998764 6899999999999999999999999 9999999999999887 799999999998764322 2
Q ss_pred cccccCCCcccCcccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l 151 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. ......+..+........++ ...+..+
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 235679999999998753 378899999999999999999999987 44555666666543222222 2468999
Q ss_pred HHHHHHhhc-CcCC--CCCHHHHhcCccccCCCCC
Q 010768 152 RRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 152 ~~LI~kcL~-dP~k--Rpsa~ElL~hpf~~~~~~~ 183 (502)
++||.+||. +|.+ |+++.+++.||||+...+.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999999999 7876 9999999999999886553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=273.15 Aligned_cols=176 Identities=28% Similarity=0.420 Sum_probs=142.2
Q ss_pred CCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 4 SGTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 4 gGsL~~~L~----k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
+|+|.+++. ....+++..++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||+++.+......
T Consensus 150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~ 227 (440)
T PTZ00036 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227 (440)
T ss_pred CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc
Confidence 467877775 3467999999999999999999999999 9999999999999876567999999999876554445
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC------------------C
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------L 139 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~------------------~ 139 (502)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+.+.+.... +
T Consensus 228 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 307 (440)
T PTZ00036 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKF 307 (440)
T ss_pred ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccC
Confidence 56788999999998754 589999999999999999999999987655544443332110 0
Q ss_pred CC--------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 140 PG--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 140 p~--------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+. .++...++++.+||.+||. +|.+||++.|+|.||||....
T Consensus 308 ~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 308 PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 10 1122356789999999999 999999999999999997643
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=259.74 Aligned_cols=175 Identities=28% Similarity=0.503 Sum_probs=148.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|..++.+ +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 83 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 83 YAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred CCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCCcc
Confidence 6889999998865 57999999999999999999999999 9999999999999987 7999999999875322 2233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...+...+..+.. .++...+..+.++|.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISIMRRL 235 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999977 455566666665543 23445688999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~ 182 (502)
|. +|.+|| ++.+++.||||+...+
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 99 999999 7999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=259.54 Aligned_cols=176 Identities=28% Similarity=0.510 Sum_probs=143.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+...+++..+..++.||+.||.|||+. + |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCccccccccc-cc
Confidence 688999999999988899999999999999999999974 6 9999999999999987 79999999999765432 23
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHH-------------------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK------------------------- 133 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~------------------------- 133 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ....+...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccccccc
Confidence 45679999999998864 5899999999999999999999999653 22222211
Q ss_pred ---------------------HHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 134 ---------------------VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 134 ---------------------i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+.....+.......++++++||.+||. ||++||++.++|.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 111112222223457889999999999 999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=258.70 Aligned_cols=176 Identities=29% Similarity=0.407 Sum_probs=139.3
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----HA 79 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----~~ 79 (502)
+++|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++...... ..
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 163 (338)
T cd07859 87 ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFW 163 (338)
T ss_pred CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCccccccccccCccccc
Confidence 5799999998889999999999999999999999999 9999999999999887 799999999997543211 12
Q ss_pred ccccCCCcccCccccc---ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHH--------------HHHHHc------
Q 010768 80 HSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--------------YKKVTS------ 136 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~---~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i--------------~~~i~~------ 136 (502)
...+||+.|+|||++. ..++.++|||||||++|+|++|++||.+......+ ...+..
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 3457999999999875 35899999999999999999999999764322211 111100
Q ss_pred -----CCCCCCc---cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 137 -----GKLPGAF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 137 -----~~~p~~~---~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
...+..+ ....++.+.++|.+||. +|.+||++.|+|.||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0011000 11246788999999999 9999999999999999986443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=259.01 Aligned_cols=177 Identities=23% Similarity=0.435 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.||+|.+++.+.+.+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCccc
Confidence 6889999999999899999999999999999999999999 9999999999999987 79999999998754322 223
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .....+.+.+..... .++...+..+.+++.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGL 235 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 45679999999998764 589999999999999999999999977 455666777766544 33455688999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|++ ..+++.||||....+.
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 99 9999997 5789999999976553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=252.63 Aligned_cols=174 Identities=22% Similarity=0.362 Sum_probs=138.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.++.|..+......+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccccccc
Confidence 5777777766666677999999999999999999999999 9999999999999887 799999999998764322 2
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC-----------------
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL----------------- 139 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~----------------- 139 (502)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||............... +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 234578999999998754 5899999999999999999999999875443332221110 110
Q ss_pred --CC---------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 140 --PG---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 140 --p~---------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+. ......+..+.+||.+||. +|.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0011257789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=276.17 Aligned_cols=181 Identities=34% Similarity=0.595 Sum_probs=160.2
Q ss_pred CCCCCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 2 FTSGTLREYRKK-YTRV--DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 2 ~~gGsL~~~L~k-~~~L--se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
+.||+|.++|+. .+++ ++..+..+.+||++||.|||.+. |||||||-+||||+.-.|.+||.|||.++.+.+- .
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 479999999975 5888 99999999999999999999999 9999999999999988899999999999887553 4
Q ss_pred CcccccCCCcccCccccc-c--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-E--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
...++.||..|||||++. | .|+.++|||||||++.||.||++||.+..++...+-++.--+..+..+...+.+++.|
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 456789999999999986 3 4999999999999999999999999998888777777665555566677779999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
|.+|+. +|.+||+|+++|.+||++..+.++
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~~kk~ 842 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHNNKKP 842 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccCCCCC
Confidence 999999 999999999999999999774443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=252.54 Aligned_cols=179 Identities=27% Similarity=0.460 Sum_probs=145.6
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++..+...
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCC
Confidence 6889999988853 356999999999999999999999999 9999999999999876 79999999999765433
Q ss_pred C-CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHHcCCCCCCccccCCHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ..+...+.... ...+...+..+
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPAS 228 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHHH
Confidence 2 233457899999999886 45889999999999999999999999763322 22233332222 23344568899
Q ss_pred HHHHHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 152 RRFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
.+++.+||. +|.+|| ++++++.||||+...+..
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 999999999 999999 889999999998865554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.33 Aligned_cols=175 Identities=22% Similarity=0.318 Sum_probs=138.0
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCC---------------CcEEEEe
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHL---------------GQVKIGD 66 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~---------------g~vKL~D 66 (502)
.|++|.+++.+.+.+++..++.|+.||+.||+|||+ .| ||||||||+|||++... ..+||+|
T Consensus 214 ~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~D 291 (467)
T PTZ00284 214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291 (467)
T ss_pred cCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCceEEECC
Confidence 488999999998999999999999999999999997 48 99999999999998642 1499999
Q ss_pred cCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCCCC-
Q 010768 67 LGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPGA- 142 (502)
Q Consensus 67 FGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p~~- 142 (502)
||.+.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+. .+.. +.+|..
T Consensus 292 fG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~g~~p~~~ 368 (467)
T PTZ00284 292 LGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH-LMEKTLGRLPSEW 368 (467)
T ss_pred CCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHcCCCCHHH
Confidence 99885432 22345789999999998764 59999999999999999999999997744332221 1111 111100
Q ss_pred -------------------------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 143 -------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 143 -------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.....++.+.+||.+||. ||.+|||++|+|.||||.....
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 369 AGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 001124567899999999 9999999999999999986443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=270.02 Aligned_cols=174 Identities=37% Similarity=0.604 Sum_probs=156.8
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
||+||+|.+.|++.+ .++++.+..|+.||+.||+|||++. |+|||||+.|||++.+ +.|||+|||+|+.+....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcCCchh
Confidence 899999999998654 5999999999999999999999888 9999999999999988 688999999999987765
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...+++|||.||+||++.+ +|+.|+|||||||++|||++-+++|.. .+...+..++..+... +.+...+.+++.+|.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~~-Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLYS-PLPSMYSSELRSLVK 239 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccCC-CCCccccHHHHHHHH
Confidence 6788999999999999986 599999999999999999999999987 6777777778777643 455667899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.||. +|..||++.++|.+|.++.
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhhh
Confidence 9999 9999999999999988864
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.19 Aligned_cols=178 Identities=26% Similarity=0.380 Sum_probs=142.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCcccccccccc
Confidence 6889999999999889999999999999999999999999 9999999999999887 79999999997532100
Q ss_pred --------------------------------------------CCcccccCCCcccCccccc-ccCCcccchhhhhHHH
Q 010768 77 --------------------------------------------QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCV 111 (502)
Q Consensus 77 --------------------------------------------~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iL 111 (502)
......+||+.|+|||++. ..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0012457999999999876 4589999999999999
Q ss_pred HHHhhccCCCCCCCChHHHHHHHHcC--CCCCCccccCCHHHHHHHHHhhc---CcCCCCCHHHHhcCccccCCCC
Q 010768 112 LEMLTSEYPYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE---NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 112 yeLLtG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~s~~l~~LI~kcL~---dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
|+|++|..||.... .......+... ..........++++++||.+|+. ++..|+++.+++.||||....+
T Consensus 239 ~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 239 FEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 99999999998744 33333344322 22222223468899999999664 5566999999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.32 Aligned_cols=177 Identities=24% Similarity=0.455 Sum_probs=144.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.||+|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceecccCCcee
Confidence 68899999999764 6899999999999999999999999 9999999999999887 799999999998764322 2
Q ss_pred cccccCCCcccCcccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l 151 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+........+ ....+..+
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 245679999999998753 278899999999999999999999977 4445556666554322222 22458899
Q ss_pred HHHHHHhhc-CcC--CCCCHHHHhcCccccCCCC
Q 010768 152 RRFVGKCLE-NVS--KRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 152 ~~LI~kcL~-dP~--kRpsa~ElL~hpf~~~~~~ 182 (502)
+++|.+||. ++. .|+++.|+++||||+...+
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 999999998 443 4899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=260.83 Aligned_cols=176 Identities=31% Similarity=0.457 Sum_probs=150.1
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 5 GTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 5 GsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
.||.++++. +.+++...++-++.||++||.|||++| |+||||||+|||+|.+.|.+||+|||.|+.+..+....
T Consensus 106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni 183 (364)
T KOG0658|consen 106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI 183 (364)
T ss_pred HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence 477777775 578999999999999999999999999 99999999999999999999999999999998887778
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC------------------CC
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------LP 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~------------------~p 140 (502)
+++.|..|.|||++-+ .|+.+.||||.||++.||+-|++.|.+.+..+++...+.--. .|
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p 263 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP 263 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence 8999999999997754 699999999999999999999999999766666543332110 01
Q ss_pred --------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 141 --------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 141 --------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
..+....++++.+|+.++|. +|.+|.++.|+|.||||.....
T Consensus 264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11334468999999999999 9999999999999999976543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=258.61 Aligned_cols=174 Identities=30% Similarity=0.429 Sum_probs=144.8
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC---CCCcc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---SQHAH 80 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~---~~~~~ 80 (502)
+-+|...++....|+...+..++.||+.||.|+|+.| |+||||||.|+|++.+ ..+||+|||+|+.... ....+
T Consensus 109 etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~~~~~~mT 185 (359)
T KOG0660|consen 109 ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKFFEDGFMT 185 (359)
T ss_pred hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeeccccCcccchh
Confidence 4578899988888999999999999999999999999 9999999999999998 6899999999998753 34456
Q ss_pred cccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc----------------------
Q 010768 81 SVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---------------------- 136 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---------------------- 136 (502)
.++-|.+|.|||++. ..|+.+.||||+|||+.||++|++.|.+.....++...+..
T Consensus 186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~ 265 (359)
T KOG0660|consen 186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK 265 (359)
T ss_pred cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence 788999999999764 46999999999999999999999999886555444221111
Q ss_pred --CCCCC-C---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 137 --GKLPG-A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 137 --~~~p~-~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
...|. . .-...++.+.+|+++||. ||.+|+|++|+|.|||+..-
T Consensus 266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 1 112458899999999999 99999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=270.03 Aligned_cols=173 Identities=26% Similarity=0.435 Sum_probs=152.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-A 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~ 79 (502)
||.| +|+.+|...+.++++.++.++.|++.||.|||+++ |+|||+||.|||+.+. +.+|++|||+|+.+..... .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCceee
Confidence 4455 99999999999999999999999999999999999 9999999999999987 8999999999998765433 4
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....|||.|||||++.+ .|+..+|+||+|||+|||++|++||.. ....++.+.|.....+ ++...+..+..|+..+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPVK--PPSTASSSFVNFLQGL 234 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCCC--CcccccHHHHHHHHHH
Confidence 56789999999998875 599999999999999999999999976 5566677777766543 3446788999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. ||.+|.+..+++.|||.++.
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcChhhcccHHHHhcChHHhhh
Confidence 99 99999999999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=248.96 Aligned_cols=171 Identities=31% Similarity=0.444 Sum_probs=137.4
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
.++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...........
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~ 166 (288)
T cd07863 90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTP 166 (288)
T ss_pred ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCccccccCcccCCC
Confidence 36899998764 34899999999999999999999999 9999999999999887 7999999999987654444455
Q ss_pred ccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC------CCC-------------
Q 010768 82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------LPG------------- 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~------~p~------------- 141 (502)
..||+.|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+.... .+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07863 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG 246 (288)
T ss_pred ccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCC
Confidence 67899999999875 4589999999999999999999999977444333322221100 000
Q ss_pred -----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 142 -----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 142 -----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
......+..++++|.+||. ||.+||++.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 247 PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112346788999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=266.26 Aligned_cols=180 Identities=22% Similarity=0.485 Sum_probs=148.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
||..|.+..--.....+++.+++.|+++++.||+|||.+| ||||||||+|+||+.+ |.|||+|||.+.....+.
T Consensus 191 y~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsDFGVs~~~~~~~~~~ 267 (576)
T KOG0585|consen 191 YCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISDFGVSNEFPQGSDEG 267 (576)
T ss_pred eccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeeccceeeecccCCccc
Confidence 3444444433222233999999999999999999999999 9999999999999998 899999999998763321
Q ss_pred ---CcccccCCCcccCcccccc-c----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 78 ---HAHSVIGTPEFMAPELYEE-D----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 78 ---~~~~~~GT~~Y~APEvl~~-~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.....+|||.|+|||++.+ . .+.+.||||+||+||.|+.|+.||.+ .....++.+|....+..+......+
T Consensus 268 ~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~pL~fP~~pe~~e 346 (576)
T KOG0585|consen 268 SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDPLEFPENPEINE 346 (576)
T ss_pred cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCcccCCCcccccH
Confidence 2234689999999998754 1 46789999999999999999999987 6677889999888775554555689
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
.+++||.+||. ||.+|+++.+|..|||.......+
T Consensus 347 ~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 347 DLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 99999999999 999999999999999998765443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=264.74 Aligned_cols=176 Identities=26% Similarity=0.436 Sum_probs=158.6
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 3 ~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
.+|+|++||-++ ..+.+..+++|+.||+.|+.|||+.. +|||||||+||.+-...|-|||.|||++..+..+....+
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 579999999887 55999999999999999999999988 999999999999888889999999999999888888999
Q ss_pred ccCCCcccCccccccc-C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 82 VIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~~-~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
.+|+..|.|||++-|. | .+++||||||+|||.|++|++||.. .+..+....|...++ ..+...+.++++||..||
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-ANDSETLTmImDCKY--tvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-ANDSETLTMIMDCKY--TVPSHVSKECRDLIQSML 254 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-ccchhhhhhhhcccc--cCchhhhHHHHHHHHHHH
Confidence 9999999999988764 5 5789999999999999999999988 566667777877776 456677999999999999
Q ss_pred c-CcCCCCCHHHHhcCccccCCCCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
. +|.+|.+.+||..++|++..+..
T Consensus 255 vRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hcCchhhccHHHHhccccccCCCCC
Confidence 9 99999999999999999986553
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=253.10 Aligned_cols=175 Identities=23% Similarity=0.384 Sum_probs=138.0
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
+|+|.+++.+. +.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 86 HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceeccCCCccCCC
Confidence 57888888764 56999999999999999999999999 9999999999999887 79999999998754322 22344
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCC---------------CCC
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL---------------PGA 142 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~---------------p~~ 142 (502)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+.. +.. +..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 578999999998753 4788999999999999999999999875554433333211 000 000
Q ss_pred c-------------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 143 F-------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 143 ~-------------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+ ....++.+++||.+||. +|.+|||+.|+|.||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 00124678899999999 999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=251.38 Aligned_cols=171 Identities=22% Similarity=0.382 Sum_probs=135.2
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
.|+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 86 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 86 DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeeccCCCccccC
Confidence 369999997654 4899999999999999999999999 9999999999999887 799999999997653322 2334
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--------------------C
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--------------------L 139 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--------------------~ 139 (502)
..+++.|+|||++.+ .++.++||||+||++|+|++|+.||.+......+...+.... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 578999999998753 489999999999999999999999987443332221111100 0
Q ss_pred CC-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 140 PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 140 p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+. ......+.++++||.+||. +|.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0011346789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=243.12 Aligned_cols=173 Identities=33% Similarity=0.573 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||+.| |+||||||+||+++.+ +.++|+|||++........
T Consensus 85 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 85 YMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred ECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecccccccc
Confidence 5789999999999889999999999999999999999999 9999999999999876 7999999999976533211
Q ss_pred --cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....|+..|+|||++.+ .++.++||||||+++|+|++|+.||.......... .+.........+...+..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHHHH
Confidence 123567889999998864 48899999999999999999999997754443333 34444333445566789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccc
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+||. +|.+||++.+++.||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=248.14 Aligned_cols=178 Identities=26% Similarity=0.432 Sum_probs=145.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~ 153 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 153 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceecccc-Ccc
Confidence 6889999999998889999999999999999999999999 9999999999999877 79999999998755432 223
Q ss_pred cccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...|++.|+|||.+. ..++.++||||+||++|+|++|..||..... ...+..... ..+...+...+..++++|.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLE 231 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHH
Confidence 456899999999875 3478999999999999999999999965322 222222111 1222344556889999999
Q ss_pred Hhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 157 KCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 157 kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
+||. +|.+|+ +++++++||||+...+..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 9999 999999 699999999998855433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=255.16 Aligned_cols=179 Identities=22% Similarity=0.413 Sum_probs=145.2
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccCCcc
Confidence 6889999999987 467999999999999999999999999 9999999999999877 7999999999876533222
Q ss_pred -cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc---cccCC
Q 010768 79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF---HRIQD 148 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~---~~~~s 148 (502)
....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. ....+.+..+........+ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccCC
Confidence 23357999999999874 3488999999999999999999999987 4455556666554321111 23458
Q ss_pred HHHHHHHHHhhc-C--cCCCCCHHHHhcCccccCCCCC
Q 010768 149 AEARRFVGKCLE-N--VSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 149 ~~l~~LI~kcL~-d--P~kRpsa~ElL~hpf~~~~~~~ 183 (502)
+.+++||.+||. + +..|+++.+++.||||....+.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 899999999997 3 3447899999999999876553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=247.25 Aligned_cols=178 Identities=23% Similarity=0.410 Sum_probs=144.9
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++...+ .+++..+..++.||+.||+|||+.| |+||||||+|||++.+ +.++|+|||++........
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCce
Confidence 678999999986543 5899999999999999999999999 9999999999999887 7999999999987655444
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCC---hHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....|++.|+|||++. ..++.++|||||||++|+|++|..||..... ...+.........+. .....+..+++|
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 229 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDI 229 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHH
Confidence 44567899999999875 4589999999999999999999999975322 223333333333322 223468899999
Q ss_pred HHHhhc-CcCCCCCH----HHHhcCccccCCCC
Q 010768 155 VGKCLE-NVSKRLPA----KELLLDPFLASDAG 182 (502)
Q Consensus 155 I~kcL~-dP~kRpsa----~ElL~hpf~~~~~~ 182 (502)
|.+||. +|.+||++ .+++.||||+...+
T Consensus 230 i~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 230 CRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 999999 99999999 67889999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=279.25 Aligned_cols=192 Identities=23% Similarity=0.431 Sum_probs=165.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.||+|-.++.++.++++.-++.|+..|+.||.-||+.| +|||||||+||||+.. |++||+|||.|-.+.....
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcEE
Confidence 7999999999999999999999999999999999999999 9999999999999987 8999999999977754333
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAE 150 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~ 150 (502)
....+|||-|++||++. +.|+..+|.||+||++|||+.|..||.. ......|.+|..-+-...|+ ..+++.
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 34568999999999884 4599999999999999999999999987 56677788887754322333 447999
Q ss_pred HHHHHHHhhcCcCCCCC---HHHHhcCccccCCCCCC---CCCCCCCCcCCC
Q 010768 151 ARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEP---LLIPKVPSFQNL 196 (502)
Q Consensus 151 l~~LI~kcL~dP~kRps---a~ElL~hpf~~~~~~~~---l~~p~~P~~~~~ 196 (502)
+++||.+++.+|..|.. +.++..||||.+..|.. ..+|.+|.+.+.
T Consensus 312 akdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 312 AKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred HHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 99999999999999998 99999999999999954 445666666543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=258.97 Aligned_cols=177 Identities=22% Similarity=0.406 Sum_probs=145.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.||+|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 124 y~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 124 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCCccc
Confidence 68899999999764 5899999999999999999999999 9999999999999887 799999999998764322 2
Q ss_pred cccccCCCcccCcccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l 151 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+...... .......+..+
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 235679999999998753 278899999999999999999999976 5556666777654322 22223468899
Q ss_pred HHHHHHhhcCcC---CCCCHHHHhcCccccCCCC
Q 010768 152 RRFVGKCLENVS---KRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 152 ~~LI~kcL~dP~---kRpsa~ElL~hpf~~~~~~ 182 (502)
+++|.+||.+|. .|+++.++++||||+...+
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 999999998443 3789999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=242.22 Aligned_cols=179 Identities=27% Similarity=0.465 Sum_probs=152.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+...+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++..........
T Consensus 74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~ 150 (262)
T cd05572 74 YCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTW 150 (262)
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccc
Confidence 5689999999998888999999999999999999999999 9999999999999887 799999999998765543344
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... +...++..+..+......+...+..+++||.+|
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 567899999999875 458899999999999999999999997644 255566666644333344444588999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~ 182 (502)
|. +|.+||+ ++|++.||||+...+
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 99 9999999 999999999987554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=247.73 Aligned_cols=179 Identities=25% Similarity=0.414 Sum_probs=146.8
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence 68899999988654 46999999999999999999999999 9999999999999887 7999999999987654444
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChH---HHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA---QIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....|++.|+|||++. ..++.++||||+||++|+|++|..||.+..... .+...+... +...+...+..+.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 235 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARSI 235 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHHH
Confidence 44567999999999876 458899999999999999999999997643221 222222222 223344568899999
Q ss_pred HHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|.+||. ||.+|| ++.+++.||||....+..
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 999999 999999 899999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=255.35 Aligned_cols=177 Identities=21% Similarity=0.428 Sum_probs=160.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|..+|.|.+|+.+.+.|++.+++.+++||.+|+.|||.++ ++|||||.+|||++.+ +++||+|||++..+.......
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccccHHH
Confidence 6789999999999999999999999999999999999999 9999999999999998 799999999999988888899
Q ss_pred cccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
+++|+|.|.+||+++|. -++.+|.||||++||.|+.|..||.+ .+...+.+.|..|.+..+. .+..+.-||+.|
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwm 286 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREPE---TPSDASGLIRWM 286 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCCC---CCchHHHHHHHH
Confidence 99999999999999875 47899999999999999999999988 6667788888888764332 355788999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
|- ||.+|.|+.+|..|=|+.-+...+
T Consensus 287 LmVNP~RRATieDiAsHWWvNwgy~~~ 313 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVNWGYNMP 313 (668)
T ss_pred HhcCcccchhHHHHhhhheeecccccc
Confidence 99 999999999999999998765544
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=245.90 Aligned_cols=179 Identities=26% Similarity=0.443 Sum_probs=148.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~ 153 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 153 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCc
Confidence 6889999999998888999999999999999999999999 9999999999999987 79999999998765432 233
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...|+..|+|||++.+ .++.++||||+|+++|+|++|..||.... ............ +..++...+..+.++|.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--CCCCCCcCCHHHHHHHH
Confidence 4579999999998853 48899999999999999999999997642 222222222222 22334456899999999
Q ss_pred Hhhc-CcCCCC-----CHHHHhcCccccCCCCCCC
Q 010768 157 KCLE-NVSKRL-----PAKELLLDPFLASDAGEPL 185 (502)
Q Consensus 157 kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~l 185 (502)
+||. +|.+|| ++.++++||||+...+...
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 9999 999999 9999999999988766553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=254.70 Aligned_cols=171 Identities=27% Similarity=0.387 Sum_probs=135.1
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.............
T Consensus 109 ~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~ 183 (359)
T cd07876 109 DANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYV 183 (359)
T ss_pred CcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCCccccccCccCCCCc
Confidence 4567776643 5899999999999999999999999 9999999999999987 799999999997654444445567
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc---------------------C--CC
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---------------------G--KL 139 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---------------------~--~~ 139 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. . ..
T Consensus 184 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (359)
T cd07876 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQY 263 (359)
T ss_pred ccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCC
Confidence 8999999998864 5899999999999999999999999875432221111100 0 00
Q ss_pred C----------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 140 P----------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 140 p----------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
+ .......++.+++||.+||. ||.+|||+.|+|.||||..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 264 PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred CCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0 00112246788999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=261.56 Aligned_cols=181 Identities=25% Similarity=0.422 Sum_probs=168.8
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
|.||.|...+++.+.|++..++.++.-+++|++|||.+| ||+|||||+|++++.+ |-+||.|||+|+.+..+....+
T Consensus 502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCceee
Confidence 789999999999999999999999999999999999999 9999999999999988 8999999999999999999999
Q ss_pred ccCCCcccCcccc-cccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 82 VIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 82 ~~GT~~Y~APEvl-~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
++|||.|.|||++ +...+.++|.||||+++||||+|.+||.+ .++...|..|.+|.-...+++.....+.++|+++..
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 9999999999965 56689999999999999999999999988 788899999999987778888889999999999888
Q ss_pred -CcCCCCC-----HHHHhcCccccCCCCCCCC
Q 010768 161 -NVSKRLP-----AKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 161 -dP~kRps-----a~ElL~hpf~~~~~~~~l~ 186 (502)
+|.+|.. +.+|-+|.||.+-+|+-+.
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 9999985 8999999999998886543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=252.35 Aligned_cols=180 Identities=22% Similarity=0.395 Sum_probs=144.0
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.||+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCCCCc
Confidence 6889999999987 467999999999999999999999999 9999999999999877 7999999999876543322
Q ss_pred -cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---CccccCC
Q 010768 79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQD 148 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s 148 (502)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||.. ....+.+..+....... ......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 22346999999999875 3478899999999999999999999976 34455555554432111 1122358
Q ss_pred HHHHHHHHHhhc---CcCCCCCHHHHhcCccccCCCCCC
Q 010768 149 AEARRFVGKCLE---NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 149 ~~l~~LI~kcL~---dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
..+++||.+||. ++..|+++.+++.||||....+..
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 899999999987 334488999999999998765533
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=266.54 Aligned_cols=174 Identities=29% Similarity=0.450 Sum_probs=148.1
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++.+ ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence 6899999998864 356999999999999999999999999 9999999999999987 79999999999876443
Q ss_pred C---CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 77 Q---HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 77 ~---~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .....+...+..+..+. ++...+..++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~-~~~~~s~~~~ 300 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDP-FPCPVSSGMK 300 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC-CCccCCHHHH
Confidence 2 2345679999999998864 589999999999999999999999976 45556666666665532 3345678999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
+||.+||. +|.+||++.+++.|+|++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999 9999999999999999964
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=268.19 Aligned_cols=174 Identities=25% Similarity=0.452 Sum_probs=149.1
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 120 y~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~vkL~DFGls~~~~~~ 196 (496)
T PTZ00283 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVKLGDFGFSKMYAAT 196 (496)
T ss_pred CCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCEEEEecccCeecccc
Confidence 67899999999753 46999999999999999999999999 9999999999999987 79999999999765432
Q ss_pred ---CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 77 ---QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 77 ---~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+..+ ..+...++.+.
T Consensus 197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 274 (496)
T PTZ00283 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSISPEMQ 274 (496)
T ss_pred ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 22345679999999998864 589999999999999999999999976 5556666666666554 24455688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
++|.+||. +|.+||++.+++.|||++.
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 99999999 9999999999999999875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=247.43 Aligned_cols=183 Identities=23% Similarity=0.366 Sum_probs=147.6
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.||+|.+++.+. ..+++..++.++.||+.||+|||+.| ++|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccccccc
Confidence 57899999999864 56999999999999999999999999 9999999999999987 799999999986542211
Q ss_pred -----------------------------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh
Q 010768 78 -----------------------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127 (502)
Q Consensus 78 -----------------------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~ 127 (502)
.....+|+..|+|||++.+ .++.++||||||+++|+|++|..||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 1123468899999998764 4888999999999999999999999775443
Q ss_pred HHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCC----HHHHhcCccccCCCCCCCCC
Q 010768 128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP----AKELLLDPFLASDAGEPLLI 187 (502)
Q Consensus 128 ~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRps----a~ElL~hpf~~~~~~~~l~~ 187 (502)
..+..+.............+..+++||.+||. +|.+||+ ++++|.||||+...+.....
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 239 -ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred -HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 33444444333222222368899999999999 9999999 99999999999876654433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=241.49 Aligned_cols=173 Identities=28% Similarity=0.497 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++...... .
T Consensus 90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~~~~~ 166 (272)
T cd06637 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG 166 (272)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEccCCCceecccccc
Confidence 57889999999864 46899999999999999999999999 9999999999999987 79999999999765432 2
Q ss_pred CcccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 78 HAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
......|++.|+|||++. ..++.++|||||||++|+|++|..||...... .....+.....+.......+..+
T Consensus 167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06637 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-RALFLIPRNPAPRLKSKKWSKKF 245 (272)
T ss_pred cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-HHHHHHhcCCCCCCCCCCcCHHH
Confidence 234567899999999874 24788999999999999999999999764332 22333333333333334567899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+||.+||. +|.+||++.+++.||||
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999999 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=252.91 Aligned_cols=176 Identities=29% Similarity=0.523 Sum_probs=141.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-cc
Confidence 688999999999988899999999999999999999974 6 9999999999999887 79999999998765332 23
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH---------------------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY--------------------------- 131 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~--------------------------- 131 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 34578999999998865 58899999999999999999999996522 11111
Q ss_pred -----------------HHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 132 -----------------KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 132 -----------------~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
..+.....+.......+.++++||.+||. +|.+||++.|++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11111122222222356789999999999 999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=250.49 Aligned_cols=176 Identities=29% Similarity=0.480 Sum_probs=145.1
Q ss_pred CCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 4 SGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 4 gGsL~~~L~k~~----~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
.-+|..|+...+ .++...++.+++||+.||+|||+++ |+||||||+||||+.. |.+||+|||+|+...-. ..
T Consensus 100 d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKlaDFGlAra~~ip~~~ 176 (323)
T KOG0594|consen 100 DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLADFGLARAFSIPMRT 176 (323)
T ss_pred cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeeeccchHHHhcCCccc
Confidence 457899998765 5888999999999999999999999 9999999999999996 89999999999876532 33
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--C-------------
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--G------------- 141 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~------------- 141 (502)
....++|.+|.|||++-+ .|+..+||||+|||++||++++..|.+..+.+++......-..| .
T Consensus 177 yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~ 256 (323)
T KOG0594|consen 177 YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA 256 (323)
T ss_pred ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc
Confidence 556789999999998764 49999999999999999999999999988777766554321111 0
Q ss_pred Ccc------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 AFH------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 ~~~------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.++ ...++...+++.+||. +|.+|.+++.+|.||||.....
T Consensus 257 ~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 257 PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 000 0123578999999999 9999999999999999987643
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=236.67 Aligned_cols=172 Identities=31% Similarity=0.582 Sum_probs=145.1
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.+|+|.+++... ..+++.+++.++.||+.||+|||++| |+||||||+||+++.+ +.++|+|||++...... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence 57899999999863 45899999999999999999999999 9999999999999887 79999999999876432 2
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..+. .....++.+.+||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 235 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELGELIA 235 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHHHHH
Confidence 2334568999999998764 588999999999999999999999976 34445555565665543 34456889999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.++++||||
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=248.44 Aligned_cols=173 Identities=31% Similarity=0.435 Sum_probs=131.0
Q ss_pred CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC---CCCcEEEEecCCc
Q 010768 3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLA 70 (502)
Q Consensus 3 ~gGsL~~~L~k~---------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~---~~g~vKL~DFGlA 70 (502)
.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+.. ..+.+||+|||++
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 457888887632 24899999999999999999999999 999999999999942 3368999999999
Q ss_pred eeccCCC----CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCCh---------HHHHHHHH
Q 010768 71 AILRGSQ----HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------AQIYKKVT 135 (502)
Q Consensus 71 ~~~~~~~----~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---------~~i~~~i~ 135 (502)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||...... .++...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8754321 2345678999999998754 4899999999999999999999999643211 11111111
Q ss_pred cCCC------------CC-----------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 136 SGKL------------PG-----------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 136 ~~~~------------p~-----------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.... +. ......+..+.+||.+||. ||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 00 0011235678899999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=258.15 Aligned_cols=172 Identities=26% Similarity=0.360 Sum_probs=142.8
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--Cccc
Q 010768 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--HAHS 81 (502)
Q Consensus 5 GsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~~~~ 81 (502)
-+|.-++... -+|++.+|+.|++||+.||+|||++| |+|||||+.|||||.+ |.+||+|||+|+++.... ..+.
T Consensus 202 hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~~~~T~ 278 (560)
T KOG0600|consen 202 HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGSAPYTS 278 (560)
T ss_pred chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEeccccceeeccCCCCccccc
Confidence 4666666653 46999999999999999999999999 9999999999999988 899999999999775443 3566
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCc--------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAF-------------- 143 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~-------------- 143 (502)
.+-|.+|.|||++-| .|+.++|+||+||||.||++|++.|.+..+.+|+.+...-..-| ..|
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~ 358 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ 358 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence 778999999998865 59999999999999999999999999987777765544332111 000
Q ss_pred ----------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 144 ----------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 144 ----------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
....++.+.+|+..||. ||.+|.||.++|.++||..
T Consensus 359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 11246788899999999 9999999999999999944
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=253.18 Aligned_cols=170 Identities=30% Similarity=0.422 Sum_probs=135.9
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++............
T Consensus 112 ~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~ 186 (364)
T cd07875 112 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV 186 (364)
T ss_pred CCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCccccCCCCcccCCc
Confidence 4678887754 5889999999999999999999999 9999999999999987 799999999998765544445668
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CC--------------------C-
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KL--------------------P- 140 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~--------------------p- 140 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...... +.++... .. +
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (364)
T cd07875 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265 (364)
T ss_pred ccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCC
Confidence 9999999998764 589999999999999999999999977443322 2222110 00 0
Q ss_pred ------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 141 ------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 141 ------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.......+..+++||.+||. ||.+|||+.++|.||||..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred cCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00011234678999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.22 Aligned_cols=172 Identities=28% Similarity=0.379 Sum_probs=135.5
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
.++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++............
T Consensus 105 ~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (355)
T cd07874 105 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV 179 (355)
T ss_pred cccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcccccCCCccccCCcc
Confidence 3567777654 5899999999999999999999999 9999999999999887 799999999998765544445678
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC--------------------C----
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--------------------K---- 138 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~--------------------~---- 138 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..- .
T Consensus 180 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (355)
T cd07874 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259 (355)
T ss_pred ccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcc
Confidence 9999999998765 58999999999999999999999997643222221111100 0
Q ss_pred ----CC-----------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 139 ----LP-----------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 139 ----~p-----------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+ .......+..+++||.+||. ||.+|||+.|+|+||||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 00112235678999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.40 Aligned_cols=174 Identities=32% Similarity=0.482 Sum_probs=143.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG----- 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~----- 75 (502)
|+.+|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+|+||||+||+++.+ +.+||+|||++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhccccc
Confidence 5789999999998888999999999999999999999999 9999999999999877 7999999999875421
Q ss_pred --CCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 76 --SQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 76 --~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
........|+..|+|||++.+ .++.++|||||||++|+|++|..||......................+...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence 111234568999999998864 48899999999999999999999997754444433333221222234455788999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||.+||. +|.+||++.+++.||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=246.41 Aligned_cols=178 Identities=24% Similarity=0.403 Sum_probs=144.1
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc
Confidence 57899999999654 35999999999999999999999999 9999999999999987 7899999999976654444
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChH--HHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA--QIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~--~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....|++.|+|||++. ..++.++||||||+++|+|++|+.||....... .....+.. ..+.......++.+++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHH
Confidence 44567999999999886 458999999999999999999999997643211 11122211 112233445688999999
Q ss_pred HHhhc-CcCCCCC-----HHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLP-----AKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRps-----a~ElL~hpf~~~~~~ 182 (502)
.+||. +|.+||+ +.|++.||||+....
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 99999 9999999 999999999986433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=245.78 Aligned_cols=188 Identities=27% Similarity=0.374 Sum_probs=152.5
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
..+|+..+..-+ +|...+++.++.|++.||+|||.+. |+|||||++|+|++.. |.+||+|||+|+.+.... ..+.
T Consensus 160 EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~ 236 (419)
T KOG0663|consen 160 EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKPYTP 236 (419)
T ss_pred HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccchhhhhcCCcccCcc
Confidence 357888887765 8999999999999999999999999 9999999999999987 899999999999886543 3456
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC------C------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP------G------------ 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p------~------------ 141 (502)
.+-|.+|.|||++-+ .|++++|+||+|||+.||+++++.|.+....+++.+.+..-..| .
T Consensus 237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f 316 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF 316 (419)
T ss_pred eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence 678999999998754 59999999999999999999999999988888876655431111 0
Q ss_pred ----------Ccccc-CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC--CCCCCCCCCCCcC
Q 010768 142 ----------AFHRI-QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA--GEPLLIPKVPSFQ 194 (502)
Q Consensus 142 ----------~~~~~-~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~--~~~l~~p~~P~~~ 194 (502)
.+... .+....+|+..+|. ||.+|.||.+.|+|.||...+ ..|-..|.+|...
T Consensus 317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~ 383 (419)
T KOG0663|consen 317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKS 383 (419)
T ss_pred CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccc
Confidence 01111 35778899999999 999999999999999998743 3334445555443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=246.41 Aligned_cols=167 Identities=22% Similarity=0.295 Sum_probs=143.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++.+ +.+||+|||+++..... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~ 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--P 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhccc--c
Confidence 689999999999988999999999999999999999984 7 8899999999999987 79999999998765432 2
Q ss_pred ccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..+......+...++.+++||.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 256 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE 256 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence 34568999999998864 689999999999999999999999987 45566667665544443444456889999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||+ +|.+||++.+++.
T Consensus 257 ~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 257 ACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHhcCCcccCcCHHHHHH
Confidence 9999 9999999999985
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=240.30 Aligned_cols=173 Identities=29% Similarity=0.487 Sum_probs=140.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||+++.+ +.+||+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence 5789999999999899999999999999999999999999 9999999999999877 799999999987654321 22
Q ss_pred ccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHHHHH
Q 010768 80 HSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEARR 153 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~ 153 (502)
....|++.|+|||++. +.++.++|||||||++|+|++|..||........+.........+.... ...+..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 3457899999999863 3488899999999999999999999876443333332222222222211 134678999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
||.+||. +|.+||++.+++.|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=251.90 Aligned_cols=183 Identities=27% Similarity=0.496 Sum_probs=163.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~-~~~~~~~ 79 (502)
|..||.|.-+|.+...+++...+.+...|+.||.|||+++ ||+||||.+|+|++.+ |++||+|||+++. +..+...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhccccccee
Confidence 6789999999999889999999999999999999999999 9999999999999998 8999999999975 4455667
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++|||.|+|||++. ..|+.++|.|.+|+++|||++|+.||.+ .+...++..|.-+.+ .+++..+++++.|+..+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHHHHHH
Confidence 8899999999999997 4699999999999999999999999987 556677777777666 56778899999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCCCCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGEPLLIPK 189 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~~l~~p~ 189 (502)
|. +|.+|. .++|+..|+||....|......+
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kk 439 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKK 439 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhc
Confidence 99 999997 48999999999998886644333
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=243.81 Aligned_cols=174 Identities=33% Similarity=0.621 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~-~~~~~~ 79 (502)
|+.+++|.+++.+.+.+++..++.++.||+.||.+||+++ |+|+||||+||+++.+ +.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccccc
Confidence 4677899999998889999999999999999999999999 9999999999999976 79999999999763 223344
Q ss_pred ccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCCCcc--ccCCHHHHH
Q 010768 80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFH--RIQDAEARR 153 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~--~~~s~~l~~ 153 (502)
....+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ......+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5667899999999887 568999999999999999999999998751 2222232222222211111 112379999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+|.+||. +|.+||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=241.37 Aligned_cols=171 Identities=26% Similarity=0.458 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+...+++.+++.++.||+.||.|||+.| ++||||||+||+++.+.+.++|+|||++...... .
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~ 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S 164 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence 6789999999998889999999999999999999999999 9999999999999987448999999998765432 2
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChH----HHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA----QIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~----~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
...|+..|+|||++.+ .++.++||||||+++|+|++|..||....... .+.... ..+.......++.+.+||
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFV 241 (267)
T ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHH
Confidence 3468999999998864 58899999999999999999999997543221 122222 122233446789999999
Q ss_pred HHhhc-CcCCCCC-HHHHhcCccccC
Q 010768 156 GKCLE-NVSKRLP-AKELLLDPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRps-a~ElL~hpf~~~ 179 (502)
.+||. +|.+|++ ++++|+||||.+
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCcccC
Confidence 99999 9999996 699999999963
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=251.06 Aligned_cols=180 Identities=21% Similarity=0.407 Sum_probs=144.9
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.||+|.+++.+ ...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCCCce
Confidence 6889999999987 467999999999999999999999999 9999999999999877 7999999999976643322
Q ss_pred -cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc---ccCC
Q 010768 79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH---RIQD 148 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---~~~s 148 (502)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+....+..+........++ ...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccccCC
Confidence 22357999999999875 3578899999999999999999999976 44455555555433211111 2357
Q ss_pred HHHHHHHHHhhc-CcCC--CCCHHHHhcCccccCCCCCC
Q 010768 149 AEARRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~k--Rpsa~ElL~hpf~~~~~~~~ 184 (502)
..++++|.+||. ++.+ |+++++++.||||....+..
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 899999999998 4332 56899999999998765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=258.19 Aligned_cols=181 Identities=27% Similarity=0.447 Sum_probs=155.9
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
+|+||+|.-+|.+.+ .++++.++.++.+|+.||++||..+ ||+|||||+|||+|.. |+++|+|+|+|..+..+..
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH-GHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC-CCeEeeccceEEecCCCCc
Confidence 489999999998876 7999999999999999999999999 9999999999999988 8999999999999988887
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....+||.+|||||++. +.|+...|.|||||++|+|+.|+.||.... ..+++-+.+... +..++...++++++|
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSEEAKSL 420 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCHHHHHH
Confidence 77789999999999886 459999999999999999999999996522 222333334333 234556679999999
Q ss_pred HHHhhc-CcCCCC-----CHHHHhcCccccCCCCCCCC
Q 010768 155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 155 I~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~l~ 186 (502)
.+.+|. ||.+|. .++++.+||||+..++..+.
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 999999 999987 57899999999998886543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=248.64 Aligned_cols=154 Identities=24% Similarity=0.384 Sum_probs=126.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APE 92 (502)
.+++..+..|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 4788899999999999999999999 9999999999999887 799999999997653221 112334568899999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++.+.++|.+||. +|.+||++.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 875 458999999999999999997 999998755555555555555443 2345668899999999999 999999999
Q ss_pred HHhc
Q 010768 170 ELLL 173 (502)
Q Consensus 170 ElL~ 173 (502)
++++
T Consensus 326 el~~ 329 (338)
T cd05102 326 ALVE 329 (338)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=238.17 Aligned_cols=175 Identities=24% Similarity=0.453 Sum_probs=147.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.++++..+.+++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.+||+|||++..... ..
T Consensus 78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc---cc
Confidence 6789999999998889999999999999999999999999 9999999999999887 7999999999876433 23
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~k 157 (502)
...|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.. +.......+..+.++|.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 4568899999998764 478999999999999999999999976 445555555554433 223334568899999999
Q ss_pred hhc-CcCCCCC---HHHHhcCccccCCCC
Q 010768 158 CLE-NVSKRLP---AKELLLDPFLASDAG 182 (502)
Q Consensus 158 cL~-dP~kRps---a~ElL~hpf~~~~~~ 182 (502)
||. +|.+||+ ++|+|.||||+..+|
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 999 9999995 579999999987554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=238.75 Aligned_cols=173 Identities=27% Similarity=0.390 Sum_probs=143.2
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc-ccc
Q 010768 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA-HSV 82 (502)
Q Consensus 5 GsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~-~~~ 82 (502)
-+|...++.. ..++...++.|+.++++||+|||.+. |+||||||.|+|++.+ |.+||+|||+|+.+...... ...
T Consensus 85 tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 85 TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccCCCCcccccc
Confidence 4777788754 45999999999999999999999999 9999999999999988 89999999999987654433 223
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCcc--------------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFH-------------- 144 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~-------------- 144 (502)
+-|.+|.|||++-| .|+..+||||.|||+.||+-|.+-|.+..+.+|+......-.. +..|+
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~ 241 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF 241 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence 77999999998754 5999999999999999999999989998888887655443111 11111
Q ss_pred ---------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 145 ---------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 145 ---------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
...+..+.+|+.+||. ||.+|+++.|+|+|+||+..
T Consensus 242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 1235677999999999 99999999999999999873
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=235.03 Aligned_cols=172 Identities=31% Similarity=0.564 Sum_probs=146.3
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.|++|.+++... ..+++..++.++.||+.||.|||+.| |+|+||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 57899999999875 56999999999999999999999998 9999999999999987 799999999998764432
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......|++.|+|||++. +.++.++|||||||++|+|++|+.||... +.......+..+..+. .....+..+.++|.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLID 234 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence 223456889999999876 45889999999999999999999999764 4556666666665543 33356889999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|++||++.+++.|||+
T Consensus 235 ~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHccCCcccCcCHHHHhhCCCC
Confidence 9999 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=256.83 Aligned_cols=174 Identities=30% Similarity=0.401 Sum_probs=135.7
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CCccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~~~~ 81 (502)
+++|.+++.....+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||++...... .....
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCccccccccccccccc
Confidence 5899999998888999999999999999999999999 9999999999999887 79999999999753221 22335
Q ss_pred ccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC-------hHHHHHHHHc-CCCC------------
Q 010768 82 VIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-------PAQIYKKVTS-GKLP------------ 140 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~-------~~~i~~~i~~-~~~p------------ 140 (502)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+...+.. +..|
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 679999999998864 589999999999999999999988643211 1111111100 0000
Q ss_pred --------------CC---cc--ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 --------------GA---FH--RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 --------------~~---~~--~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.. +. ...+..+.+||.+||. ||.+|||+.|+|.||||+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00 00 0135678999999999 99999999999999999763
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=248.91 Aligned_cols=171 Identities=30% Similarity=0.453 Sum_probs=136.9
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.+++|.++++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... .....
T Consensus 102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~--~~~~~ 175 (343)
T cd07878 102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADD--EMTGY 175 (343)
T ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCccceecCC--CcCCc
Confidence 47899888754 57999999999999999999999999 9999999999999987 7999999999987543 23456
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CC--------------------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GK-------------------- 138 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~-------------------- 138 (502)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+ ..+.. +.
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07878 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKISSEHARKYIQS 254 (343)
T ss_pred cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcchhhHHHHhhc
Confidence 78999999998764 4889999999999999999999999764332222 22111 00
Q ss_pred CCCC-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 139 LPGA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 139 ~p~~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
++.. .....++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000 011235678999999999 99999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=239.46 Aligned_cols=176 Identities=32% Similarity=0.553 Sum_probs=146.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+++|.+++... ..+++..++.++.||+.||+|||+ .+ ++|+||||+||+++.+ +.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence 56789999999876 789999999999999999999999 88 9999999999999986 7999999999876533222
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC----CChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
....++..|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......+..+.+
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 22678899999998764 5889999999999999999999999764 23334445555554443333337889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
||.+||. +|.+||++.+++.||||+..
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999 99999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=239.46 Aligned_cols=178 Identities=31% Similarity=0.526 Sum_probs=143.7
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+.+|+|..++.+ ...+++..++.++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEccccccccccccccc
Confidence 5789999998865 467999999999999999999999999 9999999999999887 79999999998754322 22
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l 151 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+.....+ ...+...+..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEF 238 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHH
Confidence 33457899999999873 237789999999999999999999997743 33333333333222 22334467899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
++||.+||. +|.+||++.++++||||+....
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999 9999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=235.74 Aligned_cols=173 Identities=32% Similarity=0.533 Sum_probs=140.4
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++.+ +.+||+|||++....... .
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhcccCccc
Confidence 5788999999976 456899999999999999999999999 9999999999999987 799999999998765433 2
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~ 156 (502)
.....|+..|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+.....+ .......+..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 334568899999998764 588999999999999999999999976433222 2222221111 1122345678999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.++|.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=282.67 Aligned_cols=178 Identities=34% Similarity=0.545 Sum_probs=160.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
||.||+|.+.+...+-.++...+.+..|++.||+|||++| ||||||||+|||++.+ |.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhcC
Confidence 7999999999999888999999999999999999999999 9999999999999988 799999999998875542
Q ss_pred --CcccccCCCcccCccccccc----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 78 --HAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 78 --~~~~~~GT~~Y~APEvl~~~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
......||+.|||||++.+. -..++|||||||++.||+||+.||.+..+.-+|+.++..|..|..+.+ .+++.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~g 1470 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSEG 1470 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHhH
Confidence 23457899999999998643 566899999999999999999999999999999999999999876666 79999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
++||..||+ ||++|-++.|||.|.|-+....
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 999999999 9999999999999999876543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=237.36 Aligned_cols=172 Identities=35% Similarity=0.620 Sum_probs=143.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.+++|.+++...+.+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||++.......
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06628 87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLST 163 (267)
T ss_pred ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCcccccccccC
Confidence 5789999999999889999999999999999999999999 9999999999999877 799999999987664211
Q ss_pred ----CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 78 ----HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 78 ----~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|+.||........+ ..+.....+ ..+...+..+.
T Consensus 164 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 241 (267)
T cd06628 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENASP-EIPSNISSEAI 241 (267)
T ss_pred CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCCC-cCCcccCHHHH
Confidence 1123458899999998764 5888999999999999999999999875444333 333333222 33445688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
++|.+||. +|.+||++.++++||||
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=239.87 Aligned_cols=173 Identities=29% Similarity=0.506 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.++|+|||++...... .
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCcchhhhhcccc
Confidence 57889999999764 45899999999999999999999999 9999999999999987 79999999998765322 2
Q ss_pred CcccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 78 HAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+.....+.......+..+
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLKSKKWSKKF 255 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCCCCcccccCHHH
Confidence 234467899999999774 347889999999999999999999997644333333 2333333333334568899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+||.+||. +|.+||++.|+|+||||
T Consensus 256 ~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=238.44 Aligned_cols=177 Identities=29% Similarity=0.518 Sum_probs=148.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+|+|.+++... ++++..++.++.||+.||.|||+++ |+||||+|+||+++.+ +.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccccccc
Confidence 57899999999875 8999999999999999999999999 9999999999999987 79999999999876543 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... +.......+..+..+.......+..+.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 45678899999998764 5899999999999999999999999763 344445555555443333222688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
|. +|.+||++++++.||||+....
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCCCc
Confidence 99 9999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=241.27 Aligned_cols=176 Identities=30% Similarity=0.559 Sum_probs=150.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||+|.|||++.+ +.+||+|||++...... ..
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--CC
Confidence 5779999999999899999999999999999999999999 9999999999999887 79999999999876543 34
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...|++.|+|||.+. ..++.++||||||+++|+|++|..||... ......+.+..+.. .++...+..++++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHHHHc
Confidence 457899999999775 45788999999999999999999999763 35555666665543 234455899999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
. +|.+|+ ++++++.||||....+..
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 9 999999 999999999998766544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=237.88 Aligned_cols=173 Identities=34% Similarity=0.585 Sum_probs=142.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.+++|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd06651 87 YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICMSG 163 (266)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccccccC
Confidence 5678999999998888999999999999999999999999 9999999999999877 79999999998755321
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.+..... ....++...++.++.+|
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 242 (266)
T cd06651 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARDFL 242 (266)
T ss_pred CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHHHH
Confidence 11223458899999998764 48899999999999999999999998755444444333322 23344555688899999
Q ss_pred HHhhc-CcCCCCCHHHHhcCcccc
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
+||. +|.+||+++|++.||||+
T Consensus 243 -~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 243 -GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -HHhcCChhhCcCHHHHhcCcccc
Confidence 5666 999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=252.00 Aligned_cols=174 Identities=29% Similarity=0.432 Sum_probs=140.0
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CCccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~~~~ 81 (502)
+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus 87 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~~~~~~ 163 (372)
T cd07853 87 QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQ 163 (372)
T ss_pred ccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccCccccCCC
Confidence 4789999988888999999999999999999999999 9999999999999987 79999999999865332 22334
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-----------------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS----------------------- 136 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~----------------------- 136 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 242 (372)
T cd07853 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACEGARAHILR 242 (372)
T ss_pred CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhHHHHHHHHh
Confidence 568999999998765 37899999999999999999999997743322 2222211
Q ss_pred C-CCCC------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 137 G-KLPG------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 137 ~-~~p~------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
. ..+. ......++.+.+||.+||. ||.+|||+.|+|.||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 1 1111 1122347889999999999 999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=236.66 Aligned_cols=174 Identities=32% Similarity=0.552 Sum_probs=143.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+|+||||+||+++.+ +.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 163 (265)
T cd06652 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTICLSG 163 (265)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCccccccccccccc
Confidence 5789999999998888999999999999999999999999 9999999999999877 79999999998765321
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+. .+.........+...+..+.++|
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i 242 (265)
T cd06652 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDHCRDFL 242 (265)
T ss_pred cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHHHHHHH
Confidence 11233568899999998754 58899999999999999999999997754444443 33333332334445678899999
Q ss_pred HHhhcCcCCCCCHHHHhcCcccc
Q 010768 156 GKCLENVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 156 ~kcL~dP~kRpsa~ElL~hpf~~ 178 (502)
.+|+.+|.+||++++++.|||+.
T Consensus 243 ~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 243 KRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHhcChhhCCCHHHHhcCcccC
Confidence 99999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=248.21 Aligned_cols=173 Identities=31% Similarity=0.511 Sum_probs=137.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+.... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceecccccccc
Confidence 6788888653 34678889999999999999999999 9999999999999987 799999999998764322 23
Q ss_pred ccccCCCcccCcccccc-----c-CCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 80 HSVIGTPEFMAPELYEE-----D-YNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-----~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
....||..|+|||++.. . .+.++|||||||++|+|++|+.||.... ....+...+..... .......+..+
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-CCCCCccCHHH
Confidence 45679999999998742 2 3568999999999999999999997422 12222333332222 23344568899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
++||.+||. +|.+||++.|+|+||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999 999999999999999998753
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=254.28 Aligned_cols=178 Identities=24% Similarity=0.352 Sum_probs=140.2
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---cc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AH 80 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~~ 80 (502)
+++|.+++...+.+++..++.|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|||++........ ..
T Consensus 169 ~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~~~ 245 (392)
T PHA03207 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCY 245 (392)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccccCccccccccc
Confidence 5789999988888999999999999999999999999 9999999999999987 7999999999976543221 23
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHH---cC----------------
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVT---SG---------------- 137 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~---~~---------------- 137 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+...+. ..
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 4679999999998864 5899999999999999999999999764321 11111110 00
Q ss_pred ------CCC-CCc-----cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 138 ------KLP-GAF-----HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 138 ------~~p-~~~-----~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
..+ ... ....+..+++||.+||. +|.+||++.|+|.||||...++..
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 000 000 01235678899999999 999999999999999998765543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=240.18 Aligned_cols=174 Identities=26% Similarity=0.458 Sum_probs=139.8
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.++++. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTST 181 (291)
T ss_pred ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEeecccchhcccc
Confidence 5789999999863 457999999999999999999999999 9999999999999887 78999999998765432
Q ss_pred C-CcccccCCCcccCcccccc------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCC
Q 010768 77 Q-HAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQD 148 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~~------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s 148 (502)
. ......|+..|+|||++.. .++.++|||||||++|+|++|+.||........+ ..+..+..+. .......
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 260 (291)
T cd06639 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPPTLLHPEKWC 260 (291)
T ss_pred cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCCCCCcccccC
Confidence 2 2234568899999998742 2678999999999999999999999774433333 3333332221 1222346
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
..+.++|.+||. +|.+||++.+++.||||+
T Consensus 261 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 789999999999 999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=259.11 Aligned_cols=176 Identities=30% Similarity=0.505 Sum_probs=150.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~ 78 (502)
||.||-+...+-.- ..|++.+|..+++|++.||.|||+++ |||||||..|||++-+ |.++|+|||++.... ....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchhHHhh
Confidence 68999999888775 45999999999999999999999999 9999999999999988 899999999986543 2345
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l 151 (502)
..+++|||+|||||++. .+|+.++||||||++|.+|..+.+|... .++..+.-+|.....| ...+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 67899999999999763 3599999999999999999999999887 5566655556554443 23344567889
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
++|+.+||. ||..||++++||+|||+++.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999 99999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=262.30 Aligned_cols=167 Identities=26% Similarity=0.462 Sum_probs=146.0
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+.||-|.+.+...+.+. .++..|++||+.|+.|||.+| ||||||||+|||++++.++++|+|||.++..... ..+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDT 472 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--hcc
Confidence 56777777777766665 888899999999999999999 9999999999999644489999999999877654 334
Q ss_pred ccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 82 VIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
.+-|..|.|||++.. .|++++||||||++||+||+|+.||.......+++..+..++.. ...+..+++||.+||+
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHhcc
Confidence 466889999999874 59999999999999999999999998877777888888777553 6679999999999999
Q ss_pred -CcCCCCCHHHHhcCccc
Q 010768 161 -NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 161 -dP~kRpsa~ElL~hpf~ 177 (502)
+|.+|+++.+++.|||+
T Consensus 549 ~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLGADEIGAHPWF 566 (612)
T ss_pred CChhhCcChhhhccCcch
Confidence 99999999999999999
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=243.31 Aligned_cols=176 Identities=24% Similarity=0.404 Sum_probs=137.3
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
.++|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 87 DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecCCCcccccc
Confidence 368999887654 5899999999999999999999999 9999999999999987 799999999997643322 2234
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--C------------------CC
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--G------------------KL 139 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~------------------~~ 139 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+...+.. . ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 568999999998753 4889999999999999999999999774432222111110 0 00
Q ss_pred CC-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 140 PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 140 p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+. ......++++++||.+||. +|.+|||+.|+|.||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 00 0011347789999999999 9999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=236.37 Aligned_cols=173 Identities=29% Similarity=0.496 Sum_probs=140.1
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDST 166 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEEECCCccceecccc
Confidence 6789999999875 357999999999999999999999999 9999999999999987 79999999998765432
Q ss_pred -CCcccccCCCcccCcccccc------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc-cccCC
Q 010768 77 -QHAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQD 148 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s 148 (502)
.......|++.|+|||++.. .++.++|||||||++|+|++|..||....... ....+..+..+... ....+
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTLKSPENWS 245 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccCCCCCCchhhcC
Confidence 22334568999999998742 36789999999999999999999997643333 33334443332222 22256
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
..+++||.+||. +|.+||++.+++.|||+
T Consensus 246 ~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 246 KKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 789999999999 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=232.93 Aligned_cols=172 Identities=31% Similarity=0.502 Sum_probs=147.1
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLH-----GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLH-----s~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
|+.+|+|.+++.. ..++++..++.++.||+.||.||| +.+ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEecccccc
Confidence 5789999999976 367999999999999999999999 777 9999999999999987 799999999998
Q ss_pred eccCCCC-cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 72 ILRGSQH-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 72 ~~~~~~~-~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
....... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||... ....+.+.+..+..+ ..+...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 236 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYSS 236 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccCH
Confidence 7654332 345678999999998764 5888999999999999999999999774 456666777666554 34445688
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+.+++.+||. +|.+||++.++++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=235.32 Aligned_cols=176 Identities=29% Similarity=0.529 Sum_probs=143.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| ++|+||||+||+++.+...+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred ccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 5789999999998889999999999999999999999999 99999999999998764469999999987654321
Q ss_pred --CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 78 --HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 78 --~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
......|+..|+|||++. ..++.++||||+|+++|+|++|..||..... .......+.........+...++.+.
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241 (268)
T ss_pred CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHH
Confidence 122356889999999876 4588999999999999999999999965322 22222233222333344555688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
++|.+||. +|.+||++.++++||||+
T Consensus 242 ~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 242 DVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=240.26 Aligned_cols=178 Identities=24% Similarity=0.410 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc
Confidence 57899999998653 46999999999999999999999999 9999999999999887 7999999999976644333
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChH---HHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA---QIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....|++.|+|||++. ..++.++|+|||||++|+|++|..||....... .+...+.... ..+....+..+.+|
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 235 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEAKSI 235 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHHHHH
Confidence 44567999999999875 458999999999999999999999997643322 2222222221 22334567889999
Q ss_pred HHHhhc-CcCCCCC-----HHHHhcCccccCCCCC
Q 010768 155 VGKCLE-NVSKRLP-----AKELLLDPFLASDAGE 183 (502)
Q Consensus 155 I~kcL~-dP~kRps-----a~ElL~hpf~~~~~~~ 183 (502)
+.+||. +|.+||+ +.+++.|+||+.....
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 999999 9999999 8999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=232.23 Aligned_cols=173 Identities=30% Similarity=0.508 Sum_probs=144.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+|+||||+||+++.+.+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 57899999999874 34899999999999999999999999 999999999999987656789999999987755444
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.....|+..|+|||.+.+ .++.++||||||+++|+|++|..||... +.......+..+... ......+..++++|.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLILS 235 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHHH
Confidence 445678999999998864 4788999999999999999999999774 334444454444332 2344568899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccc
Q 010768 158 CLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~ 177 (502)
||. +|.+||++.+++.||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=236.55 Aligned_cols=173 Identities=25% Similarity=0.481 Sum_probs=156.1
Q ss_pred CCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~--k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|...|+|...|+ ...++++...+.+++|++.||.|||..+ ||||||||+|+|+... +.+||+|||.+.... ...
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNK 178 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeecC-CCC
Confidence 567899999999 6678999999999999999999999998 9999999999999887 799999999987655 566
Q ss_pred cccccCCCcccCccccccc-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
..+.+||..|.+||+..+. ++..+|+|++|++.||++.|.+||.... ..+.+++|.+-.+ .++...+..++++|.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~--~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDL--KFPSTISGGAADLISR 255 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccc--cCCcccChhHHHHHHH
Confidence 7789999999999998864 8999999999999999999999998744 7888999988766 3446779999999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
||. +|.+|.+..|++.|||+...
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HhccCccccccHHHHhhhHHHHhc
Confidence 999 99999999999999999653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=242.18 Aligned_cols=178 Identities=32% Similarity=0.556 Sum_probs=143.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+++|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccC
Confidence 6789999998855 57999999999999999999999999 9999999999999887 799999999987543222 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~k 157 (502)
....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+.....+ .......+..++++|.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 34578999999998764 58899999999999999999999997643 33333333332111 11223457889999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
||. +|.+||++.+++.||||......
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999 99999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=234.23 Aligned_cols=177 Identities=31% Similarity=0.584 Sum_probs=150.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+++|.+++.....+++..++.++.||+.||+|||+ .+ ++||||+|+||+++.+ +.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence 57899999999988899999999999999999999999 99 9999999999999987 79999999999876543322
Q ss_pred -ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 -HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 -~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.... ...+..+.+.....+.......+..+.++|
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 25568899999998764 58889999999999999999999997754 555666666655444333333788999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. +|.+||++.+++.|||++.-
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999 99999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=235.97 Aligned_cols=175 Identities=34% Similarity=0.588 Sum_probs=141.0
Q ss_pred CCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKY-TRV--DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~L--se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+++|.+++... ..+ ++..+..++.||+.||+|||++| |+||||||+||+++.+.+.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 57899999999864 556 88999999999999999999999 99999999999998755799999999987654322
Q ss_pred -CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||............+.........+...++.+++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 2233468899999998753 378899999999999999999999976444333222222222223345566889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
||.+||. +|.+||++.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=232.55 Aligned_cols=176 Identities=28% Similarity=0.505 Sum_probs=147.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 74 YLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccc
Confidence 5778999999998889999999999999999999999999 9999999999999987 799999999987543221
Q ss_pred ------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHH
Q 010768 78 ------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 78 ------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
......++..|+|||.+. ..++.++||||||+++|+|++|..||.. .........+..+..+.......+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd05579 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDE 229 (265)
T ss_pred cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHH
Confidence 223456788999999775 4488899999999999999999999976 44556666666655433222224889
Q ss_pred HHHHHHHhhc-CcCCCCCH---HHHhcCccccCC
Q 010768 151 ARRFVGKCLE-NVSKRLPA---KELLLDPFLASD 180 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa---~ElL~hpf~~~~ 180 (502)
+.+||.+||. +|.+||++ .++|.||||+.-
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999 99999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=230.74 Aligned_cols=174 Identities=39% Similarity=0.653 Sum_probs=149.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence 4679999999998889999999999999999999999998 9999999999999986 7999999999987765432
Q ss_pred -cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||....+.......+..+......+...+..+++||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999998764 489999999999999999999999987654555555554433444455566899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=231.92 Aligned_cols=173 Identities=37% Similarity=0.594 Sum_probs=145.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+++|.+++.+.+.+++..++.++.||+.||+|||+.| |+|+||+|+||+++.+ +.+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccccccc
Confidence 5789999999998888999999999999999999999999 9999999999999887 799999999998765444345
Q ss_pred cccCCCcccCcccccc-c-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...|++.|+|||.+.. . ++.++|+||||+++|+|++|..||..........+....... ...+...++.+++||.+|
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKDFILKC 238 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-CCcCCCcCHHHHHHHHHH
Confidence 5678999999997753 3 789999999999999999999999775533333332222323 234455688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccc
Q 010768 159 LE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~ 177 (502)
|. +|.+||++.+++.|||+
T Consensus 239 l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 239 LQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hhcCcccCcCHHHHhcCCCC
Confidence 99 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=241.61 Aligned_cols=176 Identities=34% Similarity=0.560 Sum_probs=143.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.||+|.+++.+ ..+++.++..++.||+.||+|||+.| |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccccchhcccccccc
Confidence 6789999999865 46899999999999999999999999 9999999999999877 799999999987653322 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+......+..+...+...+..+.++|.+|
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 33568999999998764 48899999999999999999999997744433333333333222223445678899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.+++.||||...
T Consensus 254 l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 254 LDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CcCCcccCcCHHHHhhChhhhcc
Confidence 99 99999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=237.44 Aligned_cols=173 Identities=26% Similarity=0.474 Sum_probs=139.6
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEEccCCceeecccC
Confidence 5789999998753 356899999999999999999999999 9999999999999987 78999999999765432
Q ss_pred C-CcccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-CCCccccCC
Q 010768 77 Q-HAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQD 148 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s 148 (502)
. ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+.+ +..... ....+...+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 256 (286)
T cd06638 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQPELWS 256 (286)
T ss_pred CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccccCCCcccCCCCcC
Confidence 2 233457899999999874 3378899999999999999999999977543333322 222221 122233457
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
..+.+||.+||. +|.+||++.|+++|+||
T Consensus 257 ~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 789999999999 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=240.06 Aligned_cols=177 Identities=33% Similarity=0.555 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-A 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~ 79 (502)
|+.+|+|.+++.+. .+++.+++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||++........ .
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 97 YLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred ecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchhcccccccC
Confidence 57899999998764 6999999999999999999999999 9999999999999876 7999999999876543222 2
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....+++.|+|||.+.+ .++.++|||||||++|+|++|..||..................+...+...++.+.+||.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 34568899999998764 58899999999999999999999997754433333322222222223445678999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.||||+...
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhcc
Confidence 99 999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=233.93 Aligned_cols=173 Identities=32% Similarity=0.563 Sum_probs=140.8
Q ss_pred CCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence 57899999999864 45999999999999999999999999 9999999999999987 799999999987654322
Q ss_pred C-----cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc----ccc
Q 010768 78 H-----AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF----HRI 146 (502)
Q Consensus 78 ~-----~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~----~~~ 146 (502)
. .....|+..|+|||++.. .++.++|+||||+++|+|++|+.||...... .....+.....+... ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCcccccc
Confidence 1 234568999999998754 4889999999999999999999999774433 333333333222111 124
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+..+.+||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 57889999999999 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=236.37 Aligned_cols=177 Identities=31% Similarity=0.508 Sum_probs=142.7
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 4 SGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 4 gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
.|+|.+++.. ...+++..++.++.||+.||+|||++ + ++||||||+||+++.+ +.+||+|||++........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 4788888764 24689999999999999999999987 7 9999999999999887 7999999999986644333
Q ss_pred cccccCCCcccCcccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....|+..|+|||++.+ .++.++|+|||||++|+|++|+.||.......+....+..+..+.......+..+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 334568999999998753 368899999999999999999999976444333333444443333333446789999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
||.+||. +|.+||++.+++.||||......
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 9999999 99999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.75 Aligned_cols=179 Identities=30% Similarity=0.486 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+.+|+|..++.+ ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccceeccccccc
Confidence 6789999998865 456999999999999999999999999 9999999999999876 79999999998754322 22
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l 151 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++|..||.... ......++.....+. ......+..+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHHH
Confidence 23456889999999873 236789999999999999999999997643 444444444443321 2234457889
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
.++|.+||. +|.+||++.+++.||||......
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 999999999 99999999999999999765443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=255.29 Aligned_cols=172 Identities=25% Similarity=0.412 Sum_probs=140.5
Q ss_pred CCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---c
Q 010768 4 SGTLREYRKKYTRV-DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---A 79 (502)
Q Consensus 4 gGsL~~~L~k~~~L-se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~ 79 (502)
.-+|..+|+++... +.-.++.|..|||.|+.++|.+| |||.||||.|+|+-. |.+||+|||+|..+..... .
T Consensus 443 d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 443 DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK--GRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe--eeEEeeeechhcccCccccceee
Confidence 45899999987653 33589999999999999999999 999999999999965 7999999999998765332 3
Q ss_pred ccccCCCcccCcccccc------------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccC
Q 010768 80 HSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ 147 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~------------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 147 (502)
.+.+||+.||+||.+.. +.+.++||||||||||+|+.|+.||....+...-+..|........++...
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~ 598 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP 598 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC
Confidence 56789999999997631 257899999999999999999999977555444455555443333455555
Q ss_pred CHH-HHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 148 DAE-ARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 148 s~~-l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
... +.++++.||. ||.+|+++.+||.|||++.
T Consensus 599 ~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 599 ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 444 9999999999 9999999999999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=237.01 Aligned_cols=171 Identities=25% Similarity=0.409 Sum_probs=134.6
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
+|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCcCC
Confidence 4688888875 567999999999999999999999999 9999999999999987 799999999997653321 2234
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-------------------CC
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-------------------LP 140 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~-------------------~p 140 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|..|+..........+.+.... .+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 567899999998754 378999999999999999999988654444333333322100 00
Q ss_pred C--------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 G--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 ~--------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
. ......++.+++||.+||. +|.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0012347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=248.60 Aligned_cols=173 Identities=32% Similarity=0.463 Sum_probs=132.6
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.|+|.+++.+ ...+++..++.|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|||++............
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCccccccccCcccccc
Confidence 5789999875 466999999999999999999999999 9999999999999887 79999999999764443344456
Q ss_pred cCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCC-CCCCCh---------HHHHHHHHc-CCCCCCcc------
Q 010768 83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY-SECSNP---------AQIYKKVTS-GKLPGAFH------ 144 (502)
Q Consensus 83 ~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf-~~~~~~---------~~i~~~i~~-~~~p~~~~------ 144 (502)
.||+.|+|||++. ..++.++|||||||++|+|+++..|+ ...... ..+.+.+.. +..+..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 7999999999876 45899999999999999999855444 321111 111111111 11111111
Q ss_pred ------------------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 145 ------------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 145 ------------------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
...+..+.+||.+||. ||.+|||+.|+|.||||+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1235567789999999 9999999999999999974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=235.24 Aligned_cols=165 Identities=28% Similarity=0.509 Sum_probs=144.9
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010768 14 YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE 92 (502)
Q Consensus 14 ~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APE 92 (502)
+++++|..+-++..-++.||.||-. |+ |||||+||+|||++.. |++||||||++..+.++.......|.+.|||||
T Consensus 185 k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPE 261 (391)
T KOG0983|consen 185 KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPE 261 (391)
T ss_pred cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccC-CCEEeecccccceeecccccccccCCccccCcc
Confidence 4679999999999999999999986 46 9999999999999987 899999999998887766666778999999999
Q ss_pred ccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccc-cCCHHHHHHHHHhhc-CcCCCC
Q 010768 93 LYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR-IQDAEARRFVGKCLE-NVSKRL 166 (502)
Q Consensus 93 vl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~-~~s~~l~~LI~kcL~-dP~kRp 166 (502)
.+. .+|+..+||||||+.++||+||++||.++....+...+|.....|.-... ..++.+.+|+..||. |+.+||
T Consensus 262 Ridp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP 341 (391)
T KOG0983|consen 262 RIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP 341 (391)
T ss_pred ccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCc
Confidence 885 34999999999999999999999999999888888888887544432222 269999999999999 999999
Q ss_pred CHHHHhcCccccCCC
Q 010768 167 PAKELLLDPFLASDA 181 (502)
Q Consensus 167 sa~ElL~hpf~~~~~ 181 (502)
...++|+|||+....
T Consensus 342 ~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 342 KYNKLLEHPFIKRYE 356 (391)
T ss_pred chHHHhcCcceeecc
Confidence 999999999998654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=232.63 Aligned_cols=172 Identities=29% Similarity=0.507 Sum_probs=140.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence 57889999999876 78999999999999999999999999 9999999999999987 799999999987654322 2
Q ss_pred cccccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-C--ccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-A--FHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~--~~~~~s~~l 151 (502)
.....++..|+|||++.+ .++.++|||||||++|+|++|..||.......... .+....... . .....+..+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCCccccchhhhhHHH
Confidence 344578899999998753 58889999999999999999999998754433333 333332211 1 122346789
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
.+||.+||. +|.+||++.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.00 Aligned_cols=173 Identities=32% Similarity=0.456 Sum_probs=129.7
Q ss_pred CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC---CCCcEEEEecCCc
Q 010768 3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLA 70 (502)
Q Consensus 3 ~gGsL~~~L~k~---------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~---~~g~vKL~DFGlA 70 (502)
.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+.. ..+.+||+|||++
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 356888887532 24889999999999999999999999 999999999999942 2368999999999
Q ss_pred eeccCCC----CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCCh---------HHHHHHHH
Q 010768 71 AILRGSQ----HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------AQIYKKVT 135 (502)
Q Consensus 71 ~~~~~~~----~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---------~~i~~~i~ 135 (502)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|+||.+||...... .++.+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8654322 2234578999999998754 4789999999999999999999999643211 11111000
Q ss_pred c-C--------------CCC--------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 136 S-G--------------KLP--------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 136 ~-~--------------~~p--------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
. + ..+ .......+..+.+||.+||. ||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0 000 00011235678899999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=236.06 Aligned_cols=178 Identities=27% Similarity=0.464 Sum_probs=145.8
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||+|+||+++.+ +.+||+|||.+........
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKK 150 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCc
Confidence 678999999998766 7999999999999999999999999 9999999999999887 7999999999876654333
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCC---hHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. +.++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.+.++
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 228 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDL 228 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHH
Confidence 44556889999999875 4588899999999999999999999976432 2222222221 1223444568899999
Q ss_pred HHHhhc-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 155 I~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
|.+||. +|.+|| ++.+++.||||....+.
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 229 CEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred HHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 999999 999999 89999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=235.82 Aligned_cols=176 Identities=31% Similarity=0.540 Sum_probs=144.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence 67899999999774 56999999999999999999999999 9999999999999887 79999999998654322 22
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l 151 (502)
.....|++.|+|||++. ..++.++||||||+++|+|++|..||... ........+..+..+. ..+...+..+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 33456899999999864 23677999999999999999999999774 4444444555443322 2234567899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.++|.+||. +|.+||++.++|+||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999 99999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=232.51 Aligned_cols=172 Identities=32% Similarity=0.499 Sum_probs=145.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.|++|.+++.+...+++..++.|+.||+.||.|||.++ ++|+||||+||+++.+ +.++|+|||++..........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCcccc
Confidence 6789999999988888999999999999999999999999 9999999999999987 799999999998765443444
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
...|+..|+|||++.. .++.++|+||||+++|+|++|..||..... ...+...... .....+...+..+.++|.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINK 235 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence 5678899999998764 479999999999999999999999987543 3333333332 2223344567899999999
Q ss_pred hhc-CcCCCCCH--HHHhcCccc
Q 010768 158 CLE-NVSKRLPA--KELLLDPFL 177 (502)
Q Consensus 158 cL~-dP~kRpsa--~ElL~hpf~ 177 (502)
||. +|.+||++ +|++.||||
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HccCChhHcCCccHHHHhcCCCC
Confidence 999 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=234.98 Aligned_cols=174 Identities=29% Similarity=0.481 Sum_probs=140.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+++|..++.....+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCCcccc
Confidence 5788889888887778999999999999999999999999 9999999999999887 799999999998765433 23
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--C------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--G------------------ 137 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~------------------ 137 (502)
....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+......+...... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567899999998754 4788999999999999999999999875554443322210 0
Q ss_pred CCCCC--------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 138 KLPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 138 ~~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
..+.. .....+..+.+||.+||. +|.+||++.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000 011346789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=242.97 Aligned_cols=177 Identities=20% Similarity=0.409 Sum_probs=137.4
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+++|+|.+++..+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+++.||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccccc
Confidence 67899999999764 45999999999999999999999999 9999999999999987 799999998654332111
Q ss_pred -------CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC------
Q 010768 78 -------HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG------ 141 (502)
Q Consensus 78 -------~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~------ 141 (502)
......++..|+|||++.+ .++.++|||||||++|+|++|..||............ ..+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccc
Confidence 1122356778999998863 4889999999999999999999999764433322222 2121110
Q ss_pred --------------------------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 142 --------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 142 --------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
......++.+.+||.+||. ||.+|||++++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0112236789999999999 999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=229.89 Aligned_cols=172 Identities=31% Similarity=0.521 Sum_probs=146.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.+ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 57899999999875 46899999999999999999999999 9999999999999987 799999999998764433
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+.. ....+..+.++|.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~ 234 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPV-VSVYSSELISLVH 234 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHHHHHH
Confidence 2345678999999998764 478899999999999999999999976 455566666666655433 3556889999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.++|+|||+
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHcccCcccCCCHHHHhhCcCC
Confidence 9999 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=239.44 Aligned_cols=175 Identities=31% Similarity=0.527 Sum_probs=141.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++.+ +.+||+|||++...... ..
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence 67899999999998899999999999999999999997 57 9999999999999887 79999999998765332 23
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHH-----------------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT----------------------- 135 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~----------------------- 135 (502)
....|++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 45678999999998764 48889999999999999999999986422 222221111
Q ss_pred -------------cCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 136 -------------SGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 136 -------------~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
....+.......+..+++||.+||. +|.+||++.+++.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111122357789999999999 99999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=258.00 Aligned_cols=174 Identities=26% Similarity=0.428 Sum_probs=141.4
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCCcc
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
+-+|.+||+++ ..|+...++.++.||+.||.+||+.+ |||+||||+||||... ...|||+|||.+..... ...
T Consensus 271 ~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--~vy 346 (586)
T KOG0667|consen 271 STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--RVY 346 (586)
T ss_pred hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCC--cce
Confidence 56899999976 45999999999999999999999999 9999999999999643 35899999999987644 344
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC------------------
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG------------------ 141 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~------------------ 141 (502)
+++.+..|.|||++- ..|+.+.||||||||++||++|.+.|.+....+++...+.--..|+
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~ 426 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLK 426 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccC
Confidence 888999999999775 5799999999999999999999999998776666644332111100
Q ss_pred -----------------------------------C-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 142 -----------------------------------A-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 142 -----------------------------------~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
. ........+.+||.+||+ ||.+|+|+.++|+||||.
T Consensus 427 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 427 GFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred CceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 0 000123567899999999 999999999999999998
Q ss_pred CCC
Q 010768 179 SDA 181 (502)
Q Consensus 179 ~~~ 181 (502)
...
T Consensus 507 ~~~ 509 (586)
T KOG0667|consen 507 GTS 509 (586)
T ss_pred ccc
Confidence 643
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=226.61 Aligned_cols=172 Identities=33% Similarity=0.615 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+++|.+++... ..+++..++.++.||+.||.|||.+| ++||||+|+||+++.+ +.++|+|||.+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeeccccccccccccc
Confidence 57889999999876 68999999999999999999999998 9999999999999986 79999999999876543323
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc-ccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH-RIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~-~~~s~~l~~LI~k 157 (502)
....++..|+|||.+.+ .++.++||||||+++|+|++|..||........+... .....+.... ...+..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-HhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999998764 4788999999999999999999999775433333332 2222222222 2237889999999
Q ss_pred hhc-CcCCCCCHHHHhcCcc
Q 010768 158 CLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf 176 (502)
||. +|.+||++.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 999 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=235.45 Aligned_cols=176 Identities=32% Similarity=0.579 Sum_probs=145.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.|++|.+++.. +++++..++.++.||+.||+|||++| |+||||+|+||+++.+ +.++|+|||++....... ..
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCccc
Confidence 5789999999988 67999999999999999999999999 9999999999999987 799999999887543322 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc-cccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s~~l~~LI~k 157 (502)
....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..+... ....+..+.+||.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 34568999999998764 588999999999999999999999976 4445555555555322211 22257899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. +|.+||++.+++.||||+...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCC
Confidence 999 999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=229.50 Aligned_cols=173 Identities=38% Similarity=0.655 Sum_probs=143.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+|+||+|+||+++.+ +.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence 5789999999998888999999999999999999999999 9999999999999986 7999999999987643322
Q ss_pred ---cccccCCCcccCcccccc-c---CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccc--cCCH
Q 010768 79 ---AHSVIGTPEFMAPELYEE-D---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR--IQDA 149 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~---~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~ 149 (502)
.....+++.|+|||++.+ . ++.++||||||+++|+|++|..||............+..+..+ .++. ..+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCcccccCH
Confidence 123467899999998763 2 7889999999999999999999997754444444444443332 2222 2388
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+.+||.+||. +|.+||++.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999999 99999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=234.54 Aligned_cols=171 Identities=29% Similarity=0.429 Sum_probs=135.0
Q ss_pred CCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 4 SGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 4 gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
.|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCCCcccc
Confidence 37899998653 46999999999999999999999999 9999999999999887 799999999987653221 12
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------- 138 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~------------------- 138 (502)
....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+...............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 33467899999998754 478899999999999999999999987544433332221100
Q ss_pred CC-------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 139 LP-------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 139 ~p-------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+ .......+++++++|.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 00112357889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=234.12 Aligned_cols=169 Identities=24% Similarity=0.360 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~-~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG-LTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC-CcEEE
Confidence 57899999999875 45889999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++....... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+ ....++...+..+..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i~~~~~ 244 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMIRSRQL 244 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence 9999997653321 123345688999999765 568999999999999999998 9999977 455667777776655
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...+..+.+|+.+||. +|.+||++.+++++
T Consensus 245 ~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 245 LP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43 344568999999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=236.77 Aligned_cols=180 Identities=26% Similarity=0.425 Sum_probs=147.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.++++..+.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcCcccc
Confidence 5789999999998889999999999999999999999999 9999999999999876 799999999986421100
Q ss_pred -------------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC-
Q 010768 78 -------------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA- 142 (502)
Q Consensus 78 -------------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~- 142 (502)
......++..|+|||.+. ..++.++|||||||++|+|++|..||.+ ....++...+..+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCC
Confidence 011245788999999775 4689999999999999999999999976 445566666655543221
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCC---HHHHhcCccccCCCCCC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLP---AKELLLDPFLASDAGEP 184 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRps---a~ElL~hpf~~~~~~~~ 184 (502)
.....+..+.+||.+||. +|.+||+ +.++|.||||....+..
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 222468889999999999 9999998 79999999998766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=234.07 Aligned_cols=173 Identities=26% Similarity=0.515 Sum_probs=139.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|..+ ..+++..+..++.||+.||+|||++| |+|+||||+|||++.+ +.+||+|||++...... ...
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~ 151 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAK 151 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-ccc
Confidence 6788998765 35789999999999999999999999 9999999999999987 79999999999765432 234
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC------hHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN------PAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~------~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
...|+..|+|||++.+ .++.++|||||||++|+|++|..||..... .....+.+.....+.......++.+++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 4678999999998764 589999999999999999999999964221 122233333332222233446789999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||.+||. +|.+||++.+++.||||....
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999 999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=233.23 Aligned_cols=177 Identities=32% Similarity=0.536 Sum_probs=143.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+++|.++++. +.+++..++.++.||+.||.|||+.| |+|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 83 YAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred cCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence 5789999999876 47999999999999999999999999 9999999999999986 799999999998764432 23
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||..... ......+.....+.......+..+.+||.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 34578999999998753 368899999999999999999999976432 222222322222222222367899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
||. +|.+||++.+++.|+||+....
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcccc
Confidence 999 9999999999999999977553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=234.80 Aligned_cols=177 Identities=26% Similarity=0.406 Sum_probs=140.5
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+ +|+|.+++.... .+++..++.++.||+.||.|||++| |+|+||||+|||++.+ +.+||+|||++....... .
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCCCcc
Confidence 45 899999998876 7999999999999999999999999 9999999999999987 799999999998764432 2
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CCC------------C--
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP------------G-- 141 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~p------------~-- 141 (502)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|.+||........+ .++... ..+ .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcCCCchhhhhhcccccccc
Confidence 233457889999998753 4789999999999999999998888764433322 222211 000 0
Q ss_pred -----------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 -----------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 -----------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
......+..+.+||.+||. +|.+||++.|+|.||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 0012236788999999999 9999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=235.70 Aligned_cols=164 Identities=27% Similarity=0.458 Sum_probs=132.9
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010768 14 YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE 92 (502)
Q Consensus 14 ~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APE 92 (502)
...+++..+..++.|++.||+|||+. + |+||||||+||+++.+ +.+||+|||++.............|++.|+|||
T Consensus 101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 177 (288)
T cd06616 101 KSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177 (288)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHHhccCCccccccCccCccCHH
Confidence 46799999999999999999999974 7 9999999999999887 799999999997654433334456899999999
Q ss_pred cccc----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC---ccccCCHHHHHHHHHhhc-CcCC
Q 010768 93 LYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDAEARRFVGKCLE-NVSK 164 (502)
Q Consensus 93 vl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~~l~~LI~kcL~-dP~k 164 (502)
++.+ .++.++|||||||++|+|++|+.||............+..+..+.. .....+..+.+||.+||. +|.+
T Consensus 178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 257 (288)
T cd06616 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESK 257 (288)
T ss_pred HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhh
Confidence 8864 4889999999999999999999999765433333333333333222 122367899999999999 9999
Q ss_pred CCCHHHHhcCccccCC
Q 010768 165 RLPAKELLLDPFLASD 180 (502)
Q Consensus 165 Rpsa~ElL~hpf~~~~ 180 (502)
||++.+++.||||+..
T Consensus 258 Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 258 RPKYKELLEHPFIKDY 273 (288)
T ss_pred CcCHHHHhcChhhhch
Confidence 9999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=233.02 Aligned_cols=172 Identities=28% Similarity=0.478 Sum_probs=138.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccceeeccccccc
Confidence 5789999999988889999999999999999999999999 9999999999999877 789999999998654322 22
Q ss_pred ccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCc--cccCCHHHH
Q 010768 80 HSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAF--HRIQDAEAR 152 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~--~~~~s~~l~ 152 (502)
....|++.|+|||.+. ..++.++|||||||++|+|++|..||.......... .+...... ..+ ....+..+.
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeecCCCCCCCCccccccCHHHH
Confidence 3456889999999773 347889999999999999999999996543222222 22222211 111 123478999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
+||.+||. +|.+||+++++|.|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999 9999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=256.78 Aligned_cols=174 Identities=32% Similarity=0.483 Sum_probs=150.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||..|-|.+.|+....++......|.++|+.|+.|||.+. |||||||.-||||..+ ..|||+|||.++........-
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhh
Confidence 7899999999999999999999999999999999999999 9999999999999988 599999999998877666667
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
.+.||..|||||++.. ..++|+|||||||+|||||||+.||.+..... |+--+....+.-..+...+..++-||+.||
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-IIwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-IIWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-eEEeccCCcccccCcccCchHHHHHHHHHH
Confidence 8899999999999975 58999999999999999999999997743322 222333344444556677889999999999
Q ss_pred c-CcCCCCCHHHHhcCcccc
Q 010768 160 E-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~ 178 (502)
. .|..||++.++|.|-=+.
T Consensus 349 ~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hcCCCCCccHHHHHHHHhhc
Confidence 9 999999999999885443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=220.75 Aligned_cols=160 Identities=25% Similarity=0.305 Sum_probs=128.7
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 5 GsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
|||.+++.++ ..+++.+++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeeccc----cCC
Confidence 8999999874 45999999999999999999999876 9999999887 78998 9999876432 236
Q ss_pred CCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC-----ccccCCH--HHHHHH
Q 010768 84 GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-----FHRIQDA--EARRFV 155 (502)
Q Consensus 84 GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~-----~~~~~s~--~l~~LI 155 (502)
||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+.. .....+. .++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999886 45899999999999999999999999765444444444443322211 1111222 689999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+||. +|.+||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 99999 9999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=232.12 Aligned_cols=174 Identities=27% Similarity=0.426 Sum_probs=137.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+ +++|.+++... ..+++..++.++.||+.||+|||++| |+|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence 45 99999999754 56999999999999999999999999 9999999999999986 799999999998764432
Q ss_pred CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC----------------
Q 010768 78 HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---------------- 139 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~---------------- 139 (502)
......|+..|+|||++.+ .++.++||||+||++|+|++|.+||....+...+...+..-..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 1334578999999998753 3689999999999999999998888764433332222211000
Q ss_pred ----CC-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 140 ----PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 140 ----p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
+. ......+..+.++|.+||. +|.+||+++++|.||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0011236889999999999 999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=238.66 Aligned_cols=177 Identities=34% Similarity=0.568 Sum_probs=143.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-A 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~ 79 (502)
|+.+|+|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++........ .
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCccceEccCCccCc
Confidence 5789999999976 56899999999999999999999999 9999999999999876 7999999999876543322 2
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||........+......+..+...+...+..+++||.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 34568899999998764 58899999999999999999999997644333332222222222223445678899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.||||+...
T Consensus 253 l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 253 LEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ccCChhhCcCHHHHhcCchhcccc
Confidence 99 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=230.27 Aligned_cols=173 Identities=30% Similarity=0.545 Sum_probs=145.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.+++|.+++...+.+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (264)
T cd06653 87 YMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSG 163 (264)
T ss_pred eCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECccccccccccccccC
Confidence 5678999999998888999999999999999999999999 9999999999999887 79999999999765321
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.......|+..|+|||++.+ .++.++|+|||||++|+|++|+.||........+.+ +.....+..++...++.+.++|
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~i 242 (264)
T cd06653 164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDACRDFL 242 (264)
T ss_pred ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHHHHHHH
Confidence 11234568999999998864 488899999999999999999999987544444443 3333333445666788999999
Q ss_pred HHhhcCcCCCCCHHHHhcCccc
Q 010768 156 GKCLENVSKRLPAKELLLDPFL 177 (502)
Q Consensus 156 ~kcL~dP~kRpsa~ElL~hpf~ 177 (502)
.+||.++.+||++.+++.|||.
T Consensus 243 ~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 243 KQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHhcCcccCccHHHHhcCCCC
Confidence 9999988999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=244.03 Aligned_cols=180 Identities=24% Similarity=0.469 Sum_probs=162.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~-~~~~~~~ 79 (502)
|++||+|--.+++.+++.+..+..++..|+-||-|||++| ||+||||.+|||++.+ |++||+|||+++. +-.....
T Consensus 431 yvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCcce
Confidence 7899999999999999999999999999999999999999 9999999999999998 8999999999975 3344566
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++|||.|+|||++. ..|+..+|.||+|++|||||.|++||.+ .+.+++++.|..... .+++..+.++..++..+
T Consensus 508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSkEAv~ickg~ 584 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSKEAVAICKGL 584 (683)
T ss_pred eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccHHHHHHHHHH
Confidence 7899999999999876 6799999999999999999999999988 677888999988766 56777899999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCCCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~~~l~ 186 (502)
|. .|.+|.. -.+|-.||||+.-+|+.+.
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E 618 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE 618 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence 98 9999975 4789999999998886643
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=226.76 Aligned_cols=169 Identities=24% Similarity=0.389 Sum_probs=143.4
Q ss_pred CCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~---------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEccccccc
Confidence 57899999999886 77999999999999999999999999 9999999999999987 799999999998
Q ss_pred eccCCC---CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 72 ILRGSQ---HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 72 ~~~~~~---~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
...... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++.+.+..+... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 231 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPEY 231 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCcc
Confidence 765432 2334567889999998764 68999999999999999999 69999874 566677777665443 33445
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+..+.++|.+||. +|.+||++.+++.+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 58899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=236.03 Aligned_cols=175 Identities=25% Similarity=0.417 Sum_probs=137.6
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
.++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 87 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 87 DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhccCCCCCcccc
Confidence 46899998764 56899999999999999999999999 9999999999999987 799999999987643222 2234
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC---------------------C
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---------------------K 138 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~---------------------~ 138 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|++||........ ...+... .
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhccccccccc
Confidence 467899999998754 478899999999999999999999987443222 2211110 0
Q ss_pred CCC-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 139 LPG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 139 ~p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+. ......++.+++||.+||. +|.+|||++|+|.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 0112357789999999999 9999999999999999987553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=230.89 Aligned_cols=165 Identities=22% Similarity=0.352 Sum_probs=136.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+...+++..+..++.||+.||+|||++| |+||||||+||+++.+ +.++|+|||.+...... ..
T Consensus 66 ~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~ 140 (237)
T cd05576 66 HAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CD 140 (237)
T ss_pred cCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhccccc--cc
Confidence 6789999999998888999999999999999999999999 9999999999999987 79999999987655432 23
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...++..|+|||.+. +.++.++||||+|+++|+|++|..|+...... + ........+...++.++++|.+||
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--I-----NTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c-----ccccccCCcccCCHHHHHHHHHHc
Confidence 345677899999886 45889999999999999999999887542211 0 011111233446789999999999
Q ss_pred c-CcCCCCCH-----HHHhcCccc
Q 010768 160 E-NVSKRLPA-----KELLLDPFL 177 (502)
Q Consensus 160 ~-dP~kRpsa-----~ElL~hpf~ 177 (502)
. ||.+|+++ .+++.||||
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCHHHhcCCCccchHHHHcCCCC
Confidence 9 99999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=235.96 Aligned_cols=176 Identities=32% Similarity=0.571 Sum_probs=143.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhcccccccc
Confidence 5789999998765 57999999999999999999999999 9999999999999887 799999999987553322 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~k 157 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.....+. ......+..+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34578999999998764 5889999999999999999999999763 3344444444332221 1223457889999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. +|.+||++.+++.||||....
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccCC
Confidence 999 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=253.50 Aligned_cols=173 Identities=32% Similarity=0.498 Sum_probs=135.6
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---c
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---A 79 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~ 79 (502)
.|+|.+++.+. ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+++....... .
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence 57899998764 56999999999999999999999999 9999999999999887 7999999999987543221 2
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-------ChHHHHHHHHcCCC-----CC-----
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-------NPAQIYKKVTSGKL-----PG----- 141 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-------~~~~i~~~i~~~~~-----p~----- 141 (502)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+..... +.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 24579999999998864 58999999999999999999876543211 12344444433221 00
Q ss_pred --------------------Ccc--ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 142 --------------------AFH--RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 142 --------------------~~~--~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+. ...+..+.+||.+||. ||.+|||+.|+|+||||+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 0235678999999999 9999999999999999975
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=237.16 Aligned_cols=177 Identities=23% Similarity=0.444 Sum_probs=139.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccc
Confidence 67899999999864 45899999999999999999999999 9999999999999977 799999999886543211
Q ss_pred -------CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--------
Q 010768 78 -------HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-------- 139 (502)
Q Consensus 78 -------~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-------- 139 (502)
......++..|+|||++.. .++.++|||||||++|+|++|..||...........++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 1223457788999998854 4889999999999999999999999875544444333321100
Q ss_pred C-----------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 140 P-----------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 140 p-----------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+ .......+..+.+||.+||. +|.+||++.++|.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0 00111124678899999999 99999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=230.68 Aligned_cols=169 Identities=23% Similarity=0.362 Sum_probs=134.8
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++. +.+||+|||++............
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence 46888888764 57999999999999999999999999 999999999999988 79999999999876544444456
Q ss_pred cCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc---------------CC-----CC
Q 010768 83 IGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---------------GK-----LP 140 (502)
Q Consensus 83 ~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---------------~~-----~p 140 (502)
.+++.|+|||++. +.++.++|||||||++|+|++|..||.+.... .....+.. .. .+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 6899999999764 34788999999999999999999999764332 22222211 00 00
Q ss_pred CC-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 GA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 ~~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.. .....+..+.+||.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 012347899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=225.28 Aligned_cols=172 Identities=30% Similarity=0.563 Sum_probs=145.8
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+++|.+++.+. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 46789999999874 67999999999999999999999999 9999999999999986 79999999999876443
Q ss_pred C-CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||... ....+...+.....+ ..+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQYP-PIPSQYSSELRNL 234 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence 2 234457899999999775 45889999999999999999999999763 455566666555443 3344668899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccc
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
|.+||. +|.+||++.++|.||||
T Consensus 235 i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 235 VSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=268.84 Aligned_cols=178 Identities=26% Similarity=0.433 Sum_probs=147.7
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceecccccCcEEEeCC-------------
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHD-----PPVIHRDLKCDNIFVNGH------------- 58 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g-----~~IIHRDLKPeNILld~~------------- 58 (502)
|+.+|+|.++|.+. +.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 68899999999763 57999999999999999999999854 349999999999999642
Q ss_pred ---CCcEEEEecCCceeccCCCCcccccCCCcccCccccc---ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHH
Q 010768 59 ---LGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK 132 (502)
Q Consensus 59 ---~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~---~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~ 132 (502)
.+.+||+|||++..+.........+||+.|+|||++. ..++.++||||||||||+|++|..||........+..
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~ 254 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254 (1021)
T ss_pred cCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence 1358999999998765444445668999999999874 3488999999999999999999999987666666666
Q ss_pred HHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 133 ~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+..+.. ......+..+.+||..||. +|.+||++.++|.|||++..
T Consensus 255 ~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 255 ELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 6655432 2223457899999999999 99999999999999999754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=227.47 Aligned_cols=168 Identities=21% Similarity=0.365 Sum_probs=140.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||.||+++.+ +.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCee
Confidence 5788999999998888999999999999999999999999 9999999999999987 7999999999976543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+...++.++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~l 230 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDL 230 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHH
Confidence 11223457899999876 458889999999999999998 9999976 44566677777665433 445568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+|..
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHhccCchhCcCHHHHHH
Confidence 999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=231.45 Aligned_cols=175 Identities=27% Similarity=0.387 Sum_probs=136.3
Q ss_pred CCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~-----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
|+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+.+.+||+|||++.....
T Consensus 87 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 87 YLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred ccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 344 5899988653 35899999999999999999999999 999999999999998447999999999876532
Q ss_pred C-CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC------------
Q 010768 76 S-QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP------------ 140 (502)
Q Consensus 76 ~-~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p------------ 140 (502)
. .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+........+.+..-..+
T Consensus 164 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 2 11223457889999997753 47899999999999999999999998755544433322210000
Q ss_pred ------C-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 141 ------G-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 141 ------~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
. ......+..+.+||.+||. +|.+||++.++|.||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0012357889999999999 999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=232.45 Aligned_cols=179 Identities=36% Similarity=0.612 Sum_probs=145.8
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+.+++|.+++.... .+++..+..++.||+.||.|||+.| |+|+||||+||+++.+ +.++|+|||++....... .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchhhhhccchhh
Confidence 578899999999877 8999999999999999999999999 9999999999999976 799999999986543321 2
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~ 156 (502)
.....+++.|+|||++.+ .++.++|+||||+++|+|++|..||... +.......+.....+. ......+..+++||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 234457889999998764 5899999999999999999999999764 3333333333333322 222236788999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
+||. +|.+||++.+++.|+||+...+.
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccCch
Confidence 9999 99999999999999999885543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=230.07 Aligned_cols=175 Identities=31% Similarity=0.566 Sum_probs=142.0
Q ss_pred CCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+++|.+++... ..+++..++.++.||+.||.|||+ .+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence 67899999999773 479999999999999999999996 47 9999999999999986 79999999998765332
Q ss_pred CCcccccCCCcccCcccccc-------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH---HHHHcCCCCCCcccc
Q 010768 77 QHAHSVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY---KKVTSGKLPGAFHRI 146 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~---~~i~~~~~p~~~~~~ 146 (502)
......+++.|+|||++.+ .++.++|||||||++|+|++|..||.... ..... ..+..+..+ ..+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPP-TLPSG 233 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCCC-CCCcc
Confidence 2334568899999998743 25789999999999999999999996532 22222 233333333 33344
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+..+.+||.+||. +|.+||++.+++.||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 78999999999999 999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=226.40 Aligned_cols=172 Identities=27% Similarity=0.496 Sum_probs=144.4
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 578999999997643 5899999999999999999999999 9999999999999887 799999999997654322
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......|++.|+|||++. +.++.++|+|||||++|+|++|..||.. .+...+...+..+..+. .+...+..+.++|.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 234 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNLVS 234 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHHHH
Confidence 123456889999999875 4578899999999999999999999976 44555555666665543 33456889999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.+++.||||
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHhhCChhhCcCHHHHhhCcCC
Confidence 9999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=233.17 Aligned_cols=173 Identities=25% Similarity=0.331 Sum_probs=137.0
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
+++|.+++... ..+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||++....... ....
T Consensus 91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~ 167 (309)
T cd07845 91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTP 167 (309)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeeecCCccCCCCc
Confidence 46899988764 67999999999999999999999999 9999999999999887 799999999998764321 2233
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CC-------------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KL------------------- 139 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~------------------- 139 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+... ..
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (309)
T cd07845 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246 (309)
T ss_pred ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhhccccccccc
Confidence 356888999998753 478999999999999999999999987443 3333333221 00
Q ss_pred -CCCc-------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 140 -PGAF-------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 140 -p~~~-------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+... ....++.+.+||.+||. ||.+||++.++|.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 247 LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 01247888999999999 99999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.12 Aligned_cols=174 Identities=32% Similarity=0.571 Sum_probs=141.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++.......
T Consensus 89 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~ 165 (272)
T cd06629 89 YVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDND 165 (272)
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeecccccccccccccc
Confidence 5789999999999889999999999999999999999999 9999999999999877 799999999987643211
Q ss_pred CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC---CCCCccccCCHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK---LPGAFHRIQDAEA 151 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~---~p~~~~~~~s~~l 151 (502)
......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+.+...... .+.......+..+
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06629 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245 (272)
T ss_pred ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHH
Confidence 1233468899999998753 378899999999999999999999976444433333222221 2222223457899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+++|.+||. +|.+||++.++|.|||+
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 246 LDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999999 99999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=229.05 Aligned_cols=174 Identities=30% Similarity=0.507 Sum_probs=139.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.++.|..++.+...+++..++.++.||+.||.|||.++ |+||||+|+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCCcccc
Confidence 5677777777777777999999999999999999999999 9999999999999986 799999999998765433 3
Q ss_pred cccccCCCcccCccccc-c-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CC-----------------
Q 010768 79 AHSVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK----------------- 138 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~----------------- 138 (502)
.....++..|+|||++. . .++.++||||||+++|+|++|..||.+......+...... +.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 34467889999999875 3 5789999999999999999999999875444433322110 00
Q ss_pred --CCC---------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 139 --LPG---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 139 --~p~---------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+. .++...+..+.+||.+||. +|.+||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 1122347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=222.89 Aligned_cols=171 Identities=32% Similarity=0.563 Sum_probs=146.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+++|.+++.....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.++|+|||++...... ...
T Consensus 74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~ 150 (250)
T cd05123 74 YAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRT 150 (250)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcc
Confidence 4679999999998888999999999999999999999999 9999999999999887 79999999999776443 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....++..|+|||.+.+ ..+.++|+||||+++|+|++|..||.. .......+.+..... .++...+..+.+||.+|
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~ 227 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL--RFPEFLSPEARDLISGL 227 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 45678899999998764 478899999999999999999999966 344556666655433 34455588999999999
Q ss_pred hc-CcCCCCCH---HHHhcCccc
Q 010768 159 LE-NVSKRLPA---KELLLDPFL 177 (502)
Q Consensus 159 L~-dP~kRpsa---~ElL~hpf~ 177 (502)
|. +|.+||++ .+++.||||
T Consensus 228 l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 228 LQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hcCCHhhCCCcccHHHHHhCCCC
Confidence 99 99999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=229.37 Aligned_cols=171 Identities=28% Similarity=0.470 Sum_probs=135.8
Q ss_pred CCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010768 4 SGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAH 80 (502)
Q Consensus 4 gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~ 80 (502)
.++|.+++.. ...+++..++.++.||+.||+|||.++ ++||||+|+||+++.+ +.+||+|||++....... ...
T Consensus 82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccCccccc
Confidence 4689999865 356899999999999999999999999 9999999999999987 799999999987653321 223
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-----------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG----------------- 141 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~----------------- 141 (502)
...+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 3457889999998754 368899999999999999999999987554444443332211110
Q ss_pred ---------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 142 ---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 142 ---------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
......++.++++|.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0012347888999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=223.07 Aligned_cols=172 Identities=34% Similarity=0.593 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-c
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-A 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~ 79 (502)
|+.+++|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence 5678999999998889999999999999999999999999 9999999999999986 7999999999987654332 2
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....++..|+|||.+.+ .++.++|||++|+++|+|++|..||..........+ +.....+ .++...+..++++|.+|
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDHP-PLPEGISPELKDFLMQC 234 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCCC-CCCCCCCHHHHHHHHHH
Confidence 34568899999998754 478899999999999999999999976443333333 3333332 34455688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccc
Q 010768 159 LE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~ 177 (502)
|. +|++||++.+++.||||
T Consensus 235 l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 235 FQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HhCChhhCcCHHHHhcCCCC
Confidence 99 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=239.06 Aligned_cols=170 Identities=28% Similarity=0.399 Sum_probs=135.6
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++... +++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++.............
T Consensus 104 ~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 178 (353)
T cd07850 104 DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV 178 (353)
T ss_pred CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccceeCCCCCCCCCCc
Confidence 46888888654 999999999999999999999999 9999999999999987 799999999998765544444567
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC--------------------C-
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL--------------------P- 140 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~--------------------p- 140 (502)
+++.|+|||++.+ .++.++|||||||++|+|++|+.||........ +..+.. -.. +
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T cd07850 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257 (353)
T ss_pred ccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCC
Confidence 8999999998764 589999999999999999999999976433222 222111 000 0
Q ss_pred -----------CC--------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 141 -----------GA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 141 -----------~~--------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.. .....++.+++||.+||. ||.+||++.|+|.||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred CCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 011235678999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=230.01 Aligned_cols=177 Identities=25% Similarity=0.477 Sum_probs=143.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ ++||||||+||+++.+ +.++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IA 159 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhhh-cc
Confidence 67899999999988889999999999999999999997 57 9999999999999877 79999999998654322 22
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh----------HHHHHHHHcCCCCCCccccCC
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP----------AQIYKKVTSGKLPGAFHRIQD 148 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~----------~~i~~~i~~~~~p~~~~~~~s 148 (502)
....|+..|+|||++. +.++.++|||||||++|+|++|..||...... ......+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 3457899999999775 56889999999999999999999999753321 122333333333322222357
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
..+.+||.+||. +|.+||++.|+++|+||....
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 789999999999 999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=227.59 Aligned_cols=168 Identities=23% Similarity=0.389 Sum_probs=139.4
Q ss_pred CCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEe
Q 010768 1 MFTSGTLREYRKKYT--------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~D 66 (502)
|+.+|+|.+++...+ .+++..+..++.||+.||.|||++| ++||||||+||+++.+ +.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD-LVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC-CeEEECC
Confidence 678999999997653 4889999999999999999999999 9999999999999987 7999999
Q ss_pred cCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCC
Q 010768 67 LGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG 141 (502)
Q Consensus 67 FGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 141 (502)
||++....... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||... ........+..+..+.
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~~~~~~~ 244 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQGRLLQ 244 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCcCC
Confidence 99997643221 122334678899999876 458999999999999999998 99999774 4455666666665543
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....+..++++|.+||. +|.+||++.|++.
T Consensus 245 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 -RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 334568899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=222.96 Aligned_cols=171 Identities=31% Similarity=0.496 Sum_probs=145.1
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+++|.+++.+ ...+++..++.++.||+.||+|||+.| ++|+||+|+||+++.+ +.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 5679999999976 356899999999999999999999999 9999999999999986 79999999999876544
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||... +...+...+..+..+.. ....+..++++|
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li 233 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPPI-PPIYSQDLQNFI 233 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCC-chhhCHHHHHHH
Confidence 3334568899999998764 4888999999999999999999999774 45555566666555433 335688999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccc
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+||. +|.+||++.+++.||++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHcCCCcccCCCHHHHhcCCCC
Confidence 99999 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=224.44 Aligned_cols=173 Identities=27% Similarity=0.468 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+++|.+++.+.. .+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+...+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 578999999997654 4899999999999999999999999 99999999999998874467999999987654322
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......|++.|+|||++. ..++.++|+||||+++|+|++|..||... +..+....+..+..+. .....+..++++|.
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 235 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRSLIS 235 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHHHHH
Confidence 223346899999999775 45889999999999999999999999763 3444444444444432 23345788999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccc
Q 010768 157 KCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+||. +|.+||++.+++.||||
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 QLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHhccChhhCcCHHHHhhCCCC
Confidence 9999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=230.27 Aligned_cols=168 Identities=23% Similarity=0.383 Sum_probs=139.2
Q ss_pred CCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEec
Q 010768 1 MFTSGTLREYRKKYT-------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDL 67 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DF 67 (502)
|+.+|+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~df 164 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LLVKIGDF 164 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-CcEEeccC
Confidence 678999999998654 4899999999999999999999999 9999999999999887 79999999
Q ss_pred CCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 68 GLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 68 GlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
|++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||... ........+..+..+.
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~~~~~~~- 242 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGRVLQ- 242 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCcCC-
Confidence 99976533211 12334577899999876 458999999999999999998 99999764 4555667777665543
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....+..+.+|+.+||. +|.+||++.+++.
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 334567899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=229.21 Aligned_cols=179 Identities=26% Similarity=0.427 Sum_probs=146.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.+|+|.+++.....+++..+..++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 162 (290)
T cd05613 86 YINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVER 162 (290)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecccccccc
Confidence 5789999999998888999999999999999999999999 9999999999999887 799999999997654322 2
Q ss_pred cccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.....|+..|+|||.+.. .++.++||||||+++|+|++|..||.... ....+.+.+..... .++...++.+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (290)
T cd05613 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK 240 (290)
T ss_pred cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHHH
Confidence 234568999999998753 46789999999999999999999996422 22333333333322 23445688999
Q ss_pred HHHHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 153 ~LI~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
+++.+||. +|.+|+ ++.+++.||||....++.
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 99999999 999997 899999999998766533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=229.38 Aligned_cols=171 Identities=27% Similarity=0.388 Sum_probs=135.5
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
+++|.+++.... .+++..++.++.||+.||+|||+++ |+|+||||+|||++.+ +.+||+|||++...... .....
T Consensus 89 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~ 165 (293)
T cd07843 89 EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQ 165 (293)
T ss_pred CcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeeccCCcccccc
Confidence 469999987654 5999999999999999999999999 9999999999999987 79999999999876543 22334
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC---------------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--------------------- 138 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--------------------- 138 (502)
..+++.|+|||.+.+ .++.++||||||+++|+|++|..||..........+....-.
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (293)
T cd07843 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF 245 (293)
T ss_pred ccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccccc
Confidence 567899999998754 368899999999999999999999976443322221111000
Q ss_pred -------CCCCcccc-CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 139 -------LPGAFHRI-QDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 139 -------~p~~~~~~-~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+...++.. .++.+.++|.+||. +|++||++.|+|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00112222 47889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=227.79 Aligned_cols=168 Identities=26% Similarity=0.422 Sum_probs=137.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++........
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLDIDETE 165 (279)
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCceeecccccce
Confidence 57899999999874 56999999999999999999999999 9999999999999876 78999999999876432221
Q ss_pred ---ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+...+..+.++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 243 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICTIDVYMI 243 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCCHHHHHH
Confidence 1223467899999775 458999999999999999998 9999966 34455555555554432 234568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=260.89 Aligned_cols=170 Identities=23% Similarity=0.364 Sum_probs=140.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
||.||.|-+|+.++ .+|++.+|++|+.|+++|+.+||...+||||||||-+||||+.+ |..||||||.|.-.-...
T Consensus 123 yC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSatt~~~~~~ 201 (738)
T KOG1989|consen 123 YCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSATTKILSPT 201 (738)
T ss_pred hccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccccccccCCCc
Confidence 79999999999853 66999999999999999999999999999999999999999988 799999999986432211
Q ss_pred Cc---------ccccCCCcccCccccc---c-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc
Q 010768 78 HA---------HSVIGTPEFMAPELYE---E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144 (502)
Q Consensus 78 ~~---------~~~~GT~~Y~APEvl~---~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 144 (502)
.. -...-|+.|.|||++. + ..++|+|||+|||+||.|+....||.+... -.|..+++..+..
T Consensus 202 ~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----laIlng~Y~~P~~ 276 (738)
T KOG1989|consen 202 SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----LAILNGNYSFPPF 276 (738)
T ss_pred cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----eeEEeccccCCCC
Confidence 10 0123589999999874 3 489999999999999999999999987432 2355666644444
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
..++..+++||+.||+ +|.+||++-+++.+-+
T Consensus 277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 5668999999999999 9999999999986433
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=225.65 Aligned_cols=173 Identities=29% Similarity=0.431 Sum_probs=139.5
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+ +|+|.+++.... .+++..++.++.||+.||.|||++| ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 35 889999998765 7899999999999999999999999 9999999999999987 7999999999987655444
Q ss_pred cccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-----------------
Q 010768 79 AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----------------- 139 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~----------------- 139 (502)
.....++..|+|||++. ..++.++|+||||+++|+|++|+.||..........+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 44567899999999874 34789999999999999999999999775544443322211000
Q ss_pred ---CC-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 140 ---PG-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 140 ---p~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+. ......+..+.+||.+||. +|.+||++.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 0011125789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=229.84 Aligned_cols=168 Identities=23% Similarity=0.415 Sum_probs=138.6
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++..++ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN-LLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-CcEEE
Confidence 678999999997643 3899999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++....... ......++..|+|||++. ..++.++|||||||++|+|++ |..||.. .......+.+..+..
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~ 243 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECITQGRV 243 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhCCCC
Confidence 9999997653321 122345678899999776 458899999999999999999 9999976 344555666666555
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+. .....+..+.++|.+||. +|.+||++.++++
T Consensus 244 ~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 244 LE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 43 344568899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=234.23 Aligned_cols=176 Identities=30% Similarity=0.400 Sum_probs=141.9
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----HA 79 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----~~ 79 (502)
+++|.+++.+...+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++....... ..
T Consensus 87 ~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~ 163 (330)
T cd07834 87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFL 163 (330)
T ss_pred hhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeecccccccccc
Confidence 3589999988889999999999999999999999999 9999999999999988 899999999998765432 23
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CCCC---------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLPG--------------- 141 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~p~--------------- 141 (502)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ...++.+... ..+.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFITSEKARNY 242 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhccccchhhH
Confidence 44568999999998764 588999999999999999999999977443 3333332221 0000
Q ss_pred -------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 142 -------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 142 -------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
......+..+.+||.+||. +|.+||++.+++.||||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0011246789999999999 99999999999999999865443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=233.06 Aligned_cols=180 Identities=26% Similarity=0.452 Sum_probs=151.1
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC---
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~--- 76 (502)
+.||.|.+.|.++..|++.++.++.++|+.||.|||.+| |.||||||+|||-... ..-|||+||.+...+.-.
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 579999999999999999999999999999999999999 9999999999999653 236899999987654321
Q ss_pred -----CCcccccCCCcccCccccc---c---cCCcccchhhhhHHHHHHhhccCCCCCCC--------------ChHHHH
Q 010768 77 -----QHAHSVIGTPEFMAPELYE---E---DYNELVDIYSFGMCVLEMLTSEYPYSECS--------------NPAQIY 131 (502)
Q Consensus 77 -----~~~~~~~GT~~Y~APEvl~---~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--------------~~~~i~ 131 (502)
....+.+|+..|||||+.. + .|+.++|.||||||+|.||+|++||.+.- -...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 2234678999999999753 2 49999999999999999999999996521 134567
Q ss_pred HHHHcCCC--CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 132 KKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 132 ~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
..|..|++ |..-+...+.+++++|..+|. ++.+|.++.+++.|||++.-..+
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 88888876 444556679999999999999 99999999999999999875443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=226.23 Aligned_cols=168 Identities=21% Similarity=0.317 Sum_probs=137.7
Q ss_pred CCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKK------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k------~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 87 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADFGLSKKIY 163 (272)
T ss_pred eCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCCCcccccC
Confidence 5789999999842 234899999999999999999999999 9999999999999877 799999999998764
Q ss_pred CCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.... .....+++.|+|||.+. ..++.++|||||||++|+|++ |+.||.. .....++..+..+..+. .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (272)
T cd05075 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPPDCLD 241 (272)
T ss_pred cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence 3221 12234567899999876 458999999999999999999 8999976 45566777777665432 2334578
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.++|.+||. +|.+||++.++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 242 GLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=225.80 Aligned_cols=171 Identities=29% Similarity=0.528 Sum_probs=143.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| ++|+||||+||+++.+ +.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCccccc
Confidence 5679999999999889999999999999999999999999 9999999999999876 799999999987654322
Q ss_pred ------------------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC
Q 010768 78 ------------------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138 (502)
Q Consensus 78 ------------------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~ 138 (502)
......++..|+|||++. ..++.++||||||++++++++|..||.... .....+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhcC
Confidence 122346789999999775 458889999999999999999999998744 344444444333
Q ss_pred CCCCccccCCHHHHHHHHHhhc-CcCCCCCH----HHHhcCccc
Q 010768 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPA----KELLLDPFL 177 (502)
Q Consensus 139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa----~ElL~hpf~ 177 (502)
. .++...++.+.+||.+||. +|.+||++ .+++.||||
T Consensus 239 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 Y--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2 2334458899999999999 99999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=227.41 Aligned_cols=171 Identities=29% Similarity=0.446 Sum_probs=135.6
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010768 4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAH 80 (502)
Q Consensus 4 gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~ 80 (502)
+++|.+++.... .+++..++.++.||+.||+|||+++ ++||||+|+||+++.+ +.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccccC
Confidence 578999998766 7999999999999999999999998 9999999999999986 799999999987543221 122
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-------------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL------------------- 139 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~------------------- 139 (502)
...+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......+..+.+.....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 3456889999997754 4688999999999999999999999775443333332211000
Q ss_pred C-------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 140 P-------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 140 p-------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+ .......+..+.++|.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 00122346789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=228.43 Aligned_cols=178 Identities=28% Similarity=0.511 Sum_probs=141.6
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence 5789999998753 355899999999999999999999999 9999999999999887 78999999998755332
Q ss_pred CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCC----CChHHHHHHHHcCCCCCC---cc--cc
Q 010768 77 QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTSGKLPGA---FH--RI 146 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~----~~~~~i~~~i~~~~~p~~---~~--~~ 146 (502)
. .....++..|+|||.+. ..++.++|||||||++|+|++|..||... ....+....+.....+.. .. ..
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 2 22446788999999775 46899999999999999999999999764 233344444443222211 11 22
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.++.+.+||.+||. +|.+||++.|++.||||+....
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 35789999999999 9999999999999999976443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=229.98 Aligned_cols=174 Identities=28% Similarity=0.509 Sum_probs=140.3
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+++|..++.. ...+++..+..++.||+.||+|||+ ++ |+||||+|+||+++.+ +.+||+|||++..+........
T Consensus 97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~~~~~ 173 (296)
T cd06618 97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTR 173 (296)
T ss_pred CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchhccCCCcccC
Confidence 5677777765 4579999999999999999999997 57 9999999999999876 7999999999876644333344
Q ss_pred ccCCCcccCcccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc-cccCCHHHHHHH
Q 010768 82 VIGTPEFMAPELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQDAEARRFV 155 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s~~l~~LI 155 (502)
..+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+... ....+..+.+||
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (296)
T cd06618 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV 253 (296)
T ss_pred CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 467889999998753 27889999999999999999999997644444445555444333221 223578899999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. +|.+||++.+++.|||+...
T Consensus 254 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 254 DLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHccCChhhCCCHHHHhcChhhhcc
Confidence 99999 99999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=235.35 Aligned_cols=176 Identities=28% Similarity=0.449 Sum_probs=139.2
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-----
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH----- 78 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~----- 78 (502)
+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++........
T Consensus 91 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 167 (334)
T cd07855 91 ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYF 167 (334)
T ss_pred hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceeecccCcCCCcc
Confidence 5789999988888999999999999999999999999 9999999999999987 7999999999976533211
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-C------------------
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-G------------------ 137 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~------------------ 137 (502)
.....|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.. +
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 247 (334)
T cd07855 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKY 247 (334)
T ss_pred cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHH
Confidence 134578999999998753 4889999999999999999999999764332222111100 0
Q ss_pred --CCC----CC---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 138 --KLP----GA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 138 --~~p----~~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
..+ .. .....+..++++|.+||. +|.+||++.+++.||||.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 248 IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 000 00 112357889999999999 9999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=240.96 Aligned_cols=154 Identities=21% Similarity=0.377 Sum_probs=124.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APE 92 (502)
++++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........ .....+++.|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 4788999999999999999999999 9999999999999976 7999999999976543221 11233566899999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++|||||||++|+|++ |..||........+...+..+ .....+...++.+.++|.+||. +|.+||++.
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 363 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-cCccCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 775 569999999999999999997 999998754444444444433 2223344568899999999999 999999999
Q ss_pred HHhc
Q 010768 170 ELLL 173 (502)
Q Consensus 170 ElL~ 173 (502)
++++
T Consensus 364 ~l~~ 367 (374)
T cd05106 364 QISQ 367 (374)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=231.56 Aligned_cols=177 Identities=34% Similarity=0.563 Sum_probs=142.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.+. .+++.++..++.||+.||.|||++| ++||||||+||+++.+ +.+||+|||++....... ..
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcceeccccccccc
Confidence 57899999999764 5899999999999999999999999 9999999999999887 799999999987554322 22
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....|++.|+|||.+. +.++.++|+||||+++|+|++|+.||........+......+..........+..++++|.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 3456889999999775 458899999999999999999999997644333322222222222222334577899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.|+||+...
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcCc
Confidence 99 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=252.16 Aligned_cols=169 Identities=33% Similarity=0.518 Sum_probs=145.7
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec---cCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL---RGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~---~~~ 76 (502)
+|+|-+|..+|.. ..+|+....+.|++||++|+.|||.++ |||||||..|||+.++ +.|||+|||++..- ...
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccceeeeeeeccc
Confidence 5899999999964 367999999999999999999999999 9999999999999987 79999999999753 233
Q ss_pred CCcccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC---ccccCCH
Q 010768 77 QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDA 149 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~ 149 (502)
.......|...|||||++. ..|++.+||||||+++|||+||..||. ..+.++|+-.+.+|.+... .....+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHH
Confidence 3445567889999999885 349999999999999999999999998 6888898888888855333 2334467
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++++|+..||. ++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999 9999999999985
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=230.09 Aligned_cols=169 Identities=24% Similarity=0.361 Sum_probs=136.0
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN-LASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC-CeEEE
Confidence 567899999997643 4889999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~~~-~ 238 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRM-E 238 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-C
Confidence 9999986432211111122355799999875 458999999999999999997 9999977 4455566666655432 2
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+...+..+++||.+||. +|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 344568899999999999 99999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=226.78 Aligned_cols=168 Identities=26% Similarity=0.419 Sum_probs=138.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... +.+++..++.|+.||+.||+|||+++ ++||||||+|||++.+ +.+||+|||+++.......
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccceeccCCCcc
Confidence 57899999999764 56999999999999999999999999 9999999999999887 7999999999986543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+. ....+.+.+..+..+. .+...+..+..+
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 243 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLA-QPQICTIDVYMV 243 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCC-CCCCCCHHHHHH
Confidence 22345677899999875 569999999999999999998 99999763 4455555555554432 334567789999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||. +|.+||++.|++.
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 999999 9999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=222.98 Aligned_cols=168 Identities=24% Similarity=0.381 Sum_probs=138.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.|+.||+.||+|||.++ ++||||||+|||++.+ +.+||+|||++..........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCccc
Confidence 5788999999998888999999999999999999999999 9999999999999887 799999999998664332211
Q ss_pred ----cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 81 ----SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 81 ----~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||... ...++.+.+..+... ..+...+..++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQEIYSI 230 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHH
Confidence 112346799999775 458999999999999999998 99999774 445566666555432 3344567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=228.59 Aligned_cols=174 Identities=29% Similarity=0.526 Sum_probs=142.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.. +.+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++..+.... ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccCcchhh
Confidence 5789999999865 57999999999999999999999999 9999999999999887 799999999997654322 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....|+..|+|||++.+ .++.++|||||||++|+|++|..||... ........+..+.. .......+..+.++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCCC-CCCCcccCHHHHHHHHHH
Confidence 33468899999998864 5888999999999999999999999753 33333333333332 233345578899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.+++.|||+...
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ccCCcccCcCHHHHHHhHHHHHH
Confidence 99 99999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=228.02 Aligned_cols=175 Identities=30% Similarity=0.562 Sum_probs=143.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.||+|.+++.. +++++..+..++.||+.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCCcccc
Confidence 5789999999975 57999999999999999999999999 9999999999999877 799999999997664332 22
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....++..|+|||++.+ .++.++|+|||||++|+|++|..||.... .......+..+. +.......+..+.++|.+|
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHHHHHH
Confidence 33468889999998754 58899999999999999999999997643 333333333332 2334445678899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.|+||....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcc
Confidence 99 999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=232.37 Aligned_cols=169 Identities=26% Similarity=0.449 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++........
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 89 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEccccccccccCCCcc
Confidence 57899999999875 46899999999999999999999999 9999999999999887 78999999999876433221
Q ss_pred ---ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....++..|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+ ..+...+..+.++
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 243 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI 243 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence 1223467899999775 568999999999999999997 9999976 3444555555444333 2334567889999
Q ss_pred HHHhhc-CcCCCCCHHHHhcC
Q 010768 155 VGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~h 174 (502)
|.+||. +|.+||++.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=223.07 Aligned_cols=166 Identities=19% Similarity=0.345 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++++.+ .+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceeccccC-
Confidence 578999999998754 3899999999999999999999999 9999999999999887 799999999987653322
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .....+...+..+..+ ......++.+.++|.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMK 233 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHH
Confidence 23345678999998764 58899999999999999997 9999976 4555666666555333 344566889999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. +|.+||++.+++.
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 9999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=226.69 Aligned_cols=174 Identities=32% Similarity=0.490 Sum_probs=138.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+++|..+......+++..++.++.||+.||+|||+.+ |+||||+|+||+++.+ +.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCcccc
Confidence 5788899988877777999999999999999999999999 9999999999999887 799999999988654332 22
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CC------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK------------------ 138 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~------------------ 138 (502)
....++..|+|||++.+ .++.++||||||+++|+|++|..||..........+.... +.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999998754 4788999999999999999999999764433322221110 00
Q ss_pred -CCCC--------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 139 -LPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 139 -~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.+.. .....+..+.+||.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 012346789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=238.34 Aligned_cols=154 Identities=24% Similarity=0.398 Sum_probs=126.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APE 92 (502)
.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........ .....++..|+|||
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 286 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPE 286 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccCcccccccCCCCCCcceeChh
Confidence 4788999999999999999999999 9999999999999976 6899999999986543221 11233456799999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++|||||||++|+|++ |..||........+.+.+..+..+ ..+...+.++++||.+||. +|.+||++.
T Consensus 287 ~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 287 SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred HhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 875 468999999999999999998 899998765556666666655433 2334567899999999999 999999999
Q ss_pred HHhc
Q 010768 170 ELLL 173 (502)
Q Consensus 170 ElL~ 173 (502)
+++.
T Consensus 366 eil~ 369 (375)
T cd05104 366 QIVQ 369 (375)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=234.41 Aligned_cols=175 Identities=26% Similarity=0.405 Sum_probs=138.2
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----- 77 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----- 77 (502)
.+++|.+++.....+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 164 (332)
T cd07857 88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAG 164 (332)
T ss_pred ccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceecccccccccc
Confidence 46799999988889999999999999999999999999 9999999999999887 799999999997654321
Q ss_pred CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHH--------------HHHc-----
Q 010768 78 HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYK--------------KVTS----- 136 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~--------------~i~~----- 136 (502)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||........+.. .+..
T Consensus 165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (332)
T cd07857 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244 (332)
T ss_pred cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH
Confidence 1234578999999997653 488999999999999999999999976332211111 1100
Q ss_pred -----CCCC----CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 137 -----GKLP----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 137 -----~~~p----~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
...+ .......+..+.+||.+||. +|.+||++.+++.|||++.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0000 01112247889999999999 99999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=226.47 Aligned_cols=169 Identities=25% Similarity=0.401 Sum_probs=136.9
Q ss_pred CCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKYT----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
|+.+|+|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~-~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-CCEEECCCCCc
Confidence 678999999997632 3578899999999999999999998 9999999999999987 79999999998
Q ss_pred eeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 71 AILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 71 ~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ .......+.+..+..+ ..+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 244 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGGLL-DKPD 244 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-CCCC
Confidence 75433211 11234577899999876 458999999999999999999 7899976 4455556655555443 2344
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
..+..++++|.+||. +|.+||++.|++.+
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567889999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=235.31 Aligned_cols=155 Identities=24% Similarity=0.381 Sum_probs=126.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APE 92 (502)
.+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+.... ......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 6899999999999999999999999 9999999999999986 799999999998653221 122345677899999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++.+.+++.+||+ +|.+||++.
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 775 569999999999999999998 999997744444444455444332 3344567899999999999 999999999
Q ss_pred HHhcC
Q 010768 170 ELLLD 174 (502)
Q Consensus 170 ElL~h 174 (502)
+++++
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=224.42 Aligned_cols=171 Identities=34% Similarity=0.478 Sum_probs=136.2
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+++|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++...........
T Consensus 89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~ 165 (287)
T cd07838 89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTS 165 (287)
T ss_pred ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcceeccCCccccc
Confidence 368999987753 4999999999999999999999999 9999999999999988 7999999999987654444445
Q ss_pred ccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-----------------C--
Q 010768 82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-----------------G-- 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-----------------~-- 141 (502)
..++..|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+..-..+ .
T Consensus 166 ~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (287)
T cd07838 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYT 245 (287)
T ss_pred ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccccc
Confidence 56889999999876 458899999999999999999999997744433332222211000 0
Q ss_pred --Cc---cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 142 --AF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 142 --~~---~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.. ....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 246 PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 01235678899999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=228.40 Aligned_cols=171 Identities=28% Similarity=0.477 Sum_probs=139.1
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.+||+|||++..... ....
T Consensus 98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~---~~~~ 171 (307)
T cd06607 98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLVSP---ANSF 171 (307)
T ss_pred CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecCcceecCC---CCCc
Confidence 3677777764 457999999999999999999999999 9999999999999887 7999999999876532 2345
Q ss_pred cCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 83 ~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+++.|+|||++. +.++.++||||||+++|+|++|..||..... ......+.....+.......+..++++|.+|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-HHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 6889999999763 4588999999999999999999999976433 3333333333333333344578899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.||||....
T Consensus 251 l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 251 LQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hcCChhhCcCHHHHhcChhhcccC
Confidence 99 999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=222.16 Aligned_cols=169 Identities=28% Similarity=0.478 Sum_probs=141.2
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||.|||++| |+|+||||+||+++.+ +.++|+|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence 57899999998753 45899999999999999999999999 9999999999999877 799999999997664322
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..+++||.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 233 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSLIK 233 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHHHH
Confidence 2334678999999998864 588999999999999999999999976 45555556666555432 33456788999999
Q ss_pred Hhhc-CcCCCCCHHHHhcC
Q 010768 157 KCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~h 174 (502)
+||. +|.+||++.+++.-
T Consensus 234 ~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 234 QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhCCcccCCCHHHHhhc
Confidence 9999 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=222.75 Aligned_cols=168 Identities=20% Similarity=0.319 Sum_probs=137.8
Q ss_pred CCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||+++...
T Consensus 88 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 164 (273)
T cd05035 88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVADFGLSKKIY 164 (273)
T ss_pred ccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEECCccceeecc
Confidence 57899999998543 35899999999999999999999999 9999999999999887 799999999998654
Q ss_pred CCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ ....++.+.+..+..+. .+...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (273)
T cd05035 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK-QPEDCLD 242 (273)
T ss_pred ccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcCCCH
Confidence 3221 11223467899999876 458999999999999999999 8999976 44556666666654433 3445688
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.++|.+||. +|.+||++.+++.
T Consensus 243 ~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 243 ELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=227.30 Aligned_cols=170 Identities=24% Similarity=0.390 Sum_probs=132.2
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC----
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---- 78 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---- 78 (502)
+++|.+++.+. ..+++.+++.++.||+.||+|||++| |+|+||||+||+++.+ +.+||+|||++........
T Consensus 102 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 178 (310)
T cd07865 102 EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPN 178 (310)
T ss_pred CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEECcCCCcccccCCcccCCC
Confidence 46888888765 36999999999999999999999999 9999999999999887 7999999999976533211
Q ss_pred -cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCCCC-----------
Q 010768 79 -AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPGA----------- 142 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p~~----------- 142 (502)
.....++..|+|||++.+ .++.++||||||+++|+|++|..||..... ......+.. +..+..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T cd07865 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSITPEVWPGVDKLELF 257 (310)
T ss_pred CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhcccccchhhh
Confidence 123467889999998754 378899999999999999999999976432 222111111 111100
Q ss_pred -----------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 -----------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 -----------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.....+..+.+||.+||. +|.+||+++++|.||||
T Consensus 258 ~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011235678899999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=224.24 Aligned_cols=171 Identities=27% Similarity=0.432 Sum_probs=137.2
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
+++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||.+....... ....
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccccC
Confidence 46888888764 67999999999999999999999999 9999999999999987 799999999998765433 2233
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--C----------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--G---------------- 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~---------------- 141 (502)
..++..|+|||.+.+ .++.++||||||+++|+|++|+.||........+.+.......+ .
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 568889999997753 58899999999999999999999997755544433322211110 0
Q ss_pred ---------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 142 ---------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 142 ---------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112246789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=225.91 Aligned_cols=175 Identities=24% Similarity=0.386 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKY----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
|+.+|+|.+++++. ..++...+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-FTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-CcEEECcCCcc
Confidence 67899999999763 23567789999999999999999999 9999999999999987 79999999998
Q ss_pred eeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 71 AILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 71 ~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
+....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+ ....++.+.+..+..+. ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 244 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYLD-QPD 244 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 76433211 12234567899999875 468999999999999999998 7889976 44555666666554432 233
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhc------CccccCC
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLL------DPFLASD 180 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~------hpf~~~~ 180 (502)
..++.++++|.+||. +|.+||++.++++ ||||.+.
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 457899999999999 9999999999986 8888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=221.09 Aligned_cols=169 Identities=26% Similarity=0.382 Sum_probs=138.2
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.+||+|||++..+.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEecccccccccccccc
Confidence 567999999998764 6899999999999999999999999 9999999999999988 7999999999987643211
Q ss_pred ----cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 ----AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ----~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||... ...++.+.+.........+...+..+.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 12345678899999876 468999999999999999998 99999764 444555555532222223345678999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+++.+||. +|.+||++.+++.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=233.11 Aligned_cols=173 Identities=27% Similarity=0.392 Sum_probs=138.4
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCcccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~~ 82 (502)
+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++...... ......
T Consensus 92 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 168 (337)
T cd07858 92 DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEY 168 (337)
T ss_pred CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCccccccCCCccccccc
Confidence 5799999998889999999999999999999999999 9999999999999887 79999999999765433 223445
Q ss_pred cCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc---C--------------------
Q 010768 83 IGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---G-------------------- 137 (502)
Q Consensus 83 ~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---~-------------------- 137 (502)
.++..|+|||++. ..++.++|||||||++|+|++|+.||.+.... .....+.. .
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (337)
T cd07858 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247 (337)
T ss_pred ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcCchhhhHHHHh
Confidence 6889999999775 35889999999999999999999999763221 11111100 0
Q ss_pred ----CCC--CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 138 ----KLP--GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 138 ----~~p--~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
..+ .......++.+.+||.+||. +|.+||++.+++.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00122357889999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=231.07 Aligned_cols=176 Identities=28% Similarity=0.335 Sum_probs=138.7
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-------
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS------- 76 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~------- 76 (502)
.|+|.+++.....+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++......
T Consensus 103 ~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 179 (335)
T PTZ00024 103 ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLS 179 (335)
T ss_pred ccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CCEEECCccceeeccccccccccc
Confidence 4799999998888999999999999999999999999 9999999999999887 79999999998765411
Q ss_pred --------CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC--CCCCC--
Q 010768 77 --------QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLPGA-- 142 (502)
Q Consensus 77 --------~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~--~~p~~-- 142 (502)
.......+++.|+|||.+.+ .++.++|||||||++|+|++|..||........+...+... ..+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (335)
T PTZ00024 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWP 259 (335)
T ss_pred ccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCc
Confidence 11123356889999998754 37899999999999999999999998754433322221110 00000
Q ss_pred ---------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 143 ---------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 143 ---------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.....+..+.++|.+||. +|.+||++.++|.||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 260 QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred chhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 011236788999999999 9999999999999999986543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=225.99 Aligned_cols=179 Identities=29% Similarity=0.453 Sum_probs=144.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+...+++..++.++.||+.||.|||+.+ ++||||||.||+++.+ +.++|+|||++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 162 (288)
T cd05583 86 YVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEER 162 (288)
T ss_pred cCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECccccccccccccc
Confidence 5789999999988888999999999999999999999998 9999999999999887 7999999999876543221
Q ss_pred cccccCCCcccCccccccc---CCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~---~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.....|+..|+|||.+.+. .+.++||||||+++|+|++|..||.... ....+.+.+..... ..+...+..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 240 (288)
T cd05583 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEAR 240 (288)
T ss_pred cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHH
Confidence 2234689999999987543 6889999999999999999999996422 12333334433322 23344678999
Q ss_pred HHHHHhhc-CcCCCCC---HHHHhcCccccCCCCCC
Q 010768 153 RFVGKCLE-NVSKRLP---AKELLLDPFLASDAGEP 184 (502)
Q Consensus 153 ~LI~kcL~-dP~kRps---a~ElL~hpf~~~~~~~~ 184 (502)
++|.+||. +|.+||| +.++|.||||+.-.+..
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 99999999 9999998 57789999998866643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=223.39 Aligned_cols=170 Identities=28% Similarity=0.445 Sum_probs=140.5
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccceeccch
Confidence 5788999998863 345899999999999999999999999 9999999999999887 79999999998876432
Q ss_pred C-CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
. ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ....+...+.....+.......+..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 2 123456889999999875 458889999999999999999999986532 3455666666655555544556788999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.++++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHH
Confidence 9999999 9999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=227.25 Aligned_cols=169 Identities=25% Similarity=0.398 Sum_probs=138.5
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~-~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTED-HVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCC-CeEEe
Confidence 57899999999653 45899999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.. ....++.+.+..+..
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 252 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGYR 252 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence 99999986543221 11223457899999765 458999999999999999997 9999976 455566666666554
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...+..+.+|+.+||. +|.+|||+.+++.+
T Consensus 253 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 253 ME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33 333557899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=227.10 Aligned_cols=176 Identities=27% Similarity=0.367 Sum_probs=136.9
Q ss_pred CCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Ccc
Q 010768 4 SGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAH 80 (502)
Q Consensus 4 gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~ 80 (502)
+++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+||+++...+.+||+|||++....... ...
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 84 DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 5688888876543 588999999999999999999999 99999999999998655689999999997653221 223
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC------------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP------------------ 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p------------------ 140 (502)
...+++.|+|||++.+ .++.++|||||||++|+|++|..||........+.+.+..-..+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 3467899999998754 47889999999999999999999998754444443322110000
Q ss_pred -CC-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 141 -GA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 141 -~~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.. .....++.+.++|.+||. +|.+||++.+++.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 012347789999999999 999999999999999998643
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=222.05 Aligned_cols=168 Identities=24% Similarity=0.389 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCcccccccccee
Confidence 57899999999764 35899999999999999999999999 9999999999999877 7999999999976543221
Q ss_pred c--ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~--~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .......+.+..+..+ ..+...+..+.++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 237 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYEL 237 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1 1223456899999776 458899999999999999998 9999976 4556666666654332 3445568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=224.92 Aligned_cols=170 Identities=20% Similarity=0.357 Sum_probs=136.1
Q ss_pred CCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~ 71 (502)
|+.||+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+||+++.+ ...+||+|||+++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCcccc
Confidence 578999999998753 4899999999999999999999999 9999999999999864 2369999999998
Q ss_pred eccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 72 ILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 72 ~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
.+..... ......+..|+|||++. +.++.++|||||||++|+|++ |..||... ....+.+.+.....+ ..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~ 245 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGRL-DPPKG 245 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCC
Confidence 6532211 11223356899999875 569999999999999999997 99999874 344555555544332 23445
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+..+.+|+.+||. +|.+||++.++++|
T Consensus 246 ~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 246 CPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 57899999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=226.39 Aligned_cols=171 Identities=29% Similarity=0.474 Sum_probs=132.6
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
+++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+|||++.+ +.+||+|||++...... .....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 86 HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccccCCCCCCCCC
Confidence 47787777653 56889999999999999999999999 9999999999999877 79999999998754322 12234
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--C-----------CCC----CC
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--G-----------KLP----GA 142 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~-----------~~p----~~ 142 (502)
..+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+....+.. + ..+ ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 467899999998754 4788999999999999999999999765443332222211 0 000 00
Q ss_pred c-------------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 F-------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 ~-------------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
. ....+..+.++|.+||. +|.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 01125688999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=250.08 Aligned_cols=177 Identities=25% Similarity=0.465 Sum_probs=159.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|.|++|+.+++++.+..++.++.|++.|++|||+++ |||||||.+||||+.+ -++||+|||++..+.......
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceeeccccccc
Confidence 6789999999999999999999999999999999999999 9999999999999998 489999999999998888889
Q ss_pred cccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
+.+|++.|+|||++.+. .++.+|+||+|+++|.|+.|..||.+ .+...+...+..+++ ..+...+.+++++|+++
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKF 289 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeee--cccceeechhHHHHHHh
Confidence 99999999999999864 67899999999999999999999987 556666677777776 34445678899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+|++.++++.|.|.......
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hccCccccCCHHHhhhhcccchhhhh
Confidence 99 99999999999999999865544
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=224.71 Aligned_cols=168 Identities=21% Similarity=0.307 Sum_probs=138.1
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDK-LNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCC-CceEe
Confidence 56789999998532 34889999999999999999999999 9999999999999877 68999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ ....++...+..+..
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~ 244 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIRNRQV 244 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCc
Confidence 99999876533221 22345678999999775 568999999999999999998 8889876 455667777776654
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.. .+...+..+.+|+.+||+ +|.+||++.+++.
T Consensus 245 ~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 245 LP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 32 334568889999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=227.16 Aligned_cols=175 Identities=33% Similarity=0.568 Sum_probs=141.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+++|.+++.. +++++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++....... ..
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccccc
Confidence 6789999998754 57899999999999999999999999 9999999999999987 799999999987654322 22
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFVG 156 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~ 156 (502)
....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||... ........+..+ .+..+ ....+..+.++|.
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhh-CCcccCCcccCCHHHHHHHH
Confidence 3456899999999775 45889999999999999999999999763 333333333322 22221 2235788999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+||. +|.+||++.+++.||||....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=220.66 Aligned_cols=168 Identities=20% Similarity=0.406 Sum_probs=138.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. +.+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCCcee
Confidence 67899999999754 56899999999999999999999999 9999999999999887 79999999998765332211
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. ....+....+..+..+ ..+...+..+.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li 234 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYEVM 234 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1223566899999876 458899999999999999999 9999976 4445566666665443 23445678899999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.+++.
T Consensus 235 ~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 99999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=224.10 Aligned_cols=168 Identities=24% Similarity=0.358 Sum_probs=134.1
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||++| ++||||||+|||++.+ +.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEEE
Confidence 578999999997643 4789999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||.+ .......+.+..+... .
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~ 231 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E 231 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-C
Confidence 9999985432211111223356799999875 458899999999999999997 9999976 3444555555554332 2
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....+..+.+++.+||. +|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334457889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=213.85 Aligned_cols=174 Identities=36% Similarity=0.584 Sum_probs=149.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+++|.+++.....++...++.++.+|+.+|.|||+.+ |+|+||+|.||+++.+ +.++|+|||.+..........
T Consensus 68 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~ 144 (244)
T smart00220 68 YCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLT 144 (244)
T ss_pred CCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccc
Confidence 4677899999988777999999999999999999999999 9999999999999987 799999999998776544455
Q ss_pred cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcccc-CCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI-QDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~-~s~~l~~LI~kc 158 (502)
...++..|++||.+. ..++.++|||+||+++|+|++|..||........+.+.+..+......... .+..+.+++.+|
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 667899999999875 568889999999999999999999997756667777766665554333222 678999999999
Q ss_pred hc-CcCCCCCHHHHhcCccc
Q 010768 159 LE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~ 177 (502)
|. +|.+||++.++++||||
T Consensus 225 l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 225 LVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCchhccCHHHHhhCCCC
Confidence 99 99999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=222.76 Aligned_cols=168 Identities=25% Similarity=0.398 Sum_probs=137.7
Q ss_pred CCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKYT----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CCEEECCcccc
Confidence 578999999997532 3688899999999999999999999 9999999999999987 79999999998
Q ss_pred eeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 71 AILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 71 ~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
+...... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .......+.+..+..+ ..+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 244 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGHL-DLPE 244 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCCC-CCCC
Confidence 7654322 122345678999999775 568999999999999999998 9999976 4455666666654433 2334
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+..+.++|.+||. +|.+|||+.+++.
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 458899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=221.28 Aligned_cols=169 Identities=22% Similarity=0.412 Sum_probs=139.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+|+||||.|||++.+ +.+||+|||.++........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCCCcee
Confidence 57899999999874 46899999999999999999999999 9999999999999887 79999999998765432211
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....++..|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+..+..+ ......+..+++++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 234 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEKVYAIM 234 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 1223557899999886 468999999999999999998 99999763 445556666665443 23445688999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++.+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHcCCCcccCCCHHHHHHh
Confidence 99999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=221.48 Aligned_cols=168 Identities=20% Similarity=0.365 Sum_probs=137.8
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+|||++.+ +.+||+|||++........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSY 151 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccc
Confidence 5789999999975 457999999999999999999999999 9999999999999887 7999999999975533221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++++.+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYA 229 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHH
Confidence 11122357899999875 458899999999999999996 99999774 445566666666543 344566889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.++++
T Consensus 230 li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 230 LMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=243.78 Aligned_cols=168 Identities=30% Similarity=0.531 Sum_probs=144.3
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 5 GTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 5 GsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
|+-.+++.- .+++.+-+|..|+.+.+.||+|||+++ .||||||..|||++.. |.|||+|||.|... ....+++
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~-g~VKLaDFGSAsi~---~PAnsFv 183 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP-GLVKLADFGSASIM---APANSFV 183 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC-Ceeeeccccchhhc---Cchhccc
Confidence 566777754 367999999999999999999999999 9999999999999987 89999999999876 3467899
Q ss_pred CCCcccCcccc----cccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 84 GTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 84 GT~~Y~APEvl----~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
|||.|||||++ .|.|+-++||||||+++.||.-.++|+.++.-...+| .|.....|--....++..++.||..||
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 99999999976 3779999999999999999999999988855444444 455555554445566889999999999
Q ss_pred c-CcCCCCCHHHHhcCccccC
Q 010768 160 E-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~ 179 (502)
. -|.+|||.+++|+|+|+..
T Consensus 263 qKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hhCcccCCcHHHHhhcchhcc
Confidence 9 8999999999999999964
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=236.11 Aligned_cols=179 Identities=31% Similarity=0.541 Sum_probs=149.5
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
||-.|++.+.++- ++.|++.++..+++.-+.||+|||... -||||||..|||++.+ |..||+|||+|..+.+. ..
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhhHHh
Confidence 7888999999974 577999999999999999999999988 8999999999999988 89999999999887654 34
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI 155 (502)
.++++|||.|||||++.. .|+.++||||||++..||..|++||.+......++ .|.. +.|+.+ +...+.++.+||
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-MIPT-~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-MIPT-KPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-eccC-CCCCCCCChHhhhhHHHHHH
Confidence 578999999999999975 59999999999999999999999998743322222 2221 222222 335688899999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
++||. +|++|.|+.++++|||+++.+...
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 99999 999999999999999999865543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=220.53 Aligned_cols=168 Identities=23% Similarity=0.388 Sum_probs=136.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence 57899999999763 56899999999999999999999998 9999999999999987 7999999999987643221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. +.++.++|||||||++|+|++ |..||.. .....+...+..+... ......+..+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 236 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRM-PRMENCPDELYDI 236 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 12234567899999875 458889999999999999998 9999976 3444555555554332 2233467899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++++++.
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=249.64 Aligned_cols=179 Identities=24% Similarity=0.330 Sum_probs=130.2
Q ss_pred CCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC
Q 010768 1 MFTSGTLREYRKKYTR--------------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--------------------Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g 60 (502)
|+.+|+|.+++..... .....+..++.||+.||.|||+++ |+||||||+|||++.+.+
T Consensus 216 y~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~~~ 293 (566)
T PLN03225 216 YEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSG 293 (566)
T ss_pred ecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCCCC
Confidence 5678999999875421 123457789999999999999999 999999999999997557
Q ss_pred cEEEEecCCceeccCC--CCcccccCCCcccCcccccc-----------------------cCCcccchhhhhHHHHHHh
Q 010768 61 QVKIGDLGLAAILRGS--QHAHSVIGTPEFMAPELYEE-----------------------DYNELVDIYSFGMCVLEML 115 (502)
Q Consensus 61 ~vKL~DFGlA~~~~~~--~~~~~~~GT~~Y~APEvl~~-----------------------~~s~ksDIwSLG~iLyeLL 115 (502)
.+||+|||+++.+... ......++++.|+|||.+.. .+..++|||||||++|+|+
T Consensus 294 ~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~ 373 (566)
T PLN03225 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373 (566)
T ss_pred cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence 9999999999865432 22345788999999996521 2345679999999999999
Q ss_pred hccCCCCCCCChHHHHHHHHcCCCC---------C----C------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCc
Q 010768 116 TSEYPYSECSNPAQIYKKVTSGKLP---------G----A------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175 (502)
Q Consensus 116 tG~~Pf~~~~~~~~i~~~i~~~~~p---------~----~------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hp 175 (502)
++..|+.. ......+.+...... . . .........++||.+||. ||.+|||+.++|+||
T Consensus 374 ~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 374 FPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred hCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 97766532 222222222211110 0 0 001123345689999999 999999999999999
Q ss_pred cccCCCCC
Q 010768 176 FLASDAGE 183 (502)
Q Consensus 176 f~~~~~~~ 183 (502)
||+.....
T Consensus 452 ff~~~~~~ 459 (566)
T PLN03225 452 YFDREGLL 459 (566)
T ss_pred CcCCCCcc
Confidence 99876543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=229.22 Aligned_cols=169 Identities=24% Similarity=0.351 Sum_probs=134.8
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~-~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC-CcEEe
Confidence 578999999997643 5789999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
+|||++.............++..|+|||++.+ .++.++|||||||++|+|+| |..||.. ....+..+.+..+..+ .
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~ 243 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E 243 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCCcC-C
Confidence 99999864322111122234667999998764 48899999999999999998 9999976 3444555555443222 2
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+...++.+.+||.+||. +|.+||++.+++..
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233457889999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=221.33 Aligned_cols=170 Identities=29% Similarity=0.468 Sum_probs=139.3
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++.+ +.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhccccC
Confidence 5678999999874 356899999999999999999999999 9999999999999887 79999999998765432
Q ss_pred C-CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
. ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+.. ......+.+.....+.......+..+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2 2234568999999998754 58889999999999999999999996533 2334455555555544444557889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+|||+.++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 9999999 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=222.78 Aligned_cols=168 Identities=18% Similarity=0.277 Sum_probs=137.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++.+ +.+||+|||.+.........
T Consensus 87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCcccccccccchh
Confidence 67899999999874 57999999999999999999999999 9999999999999887 79999999987654222111
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||... ....+.+.+..+..+ ..+...+..+.+++
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 241 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRL-PAPRNCPNLLHQLM 241 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1233567899999775 568999999999999999775 99999774 445556666655433 23455688999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.+|++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 99999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=222.41 Aligned_cols=170 Identities=24% Similarity=0.346 Sum_probs=132.7
Q ss_pred CCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYT-----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEecccccccccc
Confidence 578999999997753 2467888999999999999999999 9999999999999987 7999999999865322
Q ss_pred CC---CcccccCCCcccCccccc--------ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCC---
Q 010768 76 SQ---HAHSVIGTPEFMAPELYE--------EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP--- 140 (502)
Q Consensus 76 ~~---~~~~~~GT~~Y~APEvl~--------~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p--- 140 (502)
.. ......+++.|+|||++. ..++.++|||||||++|+|++ |..||....+...+...+..+..+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence 11 112334567899999863 246789999999999999999 888997755444444444443321
Q ss_pred CCccccCCHHHHHHHHHhhcCcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~dP~kRpsa~ElL~ 173 (502)
.......+..+..++..|+.+|.+||++++|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 223345678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=245.54 Aligned_cols=177 Identities=27% Similarity=0.418 Sum_probs=132.4
Q ss_pred CCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 4 SGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 4 gGsL~~~L~k~-----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
+++|.+++... .......++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||++..+....
T Consensus 246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~ 322 (501)
T PHA03210 246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKERE 322 (501)
T ss_pred ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEeCCCceecCcccc
Confidence 56788887542 23456788899999999999999999 9999999999999887 799999999998765432
Q ss_pred -CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCC-CCCCC-C-hHHHHHHHHcC-----CCCCC-----
Q 010768 78 -HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYP-YSECS-N-PAQIYKKVTSG-----KLPGA----- 142 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~P-f~~~~-~-~~~i~~~i~~~-----~~p~~----- 142 (502)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..+ |.... . ..++.+.+... .+|..
T Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 402 (501)
T PHA03210 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLF 402 (501)
T ss_pred cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHH
Confidence 2234679999999998864 589999999999999999998754 43221 2 22222222211 01100
Q ss_pred -------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 143 -------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 143 -------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
.....+..+.++|.+||. ||.+||++.|+|.||||.....+
T Consensus 403 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 403 DYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred HHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 001235667888999999 99999999999999999876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=239.93 Aligned_cols=167 Identities=25% Similarity=0.409 Sum_probs=141.3
Q ss_pred CCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+..|+|.+||++ ...++..+.+.++.||++|++||.+++ +|||||-..||||+.+ ..+||+|||+|+.+.+...
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccccCCCce
Confidence 6889999999997 567999999999999999999999999 9999999999999988 6999999999995543322
Q ss_pred cc--cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AH--SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~--~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.. ...-...|.|||.+. +.++.|+||||||++||||+| |+.||.+.. ..++.+.+.+|..-+. +...++.+.++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~~~le~GyRlp~-P~~CP~~vY~l 436 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVLELLERGYRLPR-PEGCPDEVYEL 436 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHHHHHhccCcCCC-CCCCCHHHHHH
Confidence 11 112245799999886 679999999999999999999 999998854 4566777888766433 45578999999
Q ss_pred HHHhhc-CcCCCCCHHHHh
Q 010768 155 VGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL 172 (502)
+..||. +|++|||++.+.
T Consensus 437 M~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHhhCCcccCCCHHHHH
Confidence 999999 999999998765
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=224.90 Aligned_cols=172 Identities=23% Similarity=0.315 Sum_probs=136.0
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+..|+|.+++... ..+++.+++.|+.+|++||++||+..++++||||||.|||+.+. +.++|.|||.+....-.
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccCccccceE
Confidence 57789999999643 35999999999999999999999999999999999999999986 79999999998764311
Q ss_pred ----CC------cccccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCC
Q 010768 77 ----QH------AHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPG 141 (502)
Q Consensus 77 ----~~------~~~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~ 141 (502)
.. ......|..|.|||++.- ..++++|||||||++|.|+.|..||.... ....+.-.+..+.+..
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~ 262 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI 262 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc
Confidence 11 112356899999999863 37899999999999999999999995411 1111122233334433
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+.....++.+.+||+.||+ ||.+||++.+++.
T Consensus 263 P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 263 PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 3344478999999999999 9999999999985
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=233.33 Aligned_cols=179 Identities=25% Similarity=0.407 Sum_probs=136.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+|++||+.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence 56789999999875 34899999999999999999999999 9999999999999987 799999998653321111
Q ss_pred Cc-------ccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-------
Q 010768 78 HA-------HSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP------- 140 (502)
Q Consensus 78 ~~-------~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p------- 140 (502)
.. ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+...+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 00 11234567999998864 37899999999999999999999998755444433332211100
Q ss_pred -------------------------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 141 -------------------------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 141 -------------------------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.......++.+.+||.+||. +|.+|||+.|+|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00112235678999999999 9999999999999999976443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=219.24 Aligned_cols=170 Identities=29% Similarity=0.501 Sum_probs=140.1
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||+++.+ +.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceeeeccCC
Confidence 67899999999652 45899999999999999999999999 9999999999999887 79999999998765432
Q ss_pred C-CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ......+.+..+..+.......+..+.+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 2 2234568899999997754 58899999999999999999999996532 3344555666665554444456789999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.+++.
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 9999999 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=219.22 Aligned_cols=164 Identities=20% Similarity=0.304 Sum_probs=131.1
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC------CcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL------GQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~------g~vKL~DFGlA~~~ 73 (502)
|+.+|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+|||++.+. ..+||+|||++...
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 678999999998776 7999999999999999999999999 99999999999998762 16999999999765
Q ss_pred cCCCCcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 74 RGSQHAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.. .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.... ............ ..+.....
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~---~~~~~~~~ 231 (259)
T cd05037 159 LS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH---RLPMPDCA 231 (259)
T ss_pred cc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---CCCCCCch
Confidence 43 223456788999998864 48899999999999999999 688886643 222222222211 11122237
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.++|.+||. +|.+||++.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 89999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=224.13 Aligned_cols=168 Identities=23% Similarity=0.382 Sum_probs=136.3
Q ss_pred CCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEE
Q 010768 1 MFTSGTLREYRKKYT---------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65 (502)
Q Consensus 1 y~~gGsL~~~L~k~~---------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~ 65 (502)
|+.+|+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~-~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG-LVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC-CCEEEC
Confidence 578999999998753 4899999999999999999999999 9999999999999876 799999
Q ss_pred ecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCC
Q 010768 66 DLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP 140 (502)
Q Consensus 66 DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p 140 (502)
|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||.... .......+..+..+
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~ 243 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIECITQGREL 243 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHHHHcCccC
Confidence 9999876533211 12234568899999775 458999999999999999998 999997643 34445555554433
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 244 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 -ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2334567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=224.19 Aligned_cols=171 Identities=23% Similarity=0.402 Sum_probs=131.9
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccCCCCccccc
Confidence 36999998765 46899999999999999999999999 9999999999999887 799999999986543211 1223
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC---CCC----------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---KLP---------------- 140 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~---~~p---------------- 140 (502)
..++..|+|||++.+ .++.++||||+|+++|+|++|+.||............+... ..+
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 356889999998753 47899999999999999999999997654332222221110 000
Q ss_pred ------CCc---cccCC--HHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 ------GAF---HRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 ------~~~---~~~~s--~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
... ....+ ..+.++|.+||. +|.+||++.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 00123 778899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=232.29 Aligned_cols=172 Identities=31% Similarity=0.425 Sum_probs=138.3
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.+++|.+++.. .++++..++.++.||+.||+|||+.| |+||||||+||+++.+ +.+||+|||++...... ....
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~--~~~~ 175 (343)
T cd07851 102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLARHTDDE--MTGY 175 (343)
T ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEcccccccccccc--ccCC
Confidence 37899999876 57999999999999999999999999 9999999999999987 79999999999765432 3445
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CCCC------------------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLPG------------------ 141 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~p~------------------ 141 (502)
.++..|+|||.+.+ .++.++|||||||++|+|++|+.||.+...... ...+... ..+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07851 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELLQKISSESARNYIQS 254 (343)
T ss_pred cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhccchhHHHHHHh
Confidence 68899999998753 578899999999999999999999976443332 2222211 0000
Q ss_pred ----------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 142 ----------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 142 ----------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
......++.+.+||.+||. +|.+|||+.+|+.||||....
T Consensus 255 ~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0011247889999999999 999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=225.33 Aligned_cols=168 Identities=27% Similarity=0.508 Sum_probs=136.4
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|++|+++|||++.+ +.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccc
Confidence 67899999999987 77999999999999999999999999 9999999999999987 7999999999987632211
Q ss_pred ---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. ...++...+..+..+. .+...+..+.+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCPKDIYS 236 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchhHHHHH
Confidence 223446778999998864 48999999999999999999 78999875 6677777776665543 44556889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.++++
T Consensus 237 li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHh
Confidence 9999999 9999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=227.40 Aligned_cols=163 Identities=20% Similarity=0.304 Sum_probs=130.0
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-------
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ------- 77 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~------- 77 (502)
.++.+.++.....++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.++|+|||+++.+....
T Consensus 111 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~-~~~~l~DFGla~~~~~~~~~~~~~~ 187 (294)
T PHA02882 111 ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN-NRGYIIDYGIASHFIIHGKHIEYSK 187 (294)
T ss_pred cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CcEEEEEcCCceeeccCCccccccc
Confidence 466777776666789999999999999999999999 9999999999999877 799999999997653211
Q ss_pred -CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHH--------HHHHHcCCCCCCccccC
Q 010768 78 -HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--------YKKVTSGKLPGAFHRIQ 147 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i--------~~~i~~~~~p~~~~~~~ 147 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+ .+.+..+... ....
T Consensus 188 ~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 264 (294)
T PHA02882 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK---IKNA 264 (294)
T ss_pred ccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc---cCCC
Confidence 1223469999999998764 5899999999999999999999999875332222 2333333221 1234
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+..+.+++..|+. +|.+||++.++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 265 NKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 6889999999999 9999999999874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=219.53 Aligned_cols=169 Identities=21% Similarity=0.413 Sum_probs=137.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccccccc
Confidence 57899999999764 56899999999999999999999999 9999999999999987 79999999999765432211
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....++..|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...+..+.+++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 234 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYTIM 234 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHH
Confidence 1112345799999876 568999999999999999999 89999763 445556666554332 33455789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++..
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 99999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.14 Aligned_cols=168 Identities=21% Similarity=0.351 Sum_probs=135.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence 57889999999764 45788889999999999999999998 9999999999999887 799999999987543211
Q ss_pred ---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhc-cCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 78 ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 78 ---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
......+++.|+|||.+. ..++.++|||||||++|+|++| .+||.. .+...+...+..+..+. .+...+..+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPLY 232 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHH
Confidence 112334577899999775 5688999999999999999995 566655 45555666665554432 3344578899
Q ss_pred HHHHHhhc-CcCCCCCHHHHhc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+++.+||. +|.+||++.+++.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 99999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=229.80 Aligned_cols=174 Identities=29% Similarity=0.444 Sum_probs=134.0
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----HA 79 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----~~ 79 (502)
+++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 91 ~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 166 (336)
T cd07849 91 ETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFL 166 (336)
T ss_pred ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccceeeccccccccCCc
Confidence 4688887754 57999999999999999999999999 9999999999999887 799999999987653321 12
Q ss_pred ccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH--------------HHHHcCC-----
Q 010768 80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY--------------KKVTSGK----- 138 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~--------------~~i~~~~----- 138 (502)
....|++.|+|||.+. ..++.++|||||||++|+|++|+.||.+......+. ..+....
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (336)
T cd07849 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYI 246 (336)
T ss_pred CCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHH
Confidence 3356899999999764 358899999999999999999999997633221111 0000000
Q ss_pred --CCC----C---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 139 --LPG----A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 139 --~p~----~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+. . .....++.+.+||.+||. +|.+||++.+++.||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 247 KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000 0 011236779999999999 999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=216.45 Aligned_cols=168 Identities=26% Similarity=0.401 Sum_probs=140.0
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++..... +++..++.++.||+.||+|||+.+ ++||||||+||+++.+ +.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceecccccc
Confidence 5778999999987554 999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred cc--cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AH--SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~--~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.. ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .....+.+.+..+..+. .....+..+.++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPPEIYKL 236 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHHHH
Confidence 11 123678999999875 458999999999999999998 8888876 55566666776665543 334468899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||. +|.+||++.+++.
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=218.66 Aligned_cols=171 Identities=29% Similarity=0.498 Sum_probs=141.6
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+++|.+++.+ ...+++..++.++.||+.||.|||++| ++|+||||+||+++. +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeecCCC
Confidence 5789999998864 356999999999999999999999999 999999999999975 47999999998765432
Q ss_pred C-CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .........+..+..+. .+...+..+.++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 236 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPS-LPETYSRQLNSI 236 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCCC-CcchhcHHHHHH
Confidence 2 2334568899999997754 578899999999999999999999976 34444555555554443 345567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccc
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
|.+||. +|.+||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=226.09 Aligned_cols=168 Identities=20% Similarity=0.324 Sum_probs=130.5
Q ss_pred CCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc
Q 010768 1 MFTSGTLREYRKKYT-------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~ 61 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~~~-~~ 176 (304)
T cd05096 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGEN-LT 176 (304)
T ss_pred cCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEcCC-cc
Confidence 678999999996532 3678889999999999999999999 9999999999999987 79
Q ss_pred EEEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh--ccCCCCCCCChHHHHHHHH
Q 010768 62 VKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVT 135 (502)
Q Consensus 62 vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt--G~~Pf~~~~~~~~i~~~i~ 135 (502)
+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ +..||.+... .+....+.
T Consensus 177 ~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~~~~~~~ 255 (304)
T cd05096 177 IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD-EQVIENAG 255 (304)
T ss_pred EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH-HHHHHHHH
Confidence 99999999976533221 12334578899999765 569999999999999999986 6678876433 33332221
Q ss_pred c----C--CCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 136 S----G--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 136 ~----~--~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
. . ......+...+..+.+||.+||. +|.+||++.+|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 256 EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 1 1 11112233457889999999999 999999999985
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=223.23 Aligned_cols=169 Identities=22% Similarity=0.332 Sum_probs=135.1
Q ss_pred CCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCC
Q 010768 1 MFTSGTLREYRKKYT-----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGl 69 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.++|+|||+
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~ 176 (296)
T cd05051 100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKN-YTIKIADFGM 176 (296)
T ss_pred cCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeecCC-CceEEccccc
Confidence 567899999998776 7999999999999999999999999 9999999999999987 7999999999
Q ss_pred ceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh--ccCCCCCCCChHHHHHHHHcC------
Q 010768 70 AAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTSG------ 137 (502)
Q Consensus 70 A~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt--G~~Pf~~~~~~~~i~~~i~~~------ 137 (502)
+....... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.... ...+...+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~ 255 (296)
T cd05051 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQQVIENAGHFFRDDGR 255 (296)
T ss_pred eeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-hHHHHHHHHhccccccc
Confidence 87653322 122345678899999775 468999999999999999998 778886643 33444443322
Q ss_pred CCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..........+.++.++|.+||. +|.+||++.+++.
T Consensus 256 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 256 QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11112233456899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.43 Aligned_cols=171 Identities=30% Similarity=0.502 Sum_probs=140.1
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.|+|.+++.. ...+++..++.++.||+.||.|||++| |+|+||||+||+++.+ +.+||+|||++.... .....
T Consensus 104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~~~~~ 177 (313)
T cd06633 104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASKSS---PANSF 177 (313)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCCcccC---CCCCc
Confidence 4678887765 456999999999999999999999999 9999999999999887 799999999986432 23345
Q ss_pred cCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 83 ~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.|+..|+|||++. +.++.++|||||||++|+|++|..||.......... .+.....+.......+..+++||.+|
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHHHHHHHH
Confidence 7899999999873 458889999999999999999999997754333333 44444444444445577899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.||||....
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCCc
Confidence 99 999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=230.48 Aligned_cols=174 Identities=28% Similarity=0.410 Sum_probs=134.8
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----Cc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----HA 79 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----~~ 79 (502)
+++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++...+.+||+|||++....... ..
T Consensus 99 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (342)
T cd07854 99 ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175 (342)
T ss_pred cccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccc
Confidence 4689888865 46999999999999999999999999 99999999999998665689999999997653221 11
Q ss_pred ccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-------------------
Q 010768 80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK------------------- 138 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~------------------- 138 (502)
....++..|+|||++. ..++.++|||||||++|+|++|+.||............+....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (342)
T cd07854 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVR 255 (342)
T ss_pred ccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh
Confidence 2345788999999764 3478899999999999999999999976443332222111100
Q ss_pred ----CCC----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 139 ----LPG----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 139 ----~p~----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+. ......+.++.+||.+||. +|.+||++.++|.||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 256 NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000 0112356789999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=226.34 Aligned_cols=169 Identities=24% Similarity=0.381 Sum_probs=137.8
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.... .+++.+++.++.||+.||+|||+++ |+|+||||+|||++.+ +.+||+|||++........
T Consensus 120 ~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~ 196 (302)
T cd05055 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSN 196 (302)
T ss_pred cCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECCCcccccccCCCc
Confidence 578999999997643 3899999999999999999999999 9999999999999876 7999999999976543221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....++..|+|||++. +.++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...++.+.+
T Consensus 197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 275 (302)
T cd05055 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYD 275 (302)
T ss_pred eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 12234577899999775 458999999999999999998 999998755545555555544332 333456889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
||.+||. +|.+||++.+++.
T Consensus 276 li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 276 IMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 9999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=222.42 Aligned_cols=171 Identities=27% Similarity=0.442 Sum_probs=134.2
Q ss_pred CCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 4 SGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 4 gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
.|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcccc
Confidence 36899998764 35899999999999999999999999 9999999999999877 799999999997553321 22
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC---------------CC
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---------------GA 142 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p---------------~~ 142 (502)
....+++.|++||++.+ .++.++||||||+++|+|++|..||.+........+.+.....| ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 34467889999998754 47889999999999999999999998755443322221110000 00
Q ss_pred -----------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 -----------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 -----------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.....+..++++|.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011236788999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=258.02 Aligned_cols=173 Identities=35% Similarity=0.587 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-----
Q 010768 1 MFTSGTLREYRKKYTRV-DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR----- 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~L-se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~----- 74 (502)
||+.-+|++++.++... ....+|++++||+.||.|+|++| ||||||||.|||++.+ +.|||+|||+|+...
T Consensus 677 yCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~ 753 (1351)
T KOG1035|consen 677 YCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLES 753 (1351)
T ss_pred hhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCC-CCeeecccccchhhhhhhhh
Confidence 67888888888877655 68899999999999999999999 9999999999999987 799999999998621
Q ss_pred --------------CCCCcccccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc
Q 010768 75 --------------GSQHAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136 (502)
Q Consensus 75 --------------~~~~~~~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~ 136 (502)
.....+..+||.-|+|||++.+ .|+.|+|+||||+|++||+ +||...-.-..+...+..
T Consensus 754 ~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~ 830 (1351)
T KOG1035|consen 754 IDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK 830 (1351)
T ss_pred HhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc
Confidence 0112356789999999999852 5999999999999999999 578776666777888888
Q ss_pred CCCCCC--ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 137 GKLPGA--FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 137 ~~~p~~--~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
+.+|.. +....-+.-..+|++||. ||.+||||.|+|++.||..
T Consensus 831 g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 831 GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 888765 223334567889999999 9999999999999999974
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=225.60 Aligned_cols=170 Identities=28% Similarity=0.443 Sum_probs=131.1
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC----
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---- 78 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---- 78 (502)
+++|..++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++........
T Consensus 98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 174 (311)
T cd07866 98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKG 174 (311)
T ss_pred CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcCccchhccCCCccccc
Confidence 4567777765 357999999999999999999999999 9999999999999987 7999999999976532211
Q ss_pred --------cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CC--C------
Q 010768 79 --------AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK--L------ 139 (502)
Q Consensus 79 --------~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~--~------ 139 (502)
.....+++.|+|||++.+ .++.++|||||||++|+|++|++||.+...... ...+.. .. .
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 253 (311)
T cd07866 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKLCGTPTEETWPG 253 (311)
T ss_pred CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhchh
Confidence 123457889999997753 478999999999999999999999976433322 222211 00 0
Q ss_pred ----CC------------Cc---cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 140 ----PG------------AF---HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 140 ----p~------------~~---~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+. .. .....+.+.+||.+||. +|.+||++.+++.||||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 254 WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 00 01224678899999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=219.55 Aligned_cols=171 Identities=32% Similarity=0.468 Sum_probs=135.3
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~~~ 81 (502)
+++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||+|+||+++.+ +.+||+|||++....... ....
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCccccCc
Confidence 46999999886 67999999999999999999999999 9999999999999987 799999999997654322 2233
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-------------------CCCC
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-------------------GKLP 140 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-------------------~~~p 140 (502)
..++..|+|||.+.+ .++.++|||||||++|+|++|..||........+.+.... ...+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 456788999997753 5889999999999999999999999774433332221110 0000
Q ss_pred CC-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 GA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 ~~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.. .....+..+.++|.+||. +|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 001126789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=218.12 Aligned_cols=168 Identities=20% Similarity=0.364 Sum_probs=133.9
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.........
T Consensus 74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccc
Confidence 57899999999765 46899999999999999999999999 9999999999999887 78999999998754322111
Q ss_pred ---ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+.... +...+...+..+.+|
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 228 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGV-RLPCPELCPDAVYRL 228 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCC-CCCCcccCCHHHHHH
Confidence 1112245699999875 458999999999999999998 88998663 3344444444432 223445568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=221.29 Aligned_cols=170 Identities=25% Similarity=0.423 Sum_probs=135.3
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--Ccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--HAH 80 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~~~ 80 (502)
+++|.+++.+. ..+++..++.++.||+.||+|||++| ++|+||||+||+++.+ +.+||+|||++....... ...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccccc
Confidence 36899998765 57999999999999999999999999 9999999999999987 799999999998765432 123
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCC-----------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP----------------- 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p----------------- 140 (502)
...++..|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...+.. ...+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchhhhhc
Confidence 3457889999997653 478999999999999999999999977443332 222221 0000
Q ss_pred -----------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 -----------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 -----------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
..+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111237889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=226.78 Aligned_cols=168 Identities=27% Similarity=0.408 Sum_probs=137.5
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++...+ .+++.+++.++.||+.||+|||++| ++||||||+|||++.+ +.+||
T Consensus 105 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~-~~~kL 181 (307)
T cd05098 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI 181 (307)
T ss_pred cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcCC-CcEEE
Confidence 578999999998642 4889999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+.+.+..+..
T Consensus 182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 260 (307)
T cd05098 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR 260 (307)
T ss_pred CCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHcCCC
Confidence 99999876543211 11223456899999775 458999999999999999998 8889866 556666666665543
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
. ..+...+..+.+||.+||. +|.+||++.+++.
T Consensus 261 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 261 M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred C-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3 3344568899999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=217.92 Aligned_cols=168 Identities=24% Similarity=0.389 Sum_probs=136.3
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence 467999999998754 6999999999999999999999999 9999999999999987 7999999999987653211
Q ss_pred c--ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~--~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. .....+..|+|||++. ..++.++||||||+++|+|++ |+.||.+. ....+...+..... .......+..+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 236 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYR-MPCPPGCPKELYDI 236 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCC-CCCCCcCCHHHHHH
Confidence 1 1112245799999876 458899999999999999999 99999763 44555556554432 22334567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=226.53 Aligned_cols=170 Identities=28% Similarity=0.487 Sum_probs=139.9
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++..... ....
T Consensus 98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~---~~~~ 171 (308)
T cd06634 98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---ANXF 171 (308)
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCcccceeecC---cccc
Confidence 4688887754 456999999999999999999999999 9999999999999887 7999999999876543 2345
Q ss_pred cCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 83 ~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.|++.|+|||.+. +.++.++|||||||++|+|++|..||...... .....+..+..+.......+..+++||.+|
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence 6889999999763 45788999999999999999999999764333 333334444444444456688899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.+++.|||+...
T Consensus 251 l~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 251 LQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hhCCcccCCCHHHHhhCcccccc
Confidence 99 99999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=222.10 Aligned_cols=169 Identities=24% Similarity=0.364 Sum_probs=138.3
Q ss_pred CCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEE
Q 010768 1 MFTSGTLREYRKKY-----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63 (502)
Q Consensus 1 y~~gGsL~~~L~k~-----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vK 63 (502)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~-~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ-LHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC-CcEE
Confidence 57889999999633 24789999999999999999999999 9999999999999987 6899
Q ss_pred EEecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCC
Q 010768 64 IGDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK 138 (502)
Q Consensus 64 L~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~ 138 (502)
|+|||+++...... ......++..|+|||++. +.++.++|||||||++|+|++ |..||.+ .....+.+.+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~ 243 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMVRKRQ 243 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999997653321 122344567899999875 558999999999999999998 9999976 34556666666655
Q ss_pred CCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+. .+...++.++++|.+||. +|.+||++.+++++
T Consensus 244 ~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 433 345568899999999999 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=218.53 Aligned_cols=168 Identities=23% Similarity=0.369 Sum_probs=136.7
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.| |+|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEccCCcc
Confidence 57889999999764 34899999999999999999999999 9999999999999887 7999999999976543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||... +.++.++||||||+++|+|++ |..||.+. ........+..+..+ ......+..++++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 235 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPESLHEL 235 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence 12234567899999775 458899999999999999999 99999874 344455555544332 2334568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=225.73 Aligned_cols=168 Identities=26% Similarity=0.402 Sum_probs=136.7
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+|+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 99 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~-~~~kL 175 (314)
T cd05099 99 YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTED-NVMKI 175 (314)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcCC-CcEEE
Confidence 57899999999764 34899999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 254 (314)
T cd05099 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLREGHR 254 (314)
T ss_pred ccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 99999976543211 11223456799999875 458999999999999999999 8999976 455666666665543
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
. ......+..++++|.+||. +|.+||++.+++.
T Consensus 255 ~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 255 M-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2 2334557789999999999 9999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=224.26 Aligned_cols=169 Identities=27% Similarity=0.410 Sum_probs=138.4
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~~~-~~~kl 178 (304)
T cd05101 102 YASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 178 (304)
T ss_pred cCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEcCC-CcEEE
Confidence 57899999999864 24788899999999999999999999 9999999999999877 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+ .....+.+.+..+..
T Consensus 179 ~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 257 (304)
T cd05101 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR 257 (304)
T ss_pred CCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCc
Confidence 99999986643221 12234567899999875 458999999999999999998 8888876 456667777765543
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
. ......+..+++||.+||. +|.+||++.+++..
T Consensus 258 ~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 258 M-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred C-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 3 2334567899999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=218.02 Aligned_cols=168 Identities=23% Similarity=0.376 Sum_probs=136.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence 57799999999763 45899999999999999999999999 9999999999999987 7999999999986543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. +...+...+..+..+ ..+...+..+.+|
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 235 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPISLHEL 235 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 12234566899999775 458899999999999999999 89999774 444555555544322 3344568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+|||+.+++.
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=219.64 Aligned_cols=170 Identities=24% Similarity=0.361 Sum_probs=131.8
Q ss_pred CCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYT-----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
|+.+|+|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.+ +.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccC
Confidence 678999999997532 3677888999999999999999999 9999999999999987 7999999999865432
Q ss_pred CCC---cccccCCCcccCcccccc--------cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC--C-
Q 010768 76 SQH---AHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL--P- 140 (502)
Q Consensus 76 ~~~---~~~~~GT~~Y~APEvl~~--------~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~--p- 140 (502)
... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||............+..... +
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 211 123456788999998753 25789999999999999996 99999775444433333332222 1
Q ss_pred CCccccCCHHHHHHHHHhhcCcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~dP~kRpsa~ElL~ 173 (502)
+......+..+.+++.+|+.+|.+||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 122234577899999999989999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=260.03 Aligned_cols=173 Identities=16% Similarity=0.179 Sum_probs=130.3
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC------------------CCcE
Q 010768 2 FTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------LGQV 62 (502)
Q Consensus 2 ~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~------------------~g~v 62 (502)
+.+++|.++|.+. ..+++.+++.|++||+.||+|||++| ||||||||+||||+.. .+.+
T Consensus 61 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ 138 (793)
T PLN00181 61 CEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATT 138 (793)
T ss_pred cCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcc
Confidence 4578999999763 56999999999999999999999999 9999999999999532 2456
Q ss_pred EEEecCCceeccCC-----------------CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCC
Q 010768 63 KIGDLGLAAILRGS-----------------QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC 124 (502)
Q Consensus 63 KL~DFGlA~~~~~~-----------------~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~ 124 (502)
||+|||+++..... ......+||+.|||||++. ..|+.++|||||||+||||++|..|+...
T Consensus 139 ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 139 KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred cccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 67777776532110 0011246899999999875 46999999999999999999998887542
Q ss_pred CChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 125 SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 125 ~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
......+.....+... ....+....++.+||. +|.+||++.|+|.||||...
T Consensus 219 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 219 ---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 1222233322233221 1124566789999999 99999999999999999763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=218.22 Aligned_cols=168 Identities=25% Similarity=0.414 Sum_probs=138.2
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence 57899999999863 45899999999999999999999999 9999999999999987 7999999999976543221
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....++..|+|||++. +.++.++||||||+++|+|++ |..||.. ....++...+..+..+ ..+...++.+.++|
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i 237 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKIM 237 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHHH
Confidence 22334567899999875 458899999999999999998 8999976 3455566666654332 33456688999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.+++.
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 99999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=221.11 Aligned_cols=168 Identities=25% Similarity=0.386 Sum_probs=131.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........
T Consensus 89 ~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 89 YVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred CCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccccccCCcchhh
Confidence 57899999999774 5999999999999999999999999 9999999999999887 7999999999986543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChH--------------HHHHHHHcCCCCC
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA--------------QIYKKVTSGKLPG 141 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~--------------~i~~~i~~~~~p~ 141 (502)
.....++..|+|||.+. ..++.++||||||+++|+|++|..||....... .+...+..+.. .
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 243 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR-L 243 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC-C
Confidence 12234566799999875 558999999999999999999999986432110 11111111111 1
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...+..+.+++.+||. +|++||++++++.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1234457899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=218.84 Aligned_cols=169 Identities=22% Similarity=0.383 Sum_probs=138.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhcccccccc
Confidence 57899999999764 57999999999999999999999999 9999999999999987 7999999999987642111
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+.+.+..+... ..+...+..+.++
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 240 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRL-PPPMDCPSALYQL 240 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 11223467899999876 458999999999999999998 99999764 344556666655332 2334568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcC
Q 010768 155 VGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~h 174 (502)
+.+||. +|.+||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=224.98 Aligned_cols=173 Identities=29% Similarity=0.486 Sum_probs=141.3
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.+||+|||++..... ....
T Consensus 108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---~~~~ 181 (317)
T cd06635 108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASIASP---ANSF 181 (317)
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCCCccccCC---cccc
Confidence 3678887754 466999999999999999999999999 9999999999999887 7999999999865432 2345
Q ss_pred cCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 83 IGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 83 ~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.|++.|+|||++. +.++.++|||||||++|+|++|..||.... .......+..+..+.......+..+++||.+|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 6889999999763 458899999999999999999999997743 33334444444444344445678899999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
|. +|.+||++.+++.|+|+......
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhccCcc
Confidence 99 99999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=221.16 Aligned_cols=174 Identities=31% Similarity=0.548 Sum_probs=144.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.. ..+++..+..++.||+.||.|||++| ++|+||||+||+++.+ +.++|+|||++..+.... ..
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchhhh
Confidence 5789999999875 56899999999999999999999999 9999999999999887 799999999987654322 12
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.. .........+..+.. .......+..+.++|.+|
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCCC-CCCCcccCHHHHHHHHHH
Confidence 34568899999998754 578899999999999999999999976 344444444444433 234445688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.+++.||||...
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhh
Confidence 99 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=218.55 Aligned_cols=168 Identities=22% Similarity=0.357 Sum_probs=136.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||.+..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence 57899999999864 45899999999999999999999999 9999999999999987 7999999999976643322
Q ss_pred c--ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 A--HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~--~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. ....++..|+|||++. +.++.++|||||||++|+|++ |..||.+. ....+...+..+... ......+..+.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 235 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDL 235 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCHHHHHH
Confidence 1 2334567899999775 568999999999999999999 88899764 344555555544322 2234467889999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||+ +|.+||++.+++.
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=225.41 Aligned_cols=171 Identities=32% Similarity=0.461 Sum_probs=130.5
Q ss_pred CCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC----CCCcEEEEecCCceecc
Q 010768 4 SGTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG----HLGQVKIGDLGLAAILR 74 (502)
Q Consensus 4 gGsL~~~L~k~-----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~----~~g~vKL~DFGlA~~~~ 74 (502)
+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. + +.+||+|||++....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~~~~~~ 163 (316)
T cd07842 87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPER-GVVKIGDLGLARLFN 163 (316)
T ss_pred CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCcc-ceEEECCCccccccC
Confidence 45777777532 36899999999999999999999999 999999999999987 5 799999999998654
Q ss_pred CCCC----cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChH--------HHHHHHHc----
Q 010768 75 GSQH----AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA--------QIYKKVTS---- 136 (502)
Q Consensus 75 ~~~~----~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~--------~i~~~i~~---- 136 (502)
.... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (316)
T cd07842 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243 (316)
T ss_pred CCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCC
Confidence 3221 234567899999997754 47899999999999999999999997533211 00000000
Q ss_pred --------------------CCCCCCcc-----------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 137 --------------------GKLPGAFH-----------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 137 --------------------~~~p~~~~-----------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
......+. ...+..+.++|.+||. +|.+||++.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000000 1446788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=216.00 Aligned_cols=166 Identities=23% Similarity=0.381 Sum_probs=137.6
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++++.. .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEccccccccccccc-
Confidence 577899999998765 6999999999999999999999999 9999999999999987 799999999997663322
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.++|.
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKVMK 233 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHHHH
Confidence 1234466799999775 568889999999999999997 9999976 4455555555554332 233456889999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. +|.+||++.+++.
T Consensus 234 ~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=221.71 Aligned_cols=168 Identities=23% Similarity=0.366 Sum_probs=136.7
Q ss_pred CCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe
Q 010768 1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56 (502)
Q Consensus 1 y~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld 56 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~ 161 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVA 161 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEc
Confidence 57889999998753 34789999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHH
Q 010768 57 GHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131 (502)
Q Consensus 57 ~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~ 131 (502)
.+ +.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ ..+..+.
T Consensus 162 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~ 239 (290)
T cd05045 162 EG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPERLF 239 (290)
T ss_pred CC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHH
Confidence 87 7999999999976532211 12234567899999765 458999999999999999998 9999976 4566666
Q ss_pred HHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 132 ~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+..+..+ ..+...+..+.+||.+||+ +|.+||++.+++.
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 666554332 2344567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=218.07 Aligned_cols=169 Identities=21% Similarity=0.349 Sum_probs=131.1
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKE 152 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcc
Confidence 67899999999764 34677888999999999999999999 9999999999999887 79999999998643221
Q ss_pred C---CcccccCCCcccCcccccc--------cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC----C
Q 010768 77 Q---HAHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL----P 140 (502)
Q Consensus 77 ~---~~~~~~GT~~Y~APEvl~~--------~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~----p 140 (502)
. ......++..|+|||++.. .++.++|||||||++|+|++ |..||..... ..++..+..+.. .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFK 231 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCC
Confidence 1 1224567889999998742 35779999999999999997 5778876443 334443333221 1
Q ss_pred CCccccCCHHHHHHHHHhhcCcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLENVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~dP~kRpsa~ElL~ 173 (502)
+......++.+.+++.+||.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 223334678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=227.35 Aligned_cols=173 Identities=28% Similarity=0.355 Sum_probs=137.3
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC------
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ------ 77 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~------ 77 (502)
.++|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 92 ~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~~~~~ 167 (337)
T cd07852 92 ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENP 167 (337)
T ss_pred ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhccccccccccCc
Confidence 46899998775 8899999999999999999999999 9999999999999987 799999999997654321
Q ss_pred CcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC----------------
Q 010768 78 HAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---------------- 139 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~---------------- 139 (502)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||..........+.+.....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (337)
T cd07852 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAAT 247 (337)
T ss_pred chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHH
Confidence 223456899999999774 34788999999999999999999999765443332221111100
Q ss_pred ------------CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 140 ------------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 140 ------------p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
........+..+.++|.+||. +|.+||++.+++.|||++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 248 MLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 001112257889999999999 99999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=216.97 Aligned_cols=165 Identities=17% Similarity=0.303 Sum_probs=129.7
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC-------cEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-------QVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g-------~vKL~DFGlA~~ 72 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+||+++.+.. .++++|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 678999999998754 5899999999999999999999999 999999999999986532 379999999865
Q ss_pred ccCCCCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhcc-CCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 73 LRGSQHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 73 ~~~~~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ........... ... ..+.....
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~ 230 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYE-DRH--QLPAPKWT 230 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHH-ccc--cCCCCCcH
Confidence 432 233567889999998864 4789999999999999999984 66654 33332222222 111 22333457
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+.++|.+||+ +|.+||+++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 89999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=215.52 Aligned_cols=166 Identities=22% Similarity=0.385 Sum_probs=136.9
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| ++||||||+||+++.+ +.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceecccc--
Confidence 678999999998654 4899999999999999999999999 9999999999999887 79999999998764322
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
......+..|+|||.+. +.++.++|+|||||++|+|++ |..||... ........+..+..+. .....+..+.++|.
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 231 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMT 231 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHH
Confidence 12234467899999775 568899999999999999997 99999774 4455556665554332 33456789999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. +|.+||++++++.
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=218.67 Aligned_cols=170 Identities=22% Similarity=0.380 Sum_probs=139.9
Q ss_pred CCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKYT---------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~---------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
|+.+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.++|+|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcEEEccccccc
Confidence 578899999998766 7999999999999999999999999 9999999999999887 799999999986
Q ss_pred eccCCC--CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccC
Q 010768 72 ILRGSQ--HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ 147 (502)
Q Consensus 72 ~~~~~~--~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 147 (502)
...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLELPVPEGC 244 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcCCCCCCCC
Confidence 543211 123345677899999765 458889999999999999998 88899763 3445566666555544444566
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+..+.++|.+||. +|.+||++.+++..
T Consensus 245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 245 PSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 8899999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=214.22 Aligned_cols=168 Identities=22% Similarity=0.389 Sum_probs=135.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.|++|.+++.+. ..+++..+..++.|++.||+|||+++ ++||||||+|||++.+ +.+||+|||++.........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcce
Confidence 57899999999764 56899999999999999999999999 9999999999999887 79999999999765421111
Q ss_pred ---ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....++..|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+. ....+...+..+.+|
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 227 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRL 227 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHH
Confidence 1122356799999775 468999999999999999999 88998763 3444455554432 223345568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.|++.
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=237.09 Aligned_cols=191 Identities=25% Similarity=0.416 Sum_probs=151.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc------
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR------ 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~------ 74 (502)
|+.||++-.+|-+.+-|.|..++.|+.+|..|+++.|..| +|||||||+|||||.+ |++||.|||++.-+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceeccccc
Confidence 7899999999999999999999999999999999999999 9999999999999998 899999999996431
Q ss_pred ---CCC----------------------------------CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh
Q 010768 75 ---GSQ----------------------------------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT 116 (502)
Q Consensus 75 ---~~~----------------------------------~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt 116 (502)
.+. ..+..+||+.|+|||++. ..|+..+|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 000 012367999999999886 469999999999999999999
Q ss_pred ccCCCCCCCChHHHHHHHHc-CCCCCCccccCCHHHHHHHHHhhcCcCCCCC---HHHHhcCccccCCCCCC---CCCCC
Q 010768 117 SEYPYSECSNPAQIYKKVTS-GKLPGAFHRIQDAEARRFVGKCLENVSKRLP---AKELLLDPFLASDAGEP---LLIPK 189 (502)
Q Consensus 117 G~~Pf~~~~~~~~i~~~i~~-~~~p~~~~~~~s~~l~~LI~kcL~dP~kRps---a~ElL~hpf~~~~~~~~---l~~p~ 189 (502)
|+.||.........++.+.- ..+.......+++++.++|.++...+..|+. ++++..||||+.-+... ...+.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApY 946 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPY 946 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCc
Confidence 99999774333222222211 1122233455689999999999988888874 77899999999877654 34445
Q ss_pred CCCcC
Q 010768 190 VPSFQ 194 (502)
Q Consensus 190 ~P~~~ 194 (502)
+|...
T Consensus 947 IP~It 951 (1034)
T KOG0608|consen 947 IPRIT 951 (1034)
T ss_pred Ccccc
Confidence 55543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=216.62 Aligned_cols=168 Identities=24% Similarity=0.424 Sum_probs=136.6
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++.........
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceeeecccccce
Confidence 578999999998754 5899999999999999999999999 9999999999999987 79999999999876443221
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... ......+..+..+. .+...+..+.++|
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~li 241 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLP-MPPNCPPTLYSLM 241 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcCC-CCCCCCHHHHHHH
Confidence 1223456899999775 458899999999999999996 9999977544 34445555544332 3345678999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+|+. +|.+||++.+++.
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=241.23 Aligned_cols=172 Identities=28% Similarity=0.494 Sum_probs=149.9
Q ss_pred CCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCCc
Q 010768 4 SGTLREYRK--KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 4 gGsL~~~L~--k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~~ 79 (502)
.|++.+.|- +.++|++...+.++.||+.||.|||-+| |+|+||||+|||+... +.++||||||+|+++......
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 366666663 5688999999999999999999999999 9999999999999753 468999999999999988888
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--CCCCccccCCHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~ 156 (502)
.+++|||.|+|||++.. .|+..-|+||+|+|+|.-|.|.+||.+.. +|.+.|.... +|...+...++.+.+||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 99999999999999875 59999999999999999999999997643 4455555543 356666777999999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+|+ .-.+|.++...|.|||++..
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999 99999999999999999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=217.09 Aligned_cols=169 Identities=23% Similarity=0.378 Sum_probs=139.9
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
|+.|++|.+++.. ...+++..++.++.||+.||.|||+ .+ |+|+||||+|||++.+ +.+||+|||++.....
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~ 166 (269)
T cd08528 90 LIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTITDFGLAKQKQP 166 (269)
T ss_pred cCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEecccceeeccc
Confidence 5789999998843 3569999999999999999999996 67 9999999999999887 7999999999987654
Q ss_pred CCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 76 SQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
........|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .........+..+..........++.+.++
T Consensus 167 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 245 (269)
T cd08528 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSEDVTDV 245 (269)
T ss_pred ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcccCCHHHHHH
Confidence 434445678999999998764 588999999999999999999999976 444445555555544433344568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.|+..
T Consensus 246 i~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 246 ITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHCCCCCccCCCHHHHHH
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=218.29 Aligned_cols=168 Identities=24% Similarity=0.343 Sum_probs=137.2
Q ss_pred CCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKY--------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~--------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcEEECCCCCccc
Confidence 46789999999764 45899999999999999999999999 9999999999999887 7999999999976
Q ss_pred ccCCCC---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccC
Q 010768 73 LRGSQH---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ 147 (502)
Q Consensus 73 ~~~~~~---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 147 (502)
+..... .....++..|+|||++.+ .++.++|||||||++|++++ |+.||.. .+...+...+..+.... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 244 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA-QPINC 244 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC-CCCcC
Confidence 533221 122345678999998764 58999999999999999999 9999976 45566666665553322 23345
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++.+.+++.+||. +|++||++.+++.
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=227.14 Aligned_cols=173 Identities=29% Similarity=0.408 Sum_probs=136.7
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+.|++|.++++. ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++..... ....
T Consensus 103 ~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~~~--~~~~ 176 (345)
T cd07877 103 LMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTDD--EMTG 176 (345)
T ss_pred hcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEecccccccccc--cccc
Confidence 357899888765 46999999999999999999999999 9999999999999987 7999999999876532 2334
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC----------------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---------------------- 137 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~---------------------- 137 (502)
..+++.|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (345)
T cd07877 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESARNYIQ 255 (345)
T ss_pred cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHhhcccHhHHHHHH
Confidence 578999999998754 4788999999999999999999999764332221 211110
Q ss_pred ---CCCC----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 138 ---KLPG----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 138 ---~~p~----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
..+. ......++.+.+||.+||. +|.+||++.+++.||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000 0011347789999999999 999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=224.89 Aligned_cols=170 Identities=27% Similarity=0.409 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~~-~~~kL 175 (334)
T cd05100 99 YASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKI 175 (334)
T ss_pred cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEE
Confidence 578999999997642 3788899999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++....... .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+ .....+.+.+..+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 254 (334)
T cd05100 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGHR 254 (334)
T ss_pred CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC
Confidence 99999976543221 12223456799999875 458899999999999999998 8899976 455666666665544
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hp 175 (502)
+. .+...+..+.++|.+||. +|.+||++.+++.+-
T Consensus 255 ~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 255 MD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 32 233457889999999999 999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=212.19 Aligned_cols=168 Identities=21% Similarity=0.357 Sum_probs=136.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| ++||||||+||+++.+ +.+||+|||++.........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccc
Confidence 67899999999764 46899999999999999999999999 9999999999999877 79999999998764332211
Q ss_pred --ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 --HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 --~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+... ......+..+.+|+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 227 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVM 227 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 1223456799999876 458899999999999999998 99999774 444555555554332 23344678999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.++++
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 228 QRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 99999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=213.91 Aligned_cols=168 Identities=21% Similarity=0.424 Sum_probs=137.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... +.++++.++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccCccc
Confidence 57899999999764 56899999999999999999999999 9999999999999876 7999999999876533211
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.+|+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 234 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYELM 234 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHH
Confidence 11223467899999876 568899999999999999998 9999976 4445566666554332 23445688999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHcccChhhCCCHHHHHH
Confidence 99999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=214.31 Aligned_cols=168 Identities=23% Similarity=0.380 Sum_probs=137.0
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| ++||||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence 57899999999764 46899999999999999999999999 9999999999999987 7999999999977642221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. +.++.++||||||+++|+|++ |+.||.+. ....+.+.+..+... ......+..+.++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 235 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELYEL 235 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 12234567899999876 458899999999999999999 99999874 444555555544332 2334567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=216.65 Aligned_cols=168 Identities=27% Similarity=0.421 Sum_probs=138.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||+++........
T Consensus 89 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 89 LMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCcccccccCcccc
Confidence 57899999999874 56999999999999999999999998 9999999999999877 79999999999876432221
Q ss_pred c---cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 H---SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ~---~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
. ...++..|+|||.+. ..++.++||||||+++|++++ |..||.. ....++...+..+... ..+...+..+.++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQPPICTIDVYMV 243 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence 1 122356799999775 568999999999999999998 9999977 4556667777665432 3344567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||. +|.+||++.+++.
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=221.45 Aligned_cols=169 Identities=27% Similarity=0.463 Sum_probs=136.7
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++........
T Consensus 89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEccccccccccCcccc
Confidence 578899999998754 6899999999999999999999999 9999999999999876 6899999999986543222
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+.+.+..+..+ ..+...+..+.++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 243 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICTIDVYMV 243 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 12234567899999876 458899999999999999997 89999763 344444445444333 2334567889999
Q ss_pred HHHhhc-CcCCCCCHHHHhcC
Q 010768 155 VGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~h 174 (502)
+.+||. +|.+||++.+++..
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999 99999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=214.73 Aligned_cols=168 Identities=21% Similarity=0.387 Sum_probs=135.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. +.+++..+..++.|++.||+|||+.| |+||||||+||+++.+ +.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccceeccccccc
Confidence 57899999999764 57999999999999999999999999 9999999999999887 79999999999765432211
Q ss_pred ----ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 80 ----HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 80 ----~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....++.|+|||++. +.++.++|||||||++|+|++ |..||... ....+.+.+..+... ......+..+.+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 241 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPSAVYQ 241 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 1112345799999876 458999999999999999997 99999763 345566666554322 223345788999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++.+||. +|.+||++.+++.
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 9999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=223.64 Aligned_cols=181 Identities=21% Similarity=0.408 Sum_probs=154.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee-ccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~-~~~~~~~ 79 (502)
|+.||+|--.+++..+|+++.++.+...|+.||.|||++| ||+||||.+|+|++.. |++||.|+|+++. +..+...
T Consensus 332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCCCccc
Confidence 6789999999999999999999999999999999999999 9999999999999998 8999999999986 4556667
Q ss_pred ccccCCCcccCccccccc-CCcccchhhhhHHHHHHhhccCCCCC--CC-----ChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 80 HSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSE--CS-----NPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG~~Pf~~--~~-----~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
.+++|||.|+|||++.+. |+..+|.|+||++++||+.|+.||.- .. ..+-+++.|....+ ..++..+-.+
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprslsvka 486 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLSVKA 486 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceeehhh
Confidence 889999999999999864 99999999999999999999999952 22 23345555555444 3455567778
Q ss_pred HHHHHHhhc-CcCCCC------CHHHHhcCccccCCCCCCCC
Q 010768 152 RRFVGKCLE-NVSKRL------PAKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRp------sa~ElL~hpf~~~~~~~~l~ 186 (502)
..+++..|. ||.+|. ...++..|+||+.-.|..+.
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 889999998 999986 47899999999998887643
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=217.71 Aligned_cols=165 Identities=18% Similarity=0.303 Sum_probs=129.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC------CcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL------GQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~------g~vKL~DFGlA~~~ 73 (502)
|+.+|+|..++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+. ..+|++|||++...
T Consensus 85 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 85 FVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 57899999999764 56999999999999999999999999 99999999999997542 13899999998654
Q ss_pred cCCCCcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHh-hccCCCCCCCChHHHHHHHHcCCCCCCccccCCHH
Q 010768 74 RGSQHAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLL-tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
.. .....++..|+|||.+. ..++.++|||||||++|+|+ +|..||... ...... ....+... .....+..
T Consensus 163 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~--~~~~~~~~ 235 (262)
T cd05077 163 LS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM--LVTPSCKE 235 (262)
T ss_pred cC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc--CCCCChHH
Confidence 32 23356788999999875 45889999999999999998 588888653 222222 22222221 11223578
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+.+||.+||. +|.+||++.+|+.+
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=219.77 Aligned_cols=170 Identities=26% Similarity=0.443 Sum_probs=132.9
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--Ccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--HAH 80 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~~~ 80 (502)
+|+|..++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++....... ...
T Consensus 99 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~ 175 (302)
T cd07864 99 DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYT 175 (302)
T ss_pred CccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcccccccccCCcccccc
Confidence 35777777654 56999999999999999999999999 9999999999999987 799999999997654322 112
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc---CCCCCC-------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GKLPGA------------- 142 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---~~~p~~------------- 142 (502)
...++..|+|||++.+ .++.++|||||||++|+|++|++||........+ ..+.. +..+..
T Consensus 176 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T cd07864 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCPAVWPDVIKLPYFNTM 254 (302)
T ss_pred cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhhccccccccccccc
Confidence 2356788999998753 4788999999999999999999999764333222 22211 111110
Q ss_pred ------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 ------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 ------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.....+..+.++|.+||. +|.+||++.+++.||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 255 KPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 011347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=217.56 Aligned_cols=168 Identities=21% Similarity=0.325 Sum_probs=136.1
Q ss_pred CCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC
Q 010768 1 MFTSGTLREYRKKYT----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~ 58 (502)
|+.+|+|.+++.... .+++..++.++.||+.||+|||.++ ++||||||+|||++.+
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~~~ 166 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGEN 166 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEecCC
Confidence 578899999997532 3788899999999999999999999 9999999999999887
Q ss_pred CCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHH
Q 010768 59 LGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKK 133 (502)
Q Consensus 59 ~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~ 133 (502)
+.+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ ....++...
T Consensus 167 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~~~~~ 244 (288)
T cd05050 167 -MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEEVIYY 244 (288)
T ss_pred -CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 7999999999876532211 12233466799999775 568999999999999999997 8889876 345566666
Q ss_pred HHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 134 i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+..+..... +...+..+.+||.+||. +|.+||++.|+++
T Consensus 245 ~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 245 VRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HhcCCCCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 666655322 33457899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=213.91 Aligned_cols=168 Identities=24% Similarity=0.387 Sum_probs=136.1
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.. .+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence 578999999998753 6999999999999999999999999 9999999999999887 7999999999976643211
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||.+. +.++.++||||||+++|+|++ |+.||.+. ........+..+... ..+...+..+.++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRM-PRPPNCPEELYDL 236 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 11223456899999876 458899999999999999998 99999764 445555566554322 2233347899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||. +|.+||++++++.
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=225.01 Aligned_cols=170 Identities=31% Similarity=0.390 Sum_probs=132.1
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccC
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~G 84 (502)
++|..++ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..... ......+
T Consensus 104 ~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~--~~~~~~~ 176 (342)
T cd07879 104 TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYVV 176 (342)
T ss_pred cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC--CCCCcee
Confidence 3566654 246899999999999999999999999 9999999999999987 7999999999876432 2234567
Q ss_pred CCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC---------------------CC
Q 010768 85 TPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL---------------------PG 141 (502)
Q Consensus 85 T~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~---------------------p~ 141 (502)
++.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..... +.
T Consensus 177 ~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (342)
T cd07879 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256 (342)
T ss_pred eecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCC
Confidence 899999998754 4889999999999999999999999874332222221111000 00
Q ss_pred Cc-------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 142 AF-------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 142 ~~-------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.. ....++.+.+||.+||. +|.+||++.+++.||||....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 11346778999999999 999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=214.22 Aligned_cols=168 Identities=26% Similarity=0.414 Sum_probs=134.8
Q ss_pred CCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC-----cEEEEecC
Q 010768 1 MFTSGTLREYRKKY-------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG-----QVKIGDLG 68 (502)
Q Consensus 1 y~~gGsL~~~L~k~-------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g-----~vKL~DFG 68 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+ + .+||+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEECCcc
Confidence 57899999999753 34889999999999999999999998 9999999999999876 4 79999999
Q ss_pred CceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCc
Q 010768 69 LAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAF 143 (502)
Q Consensus 69 lA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~ 143 (502)
++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||... +.......+..+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 234 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL-QK 234 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc-CC
Confidence 9876532211 12334578899999775 568999999999999999998 99999763 444555555444332 23
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
....+..+.+||.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 34457889999999999 9999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=224.84 Aligned_cols=155 Identities=23% Similarity=0.368 Sum_probs=125.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APE 92 (502)
.+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++........ .....+++.|+|||
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 3688889999999999999999999 9999999999999877 7999999999876532211 12234567899999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++..||. +|.+||++.
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~~Rps~~ 330 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFS 330 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 775 458999999999999999997 999998755545555555555433 2234467889999999999 999999999
Q ss_pred HHhcC
Q 010768 170 ELLLD 174 (502)
Q Consensus 170 ElL~h 174 (502)
++++|
T Consensus 331 eil~~ 335 (343)
T cd05103 331 ELVEH 335 (343)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=225.10 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=137.1
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++...... .....
T Consensus 103 ~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~--~~~~~ 176 (343)
T cd07880 103 GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQTDSE--MTGYV 176 (343)
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccccccccC--ccccc
Confidence 7789888864 57999999999999999999999999 9999999999999987 79999999999765332 23456
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC---------------------CC
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK---------------------LP 140 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~---------------------~p 140 (502)
+++.|+|||++.+ .++.++|+||||+++|+|++|..||..........+.+.... .+
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07880 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP 256 (343)
T ss_pred cCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcc
Confidence 7899999998764 488899999999999999999999986543332222111100 00
Q ss_pred C-------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 141 G-------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 141 ~-------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
. ......++.+.++|.+||. +|.+||++.+++.||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 0112456789999999999 999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=216.87 Aligned_cols=169 Identities=27% Similarity=0.440 Sum_probs=132.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.||+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++..+.....
T Consensus 89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCccccccccCccc
Confidence 57899999999765 45899999999999999999999999 9999999999999887 7999999999986543221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCC--------------CChHHHHHHHHcCCCC
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPAQIYKKVTSGKLP 140 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------------~~~~~i~~~i~~~~~p 140 (502)
.....++..|+|||++. ..++.++|||||||++|+|+++..|+... .........+..+...
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC
Confidence 12345677899999765 45889999999999999999987664221 1111222222233222
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...+..+.+||.+||+ +|.+||++.+++.
T Consensus 246 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 246 -PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2234468899999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=212.27 Aligned_cols=168 Identities=21% Similarity=0.398 Sum_probs=135.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||+.| ++||||||+||+++.. +.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence 57889999999864 45889999999999999999999998 9999999999999887 7999999999976543221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....++..|+|||++. +.++.++|+|||||++|+|++ |..||... ....+...+..+... ......+..+.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENCPEELYNI 235 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccCCHHHHHH
Confidence 12234567799999876 458889999999999999998 99999774 344445555544332 2334567899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||. +|.+||++.+++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=213.43 Aligned_cols=168 Identities=23% Similarity=0.395 Sum_probs=136.4
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. +.+++..+..++.||+.||+|||+++ ++||||||+|||++.+ +.+||+|||++.........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCcccccccccce
Confidence 57899999999875 56899999999999999999999999 9999999999999887 79999999999865432211
Q ss_pred ----ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 80 ----HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 80 ----~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
....++..|+|||.+. +.++.++|+||||+++|++++ |..||.+. ...+..+.+..+..+ ......++.+.+
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPMDCPAALHQ 240 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCCCCCHHHHH
Confidence 1122356899999886 468999999999999999886 99999764 344555666555332 223345789999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++.+||. +|.+||++.+++.
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 9999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=213.31 Aligned_cols=168 Identities=19% Similarity=0.362 Sum_probs=134.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++... +.+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccccccccCccc
Confidence 57899999999864 56899999999999999999999999 9999999999999887 79999999998765432211
Q ss_pred cc---cc---CCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 80 HS---VI---GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 80 ~~---~~---GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
.. .. .+..|+|||.+. +.++.++|||||||++|+|++ |..||... ....+.+.+..... .......+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~~~~~~~~ 240 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR-LPPPMDCPTAL 240 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-CCCcccCCHHH
Confidence 11 11 135799999876 468999999999999999886 99999763 44455555544322 22234457889
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+++.+||. +|.+||++.+++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=229.58 Aligned_cols=154 Identities=26% Similarity=0.384 Sum_probs=125.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC---cccccCCCcccCcc
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPE 92 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APE 92 (502)
.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++........ .....+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 4788899999999999999999999 9999999999999987 6899999999986533221 22345678899999
Q ss_pred ccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHH
Q 010768 93 LYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK 169 (502)
Q Consensus 93 vl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ 169 (502)
++. ..++.++|||||||++|+|++ |..||........++..+..+..+ ..+...+..+.++|.+||. +|.+||++.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 775 458999999999999999997 999998755555556666555332 3344567899999999999 999999998
Q ss_pred HHhc
Q 010768 170 ELLL 173 (502)
Q Consensus 170 ElL~ 173 (502)
++.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=215.97 Aligned_cols=169 Identities=23% Similarity=0.367 Sum_probs=131.3
Q ss_pred CCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecC
Q 010768 1 MFTSGTLREYRKKYT------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 68 (502)
Q Consensus 1 y~~gGsL~~~L~k~~------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFG 68 (502)
|+.+|+|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~dfg 174 (295)
T cd05097 98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNH-YTIKIADFG 174 (295)
T ss_pred cCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEcCC-CcEEecccc
Confidence 678999999996542 3788999999999999999999999 9999999999999876 689999999
Q ss_pred CceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh--ccCCCCCCCChHHHHHHHHc------
Q 010768 69 LAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTS------ 136 (502)
Q Consensus 69 lA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt--G~~Pf~~~~~~~~i~~~i~~------ 136 (502)
++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||.... ..++...+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~ 253 (295)
T cd05097 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DEQVIENTGEFFRNQG 253 (295)
T ss_pred cccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hHHHHHHHHHhhhhcc
Confidence 9976533221 12234567899999765 568999999999999999988 677887633 3333332211
Q ss_pred CCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 137 ~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...........++.+.+||.+||. +|.+||++.++++
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 254 RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111112233457899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=214.67 Aligned_cols=165 Identities=20% Similarity=0.312 Sum_probs=129.4
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC------CCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------LGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~------~g~vKL~DFGlA~~~ 73 (502)
|+.+|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.. ...+||+|||++...
T Consensus 97 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 97 FVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence 6899999999976 467999999999999999999999998 9999999999999753 124899999987643
Q ss_pred cCCCCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHh-hccCCCCCCCChHHHHHHHHcCCCCCCccccCCHH
Q 010768 74 RGSQHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLL-tG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
.. .....++..|+|||.+.+ .++.++|||||||++|+|+ +|..||..... ......+.... ..+....+.
T Consensus 175 ~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~---~~~~~~~~~ 247 (274)
T cd05076 175 LS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKERFYEKKH---RLPEPSCKE 247 (274)
T ss_pred cc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHHHHHHhcc---CCCCCCChH
Confidence 22 123457888999998753 4899999999999999985 69999976432 22222222211 112233568
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+.++|.+||. +|.+||++.++|++
T Consensus 248 ~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 248 LATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHh
Confidence 9999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=225.72 Aligned_cols=172 Identities=22% Similarity=0.409 Sum_probs=136.6
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC-------------------CCCcE
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-------------------HLGQV 62 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~-------------------~~g~v 62 (502)
|-++.+|++++ .+++...++.++.||+.+++|||+.+ ++|-||||+|||+.. ....|
T Consensus 174 G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I 251 (415)
T KOG0671|consen 174 GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAI 251 (415)
T ss_pred ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcce
Confidence 45899999875 45999999999999999999999999 999999999999831 11368
Q ss_pred EEEecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH--HHHHHHcCCC
Q 010768 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--IYKKVTSGKL 139 (502)
Q Consensus 63 KL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~--i~~~i~~~~~ 139 (502)
+|+|||.|...... ..+.+.|..|.|||++-+ .++..+||||+||||+|+.||...|..-.+.+. +++.|.. ++
T Consensus 252 ~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG-p~ 328 (415)
T KOG0671|consen 252 KVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG-PI 328 (415)
T ss_pred EEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC-CC
Confidence 99999999875443 367789999999998765 699999999999999999999999987655443 2233222 22
Q ss_pred CCC-----------------cc-------------------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 140 PGA-----------------FH-------------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 140 p~~-----------------~~-------------------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
|.. ++ ......+.+||++||. ||.+|+|+.|+|.|||
T Consensus 329 P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 329 PSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred cHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 110 00 0012457899999999 9999999999999999
Q ss_pred ccCC
Q 010768 177 LASD 180 (502)
Q Consensus 177 ~~~~ 180 (502)
|+..
T Consensus 409 F~~~ 412 (415)
T KOG0671|consen 409 FARL 412 (415)
T ss_pred hhcC
Confidence 9764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=211.90 Aligned_cols=168 Identities=20% Similarity=0.339 Sum_probs=134.3
Q ss_pred CCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 88 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~dfg~~~~~~ 164 (273)
T cd05074 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVADFGLSKKIY 164 (273)
T ss_pred cCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEECccccccccc
Confidence 56789999887532 24899999999999999999999999 9999999999999876 799999999988653
Q ss_pred CCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
... ......+++.|++||.+. +.++.++|||||||++|+|++ |..||.. .....+...+..+.... .....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (273)
T cd05074 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRLK-QPPDCLE 242 (273)
T ss_pred CCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcCC-CCCCCCH
Confidence 322 112334567899999875 458889999999999999999 8899876 44455666665544322 2234578
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.+++.+||. +|.+||++.+++.
T Consensus 243 ~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 243 DVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=213.65 Aligned_cols=169 Identities=28% Similarity=0.409 Sum_probs=129.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccccccCCCcc
Confidence 57899999999765 46999999999999999999999999 9999999999999887 79999999999876432211
Q ss_pred ----ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh---------------HHHHHHHHcCCC
Q 010768 80 ----HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------------AQIYKKVTSGKL 139 (502)
Q Consensus 80 ----~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---------------~~i~~~i~~~~~ 139 (502)
....++..|+|||++.+ .++.++|||||||++|+|++|..|+...... ..+...+..+..
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05081 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244 (284)
T ss_pred eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc
Confidence 11223456999998764 5889999999999999999987765331110 011112222221
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.......+..+.+||.+||. +|.+|||+.+++.
T Consensus 245 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 245 -LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12234457899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=223.76 Aligned_cols=182 Identities=24% Similarity=0.442 Sum_probs=151.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
||+|.+|.-||++++-+++++++.|+.||+.||.||....+||||-||||.|||+-.. .|.+||.|||+++++.+...
T Consensus 549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy 628 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY 628 (775)
T ss_pred ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence 8999999999999999999999999999999999999999999999999999998542 37899999999998865322
Q ss_pred --------cccccCCCcccCccccc-c----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHH---HHcCCCCCC
Q 010768 79 --------AHSVIGTPEFMAPELYE-E----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK---VTSGKLPGA 142 (502)
Q Consensus 79 --------~~~~~GT~~Y~APEvl~-~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~---i~~~~~p~~ 142 (502)
.....||.+|++||.+- + +.+.++||||+|||+|..+.|+-||........|.+. +.......+
T Consensus 629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP 708 (775)
T KOG1151|consen 629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 708 (775)
T ss_pred CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence 24567999999999663 2 3788999999999999999999999775444444332 122223334
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
....++.++++||++||+ .-.+|..+.++..||+|.....
T Consensus 709 ~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 709 PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 456679999999999999 8899999999999999986443
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=214.79 Aligned_cols=169 Identities=22% Similarity=0.350 Sum_probs=129.8
Q ss_pred CCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCC
Q 010768 1 MFTSGTLREYRKKYT-----------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGl 69 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||+
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~ 176 (296)
T cd05095 100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKN-YTIKIADFGM 176 (296)
T ss_pred eCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEcCC-CCEEeccCcc
Confidence 578999999997643 3677899999999999999999999 9999999999999876 7999999999
Q ss_pred ceeccCCCC---cccccCCCcccCcccc-cccCCcccchhhhhHHHHHHhh--ccCCCCCCCChHHHHHHHHc----C--
Q 010768 70 AAILRGSQH---AHSVIGTPEFMAPELY-EEDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTS----G-- 137 (502)
Q Consensus 70 A~~~~~~~~---~~~~~GT~~Y~APEvl-~~~~s~ksDIwSLG~iLyeLLt--G~~Pf~~~~~~~~i~~~i~~----~-- 137 (502)
+..+..... .....+++.|+|||+. .+.++.++|||||||++|+|++ |..||.... ..++...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~ 255 (296)
T cd05095 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIENTGEFFRDQGR 255 (296)
T ss_pred cccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC-hHHHHHHHHHHHhhccc
Confidence 976533221 1223346789999965 4669999999999999999998 778986633 3333222211 0
Q ss_pred CCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
......+...++.+.+||.+||. +|.+||++.++++
T Consensus 256 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 256 QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11111223456899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=218.33 Aligned_cols=178 Identities=34% Similarity=0.500 Sum_probs=135.7
Q ss_pred CCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC---CCcEEEEecCCceeccCC
Q 010768 5 GTLREYRKKY-----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 5 GsL~~~L~k~-----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~---~g~vKL~DFGlA~~~~~~ 76 (502)
-+|.+.|+-+ +.++...++.|+.||+.|+.|||++- |+||||||.||||.++ .|.|||+|||+++.+...
T Consensus 112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP 189 (438)
T ss_pred hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence 4677777543 34899999999999999999999999 9999999999999865 379999999999987543
Q ss_pred C----CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCC------Ch---HHHHHHHHc-C---
Q 010768 77 Q----HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECS------NP---AQIYKKVTS-G--- 137 (502)
Q Consensus 77 ~----~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~------~~---~~i~~~i~~-~--- 137 (502)
- ....++-|.+|.|||++-| .|+.+.|||++|||+.||+|-++.|.+.. ++ +++.+...- |
T Consensus 190 lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt 269 (438)
T KOG0666|consen 190 LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT 269 (438)
T ss_pred ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc
Confidence 2 2345677999999998754 59999999999999999999988886521 11 121111110 0
Q ss_pred --------CCCCC----------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 138 --------KLPGA----------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 138 --------~~p~~----------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
+.|.. .....++...+|+.+||. ||.+|+|++++|+|+||...+-.+
T Consensus 270 ~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 270 DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 01110 011235558899999999 999999999999999999875443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=216.70 Aligned_cols=170 Identities=28% Similarity=0.347 Sum_probs=139.1
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
.++|.+.+. -.++.+.+..++.|++.|+.|||+.| |+||||||+||+++.+ ..+||.|||+|...........++
T Consensus 104 ~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~~~mtpyV 178 (369)
T KOG0665|consen 104 DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTDFMMTPYV 178 (369)
T ss_pred hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhcccCcccccCchh
Confidence 456666665 46889999999999999999999999 9999999999999987 799999999998765555667789
Q ss_pred CCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-----------------------
Q 010768 84 GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----------------------- 139 (502)
Q Consensus 84 GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~----------------------- 139 (502)
.|..|.|||++- ..|.+.+||||+||++.||++|...|.+....++..+.+..-..
T Consensus 179 vtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y 258 (369)
T KOG0665|consen 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQY 258 (369)
T ss_pred heeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHh
Confidence 999999999775 35999999999999999999999999876655555443332111
Q ss_pred ---------CCC-------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 140 ---------PGA-------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 140 ---------p~~-------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
|.. ..+.....+++++.+||. +|++|.++.++|.|||++
T Consensus 259 ~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 259 QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 110 011235678999999999 999999999999999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=240.53 Aligned_cols=101 Identities=27% Similarity=0.494 Sum_probs=80.2
Q ss_pred cCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHHhhc
Q 010768 83 IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 83 ~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~ 160 (502)
+||+.|+|||++. ..++.++|||||||++|||++|..||.+ .....+...+.....+. ......+..+.+++.+||.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~-~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 4689999999775 4589999999999999999999999977 45556666665543321 1122457889999999999
Q ss_pred -CcCCCCCHHHHhcCccccCCCCCC
Q 010768 161 -NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 161 -dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
+|.+||++.++|.||||....+..
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~~~~~~ 644 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHGVDWEN 644 (669)
T ss_pred cChhHCcCHHHHHhCHhhcCCCHHH
Confidence 999999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=225.20 Aligned_cols=172 Identities=26% Similarity=0.428 Sum_probs=132.3
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccC-C
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-S 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~ 76 (502)
|+.+|+|.++|.... .++|....+|+.+++.||+|||.. .++|||||||+.|||+|.+ ...||+|||+|+.... .
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCccc
Confidence 788999999998765 899999999999999999999985 4589999999999999988 6999999999976654 3
Q ss_pred CCcccc-cCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCC-----ChHHH-HHHHHcCCCCCCcc----
Q 010768 77 QHAHSV-IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-----NPAQI-YKKVTSGKLPGAFH---- 144 (502)
Q Consensus 77 ~~~~~~-~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-----~~~~i-~~~i~~~~~p~~~~---- 144 (502)
....+. .||.+|+|||.+. +..+.++||||||++++||+||+.+..... +.... ...+..+.+.....
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK 311 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence 333333 8999999999875 679999999999999999999998876422 11111 22333333322111
Q ss_pred -ccCC--HH---HHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 145 -RIQD--AE---ARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 145 -~~~s--~~---l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...+ .. +..+..+|+. +|.+||++.+++.
T Consensus 312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1112 23 4556678999 9999999999754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=245.68 Aligned_cols=171 Identities=28% Similarity=0.385 Sum_probs=131.1
Q ss_pred CCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCC
Q 010768 1 MFTSGTLREYRKKY-----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69 (502)
Q Consensus 1 y~~gGsL~~~L~k~-----------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGl 69 (502)
|+.||+|.+++... ..++...++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEEEecCc
Confidence 68899999998642 23567788999999999999999999 9999999999999887 7999999999
Q ss_pred ceeccCC-------------------CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH
Q 010768 70 AAILRGS-------------------QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129 (502)
Q Consensus 70 A~~~~~~-------------------~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~ 129 (502)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|+||..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865211 01123579999999998764 589999999999999999999999976333222
Q ss_pred HHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 130 IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 130 i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
..................++.+.+++.+||. +|.+|++..+.+..
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222111111111223457889999999999 99999887766644
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=223.67 Aligned_cols=153 Identities=27% Similarity=0.410 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCccc
Q 010768 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPEL 93 (502)
Q Consensus 17 Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APEv 93 (502)
+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++...... ......+++.|+|||+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 677888999999999999999998 9999999999999986 799999999997653221 1223456789999997
Q ss_pred cc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHH
Q 010768 94 YE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170 (502)
Q Consensus 94 l~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~E 170 (502)
+. ..++.++||||||+++|+|++ |..||............+..+..+ ..+...+..+.+||.+||. +|.+||++.+
T Consensus 313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 75 458899999999999999998 899998755555555555555433 2344568899999999999 9999999999
Q ss_pred Hhc
Q 010768 171 LLL 173 (502)
Q Consensus 171 lL~ 173 (502)
|+.
T Consensus 392 ll~ 394 (401)
T cd05107 392 LVH 394 (401)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=209.61 Aligned_cols=169 Identities=25% Similarity=0.432 Sum_probs=132.6
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++.+.. .+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.++|+|||++.........
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05038 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDY 165 (284)
T ss_pred cCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccccccccCCcc
Confidence 578999999998764 6999999999999999999999999 9999999999999987 79999999999876532111
Q ss_pred ----ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh--------------HHHHHHHHcCCCC
Q 010768 80 ----HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP--------------AQIYKKVTSGKLP 140 (502)
Q Consensus 80 ----~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~--------------~~i~~~i~~~~~p 140 (502)
....++..|+|||.+. ..++.++||||||+++|+|++|..|+...... ..+...+..+..
T Consensus 166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (284)
T cd05038 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER- 244 (284)
T ss_pred eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc-
Confidence 1223456799999775 56889999999999999999999998653211 112222222222
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.......+..+.+++.+||. +|.+||++.+++.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22233456889999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=215.40 Aligned_cols=173 Identities=30% Similarity=0.431 Sum_probs=134.4
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.+++|.++++. ..+++..+..++.||+.||.|||+++ |+||||||.||+++.+ +.+||+|||.+..... .....
T Consensus 92 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~--~~~~~ 165 (328)
T cd07856 92 LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQDP--QMTGY 165 (328)
T ss_pred hccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCccccccccCC--CcCCC
Confidence 36789888865 46899999999999999999999999 9999999999999876 7999999999875432 22345
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHH--------------HHHHHHcC---------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ--------------IYKKVTSG--------- 137 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~--------------i~~~i~~~--------- 137 (502)
.+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........ +...+..+
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 67889999998754 589999999999999999999999976332111 11110000
Q ss_pred CC--CCC---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 138 KL--PGA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 138 ~~--p~~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.. +.. .....+..+.++|.+||. +|.+||++.+++.||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00 000 012346889999999999 999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=208.16 Aligned_cols=175 Identities=25% Similarity=0.403 Sum_probs=137.4
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-----C
Q 010768 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-----H 78 (502)
Q Consensus 5 GsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-----~ 78 (502)
-+|.-.|... .+++..++++++.+++.||.|+|.+. |+|||+|++|+||+.+ |.+||+|||+++.+.... .
T Consensus 108 hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFGlar~fs~~~n~~kpr 184 (376)
T KOG0669|consen 108 HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFGLARAFSTSKNVVKPR 184 (376)
T ss_pred hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeeccccccceecccccCCCC
Confidence 4666777654 67999999999999999999999999 9999999999999998 899999999997654322 1
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH-----------------------HH
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY-----------------------KK 133 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~-----------------------~~ 133 (502)
....+-|.+|.+||.+-| .|+++.|||..|||+.+|+|+.+.+.+..+..++. +.
T Consensus 185 ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~s 264 (376)
T KOG0669|consen 185 YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQS 264 (376)
T ss_pred cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHh
Confidence 233456999999997754 59999999999999999999999998765554432 11
Q ss_pred HHcCCCCCCc---------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 134 VTSGKLPGAF---------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 134 i~~~~~p~~~---------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+...+++... +...++++.+|+.++|. ||.+|+.+.++|.|.||..++.
T Consensus 265 ie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 265 IELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 1111111000 11235678899999999 9999999999999999987643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=225.70 Aligned_cols=176 Identities=24% Similarity=0.349 Sum_probs=130.1
Q ss_pred CCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe
Q 010768 1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56 (502)
Q Consensus 1 y~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld 56 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 266 y~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~ 343 (507)
T PLN03224 266 FESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT 343 (507)
T ss_pred cCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC
Confidence 56788888887632 12467789999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecCCceeccCCCCccc--ccCCCcccCccccccc---------------------C--CcccchhhhhHHH
Q 010768 57 GHLGQVKIGDLGLAAILRGSQHAHS--VIGTPEFMAPELYEED---------------------Y--NELVDIYSFGMCV 111 (502)
Q Consensus 57 ~~~g~vKL~DFGlA~~~~~~~~~~~--~~GT~~Y~APEvl~~~---------------------~--s~ksDIwSLG~iL 111 (502)
.+ +.+||+|||++........... ..+|+.|+|||++... | ..+.||||+||++
T Consensus 344 ~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 344 VD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred CC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 87 7999999999976543322222 2348999999976421 1 1347999999999
Q ss_pred HHHhhccC-CCCCCC----------ChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-Cc---CCCCCHHHHhcCcc
Q 010768 112 LEMLTSEY-PYSECS----------NPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NV---SKRLPAKELLLDPF 176 (502)
Q Consensus 112 yeLLtG~~-Pf~~~~----------~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP---~kRpsa~ElL~hpf 176 (502)
|+|++|.. ||.... +....++.+.............++..++||.+||. +| .+|+|++|+|.|||
T Consensus 423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 99999875 664321 11112222333333223344568899999999998 55 68999999999999
Q ss_pred ccC
Q 010768 177 LAS 179 (502)
Q Consensus 177 ~~~ 179 (502)
|..
T Consensus 503 f~~ 505 (507)
T PLN03224 503 FLP 505 (507)
T ss_pred cCC
Confidence 964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=213.10 Aligned_cols=167 Identities=26% Similarity=0.429 Sum_probs=141.1
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010768 13 KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE 92 (502)
Q Consensus 13 k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APE 92 (502)
+..+++|..+-.|..-.+.||+||-.. ..|||||+||+|||++.. |.|||||||++..+..+-....-.|...|||||
T Consensus 160 q~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPE 237 (361)
T KOG1006|consen 160 QKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPE 237 (361)
T ss_pred HhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecC-CCEeeecccchHhHHHHHHhhhccCCccccChh
Confidence 456799999999999999999999864 249999999999999998 899999999998876655555567899999999
Q ss_pred ccc--c-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccc----cCCHHHHHHHHHhhc-CcCC
Q 010768 93 LYE--E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR----IQDAEARRFVGKCLE-NVSK 164 (502)
Q Consensus 93 vl~--~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~----~~s~~l~~LI~kcL~-dP~k 164 (502)
.+. + .|+.++||||||++|||+.||.+||.+.....+....+..|..|..... ..+..+..||..||. |.+.
T Consensus 238 Ri~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~ 317 (361)
T KOG1006|consen 238 RIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSD 317 (361)
T ss_pred ccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhccccc
Confidence 885 3 3999999999999999999999999887666566666667766543222 257889999999999 9999
Q ss_pred CCCHHHHhcCccccCCC
Q 010768 165 RLPAKELLLDPFLASDA 181 (502)
Q Consensus 165 Rpsa~ElL~hpf~~~~~ 181 (502)
||...+++++||++...
T Consensus 318 Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 318 RPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CcchhhhhcCchhhhhh
Confidence 99999999999998654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=225.12 Aligned_cols=173 Identities=29% Similarity=0.459 Sum_probs=140.0
Q ss_pred CCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 4 SGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 4 gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
.-+|++.|+++++ |....++.|+.||+.||..|-..| |+|.||||+||||+.....+||||||.|...... ...
T Consensus 517 slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en-eit 593 (752)
T KOG0670|consen 517 SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASEN-EIT 593 (752)
T ss_pred hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccc-ccc
Confidence 4589999999876 999999999999999999999999 9999999999999988778999999999876553 344
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHH-HcCCCCCC-----------cc---
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-TSGKLPGA-----------FH--- 144 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i-~~~~~p~~-----------~~--- 144 (502)
.+.-+..|.|||++-| .|+...|+||+||+||||.||+..|++..+...+.-.+ ..|++|.. |.
T Consensus 594 PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~ 673 (752)
T KOG0670|consen 594 PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDL 673 (752)
T ss_pred HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhccccc
Confidence 5556778999997765 69999999999999999999999999976655432111 12332210 00
Q ss_pred ------------------------------------cc------CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 145 ------------------------------------RI------QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 145 ------------------------------------~~------~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.. .-..+++|+.+||. ||++|.|..++|+||||+.
T Consensus 674 nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 674 NFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00 01357899999999 9999999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=236.91 Aligned_cols=168 Identities=21% Similarity=0.413 Sum_probs=140.8
Q ss_pred CCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKY-------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~-------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
||+||+|..||++. ..++....+.++.||++|..||++++ +|||||-..|+||+.. ..|||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcccchhHhh
Confidence 79999999999986 34999999999999999999999999 9999999999999998 79999999999854
Q ss_pred cCCCC-c-ccc-cCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCC
Q 010768 74 RGSQH-A-HSV-IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD 148 (502)
Q Consensus 74 ~~~~~-~-~~~-~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s 148 (502)
-.... . ... .-...|||||.+. +.++.|+|||||||++||++| |..||.+..+.+.+......|.+ ..+...+
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL--~~P~~CP 930 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL--DPPSYCP 930 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc--CCCCCCC
Confidence 32211 1 111 1235799999886 779999999999999999999 99999986665555545566644 4456778
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+.+++..||+ +|++||++..|++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 888999999999 9999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=223.38 Aligned_cols=169 Identities=21% Similarity=0.356 Sum_probs=142.6
Q ss_pred CCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~-Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
||.||+|.+||++++. ++..+...++.+.+.||+|||+++ +|||||-..|+|+..+ +.+||+|||+++.-......
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcceeec
Confidence 6899999999999875 999999999999999999999999 9999999999999987 57899999998764311111
Q ss_pred c-cccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 80 H-SVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 80 ~-~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
. ...-...|+|||.+. +.|++++|||||||++||+.+ |..||.+ ....++..+|.....+...+...+..+..++.
T Consensus 319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELAKVMK 397 (474)
T ss_pred cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHHHHHH
Confidence 1 112346899999886 569999999999999999999 8899988 45567777886655555666677889999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+|+. +|++||++.++.+
T Consensus 398 ~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 398 QCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HhccCChhhccCHHHHHH
Confidence 9999 9999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=229.69 Aligned_cols=176 Identities=28% Similarity=0.493 Sum_probs=148.8
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
||.||+.-++++.. .++.|..+..|++.++.||.+||.+. +||||||-.|||++.+ +.|||+|||++..+... .
T Consensus 102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEeeeeeeeeeecccc
Confidence 79999999999864 67999999999999999999999998 9999999999999998 89999999999887653 3
Q ss_pred CcccccCCCcccCcccccc------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC-ccccCCHH
Q 010768 78 HAHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA-FHRIQDAE 150 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~~ 150 (502)
...+.+|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+... ....-.|...+.|.. -+...+..
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-mraLF~IpRNPPPkLkrp~kWs~~ 257 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPPPKLKRPKKWSKK 257 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-hhhhccCCCCCCccccchhhHHHH
Confidence 4678899999999998852 378899999999999999999999977443 333333433333322 24556889
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+.+||..||. |..+||+..++|.|||++..
T Consensus 258 FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 258 FNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 9999999999 99999999999999999844
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=191.45 Aligned_cols=174 Identities=24% Similarity=0.411 Sum_probs=137.4
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-ccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHS 81 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~~~ 81 (502)
..+|..|... ++.++.+.++.++.|+++||.|||+++ +.||||||+|+||+.+ |.+||+|||+++.+.-.-. ...
T Consensus 84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEeeec
Confidence 3467777765 577999999999999999999999999 9999999999999998 8999999999987654322 234
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcC------CCCC-----------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG------KLPG----------- 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~------~~p~----------- 141 (502)
.+-|.+|.+|.++-+ -|++..|+||.|||+.|+.. |.+.|.+..-.+++.+....- ..|.
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 467999999998864 39999999999999999997 888888866555555443321 1110
Q ss_pred Cccc---------cCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 AFHR---------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 ~~~~---------~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.++. .....-++++.++|. +|.+|++++++|+||||...
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0000 123456899999999 99999999999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=225.81 Aligned_cols=167 Identities=26% Similarity=0.428 Sum_probs=141.4
Q ss_pred CCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEe
Q 010768 1 MFTSGTLREYRKKYT--------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~D 66 (502)
||.-|||.+||+... +|+..+.+.|+.||+.|++||-++. +|||||-..|+||..+ -.|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~-l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGEN-LVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccc-eEEEecc
Confidence 788999999997532 2889999999999999999999999 9999999999999988 4999999
Q ss_pred cCCceeccCCCCcc---cccCCCcccCcc-cccccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCC
Q 010768 67 LGLAAILRGSQHAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG 141 (502)
Q Consensus 67 FGlA~~~~~~~~~~---~~~GT~~Y~APE-vl~~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 141 (502)
||+++.+-...... ...-...||||| ++.++|++++||||+||+|||+++ |..||.+..+ +++.+.|..|.+ -
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~~g~l-L 724 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIRAGQL-L 724 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHHcCCc-c
Confidence 99998653321111 112256899999 556899999999999999999998 9999998555 566778888887 4
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
.-+...+.++.+|+..||. +|.+||+++||-
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 5677789999999999999 999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=227.71 Aligned_cols=173 Identities=27% Similarity=0.402 Sum_probs=131.8
Q ss_pred CCCHHHHHHhC-CCC---CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC----CCcEEEEecCCceeccC
Q 010768 4 SGTLREYRKKY-TRV---DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQVKIGDLGLAAILRG 75 (502)
Q Consensus 4 gGsL~~~L~k~-~~L---se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~----~g~vKL~DFGlA~~~~~ 75 (502)
.-+|.+|+... ..+ .....+.++.|++.||++||+.+ ||||||||+||||... ...++|+|||+++.+..
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 35889999874 111 11345788999999999999998 9999999999999862 24789999999998765
Q ss_pred CCC----cccccCCCcccCccccccc-CCcccchhhhhHHHHHHhhc-cCCCCCCCChHHHHHHHHcCCC-CCCccccCC
Q 010768 76 SQH----AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKL-PGAFHRIQD 148 (502)
Q Consensus 76 ~~~----~~~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG-~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s 148 (502)
+.. .....||.+|+|||++... -..++|||||||++|+.++| .+||... ..+ ...|..+.. -..+....+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R-~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LER-QANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHh-hhhhhcCccceeeeccCch
Confidence 432 3456799999999998754 56689999999999999995 9999652 122 122333332 122222333
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.++++||.+|+. +|..||+|.++|.||||-...
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 489999999999 999999999999999996543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=195.88 Aligned_cols=167 Identities=23% Similarity=0.414 Sum_probs=136.4
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCc
Q 010768 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAP 91 (502)
Q Consensus 12 ~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~AP 91 (502)
+-++.|+...++.++.||+.||.|||++| |+|||+||.|++|+.....++|+|+|+|.+...+...+-.+.+..|--|
T Consensus 124 ~ly~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGP 201 (338)
T KOG0668|consen 124 QLYPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201 (338)
T ss_pred HHhhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCc
Confidence 33456888999999999999999999999 9999999999999987778999999999988777666667788899999
Q ss_pred cccc--ccCCcccchhhhhHHHHHHhhccCCC-CCCCChHHHHHHHHc--------------CCCCC-------------
Q 010768 92 ELYE--EDYNELVDIYSFGMCVLEMLTSEYPY-SECSNPAQIYKKVTS--------------GKLPG------------- 141 (502)
Q Consensus 92 Evl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf-~~~~~~~~i~~~i~~--------------~~~p~------------- 141 (502)
|++- ..|+..-|+|||||++..|+..+-|| .+..+.+++.+...- -.+++
T Consensus 202 ELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~ 281 (338)
T KOG0668|consen 202 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKP 281 (338)
T ss_pred hheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccccc
Confidence 9875 45888999999999999999988886 455666665332210 00111
Q ss_pred -------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 -------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 -------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.-....++++.+|+.++|. |-.+|+||+|++.||||...
T Consensus 282 w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 282 WSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1122357899999999999 99999999999999999753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=190.98 Aligned_cols=128 Identities=32% Similarity=0.503 Sum_probs=110.9
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC
Q 010768 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMA 90 (502)
Q Consensus 11 L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~A 90 (502)
+++.+.++|..+-+|+.-++.||.|||++ ..|||||+||.|||++.+ |+||+||||++..+.++-......|...|||
T Consensus 139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiAkt~daGCkpYma 216 (282)
T KOG0984|consen 139 LKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYD-GQVKICDFGISGYLVDSIAKTMDAGCKPYMA 216 (282)
T ss_pred HhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccC-CcEEEcccccceeehhhhHHHHhcCCCccCC
Confidence 45567799999999999999999999987 359999999999999988 8999999999988766544444678899999
Q ss_pred cccccc-----cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC
Q 010768 91 PELYEE-----DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140 (502)
Q Consensus 91 PEvl~~-----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p 140 (502)
||.+.. .|+-++||||||++++||.++++||.....+.+..+.+.....|
T Consensus 217 PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 217 PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred hhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 998752 48999999999999999999999999988888888888776554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=198.65 Aligned_cols=172 Identities=29% Similarity=0.423 Sum_probs=133.6
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CCcccc
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QHAHSV 82 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~~~~~ 82 (502)
.+|...|-....++...++-++.||++||.|||+.+ |.||||||.|+|++.+ ..+||+|||+++..... ..+...
T Consensus 141 SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hMTqE 217 (449)
T KOG0664|consen 141 SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNMTHE 217 (449)
T ss_pred hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhhhhHHH
Confidence 356666666678999999999999999999999999 9999999999999998 69999999999875433 334455
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHH-----------------------c-
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-----------------------S- 136 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~-----------------------~- 136 (502)
+-|-.|.|||++.| .|+.++||||+|||+.||+..+..|.......++ +.|. .
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEGAk~H~LR~ 296 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEGAKNHVLRA 296 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhhhHHHhhcc
Confidence 67889999998875 4999999999999999999999888764333322 2111 1
Q ss_pred CCCCCCccc---c-----CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 137 GKLPGAFHR---I-----QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 137 ~~~p~~~~~---~-----~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+..++.+.. + ...+...++.++|. +|.+|.+..+++.|+++...
T Consensus 297 ~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 297 GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 112222221 1 23456778888888 99999999999999998654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=216.55 Aligned_cols=125 Identities=30% Similarity=0.495 Sum_probs=111.6
Q ss_pred CCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CC--cEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LG--QVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g--~vKL~DFGlA~~~~ 74 (502)
||.||+|+.++.+. ..|++.+++.++..+..||.|||.+| ||||||||.||++-.. .| .-||+|||.|+.+.
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 79999999999764 45999999999999999999999999 9999999999998532 12 56999999999999
Q ss_pred CCCCcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCCh
Q 010768 75 GSQHAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127 (502)
Q Consensus 75 ~~~~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~ 127 (502)
++....+.+||+.|.+||++. +.|+..+|.|||||++|+.+||..||.-...+
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 888889999999999999997 56999999999999999999999999644333
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=215.52 Aligned_cols=169 Identities=24% Similarity=0.384 Sum_probs=142.6
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+..|+|.+|+++.+ .++......++.||+.|++||++.. +|||||-..|||+..+ ..+||
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~-~~~kI 459 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKN-KVIKI 459 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCC-CEEEE
Confidence 688999999998876 3899999999999999999999998 9999999999999988 69999
Q ss_pred EecCCceeccCCCCc--ccccC--CCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCC
Q 010768 65 GDLGLAAILRGSQHA--HSVIG--TPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGK 138 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~--~~~~G--T~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~ 138 (502)
+|||+|+........ ....| ...|||||.+.. .|+.++||||||++|||+++ |..||.+......+++.+..|.
T Consensus 460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~ 539 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN 539 (609)
T ss_pred ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC
Confidence 999999865433222 11222 235999998764 69999999999999999999 9999998665777788888887
Q ss_pred CCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 139 ~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.... +...++++.++++.||. +|.+||++.++..
T Consensus 540 r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 540 RMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7544 34458999999999999 9999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=209.20 Aligned_cols=167 Identities=26% Similarity=0.457 Sum_probs=139.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
+++-|.|++||+.+ ..|+......++.||..||.|||+.. .|||||-..||||... ..|||+|||+++.+......
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccccchh
Confidence 46789999999876 45999999999999999999999999 9999999999999987 58999999999988765443
Q ss_pred ccccC--CCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 HSVIG--TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 ~~~~G--T~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....| ...|||||-++ ..++.++|||-||+|+||++. |..||.+-.+.+.+ -.+..|..++ .+...++.+..++
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP-~P~nCPp~LYslm 625 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLP-CPPNCPPALYSLM 625 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCC-CCCCCChHHHHHH
Confidence 33333 45799999876 679999999999999999987 99999986655443 3455565543 4556788999999
Q ss_pred HHhhc-CcCCCCCHHHHh
Q 010768 156 GKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL 172 (502)
.+||+ +|.+||.+.++.
T Consensus 626 skcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHhccCcccCCcHHHHH
Confidence 99999 999999987764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-21 Score=204.74 Aligned_cols=173 Identities=24% Similarity=0.403 Sum_probs=146.1
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
+++.|+|.+.|++. ..|-...+..|+.||+.|+.||.+++ +|||||-..||||... ..|||+|||+.+.+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeecccceeccCCCCc
Confidence 57899999999873 45889999999999999999999999 9999999999999876 6899999999998876655
Q ss_pred ccccc----CCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 AHSVI----GTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~----GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
..... -...|.|||.++ +.++.++|||++||++|||++ |+.||.++ ...+|.++|..+... ..++.++..+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL-pRPk~csedIY 345 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL-PRPKYCSEDIY 345 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-CCCCCChHHHH
Confidence 44322 245799999886 679999999999999999998 99999984 567788888766543 34566789999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
+++..||. +|.+||++..|...-++.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999 999999999987554443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=200.47 Aligned_cols=166 Identities=25% Similarity=0.400 Sum_probs=141.9
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||+.|+|.+||++..+ ++.-.++.++.||..|++||..++ +|||||-..|.||..+ ..||++|||+++.+.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhcCCce
Confidence 7899999999997644 888889999999999999999999 9999999999999988 6999999999998765322
Q ss_pred cccccC---CCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIG---TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~G---T~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
....| ...|.|||-+. ..++.|+|||+||++|||+.| |-.||.+ .+..++|..+..|.... -+..+++.+.+
T Consensus 421 -TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVYe 497 (1157)
T KOG4278|consen 421 -TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVYE 497 (1157)
T ss_pred -ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHHH
Confidence 12222 46799999776 569999999999999999998 9999998 67788888888776543 34566889999
Q ss_pred HHHHhhc-CcCCCCCHHHHh
Q 010768 154 FVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL 172 (502)
|++.||+ .|.+||+++|+-
T Consensus 498 LMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHhcCCcccCccHHHHH
Confidence 9999999 999999998874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=210.15 Aligned_cols=174 Identities=23% Similarity=0.435 Sum_probs=145.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
||++|+|..||+++ +.|+..++..+++.|+.|+.||-..| +|||||-..||||+.+ -..|++|||+++.+.+.. .
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEeccccceeecccCCCc
Confidence 79999999999876 67999999999999999999999999 9999999999999998 589999999999886544 2
Q ss_pred cccccC---CCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIG---TPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~G---T~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
..+..| ...|.|||.+. ++++.++||||+|++|||.++ |+.||.+..|. +.++.|..|... +.+...+..+..
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-dVIkaIe~gyRL-PpPmDCP~aL~q 865 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEQGYRL-PPPMDCPAALYQ 865 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-HHHHHHHhccCC-CCCCCCcHHHHH
Confidence 222222 46899999776 789999999999999999886 99999997765 455667666543 334567899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc--CccccC
Q 010768 154 FVGKCLE-NVSKRLPAKELLL--DPFLAS 179 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~--hpf~~~ 179 (502)
|+..||+ +...||.+.+|+. |..+++
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999 9999999999985 345544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=219.21 Aligned_cols=166 Identities=22% Similarity=0.351 Sum_probs=120.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.++++. +++..+..|+.||+.||+|||.. .++|+||||||+||+++.+ +..++. ||....... .
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~ 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---D 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---C
Confidence 7899999999964 89999999999999999999944 2349999999999999876 566664 665543321 1
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC----ChHHHHHHHHcC-CC----CCCc------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS----NPAQIYKKVTSG-KL----PGAF------ 143 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~----~~~~i~~~i~~~-~~----p~~~------ 143 (502)
....||+.|+|||++.+ .++.++|||||||++|||+||+.||.... ......+..... .. .+..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23468999999998764 59999999999999999999999985321 111111111100 00 0000
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.......+.+++.+||. +|.+||++.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 01112356788999999 99999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=167.55 Aligned_cols=139 Identities=35% Similarity=0.618 Sum_probs=121.2
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+.|++|.+++... ..+++..++.++.+++.+|++||+.| ++|+||+|.||+++...+.++|+|||.+....... .
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~ 149 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL 149 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcch
Confidence 45679999999876 57999999999999999999999999 99999999999999822799999999998764432 1
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~ 195 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIR 195 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHH
Confidence 334567889999998865 688899999999999999 67899999
Q ss_pred Hhhc-CcCCCCCHHHHhcCc
Q 010768 157 KCLE-NVSKRLPAKELLLDP 175 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hp 175 (502)
+|+. +|.+||++.++++++
T Consensus 196 ~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHhhCCcccCcCHHHHhhCC
Confidence 9999 999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=192.40 Aligned_cols=169 Identities=28% Similarity=0.503 Sum_probs=128.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|-..|+|.+||+.+ -+++.+..+++.-|++||+|||+- .|+|+|||||..||||..+ +..-|+|||+|..+
T Consensus 289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEEe
Confidence 45789999999885 589999999999999999999963 4689999999999999988 79999999999887
Q ss_pred cCCC---CcccccCCCcccCcccccccCC-------cccchhhhhHHHHHHhhccC------------CCCC----CCCh
Q 010768 74 RGSQ---HAHSVIGTPEFMAPELYEEDYN-------ELVDIYSFGMCVLEMLTSEY------------PYSE----CSNP 127 (502)
Q Consensus 74 ~~~~---~~~~~~GT~~Y~APEvl~~~~s-------~ksDIwSLG~iLyeLLtG~~------------Pf~~----~~~~ 127 (502)
.... .....+||..|||||++.+..+ ...||||+|.++|||++... ||.. ....
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 5432 2344789999999999986533 35899999999999998542 2321 1223
Q ss_pred HHHHHHHHcCCC----CCCccc-cCCHHHHHHHHHhhc-CcCCCCCHHHH
Q 010768 128 AQIYKKVTSGKL----PGAFHR-IQDAEARRFVGKCLE-NVSKRLPAKEL 171 (502)
Q Consensus 128 ~~i~~~i~~~~~----p~~~~~-~~s~~l~~LI~kcL~-dP~kRpsa~El 171 (502)
+++...+...+. |..+.. .....+++.++.||. |++.|.|+.=+
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 444444443332 222222 224568999999999 99999997543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=192.47 Aligned_cols=163 Identities=28% Similarity=0.486 Sum_probs=124.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC--------C------CC---
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--------S------QH--- 78 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~--------~------~~--- 78 (502)
.++..+++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||+|..... . ..
T Consensus 128 ~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g 205 (418)
T KOG1167|consen 128 SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMG 205 (418)
T ss_pred cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcccc
Confidence 3779999999999999999999999 999999999999999888999999999962100 0 00
Q ss_pred ----------------------------cccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChH
Q 010768 79 ----------------------------AHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128 (502)
Q Consensus 79 ----------------------------~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~ 128 (502)
.....||++|.|||++. ...++++||||.|+|++-++++.+||....+..
T Consensus 206 ~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~ 285 (418)
T KOG1167|consen 206 KDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDA 285 (418)
T ss_pred CcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCcccc
Confidence 00146999999999875 458899999999999999999999986432211
Q ss_pred HHHHHH--------------HcCC-----------------------------------CCCCccccCCHHHHHHHHHhh
Q 010768 129 QIYKKV--------------TSGK-----------------------------------LPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 129 ~i~~~i--------------~~~~-----------------------------------~p~~~~~~~s~~l~~LI~kcL 159 (502)
.....+ ..|. ....+....+..+.+|+.+||
T Consensus 286 ~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~l 365 (418)
T KOG1167|consen 286 DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCL 365 (418)
T ss_pred chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHc
Confidence 110000 0011 001112233568899999999
Q ss_pred c-CcCCCCCHHHHhcCccccCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+ ||.+|.+++++|+||||...
T Consensus 366 e~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 366 ELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cCChhhcccHHHHhcCcCCcch
Confidence 9 99999999999999999843
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=208.70 Aligned_cols=178 Identities=25% Similarity=0.467 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
||.+ +|..++...+++...++..+++||+.||+|+|+.| |.||||||+|+++..+ |.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeeccCcchh
Confidence 5777 99999999889999999999999999999999999 9999999999999988 79999999999775432
Q ss_pred -CCcccccCCCcccCcccccc-cCCc-ccchhhhhHHHHHHhhccCCCCCCCChHHHHHHH-HcCC-----CCCCccccC
Q 010768 77 -QHAHSVIGTPEFMAPELYEE-DYNE-LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-TSGK-----LPGAFHRIQ 147 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~-~~s~-ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i-~~~~-----~p~~~~~~~ 147 (502)
......+|+..|+|||++.+ .|.+ .+||||.|+++..|++|++||......++.+... ..+. -+..+....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 22356789999999998875 4554 7899999999999999999997644333321111 1111 122334456
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+...+.+|.+||+ +|.+|.|+++|++++||+....
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 7888999999999 9999999999999999987543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=196.54 Aligned_cols=169 Identities=21% Similarity=0.347 Sum_probs=133.2
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|++.|+|.+|+.++. .+..+....|+.||+.|++||.+.+ +|||||.+.|+|++++ .++||+|||+++.+-.+..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccCCc
Confidence 688999999999883 3456677789999999999999999 9999999999999998 6999999999986533221
Q ss_pred ---cccccCCCcccCcc-cccccCCcccchhhhhHHHHHHhh--ccCCCCCCCChHHHHHHHHc---CCC---CCCcccc
Q 010768 79 ---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT--SEYPYSECSNPAQIYKKVTS---GKL---PGAFHRI 146 (502)
Q Consensus 79 ---~~~~~GT~~Y~APE-vl~~~~s~ksDIwSLG~iLyeLLt--G~~Pf~~~~~~~~i~~~i~~---~~~---p~~~~~~ 146 (502)
....+-...||||| ++.+++++++|+|+||+++||+++ .+.||....+. ++.+.... ..- -...+..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCCCcceeccCCCc
Confidence 12234467999999 567999999999999999999865 78999875443 33332221 111 1223456
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+..+.+++.+||. +..+||+++++..
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 68889999999999 9999999999854
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=198.54 Aligned_cols=168 Identities=27% Similarity=0.453 Sum_probs=142.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+|++.+ .++-.+..+.|+.||++|+.|||.++ +|||||-..||||..- ..+||.|||+++.+......
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccCccccc
Confidence 67899999999875 56999999999999999999999999 9999999999999876 69999999999987654332
Q ss_pred ccc---cCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 HSV---IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ~~~---~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
... .-.+.|||-|.+. ..|+.++|||||||++||++| |..||.+ ...++|-+.+..|.. -..+.+.+-++..+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDVYMV 932 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHHHHH
Confidence 222 2246688888665 679999999999999999999 9999988 566777777777766 34566778899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||- |+..||+++++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 999999 9999999998763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=186.89 Aligned_cols=170 Identities=31% Similarity=0.505 Sum_probs=130.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----C-CCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-----H-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-----~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|-+.|+|++||.+ ..++.+...+++.-++.||++||. + .|.|.|||||..||||..+ +..-|+|+|+|....
T Consensus 290 YHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD 367 (513)
T ss_pred cccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeeceeeEEec
Confidence 6689999999988 679999999999999999999994 2 3569999999999999988 899999999997654
Q ss_pred CCC-----CcccccCCCcccCcccccccCC-------cccchhhhhHHHHHHhhc----------cCCCCCC----CChH
Q 010768 75 GSQ-----HAHSVIGTPEFMAPELYEEDYN-------ELVDIYSFGMCVLEMLTS----------EYPYSEC----SNPA 128 (502)
Q Consensus 75 ~~~-----~~~~~~GT~~Y~APEvl~~~~s-------~ksDIwSLG~iLyeLLtG----------~~Pf~~~----~~~~ 128 (502)
... ..+..+||..|||||++....+ ..+||||||.++||++.. ++||.+. ...+
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 431 2356789999999999975432 358999999999999863 3777543 3445
Q ss_pred HHHHHHHcCCCCCCccc-cC-CH---HHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 129 QIYKKVTSGKLPGAFHR-IQ-DA---EARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 129 ~i~~~i~~~~~p~~~~~-~~-s~---~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
++.+.+...++.+.++. .. .+ .+.++++.||. +|..|.||--+-
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 55555544444322222 21 23 35678889999 999999986654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=188.81 Aligned_cols=119 Identities=29% Similarity=0.428 Sum_probs=79.7
Q ss_pred EEEEecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC------CChHH---HH
Q 010768 62 VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPAQ---IY 131 (502)
Q Consensus 62 vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~------~~~~~---i~ 131 (502)
|||+|||-|.... ...+.-+.|..|.|||++-+ .|++.+||||++|++|||+||.+.|.-. .+.+- +.
T Consensus 393 vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ 470 (590)
T KOG1290|consen 393 VKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM 470 (590)
T ss_pred EEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence 4555555554432 12233457889999998765 6999999999999999999999998521 11111 21
Q ss_pred HH--------HHcCCCCC----------------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 132 KK--------VTSGKLPG----------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 132 ~~--------i~~~~~p~----------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.. +..|+... .|......++.+|+.-||+ +|.+|+||.++|+|
T Consensus 471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 11 11121110 0111124567899999999 99999999999999
Q ss_pred ccccCCCC
Q 010768 175 PFLASDAG 182 (502)
Q Consensus 175 pf~~~~~~ 182 (502)
||+.....
T Consensus 551 PwLn~~~~ 558 (590)
T KOG1290|consen 551 PWLNPVAG 558 (590)
T ss_pred ccccCCCC
Confidence 99987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-20 Score=198.44 Aligned_cols=176 Identities=30% Similarity=0.496 Sum_probs=148.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||-||+|.+.-.-.++|++.++..+++..++||+|||+.| -+|||||-.||+++.. |.+||+|||.+..+... .+.
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccCchhhhhhhhhhh
Confidence 7899999998888899999999999999999999999999 9999999999999987 89999999998776432 345
Q ss_pred ccccCCCcccCcccc----cccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-CCCCc--cccCCHHHH
Q 010768 80 HSVIGTPEFMAPELY----EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-LPGAF--HRIQDAEAR 152 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl----~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~-~p~~~--~~~~s~~l~ 152 (502)
..++||+.|||||+. ++.|+.++|||++|+...|+---++|-.. ..+.+....+.... -|+.+ ....++.+.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-lhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-LHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-cchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 678999999999976 36699999999999999999988888655 34445444444433 33322 234578899
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+|++.+|. +|++||++..+|.|||+...
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999 99999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=163.18 Aligned_cols=136 Identities=32% Similarity=0.531 Sum_probs=116.2
Q ss_pred CCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~-Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+++|.+++..... +++..++.++.|++.+|.+||+++ ++|+||+|.||+++.+ +.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 4677899999998777 899999999999999999999998 9999999999999987 799999999998765432
Q ss_pred CcccccCCCcccCcccc-c-ccCCcccchhhhhHHHHHHhhccCCCCC-CCChHHHHHHHHcCCC
Q 010768 78 HAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLTSEYPYSE-CSNPAQIYKKVTSGKL 139 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl-~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~-~~~~~~i~~~i~~~~~ 139 (502)
......++..|++||++ . ..++.++|+|+||+++++|++|+.||.. ......+.+.+..+..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 33455788899999987 3 3477799999999999999999999977 5556677777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-17 Score=160.11 Aligned_cols=177 Identities=29% Similarity=0.396 Sum_probs=143.1
Q ss_pred CCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~---~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+++|.+++.... .+....+..++.|++.+|.|+|..+ ++||||||+||+++.....++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 578899998888775 7999999999999999999999999 99999999999999873379999999998654432
Q ss_pred -------CcccccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCCCC---hHHHHHHHHcCCCC-CC
Q 010768 78 -------HAHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLP-GA 142 (502)
Q Consensus 78 -------~~~~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---~~~i~~~i~~~~~p-~~ 142 (502)
......|+..|+|||.+.+ .+....|+|++|++++++++|..||..... .......+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2456789999999998864 688899999999999999999999877543 45566666555433 11
Q ss_pred ccccC------CHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 143 FHRIQ------DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 143 ~~~~~------s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
..... ...+.+++.+++. +|..|.+..+...++|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11111 2578999999999 9999999999988866554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-18 Score=172.59 Aligned_cols=166 Identities=23% Similarity=0.346 Sum_probs=137.2
Q ss_pred CCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 3 TSGTLREYRKKY--------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 3 ~gGsL~~~L~k~--------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
.=|+|+.|++.. ..++..++..++.||+.|++|||.+| |||.||-..|.+|++. -+|||+|=.+++.+-
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeEEeccchhccccC
Confidence 348999999822 23788889999999999999999999 9999999999999987 599999999987643
Q ss_pred CCC-C--cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQ-H--AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~-~--~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
... . ....-....||+||.+. ..|+.++|+||||++||||+| |+.||.+ .++.++...+..|..- ..+...++
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRl-aQP~NCPD 525 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRL-AQPFNCPD 525 (563)
T ss_pred cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcccee-cCCCCCcH
Confidence 211 1 11112346799999775 569999999999999999999 9999977 7788888888888664 34456788
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++..++.-||. .|++||+++++..
T Consensus 526 eLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 526 ELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99999999999 9999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-19 Score=186.14 Aligned_cols=117 Identities=28% Similarity=0.485 Sum_probs=107.0
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
+|-+|++||..+++++|.+++.|++||+.|+++||++| |||||||-+|+.++.+ |-+||+|||.+..... .....+
T Consensus 653 ~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~~ks-gpfd~f 728 (772)
T KOG1152|consen 653 EGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAYTKS-GPFDVF 728 (772)
T ss_pred CCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhhhcC-CCccee
Confidence 46799999999999999999999999999999999999 9999999999999998 8999999999986654 455678
Q ss_pred cCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCC
Q 010768 83 IGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123 (502)
Q Consensus 83 ~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~ 123 (502)
+||..|.|||++.|. .+..-|||++|++||.++..+.||.+
T Consensus 729 ~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 729 VGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999865 47788999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=170.73 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=127.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe-CCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld-~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.-|+|.+-+.. ..+-|...+.++.|+++||.|+|+.+ +||||||.+||||- .++.+|||+|||+...... ..
T Consensus 103 ~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TV 177 (378)
T ss_pred cCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc--ee
Confidence 5678899888766 45889999999999999999999999 99999999999984 5567999999999865432 22
Q ss_pred ccccCCCcccCccccc----cc--CCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHHcCCC---CCCccccC
Q 010768 80 HSVIGTPEFMAPELYE----ED--YNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL---PGAFHRIQ 147 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~----~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~~~~~---p~~~~~~~ 147 (502)
...-.+..|.+||+.. +. ..+.+|||.||+++|..|||.+||....-. -.-+.+...++. |..+. ..
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~-~f 256 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN-PF 256 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc-cc
Confidence 2233456789999663 22 678899999999999999999999753222 122333333333 33333 34
Q ss_pred CHHHHHHHHHhhc-CcCCC---CCHHHHhcCcccc
Q 010768 148 DAEARRFVGKCLE-NVSKR---LPAKELLLDPFLA 178 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kR---psa~ElL~hpf~~ 178 (502)
++.+..+.++-|. ++++| -+++...+.-|..
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 7778888888888 88888 4566666666664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-18 Score=180.80 Aligned_cols=166 Identities=28% Similarity=0.469 Sum_probs=134.0
Q ss_pred CCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~---~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
+|+.++|.+||.... ..+...++.|+.|+..|++| ++ .+|||+||.||++..+ ..+||+|||+........
T Consensus 337 ~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl~ts~~~~~ 410 (516)
T KOG1033|consen 337 LCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGLVTSQDKDE 410 (516)
T ss_pred hhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhheeecccCC
Confidence 477889999997543 37788899999999999999 67 9999999999999877 589999999998765544
Q ss_pred -------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCC
Q 010768 78 -------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD 148 (502)
Q Consensus 78 -------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s 148 (502)
.....+||..||+||.+.+ .|+.++||||||+|++||+. -..++ ........+..+.+|+.+... .
T Consensus 411 ~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip~~~~~d-~ 485 (516)
T KOG1033|consen 411 TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIPPEFLQD-Y 485 (516)
T ss_pred cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCChHHhhc-C
Confidence 3456789999999998875 59999999999999999997 33333 233446667778787554433 4
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
+.-..|+.+||. .|.+||++.+.-.|+|+
T Consensus 486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 486 PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 556789999999 99999988888877775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-18 Score=182.09 Aligned_cols=169 Identities=26% Similarity=0.367 Sum_probs=146.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|..||+|...+.+...+++..++.+...++-+++++|+.+ |+|||+|++||+++.+ |++|+.|||+++..-.....
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence 4578889988888888999999999999999999999999 9999999999999998 89999999999876443332
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
+||..|||||+++ .....+|.||||+++++|+||..||.. ++.+.|...++ ..+...+..+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL--EMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc--CCchhhhHHHHHHHHHHHh
Confidence 8999999999998 667789999999999999999999976 55666665554 3455667889999999999
Q ss_pred -CcCCCCC-----HHHHhcCccccCCCCC
Q 010768 161 -NVSKRLP-----AKELLLDPFLASDAGE 183 (502)
Q Consensus 161 -dP~kRps-----a~ElL~hpf~~~~~~~ 183 (502)
+|.+|.- +.|++.|+||+.-.+.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999875 5899999999887665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.2e-17 Score=182.36 Aligned_cols=153 Identities=30% Similarity=0.506 Sum_probs=126.1
Q ss_pred HHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----------------CcccccCCCcccCccc
Q 010768 30 LRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----------------HAHSVIGTPEFMAPEL 93 (502)
Q Consensus 30 l~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----------------~~~~~~GT~~Y~APEv 93 (502)
+.+++|||+.| |+|||+||+|++|+.- |++|+.|||+.+..-... ....++|||.|+|||+
T Consensus 153 vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 67999999998 9999999999999986 899999999987532110 1134689999999997
Q ss_pred cc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHHHHHhhc-CcCCCC---
Q 010768 94 YE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL--- 166 (502)
Q Consensus 94 l~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~kRp--- 166 (502)
+. ..|+..+|+|++|+|+|+.+-|+.||.+ ..+++++..+..... |+. .....++++++|.++|. +|..|.
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 65 5699999999999999999999999988 667777777766433 333 34457899999999999 999885
Q ss_pred CHHHHhcCccccCCCCCCCCC
Q 010768 167 PAKELLLDPFLASDAGEPLLI 187 (502)
Q Consensus 167 sa~ElL~hpf~~~~~~~~l~~ 187 (502)
.+.++..|+||+..+|..++.
T Consensus 308 ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred hhhhhhhccceeecccchhhh
Confidence 578899999999999885443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.1e-16 Score=173.56 Aligned_cols=163 Identities=19% Similarity=0.254 Sum_probs=122.0
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec--cCCCC--c-
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL--RGSQH--A- 79 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~--~~~~~--~- 79 (502)
.+|.+.|..++-|...+.+.|+.||+.||.-||..| |+|||||.+||||+.- +-+.|+||..-+.. ..... .
T Consensus 105 hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 105 HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCCCCcccce
Confidence 367777777777899999999999999999999999 9999999999999986 68999999876432 21111 1
Q ss_pred ---ccccCCCcccCcccccc-----------c-CCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC--CC
Q 010768 80 ---HSVIGTPEFMAPELYEE-----------D-YNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL--PG 141 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~~-----------~-~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~--p~ 141 (502)
.+...-.+|+|||.+.. . ..++.||||+||+++||++ |++||.- .++...-..+.. ..
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQ 257 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHH
Confidence 12223458999997631 1 4678999999999999998 7888843 333322222111 11
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+..+.+..++.+|..|++ +|.+|.+|++.|+.
T Consensus 258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2344567789999999999 99999999999964
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-15 Score=152.72 Aligned_cols=160 Identities=27% Similarity=0.350 Sum_probs=119.2
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC---CCcEEEEecCCceeccCC-----
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH---LGQVKIGDLGLAAILRGS----- 76 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~---~g~vKL~DFGlA~~~~~~----- 76 (502)
.||++|+-.+ ..+....+-++.|+++|+.|||.+| |.|||||.+||||.-+ -..+.|+|||.+-.-...
T Consensus 327 ~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp 403 (598)
T KOG4158|consen 327 QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP 403 (598)
T ss_pred hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc
Confidence 4788888764 3567777888999999999999999 9999999999999533 236899999987432211
Q ss_pred --CCcccccCCCcccCccccccc-------CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccC
Q 010768 77 --QHAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ 147 (502)
Q Consensus 77 --~~~~~~~GT~~Y~APEvl~~~-------~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~ 147 (502)
...-..-|.-.-||||+.... --.++|.|+.|.+.||+++...||....+..--.....+..+| .++..+
T Consensus 404 y~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-alp~~v 482 (598)
T KOG4158|consen 404 YESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-ALPSRV 482 (598)
T ss_pred cccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-CCcccC
Confidence 111223477889999988632 2358999999999999999999997632221112234444554 445566
Q ss_pred CHHHHHHHHHhhc-CcCCCCCH
Q 010768 148 DAEARRFVGKCLE-NVSKRLPA 168 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa 168 (502)
++.++++|..+|+ +|++|++.
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCc
Confidence 8999999999999 99999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.9e-14 Score=143.64 Aligned_cols=169 Identities=21% Similarity=0.243 Sum_probs=124.8
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC----CcEEEEecCCce--ecc
Q 010768 3 TSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL----GQVKIGDLGLAA--ILR 74 (502)
Q Consensus 3 ~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~----g~vKL~DFGlA~--~~~ 74 (502)
.|-+|.++.+.. ++++...+..++.|++.+|++||+.| ++||||||+|+++.... ..+.|.|||+++ ...
T Consensus 103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~ 180 (322)
T KOG1164|consen 103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYV 180 (322)
T ss_pred cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCcccccc
Confidence 578999988665 57999999999999999999999999 99999999999997542 369999999998 321
Q ss_pred CCC--------C-cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHH--HHHHHcCCCCCC
Q 010768 75 GSQ--------H-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI--YKKVTSGKLPGA 142 (502)
Q Consensus 75 ~~~--------~-~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i--~~~i~~~~~p~~ 142 (502)
... . .....||..|+++.+..+ ..+.+.|+||++.++.+++.|..||......... ............
T Consensus 181 ~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T KOG1164|consen 181 GDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR 260 (322)
T ss_pred CCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc
Confidence 111 1 123569999999997664 5899999999999999999999999765432221 222222111111
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....+..+..+...+-. +...+|....+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 261 FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 233345667777666666 8888888776654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-15 Score=149.75 Aligned_cols=136 Identities=20% Similarity=0.263 Sum_probs=91.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcccccc-
Q 010768 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE- 96 (502)
Q Consensus 18 se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~- 96 (502)
.......+..|+++.+++||.+| |||+||||+|+|++.+ |.++|+||+......... .....+..|.+||+...
T Consensus 143 ~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~ 217 (288)
T PF14531_consen 143 AFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQD-GGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCA 217 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TT-S-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCC-CCEEEcChHHHeecCcee--eccCCCcccCChhhhhhh
Confidence 34445566699999999999999 9999999999999998 899999998876543321 21345678999996632
Q ss_pred --------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCC
Q 010768 97 --------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKR 165 (502)
Q Consensus 97 --------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kR 165 (502)
.++.+.|.|+||+++|.|++|..||........... .+. .-. ..++.++.||..+|. +|.+|
T Consensus 218 ~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 218 GQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 378899999999999999999999975321110000 111 111 457899999999999 99887
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.1e-14 Score=149.49 Aligned_cols=170 Identities=26% Similarity=0.406 Sum_probs=130.5
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--- 76 (502)
||.-|+|.+.+.. .-.++.-....++++|+.||+|||..-. .+|+.|+..|.+++.. ..+||.|||+.......
T Consensus 28 ~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~nClvd~~-w~lklt~~Gl~~~~~~~~~~ 105 (484)
T KOG1023|consen 28 YCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSNCLVDSR-WVLKLTDFGLNSLLEETAEP 105 (484)
T ss_pred eecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccccceeeee-EEEEechhhhcccccccccc
Confidence 6889999999987 4679999999999999999999998652 2999999999999998 69999999998766421
Q ss_pred CCcccccCCCcccCccccccc--------CCcccchhhhhHHHHHHhhccCCCCCC---CChHHHHHHHHcCCC----CC
Q 010768 77 QHAHSVIGTPEFMAPELYEED--------YNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKL----PG 141 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~~--------~s~ksDIwSLG~iLyeLLtG~~Pf~~~---~~~~~i~~~i~~~~~----p~ 141 (502)
.......-...|.|||++... .+.+.||||||++++|+++...||... ..+.++...+..+.. |.
T Consensus 106 ~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~ 185 (484)
T KOG1023|consen 106 EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPS 185 (484)
T ss_pred cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcc
Confidence 111112234579999988642 467899999999999999999999753 223456556655222 21
Q ss_pred Cccc-cCCHHHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 142 AFHR-IQDAEARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 142 ~~~~-~~s~~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
.... ...+.+..++..||. +|.+||+++++-
T Consensus 186 i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 186 IELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred hhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 1111 234578999999999 999999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.7e-13 Score=138.46 Aligned_cols=175 Identities=31% Similarity=0.558 Sum_probs=125.4
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+..|+|.+||++- ..+..+..++|+.||+.||.|||+..|+|+|+++.++.|++..+ |-+||+--........-
T Consensus 153 ymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~ 231 (458)
T KOG1266|consen 153 YMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSV 231 (458)
T ss_pred cccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCC-ceEEecccCccccchhh
Confidence 78899999999864 45899999999999999999999999999999999999999966 77776543222111100
Q ss_pred -----CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHH
Q 010768 77 -----QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 77 -----~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
.......+.++|.+||.-. .+.+.++|||+||++.++|..++.--.+..........+.. .........
T Consensus 232 ~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~l 306 (458)
T KOG1266|consen 232 NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENGL 306 (458)
T ss_pred hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCcc
Confidence 0111234678999999654 45777899999999999999987653332111111111111 111122334
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
-+.+|.+||+ .|..||++.++|.||.+-...
T Consensus 307 qr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 307 QRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 5778999999 999999999999999886543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.5e-14 Score=153.94 Aligned_cols=176 Identities=30% Similarity=0.422 Sum_probs=139.8
Q ss_pred CCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCceecccccCcEEEeCCCC-cEEEEecCCceeccC-
Q 010768 1 MFTSGTLREYR-KKYT-RVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLG-QVKIGDLGLAAILRG- 75 (502)
Q Consensus 1 y~~gGsL~~~L-~k~~-~Lse~~i~~i~~QIl~aL~yLH-s~g~~IIHRDLKPeNILld~~~g-~vKL~DFGlA~~~~~- 75 (502)
|..||++.+-+ .... ..+...+..++.|+..+|.|+| ..+ +.||||||+|.+++.. + .+|++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCchhhcccccc
Confidence 35678888887 4444 6788888999999999999999 888 9999999999999987 6 899999999987654
Q ss_pred CC---CcccccC-CCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--CCCCccccC
Q 010768 76 SQ---HAHSVIG-TPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQ 147 (502)
Q Consensus 76 ~~---~~~~~~G-T~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~ 147 (502)
.. .....+| ++.|+|||...+ ...+..|+||+|+++..+++|..|+.........+....... .....+...
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 22 2234578 999999998876 468899999999999999999999976443333222222221 123344556
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
+.....++.+++. +|..|.+..++..+||+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 7888999999997 9999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-12 Score=126.37 Aligned_cols=165 Identities=20% Similarity=0.314 Sum_probs=125.4
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC-CcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~-g~vKL~DFGlA~~~~~~~ 77 (502)
|+.-|+|...+..... ++..++.+++.+|++|++|||+..+-|.---|....++|+.+. .++..+|--++.+.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence 6788999999987654 7888999999999999999999975455557888899998763 23444554333221
Q ss_pred CcccccCCCcccCccccccc----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
......|.||+||.+..+ --.++|+|||++++|||.|.+.||.+....+.-.+....|-.+ ..+...+..+..
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~k 420 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNK 420 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHH
Confidence 122347899999988643 3457999999999999999999998866655555555555444 444556788999
Q ss_pred HHHHhhc-CcCCCCCHHHHh
Q 010768 154 FVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL 172 (502)
++.-|+. ||.+||.+..++
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 9999999 999999987664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-11 Score=125.09 Aligned_cols=134 Identities=23% Similarity=0.402 Sum_probs=107.5
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC----CCCcEEEEecCCceeccCCC
Q 010768 3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG----HLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 3 ~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~----~~g~vKL~DFGlA~~~~~~~ 77 (502)
-|-+|.++..-. .+|+.+.+..++.|++.-++|+|++. +|.|||||+|+||.. +...|.|+|||+|+...+..
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 467788887654 45999999999999999999999999 999999999999953 22478999999999875432
Q ss_pred C--------cccccCCCcccCccc-ccccCCcccchhhhhHHHHHHhhccCCCCCC--CChHHHHHHHHcCC
Q 010768 78 H--------AHSVIGTPEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGK 138 (502)
Q Consensus 78 ~--------~~~~~GT~~Y~APEv-l~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--~~~~~i~~~i~~~~ 138 (502)
. ..+..||..||+--- +...-+...|+=|||-++++.|.|..||.+. .+..+-+++|...+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 2 234679999998763 3445788899999999999999999999874 34556666665544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.2e-12 Score=122.69 Aligned_cols=113 Identities=19% Similarity=0.158 Sum_probs=84.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccc-ccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDL-KCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDL-KPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.|++|.+.+.. ....++.|++.+|.++|.+| |+|||| ||+|||++.+ +.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchH
Confidence 4678888654322 12457899999999999999 999999 7999999876 79999999999865433211
Q ss_pred --------------ccccCCCcccCccccc--ccCC-cccchhhhhHHHHHHhhccCCCCC
Q 010768 80 --------------HSVIGTPEFMAPELYE--EDYN-ELVDIYSFGMCVLEMLTSEYPYSE 123 (502)
Q Consensus 80 --------------~~~~GT~~Y~APEvl~--~~~s-~ksDIwSLG~iLyeLLtG~~Pf~~ 123 (502)
.-...++.|+.|+... ...+ ...+.++.|+-+|.++|+..++.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 1123578888887432 2233 567888999999999999988754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.8e-12 Score=132.61 Aligned_cols=95 Identities=20% Similarity=0.274 Sum_probs=72.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccc-ccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDL-KCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDL-KPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||.|++|... .. .. ...|+.|++.||.|||++| |+|||| ||+|||++.+ +.+||+|||+|+.+.....
T Consensus 99 ~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~~~~~ 168 (365)
T PRK09188 99 WTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFRRRGAL 168 (365)
T ss_pred ccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECccceecccCcch
Confidence 6789999732 11 11 2568999999999999999 999999 9999999876 7899999999987643321
Q ss_pred --------cccccCCCcccCccccccc-------CCcccchh
Q 010768 79 --------AHSVIGTPEFMAPELYEED-------YNELVDIY 105 (502)
Q Consensus 79 --------~~~~~GT~~Y~APEvl~~~-------~s~ksDIw 105 (502)
.....+++.|+|||.+... .+...|-|
T Consensus 169 ~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 169 YRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 1345688899999988532 33446666
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-11 Score=141.16 Aligned_cols=118 Identities=24% Similarity=0.276 Sum_probs=102.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC------CCCcEEEEecCCceec-
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG------HLGQVKIGDLGLAAIL- 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~------~~g~vKL~DFGlA~~~- 73 (502)
|..-|||.+++...+.+++..+..+..|++..|+.||.++ |||+||||+|+||.. +..-++|+|||.+.-+
T Consensus 775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 5678999999998889999999999999999999999999 999999999999953 2246999999998543
Q ss_pred --cCCCCcccccCCCcccCccccccc-CCcccchhhhhHHHHHHhhccCC
Q 010768 74 --RGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120 (502)
Q Consensus 74 --~~~~~~~~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG~~P 120 (502)
.........++|-.+-.+|+..|. ++..+|.|.|+.+++-||.|++-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 344455667889999999999865 89999999999999999999853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-11 Score=137.49 Aligned_cols=185 Identities=25% Similarity=0.414 Sum_probs=151.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc------
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR------ 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~------ 74 (502)
|+.||+|...+...+..+++-++.++..+..+++|||... ++|||++|.|+++..+ +..++.+||......
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccCcC
Confidence 4567899999988888999999999999999999999987 9999999999999877 799999998432210
Q ss_pred CC--------------------------CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh
Q 010768 75 GS--------------------------QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP 127 (502)
Q Consensus 75 ~~--------------------------~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~ 127 (502)
.. .......||+.|.+||...+ .....+|+|++|+++++.++|.+||.. ..+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cch
Confidence 00 01234678999999997754 578889999999999999999999976 677
Q ss_pred HHHHHHHHcCCCCCCc-cccCCHHHHHHHHHhhc-CcCCCCCHH---HHhcCccccCCCCCCCCCCC
Q 010768 128 AQIYKKVTSGKLPGAF-HRIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLASDAGEPLLIPK 189 (502)
Q Consensus 128 ~~i~~~i~~~~~p~~~-~~~~s~~l~~LI~kcL~-dP~kRpsa~---ElL~hpf~~~~~~~~l~~p~ 189 (502)
.++++.+..+..+... +...+..+++++.++|. ++.+|..+. ++-.|+||+..+|..+....
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 8888888877665432 33458899999999998 999999988 89999999999998765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.8e-11 Score=118.23 Aligned_cols=163 Identities=21% Similarity=0.325 Sum_probs=119.8
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCCCC-
Q 010768 3 TSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 3 ~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~~~- 78 (502)
-|.+|.++..-. .+++.+.++-++-|++.-++|+|.++ +|||||||+|+|..- ...++.|+|||+|+...+...
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 467788877643 56999999999999999999999999 999999999999853 335799999999987643211
Q ss_pred -------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCCC---ccc
Q 010768 79 -------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPGA---FHR 145 (502)
Q Consensus 79 -------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~~---~~~ 145 (502)
.....||..|++--...+ ..+...|+-|+|.+|.++..|..||.+.. ...+-+++|.+.+.... +-.
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 134568999998764443 46778899999999999999999998743 33455666665544322 223
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCC
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLP 167 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRps 167 (502)
..+.++...+.-|-. --.+-|.
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCc
Confidence 346677777776655 4444444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.2e-11 Score=115.19 Aligned_cols=69 Identities=16% Similarity=0.189 Sum_probs=60.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYL-HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yL-Hs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.|++|...+.+.+.+++..++.++.||+.+|.|| |+.| |+||||||+|||++. +.++|+|||+|...
T Consensus 98 ~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~--~~v~LiDFG~a~~~ 167 (190)
T cd05147 98 FIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD--GKLYIIDVSQSVEH 167 (190)
T ss_pred EeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC--CcEEEEEccccccC
Confidence 567777776655567899999999999999999999 6888 999999999999984 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=8e-11 Score=111.90 Aligned_cols=71 Identities=20% Similarity=0.192 Sum_probs=59.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
|+.|+++...+.....++...+..++.|++.+|.++|+ +| |+||||||+|||++ + +.++|+|||++.....
T Consensus 98 ~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~-~~~~liDFG~a~~~~~ 169 (190)
T cd05145 98 FIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D-GKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C-CCEEEEEcccceecCC
Confidence 46677655443345678999999999999999999999 89 99999999999998 4 7999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=114.65 Aligned_cols=93 Identities=19% Similarity=0.221 Sum_probs=69.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|++|.+|.++. .+++ ..+.+|+.+|..||.+| ++||||||.||+++.+ | ++|+|||............
T Consensus 124 yi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i~liDfg~~~~~~e~~a~d 191 (232)
T PRK10359 124 YIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-LRIIDLSGKRCTAQRKAKD 191 (232)
T ss_pred EECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-EEEEECCCcccccchhhHH
Confidence 56788998873 2333 24669999999999999 9999999999999876 6 9999999886543211110
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEML 115 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLL 115 (502)
. =++...|+.++|+|+||+++..+.
T Consensus 192 ~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 192 R----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred H----------HHHHhHhcccccccceeEeehHHH
Confidence 0 022345778999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.8e-10 Score=121.03 Aligned_cols=173 Identities=23% Similarity=0.300 Sum_probs=138.0
Q ss_pred CCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 3 TSGTLREYRKKYTR-VDIRAVKNWARQILR----GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 3 ~gGsL~~~L~k~~~-Lse~~i~~i~~QIl~----aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
.+.+|.+|...... ++...++..+.+... ||..+|+.+ ++|-|+||+||+...+....+++|||+...+....
T Consensus 200 ~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~ 277 (524)
T KOG0601|consen 200 CGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGN 277 (524)
T ss_pred ccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEccCCc
Confidence 45778888876555 899999999999999 999999999 99999999999998875689999999998876544
Q ss_pred Cc------ccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 78 HA------HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 78 ~~------~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
.. ....|...|++||+.++-++...|||++|.++.+..++..++....+. .+..+..+.++..+-...+..+
T Consensus 278 ~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~~~~~s~~l 355 (524)
T KOG0601|consen 278 FSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEFCEGGSSSL 355 (524)
T ss_pred cccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhhhcCcchhh
Confidence 22 122577889999999999999999999999999999987665442111 1233334445545554556677
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
...+..|+. ++..|++++.++.++++..
T Consensus 356 ~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 356 RSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 778888998 9999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.3e-09 Score=103.25 Aligned_cols=64 Identities=23% Similarity=0.205 Sum_probs=51.6
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceecccccCcEEEeCC---CCcEEEEecCCc
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGI-AYLHGHDPPVIHRDLKCDNIFVNGH---LGQVKIGDLGLA 70 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL-~yLHs~g~~IIHRDLKPeNILld~~---~g~vKL~DFGlA 70 (502)
+.+|||.+++++. .+++. ..++.|++.++ +|||+++ ||||||||+|||++.. ...++|+||+.+
T Consensus 89 ~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 89 KPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3469999999774 57666 36688888888 9999999 9999999999999742 247999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.2e-09 Score=103.51 Aligned_cols=70 Identities=24% Similarity=0.236 Sum_probs=59.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.|++|..+......+....+..++.||+.+|.+||.+| .|+||||||+||+++ + +.++|+|||.+...
T Consensus 129 ~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~~ 198 (237)
T smart00090 129 FIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-D-GKVVIIDVSQSVEL 198 (237)
T ss_pred EecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-C-CCEEEEEChhhhcc
Confidence 4677788776655566777788999999999999999876 499999999999998 4 68999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.73 E-value=2e-08 Score=99.47 Aligned_cols=63 Identities=21% Similarity=0.270 Sum_probs=53.4
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 2 FTS-GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 2 ~~g-GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++| ++|.+++.+ ..+++.. +.||+.+|.+||.+| |+||||||.|||++.+ +.++|+|||.+..
T Consensus 128 l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 128 IEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEECCCccc
Confidence 565 699999865 4566543 578999999999999 9999999999999876 6899999998865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-08 Score=112.70 Aligned_cols=154 Identities=18% Similarity=0.254 Sum_probs=110.3
Q ss_pred HHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc----------ccccCCCcccCccccc
Q 010768 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA----------HSVIGTPEFMAPELYE 95 (502)
Q Consensus 26 ~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~----------~~~~GT~~Y~APEvl~ 95 (502)
+.++..||.|+|.+ +++||+.|.|++|.++.+ +..||+.|+++....+.... ....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45666899999976 459999999999999998 89999999998655432111 0112356799999876
Q ss_pred c-cCCcccchhhhhHHHHHHh-hccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHHHHHHHHhhc-CcCCCCCHHHH
Q 010768 96 E-DYNELVDIYSFGMCVLEML-TSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARRFVGKCLE-NVSKRLPAKEL 171 (502)
Q Consensus 96 ~-~~s~ksDIwSLG~iLyeLL-tG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~El 171 (502)
+ ..+.++|+||+|+++|.+. .|+.-+................... .......+.++++-+.++|. ++..||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 5 4788999999999999999 5665554422221111111112111 12234567899999999999 99999999999
Q ss_pred hcCccccCCC
Q 010768 172 LLDPFLASDA 181 (502)
Q Consensus 172 L~hpf~~~~~ 181 (502)
+..|||....
T Consensus 263 ~~~~ff~D~~ 272 (700)
T KOG2137|consen 263 LSIPFFSDPG 272 (700)
T ss_pred hcccccCCch
Confidence 9999997653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-08 Score=95.04 Aligned_cols=64 Identities=25% Similarity=0.400 Sum_probs=56.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.|++|.+++..... .+..++.+|+.+|.++|+.+ ++|||++|.|||++ + +.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 5789999999876432 88899999999999999999 99999999999998 3 6899999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=98.85 Aligned_cols=157 Identities=18% Similarity=0.280 Sum_probs=116.3
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCc
Q 010768 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAP 91 (502)
Q Consensus 12 ~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~AP 91 (502)
+.+...++..+.+.++.|+.+.+-||.+| .+-+|++++|+||..+ +.|.|.|-..-.....+......+|.+.|.+|
T Consensus 109 qs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPP 185 (637)
T COG4248 109 QSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGTLHLCPVGVSEFTPP 185 (637)
T ss_pred ccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-ceEEEEcccceeeccCCceEecccCccccCCH
Confidence 34456899999999999999999999999 9999999999999887 79999986654444444445567899999999
Q ss_pred cccc-c-----cCCcccchhhhhHHHHHHhhc-cCCCCCCCC----hHHHHHHHHc-----------CCCC---CCcccc
Q 010768 92 ELYE-E-----DYNELVDIYSFGMCVLEMLTS-EYPYSECSN----PAQIYKKVTS-----------GKLP---GAFHRI 146 (502)
Q Consensus 92 Evl~-~-----~~s~ksDIwSLG~iLyeLLtG-~~Pf~~~~~----~~~i~~~i~~-----------~~~p---~~~~~~ 146 (502)
|.-. + ..+...|.|.||++++++|.| +.||.+... +.-....|.. +..| .+....
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~ 265 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSM 265 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhh
Confidence 9654 2 356789999999999999986 999976311 0011112222 2222 123345
Q ss_pred CCHHHHHHHHHhhc---CcCCCCCHHHH
Q 010768 147 QDAEARRFVGKCLE---NVSKRLPAKEL 171 (502)
Q Consensus 147 ~s~~l~~LI~kcL~---dP~kRpsa~El 171 (502)
.++.++.+..+|+. ++.-||+++.-
T Consensus 266 Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 266 LPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred cCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 68889999999997 35689997653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.1e-08 Score=95.50 Aligned_cols=65 Identities=23% Similarity=0.190 Sum_probs=53.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.|++|...... .....++.+|+.++.++|..| |+||||||+||+++.+ +.++|+|||++....
T Consensus 112 ~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~-~~~~liDfg~~~~~~ 176 (198)
T cd05144 112 YIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD-EKIYIIDWPQMVSTD 176 (198)
T ss_pred EeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC-CcEEEEECCccccCC
Confidence 4677787765421 345678999999999999999 9999999999999876 799999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.7e-08 Score=93.26 Aligned_cols=61 Identities=25% Similarity=0.377 Sum_probs=53.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.|++|.+++..... .++.||+.+|.+||+.| ++|||++|.||+++ + +.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 4689999998866432 78999999999999999 99999999999998 4 7999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.3e-08 Score=107.11 Aligned_cols=61 Identities=21% Similarity=0.334 Sum_probs=54.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.|++|.+++. ....++.||+.+|.|||++| |+||||||+|||++ + +.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence 678999999986 35778999999999999999 99999999999994 3 68999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-07 Score=88.78 Aligned_cols=52 Identities=29% Similarity=0.294 Sum_probs=46.7
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 20 RAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 20 ~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
.+++.++.+++.++.++|. ++ |+||||||+||+++ + +.++|+|||.+.....
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~-~~~~liDfg~a~~~~~ 166 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D-GKVYIIDVPQAVEIDH 166 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C-CcEEEEECcccccccC
Confidence 6788999999999999999 88 99999999999999 4 7999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.2e-08 Score=104.90 Aligned_cols=167 Identities=20% Similarity=0.201 Sum_probs=121.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.++++...+.-...+++...+.+..|++.++.++|+.. ++|+|+||+||++..+.+..+++|||.+..+.-. ..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~ 422 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SG 422 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee--cc
Confidence 6788888888866667999999999999999999999998 9999999999999876568899999998642211 11
Q ss_pred cccCCCccc-Ccccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 81 SVIGTPEFM-APELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 81 ~~~GT~~Y~-APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.....-++. ..|++.. .+..++|+++||..+.+.+++..--.. ......+..+..+.... . ...+..+.+.
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~~~p~~~~-~-~~~~q~~~kv 496 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSGDTPNLPG-L-KLQLQVLLKV 496 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecccccCCCc-h-HHhhhhhhhh
Confidence 122333444 3555443 478899999999999999998643222 12233445555543222 1 2566777777
Q ss_pred hhc-CcCCCCCHHHHhcCccc
Q 010768 158 CLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~ 177 (502)
++. ++..|+.+.++..|.-|
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hcCCccccchhhhhhcccchh
Confidence 877 89999999998877654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.4e-07 Score=79.08 Aligned_cols=54 Identities=26% Similarity=0.220 Sum_probs=46.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCC-CCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 18 DIRAVKNWARQILRGIAYLHGHD-PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 18 se~~i~~i~~QIl~aL~yLHs~g-~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+......++.+++.+|+++|... .+++|+||+|.||+++.. +.++++|||.+..
T Consensus 84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 45677888999999999999852 239999999999999985 7999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.08 E-value=7e-06 Score=79.29 Aligned_cols=56 Identities=21% Similarity=0.253 Sum_probs=48.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHH-HhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 15 TRVDIRAVKNWARQILRGIAYL-HGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 15 ~~Lse~~i~~i~~QIl~aL~yL-Hs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
..++...+..++.|++.+|..| |..| |||+||++.||++.. +.+.|+|||.+....
T Consensus 119 ~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 119 AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEC--CcEEEEECCCceeCC
Confidence 3466677788899999999999 8888 999999999999974 589999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.2e-05 Score=73.70 Aligned_cols=48 Identities=21% Similarity=0.250 Sum_probs=40.2
Q ss_pred HHHHHHHHHHHHHHHhCCC---CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 23 KNWARQILRGIAYLHGHDP---PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 23 ~~i~~QIl~aL~yLHs~g~---~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
..++.+++.+|..||..+. .++|+|++|.||+++ + +.++|+|||.+..
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~ 136 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence 4567899999999999871 249999999999998 3 5899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.4e-05 Score=77.92 Aligned_cols=65 Identities=18% Similarity=0.205 Sum_probs=55.4
Q ss_pred CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC------CCCcEEEEecCCcee
Q 010768 6 TLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG------HLGQVKIGDLGLAAI 72 (502)
Q Consensus 6 sL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~------~~g~vKL~DFGlA~~ 72 (502)
+|.+++.. ....+......++.+|+..+.-||.+| |+|+||++.|||++. +...+.|+||+.+..
T Consensus 122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 78999864 345677788899999999999999999 999999999999975 235899999998854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.86 E-value=3.1e-05 Score=74.86 Aligned_cols=67 Identities=25% Similarity=0.312 Sum_probs=58.7
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceec
Q 010768 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAIL 73 (502)
Q Consensus 5 GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~ 73 (502)
-+|.+++.....++......++.+|+..+.-||.+| |+|+|+++.|||++.+. ..+.|+||+.+...
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 103 QDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred ccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 479999988666888889999999999999999999 99999999999998762 27899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.8e-05 Score=83.84 Aligned_cols=68 Identities=24% Similarity=0.278 Sum_probs=52.2
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILR-GIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~-aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.|++|.++.... ..++ ...++.+++. .+..+|..| ++|+|+||.||+++.+ +.++|+|||++..+.
T Consensus 239 ~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 239 WIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 57899998887532 1222 3345666655 478889999 9999999999999877 799999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=4e-05 Score=73.26 Aligned_cols=61 Identities=23% Similarity=0.392 Sum_probs=50.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|..|-.|++++... ...+++.|-.-+.-||..| |||+||.++||++.+. .+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence 45677788888765 2556777888888999999 9999999999999875 599999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00012 Score=70.12 Aligned_cols=66 Identities=27% Similarity=0.435 Sum_probs=53.3
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcE--EEEecCCcee
Q 010768 5 GTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV--KIGDLGLAAI 72 (502)
Q Consensus 5 GsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~v--KL~DFGlA~~ 72 (502)
-++.+|+...- ....+....++++|-+.|.-||.++ |||+||..+||++..+.+.+ .|+|||++..
T Consensus 96 ~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 96 STVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 38889987642 2333444788999999999999999 99999999999998765444 8999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00019 Score=79.48 Aligned_cols=105 Identities=25% Similarity=0.342 Sum_probs=73.7
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-cccccCC
Q 010768 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGT 85 (502)
Q Consensus 7 L~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-~~~~~GT 85 (502)
|..++++. ....+..-+.||+.||.|||..+ .++|++|..+.|+|+.. |..||++|.++....+... .....--
T Consensus 94 l~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~ 168 (690)
T KOG1243|consen 94 LETVLKEL---GKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLI 168 (690)
T ss_pred HHHHHHHh---HHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhh
Confidence 34444443 36677778999999999998442 39999999999999998 8999999998865443221 1111112
Q ss_pred CcccCcccccccCCcccchhhhhHHHHHHhhc
Q 010768 86 PEFMAPELYEEDYNELVDIYSFGMCVLEMLTS 117 (502)
Q Consensus 86 ~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG 117 (502)
-.|..|+.+... .-..|.|-|||++++++.|
T Consensus 169 ~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 235555533211 1346999999999999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00022 Score=83.09 Aligned_cols=168 Identities=23% Similarity=0.344 Sum_probs=119.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccC---cEEEeCCCCcEEEE--ecCCceeccC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCD---NIFVNGHLGQVKIG--DLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPe---NILld~~~g~vKL~--DFGlA~~~~~ 75 (502)
+|.+-++...++..+.++...++.+..+++.||.|+|+.. +.|.-|... +--+++. +.+.+. ||+.......
T Consensus 267 ~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 267 ICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred hcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCC
Confidence 4677788888888899999999999999999999999986 666555544 2333333 455665 8888776655
Q ss_pred CCCcccccCCCcccCccccccc---CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 76 SQHAHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~~~---~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
........-+..+.++|....+ .....|+|.+|.....+..|..+-..... ...+. .........
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~----~~~~l--------~~~~~~~~~ 411 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV----PVSLL--------DVLSTSELL 411 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc----hhhhh--------ccccchhhh
Confidence 5544555566778888877654 33346999999999999988755322111 11111 111112567
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
+++.+|+. ++++|+.+.+++.|+|++.....
T Consensus 412 d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 412 DALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred hhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 88889998 99999999999999999875543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00013 Score=80.43 Aligned_cols=65 Identities=20% Similarity=0.253 Sum_probs=49.8
Q ss_pred CCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC----cEEEEecCCc
Q 010768 1 MFTSGTLREY--RKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----QVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~--L~k~~----~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g----~vKL~DFGlA 70 (502)
|+.|+.|.++ +.+.+ .+.+..+..++.||+. .| ++|+|+||.||+++.+ + .++++|||++
T Consensus 242 ~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~G--ffHaDpHPGNIlv~~~-g~~~~~i~llDFGiv 311 (537)
T PRK04750 242 RMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------DG--FFHADMHPGNIFVSYD-PPENPRYIALDFGIV 311 (537)
T ss_pred eecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------CC--eeeCCCChHHeEEecC-CCCCCeEEEEecceE
Confidence 6789999875 33433 3556666667777653 67 9999999999999876 5 8999999999
Q ss_pred eeccC
Q 010768 71 AILRG 75 (502)
Q Consensus 71 ~~~~~ 75 (502)
..+..
T Consensus 312 g~l~~ 316 (537)
T PRK04750 312 GSLNK 316 (537)
T ss_pred EECCH
Confidence 87643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0024 Score=69.27 Aligned_cols=132 Identities=15% Similarity=0.262 Sum_probs=94.3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcccc
Q 010768 15 TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELY 94 (502)
Q Consensus 15 ~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl 94 (502)
.+.++..+|.++.||..||.++|+.| +.-+-|.|.+||++++. +++|...|....+..... |-+
T Consensus 388 ~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~~-------------~~l 451 (655)
T KOG3741|consen 388 LKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDPT-------------EPL 451 (655)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccceeeecCCCC-------------cch
Confidence 45889999999999999999999999 88899999999999984 888888887766544320 111
Q ss_pred cccCCcccchhhhhHHHHHHhhccCCCCCCCChHHH-HHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 95 EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQI-YKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 95 ~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i-~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
. --.+-|.-.||.+++.|.||..--.......+. .+. .....+.+++++|.-+.. ++.+ -++.+++
T Consensus 452 e--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 452 E--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred h--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 1 123458889999999999996432221222222 222 223457788889888877 6665 6777777
Q ss_pred cC
Q 010768 173 LD 174 (502)
Q Consensus 173 ~h 174 (502)
.+
T Consensus 520 p~ 521 (655)
T KOG3741|consen 520 PM 521 (655)
T ss_pred HH
Confidence 43
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0014 Score=64.10 Aligned_cols=65 Identities=11% Similarity=0.119 Sum_probs=55.7
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc--EEEEecCCcee
Q 010768 5 GTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLAAI 72 (502)
Q Consensus 5 GsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~--vKL~DFGlA~~ 72 (502)
-+|.+++.+. .+.+......++.+|+..|.-||..| +.|+|+-+.|||++.. +. ++++||.-++.
T Consensus 111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 5788888663 45688888999999999999999999 9999999999999855 45 99999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0019 Score=61.97 Aligned_cols=52 Identities=33% Similarity=0.360 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHHH-HHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 19 IRAVKNWARQILRGIAY-LHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 19 e~~i~~i~~QIl~aL~y-LHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+|||.+....
T Consensus 105 ~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 105 PEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYIIDFGQAVDSS 157 (188)
T ss_dssp GSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE--GTTEEETT
T ss_pred chhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEEEecCcceecC
Confidence 34566778888885555 57888 9999999999999875 89999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0013 Score=62.32 Aligned_cols=31 Identities=23% Similarity=0.358 Sum_probs=25.8
Q ss_pred CceecccccCcEEEeCC-CCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~ 72 (502)
.++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus 175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 37999999999999883 25689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0008 Score=80.36 Aligned_cols=172 Identities=13% Similarity=0.057 Sum_probs=117.1
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGH---DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~---g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.+|.+.+.|-+. ..++..-+.....+.+.+..-+|+. |--.+|++||+-|.+|..+ ..+|++++|+.++.
T Consensus 1312 ~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIk 1390 (2724)
T KOG1826|consen 1312 YVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIK 1390 (2724)
T ss_pred HHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC-Cccccccccccccc
Confidence 46678888888653 4466666766677767777777754 2347999999999999988 48999999999833
Q ss_pred -cCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC----CCCccccC
Q 010768 74 -RGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL----PGAFHRIQ 147 (502)
Q Consensus 74 -~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~----p~~~~~~~ 147 (502)
.........++++.|+.|++.+. .++.++|+|..|+-+|.+..|..+|-. ..+.+..+.. ....+...
T Consensus 1391 np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~------flq~~Lkgiidn~tf~sIe~l~ 1464 (2724)
T KOG1826|consen 1391 NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF------FLQPALKGIIDNHTFFSIEKLK 1464 (2724)
T ss_pred CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH------HHHHHHcCcccccccccccccC
Confidence 33334456778899999998865 577779999999999999988877632 2233333332 22233333
Q ss_pred CHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
+.++......+|- .-..||.-...+.-+.+..
T Consensus 1465 pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1465 PGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred CCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 3333333333333 5567888888877666643
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0061 Score=43.08 Aligned_cols=32 Identities=38% Similarity=0.560 Sum_probs=26.4
Q ss_pred eEEEEEEEcCCC------CeeeeecCCCCCcccHHHHH
Q 010768 234 IFLKVQITDKDG------QARNIYFPYDIFNDTATEVA 265 (502)
Q Consensus 234 i~L~l~i~d~~g------~~r~i~f~f~~~~Dt~~~Va 265 (502)
|.|+||+.|+.+ +...|+|.|++..|++.+||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 578999999988 78899999999999999997
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.0073 Score=59.55 Aligned_cols=44 Identities=27% Similarity=0.366 Sum_probs=37.6
Q ss_pred HHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 25 i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+...|.+++.-||..| ++|+|..|.|++++.+ .++++||+..+.
T Consensus 140 ~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEEEECccccc
Confidence 4566778899999999 9999999999999865 699999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0026 Score=70.49 Aligned_cols=152 Identities=21% Similarity=0.242 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCccccc-cc
Q 010768 19 IRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-ED 97 (502)
Q Consensus 19 e~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~-~~ 97 (502)
.-+...+++.-+.+|+++|+.- -+|+| ||+... +..|+.+|+....+.......+..+++.++|||+.. +.
T Consensus 335 ~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~ 406 (829)
T KOG0576|consen 335 QYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT 406 (829)
T ss_pred hhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccCCcccCcccccccCCCCCCCCCchhhcccc
Confidence 3345556677778999999864 48888 888765 589999999998887766677889999999999665 56
Q ss_pred CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHHH-HHHHHHhhc-CcCCCCCHHHHhc
Q 010768 98 YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEA-RRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 98 ~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l-~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+....|.|++|.-..+|.-|.+|-... ......+..+.-...+. ....+.. +++...|+. -|..|+....++.
T Consensus 407 ~~~~p~~~~~~~~~~~~ap~~pPr~~P---~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacf 483 (829)
T KOG0576|consen 407 IDGCPDSGSLAVSAIQMAPGLPPRSSP---PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACF 483 (829)
T ss_pred cccCCCccCCCcchhhcCCCCCCCCCC---ccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHH
Confidence 999999999998878888887775431 10011111111000000 0011111 247778888 8999999999999
Q ss_pred CccccCCC
Q 010768 174 DPFLASDA 181 (502)
Q Consensus 174 hpf~~~~~ 181 (502)
|.+|..-+
T Consensus 484 sKvfngCp 491 (829)
T KOG0576|consen 484 SKVFNGCP 491 (829)
T ss_pred HHHhccCc
Confidence 99997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.067 Score=54.37 Aligned_cols=51 Identities=22% Similarity=0.259 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 19 IRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 19 e~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.+....++..|+.-+.-+-..| |||+|+.+-||+++.+ |.+.++||--+..
T Consensus 201 ~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d-g~~~vIDwPQ~v~ 251 (304)
T COG0478 201 VENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED-GDIVVIDWPQAVP 251 (304)
T ss_pred ccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC-CCEEEEeCccccc
Confidence 4455556666666666555677 9999999999999997 7999999976543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.15 Score=48.79 Aligned_cols=58 Identities=22% Similarity=0.112 Sum_probs=48.8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCC-CceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 15 TRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 15 ~~Lse~~i~~i~~QIl~aL~yLHs~g~-~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
-.-++..+.+++.+++..+.+|+..-. .+.-.|++++|+-++.+ +.+|++|...+...
T Consensus 54 ~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 54 LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 346899999999999999999997311 28889999999999977 79999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.98 E-value=0.28 Score=49.66 Aligned_cols=31 Identities=23% Similarity=0.258 Sum_probs=26.4
Q ss_pred CCceecccccCcEEEeCC---CCcEEEEecCCce
Q 010768 41 PPVIHRDLKCDNIFVNGH---LGQVKIGDLGLAA 71 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~---~g~vKL~DFGlA~ 71 (502)
..++|+|+.+.||+++.+ .+.+.|+||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 458999999999999873 3589999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.32 Score=48.95 Aligned_cols=53 Identities=21% Similarity=0.306 Sum_probs=43.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 18 DIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 18 se~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
..+++..+..++++.+.-|-. .+ +||+||..-|||+.. +.+.|+|||-|....
T Consensus 164 e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~~--~~p~iID~~QaV~~~ 217 (268)
T COG1718 164 ELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVHD--GEPYIIDVSQAVTID 217 (268)
T ss_pred CchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEEC--CeEEEEECccccccC
Confidence 334677888889888887776 67 999999999999983 689999999886553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=91.73 E-value=0.3 Score=46.16 Aligned_cols=32 Identities=38% Similarity=0.471 Sum_probs=21.3
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
..++|+|+.|.|||++...+.+-|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 34999999999999994335678999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.52 E-value=0.25 Score=47.84 Aligned_cols=30 Identities=33% Similarity=0.333 Sum_probs=25.8
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
.++|+|+.+.|||+++..+.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 499999999999999733579999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=91.17 E-value=0.22 Score=48.58 Aligned_cols=30 Identities=23% Similarity=0.303 Sum_probs=24.6
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+.+.||++++. +..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 38999999999999865 3456999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=91.05 E-value=0.49 Score=46.47 Aligned_cols=31 Identities=26% Similarity=0.424 Sum_probs=26.0
Q ss_pred CCCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 39 HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 39 ~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
..+.++|+|+.|.||+++++ + +.|+||+.+.
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred CCCceEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 33458999999999999876 5 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=90.42 E-value=0.42 Score=48.70 Aligned_cols=30 Identities=33% Similarity=0.421 Sum_probs=25.6
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
.+++|+|+.+.||+++++ +.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 349999999999999886 556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.36 E-value=0.53 Score=47.96 Aligned_cols=29 Identities=34% Similarity=0.408 Sum_probs=24.4
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
++||+|+.|.||+++++ ...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 49999999999999865 345799999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.27 E-value=0.59 Score=47.17 Aligned_cols=29 Identities=21% Similarity=0.353 Sum_probs=24.7
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 34999999999999987 468999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.21 E-value=0.66 Score=49.27 Aligned_cols=84 Identities=20% Similarity=0.322 Sum_probs=56.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcccccc
Q 010768 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE 96 (502)
Q Consensus 17 Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~ 96 (502)
-..+++..++.+.+..|.-+... .+.-||++.-.||||+ + |+|.|+||-+++.-.... .+-....--|-.+.|
T Consensus 318 ~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~-GnvtLIDfklsRl~~~q~----~isy~rldhp~lF~G 390 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-E-GNVTLIDFKLSRLSYSQG----IISYNRLDHPDLFNG 390 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-c-CceEEEEeeeeecccCCc----eeeccccCchhhhcC
Confidence 45678888898888777766654 5689999999999999 4 899999999998432211 111222333444555
Q ss_pred cCCcccchhhh
Q 010768 97 DYNELVDIYSF 107 (502)
Q Consensus 97 ~~s~ksDIwSL 107 (502)
.-+..-+||-+
T Consensus 391 ~dd~QFeIYrl 401 (488)
T COG5072 391 VDDYQFEIYRL 401 (488)
T ss_pred ccceeeeHHHH
Confidence 54555566653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.65 E-value=0.59 Score=51.71 Aligned_cols=68 Identities=18% Similarity=0.265 Sum_probs=43.5
Q ss_pred CCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 2 FTSGTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 2 ~~gGsL~~~--L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
+.|--+.+. +++ ..++.+.+...+.++.- .-+=..| ++|.|..|.||+++.+ |++.+.|||+...+..
T Consensus 248 i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 248 IDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred eCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 445555555 333 34554444333333221 1222257 9999999999999998 8999999999876643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=88.57 E-value=0.57 Score=48.95 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=26.6
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+++.||+++...+.+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 4899999999999986546899999988753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=88.40 E-value=0.65 Score=46.67 Aligned_cols=29 Identities=34% Similarity=0.449 Sum_probs=24.9
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
.++|+|+.|.||+++++ +.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 49999999999999875 456899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.14 E-value=0.73 Score=46.68 Aligned_cols=54 Identities=19% Similarity=0.283 Sum_probs=40.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 18 DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 18 se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+...+...+..+-.++.-++..-.-++|+|+.|+|++.++. +.++|+||..|..
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg~ 183 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAGL 183 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCCC
Confidence 44455556667777777666551238999999999999986 6999999988754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=87.84 E-value=0.39 Score=46.94 Aligned_cols=30 Identities=30% Similarity=0.188 Sum_probs=25.7
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
+.++|+|+.|.|||++++ +.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPG-KFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCC-cEEEEEEccccc
Confidence 449999999999999985 567899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=87.61 E-value=1.4 Score=42.64 Aligned_cols=60 Identities=28% Similarity=0.379 Sum_probs=40.4
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--C-cEEEEe-cCCc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--G-QVKIGD-LGLA 70 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g-~vKL~D-FGlA 70 (502)
+-||.+|+++ +.+++ +++..+.++ ..||-.++ |+.+||+|.||++.... . .+.|+| ||..
T Consensus 107 s~TL~~~l~~-~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 107 SPTLEDYLKE-GGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CccHHHHHHc-CCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 4589999955 45666 454444444 45666677 99999999999996532 2 567777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=86.78 E-value=0.47 Score=45.49 Aligned_cols=30 Identities=37% Similarity=0.521 Sum_probs=19.9
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|.||.|.|||++...+.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 889999999999943347999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=85.78 E-value=0.7 Score=46.09 Aligned_cols=39 Identities=23% Similarity=0.389 Sum_probs=33.5
Q ss_pred HHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCC
Q 010768 30 LRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69 (502)
Q Consensus 30 l~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGl 69 (502)
+.+|.-.|+.....+|+|-.|+||+-+.. |.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhh
Confidence 56788899766679999999999999987 8999999764
|
The function of this family is unknown. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=85.77 E-value=0.56 Score=46.31 Aligned_cols=29 Identities=28% Similarity=0.385 Sum_probs=25.1
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+.|.||+++++ + +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCC-C-CEEEeccccCc
Confidence 48999999999999876 3 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.75 E-value=0.66 Score=44.64 Aligned_cols=29 Identities=21% Similarity=0.357 Sum_probs=25.0
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
..+|+|+.|.||+++++ + ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~-~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS-G-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECC-C-EEEEeCCcccC
Confidence 36999999999999875 4 99999998854
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.46 E-value=0.62 Score=51.85 Aligned_cols=52 Identities=29% Similarity=0.433 Sum_probs=46.8
Q ss_pred eeeeecCCCCCcccHHHHHHHHHhccCCCCCCHHHHHHHHHHHHHhhCCCCc
Q 010768 247 ARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLVPNWK 298 (502)
Q Consensus 247 ~r~i~f~f~~~~Dt~~~Va~EMV~~~~i~~~d~~~ia~~I~~~i~~l~p~~~ 298 (502)
.+.|.|.|++..|+...||.|||++..+.+.|...+|+.|...+..+--...
T Consensus 336 ~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~ 387 (632)
T KOG0584|consen 336 ANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRN 387 (632)
T ss_pred cccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhh
Confidence 4578999999999999999999999999999999999999998888876654
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=84.17 E-value=2 Score=41.10 Aligned_cols=31 Identities=29% Similarity=0.334 Sum_probs=25.1
Q ss_pred CceecccccCcEEEeCCC-C---cEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHL-G---QVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~-g---~vKL~DFGlA~~ 72 (502)
.++|||+.+.||++..+. | .+.|+||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 489999999999997542 2 689999988753
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=83.51 E-value=0.8 Score=46.40 Aligned_cols=31 Identities=19% Similarity=0.335 Sum_probs=25.3
Q ss_pred CCceecccccCcEEEeCCCCc-EEEEecCCcee
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQ-VKIGDLGLAAI 72 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~-vKL~DFGlA~~ 72 (502)
+.++|+|++|.|||++++ +. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 348999999999999875 44 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.89 E-value=0.69 Score=51.06 Aligned_cols=82 Identities=16% Similarity=0.105 Sum_probs=55.1
Q ss_pred CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---------CccccCCHHHHHHHHHhhc-CcCCCCCH
Q 010768 99 NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---------AFHRIQDAEARRFVGKCLE-NVSKRLPA 168 (502)
Q Consensus 99 s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~---------~~~~~~s~~l~~LI~kcL~-dP~kRpsa 168 (502)
.+|+|||++|.++.++.-|...+....+.........-...+. .+....+.....+..+|+- .|..||..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 4699999999999999999877755333333222222222211 1122346667788889998 99999998
Q ss_pred HHHhcCccccCC
Q 010768 169 KELLLDPFLASD 180 (502)
Q Consensus 169 ~ElL~hpf~~~~ 180 (502)
.++.+++-|...
T Consensus 189 ~~~~k~~i~~ev 200 (725)
T KOG1093|consen 189 MELSKRCSFTEV 200 (725)
T ss_pred hHHhcCccHHHH
Confidence 888888877643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.20 E-value=2.5 Score=47.01 Aligned_cols=70 Identities=16% Similarity=0.135 Sum_probs=45.5
Q ss_pred CCCCCCHH--HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC---CCCcEEEEecCCceeccC
Q 010768 1 MFTSGTLR--EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~--~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~---~~g~vKL~DFGlA~~~~~ 75 (502)
|+.|.-+. ++|++. .++...+..-+.++..-.-+ ..| ++|+|-.|.||++.. ..+.+.+.|||+...+..
T Consensus 283 ~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf--~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 283 YVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIF--KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHH--hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 34554444 344443 46666555555444333333 346 999999999999984 247899999999876643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=82.15 E-value=2.1 Score=43.72 Aligned_cols=30 Identities=10% Similarity=0.122 Sum_probs=26.1
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+++|+|+.++|||++++ +.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 49999999999999877 6899999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=81.91 E-value=2.3 Score=44.18 Aligned_cols=30 Identities=23% Similarity=0.380 Sum_probs=26.1
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|.||.+.|||++.+.+.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999986546899999998854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=81.04 E-value=3 Score=49.99 Aligned_cols=31 Identities=32% Similarity=0.387 Sum_probs=25.0
Q ss_pred CceecccccCcEEEeCCC-CcEE-EEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHL-GQVK-IGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~-g~vK-L~DFGlA~~ 72 (502)
.+||+|+.+.|||++++. +.+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999998762 1455 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 502 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-52 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-96
Identities = 97/180 (53%), Positives = 128/180 (71%), Gaps = 2/180 (1%)
Query: 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
TSGTL+ Y K++ + I+ +++W RQIL+G+ +LH PP+IHRDLKCDNIF+ G G
Sbjct: 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170
Query: 62 VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
VKIGDLGLA + R S A +VIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYPY
Sbjct: 171 VKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPY 229
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
SEC N AQIY++VTSG P +F ++ E + + C+ N +R K+LL F +
Sbjct: 230 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-46
Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAH 80
+ + +QIL G+ YLH + ++HRD+K DN+ +N + G +KI D G + L G
Sbjct: 124 IGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
Query: 81 SVIGTPEFMAPE---LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG 137
+ GT ++MAPE Y + DI+S G ++EM T + P+ E P KV
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241
Query: 138 K----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKV 190
K +P + AEA+ F+ KC E + KR A +LL+D FL + + PK+
Sbjct: 242 KVHPEIPESM----SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 9/175 (5%)
Query: 5 GTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+L+++ + + + V + R L +A+LH ++H D+K NIF+ G+ K
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCK 197
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
+GD GL L + G P +MAPEL + Y D++S G+ +LE+ +
Sbjct: 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG 257
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
Q+ + + +E R + LE + R A+ LL P L
Sbjct: 258 GEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-41
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 14/177 (7%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
GTL ++ +++ ++D QI +G+ Y+H +I+RDLK NIF+ QV
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQV 161
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
KIGD GL L+ GT +M+PE Y + VD+Y+ G+ + E+L
Sbjct: 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
E S + + G + F D + + + K L R E+L +
Sbjct: 222 FETSK---FFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 43/207 (20%), Positives = 75/207 (36%), Gaps = 18/207 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + K+ + + Q L G+ YLH ++H D+K DN+ ++ + +
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAAL 192
Query: 65 GDLGLAAILRGSQ------HAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTS 117
D G A L+ + GT MAPE+ + VDI+S +L ML
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 118 EYPYSECSNPAQIYKKVTSGK----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+P+++ K + +P + + + + L R A EL
Sbjct: 253 CHPWTQYFRGPLCLKIASEPPPIREIPPSC----APLTAQAIQEGLRKEPVHRASAMELR 308
Query: 173 LDPFLASDAGEPLLIPKVPSFQNLNPN 199
A L P ++ N
Sbjct: 309 RKVGKALQEVGGLKSPWKGEYKEPRGN 335
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
GTL + + RQIL ++Y+H +IHRDLK NIF++ VK
Sbjct: 100 GTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVK 156
Query: 64 IGDLGLAAIL---------------RGSQHAHSVIGTPEFMAPELYEE--DYNELVDIYS 106
IGD GLA + S + S IGT ++A E+ + YNE +D+YS
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216
Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVS 163
G+ EM+ YP+S I KK+ S P F + ++ + ++ + +
Sbjct: 217 LGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
Query: 164 KRLPAKELLLDPFLASDAGEPLL 186
KR A+ LL +L + ++
Sbjct: 274 KRPGARTLLNSGWLPVKHQDEVI 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 25/193 (12%)
Query: 5 GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
L+++ R + + QI + +LH ++HRDLK NIF
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DV 202
Query: 62 VKIGDLGLAAILRGSQHAHSV-------------IGTPEFMAPELYEED-YNELVDIYSF 107
VK+GD GL + + +V +GT +M+PE + Y+ VDI+S
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRL 166
G+ + E+L Y +S +I V + K P F + + V L + ++R
Sbjct: 263 GLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERP 318
Query: 167 PAKELLLDPFLAS 179
A +++ + +
Sbjct: 319 EATDIIENAIFEN 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 49/140 (35%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 5 GTLREY-RKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
G+L K R +D R + A + +G+ YLH +PP++HR+LK N+ V+
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YT 177
Query: 62 VKIGDLGLAAIL-RGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
VK+ D GL+ + + S GTPE+MAPE+ E NE D+YSFG+ + E+ T +
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 120 PYSECSNPAQIYKKVTSGKL 139
P+ NPAQ+ V
Sbjct: 238 PWGNL-NPAQVVAAVGFKCK 256
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 5 GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLG 60
G+L + +W Q +G+AYLH P +IHRDLK N+ +
Sbjct: 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
+KI D G A + H + G+ +MAPE++E +Y+E D++S+G+ + E++T
Sbjct: 144 VLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 120 PYSECSNPAQ-IYKKVTSGKLP 140
P+ E PA I V +G P
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRP 223
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 45/193 (23%), Positives = 75/193 (38%), Gaps = 25/193 (12%)
Query: 5 GTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
L+++ R + + QI + +LH ++HRDLK NIF
Sbjct: 100 ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DV 156
Query: 62 VKIGDLGLAAILRGSQHAHSV-------------IGTPEFMAPELYEE-DYNELVDIYSF 107
VK+GD GL + + +V +GT +M+PE Y+ VDI+S
Sbjct: 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216
Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
G+ + E+L YP+S + V + K P F + V L + +R
Sbjct: 217 GLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQK-YPCEYVMVQDMLSPSPMERP 272
Query: 167 PAKELLLDPFLAS 179
A ++ +
Sbjct: 273 EAINIIENAVFED 285
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 47/183 (25%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G L + +K + +W QI + ++H ++HRD+K NIF+ G V
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTV 164
Query: 63 KIGDLGLAAIL-RGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
++GD G+A +L + A + IGTP +++PE+ E YN DI++ G + E+ T ++
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 121 YSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
+ E + + K+ SG + + + R V + + N R +L F
Sbjct: 225 F-EAGSMKNLVLKIISGSFPPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279
Query: 177 LAS 179
+A
Sbjct: 280 IAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-37
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
++ ++K+ + R V + Q+ + ++H V+HRD+K N+F+ G VK+GD
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGD 179
Query: 67 LGLAAILRGS-QHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY-SE 123
LGL AHS++GTP +M+PE E+ YN DI+S G + EM + P+ +
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
N + KK+ P E R+ V C+ + KR +
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLH---GHDPPVIHRDLKCDNIFVNGHLGQVK 63
+ + K+ +D V Q+ + H V+HRDLK N+F++G VK
Sbjct: 98 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVK 156
Query: 64 IGDLGLAAIL-RGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVL-EMLTSEYP 120
+GD GLA IL + A + +GTP +M+PE YNE DI+S G C+L E+ P
Sbjct: 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPP 215
Query: 121 YSECSNPAQIYKKVTSGK---LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
+ + ++ K+ GK +P + E + + L R +E+L +P
Sbjct: 216 F-TAFSQKELAGKIREGKFRRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPL 270
Query: 177 L 177
+
Sbjct: 271 I 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 41/144 (28%), Positives = 59/144 (40%), Gaps = 11/144 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-- 61
G L K + I GI Y+ +PP++HRDL+ NIF+
Sbjct: 106 GDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165
Query: 62 --VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLT 116
K+ D GL+ ++G ++MAPE EE Y E D YSF M + +LT
Sbjct: 166 VCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
Query: 117 SEYPYSECSN-PAQIYKKVTSGKL 139
E P+ E S + + L
Sbjct: 224 GEGPFDEYSYGKIKFINMIREEGL 247
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 11/152 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+L + T+ +++ + + ARQ RG+ YLH +IHRDLK +NIF++ VK
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHED-NTVK 160
Query: 64 IGDLGLAAILR---GSQHAHSVIGTPEFMAPEL--YEED--YNELVDIYSFGMCVLEMLT 116
IGD GLA GS + G+ +MAPE+ ++ Y+ D+Y+FG+ + E++T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD 148
+ PYS +N QI + V G L +++
Sbjct: 221 GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 41/193 (21%), Positives = 79/193 (40%), Gaps = 22/193 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVK 63
L + KK +D K++ + +L + +H H ++H DLK N V+G +K
Sbjct: 112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 166
Query: 64 IGDLGLAAILRG---SQHAHSVIGTPEFMAPELYEED------------YNELVDIYSFG 108
+ D G+A ++ S S +GT +M PE ++ + D++S G
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226
Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
+ M + P+ + N + F I + + + + CL+ + +R+
Sbjct: 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286
Query: 168 AKELLLDPFLASD 180
ELL P++
Sbjct: 287 IPELLAHPYVQIQ 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 22/202 (10%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVK 63
L + KK +D K++ + +L + +H H ++H DLK N V+G +K
Sbjct: 93 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 147
Query: 64 IGDLGLAAILRG---SQHAHSVIGTPEFMAPEL------------YEEDYNELVDIYSFG 108
+ D G+A ++ S S +GT +M PE + + D++S G
Sbjct: 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207
Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
+ M + P+ + N + F I + + + + CL+ + +R+
Sbjct: 208 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 267
Query: 168 AKELLLDPFLASDAGEPLLIPK 189
ELL P++ + K
Sbjct: 268 IPELLAHPYVQIQTHPVNQMAK 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 39/197 (19%), Positives = 73/197 (37%), Gaps = 37/197 (18%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---------- 56
+ E + + +K+ Q+ RG+ Y+H ++H D+K NIF++
Sbjct: 102 ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASE 159
Query: 57 --------GHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED--YNELVDIYS 106
+ KIGDLG + G F+A E+ +E+ + DI++
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFA 216
Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NV 162
+ V+ +E + ++ G+LP RI E + + +
Sbjct: 217 LALTVVCAAGAEPLPRN----GDQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDP 268
Query: 163 SKRLPAKELLLDPFLAS 179
+R A L+ L S
Sbjct: 269 ERRPSAMALVKHSVLLS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
TL R +D+ + A++I++G+ YLH ++H+DLK N+F + +V
Sbjct: 114 RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNG--KVV 169
Query: 64 IGDLGLAAILRGSQHAH------SVIGTPEFMAPEL----------YEEDYNELVDIYSF 107
I D GL +I Q G +APE+ + +++ D+++
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
G E+ E+P+ I ++ +G P
Sbjct: 230 GTIWYELHAREWPFKT-QPAEAIIWQMGTGMKP 261
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 11/142 (7%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L VD +A + RG+A+LH +P + L ++ ++ +
Sbjct: 94 GSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TA 152
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSE 118
+I + S + + P ++APE + + D++SF + + E++T E
Sbjct: 153 RISMADVKF----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
P+++ SN K G P
Sbjct: 209 VPFADLSNMEIGMKVALEGLRP 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 40/193 (20%), Positives = 78/193 (40%), Gaps = 22/193 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVK 63
L + KK +D K++ + +L + +H H ++H DLK N V+G +K
Sbjct: 140 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG---MLK 194
Query: 64 IGDLGLAAILRG---SQHAHSVIGTPEFMAPELYEED------------YNELVDIYSFG 108
+ D G+A ++ S S +G +M PE ++ + D++S G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254
Query: 109 MCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
+ M + P+ + N + F I + + + + CL+ + +R+
Sbjct: 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314
Query: 168 AKELLLDPFLASD 180
ELL P++
Sbjct: 315 IPELLAHPYVQIQ 327
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGHLGQ- 61
G L K R+ + NWA QI RG+ YLH P+IHRDLK NI + +
Sbjct: 91 GPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148
Query: 62 ------VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEM 114
+KI D GLA + S G +MAPE+ +++ D++S+G+ + E+
Sbjct: 149 DLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
Query: 115 LTSEYPYSECSNPAQIYKKVTSGKLP 140
LT E P+ A Y +
Sbjct: 208 LTGEVPFRGIDGLAVAYGVAMNKLAL 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 16/177 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGT 85
R+ L+ + +LH + VIHRD+K DNI + G VK+ D G A + Q +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 86 PEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ + Y VDI+S G+ +EM+ E PY NP + + + P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP---- 234
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQN 195
+Q+ E R F+ +CLE +V KR AKELL FL L P + + +
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A I++ + +LH VIHRD+K N+ +N LGQVK+ D G++ L G
Sbjct: 115 AVSIVKALEHLH-SKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGC 172
Query: 86 PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140
+MAPE L ++ Y+ DI+S G+ ++E+ +PY P Q K+V P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
AE F +CL+ N +R EL+ PF
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 55/164 (33%), Positives = 91/164 (55%), Gaps = 14/164 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGT 85
R+IL+G+ YLH IHRD+K N+ ++ H G+VK+ D G+A L +Q ++ +GT
Sbjct: 126 REILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGT 182
Query: 86 PEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ-IYKKVTSG--KLPG 141
P +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P + ++ + L G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 241
Query: 142 AFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFLASDAGEP 184
+ + + FV CL + S R AKELL F+ +A +
Sbjct: 242 NYSK----PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 16/172 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGT 85
+L+ +AYLH VIHRD+K D+I + G+VK+ D G A + S++GT
Sbjct: 148 EAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGT 204
Query: 86 PEFMAPEL-YEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE+ Y VDI+S G+ V+EM+ E PY +P Q K++ P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP---- 259
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKV 190
+++++ R F+ + L + +R A+ELL PFL L+P +
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 27/171 (15%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA------H 80
R++L G+ YLH + IHRD+K NI + G V+I D G++A L
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSEC-----------SNP 127
+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY + ++P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 128 AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
+ V ++ + + R+ + CL ++ KR A ELL F
Sbjct: 245 PSLETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 27/204 (13%), Positives = 60/204 (29%), Gaps = 32/204 (15%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
L + + + A Q++R +A LH + ++H L+ +I ++ G V +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 247
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPEL------------YEEDYNELVDIYSFGMCVL 112
+ F PEL D ++ G+ +
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 113 EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAK 169
+ ++ P ++ + + F ++ R + L RL
Sbjct: 305 WIWCADLPITK-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355
Query: 170 ELLLDPFLASDAGEPLLIPKVPSF 193
+ + P L +P +
Sbjct: 356 QAMETPEYEQ--LRTELSAALPLY 377
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
++ + +L + +IHRD+K NI ++ G +K+ D G++ L S G
Sbjct: 131 TLATVKALNHLK-ENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 86 PEFMAPE-----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--- 137
+MAPE + Y+ D++S G+ + E+ T +PY + ++ +V G
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+L + R FV CL + SKR KELL PF+
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ E + T I+ V RQ+L + +LH +IHRDLK N+ + G +++ D
Sbjct: 107 MLELDRGLTEPQIQVV---CRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLAD 160
Query: 67 LGLAAILRGSQH-AHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEY 119
G++A + S IGTP +MAPE + + Y+ DI+S G+ ++EM E
Sbjct: 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
Query: 120 PYSECSNPAQ-IYKKVTSG----KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
P+ E NP + + K S P + E R F+ L+ N R A +LL
Sbjct: 221 PHHEL-NPMRVLLKIAKSDPPTLLTPSKWSV----EFRDFLKIALDKNPETRPSAAQLLE 275
Query: 174 DPFLASDAGEPLLIP 188
PF++S L
Sbjct: 276 HPFVSSITSNKALRE 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HAHSVIGT 85
+ L+G+ YLH IHRD+K NI +N G K+ D G+A L + ++VIGT
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGT 188
Query: 86 PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
P +MAPE + E YN + DI+S G+ +EM + PY++ +P + + + P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPP---- 243
Query: 145 RIQDAEA-----RRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKV 190
+ E FV +CL + +R A +LL PF+ S G +L +
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 10/182 (5%)
Query: 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+ + ++ + R + I++ + YL VIHRD+K NI ++ GQ+K
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLD-ERGQIK 165
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTS 117
+ D G++ L + G +MAPE + DY+ D++S G+ ++E+ T
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQ-DAEARRFVGKCLE-NVSKRLPAKELLLDP 175
++PY C ++ KV + P + + + FV CL + KR +LL
Sbjct: 226 QFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285
Query: 176 FL 177
F+
Sbjct: 286 FI 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 20/174 (11%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-AHSVIGT 85
R+ILRG+++LH H VIHRD+K N+ + + +VK+ D G++A L + ++ IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 86 PEFMAPE------LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139
P +MAPE + Y+ D++S G+ +EM P + +P + +
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 251
Query: 140 PGAFHRIQD----AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
P R++ + + F+ CL N S+R ++L+ PF+ E +
Sbjct: 252 P----RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRI 301
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTP 86
L+G+AYLH H+ +IHRD+K NI ++ G VK+GD G A+I+ A+S +GTP
Sbjct: 161 HGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM---APANSFVGTP 214
Query: 87 EFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
+MAPE + E Y+ VD++S G+ +E+ + P N + + P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP-- 271
Query: 143 FHRIQD----AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
+Q R FV CL+ R ++ LL F+ + +++
Sbjct: 272 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 38/138 (27%), Positives = 61/138 (44%), Gaps = 20/138 (14%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
G+L +Y K T +D +++ A + G+ +LH P + HRDLK NI V +
Sbjct: 120 GSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 59 LGQVKIGDLGLAAILRGSQH-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
G I DLGLA + ++ +GT +M PE+ +E + D+YS
Sbjct: 179 -GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 107 FGMCVLEMLTSEYPYSEC 124
FG+ + E+
Sbjct: 238 FGLILWEVARRCVSGGIV 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 21/194 (10%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGH 58
TL+EY +K + + + +Q G+A+LH + ++HRDLK NI +
Sbjct: 102 ATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHG 158
Query: 59 LGQVKIGDLGLAAILRGSQHA----HSVIGTPEFMAPELYEED----YNELVDIYSFGMC 110
+ I D GL L +H+ V GT ++APE+ ED VDI+S G
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 111 VLEMLTSEY-PYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLP 167
+++ P+ + S Q + + L + +D AR + K + + KR
Sbjct: 219 FYYVISEGSHPFGK-SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
Query: 168 AKELLLDPFLASDA 181
AK +L PF S
Sbjct: 278 AKHVLKHPFFWSLE 291
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 42/138 (30%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
G+L +Y + T +D + I G+A+LH P + HRDLK NI V +
Sbjct: 91 GSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149
Query: 59 LGQVKIGDLGLAAILRGSQH-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
GQ I DLGLA + S + + +GT +MAPE+ +E D + VDI++
Sbjct: 150 -GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208
Query: 107 FGMCVLEMLTSEYPYSEC 124
FG+ + E+
Sbjct: 209 FGLVLWEVARRMVSNGIV 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 56/247 (22%), Positives = 111/247 (44%), Gaps = 25/247 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R K+ VD + +Q+L G+ YLH H+ ++HRDLK +N+ + +KI D G
Sbjct: 130 RMKFNEVDAAVI---IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
L+A+ + +GT ++APE+ + Y+E D++S G+ + +L P+
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQ 243
Query: 129 QIYKKVTSGKLPGAFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183
+I +KV GK F + A+ + + L+ + +R+ A++ L P++ +
Sbjct: 244 EILRKVEKGKYT--FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301
Query: 184 PLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI--- 240
++PS E + +F ++ + + + +++T L
Sbjct: 302 KESGIELPSLA------NAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHI 355
Query: 241 -TDKDGQ 246
+ DGQ
Sbjct: 356 DKNGDGQ 362
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 47/187 (25%), Positives = 95/187 (50%), Gaps = 13/187 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
GT+ +K ++ D + + ++ ++Y H VIHRD+K +N+ + G G++KI
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKI 150
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSE 123
D G + S+ + GT +++ PE+ E ++E VD++S G+ E L + P+ E
Sbjct: 151 ADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 208
Query: 124 CSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ + YK+++ + P AR + + L+ N S+R +E+L P++ ++
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264
Query: 181 AGEPLLI 187
+ +P
Sbjct: 265 SSKPSNC 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 23/246 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLG 68
RK+++ D + +Q+ GI Y+H H+ ++HRDLK +NI + +KI D G
Sbjct: 115 RKRFSEHDAARI---IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
L+ + + IGT ++APE+ Y+E D++S G+ + +L+ P+ N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEY 228
Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
I K+V +GK + I D +A+ + K L + S R+ A + L P++ + E
Sbjct: 229 DILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287
Query: 185 LLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI---- 240
I +PS + + QF + ++ + + + D+T L
Sbjct: 288 PTISDLPS------LESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLD 341
Query: 241 TDKDGQ 246
T+ DG
Sbjct: 342 TNNDGM 347
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 20/146 (13%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
G+L +Y +YT V + + A G+A+LH P + HRDLK NI V +
Sbjct: 125 GSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183
Query: 59 LGQVKIGDLGLAAILRGSQH-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
G I DLGLA + + +GT +MAPE+ ++ + + DIY+
Sbjct: 184 -GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 107 FGMCVLEMLTSEYPYSECSNPAQIYK 132
G+ E+ + Y
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYY 268
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 29/183 (15%), Positives = 61/183 (33%), Gaps = 15/183 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
TL I A+ Q++R A L ++H DN+F+ G++ +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLML 235
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEMLTSEYPY 121
GD+ + + + E + ++ + G+ + + P+
Sbjct: 236 GDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 122 SECSNPAQIYKKVTSGKLPGA----FHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLD 174
+ + K S ++PG F + +G+ L + +RL E +
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 175 PFL 177
P
Sbjct: 354 PEF 356
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 29/227 (12%), Positives = 65/227 (28%), Gaps = 25/227 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
L + + + A Q++R +A LH + ++H L+ +I ++ G V +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 252
Query: 65 GDLGLAAIL--RGSQHAHSVIGTPEFMAPELYEED------YNELVDIYSFGMCVLEMLT 116
PE A + D ++ G+ + +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLL 173
++ P ++ + + F ++ R + L RL + +
Sbjct: 313 ADLPNTD-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
Query: 174 DPFLASDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTD 220
P + L +P +Q P D + +
Sbjct: 364 TPEY--EQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 38/182 (20%), Positives = 60/182 (32%), Gaps = 20/182 (10%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ + K + + I RG+ +H HRDLK NI + GQ + D
Sbjct: 121 IERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDE-GQPVLMD 177
Query: 67 LGLAAILRGS----------QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVL 112
LG Q + T + APEL+ +E D++S G CVL
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVL 236
Query: 113 -EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKE 170
M+ E PY +L + + + + + +R
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296
Query: 171 LL 172
LL
Sbjct: 297 LL 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 44/195 (22%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + +K+ R D + + ++ + Y H VIHRD+K +N+ + G++KI
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKI 155
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE 123
D G + + ++ GT +++ PE+ E + ++E VD++ G+ E L P+ +
Sbjct: 156 ADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-D 213
Query: 124 CSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ + ++++ + L P ++ + K L + +RLP K ++ P++ ++
Sbjct: 214 SPSHTETHRRIVNVDLKFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269
Query: 181 AGEPLLIPKVPSFQN 195
+ +L P S Q+
Sbjct: 270 S-RRVLPPVYQSTQS 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 58/246 (23%), Positives = 112/246 (45%), Gaps = 24/246 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
RK+++ VD + RQ+L GI Y+H + ++HRDLK +N+ + ++I D G
Sbjct: 120 RKRFSEVDAARI---IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
L+ S+ IGT ++APE+ Y+E D++S G+ + +L+ P++ +N
Sbjct: 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEY 233
Query: 129 QIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
I KKV GK + ++ + A+ + K L S R+ A++ L ++ + E
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292
Query: 185 LLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI---- 240
+ + ++ + QF ++ + + + +D+T L
Sbjct: 293 ISV-------DVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMD 345
Query: 241 TDKDGQ 246
+ DGQ
Sbjct: 346 KNGDGQ 351
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQV 62
G LR + ++ VK + +++ + YL +IHRD+K DNI + +GH V
Sbjct: 100 GDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGH---V 154
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSE 118
I D +AA+L ++ GT +MAPE++ Y+ VD +S G+ E+L
Sbjct: 155 HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 119 YPYSECS--NPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL-PAKELL 172
PY S + +I + + P A+ + E + K LE N +R ++
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ----EMVSLLKKLLEPNPDQRFSQLSDVQ 270
Query: 173 LDPFLAS 179
P++
Sbjct: 271 NFPYMND 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
+L E K+ + + + RQI+ G YLH + VIHRDLK N+F+N +V
Sbjct: 98 RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEV 154
Query: 63 KIGDLGLAAILRGSQHAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEY 119
KIGD GLA + V+ GTP ++APE L ++ ++ VD++S G C++ +L +
Sbjct: 155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKP 213
Query: 120 PYSECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
P+ E S + Y ++ +P + A + K L+ + + R ELL D F
Sbjct: 214 PF-ETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 177 LASDAGEPLLIP 188
S P +P
Sbjct: 269 FTSGY-IPARLP 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 50/229 (21%), Positives = 84/229 (36%), Gaps = 31/229 (13%)
Query: 2 FTSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH 58
G L E+ + + V Q R + ++H PP+IHRDLK +N+ ++
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174
Query: 59 LGQVKIGDLGLAAILRGS-------------QHAHSVIGTPEFMAPELYE----EDYNEL 101
G +K+ D G A + + + TP + PE+ + E
Sbjct: 175 -GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 102 VDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL- 159
DI++ G C+L + ++P+ E +I +GK H Q + L
Sbjct: 234 QDIWALG-CILYLLCFRQHPF-EDGAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 160 ENVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVTELVPQ 208
N +RL E++ A + PK P + L NG
Sbjct: 288 VNPEERLSIAEVVHQLQEI--AAARNVNPKSPITELLEQNGGYGSATLS 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 28/248 (11%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R K+ D + +QIL GI YLH H+ ++HRD+K +NI N + +KI D G
Sbjct: 140 RHKFDECDAANI---MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNP 127
L++ +GT ++APE+ ++ YNE D++S G+ + +L P + N
Sbjct: 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ--ND 252
Query: 128 AQIYKKVTSGKLPGAFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
I KKV GK F EA+ + L + +KR A+E L ++ A
Sbjct: 253 QDIIKKVEKGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA- 309
Query: 183 EPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFLKVQI-- 240
+ + + +F ++ + I + ++ L
Sbjct: 310 ------NNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKK 363
Query: 241 --TDKDGQ 246
+ DGQ
Sbjct: 364 LDKNGDGQ 371
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 19/192 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDL 67
++ + + + +QIL G+ YLH + H DLK +NI + N + +K+ D
Sbjct: 109 KESLSEEEATSF---IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 68 GLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
GLA + ++ GTPEF+APE + E D++S G + +L S +
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 221
Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ +TS F + A+ F+ K L KRL +E L P++
Sbjct: 222 -TKQETLANITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279
Query: 181 AGEPLLIPKVPS 192
+ ++ +
Sbjct: 280 DNQQAMVRRESV 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
+L E K+ + + + RQI+ G YLH + VIHRDLK N+F+N +VKI
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKI 182
Query: 65 GDLGLAAILRGSQHAHSVI-GTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPY 121
GD GLA + V+ GTP ++APE L ++ ++ VD++S G C++ +L + P+
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPF 241
Query: 122 SECSNPAQIYKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
E S + Y ++ +P + A + K L+ + + R ELL D F
Sbjct: 242 -ETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFT 296
Query: 179 SDAGEPLLIP 188
S P +P
Sbjct: 297 SGY-IPARLP 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVN 56
G+L ++ K V + + A + RG+AYLH GH P + HRD+K N+ +
Sbjct: 107 GSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165
Query: 57 GHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPEL------YEEDYNELVDIYSF 107
+ I D GLA + H +GT +MAPE+ ++ D +D+Y+
Sbjct: 166 NN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 108 GMCVLEMLTSEYPYSECSNPAQI 130
G+ + E+ + + +
Sbjct: 225 GLVLWELASRCTAADGPVDEYML 247
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 46/216 (21%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + KK R+ + + + +++G+ YL ++HRD+K NI VN G++K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVN-SRGEIKL 173
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
D G++ L S A+S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 174 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQD----------------------------------- 148
+ A +
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292
Query: 149 ------AEARRFVGKCL-ENVSKRLPAKELLLDPFL 177
E + FV KCL +N ++R K+L++ F+
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 21/193 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
+ Y+ D +QIL +AYLH + ++HRDLK +N+ + +KI D G
Sbjct: 142 KGYYSERDAADA---VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
L+ I+ +V GTP + APE L Y VD++S G + +L + Y E
Sbjct: 197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG-IITYILLCGFEPFYDE-R 254
Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+++++ + + F + A+ V K + + KRL + L P++
Sbjct: 255 GDQFMFRRILNCEY--YFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
Query: 180 DAGEPLLIPKVPS 192
A + +
Sbjct: 312 KAANFVHMDTAQK 324
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 36/228 (15%), Positives = 67/228 (29%), Gaps = 60/228 (26%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-------- 78
+ +L+ + Y+H +HR +K +I ++ G+V + L +
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 79 AHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSE------------ 123
+ +++PE+ +++ Y+ DIYS G+ E+ P+ +
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 124 ------------------------CSNPAQIYKKVTSGKLPGAFHRIQDAEARR------ 153
+N TS P R
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 154 -FVGKCLE-NVSKRLPAKELLLDPFL--ASDAGEPLLIPKVPSFQNLN 197
FV +CL+ N R A LL F L + +
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPIT 359
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R+ Y+ D +QIL IAY H + ++HR+LK +N+ + G VK+ D G
Sbjct: 99 REFYSEADASHC---IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG 153
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
LA + S+ H GTP +++PE L ++ Y++ VDI++ G +L +L YP + E
Sbjct: 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE-- 210
Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ ++Y ++ +G + + EA+ + L N KR+ A + L P++ +
Sbjct: 211 DQHRLYAQIKAGAY--DYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICN 267
Query: 180 DAGEPLLIPKVPSFQNL 196
I + + L
Sbjct: 268 RERVASAIHRQDTVDCL 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 20/197 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDL 67
++ T + +QIL G+ YLH + H DLK +NI + N ++KI D
Sbjct: 108 KESLTEEEATEF---LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 68 GLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
GLA + ++ GTPEF+APE + E D++S G + +L S +
Sbjct: 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 220
Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ V++ F A+ F+ + L + KR+ ++ L P++
Sbjct: 221 -TKQETLANVSAVNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
Query: 181 AGEPLLIPKVPSFQNLN 197
+ L + S N+
Sbjct: 279 DTQQAL-SRKASAVNME 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 14/173 (8%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSQH 78
V N+ RQ G+ ++H H ++H D+K +NI VKI D GLA L +
Sbjct: 149 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
Query: 79 AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
T EF APE + E D+++ G + +L S E + + + V
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVK 263
Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
AF + EA+ F+ L+ KRL + L P+L D
Sbjct: 264 RCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 19/192 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDL 67
++ + + + +QIL G+ YLH + H DLK +NI + N + +K+ D
Sbjct: 109 KESLSEEEATSF---IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 68 GLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
GLA + ++ GTPEF+APE + E D++S G + +L S +
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD- 221
Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ +T+ F + + A+ F+ K L KRL +E L P++
Sbjct: 222 -TKQETLANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279
Query: 181 AGEPLLIPKVPS 192
+ ++ +
Sbjct: 280 DTQQAMVRRESV 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+Q++ +AY H V+H+DLK +NI F + +KI D GLA + + +H+ + G
Sbjct: 131 KQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
Query: 85 TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGKL--P 140
T +MAPE+++ D DI+S G V+ L + + ++ +K T +
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYA 245
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ +A + + L + +R A ++L +
Sbjct: 246 VECRPLTP-QAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 37/182 (20%), Positives = 78/182 (42%), Gaps = 17/182 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
++ + D + + +L +AY H + V HRDLK +N F+ +K+ D G
Sbjct: 100 KRVFRESDAARI---MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFG 154
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN 126
LAA + + + +GTP +++P++ E Y D +S G ++ +L YP +
Sbjct: 155 LAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--T 211
Query: 127 PAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
+++ K+ G + + +A + + L + +R+ + + L +
Sbjct: 212 DSEVMLKIREGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
Query: 183 EP 184
Sbjct: 271 SS 272
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 37/198 (18%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
GTLR + ++ ++A+ I G+AYLH + +IHRDL N V + V
Sbjct: 92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVV 148
Query: 64 IGDLGLAAILRGSQHA---------------HSVIGTPEFMAPE-LYEEDYNELVDIYSF 107
+ D GLA ++ + ++V+G P +MAPE + Y+E VD++SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 108 GMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--------PGAFHRI------QDAEAR- 152
G+ + E++ + + G L P +F I D E R
Sbjct: 209 GIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268
Query: 153 RF--VGKCLENVSKRLPA 168
F + LE + L
Sbjct: 269 SFVKLEHWLETLRMHLAG 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 49/186 (26%), Positives = 71/186 (38%), Gaps = 17/186 (9%)
Query: 5 GTLREYRKKYTRVDI---RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI--FVNGHL 59
G LR+Y ++ ++ I + YLH + +IHRDLK +NI
Sbjct: 103 GDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQR 160
Query: 60 GQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE 118
KI DLG A L + +GT +++APEL E + Y VD +SFG E +T
Sbjct: 161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
Query: 119 YPYSECSNPAQIYKKVTSG---------KLPGAFHRIQDAEARRFVGKCLENVSKRLPAK 169
P+ P Q + KV L GA + L +R
Sbjct: 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280
Query: 170 ELLLDP 175
L+
Sbjct: 281 MLMWHQ 286
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 40/185 (21%), Positives = 77/185 (41%), Gaps = 19/185 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDL 67
++ T + +QIL G+ YLH + H DLK +NI + N ++K+ D
Sbjct: 102 KESLTEDEATQF---LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 68 GLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
G+A + ++ GTPEF+APE + E D++S G + +L S E
Sbjct: 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE- 214
Query: 125 SNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
+ +++ F + A+ F+ + L + +R+ + L ++ +
Sbjct: 215 -TKQETLTNISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
Query: 181 AGEPL 185
+
Sbjct: 273 RRRNV 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R+ Y+ D +QIL IAY H + ++HR+LK +N+ + G VK+ D G
Sbjct: 122 REFYSEADASHC---IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
LA + S+ H GTP +++PE L ++ Y++ VDI++ G +L +L YP + E
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE-- 233
Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ ++Y ++ +G + + EA+ + L N KR+ A + L P++ +
Sbjct: 234 DQHRLYAQIKAGAY--DYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICN 290
Query: 180 DAGEPLLIPKVPSFQNL 196
I + + L
Sbjct: 291 RERVASAIHRQDTVDCL 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 17/181 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLG 68
RK+++ D + +Q+ GI Y+H H+ ++HRDLK +NI + +KI D G
Sbjct: 115 RKRFSEHDAARI---IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 69 LAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN 126
L+ + + IGT ++APE+ Y+E D++S G +L +L S P Y + N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--N 226
Query: 127 PAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182
I K+V +GK + I D +A+ + K L + S R+ A + L P++ +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
Query: 183 E 183
E
Sbjct: 286 E 286
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 16/188 (8%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSQH 78
R + ++ Q+ + +LH H+ + H D++ +NI + +KI + G A L+ +
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 79 AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
+ PE+ APE + + D++S G ++ +L S +E QI + +
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIM 216
Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD--AGEPLLIPK 189
+ + AF I EA FV + L R+ A E L P+L +I
Sbjct: 217 NAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
Query: 190 VPSFQNLN 197
+ + +
Sbjct: 276 LKHRRYYH 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 18/198 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
K+ + Q+L + YLH + +IHRDLK +N+ + +KI D G
Sbjct: 108 NKRLKEATCKLY---FYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEY-PYSE 123
+ IL + ++ GTP ++APE + YN VD +S G +L + S Y P+SE
Sbjct: 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSE 221
Query: 124 CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ ++TSGK P + + + +A V K L + R +E L P+L
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
Query: 180 DAGEPLLIPKVPSFQNLN 197
+ + +
Sbjct: 281 EDMKRKFQDLLSEENEST 298
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLG 68
K+ + Q+L + YLH + +IHRDLK +N+ ++ +KI D G
Sbjct: 233 NKRLKEATCKLY---FYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE----LYEEDYNELVDIYSFGMCVLEMLTSEY-PYSE 123
+ IL + ++ GTP ++APE + YN VD +S G +L + S Y P+SE
Sbjct: 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSE 346
Query: 124 CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ ++TSGK P + + + +A V K L + R +E L P+L
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
Query: 180 DA 181
+
Sbjct: 406 ED 407
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 12 KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGL 69
+K D + + +I+ + YLHG +IHRDLK +NI + + H ++I D G
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMH---IQITDFGT 176
Query: 70 AAILRGSQH---AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
A +L A+S +GT ++++PE L E+ + D+++ G + +++ P+
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG 235
Query: 126 NPAQIYKKVTSGKL--PGAFHRIQDAEARRFVGKCLE-NVSKRL 166
N I++K+ + P F +AR V K L + +KRL
Sbjct: 236 NEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRL 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 20/170 (11%)
Query: 3 TSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-- 57
G+L + R ++ G+ +L + ++HR++K NI
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGE 149
Query: 58 -HLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE---------EDYNELVDIYSF 107
K+ D G A L + S+ GT E++ P++YE + Y VD++S
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209
Query: 108 GMCVLEMLTSE---YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
G+ T P+ ++ K+ +GK GA +Q AE
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDL 67
+K ++ + AV I + + YLH V+HRDLK NI +G+ ++I D
Sbjct: 110 QKFFSEREASAV---LFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 68 GLAAILRGSQHA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSE 123
G A LR + T F+APE L + Y+ DI+S G +L + + Y +
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANG 223
Query: 124 CS-NPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
P +I ++ SGK G ++ + D A+ V K L + +RL A +L P++
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
Query: 179 SDAGEP 184
P
Sbjct: 283 HWDQLP 288
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSQ 77
V +QIL G+ YLH ++ ++H DLK NI + LG +KI D G++ + +
Sbjct: 131 NDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 78 HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKV 134
++GTPE++APE L + D+++ G+ + ML + E + + Y +
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNI 245
Query: 135 TSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKV 190
+ + F + A F+ L N KR A+ L +L E L P+
Sbjct: 246 SQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304
Query: 191 PS 192
S
Sbjct: 305 TS 306
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 44/212 (20%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
L + + I+ +K + +L +Y+H + HRD+K NI ++ + G+VK+
Sbjct: 138 FVLDKNYTC--FIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKL 193
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPY 121
D G + + GT EFM PE + VDI+S G+C+ M + P+
Sbjct: 194 SDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 122 SECSNPAQIYKKVTSGKL--PGAFHRIQDA---------------EARRFVGKCLE-NVS 163
S + +++ + + + P + E F+ L N +
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 164 KRLPAKELLLDPFLASDAGEPLLIPKVPSFQN 195
+R+ +++ L +LA E L ++
Sbjct: 313 ERITSEDALKHEWLADTNIEDLREFSKELYKK 344
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSQH 78
+ +QI GI ++H ++H DLK +NI VN Q+KI D GLA + +
Sbjct: 187 LDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 79 AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
GTPEF+APE + + + D++S G+ + ML S + N A+ +
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNIL 301
Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVP 191
+ + F I + EA+ F+ K L S R+ A E L P+L+ L +
Sbjct: 302 ACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
Query: 192 SFQNLN 197
+ +
Sbjct: 361 KNRGSD 366
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 23/182 (12%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R YT D V +Q+L + YLH + ++HRDLK +N+ ++ ++ I D G
Sbjct: 100 RGVYTEKDASLV---IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 69 LAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECS 125
L+ + + + GTP ++APE L ++ Y++ VD +S G + +L YP Y E
Sbjct: 155 LSKMEQNGI-MSTACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE-- 210
Query: 126 NPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+++++K+ G F I + A+ F+ LE + ++R ++ L P++
Sbjct: 211 TESKLFEKIKEGYY--EFESPFWDDISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
Query: 180 DA 181
+
Sbjct: 268 NT 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 46/214 (21%), Positives = 88/214 (41%), Gaps = 22/214 (10%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLG 68
+K ++ + + R+++ ++++H V+HRDLK +N+ F + ++KI D G
Sbjct: 100 KKHFSETEASYI---MRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFG 154
Query: 69 LAAILRGSQHA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSE- 123
A + + T + APE L + Y+E D++S G +L + S S
Sbjct: 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHD 213
Query: 124 ----CSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
C++ +I KK+ G A+ + EA+ + L + +KRL L +
Sbjct: 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNE 272
Query: 176 FLASDAGEPLLIPKVPSFQNLNPNGAVTELVPQF 209
+L + P + T + F
Sbjct: 273 WLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATF 306
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 20/170 (11%)
Query: 3 TSGTLREY---RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-- 57
G+L + R ++ G+ +L + ++HR++K NI
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGE 149
Query: 58 -HLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED---------YNELVDIYSF 107
K+ D G A L + S+ GT E++ P++YE Y VD++S
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209
Query: 108 GMCVLEMLTSE---YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154
G+ T P+ ++ K+ +GK GA +Q AE
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 34/215 (15%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---- 60
E K + ++ RQI G+A+LH +IHRDLK NI V+
Sbjct: 103 NVSDENLKLQKEYNPISL---LRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTAD 157
Query: 61 --------QVKIGDLGLAAILRGSQHA-----HSVIGTPEFMAPELYEED--------YN 99
++ I D GL L Q + ++ GT + APEL EE
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 100 ELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGK-LPGAFHRIQDAEARRFVG 156
+DI+S G +L+ + S + I + + S + R AEA +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 157 KCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKV 190
+ ++ + KR A ++L P + + + KV
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKV 312
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSQH 78
+ + N RQI + YLH + HRD+K +N F ++K+ D GL+ +
Sbjct: 168 KLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 79 A-----HSVIGTPEFMAPEL---YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQ 129
+ GTP F+APE+ E Y D +S G+ + +L P N A
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV--NDAD 283
Query: 130 IYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
+V + KL ++ + AR + L NV +R A L P+++ +
Sbjct: 284 TISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLG 68
R+ Y+ D +QIL + + H V+HR+LK +N+ + G VK+ D G
Sbjct: 104 REYYSEADASHC---IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 69 LAAILRGSQHA-HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSEC 124
LA + G Q A GTP +++PE L ++ Y + VD+++ G +L +L YP + E
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPPFWDE- 216
Query: 125 SNPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
+ ++Y+++ +G F + EA+ + K L N SKR+ A E L P+++
Sbjct: 217 -DQHRLYQQIKAGAY--DFPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 179 SDAGEPLLIPKVPSFQNL 196
+ + + + L
Sbjct: 273 HRSTVASCMHRQETVDCL 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 14/177 (7%)
Query: 20 RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSQH 78
+ RQ+ +G+ ++H ++ +H DLK +NI F ++K+ D GL A L Q
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 79 AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVT 135
GT EF APE + D++S G + +L S E N + + V
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVK 369
Query: 136 SGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
S AF I + + + F+ K L + + R+ + L P+L
Sbjct: 370 SCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 23/188 (12%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70
+ + + R + R +L I LH + ++HRDLK +NI ++ + +K+ D G +
Sbjct: 118 KVTLSEKETRKI---MRALLEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFS 171
Query: 71 AILRGSQHAHSVIGTPEFMAPE-------LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
L + V GTP ++APE Y + VD++S G ++ L + P +
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFW 230
Query: 122 SECSNPAQIYKKVTSGKL---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ + + SG + D + V + L KR A+E L PF
Sbjct: 231 HR--KQMLMLRMIMSGNYQFGSPEWDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 178 ASDAGEPL 185
E +
Sbjct: 288 QQYVVEEV 295
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 24 NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAA--ILRG 75
WAR +++ + +H IHRD+K DN+ + +GH +K+ D G G
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKEG 222
Query: 76 SQHAHSVIGTPEFMAPEL-----YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQ 129
+ +GTP++++PE+ + Y D +S G+ + EML + P Y++ +
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVG 280
Query: 130 IYKKVTSGKLPGAFHRIQD--AEARRFVGKCLENVSKRL 166
Y K+ + K F D EA+ + L + RL
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 24 NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAA--ILRG 75
AR +I+ I +H +HRD+K DNI + GH +++ D G G
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGH---IRLADFGSCLKLRADG 216
Query: 76 SQHAHSVIGTPEFMAPEL--------YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSN 126
+ + +GTP++++PE+ Y D ++ G+ EM + P Y++ +
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--S 274
Query: 127 PAQIYKKVTSGKLPGAFHRIQDA---EARRFVGKCLENVSKRL 166
A+ Y K+ K + + + EAR F+ + L RL
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 26/136 (19%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH-------GHDPPVIHRDLKCDNIFVNG 57
G+L +Y +T D + A + RG+AYLH + P + HRDL N+ V
Sbjct: 97 GSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155
Query: 58 HLGQVKIGDLGLAAILRGSQHA---------HSVIGTPEFMAPELYE--------EDYNE 100
G I D GL+ L G++ S +GT +MAPE+ E E +
Sbjct: 156 D-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214
Query: 101 LVDIYSFGMCVLEMLT 116
VD+Y+ G+ E+
Sbjct: 215 QVDMYALGLIYWEIFM 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-22
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI-GT 85
QI+ G+ YLH H ++HRDL N+ + + +KI D GLA L+ H + GT
Sbjct: 119 HQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 86 PEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSEYPYSECSNPAQIYKKVTSG--KLPG 141
P +++PE + D++S G C+ +L P+ + KV ++P
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPS 233
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
EA+ + + L N + RL +L PF
Sbjct: 234 FLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPF 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 48/145 (33%), Positives = 68/145 (46%), Gaps = 15/145 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
+I + +LH +I+RDLK +NI + GH VK+ D GL + H+ G
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCG 183
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
T E+MAPE L +N VD +S G + +MLT P E N + K+ KL
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLN-- 239
Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
EAR + K L+ N + RL
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRL 264
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 17/180 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSQHA-HSVI 83
RQIL + Y H ++ +IHRD+K + + VK+G G+A L S +
Sbjct: 137 RQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQIYKKVTSGKL- 139
GTP FMAPE + E Y + VD++ G +L +L S Y ++++ + GK
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYK 250
Query: 140 --PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
P + I + A+ V + L + ++R+ E L P+L I + + L
Sbjct: 251 MNPRQWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 14/145 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSQHAHSVI 83
A ++ + YLH D +I+RDLK +NI + NGH +KI D G A +++
Sbjct: 112 AAEVCLALEYLHSKD--IIYRDLKPENILLDKNGH---IKITDFGFAK--YVPDVTYTLC 164
Query: 84 GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142
GTP+++APE + + YN+ +D +SFG+ + EML P+ SN + Y+K+ + +L
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAEL--R 221
Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
F + + + + + + ++S+RL
Sbjct: 222 FPPFFNEDVKDLLSRLITRDLSQRL 246
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 39/160 (24%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHSV 82
+ + +++GI YLH +IHRD+K N+ V G +KI D G++ +GS +
Sbjct: 141 FYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNT 197
Query: 83 IGTPEFMAPEL---YEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
+GTP FMAPE + ++ + +D+++ G+ + + + P+ + ++ K+ S
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQA 256
Query: 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
L + + + + L+ N R+ E+ L P++
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 15/169 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+ I I YLH + + HRD+K +N+ + + +K+ D G A +
Sbjct: 168 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQ--IYKKVTSGKL 139
TP ++APE L E Y++ D++S G ++ +L YP YS + ++ G+
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
+ + + E + + L+ ++R+ E + P++ P
Sbjct: 285 EFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 15/145 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
++ + +LH +I+RDLK +NI + GH +K+ D GL+ + + A+S G
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCG 188
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
T E+MAPE + + + D +SFG+ + EMLT P + + + + KL
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLG-- 244
Query: 143 FHRIQDAEARRFVGKCLE-NVSKRL 166
+ EA+ + + N + RL
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRL 269
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSV 82
A +I + YLH + +++RDLK +NI + GH + + D GL + + +
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTF 199
Query: 83 IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
GTPE++APE L+++ Y+ VD + G + EML P+ N A++Y + + L
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQ- 257
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
AR + L+ + +KRL AK+
Sbjct: 258 -LKPNITNSARHLLEGLLQKDRTKRLGAKD 286
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-22
Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ + + QI+ G+ +LH + +I+RDLK +N+ ++ G V+I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISD 332
Query: 67 LGLA-AILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY--- 121
LGLA + G GTP FMAPE L E+Y+ VD ++ G+ + EM+ + P+
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
E ++ ++V + + ++ F L+ + KRL
Sbjct: 393 GEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRL 436
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 36/193 (18%), Positives = 63/193 (32%), Gaps = 31/193 (16%)
Query: 5 GTLREYRKKYTRVDIRA-----VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
GTL Y + V ++A ++L I +H + +IH D+K DN +
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209
Query: 60 ----------GQVKIGDLGLAAILRG---SQHAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
+ + DLG + ++ + T F E L + +N +D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 106 SFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA-RRFVGKCL-ENVS 163
V ML Y + + + F R+ + F L
Sbjct: 270 GVAATVYCMLFGTYMKVKNEGGECKPEGL--------FRRLPHLDMWNEFFHVMLNIPDC 321
Query: 164 KRLPAKELLLDPF 176
LP+ +LL
Sbjct: 322 HHLPSLDLLRQKL 334
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A QI+ YLH D +I+RDLK +N+ ++ G +++ D G A R ++ GT
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAK--RVKGRTWTLCGT 201
Query: 86 PEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
PE +APE + + YN+ VD ++ G+ + EM P+ P QIY+K+ SGK+ F
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKV--RFP 258
Query: 145 RIQDAEARRFVGKCLE-NVSKRL 166
++ + + L+ +++KR
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 38/182 (20%), Positives = 82/182 (45%), Gaps = 27/182 (14%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70
+ + + R++ R +L +++LH ++ ++HRDLK +NI ++ ++ Q+++ D G +
Sbjct: 194 KVALSEKETRSI---MRSLLEAVSFLHANN--IVHRDLKPENILLDDNM-QIRLSDFGFS 247
Query: 71 AILRGSQHAHSVIGTPEFMAPE-------LYEEDYNELVDIYSFGMCVLEMLTSEYP--Y 121
L + + GTP ++APE Y + VD+++ G +L L + P +
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFW 306
Query: 122 SECSNPAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
+ + + G+ F + + + L+ + RL A++ L P
Sbjct: 307 HR--RQILMLRMIMEGQY--QFSSPEWDDRSS-TVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 176 FL 177
F
Sbjct: 362 FF 363
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 24 NWAR----QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAA--ILRG 75
AR +++ I +H +HRD+K DNI + NGH +++ D G + G
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDG 229
Query: 76 SQHAHSVIGTPEFMAPEL------YEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPA 128
+ + +GTP++++PE+ + Y D +S G+C+ EML E P Y+E +
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLV 287
Query: 129 QIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLENVSKRL 166
+ Y K+ + K F A+ + + + + RL
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRL 328
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 41/150 (27%), Positives = 80/150 (53%), Gaps = 18/150 (12%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA--AILRGSQHAHSVI 83
+I+ + +LH +I+RD+K +NI + NGH V + D GL+ + ++ A+
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFC 221
Query: 84 GTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPY---SECSNPAQIYKKVTSG 137
GT E+MAP++ +++ VD +S G+ + E+LT P+ E ++ A+I +++
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ P + + A A+ + + L + KRL
Sbjct: 282 EPP--YPQEMSALAKDLIQRLLMKDPKKRL 309
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 37/169 (21%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSQHAHSVIG 84
R I I +LH H+ + HRD+K +N+ + + +K+ D G A + +
Sbjct: 135 RDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCY 191
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSN--PAQIYKKVTSGKL 139
TP ++APE L E Y++ D++S G ++ +L +P YS + +++ G+
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 140 ---PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
+ + + +A++ + L+ + ++RL + + P++ P
Sbjct: 251 GFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 26/178 (14%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSV 82
+I+ + YLH D V++RD+K +N+ + +GH +KI D GL + +
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTF 165
Query: 83 IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLP 140
GTPE++APE L + DY VD + G+ + EM+ P Y++ + ++++ + ++
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR 223
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLN 197
F R EA+ + L+ + +RL SDA E + + F ++N
Sbjct: 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGP--------SDAKE---VMEHRFFLSIN 268
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
++ +A +I+ G+ ++H V++RDLK NI ++ H G V+I DLGLA + H+
Sbjct: 294 MRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHA 349
Query: 82 VIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTSEYPY--SECSNPAQIYKKVTSG 137
+GT +MAPE Y+ D +S G + ++L P+ + + +I + +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ E R + L+ +V++RL
Sbjct: 410 AVE--LPDSFSPELRSLLEGLLQRDVNRRL 437
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
TL EY + + + + N+ QIL GI + H ++HRD+K NI ++ + +KI
Sbjct: 97 TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIF 153
Query: 66 DLGLAAILRGSQ--HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPY 121
D G+A L + + V+GT ++ +PE + E +E DIYS G VL EML E P+
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG-IVLYEMLVGEPPF 212
Query: 122 SECSNPAQI-YKKVTSG--KLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-AKELLLD 174
+ I K + + + + + E + + R +E+ D
Sbjct: 213 NG-ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A +I G+ LH +++RDLK +NI ++ H G ++I DLGLA + Q +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY---SECSNPAQIYKKVTSGKLP 140
T +MAPE + E Y D ++ G + EM+ + P+ + ++ + V
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
+ +AR + L + ++RL +
Sbjct: 408 --YSERFSPQARSLCSQLLCKDPAERLGCRG 436
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 15/149 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
+I+ G+ +LH +++RDLK DNI + +GH +KI D G+ + G ++ G
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFCG 180
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP-YSECSNPAQIYKKVTSGKLPGA 142
TP+++APE L + YN VD +SFG+ + EML + P + + + +++ +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF-- 236
Query: 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKE 170
+ R + EA+ + K KRL +
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 11/119 (9%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
+L+ + + ++ + + +IL ++YLH +++ DLK +NI + Q+K+
Sbjct: 169 QSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTE--EQLKL 222
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVL-EMLTSEYPYS 122
DLG + GTP F APE+ DIY+ G L + +
Sbjct: 223 IDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQHAHSVIGTP 86
+I+ + +LH +I+RDLK DN+ ++ G K+ D G+ + + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 87 EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHR 145
+++APE L E Y VD ++ G+ + EML P+ E N +++ + + ++ +
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVV--YPT 245
Query: 146 IQDAEARRFVGKCLE-NVSKRLPAKE 170
+A + + N + RL +
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSLT 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 11 RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLG 68
R+ + ++ V + + + +LH + HRDLK +NI + + VKI D
Sbjct: 105 RRHFNELEASVV---VQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD 159
Query: 69 LAAILR--------GSQHAHSVIGTPEFMAPE------LYEEDYNELVDIYSFGMCVLEM 114
L + ++ + + G+ E+MAPE Y++ D++S G +L +
Sbjct: 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYI 218
Query: 115 LTSEYP--YSEC-SNPAQIYKKVTSGKLPGAFHRIQDA--------------EARRFVGK 157
L S YP C S+ + F IQ+ A+ + K
Sbjct: 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 158 CLE-NVSKRLPAKELLLDPFLASDAGE-PLLIPKV 190
L + +RL A ++L P++ A E L P V
Sbjct: 279 LLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 13/144 (9%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
+I G+ +L +I+RDLK DN+ + GH +KI D G+ + + G
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCG 183
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TP+++APE + + Y + VD ++FG+ + EML + P+ E + ++++ + + +
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA--Y 240
Query: 144 HRIQDAEARRFVGKCLE-NVSKRL 166
+ EA + + KRL
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRL 264
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 40/192 (20%), Positives = 86/192 (44%), Gaps = 10/192 (5%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTP 86
RQI+ + Y H ++HRDLK +N+ ++ +KI D G + + G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAP 177
Query: 87 EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
+ APEL++ + Y+ VD++S G+ + +++ P+ + ++ ++V GK F+
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVLRGKYRIPFY 236
Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVT 203
+ + + L N KR ++++ D ++ + E L P V + +
Sbjct: 237 --MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP-ELDISDQKRI 293
Query: 204 ELVPQFAVDSDR 215
+++ +
Sbjct: 294 DIMVGMGYSQEE 305
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
TLR+ + + + + + H + +IHRD+K NI ++ VK+
Sbjct: 102 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVM 158
Query: 66 DLGLAAILRGSQ----HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEY 119
D G+A + S +VIGT ++++PE + + D+YS G CVL E+LT E
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG-CVLYEVLTGEP 217
Query: 120 PYSECSNPAQI-YKKVTSG-KLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-AKELLLDP 175
P++ +P + Y+ V P A H A+ V K L N R A E+ D
Sbjct: 218 PFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD- 275
Query: 176 FLASDAGEPLLIPKVPS 192
+ GEP PKV +
Sbjct: 276 LVRVHNGEPPEAPKVLT 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 15/173 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTP 86
Q++ I + H V+HRD+K +NI ++ G K+ D G A+L + GT
Sbjct: 146 GQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 87 EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
+ PE Y+ ++S G+ + +M+ + P+ +++ +L H
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELHFPAH 255
Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
+ + +CL S R +E+LLDP++ + A + L P L
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPL 306
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 20/154 (12%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSV 82
+ +I + YLH +I+RDLK DN+ + GH +K+ D G+ LR +
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 170
Query: 83 IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS--------NPAQIYKK 133
GTP ++APE L EDY VD ++ G+ + EM+ P+ +++
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ ++ R +A + L + +RL
Sbjct: 231 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERL 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 14/219 (6%)
Query: 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
+ G L +Y + R+ + + +QI+ I Y H H ++HRDLK +N+ ++ +
Sbjct: 90 YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LN 146
Query: 62 VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEY 119
VKI D GL+ I+ + G+P + APE+ + Y VD++S G+ + ML
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206
Query: 120 PYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176
P+ + ++KKV S +P A+ + + + + +R+ +E+ DP+
Sbjct: 207 PFDD-EFIPNLFKKVNSCVYVMPDFLSP----GAQSLIRRMIVADPMQRITIQEIRRDPW 261
Query: 177 LASDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDR 215
+ + L + + V++L D
Sbjct: 262 FNVNLPDYLRPMEEVQGSYADSR-IVSKLGEAMGFSEDY 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 39/178 (21%), Positives = 75/178 (42%), Gaps = 17/178 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL---RGSQHAHSVI 83
Q++ G+ YLH ++H+D+K N+ + G +KI LG+A L +
Sbjct: 116 CQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 84 GTPEFMAPELY--EEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-- 138
G+P F PE+ + ++ VDI+S G+ + + T YP+ E N ++++ + G
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYA 231
Query: 139 LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQN 195
+PG + LE +KR +++ + +P +
Sbjct: 232 IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 2e-19
Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
A +I G+ +L +I+RDLK DN+ ++ G +KI D G+ + + G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TP+++APE + + Y + VD ++FG+ + EML + P+ E + ++++ + + +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA--Y 561
Query: 144 HRIQDAEARRFVGKCLE-NVSKRL 166
+ EA + + KRL
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRL 585
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQHAHSVIGT 85
+Q+L G++Y H + HRDLK +N ++G ++KI D G + S +GT
Sbjct: 123 QQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180
Query: 86 PEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK----VTSGK- 138
P ++APE+ ++Y+ ++ D++S G+ + ML YP+ E + Y+K + S K
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKY 239
Query: 139 -LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
+P E + + + + R+ E+ + + L+ Q
Sbjct: 240 SIPDDIRI--SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQ 297
Query: 197 NPNGAVTELVPQFAVDSDRRKSTDMT 222
P + L + S+
Sbjct: 298 EPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 20/154 (12%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSV 82
+ +I + YLH +I+RDLK DN+ + GH +K+ D G+ LR +
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 213
Query: 83 IGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS--------NPAQIYKK 133
GTP ++APE L EDY VD ++ G+ + EM+ P+ +++
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 134 VTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
+ ++ R +A + L + +RL
Sbjct: 274 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERL 305
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSQHAHSVIG 84
+I+ + YLH V++RDLK +N+ + +GH +KI D GL ++ + G
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCG 311
Query: 85 TPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143
TPE++APE L + DY VD + G+ + EM+ P+ + ++++ + ++ F
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR--F 368
Query: 144 HRIQDAEARRFVGKCLE-NVSKRL-----PAKELLLDPFLAS 179
R EA+ + L+ + +RL AKE++ F A
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA---HSVI 83
Q++ G+ YLHG + HRD+K +N+ ++ +KI D GLA + R + + +
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 84 GTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
GT ++APEL + +++ E VD++S G+ + ML E P+ + S+ Q Y K
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--- 225
Query: 142 AFHRIQ----DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
+ D+ + K L N S R+ ++ D + + P+V S
Sbjct: 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVS 284
Query: 197 NPNGAVTELVPQ 208
++ +
Sbjct: 285 ESPSGFSKHIQS 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA---HSVI 83
Q++ G+ YLHG + HRD+K +N+ ++ +KI D GLA + R + + +
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 84 GTPEFMAPE-LYEEDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG 141
GT ++APE L +++ E VD++S G+ + ML E P+ + S+ Q Y K
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP 188
+ D+ + K L N S R+ ++ D + + P
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
L ++ + RQI + H HRD+K +NI V+ +
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLV 176
Query: 66 DLGLAAILRGSQ--HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVL-EMLTSEYPY 121
D G+A+ + + +GT +MAPE + DIY+ CVL E LT PY
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY 235
Query: 122 S 122
Sbjct: 236 Q 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 46/207 (22%), Positives = 73/207 (35%), Gaps = 38/207 (18%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
R Y ++ +K + Q++R I LH V HRD+K N+ VN G +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 67 LGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE----- 118
G A L S+ + I + + APEL + Y VDI+S G C+ EM+ E
Sbjct: 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRG 234
Query: 119 --------------------------YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152
+++ S + EA
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLY-NSKGIPWSNVFSDHSLKD-AKEAY 292
Query: 153 RFVGKCLE-NVSKRLPAKELLLDPFLA 178
+ L+ +R+ E L P+
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFD 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 64/267 (23%), Positives = 101/267 (37%), Gaps = 48/267 (17%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
R Y K + + +K + Q+LR +AY+H + HRD+K N+ ++ G +K+ D
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLID 185
Query: 67 LGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT------- 116
G A IL + S I + + APEL +Y +DI+S G CV+ E++
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPG 244
Query: 117 -SEY------------PYSE---CSNPAQI------YKKVTSGKLPGAFHRIQDAEARRF 154
S P E NP + + K+ F +A
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV---FRPRTPPDAIDL 301
Query: 155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIP---KVPSFQNLNPNGA------VTE 204
+ + LE S RL A E L PF +P ++P N ++
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISR 361
Query: 205 LVPQFAVDSDRRKSTDMTITGTMNPED 231
LVPQ A + D+ + E
Sbjct: 362 LVPQHAEAELLSRGIDVHNFQPIPLES 388
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 42/236 (17%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
L+ + + + + + + Q+ R + ++H + HRD+K N+ VN +K+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 67 LGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EML-------- 115
G A L S+ + + I + + APEL +Y +D++S G CV E++
Sbjct: 186 FGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFSG 244
Query: 116 -----------------TSEYPYSECSNPAQIYKKVTSGK-LPGAFHRIQDAEARRFVGK 157
T E + ++ K + A + +
Sbjct: 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304
Query: 158 CLE-NVSKRLPAKELLLDPFLAS---DAGEPLLIPKVPSFQNLNPNGAVTELVPQF 209
L R+ E + PF + P+G + F
Sbjct: 305 ILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSN------FPHGVNQNIPQLF 354
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y K+ RV+ + +QIL + Y H H V+HRDLK +N+ ++ H KI
Sbjct: 96 GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKI 152
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYS 122
D GL+ ++ + + G+P + APE+ Y VDI+S G+ + +L P+
Sbjct: 153 ADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
Query: 123 ECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ + ++KK+ G +P +R + L+ + KR K++ +
Sbjct: 213 D-EHVPTLFKKIRGGVFYIPEYLNR----SVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267
Query: 180 DAGEPLL 186
D L
Sbjct: 268 DLPSYLF 274
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 33/203 (16%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
R Y + + + VK + Q+ R +AY+H + HRD+K N+ ++ +K+ D
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 67 LGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE--YPY 121
G A L + S I + + APEL DY +D++S G CVL E+L + +P
Sbjct: 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPG 259
Query: 122 SECSN------------PAQIYKKVTSGKLPGAFHRIQ------------DAEARRFVGK 157
+ + +++ F +I+ EA +
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 158 CLE-NVSKRLPAKELLLDPFLAS 179
LE + RL E F
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDE 342
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 35/176 (19%), Positives = 76/176 (43%), Gaps = 15/176 (8%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTP 86
Q+L + + H V+HRD+K +NI ++ + G++K+ D G A+L+ + + GT
Sbjct: 156 WQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTR 212
Query: 87 EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
+ PE Y+ ++S G+ + +M+ + P+ +++ G++ F
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQV--FFR 263
Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPN 199
+ +E + + CL S R +E+ P++ + P+
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 6 TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
T+ +Y R V VK+ Q L+ + + H H+ IHRD+K +NI + H +K+
Sbjct: 87 TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKL 143
Query: 65 GDLGLAAILRGSQHA--HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE- 118
D G A +L G V T + +PEL + Y VD+++ G CV E+L+
Sbjct: 144 CDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGVP 201
Query: 119 -YPYSECSNPAQIYK--KV----TSGKLPG-----AFHRIQ-----------------DA 149
+P S+ Q+Y K F ++
Sbjct: 202 LWPGK--SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISY 259
Query: 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLAS--DAGEPLLIPKVPS 192
A + CL + ++RL ++LL P+ + + + P+
Sbjct: 260 PALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPA 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 13/218 (5%)
Query: 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
+ G L +Y K R+D + + +QIL G+ Y H H V+HRDLK +N+ ++ H
Sbjct: 99 SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNA 155
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYP 120
KI D GL+ ++ + + G+P + APE+ Y VDI+S G+ + +L P
Sbjct: 156 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
Query: 121 YSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ + + ++KK+ G P + + L+ + KR K++ +
Sbjct: 216 FDD-DHVPTLFKKICDGIFYTPQYLNP----SVISLLKHMLQVDPMKRATIKDIREHEWF 270
Query: 178 ASDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDR 215
D + L + + A+ E+ +F +
Sbjct: 271 KQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEE 308
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 43/208 (20%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTP 86
RQ++ + YL D +IHRD+K +NI + +K+ D G AA L + ++ GT
Sbjct: 137 RQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 87 EFMAPELYE-EDYN-ELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
E+ APE+ Y ++++S G+ L L E NP ++ + +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCELEETVEAAIHPPYL 246
Query: 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVT 203
E V L+ +R ++L+ DP++ +P+ + + N +
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT----QPVNLADYTWEEVFRVNKPES 300
Query: 204 ELVPQFAVDSDRRKSTDMTITGTMNPED 231
++ +++ R +D+ + +
Sbjct: 301 GVLSAASLEMGNRSLSDVAQAQELCGGE 328
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 42/214 (19%), Positives = 79/214 (36%), Gaps = 50/214 (23%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
+K + +L G+ Y+H + ++HRD+K N+ + G +K+ D GLA ++++
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 82 VIGTPE-----FMAPELY--EEDYNELVDIYSFGMCVL-EMLT----------------- 116
T + PEL E DY +D++ G C++ EM T
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLALI 241
Query: 117 ---------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE- 160
Y E + K+ +L ++D A + K L
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLLVL 298
Query: 161 NVSKRLPAKELLLDPFLASD--AGEPLLIPKVPS 192
+ ++R+ + + L F SD + +
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHL 332
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 50/193 (25%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+LRG+ Y+H + V+HRDLK N+F+N +KIGD GLA R +S
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA---RIMDPHYS---HKG 179
Query: 88 FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
+ +P L +Y + +D+++ G C+ EMLT
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 117 ------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRL 166
E E + +Y + + ++ EA F+ + L + RL
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 167 PAKELLLDPFLAS 179
A+E L P+++
Sbjct: 299 TAEEALSHPYMSI 311
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 44/107 (41%), Positives = 59/107 (55%), Gaps = 13/107 (12%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLA----AILR 74
VK+ QIL GI YLH + V+HRDLK NI V G G+VKI D+G A + L+
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 75 GSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSE 118
V+ T + APEL Y + +DI++ G C+ E+LTSE
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 46/209 (22%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSQHA 79
+K+ Q+LRG+ +LH H V+HRDLK NI V GQ+K+ D GLA R Q A
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA---RIYSFQMA 175
Query: 80 --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLTSE--YPYSECSNPAQIYK- 132
V+ T + APE L + Y VD++S G C+ EM + + S S+ Q+ K
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFRRKPLFRGS--SDVDQLGKI 231
Query: 133 ------------------------KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
++ + I D + + KCL N +KR+
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-DELGKDLLLKCLTFNPAKRIS 290
Query: 168 AKELLLDPFLAS-DAGEPLLIPKVPSFQN 195
A L P+ + + L +P QN
Sbjct: 291 AYSALSHPYFQDLERCKENLDSHLPPSQN 319
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 50/215 (23%)
Query: 6 TLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
T+ + + + +D + V+ + QI+ GI + H H+ +IHRD+K +NI V+ G VK+
Sbjct: 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKL 165
Query: 65 GDLGLAAILRGSQHA--HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT--- 116
D G A L V T + APEL + Y + VD+++ G C++ EM
Sbjct: 166 CDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGEP 223
Query: 117 -----------------------------SEYP-YSECSNPAQIYKKVTSGKLPGAFHRI 146
++ P ++ P ++ + P
Sbjct: 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL---- 279
Query: 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
KCL + KR ELL F D
Sbjct: 280 -SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 16/108 (14%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-----GS 76
VK++ Q+L+G+ + H + V+HRDLK N+ +N G++K+ + GLA R
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLA---RAFGIPVR 156
Query: 77 QHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSEYPY 121
++ V+ T + P++ + Y+ +D++S G C+ E+ + P
Sbjct: 157 CYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R+ + + + NW QI +G+ YL ++HRDL N+ V VK
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVK 157
Query: 64 IGDLGLAAILRGSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
I D GLA +L + + G P ++MA E + Y D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY ++I + G
Sbjct: 218 KPYDGIPA-SEISSILEKG 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN----GHLGQV 62
L++Y K V +R +K++ Q++ G+ + H +HRDLK N+ ++ +
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL 176
Query: 63 KIGDLGLAAILR-----GSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EM 114
KIGD GLA R Q H +I T + PE+ Y+ VDI+S C+ EM
Sbjct: 177 KIGDFGLA---RAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEM 231
Query: 115 LT--------SE------------------YP-YSECSNPAQIYKKVTSGKLPGAFHRIQ 147
L SE +P + + Q + K L +
Sbjct: 232 LMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALL 291
Query: 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
D E + LE + KR+ AK L P+ + + +P
Sbjct: 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 57/218 (26%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81
VK + Q+L+G+A+ H + ++HRDLK N+ +N GQ+K+GD GLA A
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA-------RAFG 159
Query: 82 VIG---TPEFM-----APELY--EEDYNELVDIYSFGMCVL-EMLT-------------- 116
+ + E + AP++ Y+ +DI+S G C+L EM+T
Sbjct: 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMITGKPLFPGTNDEEQL 218
Query: 117 ------------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158
++ P + + + + L D F+
Sbjct: 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQ-VLQPHTKEPLDGNLMDFLHGL 277
Query: 159 LE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQN 195
L+ N RL AK+ L P+ ++ + S +
Sbjct: 278 LQLNPDMRLSAKQALHHPWF-AEYYHHASMGGSRSHHH 314
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 42/218 (19%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA-- 79
VK + Q+LRG+AY H V+HRDLK N+ +N G++K+ D GLA
Sbjct: 102 VKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYD 158
Query: 80 HSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLTSEYPY----SE--------- 123
+ V+ T + P++ DY+ +D++ G C+ EM T P +
Sbjct: 159 NEVV-TLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMATGR-PLFPGSTVEEQLHFIFR 215
Query: 124 -------------CSNP---AQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL 166
SN Y K + L R+ D++ + K L+ R+
Sbjct: 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL-DSDGADLLTKLLQFEGRNRI 274
Query: 167 PAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVTE 204
A++ + PF S +P S L E
Sbjct: 275 SAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE 312
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 51/213 (23%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSQHAHSVIGTP 86
Q LR + LHG + VIHRDLK N+ +N + +K+ D GLA I + G
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 87 EFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLTSE--------------- 118
M APE L Y+ +D++S G C+L E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLI 235
Query: 119 -----YPYSE------CSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVS 163
P+S+ S A+ Y K ++ + + + + L + +
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 164 KRLPAKELLLDPFLAS---DAGEPLLIPKVPSF 193
KR+ AKE L P+L + EP P PSF
Sbjct: 296 KRITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 23/112 (20%)
Query: 15 TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73
R I A RG+AYLH H DP +IHRD+K NI ++ + +GD GLA L
Sbjct: 132 KRQRI------ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK-L 183
Query: 74 RGSQHAH---SVIGTPEFMAPELYEEDY------NELVDIYSFGMCVLEMLT 116
+ H +V GT +APE Y +E D++ +G+ +LE++T
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 16/103 (15%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-----GS 76
+K + Q+LRG+A+ H H ++HRDLK N+ +N G +K+ D GLA R
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA---RAFGIPVR 174
Query: 77 QHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
+ H V+ T + AP++ + Y+ VDI+S G C+ EM+T
Sbjct: 175 SYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 51/202 (25%), Positives = 75/202 (37%), Gaps = 55/202 (27%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSQHA 79
+K+ RQ LRG+ +LH + ++HRDLK +NI V G VK+ D GLA R Q A
Sbjct: 122 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLA---RIYSYQMA 175
Query: 80 --HSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------- 116
V+ T + APE L + Y VD++S G C+ EM
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFRRKPLFCGNSEADQLGKIFD 233
Query: 117 -------------SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NV 162
P + + + + + + + L N
Sbjct: 234 LIGLPPEDDWPRDVSLPRGA-------FPPRGPRPVQSVVPEM-EESGAQLLLEMLTFNP 285
Query: 163 SKRLPAKELLLDPFLASDAGEP 184
KR+ A L +L D G P
Sbjct: 286 HKRISAFRALQHSYLHKDEGNP 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 31 RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH---SVIGTPE 87
GI +LH + IHRD+K NI ++ KI D GLA ++GT
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 88 FMAPELYEEDYNELVDIYSFGMCVLEMLT 116
+MAPE + DIYSFG+ +LE++T
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 16/103 (15%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-----GS 76
K++ Q+L GIAY H V+HRDLK N+ +N G++KI D GLA R
Sbjct: 102 AKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLA---RAFGIPVR 155
Query: 77 QHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
++ H ++ T + AP++ + Y+ +DI+S G C+ EM+
Sbjct: 156 KYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 52/194 (26%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
QILRG+ Y+H + V+HRDLK N+ +N +KI D GLA R + H
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLA---RVADPDH---DHTG 186
Query: 88 FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
F+ APE L + Y + +DI+S G C+L EML+
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKR 165
E + A+ Y K ++R+ D++A + K L N KR
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305
Query: 166 LPAKELLLDPFLAS 179
+ ++ L P+L
Sbjct: 306 IEVEQALAHPYLEQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 31 RGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH---SVIGTPE 87
RG+ YLH +IHRD+K NI ++ + KI D G++ H V GT
Sbjct: 150 RGLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 88 FMAPELYEEDY-NELVDIYSFGMCVLEMLT 116
++ PE + + E D+YSFG+ + E+L
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R+ + + + NW QI +G+ YL ++HRDL N+ V VK
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVK 157
Query: 64 IGDLGLAAILRGSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
I D GLA +L + + G P ++MA E + Y D++S+G+ V E++T
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY ++I + G
Sbjct: 218 KPYDGIPA-SEISSILEKG 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 45/195 (23%), Positives = 69/195 (35%), Gaps = 57/195 (29%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
IL G+ LH V+HRDL NI + + + I D LA R
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA---RE-------DTADA 188
Query: 88 FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
APE + + + +LVD++S G CV+ EM
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPG-AFHRI---QDAEARRFVGKCLE-NVSK 164
E S A+ Y + + +P A+ + D A + K LE N +
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 165 RLPAKELLLDPFLAS 179
R+ ++ L P+ S
Sbjct: 308 RISTEQALRHPYFES 322
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 16/103 (15%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GS--- 76
+K + L+G+ YLH H ++HRDLK +N+ ++ G +K+ D GLA + GS
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLA---KSFGSPNR 167
Query: 77 QHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVL-EMLT 116
+ H V+ T + APEL Y VD+++ G C+L E+L
Sbjct: 168 AYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 36/139 (25%), Positives = 68/139 (48%), Gaps = 10/139 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L ++ R+ + + + NW QI +G+ YL H ++HR+L N+ + QV+
Sbjct: 99 GSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQ 155
Query: 64 IGDLGLAAILRGSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
+ D G+A +L P ++MA E ++ Y D++S+G+ V E++T
Sbjct: 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY+ A++ + G
Sbjct: 216 EPYAGLRL-AEVPDLLEKG 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 44/192 (22%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHAHSVIGTP 86
+IL+ + Y H ++HRD+K N+ ++ ++++ D GLA G ++ V +
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASR 194
Query: 87 EFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT--------------------------- 116
F PE + + Y+ +D++S G C+L M+
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253
Query: 117 SEYPYSECSNPAQIY--------KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP 167
+Y + +K + + EA F+ K L + RL
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 168 AKELLLDPFLAS 179
A+E + P+ +
Sbjct: 314 AREAMEHPYFYT 325
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 32/168 (19%), Positives = 65/168 (38%), Gaps = 34/168 (20%)
Query: 27 RQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSQHAHSVIG 84
+ I I YLH + + HRD+K +N+ + + +K+ D G
Sbjct: 124 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166
Query: 85 TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYP--YSECSNPAQ--IYKKVTSGKL- 139
A E E Y++ D++S G ++ +L YP YS + ++ G+
Sbjct: 167 -----AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220
Query: 140 --PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184
+ + + E + + L+ ++R+ E + P++ P
Sbjct: 221 FPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 37/140 (26%), Positives = 56/140 (40%), Gaps = 12/140 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G + R + R+ ++ + G+ YL IHRDL N V +K
Sbjct: 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKN-VLK 253
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
I D G++ +A S G + APE L Y+ D++SFG+ + E +
Sbjct: 254 ISDFGMSREEADGVYAASG-GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312
Query: 118 EYPYSECSNPAQIYKKVTSG 137
PY SN Q + V G
Sbjct: 313 ASPYPNLSN-QQTREFVEKG 331
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 45/142 (31%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+LR+Y +K R+D + + QI +G+ YL IHRDL NI V +VK
Sbjct: 98 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVK 154
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
IGD GL +L + V E APE L E ++ D++SFG+ + E+ T
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 212
Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
Y E S G
Sbjct: 213 --YIEKSKSPPAEFMRMIGNDK 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 40/185 (21%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV-IGTP 86
Q+L+G+ Y+H +IHRDLK N+ VN ++KI D GLA R + + + T
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA---RQADSEMTGYVVTR 189
Query: 87 EFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT-------------------------SE 118
+ APE L Y + VDI+S G C++ EM+T +E
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKELLLD 174
+ S+ A+ Y K F I A + K L + +R+ A E L
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 175 PFLAS 179
P+ S
Sbjct: 309 PYFES 313
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 57/225 (25%)
Query: 7 LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-----NGHL 59
L KK + + + VK ++Q+L G+ Y+H +IH D+K +N+ + +L
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENL 174
Query: 60 GQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
Q+KI DLG A +H + I T E+ +PE L + DI+S + E++T +
Sbjct: 175 IQIKIADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
Query: 119 Y------PYSECSNPAQI------------------------------YKKVTSGKLPG- 141
+ +S + I + ++ K
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292
Query: 142 -----AFHRIQDAEARRF---VGKCLE-NVSKRLPAKELLLDPFL 177
++ EA+ + L+ + KR A L+ P+L
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 54/185 (29%), Positives = 80/185 (43%), Gaps = 40/185 (21%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV-IGTP 86
Q+L+G+ Y+H V+HRDLK N+ VN ++KI D GLA R + + + T
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTR 187
Query: 87 EFMAPE--LYEEDYNELVDIYSFGMCVL-EMLT-------------------------SE 118
+ APE L YN+ VDI+S G C++ EMLT +E
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKRLPAKELLLD 174
+ A+ Y + F ++ +A + K LE +V KRL A + L
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 175 PFLAS 179
PF
Sbjct: 307 PFFEP 311
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 1e-13
Identities = 70/493 (14%), Positives = 141/493 (28%), Gaps = 150/493 (30%)
Query: 12 KKY--TRVD-IRAVKNWARQILRGIAY--LHG--------------HDPPVIHRDLKCDN 52
KY +R+ ++ + LR + G V +
Sbjct: 127 AKYNVSRLQPYLKLRQALLE-LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK--MDFK 183
Query: 53 IF-VNGHLGQVKIGDLGLAAILR-----------GSQHAHSVIGTPEFMAPEL----YEE 96
IF +N L + L + + S H+ ++ + EL +
Sbjct: 184 IFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 97 DYNE--LV--DIYS------FGM-C-VLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144
Y LV ++ + F + C +L LT+ + A ++
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKIL--LTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 145 RIQDAEARRFVGKCLENVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVTE 204
E + + K L+ + LP + L +P S E + + ++ N
Sbjct: 300 ---PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDGLATWDNWK------- 348
Query: 205 LVPQFAVDSDRRKST-DMTITGTMNPEDDTIFLKVQITDKDGQARNIYFPYDIFNDTA-- 261
V+ D+ + + ++ + P + R ++ +F +A
Sbjct: 349 -----HVNCDKLTTIIESSLN-VLEPAEY---------------RKMFDRLSVFPPSAHI 387
Query: 262 TEVALEMVKELEITDWEPL--EIAEMIEQEI--SSLVPNW----------------KECG 301
+ L ++ W + ++ ++ SLV +
Sbjct: 388 PTILLSLI-------WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 302 SPQFCHQ---------HSFSYEDE-DDDNDDYGIY-HPFY--SNSSHSSSHASLPAFFTN 348
+ H+ +F +D D Y Y H + N H F +
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 349 NANSPPSWLQQ----EDLLGNDDASSNGSVNSFK-YSSWDYHSGNEDDYE--------FS 395
+L+Q + N S ++ K Y Y N+ YE F
Sbjct: 500 F-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYK--PYICDNDPKYERLVNAILDFL 552
Query: 396 HRAGEPLCIARAT 408
+ E L ++ T
Sbjct: 553 PKIEENLICSKYT 565
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 5e-06
Identities = 78/568 (13%), Positives = 150/568 (26%), Gaps = 197/568 (34%)
Query: 7 LREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
L + + D + V++ + IL + D+I ++ G
Sbjct: 22 LSVFEDAFVDNFDCKDVQDMPKSILS---------------KEEIDHIIMSKD---AVSG 63
Query: 66 DLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY--SE 123
L L L Q +F+ E+ +Y L+ M+T Y
Sbjct: 64 TLRLFWTLLSKQEE----MVQKFVE-EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 124 CSNPAQIYKK--VTSGKLPGAFHRIQDA--EAR--RFV--------GK-CL-------EN 161
N Q++ K V+ + + +++ A E R + V GK +
Sbjct: 119 LYNDNQVFAKYNVSRLQP---YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK 175
Query: 162 VSKRLPAK------------ELLLDPFLASDAGEPLLIPKVPSFQNLNPNGAVTELVPQF 209
V ++ K E +L+ LL P++ + + + + +L
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQK------LLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 210 AVDSDRRKSTDMTITGTMNPE-----DD---------------TIFL--KVQITDKDGQA 247
RR + + + Q+TD A
Sbjct: 230 IQAELRR-----LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 248 RNIYFPYDIFNDTATEV-ALEM--------VKEL--EITDWEPLE---IAEMIEQEISSL 293
+ D + T T + ++L E+ P IAE I +++
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 294 VPNWKECGSPQFCHQHSFSYEDEDDDNDDYGIYHPFYSNSSHSSSHASLPAFFTNNANSP 353
NWK + S + + ++ + F +A+ P
Sbjct: 345 -DNWKHVNCDKLTTIIESSLNVLEPA-EYRKMFDRL--------------SVFPPSAHIP 388
Query: 354 PSWLQQEDLLGNDDASSNGSVNSFKYSSWDYHSGNEDDYEFSHRAGEPLCIARATQKSTR 413
L L+ W +
Sbjct: 389 TILLS---LI------------------W-----FDVIKS-------------------- 402
Query: 414 FCPEAAMNNDRCNSEDVNSWKACSTNSNNHRKLSRIRSL-VDVRSQL-----LHRSLVEE 467
+N K I S+ ++++ +L LHRS+V+
Sbjct: 403 -DVMVVVNKLH---------KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452
Query: 468 IHKRRLFKTVGAIEN---------IGFH 486
+ + F + I IG H
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHH 480
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 49/211 (23%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA S + T
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------------SEYPY 121
+ APE + Y E VDI+S G C++ EM+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250
Query: 122 SECSNPAQIY--------KKVTSGKLPGAFH-------RIQDAEARRFVGKCLE-NVSKR 165
+ + Y P +++ ++AR + K L + SKR
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 166 LPAKELLLDPFLAS---DAGEPLLIPKVPSF 193
+ E L P++ + PK+P
Sbjct: 311 ISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 54/194 (27%), Positives = 77/194 (39%), Gaps = 58/194 (29%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
QILRG+ Y+H D +IHRDLK N+ VN ++KI D GLA R T +
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA---R---------HTAD 184
Query: 88 FM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------------------ 116
M APE L YN+ VDI+S G C++ E+LT
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 117 -------SEYPYSECSNPAQIYKKVTSGKLPGAFHRI---QDAEARRFVGKCLE-NVSKR 165
+E S A+ Y + + F + + A + K L + KR
Sbjct: 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303
Query: 166 LPAKELLLDPFLAS 179
+ A + L + A
Sbjct: 304 ITAAQALAHAYFAQ 317
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 45/142 (31%), Positives = 64/142 (45%), Gaps = 13/142 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+LR+Y +K R+D + + QI +G+ YL IHRDL NI V +VK
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVK 185
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
IGD GL +L + + V E APE L E ++ D++SFG+ + E+ T
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-- 243
Query: 119 YPYSECSNPAQIYKKVTSGKLP 140
Y E S G
Sbjct: 244 --YIEKSKSPPAEFMRMIGNDK 263
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 10/139 (7%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G L +Y ++ R ++ AV A QI + YL + IHR+L N V + V
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENH-LV 357
Query: 63 KIGDLGLAAILRGSQHAHSVIGT-P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
K+ D GL+ ++ G + P ++ APE L ++ D+++FG+ + E+ T
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 417
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY +Q+Y+ +
Sbjct: 418 SPYPGIDL-SQVYELLEKD 435
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 36/138 (26%), Positives = 70/138 (50%), Gaps = 9/138 (6%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR + + + +D+ ++ +A Q+ +AYL +HRD+ N+ V+ + VK
Sbjct: 475 GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVK 531
Query: 64 IGDLGLAAILRGSQHAHSVIG-TP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEY 119
+GD GL+ + S + + G P ++MAPE + + D++ FG+C+ E+L
Sbjct: 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
Query: 120 PYSECSNPAQIYKKVTSG 137
P+ N + ++ +G
Sbjct: 592 PFQGVKNN-DVIGRIENG 608
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 10/139 (7%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K T +R + + A QI G+AY+ + +HRDL+ NI V +L
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VC 319
Query: 63 KIGDLGLAAILRGSQHAHSVIGT-P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
K+ D GLA ++ +++ P ++ APE + D++SFG+ + E+ T
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY N ++ +V G
Sbjct: 380 VPYPGMVNR-EVLDQVERG 397
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 10/139 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y ++ V + + Q+ G+ YL + +HRDL N+ + KI
Sbjct: 102 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQH-YAKI 158
Query: 65 GDLGLA-AILRGSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-E 118
D GL+ A+ + + P ++ APE + ++ D++SFG+ + E + +
Sbjct: 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY ++ + G
Sbjct: 219 KPYRGMKGS-EVTAMLEKG 236
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 10/139 (7%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K T +R + + A QI G+AY+ + +HRDL+ NI V +L
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VC 402
Query: 63 KIGDLGLAAILRGSQHAHSVIGT-P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
K+ D GLA ++ +++ P ++ APE + D++SFG+ + E+ T
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY N ++ +V G
Sbjct: 463 VPYPGMVNR-EVLDQVERG 480
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 10/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR++ ++ R+D + ++ QI +G+ YL +HRDL NI V VK
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEA-HVK 167
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
I D GLA +L + + V + APE L + ++ D++SFG+ + E+ T
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ S + ++
Sbjct: 228 DKSCSPSAEFLRMMGCERDV 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 46/194 (23%), Positives = 72/194 (37%), Gaps = 46/194 (23%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPE 87
Q+L GI +LH +IHRDLK NI V +KI D GLA S + T
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 88 FMAPE-LYEEDYNELVDIYSFGMCVL-EMLT------------------------SEYPY 121
+ APE + Y E VDI+S G C++ EM+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 122 SECSNPAQIY--------KKVTSGKLPGAFH-------RIQDAEARRFVGKCLE-NVSKR 165
+ + Y P + +++ ++AR + K L + +KR
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 166 LPAKELLLDPFLAS 179
+ + L P++
Sbjct: 348 ISVDDALQHPYINV 361
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L+EY K +++++ +A QI +G+ YL +HRDL N+ V QVK
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVK 166
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-- 116
IGD GL + + ++V + APE L + + D++SFG+ + E+LT
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 117 -------------SEYPYSECSNPAQIYKKVTSGK-LP 140
+ + + ++ + GK LP
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTV-TRLVNTLKEGKRLP 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 13/140 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR + + + +D+ ++ +A Q+ +AYL +HRD+ N+ V+ + VK
Sbjct: 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVK 156
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
+GD GL+ + S + + G + MAPE + + D++ FG+C+ E+L
Sbjct: 157 LGDFGLSRYMEDSTYYKASKG--KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 118 EYPYSECSNPAQIYKKVTSG 137
P+ N + ++ +G
Sbjct: 215 VKPFQGVKN-NDVIGRIENG 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 11/137 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L + RK + + +A Q+ G+ YL IHRDL N+ + VK
Sbjct: 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVK 161
Query: 64 IGDLGLA-AILRGSQHAHSVIGT--P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
IGD GL A+ + H P + APE L ++ D + FG+ + EM T
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 118 EYPYSECSNPAQIYKKV 134
+ P+ + +QI K+
Sbjct: 222 QEPWIGLNG-SQILHKI 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 30/140 (21%), Positives = 59/140 (42%), Gaps = 11/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ K + + V Q+ G+ YL + +HRDL N+ + K
Sbjct: 94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-YAK 150
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
I D GL+ L ++ ++ APE + ++ D++S+G+ + E L+
Sbjct: 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ PY + ++ + G
Sbjct: 211 QKPYKKMKG-PEVMAFIEQG 229
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 31/140 (22%), Positives = 61/140 (43%), Gaps = 13/140 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y + + + + ++ QI + +AYL + +HRD+ NI V VK
Sbjct: 97 GELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPE-CVK 153
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
+GD GL+ + + + + M+PE + + D++ F +C+ E+L+
Sbjct: 154 LGDFGLSRYIEDEDYYKASVT--RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ P+ N + + G
Sbjct: 212 KQPFFWLEN-KDVIGVLEKG 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/225 (20%), Positives = 78/225 (34%), Gaps = 80/225 (35%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA------------AILRG 75
Q+++ I YLH ++HRD+K NI +N VK+ D GL+ L
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 76 SQHAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT------ 116
+++ + + APE L Y + +D++S G C+L E+L
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIFP 232
Query: 117 ---------------------------SEY--------------PYSECSNPAQIYKKVT 135
S + S + +K +
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 136 SGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
P A + EA + K L+ N +KR+ A + L PF++
Sbjct: 293 LKINPKAD---CNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 26/157 (16%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+LR+Y ++ + + + +A+QI G+AYLH IHRDL N+ ++ VKI
Sbjct: 120 GSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDR-LVKI 175
Query: 65 GDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT--- 116
GD GLA + + V + APE L E + D++SFG+ + E+LT
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD 235
Query: 117 ------------SEYPYSECSNPAQIYKKVTSGK-LP 140
+ + ++ + + G+ LP
Sbjct: 236 SSQSPPTKFLELIGIAQGQMTV-LRLTELLERGERLP 271
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 31/127 (24%), Positives = 45/127 (35%), Gaps = 35/127 (27%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA----------------- 70
+L G+ Y+H ++HRDLK N VN VK+ D GLA
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 71 -AILRGSQHAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLT 116
+ APE L +E+Y E +D++S G C+ E+L
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279
Query: 117 SEYPYSE 123
Sbjct: 280 MIKENVA 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 27/144 (18%), Positives = 58/144 (40%), Gaps = 17/144 (11%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN------- 56
G+L Y +K ++I A+Q+ + +L + +IH ++ NI +
Sbjct: 97 GSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKT 154
Query: 57 GHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEM 114
G+ +K+ D G++ + I ++ PE ++ N D +SFG + E+
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI---PWVPPECIENPKNLNLATDKWSFGTTLWEI 211
Query: 115 LTS-EYPYSECSNPAQIYKKVTSG 137
+ + P S + + +
Sbjct: 212 CSGGDKPLSALDS-QRKLQFYEDR 234
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 6/114 (5%)
Query: 7 LREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVK 63
L + + V + + +A+Q+ + +L + +IH DLK +NI N +K
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
I D G + L Q + I + + +PE L Y+ +D++S G ++EM T
Sbjct: 202 IVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R + + + G+AYL VIHRDL N V + +K
Sbjct: 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQ-VIK 144
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
+ D G+ + Q+ S +F +PE Y+ D++SFG+ + E+ +
Sbjct: 145 VSDFGMTRFVLDDQYTSSTGT--KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ PY SN +++ + +++G
Sbjct: 203 KIPYENRSN-SEVVEDISTG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y R ++ + + G+A+L H IHRDL N V+ L VK
Sbjct: 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDL-CVK 144
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
+ D G+ + Q+ SV +F APE + Y+ D+++FG+ + E+ +
Sbjct: 145 VSDFGMTRYVLDDQYVSSVGT--KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ PY +N +++ KV+ G
Sbjct: 203 KMPYDLYTN-SEVVLKVSQG 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 11/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L + R + I + R + G+ YL +HRDL N+ V+ +L K
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCK 191
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
+ D GL+ +L A + APE + ++ D++SFG+ + E+L
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 118 EYPYSECSNPAQIYKKVTSG 137
E PY +N + V G
Sbjct: 252 ERPYWNMTN-RDVISSVEEG 270
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L + RK + + + R I G+ YL +HRDL NI +N +L K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCK 187
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
+ D GL +L A + +PE + + D++S+G+ + E+++
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 118 EYPYSECSNPAQIYKKVTSG 137
E PY E SN + K V G
Sbjct: 248 ERPYWEMSN-QDVIKAVDEG 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 30/122 (24%)
Query: 28 QILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-------------AILR 74
+L G ++H +IHRDLK N +N VK+ D GLA +
Sbjct: 137 NLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 75 GSQHAHSVIGTPEFM----------APE--LYEEDYNELVDIYSFGMCVL-EMLTSEYPY 121
+ + + APE L +E+Y + +DI+S G C+ E+L +
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSH 252
Query: 122 SE 123
Sbjct: 253 IN 254
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 31/144 (21%), Positives = 62/144 (43%), Gaps = 12/144 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ K + + V Q+ G+ YL + +HR+L N+ + K
Sbjct: 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRH-YAK 476
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
I D GL+ L ++ ++ APE + ++ D++S+G+ + E L+
Sbjct: 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 118 EYPYSECSNPAQIYKKVTSGK-LP 140
+ PY + P ++ + GK +
Sbjct: 537 QKPYKKMKGP-EVMAFIEQGKRME 559
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 30/119 (25%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83
++ Q+ +G+ +L IHRDL NI ++ VKI D GLA +
Sbjct: 197 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253
Query: 84 GTP---EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSG 137
++MAPE +++ Y D++SFG+ + E+ + PY + +++ G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 34/140 (24%), Positives = 61/140 (43%), Gaps = 13/140 (9%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y R+ R + + + + + YL +HRDL N VN VK
Sbjct: 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQG-VVK 160
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS- 117
+ D GL+ + ++ SV +F PE L ++ DI++FG+ + E+ +
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 118 EYPYSECSNPAQIYKKVTSG 137
+ PY +N ++ + + G
Sbjct: 219 KMPYERFTN-SETAEHIAQG 237
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 14/141 (9%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ K + + + K + A QI G+A++ + IHRDL+ NI V+ L
Sbjct: 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SC 148
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
KI D GLA ++ +++ +F APE + + D++SFG+ + E++T
Sbjct: 149 KIADFGLARLIEDNEYTAREGA--KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 117 SEYPYSECSNPAQIYKKVTSG 137
PY +NP ++ + + G
Sbjct: 207 GRIPYPGMTNP-EVIQNLERG 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 37/141 (26%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L ++ + ++ + + +++ QI G+A++ + IHRDL+ NI V+ L
Sbjct: 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VC 323
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
KI D GLA ++ +++ +F APE + + D++SFG+ ++E++T
Sbjct: 324 KIADFGLARVIEDNEYTAREGA--KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
Query: 118 -EYPYSECSNPAQIYKKVTSG 137
PY SNP ++ + + G
Sbjct: 382 GRIPYPGMSNP-EVIRALERG 401
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G L +Y ++ R ++ AV A QI + YL + IHRDL N V + V
Sbjct: 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LV 150
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
K+ D GL+ ++ G + +F APE L ++ D+++FG+ + E+ T
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 118 -EYPYSECSNPAQIYKKVTSG 137
PY +Q+Y+ +
Sbjct: 209 GMSPYPGIDL-SQVYELLEKD 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 11/140 (7%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ R+K + + R I G+ YL + +HRDL NI VN +L K
Sbjct: 131 GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNL-VCK 187
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-S 117
+ D GL+ +L A + APE + + D++SFG+ + E++T
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 118 EYPYSECSNPAQIYKKVTSG 137
E PY E SN ++ K + G
Sbjct: 248 ERPYWELSN-HEVMKAINDG 266
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 36/141 (25%), Positives = 64/141 (45%), Gaps = 12/141 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR + R + ++ + + Q+ +G+ YL +HRDL N ++ VK
Sbjct: 112 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVK 168
Query: 64 IGDLGLA-AILRG---SQHAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
+ D GLA + S H + P ++MA E L + + D++SFG+ + E++T
Sbjct: 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 117 SEYPYSECSNPAQIYKKVTSG 137
PY + + I + G
Sbjct: 229 GAPPYPDVNT-FDITVYLLQG 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 12/141 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ R ++ + ++ Q+ RG+ YL +HRDL N ++ VK
Sbjct: 108 GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVK 164
Query: 64 IGDLGLA-AILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
+ D GLA IL ++ A E L + D++SFG+ + E+LT
Sbjct: 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 117 SEYPYSECSNPAQIYKKVTSG 137
PY + + G
Sbjct: 225 GAPPYRHIDP-FDLTHFLAQG 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 12/141 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR + R + ++ + + Q+ +G+ +L +HRDL N ++ VK
Sbjct: 176 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVK 232
Query: 64 IGDLGLA-AILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT- 116
+ D GLA + + + MA E L + + D++SFG+ + E++T
Sbjct: 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 117 SEYPYSECSNPAQIYKKVTSG 137
PY + + I + G
Sbjct: 293 GAPPYPDVNT-FDITVYLLQG 312
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 57/273 (20%), Positives = 83/273 (30%), Gaps = 104/273 (38%)
Query: 6 TLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-------- 55
L ++ K Y + + VK +Q+L+G+ YLH +IH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIR 188
Query: 56 ----------------------------------------NGHLGQVKIGDLGLAAILRG 75
N +VKI DLG A
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WV 246
Query: 76 SQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP------- 127
+H I T ++ + E L YN DI+S E+ T +Y + S
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
Query: 128 --AQIYKKVTSGKLPGAF-----------------------------------HRIQDAE 150
A I + GK+P + E
Sbjct: 307 HIALIIE--LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364
Query: 151 AR---RFVGKCLE-NVSKRLPAKELLLDPFLAS 179
A F+ LE KR A E L P+L S
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 7 LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQVK 63
L E KK + + V+ +A IL+ + LH + +IH DLK +NI +K
Sbjct: 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIK 242
Query: 64 IGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
+ D G + Q ++ I + + APE + Y +D++S G + E+LT
Sbjct: 243 VIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 11/118 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A QI G+ YL +HRDL N V +L VKIGD G++ + S + V G
Sbjct: 139 ASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVY-STDYYRVGGH 194
Query: 86 PEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
M PE + + D++SFG+ + E+ T + P+ + SN ++ + +T G
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83
A +I G+AYL+ + +HRDL N V VKIGD G+ + +
Sbjct: 142 QMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIY-ETDYYRKG 197
Query: 84 GTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
G M+PE L + + D++SFG+ + E+ T +E PY SN Q+ + V G
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEG 256
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 34/141 (24%), Positives = 61/141 (43%), Gaps = 18/141 (12%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L +Y + R + ++ + + YL G++ +HRDL N+ V+
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VA 328
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
K+ D GL + A S T + APE L E+ ++ D++SFG+ + E+ +
Sbjct: 329 KVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 382
Query: 118 -EYPYSECSNPAQIYKKVTSG 137
PY + +V G
Sbjct: 383 GRVPYPRIPL-KDVVPRVEKG 402
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 12/138 (8%)
Query: 5 GTLREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L +Y + R + ++ + + YL G++ +HRDL N+ V+
Sbjct: 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VA 156
Query: 63 KIGDLGLAAILRGSQHAHSVIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS-EY 119
K+ D GL + + P ++ APE L E+ ++ D++SFG+ + E+ +
Sbjct: 157 KVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
Query: 120 PYSECSNPAQIYKKVTSG 137
PY + +V G
Sbjct: 214 PYPRIPL-KDVVPRVEKG 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 15/120 (12%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--SQHAHSVI 83
A Q+ G+ YL G +HRDL N V L VKIGD G++ R S + V
Sbjct: 164 ASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMS---RDIYSTDYYRVG 217
Query: 84 GTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
G M PE + + D++SFG+ + E+ T + P+ + SN + +T G
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 14/121 (11%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
++ Q+ +G+ +L IHRDL NI ++ VKI D GLA R +
Sbjct: 153 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGLA---RDIYKDPDYVR 206
Query: 85 TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
+ +MAPE +++ Y D++SFG+ + E+ + PY + +++
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 137 G 137
G
Sbjct: 267 G 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 33/139 (23%), Positives = 58/139 (41%), Gaps = 13/139 (9%)
Query: 7 LREYRKKYTRVDIRAVK--NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
L R ++ + I G+ YL + IHRDL N + + V +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCV 178
Query: 65 GDLGLAAILRGSQHAHSVIGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SE 118
D GL+ + S + + +A E L + Y D+++FG+ + E++T +
Sbjct: 179 ADFGLSRKIY-SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237
Query: 119 YPYSECSNPAQIYKKVTSG 137
PY+ N A+IY + G
Sbjct: 238 TPYAGIEN-AEIYNYLIGG 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 14/122 (11%)
Query: 24 NWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83
+++ Q+ +G+A+L + IHRDL NI + H KI D GLA R ++ + +
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGLA---RDIKNDSNYV 202
Query: 84 GTPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVT 135
+MAPE ++ Y D++S+G+ + E+ + PY ++ YK +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 136 SG 137
G
Sbjct: 263 EG 264
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
QI G+ YL H V+H+DL N+ V L VKI DLGL + + + ++G
Sbjct: 134 VAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVY-AADYYKLLGN 189
Query: 86 PEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
MAPE + ++ DI+S+G+ + E+ + PY SN + + + +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIRNR 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 11/118 (9%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
I G+ YL + +HRDL N + + V + D GL+ + S +
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGLSKKIY-SGDYYRQGRI 208
Query: 86 PEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
+ +A E L + Y D+++FG+ + E+ T PY N ++Y + G
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHG 265
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 34/127 (26%), Positives = 54/127 (42%), Gaps = 26/127 (20%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A Q+ +G+ +L +HRDL N+ V VKI D GL A ++
Sbjct: 177 FAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL---------ARDIMS 224
Query: 85 TPEF------------MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
+ MAPE L+E Y D++S+G+ + E+ + PY A
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 131 YKKVTSG 137
YK + +G
Sbjct: 285 YKLIQNG 291
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 33/119 (27%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGS---QHAHS 81
ARQ+ G+AYL +HRDL N V ++ VKI D GL+ I +
Sbjct: 180 ARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGND 236
Query: 82 VIGTP-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
I P +M PE ++ Y D++++G+ + E+ + PY ++ ++ V G
Sbjct: 237 AI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 38/121 (31%), Positives = 52/121 (42%), Gaps = 14/121 (11%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLA-AILRGSQHAHSV 82
AR I G YL + IHRD+ N + KIGD G+A I R S +
Sbjct: 146 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG- 202
Query: 83 IGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
G M PE E + D +SFG+ + E+ + PY SN ++ + VTS
Sbjct: 203 -GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTS 260
Query: 137 G 137
G
Sbjct: 261 G 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 12/117 (10%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGT 85
A + RG+ YL IHRDL NI V + KI D GL+ RG +
Sbjct: 148 AADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS---RGQEVYVKKTMG 201
Query: 86 --P-EFMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
P +MA E L Y D++S+G+ + E+++ PY + A++Y+K+ G
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 15/121 (12%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
Q+ RG+ YL IHRDL N+ V + +KI D GLA R +
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---RDINNIDYYKK 261
Query: 85 TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
T +MAPE L++ Y D++SFG+ + E+ T PY +++K +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKE 320
Query: 137 G 137
G
Sbjct: 321 G 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 37/121 (30%), Positives = 51/121 (42%), Gaps = 14/121 (11%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLA-AILRGSQHAHSV 82
AR I G YL + IHRD+ N + KIGD G+A I R +
Sbjct: 187 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG- 243
Query: 83 IGTPEF----MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
G M PE E + D +SFG+ + E+ + PY SN ++ + VTS
Sbjct: 244 -GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTS 301
Query: 137 G 137
G
Sbjct: 302 G 302
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 27/127 (21%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
+A QI +G+ YL ++HRDL NI V ++KI D GL + V
Sbjct: 155 FAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL---------SRDVYE 202
Query: 85 TPEF------------MAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQI 130
+ MA E L++ Y D++SFG+ + E++T PY ++
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERL 261
Query: 131 YKKVTSG 137
+ + +G
Sbjct: 262 FNLLKTG 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 15/121 (12%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
Q+ RG+ YL IHRDL N+ V + +KI D GLA R +
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---RDINNIDYYKK 215
Query: 85 TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
T +MAPE L++ Y D++SFG+ + E+ T PY +++K +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKE 274
Query: 137 G 137
G
Sbjct: 275 G 275
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-08
Identities = 20/77 (25%), Positives = 36/77 (46%), Gaps = 10/77 (12%)
Query: 228 NPEDDTIFLKVQITD--------KDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEP 279
+ E I L ++I D KD +A I F +D+ D +VA EMV+ + + +
Sbjct: 20 DGEKIAIKLWLRIEDIKKLKGKYKDNEA--IEFSFDLERDVPEDVAQEMVESGYVCEGDH 77
Query: 280 LEIAEMIEQEISSLVPN 296
+A+ I+ +S +
Sbjct: 78 KTMAKAIKDRVSLIKRK 94
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 36/155 (23%)
Query: 7 LREYRKKYTRVDIRAVKN----------WARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56
LR + A+ N ++ Q+ +G+A+L + IHRD+ N+ +
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT 198
Query: 57 GHLGQVKIGDLGLAAILRGSQHAHSVIGTPEF------------MAPE-LYEEDYNELVD 103
KIGD GL A ++ + MAPE +++ Y D
Sbjct: 199 NGH-VAKIGDFGL---------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 104 IYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137
++S+G+ + E+ + PY ++ YK V G
Sbjct: 249 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 15/121 (12%)
Query: 25 WARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIG 84
A Q+ RG+ YL IHRDL N+ V +KI D GLA R H
Sbjct: 196 CAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA---RDIHHIDYYKK 249
Query: 85 TPE------FMAPE-LYEEDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTS 136
T +MAPE L++ Y D++SFG+ + E+ T PY +++K +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKE 308
Query: 137 G 137
G
Sbjct: 309 G 309
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 24/172 (13%), Positives = 42/172 (24%), Gaps = 46/172 (26%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L+E T + + H V + V+ G V +
Sbjct: 116 GSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVL 170
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVL-EMLTSEYPYSE 123
P M ++D I G L +L + +P E
Sbjct: 171 AY-------------------PATMPDANPQDD------IRGIG-ASLYALLVNRWPLPE 204
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQD-----AEARRFVGKCLENVSKRLPAKE 170
+ L A A+ R + + V+ R +
Sbjct: 205 AGVRSG---------LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 27/132 (20%)
Query: 7 LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLGQ-- 61
++ K+ + + ++ A QI + + +LH + + H DLK +NI FV +
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAY 160
Query: 62 ---------------VKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
+K+ D G A +H +++ T + APE + +++ D++
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVW 218
Query: 106 SFGMCVL-EMLT 116
S G C+L E
Sbjct: 219 SIG-CILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 27/132 (20%), Positives = 54/132 (40%), Gaps = 27/132 (20%)
Query: 7 LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--- 61
E+ K+ + + V++ A Q+ + +LH + + H DLK +NI +
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLY 165
Query: 62 ---------------VKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIY 105
+++ D G A +H +++ T + PE + E + + D++
Sbjct: 166 NEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVW 223
Query: 106 SFGMCVL-EMLT 116
S G C+L E
Sbjct: 224 SIG-CILFEYYR 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 11/73 (15%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLAAILR-GSQHAH--- 80
+ +IL + Y+H H+ +H D+K N+ +N + QV + D GLA H
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 81 ----SVIGTPEFM 89
GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 33/138 (23%)
Query: 7 LREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNI-FVNGHLG--- 60
L E + Y I +K + +IL+ + YL + H DLK +NI + +
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSL 179
Query: 61 --------------------QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYN 99
+K+ D G A S + S+I T ++ APE + ++
Sbjct: 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWD 237
Query: 100 ELVDIYSFGMCVL-EMLT 116
D++SFG CVL E+ T
Sbjct: 238 VSSDMWSFG-CVLAELYT 254
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 11/92 (11%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQVKIG 65
L++ + V ++L + Y+H ++ +H D+K N+ + + QV +
Sbjct: 138 LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLA 195
Query: 66 DLGLAAILR-GSQHAH-------SVIGTPEFM 89
D GL+ H GT EF
Sbjct: 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 11/73 (15%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLAAILR-GSQHAH--- 80
A ++L + +LH ++ +H ++ +NIFV+ QV + G A +H
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 81 ----SVIGTPEFM 89
G EF+
Sbjct: 223 GSRSPHEGDLEFI 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 12/90 (13%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDL 67
+ + ++ V A Q++ I Y+H + IHRD+K DN + V I D
Sbjct: 95 FNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF 152
Query: 68 GLAAILRGSQ-HAH-------SVIGTPEFM 89
GLA R ++ H H ++ GT +
Sbjct: 153 GLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 35/200 (17%), Positives = 61/200 (30%), Gaps = 32/200 (16%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
F L + R K + + K+ Q+ +A HRDL N+ +
Sbjct: 144 EFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSL 200
Query: 61 -------------------QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNEL 101
QV I D L+ + R V+ M +L+ D +
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQ 256
Query: 102 VDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLEN 161
DIY + E Y SN ++ F + A + + + ++
Sbjct: 257 FDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314
Query: 162 VSKRLP----AKELLLDPFL 177
+ + A +LL L
Sbjct: 315 FHRTMLNFSSATDLLCQHSL 334
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 14/76 (18%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQVKIGDLGLAAILRGSQ-HAH 80
A Q++ + Y+H + +I+RD+K +N + N + I D LA + H
Sbjct: 111 AIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
Query: 81 -------SVIGTPEFM 89
S+ GT +M
Sbjct: 169 IPYREHKSLTGTARYM 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 21/74 (28%), Positives = 33/74 (44%), Gaps = 12/74 (16%)
Query: 26 ARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGS---QH-- 78
A Q++ + ++H +HRD+K DN + QV I D GLA R + QH
Sbjct: 109 ADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
Query: 79 ---AHSVIGTPEFM 89
++ GT +
Sbjct: 167 YRENKNLTGTARYA 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 15/96 (15%)
Query: 7 LREYRKKYTRV-DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----Q 61
L + R ++ V A+Q+L + +H +++RD+K DN +
Sbjct: 92 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANM 149
Query: 62 VKIGDLGLAAILRGSQ-HAH-------SVIGTPEFM 89
+ + D G+ R H ++ GT +M
Sbjct: 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.98 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.98 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.98 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.88 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.59 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.27 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 98.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.87 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 98.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 93.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 88.15 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 87.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 87.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 86.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 85.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 85.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 83.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 81.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 81.49 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=354.40 Aligned_cols=178 Identities=54% Similarity=1.033 Sum_probs=164.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|.+++++.+.+++..++.|+.||+.||+|||++|++||||||||+||||+...+.+||+|||+|+.... ....
T Consensus 110 y~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~ 188 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAK 188 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBE
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccC
Confidence 799999999999999999999999999999999999999888999999999999986558999999999975433 4456
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
+.+||+.|||||++.+.|+.++|||||||++|+|+||+.||.+..+...+++.+..+..|..++...++++++||.+||.
T Consensus 189 ~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence 78999999999999989999999999999999999999999988888899999998888777778889999999999999
Q ss_pred -CcCCCCCHHHHhcCccccC
Q 010768 161 -NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 161 -dP~kRpsa~ElL~hpf~~~ 179 (502)
||.+|||+.|+|+||||+.
T Consensus 269 ~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 269 QNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC-
T ss_pred CChhHCcCHHHHhcCccccC
Confidence 9999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.05 Aligned_cols=180 Identities=30% Similarity=0.503 Sum_probs=161.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---~ 77 (502)
||.||+|.+++++.+.+++.+++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCCcc
Confidence 7999999999999999999999999999999999999999 9999999999999987 79999999999987432 2
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+.. .++...++++++||.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDLVE 266 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHHHH
Confidence 3457899999999999875 599999999999999999999999977 677888888888765 345567899999999
Q ss_pred Hhhc-CcCCCCCHHH------HhcCccccCCCCCCCC
Q 010768 157 KCLE-NVSKRLPAKE------LLLDPFLASDAGEPLL 186 (502)
Q Consensus 157 kcL~-dP~kRpsa~E------lL~hpf~~~~~~~~l~ 186 (502)
+||. ||.+|||++| |++||||++-.|..+.
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 9999 9999999988 5899999988887654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.37 Aligned_cols=173 Identities=25% Similarity=0.523 Sum_probs=144.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|| +|+|.+++.+.+++++.+++.|++||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.........
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecCCCCccC
Confidence 55 7999999999999999999999999999999999999 9999999999999987 799999999998876666667
Q ss_pred cccCCCcccCccccccc-C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~-~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
+.+||+.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+...+++.+..+..+ ++...++.+++||.+|
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAAGLIKRM 246 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHHHHHH
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHH
Confidence 78999999999998754 4 6899999999999999999999977 6677888888887653 4556799999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|+ ||.+|||+.|+|+||||+..
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHTT
T ss_pred ccCChhHCcCHHHHHcCcccccC
Confidence 99 99999999999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.98 Aligned_cols=178 Identities=26% Similarity=0.399 Sum_probs=157.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
||.||+|.+++++.+.+++.+++.|+.||+.||+|||++| ||||||||+|||++.+ |.+||+|||+|+.... ....
T Consensus 107 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp CCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC-----CCC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceeccCCCccc
Confidence 7999999999999999999999999999999999999999 9999999999999987 8999999999986543 3345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..+ ++...++++++||.+|
T Consensus 184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 260 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRML 260 (304)
T ss_dssp CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHH
Confidence 67889999999998864 599999999999999999999999987 5677788888877653 4556799999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
|+ ||.+||| ++|+++||||+.-+|..
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 99 9999998 57999999999876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.65 Aligned_cols=176 Identities=32% Similarity=0.553 Sum_probs=154.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||.||+|.+++.+ +++++.+++.|+.||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+.+... ...
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCceecCCCCCcc
Confidence 7999999999976 57999999999999999999999999 9999999999999987 89999999999887543 345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~k 157 (502)
.+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+ .+..+++..+..+..+. ......++++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 67899999999998874 599999999999999999999999987 56667777776654332 2334578999999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. ||.+|||+.|+|+||||+...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCC
Confidence 999 999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.45 Aligned_cols=176 Identities=26% Similarity=0.480 Sum_probs=154.8
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
||.||+|.++|... ..+++.+++.|+.||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccceeecCCcc
Confidence 79999999999764 35799999999999999999999999 9999999999999987 799999999998764322
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+..+. .+...++++++||.
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence 2346789999999999875 599999999999999999999999987 56777888888887754 34456899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+||. ||.+|||+.|+|+||||+...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999 999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.13 Aligned_cols=176 Identities=32% Similarity=0.553 Sum_probs=154.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||.||+|.++++. +++++.+++.|++||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+.+... ...
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccceECCCCCccc
Confidence 7999999999976 57999999999999999999999999 9999999999999987 89999999999877543 345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~k 157 (502)
.+.+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+ .+..+++..+..+..+. ......++.+++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 67899999999998874 599999999999999999999999987 56667777776654332 2334568999999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. ||.+|||+.|+|+||||+...
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999 999999999999999998643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=330.04 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=147.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
||.||+|.++|++.+.+++.+++.|+.||+.||+|||++| ||||||||+||||+.+...+||+|||+|+.+.....
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 7999999999999999999999999999999999999999 999999999999998733799999999987653221
Q ss_pred ----cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHHH
Q 010768 79 ----AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEAR 152 (502)
Q Consensus 79 ----~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~ 152 (502)
....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+. +...+..++..+..+ ..++...++.++
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 234689999999998875 5999999999999999999999999874 334455556655443 234556789999
Q ss_pred HHHHHhhc-CcCCCCCHHHH-------------hcCccccC
Q 010768 153 RFVGKCLE-NVSKRLPAKEL-------------LLDPFLAS 179 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~El-------------L~hpf~~~ 179 (502)
+||.+||. ||.+|||+.|+ |+|||+..
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 99999999 99999999997 57888865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=318.29 Aligned_cols=174 Identities=24% Similarity=0.466 Sum_probs=140.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
||.||+|.++++ .+++.+++.|++||+.||+|||++| ||||||||+|||++.+.+.+||+|||+|+......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 789999999984 5999999999999999999999999 99999999999999876899999999998653321
Q ss_pred --------------------------CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHH
Q 010768 78 --------------------------HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ 129 (502)
Q Consensus 78 --------------------------~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~ 129 (502)
...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~ 255 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 1234679999999998864 489999999999999999999999976555433
Q ss_pred HHHHHHc--C-------------------CC-------------------C------------CCccccCCHHHHHHHHH
Q 010768 130 IYKKVTS--G-------------------KL-------------------P------------GAFHRIQDAEARRFVGK 157 (502)
Q Consensus 130 i~~~i~~--~-------------------~~-------------------p------------~~~~~~~s~~l~~LI~k 157 (502)
....+.. | .. | .......++++++||.+
T Consensus 256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~ 335 (361)
T 4f9c_A 256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK 335 (361)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence 3322211 0 00 0 01123457899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
||. ||.+|+|++|+|+||||+.
T Consensus 336 lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 336 LLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HCcCChhHCcCHHHHhcCcccCC
Confidence 999 9999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.13 Aligned_cols=171 Identities=30% Similarity=0.481 Sum_probs=143.8
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--- 76 (502)
||.||+|.++|... +++++.++..|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceecccCCcc
Confidence 79999999999765 67999999999999999999999999 9999999999999987 79999999999865432
Q ss_pred CCcccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---CccccCCH
Q 010768 77 QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDA 149 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~ 149 (502)
......+||+.|||||++. +.|+.++|||||||++|||+||+.||.+..+...+...+..+..++ ..+...++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 2345678999999999885 3489999999999999999999999998777777777777765433 23445689
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+.+||.+||+ +|.+|||+.|++.+
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999 99999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.16 Aligned_cols=174 Identities=24% Similarity=0.399 Sum_probs=137.0
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
||.||+|.+++.+... .++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 96 ~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~DFGla~~~~~~~ 172 (299)
T 4g31_A 96 LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDE 172 (299)
T ss_dssp CCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCCCC-------
T ss_pred cCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEccCccceecCCCc
Confidence 7899999999998755 456678999999999999999999 9999999999999987 799999999998764322
Q ss_pred C-------------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc
Q 010768 78 H-------------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143 (502)
Q Consensus 78 ~-------------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 143 (502)
. ..+.+||+.|||||++.+ .|+.++|||||||++|||++ ||....+.......+.....|..+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~ 249 (299)
T 4g31_A 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLF 249 (299)
T ss_dssp -------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHH
T ss_pred cccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCC
Confidence 1 234679999999998875 59999999999999999996 886533334445556666665433
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
. ..++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 250 ~-~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 250 T-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp H-HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred c-ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2 235678899999999 999999999999999998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.21 Aligned_cols=179 Identities=26% Similarity=0.447 Sum_probs=157.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+.+... ...
T Consensus 273 y~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~~-~~~ 348 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 348 (689)
T ss_dssp CCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-CCC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeecCCC-CCC
Confidence 7999999999999999999999999999999999999999 9999999999999987 89999999999877543 456
Q ss_pred cccCCCcccCccccc-c-cCCcccchhhhhHHHHHHhhccCCCCCC--CChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+. .+...+.+.+..... .++...++++++||.
T Consensus 349 t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--~~p~~~S~~a~dLI~ 426 (689)
T 3v5w_A 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSPELRSLLE 426 (689)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--CCCccCCHHHHHHHH
Confidence 789999999999885 3 5999999999999999999999999753 344566666666554 345567999999999
Q ss_pred Hhhc-CcCCCCC-----HHHHhcCccccCCCCCCC
Q 010768 157 KCLE-NVSKRLP-----AKELLLDPFLASDAGEPL 185 (502)
Q Consensus 157 kcL~-dP~kRps-----a~ElL~hpf~~~~~~~~l 185 (502)
+||. ||.+|++ +.||+.||||++-.|..+
T Consensus 427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 9999 9999998 799999999999877553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.36 Aligned_cols=175 Identities=29% Similarity=0.443 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|| +|+|.+++.+.+.+++..++.|++||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 140 ~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~~~~~~~ 215 (398)
T 4b99_A 140 LM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMARGLCTSPAEH 215 (398)
T ss_dssp CC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCBCC-------
T ss_pred CC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecceeeecccCcccc
Confidence 56 5789999999999999999999999999999999999 9999999999999987 89999999999865332
Q ss_pred -CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCCC----------
Q 010768 77 -QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG---------- 141 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p~---------- 141 (502)
....+.+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+.. .......|.. +..+.
T Consensus 216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~~~~~~~~~~ 294 (398)
T 4b99_A 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPAVIQAVGAER 294 (398)
T ss_dssp CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 23456799999999998764 47999999999999999999999998844 3444444332 11110
Q ss_pred --------------C---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 --------------A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 --------------~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. .....++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 012347899999999999 99999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.27 Aligned_cols=179 Identities=24% Similarity=0.392 Sum_probs=157.9
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.++|.+ .+.+++.+++.|++||+.||+|||++| |+||||||+|||++.+ .+.+||+|||+|+.+.....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 7899999999964 468999999999999999999999999 9999999999999853 37899999999998877666
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI 155 (502)
....+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+.. +.......++.+++||
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 777899999999998875 599999999999999999999999987 566777778877654 3334456799999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+||. ||.+||++.|+|+||||+...+
T Consensus 392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999 9999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.79 Aligned_cols=172 Identities=22% Similarity=0.379 Sum_probs=148.5
Q ss_pred CCCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEec
Q 010768 1 MFTSGTLREYRKKY-------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDL 67 (502)
Q Consensus 1 y~~gGsL~~~L~k~-------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DF 67 (502)
||.+|+|.++|.+. ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~-~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC-CcEEECCc
Confidence 79999999999875 36999999999999999999999999 9999999999999987 79999999
Q ss_pred CCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 68 GLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 68 GlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
|+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~~~~- 250 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGRVLQ- 250 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTCCCC-
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 99986543222 23456899999999886 569999999999999999998 9999987 56677888888887653
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+...++.+.+||.+||+ +|.+|||+.+++ +|++.
T Consensus 251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 251 RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 345678999999999999 999999999994 56653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.66 Aligned_cols=170 Identities=23% Similarity=0.360 Sum_probs=148.6
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
||.+|+|.+||++. ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||
T Consensus 150 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~-~~vKi 226 (353)
T 4ase_A 150 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI 226 (353)
T ss_dssp CCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCC-CCEEE
Confidence 79999999999863 34899999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+|+.+..... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+......+.+.+..+..
T Consensus 227 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~ 306 (353)
T 4ase_A 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 306 (353)
T ss_dssp CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred CcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 99999987644322 24567899999999886 569999999999999999998 99999987767777888887765
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...++++.+||.+||. ||.+|||+.||++|
T Consensus 307 ~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 307 MR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43 345668999999999999 99999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=299.83 Aligned_cols=168 Identities=22% Similarity=0.367 Sum_probs=139.1
Q ss_pred CCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEE
Q 010768 1 MFTSGTLREYRKKY---------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65 (502)
Q Consensus 1 y~~gGsL~~~L~k~---------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~ 65 (502)
||.+|+|.+|+.+. +++++.+++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~-~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG-LVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC-CcEEEc
Confidence 79999999999764 35999999999999999999999999 9999999999999987 799999
Q ss_pred ecCCceeccCCC---CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCC
Q 010768 66 DLGLAAILRGSQ---HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLP 140 (502)
Q Consensus 66 DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p 140 (502)
|||+++...... ......||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ ....++...+..+..+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~g~~~ 279 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCITQGREL 279 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHHHHTCCC
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999998764322 2245679999999998864 69999999999999999999 9999987 4566777788777654
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
. .+...++.+.+||.+||. ||.+|||+.||+.
T Consensus 280 ~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 280 E-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp C-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred C-CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 3 445678999999999999 9999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=296.59 Aligned_cols=169 Identities=22% Similarity=0.327 Sum_probs=146.7
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
||.+|+|.+||... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+ +.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~-~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCC-CCEEE
Confidence 79999999999753 35999999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCC---CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGS---QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~---~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++..... ......+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~~~~~ 265 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIRNRQV 265 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHHTTCC
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 999999865432 2234568999999999876 569999999999999999998 8999987 456778888888766
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
++ .+...++.+.+||.+||. +|.+|||+.||+.+
T Consensus 266 ~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 LP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54 345678999999999999 99999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.64 Aligned_cols=176 Identities=22% Similarity=0.463 Sum_probs=156.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+++++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..........
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCGGG
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCccc
Confidence 6889999999999899999999999999999999999999 9999999999999987 799999999998776655666
Q ss_pred cccCCCcccCccccccc-C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~-~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
..+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...+...+..+... .+...++.+.+||.+|
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRF 248 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHH
Confidence 78899999999988654 4 5799999999999999999999987 6677778888877663 3445789999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
|. ||.+|||+.|+|+||||+....
T Consensus 249 L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 249 LVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp CCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CCCChhHCcCHHHHhcCHhhcCCCc
Confidence 99 9999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=281.39 Aligned_cols=179 Identities=54% Similarity=1.032 Sum_probs=161.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++...+.+||+|||++..... ....
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-~~~~ 188 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAK 188 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBE
T ss_pred ecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc-cccc
Confidence 678999999999989999999999999999999999998877999999999999985458999999999975433 3344
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
...||+.|+|||++.+.++.++|||||||++|+|++|..||........+...+..+..+..+....++.+.+||.+||.
T Consensus 189 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 56799999999999988999999999999999999999999988888888888888877777777788999999999999
Q ss_pred -CcCCCCCHHHHhcCccccCC
Q 010768 161 -NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 161 -dP~kRpsa~ElL~hpf~~~~ 180 (502)
+|.+||++.++|+||||+..
T Consensus 269 ~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 269 QNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC--
T ss_pred CChhhCCCHHHHhhCcccccC
Confidence 99999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=295.39 Aligned_cols=178 Identities=24% Similarity=0.464 Sum_probs=152.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 105 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 105 FVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeecccCCccc
Confidence 6899999999999999999999999999999999999999 9999999999999987 899999999998643 23344
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+++||.+|
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~l 258 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDATGILKSF 258 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 56789999999998864 599999999999999999999999987 567778888887765 33455789999999999
Q ss_pred hc-CcCCCCCH------HHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPA------KELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa------~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+||++ .+++.||||+...|..
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 99 99999998 8999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.36 Aligned_cols=178 Identities=26% Similarity=0.480 Sum_probs=156.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCB
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhcccCCCcc
Confidence 6889999999999899999999999999999999999999 9999999999999987 799999999998643 33345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+.. .++...++.+++||.+|
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 66789999999998864 589999999999999999999999977 566677777776654 34456789999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+|| ++.|+++||||+...+..
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~ 271 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 999999 899999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.36 Aligned_cols=178 Identities=24% Similarity=0.442 Sum_probs=156.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 102 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCcccccccCCccc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999998643 23345
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+ .+...+++.+..+.. .++...++.+++||.+|
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 255 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL 255 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 5678999999999886 4589999999999999999999999977 566777888877655 34456789999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+|| ++.+++.||||+...|..
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 99 999999 479999999999876644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=278.25 Aligned_cols=177 Identities=34% Similarity=0.551 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.||+|.+++.+. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCceecCCccccc
Confidence 68899999999875 6999999999999999999999999 9999999999999987 799999999998765432 34
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.............+......+...++.+++||.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 4568999999999886 458999999999999999999999998755444444444444444445566789999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. ||.+||++.|+|+||||+...
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccCChhHCcCHHHHhhChhhcccC
Confidence 99 999999999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=288.86 Aligned_cols=178 Identities=25% Similarity=0.428 Sum_probs=156.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC---cEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---QVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g---~vKL~DFGlA~~~~~~~ 77 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+ .+||+|||++.......
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~ 173 (361)
T 2yab_A 96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (361)
T ss_dssp CCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence 6889999999998889999999999999999999999999 999999999999987632 79999999999876655
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~L 154 (502)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+.... ......++.+++|
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 252 (361)
T 2yab_A 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDF 252 (361)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 5667789999999998875 699999999999999999999999987 56667777777765432 2334568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|.+||. ||.+|||+.|+|+||||+...
T Consensus 253 i~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 253 IRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 999999 999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.40 Aligned_cols=179 Identities=22% Similarity=0.429 Sum_probs=154.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec-cCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~-~~~~~~ 79 (502)
|+.||+|..++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.. ......
T Consensus 134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeecccCCCcc
Confidence 6899999999999899999999999999999999999999 9999999999999987 89999999999863 334455
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--------CChHHHHHHHHcCCCCCCccccCCHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+.+.+..... .++...++.
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~ 288 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK 288 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCcCCHH
Confidence 67889999999998865 5999999999999999999999999642 223445666666554 344567899
Q ss_pred HHHHHHHhhc-CcCCCCCH------HHHhcCccccCCCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPA------KELLLDPFLASDAGEP 184 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa------~ElL~hpf~~~~~~~~ 184 (502)
+++||.+||. ||.+||++ .|++.||||+...|..
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 9999999999 99999985 8999999999876643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=282.23 Aligned_cols=176 Identities=28% Similarity=0.544 Sum_probs=155.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--~~~ 161 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--VTY 161 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS--CBC
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC--ccc
Confidence 6889999999999999999999999999999999999999 9999999999999887 7999999999987643 334
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. .++...++.+++||.+||
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHh
Confidence 5789999999998864 589999999999999999999999977 556667777777654 344567899999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
. +|.+|| ++.+++.||||+...+..
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 9 999999 899999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.90 Aligned_cols=178 Identities=26% Similarity=0.514 Sum_probs=156.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 99 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhcccCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999998643 23345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+++||.+|
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 252 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKL 252 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHHH
Confidence 66789999999998864 589999999999999999999999977 566777777777654 34456789999999999
Q ss_pred hc-CcCCCCCHH-HHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPAK-ELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa~-ElL~hpf~~~~~~~~ 184 (502)
|. +|.+||++. +++.||||+...|..
T Consensus 253 L~~dp~~R~~~~~~i~~hp~f~~~~w~~ 280 (345)
T 1xjd_A 253 FVREPEKRLGVRGDIRQHPLFREINWEE 280 (345)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred hcCCHhHcCCChHHHHcCccccCCCHHH
Confidence 99 999999998 999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=284.71 Aligned_cols=179 Identities=21% Similarity=0.416 Sum_probs=153.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTTCCB
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEeccccccccCCCCcc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999998632 33345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--------CChHHHHHHHHcCCCCCCccccCCHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--------SNPAQIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... .++...+..
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~ 245 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVK 245 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCCCHH
Confidence 56789999999998864 5899999999999999999999999642 233445666666544 344567899
Q ss_pred HHHHHHHhhc-CcCCCCCH------HHHhcCccccCCCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPA------KELLLDPFLASDAGEP 184 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa------~ElL~hpf~~~~~~~~ 184 (502)
+++||.+||. +|.+||++ .+++.||||+...|..
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 9999999999 99999995 8999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=285.35 Aligned_cols=175 Identities=27% Similarity=0.513 Sum_probs=156.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~--~~ 196 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceeccCC--cc
Confidence 6889999999999899999999999999999999999999 9999999999999887 79999999999876442 34
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...++.+++||.+||
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 273 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHS
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5689999999998764 589999999999999999999999987 567778888887765 344567899999999999
Q ss_pred c-CcCCCCC-----HHHHhcCccccCCCCC
Q 010768 160 E-NVSKRLP-----AKELLLDPFLASDAGE 183 (502)
Q Consensus 160 ~-dP~kRps-----a~ElL~hpf~~~~~~~ 183 (502)
. +|.+||+ +.+++.||||+...+.
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9 9999998 9999999999987664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=283.73 Aligned_cols=171 Identities=27% Similarity=0.397 Sum_probs=133.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
||+||+|.+++++. .+++..+..|+.||+.||+|||++ .++||||||||+||||+.+ +.+||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCcccc
Confidence 78999999999874 699999999999999999999987 2349999999999999988 799999999998765
Q ss_pred CCCC-----cccccCCCcccCcccccc-------cCCcccchhhhhHHHHHHhhccCCCCCC--------------CChH
Q 010768 75 GSQH-----AHSVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPA 128 (502)
Q Consensus 75 ~~~~-----~~~~~GT~~Y~APEvl~~-------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------------~~~~ 128 (502)
.... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||... ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 4322 234679999999998864 3678999999999999999997765321 1234
Q ss_pred HHHHHHHcCCCCCCcccc-----CCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 129 QIYKKVTSGKLPGAFHRI-----QDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 129 ~i~~~i~~~~~p~~~~~~-----~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.+.+......+.++.. ....+.+|+.+||. ||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 555555554443332221 12468899999999 9999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=279.04 Aligned_cols=178 Identities=25% Similarity=0.443 Sum_probs=152.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~---g~vKL~DFGlA~~~~~~~ 77 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. ..+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 172 (326)
T 2y0a_A 95 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172 (326)
T ss_dssp CCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence 6889999999998889999999999999999999999999 99999999999998762 279999999998876555
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~L 154 (502)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .........+...... .......++.+++|
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccccccCCHHHHHH
Confidence 556678999999999886 4589999999999999999999999977 4455555555554432 22234568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|.+||. +|.+|||+.++|.||||+...
T Consensus 252 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 252 IRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 999999 999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-32 Score=282.14 Aligned_cols=179 Identities=26% Similarity=0.463 Sum_probs=156.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..+.......
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTCCBC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeeccCCCcee
Confidence 6889999999999999999999999999999999999999 9999999999999987 799999999999876666667
Q ss_pred cccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCC--CChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 81 SVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
..+||+.|+|||++.. .|+.++|||||||++|+|++|..||... .....+...+..... .++...++.+.+|
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~~~l 250 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQEMVSL 250 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcCCHHHHHH
Confidence 7899999999998852 4899999999999999999999999743 344555555555444 3345568999999
Q ss_pred HHHhhc-CcCCCCC-HHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRLP-AKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRps-a~ElL~hpf~~~~~~~~ 184 (502)
|.+||. +|.+||+ +.+++.||||+...|..
T Consensus 251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~ 282 (384)
T 4fr4_A 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA 282 (384)
T ss_dssp HHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred HHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence 999999 9999998 99999999999877644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.79 Aligned_cols=176 Identities=31% Similarity=0.444 Sum_probs=142.6
Q ss_pred CCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+|+|.+++.+... +++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...........
T Consensus 102 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~ 178 (308)
T 3g33_A 102 DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTP 178 (308)
T ss_dssp CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEECSCSCTTTSTTCCCSGG
T ss_pred hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEeeCccccccCCCcccCC
Confidence 4799999988755 999999999999999999999999 9999999999999887 7999999999987765555667
Q ss_pred ccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCC-CC----------------
Q 010768 82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP-GA---------------- 142 (502)
Q Consensus 82 ~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p-~~---------------- 142 (502)
..||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+.+.+.. +..+ ..
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (308)
T 3g33_A 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 258 (308)
T ss_dssp GGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCC
T ss_pred ccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCC
Confidence 78999999999875 56999999999999999999999999875443333332221 1111 00
Q ss_pred ------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 143 ------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 143 ------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.....++.+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 259 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 112357899999999999 9999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=277.72 Aligned_cols=169 Identities=28% Similarity=0.441 Sum_probs=144.8
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++............
T Consensus 140 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~ 216 (311)
T 3p1a_A 140 GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQ 216 (311)
T ss_dssp CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC------CC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecccCCCCccc
Confidence 78999998765 45999999999999999999999999 9999999999999887 79999999999877655555566
Q ss_pred cCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-C
Q 010768 83 IGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-N 161 (502)
Q Consensus 83 ~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-d 161 (502)
.||+.|+|||++.+.++.++|||||||++|+|++|..|+.. ......+..+..+..+....++.+.+||.+||. +
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 217 EGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp CCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCC
Confidence 79999999999988999999999999999999999776644 234555666666655666778999999999999 9
Q ss_pred cCCCCCHHHHhcCccccC
Q 010768 162 VSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 162 P~kRpsa~ElL~hpf~~~ 179 (502)
|.+||++.|+|+||||+.
T Consensus 293 P~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 293 PKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TTTSCCHHHHHTSGGGSC
T ss_pred hhhCcCHHHHHhCccccC
Confidence 999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=291.91 Aligned_cols=178 Identities=26% Similarity=0.480 Sum_probs=153.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~ 78 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||+ +| ||||||||+||||+.+ +.+||+|||+++... ....
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceeccCCCcc
Confidence 68899999999998999999999999999999999998 88 9999999999999987 799999999997643 2333
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+ .+...+...+..... .++...++.+++||.+
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAKSLLSG 382 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHH
Confidence 45678999999999886 4599999999999999999999999977 556667777766654 3445678999999999
Q ss_pred hhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 158 CLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 158 cL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
||. ||.+|| ++.|+|+||||+...+..
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 999 999999 999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=286.84 Aligned_cols=178 Identities=25% Similarity=0.415 Sum_probs=156.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++... .....
T Consensus 120 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGBCCCCCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccccCCCcc
Confidence 6899999999999899999999999999999999999999 9999999999999987 799999999998643 33345
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..++++.+..+.. .++...+..+++||.+|
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGL 273 (373)
T ss_dssp CSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCC--CCCSSSCHHHHHHHHHH
T ss_pred ccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccc--CCCCCCCHHHHHHHHHH
Confidence 66789999999998865 589999999999999999999999977 566777888877654 34456789999999999
Q ss_pred hc-CcCCCCCH----HHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRLPA----KELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRpsa----~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+||++ .+++.||||+...|..
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 99 99999986 6999999999877644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.21 Aligned_cols=176 Identities=22% Similarity=0.357 Sum_probs=154.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE---eCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl---d~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.+ +.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence 6789999999999899999999999999999999999999 9999999999999 544 799999999998876666
Q ss_pred CcccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI 155 (502)
......||+.|+|||++.+.++.++||||||+++|+|++|..||.. .........+..+...... ....++.+.+||
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 6667789999999999988899999999999999999999999987 4556666667666553322 225688999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. +|.+||++.++|+||||+..
T Consensus 243 ~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999 99999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.39 Aligned_cols=180 Identities=21% Similarity=0.437 Sum_probs=152.7
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||.||+|.+++.+ .+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++.......
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhcccCCCc
Confidence 6889999999988 478999999999999999999999999 9999999999999987 7999999999987644332
Q ss_pred -cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC----CCCCCccccC
Q 010768 79 -AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG----KLPGAFHRIQ 147 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~----~~p~~~~~~~ 147 (502)
....+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+ .+..+++.++... .+|.. ....
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~-~~~~ 309 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQ-VTDV 309 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSS-CCCS
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcc-cccC
Confidence 23468999999999875 3589999999999999999999999987 5566666666542 22222 2346
Q ss_pred CHHHHHHHHHhhc-CcCC--CCCHHHHhcCccccCCCCCCC
Q 010768 148 DAEARRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGEPL 185 (502)
Q Consensus 148 s~~l~~LI~kcL~-dP~k--Rpsa~ElL~hpf~~~~~~~~l 185 (502)
++.+++||.+||. +|.+ |++++|+++||||+...|..+
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 8999999999998 7777 999999999999999888764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.56 Aligned_cols=176 Identities=27% Similarity=0.472 Sum_probs=154.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++........
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 6889999999998889999999999999999999999999 9999999999999864 24699999999987765555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+... .......++.+++||
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 566789999999998875 599999999999999999999999977 5566777777776543 233345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+||. ||.+||++.++|+||||..
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999 9999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=287.10 Aligned_cols=179 Identities=22% Similarity=0.395 Sum_probs=152.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
||.||+|.+++++ ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++...... .
T Consensus 150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSEEE
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEeeccCCccc
Confidence 6889999999976 46999999999999999999999999 9999999999999987 799999999998765433 2
Q ss_pred cccccCCCcccCccccccc-----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--CCCCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYEED-----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LPGAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~-----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l 151 (502)
..+.+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+...++.++..+. .........++.+
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccHHH
Confidence 3467899999999988532 78999999999999999999999987 56666777776542 2222234568999
Q ss_pred HHHHHHhhc-CcCC--CCCHHHHhcCccccCCCCCC
Q 010768 152 RRFVGKCLE-NVSK--RLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 152 ~~LI~kcL~-dP~k--Rpsa~ElL~hpf~~~~~~~~ 184 (502)
++||.+||. +|.+ |+++.|+++||||+...|..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 999999999 7888 99999999999999887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=305.86 Aligned_cols=179 Identities=24% Similarity=0.448 Sum_probs=159.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc-CCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~-~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++... .....
T Consensus 423 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECCCTTCCB
T ss_pred CcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeeccccCCccc
Confidence 6899999999999899999999999999999999999999 9999999999999987 799999999998643 33445
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+..+++..+..+.. .++...++.+++||.+|
T Consensus 500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 576 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGL 576 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 6778999999999886 4699999999999999999999999987 667788888887765 34556799999999999
Q ss_pred hc-CcCCCCCH-----HHHhcCccccCCCCCCC
Q 010768 159 LE-NVSKRLPA-----KELLLDPFLASDAGEPL 185 (502)
Q Consensus 159 L~-dP~kRpsa-----~ElL~hpf~~~~~~~~l 185 (502)
|. ||.+|+++ .||+.||||+...|..+
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 99 99999997 99999999998776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=280.90 Aligned_cols=178 Identities=22% Similarity=0.377 Sum_probs=154.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 68899999999875 47999999999999999999999999 9999999999999862 37999999999988766555
Q ss_pred cccccCCCcccCccccccc-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .....+...+..+..... .....++.+++||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 5667899999999988754 79999999999999999999999987 556667777776655322 2235689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+||. ||.+|||+.|+|+||||+...
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999 999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=270.73 Aligned_cols=176 Identities=25% Similarity=0.415 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.. .+.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 67899999999643 67999999999999999999999999 9999999999999542 2689999999998766
Q ss_pred CCCCcccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHHHH
Q 010768 75 GSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEARR 153 (502)
Q Consensus 75 ~~~~~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~ 153 (502)
.........||+.|+|||++.+.++.++|||||||++|+|++|+.||.+ .....+...+...... .......++.+.+
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPLTPQAVD 257 (285)
T ss_dssp --------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCCCHHHHH
T ss_pred CcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcCCHHHHH
Confidence 5555566789999999999988899999999999999999999999987 4445555555443332 2222335889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
||.+||. +|.+||++.|+|.||||+.
T Consensus 258 li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999 9999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=280.05 Aligned_cols=180 Identities=26% Similarity=0.413 Sum_probs=152.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---~ 77 (502)
|+.||+|.+++.....+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeeccceeccCCccc
Confidence 6889999999988888999999999999999999999999 9999999999999987 79999999999865322 2
Q ss_pred CcccccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||.........+................++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 23456899999999988643 4778999999999999999999998765554555555554444344456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
.+||. +|.+|||+.|+++||||+.....
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 271 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLKK 271 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccccc
Confidence 99999 99999999999999999865443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=280.00 Aligned_cols=180 Identities=26% Similarity=0.427 Sum_probs=145.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++........
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 6889999999999889999999999999999999999999 999999999999974 237999999999987655444
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||........+...+..+... .......+..+++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 556789999999998865 58999999999999999999999998877766677777766543 233345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+||. ||.+||++.++|+||||.....
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 99999 9999999999999999986543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=277.63 Aligned_cols=178 Identities=30% Similarity=0.399 Sum_probs=149.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.... ....
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 178 (327)
T 3a62_A 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVT 178 (327)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC----------
T ss_pred CCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCcccccccCCccc
Confidence 6889999999999889999999999999999999999999 9999999999999987 7999999999976432 2334
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+...+...+..+.. .++...++.+++||.+|
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 255 (327)
T 3a62_A 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEARDLLKKL 255 (327)
T ss_dssp CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHH
Confidence 5568999999999876 4589999999999999999999999987 455666666766554 23455689999999999
Q ss_pred hc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 159 LE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 159 L~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|. +|.+|| ++.+++.||||+...+..
T Consensus 256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 256 LKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp SCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 99 999999 899999999998765533
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=265.46 Aligned_cols=180 Identities=26% Similarity=0.456 Sum_probs=155.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++........
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 6789999999999899999999999999999999999999 9999999999999764 23599999999987766555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .....+...+..+... .......++.+.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 566789999999998865 589999999999999999999999977 4556666666665543 233345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
.+||. +|.+||++.|+|+||||+.....
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred HHHcccChhhCCCHHHHhcCccccCChhH
Confidence 99999 99999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=288.53 Aligned_cols=177 Identities=27% Similarity=0.453 Sum_probs=154.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~~- 77 (502)
||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. +.+.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 6889999999999999999999999999999999999999 999999999999984 23689999999998765432
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~L 154 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+... .......++.+++|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 2345789999999998875 599999999999999999999999977 5667777778777553 33334678999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|.+||. ||.+||++.|+|+||||+..
T Consensus 248 i~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999 99999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=288.41 Aligned_cols=181 Identities=25% Similarity=0.443 Sum_probs=151.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++.......
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheeccCCCcc
Confidence 68899999999876 47999999999999999999999999 9999999999999987 7999999999987654332
Q ss_pred -cccccCCCcccCccccc--------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--C-CCCcccc
Q 010768 79 -AHSVIGTPEFMAPELYE--------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--L-PGAFHRI 146 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~--------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--~-p~~~~~~ 146 (502)
....+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.. .+...++.++.... . .+.....
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 297 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEG 297 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC----C
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccccC
Confidence 23468999999999885 3589999999999999999999999987 55566666665422 1 1122345
Q ss_pred CCHHHHHHHHHhhcCcCCC---CCHHHHhcCccccCCCCCCC
Q 010768 147 QDAEARRFVGKCLENVSKR---LPAKELLLDPFLASDAGEPL 185 (502)
Q Consensus 147 ~s~~l~~LI~kcL~dP~kR---psa~ElL~hpf~~~~~~~~l 185 (502)
.++.+++||.+||.+|.+| ++++|++.||||+...|..+
T Consensus 298 ~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 7899999999999988887 59999999999998888764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=283.92 Aligned_cols=175 Identities=22% Similarity=0.404 Sum_probs=149.4
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---C
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---H 78 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~ 78 (502)
+.+|+|.+++.+.+.+++.+++.|+.||+.||.|||++| |+||||||+|||++. +.+||+|||++..+.... .
T Consensus 137 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEESS--SCEEECCCSSSCCC--------
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEEC--CeEEEEecCccccccCCCcccc
Confidence 467899999999999999999999999999999999999 999999999999953 689999999998764322 2
Q ss_pred cccccCCCcccCcccccc------------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 79 AHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~------------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....+.......+........++..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCC
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCcc
Confidence 345679999999998754 58899999999999999999999998866666666666666555556666
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+..+.+||.+||. +|.+||++.|+|.||||+..
T Consensus 293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 78999999999999 99999999999999999854
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=278.21 Aligned_cols=177 Identities=28% Similarity=0.460 Sum_probs=153.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC---CcEEEEecCCceeccCC-
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRGS- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~---g~vKL~DFGlA~~~~~~- 76 (502)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+.... +.+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 6889999999999999999999999999999999999999 99999999999996542 35999999999876543
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--CChHHHHHHHHcCCCCCC--ccccCCHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGA--FHRIQDAEA 151 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--~~~~~i~~~i~~~~~p~~--~~~~~s~~l 151 (502)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ....++...+..+..... .+...++.+
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 33456789999999998875 4899999999999999999999999763 456778888887765432 335578999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
++||.+||. ||.+||++.++|+||||..
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999 9999999999999999965
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=277.47 Aligned_cols=175 Identities=22% Similarity=0.403 Sum_probs=147.6
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---C
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---H 78 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~ 78 (502)
+.+|+|.+++.+.+.+++.+++.|+.||+.||.|||++| |+||||||+|||++. +.+||+|||++....... .
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 90 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSCCC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC--CcEEEeecccccccCccccccc
Confidence 468899999999999999999999999999999999999 999999999999974 689999999998764322 2
Q ss_pred cccccCCCcccCccccc------------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 79 AHSVIGTPEFMAPELYE------------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||....+.......+........++..
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCccc
Confidence 33567999999999874 458889999999999999999999998866666666666665555566677
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+..+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 78899999999999 99999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=290.56 Aligned_cols=179 Identities=28% Similarity=0.492 Sum_probs=155.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++........
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 6889999999998899999999999999999999999999 9999999999999642 35799999999987766555
Q ss_pred cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~ 156 (502)
....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+.. .....++.+++||.
T Consensus 180 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 258 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (486)
T ss_dssp --CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred cCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence 667789999999999999999999999999999999999999987 566677777877765433 33456899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+||. +|.+|||+.++|+||||+....
T Consensus 259 ~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 259 KMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999 9999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-33 Score=283.85 Aligned_cols=173 Identities=26% Similarity=0.505 Sum_probs=147.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+ +|+|.+++.+.+.+++.+++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..........
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSBTTC
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceeccCCcccc
Confidence 45 7999999999899999999999999999999999999 9999999999999987 799999999998776666667
Q ss_pred cccCCCcccCccccccc-C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~-~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
..+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.. ...+.+.+..+.. ..+...++.+++||.+|
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCVY--VMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSSCC--CCCTTSCHHHHHHHHTT
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCCC--CCcccCCHHHHHHHHHH
Confidence 77899999999998754 3 789999999999999999999997632 2222222222222 34455789999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. ||.+|||+.|+++||||+..
T Consensus 243 L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCChhHCcCHHHHHhChhhccC
Confidence 99 99999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=290.12 Aligned_cols=177 Identities=25% Similarity=0.488 Sum_probs=157.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+...+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++........
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 6899999999999899999999999999999999999999 9999999999999764 24699999999988776666
Q ss_pred cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~ 156 (502)
....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .....+...+..+.... ......++.+++||.
T Consensus 195 ~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 667789999999999988899999999999999999999999987 56677777787776543 233457899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||. +|.+|||+.++|+||||+..
T Consensus 274 ~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 274 QMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHCCCChhhCccHHHHhcCcccccC
Confidence 9999 99999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=292.26 Aligned_cols=179 Identities=27% Similarity=0.456 Sum_probs=158.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++........
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 6889999999999999999999999999999999999999 999999999999952 237899999999987766555
Q ss_pred cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~ 156 (502)
....+||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .+...+...+..+..... .+...++.+++||.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 263 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263 (484)
T ss_dssp HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence 666789999999999988999999999999999999999999987 566777778877765433 33457899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+||. +|.+|||+.|+|.||||+....
T Consensus 264 ~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 264 KMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999 9999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=271.82 Aligned_cols=179 Identities=22% Similarity=0.374 Sum_probs=142.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceeccCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGS-- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~~~~-- 76 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+. ..+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 6889999999999889999999999999999999999999 99999999999998762 23999999998765321
Q ss_pred ------CCcccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCC--------------hHHH
Q 010768 77 ------QHAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSN--------------PAQI 130 (502)
Q Consensus 77 ------~~~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--------------~~~i 130 (502)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ...+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 1123456999999999885 3489999999999999999999999976432 2345
Q ss_pred HHHHHcCCCCCCc--cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 131 YKKVTSGKLPGAF--HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 131 ~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
...+..+...... ....++.+++||.+||. ||.+||++.|+|+||||+...
T Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 6666666543221 23468899999999999 999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=284.52 Aligned_cols=179 Identities=20% Similarity=0.366 Sum_probs=142.2
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~ 76 (502)
||.||+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||+++.....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 688999999998754 5999999999999999999999999 9999999999999873 378999999999877655
Q ss_pred CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHHcCCC--CCCccccCCHH
Q 010768 77 QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL--PGAFHRIQDAE 150 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~~~~~--p~~~~~~~s~~ 150 (502)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... ..+...+..+.. +.......+..
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 297 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHH
Confidence 5556778999999999886 46999999999999999999999999764321 123444555543 22233456899
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+++||.+||. ||.+|||+.++|.||||....
T Consensus 298 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999 999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=277.85 Aligned_cols=174 Identities=22% Similarity=0.511 Sum_probs=152.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..+.......
T Consensus 181 ~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~~~~~~~ 257 (365)
T 2y7j_A 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLR 257 (365)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCcccccCCCcccc
Confidence 6889999999998889999999999999999999999999 9999999999999987 799999999998876655566
Q ss_pred cccCCCcccCcccccc-------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHH
Q 010768 81 SVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEA 151 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l 151 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+..+...... ....+..+
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 336 (365)
T 2y7j_A 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSSTV 336 (365)
T ss_dssp CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHSSSCHHH
T ss_pred cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence 7789999999998752 478899999999999999999999977 4555666667666553322 23568889
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
.+||.+||. +|.+||++.++|+||||+
T Consensus 337 ~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 337 KDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 999999999 999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=278.91 Aligned_cols=178 Identities=22% Similarity=0.413 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC-CcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~-g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.||+|.+++.+.+++++..++.|+.||+.||+|||++| |+||||||+|||++.+. +.+||+|||+++........
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 6889999999998889999999999999999999999999 99999999999998652 35999999999765444445
Q ss_pred ccccCCCcccCcccccc-cCCc-ccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNE-LVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~-ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
...+||+.|+|||++.+ .+.. ++|||||||++|+|++|+.||.+.. ....+...+.............++.+++|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 56789999999998754 4544 4899999999999999999997643 23445555555554433344568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|.+||. +|.+|||+.|++.||||...
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999 99999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=274.27 Aligned_cols=179 Identities=25% Similarity=0.410 Sum_probs=135.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+. ..+||+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 6889999999999999999999999999999999999999 99999999999998652 27999999999865432 2
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC------CChHHHHHHHHcCCCCCC--ccccCC
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC------SNPAQIYKKVTSGKLPGA--FHRIQD 148 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~------~~~~~i~~~i~~~~~p~~--~~~~~s 148 (502)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+..+..+.. .....+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 3455678999999998864 5899999999999999999999999753 234566777777665332 223568
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+.+++||.+||. ||.+||++.+++.||||+...
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 999999999999 999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=289.74 Aligned_cols=178 Identities=31% Similarity=0.489 Sum_probs=158.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+. ..+||+|||++........
T Consensus 127 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 204 (504)
T 3q5i_A 127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204 (504)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc
Confidence 6889999999999899999999999999999999999999 99999999999998762 2699999999998776666
Q ss_pred cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc--cccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF--HRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~ 156 (502)
....+||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .+...+...+..+...... ....++.+++||.
T Consensus 205 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 283 (504)
T 3q5i_A 205 LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIK 283 (504)
T ss_dssp BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHH
Confidence 667789999999999998899999999999999999999999987 5667778888877654332 2456899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+||. +|.+|||+.|+|.||||+...
T Consensus 284 ~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 284 LMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHcCCChhHCCCHHHHhcCHhhhhch
Confidence 9999 999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=270.79 Aligned_cols=178 Identities=26% Similarity=0.441 Sum_probs=153.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC---cEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG---QVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g---~vKL~DFGlA~~~~~~~ 77 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+.. .+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~ 173 (321)
T 2a2a_A 96 LVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (321)
T ss_dssp CCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence 6789999999999889999999999999999999999999 999999999999987632 79999999998876655
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~L 154 (502)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .........+....... ......++.+++|
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 252 (321)
T 2a2a_A 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKDF 252 (321)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcccCHHHHHH
Confidence 556678999999999886 4589999999999999999999999977 45555666666554322 2234568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|.+||. +|.+||++.|+|.||||+...
T Consensus 253 i~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 999999 999999999999999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=289.56 Aligned_cols=174 Identities=26% Similarity=0.497 Sum_probs=154.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..........
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCTTCCBC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhcccccccc
Confidence 6889999999999889999999999999999999999999 9999999999999987 799999999999876655566
Q ss_pred cccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+...+..++..+... .+...++.+.+||.+|
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISLLKHM 250 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHHHHHH
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHHHHHH
Confidence 77899999999988754 47899999999999999999999987 4556677777776553 3445689999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. ||.+|||+.+++.||||+..
T Consensus 251 L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 251 LQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCCchhCcCHHHHHhCHHhhhc
Confidence 99 99999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=269.14 Aligned_cols=173 Identities=24% Similarity=0.487 Sum_probs=147.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 119 ~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 194 (298)
T 2zv2_A 119 LVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALL 194 (298)
T ss_dssp CCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECSSSSCEE
T ss_pred cCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CCEEEecCCCccccccccccc
Confidence 578899988654 467999999999999999999999999 9999999999999887 799999999998765432 23
Q ss_pred ccccCCCcccCccccccc----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .....+...+.............++.+++||
T Consensus 195 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (298)
T 2zv2_A 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLI 273 (298)
T ss_dssp CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHH
T ss_pred cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHHhcccCCCCCccccCHHHHHHH
Confidence 456799999999988643 37789999999999999999999977 4555666666666554444456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCcccc
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
.+||. ||.+||++.|+|+||||+
T Consensus 274 ~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 274 TRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhhcChhhCCCHHHHhcCcccc
Confidence 99999 999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=265.85 Aligned_cols=175 Identities=25% Similarity=0.494 Sum_probs=148.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+...+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~-~~~ 165 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-RRT 165 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC-------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCcc-ccc
Confidence 6789999999999899999999999999999999999999 9999999999999887 79999999998654332 234
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..... .++...++.+++||.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLL 242 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHC
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHh
Confidence 5679999999998865 478999999999999999999999987 555666666666544 344557899999999999
Q ss_pred c-CcCCCCCHHHHhcCccccCCCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
. +|.+||++.|+|+||||+....
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ccChhhCCCHHHHhhCccccCCcc
Confidence 9 9999999999999999987544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=264.74 Aligned_cols=176 Identities=23% Similarity=0.384 Sum_probs=140.8
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+. |+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence 344 456665554 678999999999999999999999999 9999999999999987 79999999999876432 23
Q ss_pred cccccCCCcccCcccccc-c-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC--CCC-C------------
Q 010768 79 AHSVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG--KLP-G------------ 141 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~--~~p-~------------ 141 (502)
.....||+.|+|||++.+ . ++.++|||||||++|+|++|..||............+... ..+ .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 345678999999998754 3 8999999999999999999888865555655555554321 100 0
Q ss_pred ------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 ------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 ------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
......++.+++||.+||. ||.+|||++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0112357899999999999 99999999999999999853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=280.44 Aligned_cols=173 Identities=24% Similarity=0.360 Sum_probs=139.0
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC--------
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-------- 75 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-------- 75 (502)
+|+|.++++. +.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 94 ~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~ 169 (388)
T 3oz6_A 94 ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNI 169 (388)
T ss_dssp SEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCCCCCG
T ss_pred CcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCcccccccccccccccc
Confidence 3799999987 57999999999999999999999999 9999999999999987 7999999999986532
Q ss_pred --------------CCCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC
Q 010768 76 --------------SQHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 76 --------------~~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.....++...+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 249 (388)
T 3oz6_A 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF 249 (388)
T ss_dssp GGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 112344689999999998854 5899999999999999999999999885544443333221111
Q ss_pred CCC--------------------------------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGA--------------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~--------------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
|.. .....++.+.+||.+||. ||.+|||+.|+|+|
T Consensus 250 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 110 011457899999999999 99999999999999
Q ss_pred ccccCC
Q 010768 175 PFLASD 180 (502)
Q Consensus 175 pf~~~~ 180 (502)
|||+..
T Consensus 330 p~~~~~ 335 (388)
T 3oz6_A 330 PFVSIF 335 (388)
T ss_dssp TTTTTT
T ss_pred HHHHHh
Confidence 999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=263.13 Aligned_cols=178 Identities=25% Similarity=0.447 Sum_probs=153.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++..........
T Consensus 105 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 181 (298)
T 1phk_A 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLR 181 (298)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEecccchhhcCCCcccc
Confidence 6789999999999889999999999999999999999999 9999999999999887 799999999998876655556
Q ss_pred cccCCCcccCccccc-------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHH
Q 010768 81 SVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEA 151 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l 151 (502)
...|++.|+|||++. ..++.++||||||+++|+|++|..||.. .........+..+..... .....+..+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (298)
T 1phk_A 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260 (298)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccCcccccccCHHH
Confidence 678999999999874 3478899999999999999999999977 455566666666554322 224568899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+||.+||. +|.+||++.++|+||||+....
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 999999999 9999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=263.58 Aligned_cols=176 Identities=23% Similarity=0.449 Sum_probs=151.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~ 170 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL-RRR 170 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECSSS-CBC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCccc-ccc
Confidence 5788999999999889999999999999999999999999 9999999999999887 79999999999765432 334
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..... .++...+..+++||.+||
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHS
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHh
Confidence 5679999999998864 589999999999999999999999977 445555566655543 334556899999999999
Q ss_pred c-CcCCCCCHHHHhcCccccCCCCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
. +|.+||++.++++||||+.....
T Consensus 248 ~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 248 RYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred hcCHhhCCCHHHHhhCHHHHhhccc
Confidence 9 99999999999999999875543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=273.25 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=148.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++... +.+++..++.|+.||+.||+|||++| |+||||||+|||++. ..+.+||+|||++......
T Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 68899999998653 67999999999999999999999999 999999999999987 2379999999999887655
Q ss_pred CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEARR 153 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~ 153 (502)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+..... +.......++.+.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFSSVSQLATD 266 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhcccCHHHHH
Confidence 5556678999999999886 45899999999999999999999999874 44455555544332 33334456899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCCCCCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~l~ 186 (502)
||.+||. +|.+||+++++|+||||+...+....
T Consensus 267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred HHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 9999999 99999999999999999987765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=280.18 Aligned_cols=179 Identities=25% Similarity=0.398 Sum_probs=152.6
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ .+.+||+|||++........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 688999999998654 7999999999999999999999999 9999999999999743 36899999999988765555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+...... .......++.+++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 556689999999998864 589999999999999999999999987 4555566666655432 223345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+||. ||.+||++.++|+||||+....
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999 9999999999999999987644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=272.67 Aligned_cols=181 Identities=28% Similarity=0.420 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC----CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~----~g~vKL~DFGlA~~~~~~ 76 (502)
|+. |+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ .+.+||+|||++......
T Consensus 114 ~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 114 YAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred cCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 344 699999999999999999999999999999999999 9999999999999632 246999999999766432
Q ss_pred -CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC-----------
Q 010768 77 -QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA----------- 142 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~----------- 142 (502)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+.+.+.....+..
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 23345678999999998864 4899999999999999999999999885554444443332111110
Q ss_pred ----------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 143 ----------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 143 ----------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
.....++.+.+||.+||. ||.+|||+.|+|+||||+...+.|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 011257899999999999 999999999999999999876643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=263.30 Aligned_cols=178 Identities=26% Similarity=0.418 Sum_probs=149.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---~ 77 (502)
|+.+|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++...... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCCCcchh
Confidence 5788999999988888999999999999999999999999 9999999999999987 79999999999865322 1
Q ss_pred CcccccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.........+..+.............++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 23456799999999988653 4778999999999999999999998765544445555444333333445689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+||. +|.+||++.++++||||+...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChh
Confidence 99999 999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=268.69 Aligned_cols=176 Identities=32% Similarity=0.570 Sum_probs=149.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCB
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcccc
Confidence 6889999999865 57999999999999999999999999 9999999999999987 799999999998765432 33
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~k 157 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. ....+....+.....+. ......++.+++||.+
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 45689999999998864 589999999999999999999999977 45555666666554432 2234568899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. +|.+||++.++|.||||....
T Consensus 278 ~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HccCChhhCcCHHHHhcChhhccCC
Confidence 999 999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.22 Aligned_cols=180 Identities=25% Similarity=0.406 Sum_probs=150.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~ 78 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 140 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~ 216 (355)
T 1vzo_A 140 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETER 216 (355)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGG
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCeecccCCCCc
Confidence 6889999999999889999999999999999999999999 9999999999999987 79999999999865322 22
Q ss_pred cccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCC---CChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... .++...+..++
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 294 (355)
T 1vzo_A 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK 294 (355)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccCHHHH
Confidence 345679999999998864 3789999999999999999999999643 234455555554433 33445688999
Q ss_pred HHHHHhhc-CcCCCC-----CHHHHhcCccccCCCCCCC
Q 010768 153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEPL 185 (502)
Q Consensus 153 ~LI~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~l 185 (502)
+||.+||. ||.+|| ++.|+++||||+...+..+
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 99999999 999999 9999999999987655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.85 Aligned_cols=176 Identities=26% Similarity=0.430 Sum_probs=148.4
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~ 74 (502)
||.||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ .+.+||+|||++....
T Consensus 107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 68899999988653 35899999999999999999999999 9999999999999764 2359999999998765
Q ss_pred CCCC-cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHH
Q 010768 75 GSQH-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAE 150 (502)
Q Consensus 75 ~~~~-~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~ 150 (502)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ ....+...+..+..... .....++.
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccccccCCHH
Confidence 4332 345689999999998864 589999999999999999999999976 34566667766655322 22456899
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+++||.+||. ||.+||++.++|+||||+..
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 9999999999 99999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.32 Aligned_cols=178 Identities=21% Similarity=0.427 Sum_probs=141.7
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-- 76 (502)
||.+|+|.+++... ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||.+......
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccccceeeccccc
Confidence 68899999999876 67999999999999999999999999 9999999999999987 79999999998654221
Q ss_pred ------CCcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-------
Q 010768 77 ------QHAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP------- 140 (502)
Q Consensus 77 ------~~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p------- 140 (502)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+. +..+
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 262 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTST 262 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCccccccc
Confidence 11233478999999998865 589999999999999999999999987554443332221 1110
Q ss_pred -------------------------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 141 -------------------------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 141 -------------------------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.......++.+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 11234457889999999999 9999999999999999987544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=264.85 Aligned_cols=174 Identities=29% Similarity=0.470 Sum_probs=137.9
Q ss_pred CCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 4 SGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 4 gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
+|+|.+++.. ...+++..++.|+.||+.||+|||++ | |+||||||+|||++.+ +.+||+|||++........
T Consensus 89 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-----------
T ss_pred ccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecCCccccccccc
Confidence 3688877754 56799999999999999999999998 8 9999999999999987 7999999999987665544
Q ss_pred cccccCCCcccCccccc-----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||..................+.......++.+.+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 55567999999999862 3588999999999999999999999987666666666666655555555667899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
||.+||. +|.+|||+.|+++||||+..
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999 99999999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=284.99 Aligned_cols=178 Identities=29% Similarity=0.455 Sum_probs=145.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ ...+||+|||+++.......
T Consensus 220 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~ 297 (419)
T 3i6u_A 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297 (419)
T ss_dssp CCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCCCcc
Confidence 6889999999998899999999999999999999999999 9999999999999754 23699999999987765555
Q ss_pred cccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~ 152 (502)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..... .....++.+.
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 377 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHH
Confidence 56778999999999874 45888999999999999999999999876555556666666655322 2234688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||.+||. +|.+||++.|+|+||||+..
T Consensus 378 ~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 378 DLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99999999 99999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.03 Aligned_cols=179 Identities=24% Similarity=0.393 Sum_probs=155.6
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++...+. +++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||++........
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCTTCC
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccceecccCcc
Confidence 6889999999987654 999999999999999999999999 9999999999999987 7999999999988766555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+...+..... .++...++.+++|
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~s~~~~dL 419 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERFSPQARSL 419 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence 566789999999998865 59999999999999999999999997643 34566666665433 3456678999999
Q ss_pred HHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
|.+||. ||.+|| ++.|++.||||+...+..
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~ 455 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR 455 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence 999999 999999 899999999999876644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=261.62 Aligned_cols=174 Identities=26% Similarity=0.481 Sum_probs=142.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCCCccee
Confidence 5789999999999889999999999999999999999999 9999999999999987 799999999998765544445
Q ss_pred cccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...||+.|+|||++.+. .+.++||||||+++|+|++|..||.. .....+.+.+..+... .+...+..+.++|.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHM 245 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHH
Confidence 66799999999998754 36899999999999999999999977 4556667777666542 3445688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.++++||||+..
T Consensus 246 l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCChhhCCCHHHHHhChhhccC
Confidence 99 99999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=270.48 Aligned_cols=172 Identities=24% Similarity=0.363 Sum_probs=138.9
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC---------------------
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--------------------- 57 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--------------------- 57 (502)
|+ +|+|.+++.+.. .+++..++.|+.||+.||+|||++| |+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 45 899999998764 5999999999999999999999999 999999999999974
Q ss_pred ---CCCcEEEEecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHH
Q 010768 58 ---HLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK 133 (502)
Q Consensus 58 ---~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~ 133 (502)
..+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~ 270 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE-HMEHLAM 270 (360)
T ss_dssp EEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHH
T ss_pred cccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc-HHHHHHH
Confidence 237899999999986543 2345679999999998764 69999999999999999999999998743 3333333
Q ss_pred HHcC--CCCC------------------------------------------CccccCCHHHHHHHHHhhc-CcCCCCCH
Q 010768 134 VTSG--KLPG------------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPA 168 (502)
Q Consensus 134 i~~~--~~p~------------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa 168 (502)
+... ..|. ......++.+.+||.+||. ||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 3221 1110 0011124778899999999 99999999
Q ss_pred HHHhcCcccc
Q 010768 169 KELLLDPFLA 178 (502)
Q Consensus 169 ~ElL~hpf~~ 178 (502)
.|+|+||||+
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999995
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=266.30 Aligned_cols=177 Identities=28% Similarity=0.448 Sum_probs=143.0
Q ss_pred CCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCccceecC
Confidence 344 7999999764 35999999999999999999999999 9999999999999987 799999999998764
Q ss_pred CC-CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCCC--------
Q 010768 75 GS-QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLPG-------- 141 (502)
Q Consensus 75 ~~-~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p~-------- 141 (502)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ......+.. +..+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhhhh
Confidence 32 23345679999999998864 589999999999999999999999987443 333333321 11000
Q ss_pred ----------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 ----------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 ----------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
......+..+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0112357899999999999 9999999999999999987544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=270.19 Aligned_cols=178 Identities=29% Similarity=0.457 Sum_probs=150.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. ..+||+|||++........
T Consensus 95 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 172 (322)
T 2ycf_A 95 LMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172 (322)
T ss_dssp CCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc
Confidence 6789999999998889999999999999999999999999 99999999999998652 3599999999987755444
Q ss_pred cccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC--ccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA--FHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~ 152 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..... .....+..+.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHH
Confidence 45567999999999863 45889999999999999999999999876555455566666554321 2244688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||.+||. +|.+||++.++|+||||+..
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99999999 99999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=271.16 Aligned_cols=168 Identities=25% Similarity=0.409 Sum_probs=144.2
Q ss_pred CCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSG-TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gG-sL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+| +|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.........
T Consensus 110 ~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~ 186 (335)
T 3dls_A 110 KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLF 186 (335)
T ss_dssp CCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTCCB
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecccceECCCCCce
Confidence 35455 99999999999999999999999999999999999 9999999999999987 79999999999987666656
Q ss_pred ccccCCCcccCccccccc-C-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEED-Y-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~~-~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
....||+.|+|||++.+. + +.++|||||||++|+|++|..||.... ....... ..+...++.+.+||.+
T Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~--~~~~~~~~~l~~li~~ 257 (335)
T 3dls_A 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-------ETVEAAI--HPPYLVSKELMSLVSG 257 (335)
T ss_dssp CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-------GGTTTCC--CCSSCCCHHHHHHHHH
T ss_pred eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-------HHHhhcc--CCCcccCHHHHHHHHH
Confidence 677899999999988654 4 789999999999999999999997621 1111111 2334568999999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
||. +|.+||++.++|+||||+..
T Consensus 258 ~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 258 LLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HccCChhhCcCHHHHhcCccccCC
Confidence 999 99999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=263.63 Aligned_cols=174 Identities=26% Similarity=0.422 Sum_probs=137.2
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
.|+|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-------
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccCcccccccc
Confidence 35999999875 67999999999999999999999999 9999999999999987 79999999999765432 22344
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCC-C----------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP-G---------------- 141 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p-~---------------- 141 (502)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +..+ .
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 578999999998854 4899999999999999999999999875544433332221 1000 0
Q ss_pred --------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 --------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 --------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0112357899999999999 99999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=276.57 Aligned_cols=177 Identities=27% Similarity=0.348 Sum_probs=149.9
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC-CCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~-~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||+.. ..+.+||+|||++........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 68899999999765 46999999999999999999999999 999999999999952 336899999999998766555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+...... .......++.+++||
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 566789999999998864 5899999999999999999999999874 445555555554432 222345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. +|.+||++.|+|+||||+..
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999 99999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=266.39 Aligned_cols=177 Identities=25% Similarity=0.387 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+. |+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEETTSCCC-
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcCceecCCCccc
Confidence 344 6888888765 45999999999999999999999999 9999999999999987 79999999999876432 23
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHH--cCCCCCCc-----------
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT--SGKLPGAF----------- 143 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~--~~~~p~~~----------- 143 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..... ....+..+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 345678999999998754 589999999999999999999999987555444333222 11111111
Q ss_pred --------------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 144 --------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 144 --------------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
....++++.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 11246789999999999 999999999999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=265.39 Aligned_cols=176 Identities=19% Similarity=0.371 Sum_probs=144.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.+|+|.++++. +++..++.++.||+.||+|||++| |+||||||+|||++.+...+||+|||++..........
T Consensus 114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 6789999999854 899999999999999999999999 99999999999999774589999999998876655566
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHH-------------HcCCC------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKV-------------TSGKL------ 139 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i-------------~~~~~------ 139 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||............+ .....
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 6789999999998764 58999999999999999999999996544433222211 11111
Q ss_pred ----------------CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 140 ----------------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 140 ----------------p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
........++.+.+||.+||. ||.+|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 011122368999999999999 999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=274.89 Aligned_cols=169 Identities=28% Similarity=0.401 Sum_probs=139.5
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccCcc
Q 010768 13 KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE 92 (502)
Q Consensus 13 k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APE 92 (502)
....+++..++.|+.||+.||+|||++| |+||||||+|||++...+.+||+|||+++...........+||+.|+|||
T Consensus 134 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE 211 (394)
T 4e7w_A 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE 211 (394)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHH
Confidence 3577999999999999999999999999 99999999999999544899999999999876655566778999999999
Q ss_pred cccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC------------------CCCC--------Ccc
Q 010768 93 LYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG------------------KLPG--------AFH 144 (502)
Q Consensus 93 vl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~------------------~~p~--------~~~ 144 (502)
++.+ .++.++|||||||++|+|++|+.||.+......+...+... ..+. .+.
T Consensus 212 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (394)
T 4e7w_A 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFR 291 (394)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSC
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhcc
Confidence 8754 48999999999999999999999998855444444333211 1110 122
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
...++.+.+||.+||. +|.+|||+.|+|.||||+.....
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 292 PRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred ccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 2367899999999999 99999999999999999875443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=261.45 Aligned_cols=181 Identities=32% Similarity=0.556 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKY---TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~---~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++...+.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 57899999999875 24679999999999999999999999 99999999999999844899999999998764422
Q ss_pred -CcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||......................+...++.+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 2345679999999998864 388999999999999999999999976544443333332222333445567899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDAGE 183 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~ 183 (502)
||.+||. +|.+||++.++|.||||+.....
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 9999999 99999999999999999865443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=266.06 Aligned_cols=178 Identities=24% Similarity=0.394 Sum_probs=138.1
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
+|+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC---------
T ss_pred ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCcccccccCCcccccc
Confidence 469999998764 5999999999999999999999999 9999999999999987 79999999999765432 22345
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc---CCCCCCc-------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS---GKLPGAF------------- 143 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~---~~~p~~~------------- 143 (502)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.. ...+..+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 578999999998754 589999999999999999999999987443 333333322 1111111
Q ss_pred ------------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCCCCC
Q 010768 144 ------------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPL 185 (502)
Q Consensus 144 ------------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~l 185 (502)
....++.+.+||.+||. ||.+|||+.|+|+||||........
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 11347889999999999 9999999999999999987665443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=257.50 Aligned_cols=170 Identities=22% Similarity=0.362 Sum_probs=140.5
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC------------------
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------ 58 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~------------------ 58 (502)
|+.||+|.+++.+. +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 67899999999875 67999999999999999999999999 9999999999999742
Q ss_pred CCcEEEEecCCceeccCCCCcccccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc
Q 010768 59 LGQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS 136 (502)
Q Consensus 59 ~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~ 136 (502)
...+||+|||.+...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+|+... .....+..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~ 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQ 242 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHT
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHc
Confidence 247999999999876542 234699999999988654 567999999999999999998876542 23455555
Q ss_pred CCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 137 GKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 137 ~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+..+ ..+...++.+.+||.+||. +|.+||++.++|+||||+..
T Consensus 243 ~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 5554 3345668999999999999 99999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.65 Aligned_cols=172 Identities=24% Similarity=0.419 Sum_probs=140.8
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
||.||+|.+++.+... .++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 142 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~ 218 (332)
T 3qd2_B 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDE 218 (332)
T ss_dssp CCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC-
T ss_pred ecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccch
Confidence 6889999999987644 566779999999999999999999 9999999999999987 799999999998765432
Q ss_pred -------------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc
Q 010768 78 -------------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143 (502)
Q Consensus 78 -------------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 143 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..|+. ....+...+.....+..+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~ 295 (332)
T 3qd2_B 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLF 295 (332)
T ss_dssp -------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHH
T ss_pred hhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCccc
Confidence 2234579999999998864 58999999999999999999877652 233444555555544322
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
...++.+.+||.+||. +|.+||++.|+|+||||+.
T Consensus 296 -~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 -TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp -HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred -ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 2346778999999999 9999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.72 Aligned_cols=173 Identities=22% Similarity=0.335 Sum_probs=143.2
Q ss_pred CCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 5 GTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 5 GsL~~~L~----k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+|.+++. ....+++..++.|+.||+.||.|||++| |+||||||+|||++...+.+||+|||+++.........
T Consensus 122 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 199 (383)
T 3eb0_A 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV 199 (383)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC
T ss_pred ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc
Confidence 57666664 4578999999999999999999999999 99999999999998655899999999999876666666
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC------------------C
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL------------------P 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~------------------p 140 (502)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..... +
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (383)
T 3eb0_A 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279 (383)
T ss_dssp CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC
T ss_pred CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCC
Confidence 7789999999998754 4899999999999999999999999886555544443321111 1
Q ss_pred C--------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 141 G--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 141 ~--------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
. .++...++.+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred ccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 0 0233467889999999999 9999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=259.91 Aligned_cols=177 Identities=21% Similarity=0.413 Sum_probs=146.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~---g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+||+++.+. ..+||+|||++.......
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~ 166 (283)
T 3bhy_A 89 LVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166 (283)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence 5789999999998889999999999999999999999999 99999999999998752 279999999998776554
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~L 154 (502)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .........+....... ......+..+.+|
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKDF 245 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCCHHHHHH
Confidence 555667999999999886 4589999999999999999999999987 44555566665544322 2234568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|.+||. +|.+||++.++|.||||+..
T Consensus 246 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999 99999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=262.71 Aligned_cols=177 Identities=29% Similarity=0.503 Sum_probs=154.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++........
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 5789999999998889999999999999999999999999 9999999999999764 24799999999987655544
Q ss_pred cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc--ccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH--RIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~ 156 (502)
.....||+.|+|||++.+.++.++||||||+++|+|++|..||.+ .+...+.+.+..+..+...+ ...++.+.+||.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 258 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence 555678999999999988899999999999999999999999987 45666777777776543322 456899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||. +|.+||++.++|.||||+..
T Consensus 259 ~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 259 KMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999 99999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=262.05 Aligned_cols=175 Identities=23% Similarity=0.463 Sum_probs=150.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE---eCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl---d~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||++ +.+ +.+||+|||++..... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence 6789999999998889999999999999999999999999 9999999999999 444 7999999999976433 2
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~L 154 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+...+..+... .......++.+.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 3345679999999998864 589999999999999999999999977 4556667777766543 23345568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|.+||. +|.+||++.++|.||||...
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999 99999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=264.65 Aligned_cols=177 Identities=28% Similarity=0.510 Sum_probs=143.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-C
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~ 77 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... .
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 184 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVG 184 (326)
T ss_dssp CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEECCCTTTC-------
T ss_pred cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEEeeCcCceecCcCcc
Confidence 57889999999875 56999999999999999999999999 9999999999999877 79999999999765432 2
Q ss_pred CcccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 78 HAHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
......||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+.....+.......+..+
T Consensus 185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 263 (326)
T 2x7f_A 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWSKKF 263 (326)
T ss_dssp ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCSCHHH
T ss_pred ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCccccCHHH
Confidence 234567999999999874 35889999999999999999999999774 44444555555555555556678999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
++||.+||. +|.+||++.++++||||+...
T Consensus 264 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 264 QSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 999999999 999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=263.73 Aligned_cols=176 Identities=22% Similarity=0.407 Sum_probs=145.9
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---C
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---H 78 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~ 78 (502)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||++....... .
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSCC---------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC--CeEEEeeccccccccCcccccc
Confidence 467899999999999999999999999999999999999 999999999999975 689999999998654322 1
Q ss_pred cccccCCCcccCcccccc------------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 79 AHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~------------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||............+........++..
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCccc
Confidence 234579999999998754 58889999999999999999999998766665555666655554455666
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+..+.+||.+||. +|.+||++.++|+||||+...
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred chHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 78999999999999 999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=258.80 Aligned_cols=175 Identities=30% Similarity=0.493 Sum_probs=151.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCceecccCcccc
Confidence 6789999999999889999999999999999999999999 9999999999999987 79999999999876432 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..+.. ..+...++.+.++|.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM 249 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHHHHHHHHHH
Confidence 45679999999998864 488999999999999999999999977 445555556655544 23445688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.+++.||||....
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cccChhhCcCHHHHhhChheecCC
Confidence 99 999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=275.86 Aligned_cols=175 Identities=25% Similarity=0.356 Sum_probs=142.5
Q ss_pred CCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 5 GTLREYRK----KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 5 GsL~~~L~----k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+|.+++. ....+++..++.|+.||+.||+|||++| |+||||||+||||+.+.+.+||+|||+++.+.......
T Consensus 137 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~ 214 (420)
T 1j1b_A 137 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214 (420)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCce
Confidence 46666554 3577999999999999999999999999 99999999999999765679999999999876555556
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC------------------CCC
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG------------------KLP 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~------------------~~p 140 (502)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.....++.+.+... .++
T Consensus 215 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p 294 (420)
T 1j1b_A 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294 (420)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCC
T ss_pred eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccC
Confidence 6789999999998754 58999999999999999999999998865544444433210 011
Q ss_pred C--------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 141 G--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 141 ~--------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
. .+....++.+.+||.+||. ||.+||++.|+|.||||....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0 0123457899999999999 999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=263.94 Aligned_cols=179 Identities=26% Similarity=0.431 Sum_probs=139.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccccc
Confidence 6788999999998889999999999999999999999999 9999999999999887 79999999999876532 233
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-C-------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-G------------------- 137 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~------------------- 137 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+............. +
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 45679999999998854 5899999999999999999999999875444333221110 0
Q ss_pred CCCCC--------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 138 KLPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 138 ~~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
..+.. .....+..+.+||.+||. ||.+|||++|+|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 01100 012357889999999999 9999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=286.42 Aligned_cols=179 Identities=26% Similarity=0.457 Sum_probs=153.6
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++.+...
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeecceeeeccCC
Confidence 68999999999874 36999999999999999999999999 9999999999999987 79999999999876544
Q ss_pred CC-cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 77 QH-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 77 ~~-~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
.. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.... ....+.+.+..... .++...++.+
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 420 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSPAS 420 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCHHH
Confidence 33 345689999999998865 59999999999999999999999997643 44667777766544 3345678999
Q ss_pred HHHHHHhhc-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 152 RRFVGKCLE-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
++||.+||. +|.+||+ +.+++.||||+...|..
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~ 459 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ 459 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence 999999999 9999996 58999999999876643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=259.61 Aligned_cols=175 Identities=25% Similarity=0.489 Sum_probs=124.2
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++...... ..
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceeeccCCCCc
Confidence 67899999999876 67999999999999999999999999 9999999999999887 79999999999876432 22
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+..... ..+...+..+.+||.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVLADY--EMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCC--CCCTTSCHHHHHHHHH
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHhhccc--CCccccCHHHHHHHHH
Confidence 335678999999998864 5889999999999999999999999764332 22222222222 2344568899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
||. +|.+||++.++|.||||....
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HcccCHhhCCCHHHHhcCccccCCC
Confidence 999 999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=271.26 Aligned_cols=177 Identities=28% Similarity=0.521 Sum_probs=145.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||+. | |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-C-
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCcccccc-cc
Confidence 678999999999988999999999999999999999985 8 9999999999999987 79999999999755322 23
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH-----------------------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ----------------------------- 129 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~----------------------------- 129 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC-HHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 45679999999998864 58999999999999999999999997632 222
Q ss_pred -------------HHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 130 -------------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 130 -------------i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
....+.....+.......+..+.+||.+||. +|.+|||+.|+|+||||+....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 2223333333333444568899999999999 9999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=265.01 Aligned_cols=175 Identities=30% Similarity=0.493 Sum_probs=151.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCceecccCcccc
Confidence 6789999999999889999999999999999999999999 9999999999999987 79999999999876432 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. ......+..+..+.. .++...++.+.+||.+|
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM 275 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999977 445555566665544 23445688999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. ||.+||++.++|+||||....
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCChhHCcCHHHHhcCccccCCC
Confidence 99 999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=267.82 Aligned_cols=181 Identities=26% Similarity=0.400 Sum_probs=143.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--- 77 (502)
|+.||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 97 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~ 173 (311)
T 3ork_A 97 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSV 173 (311)
T ss_dssp CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC----------
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCccccccccccc
Confidence 6789999999998889999999999999999999999999 9999999999999987 799999999998654321
Q ss_pred -CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRF 154 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~L 154 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+.....+. ......++.+.+|
T Consensus 174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (311)
T 3ork_A 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 253 (311)
T ss_dssp --------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHH
T ss_pred ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHH
Confidence 2234579999999998864 589999999999999999999999987544444444444443322 1233468899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
|.+||. ||.+||++.++|.|+|++.....+
T Consensus 254 i~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 254 VLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred HHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 999999 999999999999999998654433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=259.64 Aligned_cols=178 Identities=29% Similarity=0.512 Sum_probs=148.4
Q ss_pred CCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-C
Q 010768 1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-H 78 (502)
Q Consensus 1 y~~gGsL~~~L~-k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~ 78 (502)
|+.+|+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....... .
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccchhhhhhccc
Confidence 678999999997 4577999999999999999999999999 9999999999999887 799999999998765432 2
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-CCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~ 156 (502)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+..... ....+...+..+.+||.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-RAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 345679999999998864 5899999999999999999999999874433 33333333322 22334556899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+||. +|.+||++.++|.||||+....
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999 9999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=270.17 Aligned_cols=171 Identities=27% Similarity=0.404 Sum_probs=141.8
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+++|.++++. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.... .....+
T Consensus 113 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~--~~~~~~ 186 (367)
T 1cm8_A 113 GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADS--EMTGYV 186 (367)
T ss_dssp SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCS--SCCSSC
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeeeccccccc--ccCcCc
Confidence 8899999987 67999999999999999999999999 9999999999999987 7999999999987543 244568
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCC--------------------
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP-------------------- 140 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p-------------------- 140 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 266 (367)
T 1cm8_A 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266 (367)
T ss_dssp SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred CCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCC
Confidence 9999999998764 5999999999999999999999999875444333322211 1110
Q ss_pred ----C---CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 ----G---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 ----~---~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. ......++.+.+||.+||. ||.+|||+.++|.||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0 1112357899999999999 99999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=265.57 Aligned_cols=176 Identities=27% Similarity=0.331 Sum_probs=139.7
Q ss_pred CCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 5 GTLREYR----KKYTRVDIRAVKNWARQILRGIAYLH--GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 5 GsL~~~L----~k~~~Lse~~i~~i~~QIl~aL~yLH--s~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+|...+ .....+++..++.++.||+.||.||| ++| |+||||||+|||++...+.+||+|||++........
T Consensus 110 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~ 187 (360)
T 3e3p_A 110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187 (360)
T ss_dssp CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC
T ss_pred ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC
Confidence 4555444 35677999999999999999999999 777 999999999999997448999999999988766555
Q ss_pred cccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC----------------
Q 010768 79 AHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---------------- 140 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p---------------- 140 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 188 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3e3p_A 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD 267 (360)
T ss_dssp CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG
T ss_pred cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcc
Confidence 566789999999998753 38999999999999999999999998854433333322211100
Q ss_pred -------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 141 -------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 141 -------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.......++.+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 268 LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00111145789999999999 9999999999999999987544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=265.04 Aligned_cols=174 Identities=22% Similarity=0.394 Sum_probs=139.6
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-----C
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-----Q 77 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-----~ 77 (502)
+|+|.+++... ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+... .
T Consensus 107 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 183 (351)
T 3mi9_A 107 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 183 (351)
T ss_dssp SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCCCSSSSCC
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEccchhccccccccccccc
Confidence 35788877664 67999999999999999999999999 9999999999999987 79999999999876421 2
Q ss_pred CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCC-CCcccc------
Q 010768 78 HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP-GAFHRI------ 146 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p-~~~~~~------ 146 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.. +..+ ..++..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 262 (351)
T 3mi9_A 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITPEVWPNVDNYELY 262 (351)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGCGGG
T ss_pred ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhccccccchhh
Confidence 2345678999999998754 489999999999999999999999987443 333333322 2222 111111
Q ss_pred ---------------------CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 147 ---------------------QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 147 ---------------------~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 26789999999999 999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=272.98 Aligned_cols=177 Identities=25% Similarity=0.313 Sum_probs=135.3
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----- 77 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----- 77 (502)
.+|+|.++++....+++..++.|+.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++......
T Consensus 112 ~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~ 188 (432)
T 3n9x_A 112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIV 188 (432)
T ss_dssp CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEEC---------
T ss_pred CCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC-CCEEEccCCCccccccccccccc
Confidence 35799999999888999999999999999999999999 9999999999999987 799999999998764321
Q ss_pred ------------------CcccccCCCcccCcccc-c-ccCCcccchhhhhHHHHHHhhcc-----------CCCCCCCC
Q 010768 78 ------------------HAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLTSE-----------YPYSECSN 126 (502)
Q Consensus 78 ------------------~~~~~~GT~~Y~APEvl-~-~~~s~ksDIwSLG~iLyeLLtG~-----------~Pf~~~~~ 126 (502)
.....+||+.|+|||++ . ..|+.++|||||||++|+|++|. ++|.+...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~ 268 (432)
T 3n9x_A 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268 (432)
T ss_dssp ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCS
T ss_pred ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccc
Confidence 23567899999999975 3 45999999999999999999843 33433210
Q ss_pred -----------------hHHH-----------------------HHHHHcCCCCC--C---ccccCCHHHHHHHHHhhc-
Q 010768 127 -----------------PAQI-----------------------YKKVTSGKLPG--A---FHRIQDAEARRFVGKCLE- 160 (502)
Q Consensus 127 -----------------~~~i-----------------------~~~i~~~~~p~--~---~~~~~s~~l~~LI~kcL~- 160 (502)
..++ .+.+....... . .....++.+.+||.+||.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 348 (432)
T 3n9x_A 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKF 348 (432)
T ss_dssp CC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred cccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcC
Confidence 1111 11111111100 0 012358899999999999
Q ss_pred CcCCCCCHHHHhcCccccCCCC
Q 010768 161 NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 161 dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
||.+|||++|+|+||||+...+
T Consensus 349 dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 349 NPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp STTTSCCHHHHHTCGGGTTTCC
T ss_pred CcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999987544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=277.90 Aligned_cols=177 Identities=26% Similarity=0.383 Sum_probs=135.2
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-----
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----- 77 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----- 77 (502)
.+|+|.++++....+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++......
T Consensus 139 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~~ 215 (458)
T 3rp9_A 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQ 215 (458)
T ss_dssp CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCBCTTSCTTCCCC
T ss_pred cccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccchhccCccccccc
Confidence 47899999999889999999999999999999999999 9999999999999987 799999999998754211
Q ss_pred -----------------------CcccccCCCcccCcccc-c-ccCCcccchhhhhHHHHHHhh-----------ccCCC
Q 010768 78 -----------------------HAHSVIGTPEFMAPELY-E-EDYNELVDIYSFGMCVLEMLT-----------SEYPY 121 (502)
Q Consensus 78 -----------------------~~~~~~GT~~Y~APEvl-~-~~~s~ksDIwSLG~iLyeLLt-----------G~~Pf 121 (502)
.....+||+.|+|||++ . ..|+.++|||||||++|||++ |.++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f 295 (458)
T 3rp9_A 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295 (458)
T ss_dssp CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSC
T ss_pred cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccC
Confidence 23456789999999975 3 459999999999999999999 66777
Q ss_pred CCCCC--------------------hHHHHHHHHc-CC--------------------CC-------CCccccCCHHHHH
Q 010768 122 SECSN--------------------PAQIYKKVTS-GK--------------------LP-------GAFHRIQDAEARR 153 (502)
Q Consensus 122 ~~~~~--------------------~~~i~~~i~~-~~--------------------~p-------~~~~~~~s~~l~~ 153 (502)
.+... ..++...+.. |. .+ .......++.+.+
T Consensus 296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 375 (458)
T 3rp9_A 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIH 375 (458)
T ss_dssp C--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHH
T ss_pred CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHH
Confidence 55321 1111100000 00 00 0011234889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
||.+||. ||.+|||++|+|+||||+...+
T Consensus 376 Ll~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 376 LLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 9999999 9999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=267.69 Aligned_cols=163 Identities=26% Similarity=0.410 Sum_probs=131.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC-CcEEEEecCCceeccCCC-----CcccccCCCcccC
Q 010768 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSQ-----HAHSVIGTPEFMA 90 (502)
Q Consensus 17 Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~-g~vKL~DFGlA~~~~~~~-----~~~~~~GT~~Y~A 90 (502)
+++..++.|+.||+.||+|||++| |+||||||+|||++.+. +.+||+|||++..+.... ......||+.|+|
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 242 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence 468889999999999999999999 99999999999998652 389999999998753311 2345679999999
Q ss_pred ccccc---ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHHHHHhhc-CcCC
Q 010768 91 PELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFVGKCLE-NVSK 164 (502)
Q Consensus 91 PEvl~---~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~k 164 (502)
||++. ..++.++|||||||++|+|++|+.||.+.. .......+..+.... ......++.+++||.+||. +|.+
T Consensus 243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 99885 458999999999999999999999998754 444445555444322 2233468999999999999 9999
Q ss_pred CCCHHHHhcCccccCCCC
Q 010768 165 RLPAKELLLDPFLASDAG 182 (502)
Q Consensus 165 Rpsa~ElL~hpf~~~~~~ 182 (502)
||++.++|+||||+...+
T Consensus 322 Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 322 RFDAMRALQHPWISQFSD 339 (345)
T ss_dssp SCCHHHHHHSHHHHTTSS
T ss_pred CCCHHHHhcChhhccChH
Confidence 999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.24 Aligned_cols=176 Identities=33% Similarity=0.470 Sum_probs=143.9
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+|+|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...........
T Consensus 102 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~ 178 (326)
T 1blx_A 102 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS 178 (326)
T ss_dssp SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCC
T ss_pred CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEEecCcccccccCCCCccc
Confidence 379999998764 4999999999999999999999999 9999999999999887 7999999999987654444456
Q ss_pred ccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--------------------
Q 010768 82 VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-------------------- 140 (502)
Q Consensus 82 ~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-------------------- 140 (502)
..||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...+.....+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 1blx_A 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258 (326)
T ss_dssp CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC
T ss_pred cccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccC
Confidence 77999999999876 458999999999999999999999998754443333322211100
Q ss_pred ----CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 141 ----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 141 ----~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
..+....+..+++||.+||. +|.+||++.++|.||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 01123468899999999999 9999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=275.82 Aligned_cols=173 Identities=26% Similarity=0.377 Sum_probs=139.0
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc--EEEEecCCceeccCCCCc
Q 010768 4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 4 gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~--vKL~DFGlA~~~~~~~~~ 79 (502)
+|+|.+++.... .+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +. +||+|||++..... ..
T Consensus 182 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~~~~--~~ 256 (429)
T 3kvw_A 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVIDFGSSCYEHQ--RV 256 (429)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEECCCTTCEETTC--CC
T ss_pred CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEeecccceecCC--cc
Confidence 579999998764 4999999999999999999999999 9999999999999887 45 99999999976543 34
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-----------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG----------------- 141 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~----------------- 141 (502)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.....+.
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 336 (429)
T 3kvw_A 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSK 336 (429)
T ss_dssp CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTT
T ss_pred cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCC
Confidence 45689999999998764 599999999999999999999999988554443332222111000
Q ss_pred ---------------------------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 142 ---------------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 142 ---------------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+....++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 337 GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred CCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 0111237889999999999 999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=278.28 Aligned_cols=163 Identities=15% Similarity=0.165 Sum_probs=133.4
Q ss_pred CCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 4 SGTLREYRKKYTRVDI-------RAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse-------~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
+|+|.+++.+.+.+++ ..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~- 258 (377)
T 3byv_A 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA- 258 (377)
T ss_dssp SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCGGGCEETTC-
T ss_pred CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEEechhheecCC-
Confidence 7899999997666666 888899999999999999999 9999999999999987 7999999999986432
Q ss_pred CCcccccCCCcccCcccccc------------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc
Q 010768 77 QHAHSVIGTPEFMAPELYEE------------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~------------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 144 (502)
......| +.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ......+.. ..
T Consensus 259 -~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~------~~ 329 (377)
T 3byv_A 259 -RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA-LGGSEWIFR------SC 329 (377)
T ss_dssp -EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGGS------SC
T ss_pred -cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc-ccchhhhhh------hc
Confidence 3445678 99999998864 599999999999999999999999976321 111111111 11
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
...++.+.+||.+||. ||.+||++.++|+||||+.
T Consensus 330 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 3458899999999999 9999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.85 Aligned_cols=174 Identities=21% Similarity=0.368 Sum_probs=139.7
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC------------------CC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------------LG 60 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~------------------~g 60 (502)
|+ +|+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.. .+
T Consensus 98 ~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~ 174 (339)
T 1z57_A 98 LL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174 (339)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred CC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence 45 899999998875 6899999999999999999999999 9999999999999863 25
Q ss_pred cEEEEecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--C
Q 010768 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--G 137 (502)
Q Consensus 61 ~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~ 137 (502)
.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ......+.. +
T Consensus 175 ~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~ 251 (339)
T 1z57_A 175 DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-KEHLAMMERILG 251 (339)
T ss_dssp CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-HHHHHHHHHHHC
T ss_pred CceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhC
Confidence 799999999987543 2345679999999998864 589999999999999999999999987433 322222211 1
Q ss_pred CCCCC----------------------------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 138 KLPGA----------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 138 ~~p~~----------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
..|.. .....++.+.+||.+||. ||.+|||+.|+|+|||
T Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 11110 011124678999999999 9999999999999999
Q ss_pred ccCC
Q 010768 177 LASD 180 (502)
Q Consensus 177 ~~~~ 180 (502)
|+..
T Consensus 332 f~~~ 335 (339)
T 1z57_A 332 FDLL 335 (339)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 9864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=270.30 Aligned_cols=175 Identities=22% Similarity=0.327 Sum_probs=136.9
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC-CCCcEEEEecCCceeccCCCCcc
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~-~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
+|+|.+++... +.+++..++.++.||+.||.|||++..+||||||||+|||++. ..+.+||+|||++..... ...
T Consensus 139 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~ 216 (382)
T 2vx3_A 139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIY 216 (382)
T ss_dssp CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCC
T ss_pred CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccc
Confidence 57999999876 4699999999999999999999964334999999999999964 236899999999987643 234
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCCC-----------------
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLPG----------------- 141 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p~----------------- 141 (502)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...... ...+.. ...+.
T Consensus 217 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (382)
T 2vx3_A 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ-MNKIVEVLGIPPAHILDQAPKARKFFEKL 295 (382)
T ss_dssp SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTCTTHHHHEEEC
T ss_pred cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhHHHHHHHHhc
Confidence 5689999999998865 599999999999999999999999987544333 333322 11000
Q ss_pred --Ccc---------------c---------------------------cCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 142 --AFH---------------R---------------------------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 142 --~~~---------------~---------------------------~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
..+ . ...+.+++||.+||. ||.+|||++|+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp TTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcc
Confidence 000 0 001478999999999 9999999999999999
Q ss_pred ccCCC
Q 010768 177 LASDA 181 (502)
Q Consensus 177 ~~~~~ 181 (502)
|+...
T Consensus 376 f~~~~ 380 (382)
T 2vx3_A 376 FKKTA 380 (382)
T ss_dssp GCC--
T ss_pred cccCC
Confidence 98643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=281.54 Aligned_cols=171 Identities=29% Similarity=0.379 Sum_probs=131.6
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++...........+
T Consensus 150 ~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~ 224 (464)
T 3ttj_A 150 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV 224 (464)
T ss_dssp SEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC-----CCCC----
T ss_pred CCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeeeecCCCcccCCCc
Confidence 3557777644 5999999999999999999999999 9999999999999987 799999999998876655566788
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---------------------
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--------------------- 141 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------- 141 (502)
||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++.+.+.....|.
T Consensus 225 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~ 304 (464)
T 3ttj_A 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 304 (464)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCC
T ss_pred ccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccccc
Confidence 9999999998764 699999999999999999999999988544443333222111000
Q ss_pred ---C----ccc-----------cCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 142 ---A----FHR-----------IQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 142 ---~----~~~-----------~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
. ++. ..++.+++||.+||. ||.+|||++|+|+||||+.
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0 000 014678999999999 9999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=267.09 Aligned_cols=173 Identities=28% Similarity=0.487 Sum_probs=146.5
Q ss_pred CCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~-k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+. |+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... .
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---A 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---B
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCceecCC---C
Confidence 344 78888886 4567999999999999999999999999 9999999999999987 7999999999976543 3
Q ss_pred ccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
....||+.|+|||++. +.++.++|||||||++|+|++|..||.+... ......+..+..+.......++.+++||
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 4567999999999873 4689999999999999999999999987544 4444455555555555566789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+||. +|.+||++.++|+||||....
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999 999999999999999997643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=255.65 Aligned_cols=175 Identities=22% Similarity=0.423 Sum_probs=147.0
Q ss_pred CCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--
Q 010768 1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-- 76 (502)
|+.+| |.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 89 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAA 164 (305)
T ss_dssp CCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCS
T ss_pred hccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeeccccccccCcccc
Confidence 34544 8888876 356999999999999999999999999 9999999999999887 79999999999876432
Q ss_pred -CCcccccCCCcccCccccccc---CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 77 -QHAHSVIGTPEFMAPELYEED---YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~~---~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.. .+...+...+..+.. .++...++.+.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~~~l~ 241 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCGPPLS 241 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSCHHHH
T ss_pred ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccCHHHH
Confidence 223455799999999988642 47899999999999999999999977 556667777776654 33455689999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+||.+||. ||.+||++.++++||||+....
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999 9999999999999999987544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=260.60 Aligned_cols=177 Identities=30% Similarity=0.499 Sum_probs=139.8
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++.+.+. +++..++.++.||+.||+|||++|++|+||||||+|||++.+ +.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCccccccc
Confidence 6889999999987654 999999999999999999999998889999999999999987 799999999997654322
Q ss_pred -CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ ....+....+.........+...++.+.+||
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 272 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 2345679999999998865 589999999999999999999999987 4555555555544444455667789999999
Q ss_pred HHhhc-CcCCCCCHHHHhc--CccccC
Q 010768 156 GKCLE-NVSKRLPAKELLL--DPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~--hpf~~~ 179 (502)
.+||. +|.+||++.++++ .++++.
T Consensus 273 ~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 273 EGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999 9999999999987 455543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=256.49 Aligned_cols=178 Identities=29% Similarity=0.543 Sum_probs=139.3
Q ss_pred CCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKK--------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k--------~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.||+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEEEeccchhe
Confidence 6789999999974 456999999999999999999999999 9999999999999887 7999999999876
Q ss_pred ccCCC------CcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---
Q 010768 73 LRGSQ------HAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--- 141 (502)
Q Consensus 73 ~~~~~------~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--- 141 (502)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............+ ....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 249 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLET 249 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSSCCCTTC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccCCCcccc
Confidence 53221 1234579999999998863 58999999999999999999999998755444433333 222211
Q ss_pred -----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 -----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 -----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
......+..+.+||.+||. +|.+||++.++++||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 1223457899999999999 9999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=259.89 Aligned_cols=172 Identities=21% Similarity=0.390 Sum_probs=137.2
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE-------------------eCCCCcE
Q 010768 4 SGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-------------------NGHLGQV 62 (502)
Q Consensus 4 gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl-------------------d~~~g~v 62 (502)
+|+|.+++.... .+++..++.|+.||+.||+|||++| |+||||||+|||+ +.+ +.+
T Consensus 105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~-~~~ 181 (355)
T 2eu9_A 105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN-TSI 181 (355)
T ss_dssp CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC-CCE
T ss_pred CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCC-CcE
Confidence 788888887654 6999999999999999999999999 9999999999999 344 789
Q ss_pred EEEecCCceeccCCCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCC
Q 010768 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL 139 (502)
Q Consensus 63 KL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~ 139 (502)
||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........+ ..+.. +..
T Consensus 182 kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~ 258 (355)
T 2eu9_A 182 RVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL-VMMEKILGPI 258 (355)
T ss_dssp EECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCC
T ss_pred EEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCC
Confidence 9999999986543 234567999999999876 46899999999999999999999999874433322 22211 121
Q ss_pred CCC----------------------------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 140 PGA----------------------------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 140 p~~----------------------------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
|.. .....+..+.+||.+||. ||.+|||+.|+|+||||+
T Consensus 259 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 338 (355)
T 2eu9_A 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338 (355)
T ss_dssp CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 110 001114578899999999 999999999999999998
Q ss_pred CCC
Q 010768 179 SDA 181 (502)
Q Consensus 179 ~~~ 181 (502)
...
T Consensus 339 ~~~ 341 (355)
T 2eu9_A 339 GLT 341 (355)
T ss_dssp GCC
T ss_pred CCC
Confidence 654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.12 Aligned_cols=177 Identities=24% Similarity=0.500 Sum_probs=151.0
Q ss_pred CCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 1 MFTSGTLREY------RKK--YTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~------L~k--~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
|+.+|+|.++ +.+ ...+++..++.++.||+.||.|||+ +| |+||||||+|||++.+ +.+||+|||++.
T Consensus 124 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~ 200 (348)
T 2pml_X 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN-GRVKLSDFGESE 200 (348)
T ss_dssp CCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred ccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCC-CcEEEecccccc
Confidence 6788999999 666 5779999999999999999999999 88 9999999999999887 799999999998
Q ss_pred eccCCCCcccccCCCcccCccccccc--CCc-ccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc----
Q 010768 72 ILRGSQHAHSVIGTPEFMAPELYEED--YNE-LVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH---- 144 (502)
Q Consensus 72 ~~~~~~~~~~~~GT~~Y~APEvl~~~--~s~-ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---- 144 (502)
..... ......||+.|+|||++.+. ++. ++|||||||++|+|++|..||........+...+..+.......
T Consensus 201 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 279 (348)
T 2pml_X 201 YMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF 279 (348)
T ss_dssp ECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSS
T ss_pred ccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhh
Confidence 76443 34556799999999988754 555 99999999999999999999988666577777777765432211
Q ss_pred -------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 145 -------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 145 -------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
...++.+.+||.+||. +|.+||++.|+|+||||+...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 4568999999999999 999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=261.02 Aligned_cols=167 Identities=20% Similarity=0.392 Sum_probs=141.7
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 2 FTS-GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 2 ~~g-GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
+.+ |+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||++...... ...
T Consensus 130 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~ 206 (320)
T 3a99_A 130 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYT 206 (320)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBC
T ss_pred CCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-ccc
Confidence 444 899999999899999999999999999999999999 9999999999999955589999999999876543 334
Q ss_pred cccCCCcccCcccccc-c-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 81 SVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...||+.|+|||++.+ . ++.++|||||||++|+|++|..||... ..+..+.. .+....++.+.+||.+|
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~--~~~~~~~~~~~~li~~~ 277 (320)
T 3a99_A 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQV--FFRQRVSSECQHLIRWC 277 (320)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHCCC--CCSSCCCHHHHHHHHHH
T ss_pred CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------hhhhcccc--cccccCCHHHHHHHHHH
Confidence 5679999999998764 3 478899999999999999999999652 12233322 23455689999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. +|.+||++.++++||||+..
T Consensus 278 l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 278 LALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCChhhCcCHHHHhcCHhhcCc
Confidence 99 99999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.54 Aligned_cols=174 Identities=14% Similarity=0.199 Sum_probs=135.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAV------KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i------~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+. |+|.+++... ..+.+..+ +.++.||+.||+|||++| |+||||||+||||+.+ +.+||+|||+++..
T Consensus 169 ~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 169 AAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLGDVSALWKV 244 (371)
T ss_dssp CCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTT-SCEEECCGGGEEET
T ss_pred CCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCC-CCEEEEecceeeec
Confidence 455 8999999874 33455555 677799999999999999 9999999999999987 79999999999876
Q ss_pred cCCCCcccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCCChH-HHHHH---HH--cCCCCCCcc
Q 010768 74 RGSQHAHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECSNPA-QIYKK---VT--SGKLPGAFH 144 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~-~i~~~---i~--~~~~p~~~~ 144 (502)
.. ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... ..+.. .. .........
T Consensus 245 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (371)
T 3q60_A 245 GT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322 (371)
T ss_dssp TC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTS
T ss_pred CC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhc
Confidence 43 2224567899999998864 58999999999999999999999997642210 00000 00 011111222
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
...++.+.+||.+||. ||.+||++.++|+||||+..
T Consensus 323 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 3568999999999999 99999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=263.14 Aligned_cols=176 Identities=23% Similarity=0.327 Sum_probs=141.3
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~~ 81 (502)
.|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++...... .....
T Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 171 (346)
T 1ua2_A 95 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTH 171 (346)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCC
T ss_pred CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEecccceeccCCcccCCc
Confidence 35899998765 46999999999999999999999999 9999999999999987 79999999999876432 23345
Q ss_pred ccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC-CCCc--------------
Q 010768 82 VIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-PGAF-------------- 143 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~-p~~~-------------- 143 (502)
..||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+.+.+.. +.. ...+
T Consensus 172 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T 1ua2_A 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251 (346)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred ccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccc
Confidence 679999999998853 4899999999999999999999999875444333332221 111 0000
Q ss_pred ---------cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 144 ---------HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 144 ---------~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
....+..+++||.+||. ||.+|||+.|+|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 12346899999999999 9999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=265.40 Aligned_cols=177 Identities=30% Similarity=0.460 Sum_probs=140.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|+.+++|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceeecCCcccc
Confidence 6788999999888888999999999999999999999999 9999999999999887 79999999999765432 233
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CC------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK------------------ 138 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~------------------ 138 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +.
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 45679999999998865 5899999999999999999999999885554444333221 10
Q ss_pred -CCCC--------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 139 -LPGA--------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 139 -~p~~--------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+.. .....++.+.+||.+||. ||.+||++.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0100 011357899999999999 99999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=266.74 Aligned_cols=172 Identities=29% Similarity=0.398 Sum_probs=134.8
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCC---------------------
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHL--------------------- 59 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~--------------------- 59 (502)
+|+|.+++.+. +.+++..++.|+.||+.||+|||++ | |+||||||+|||++.+.
T Consensus 128 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (397)
T 1wak_A 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205 (397)
T ss_dssp CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence 77888877664 5699999999999999999999998 8 99999999999998652
Q ss_pred ---------------------------CcEEEEecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHH
Q 010768 60 ---------------------------GQVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCV 111 (502)
Q Consensus 60 ---------------------------g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iL 111 (502)
..+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 283 (397)
T 1wak_A 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA 283 (397)
T ss_dssp -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred CCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHH
Confidence 27999999999876432 345679999999998864 599999999999999
Q ss_pred HHHhhccCCCCCCCC-----hHHHHHHHH--cCCCCC--------------------------------------Ccccc
Q 010768 112 LEMLTSEYPYSECSN-----PAQIYKKVT--SGKLPG--------------------------------------AFHRI 146 (502)
Q Consensus 112 yeLLtG~~Pf~~~~~-----~~~i~~~i~--~~~~p~--------------------------------------~~~~~ 146 (502)
|+|++|..||..... .......+. .+..|. .+...
T Consensus 284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
T 1wak_A 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363 (397)
T ss_dssp HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHH
T ss_pred HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchh
Confidence 999999999975432 111111111 111110 01112
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.++.+.+||.+||. ||.+|||++|+|+||||+.
T Consensus 364 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 364 EAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 24678899999999 9999999999999999963
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=257.45 Aligned_cols=177 Identities=30% Similarity=0.471 Sum_probs=143.8
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~ 78 (502)
|+.+|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHHHHHHHHHHHC
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCCCccccccccc
Confidence 6789999999876 467999999999999999999999999 9999999999999877 7999999998754321 112
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l 151 (502)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||... +.......+..+..+ ...+...+..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCccccCHHH
Confidence 23457899999999872 45889999999999999999999999874 444444445444433 23345568899
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+||.+||. +|.+||++.++++||||+...
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 999999999 999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=262.53 Aligned_cols=173 Identities=22% Similarity=0.395 Sum_probs=141.6
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE----eCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl----d~~~g~vKL~DFGlA~~~ 73 (502)
|+.+|+|.+++..... +++..++.|+.||+.||+|||++| |+||||||+|||+ +.+ +.+||+|||++...
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEEccCCCceec
Confidence 6789999999987543 999999999999999999999999 9999999999998 544 67999999999987
Q ss_pred cCCCCcccccCCCcccCccccc---------ccCCcccchhhhhHHHHHHhhccCCCCCCCC---hHHHHHHHHcCCCCC
Q 010768 74 RGSQHAHSVIGTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSECSN---PAQIYKKVTSGKLPG 141 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~---------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---~~~i~~~i~~~~~p~ 141 (502)
..........||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+...+..+..+.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 6665556678999999999874 4689999999999999999999999964332 233444444333211
Q ss_pred -----------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 142 -----------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 142 -----------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
.+....+..+.+||.+||+ ||.+||+++|+|+||-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1122335678999999999 9999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=259.02 Aligned_cols=181 Identities=20% Similarity=0.349 Sum_probs=134.5
Q ss_pred CCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYT------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~-~~~kl~Dfg~a~~~~ 188 (323)
T 3qup_A 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLSRKIY 188 (323)
T ss_dssp CCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred eccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-CCEEEeecccccccc
Confidence 678999999997543 5999999999999999999999999 9999999999999987 799999999998654
Q ss_pred CCCC---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQH---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~~---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+. ....+...+..+..+ ......++
T Consensus 189 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 266 (323)
T 3qup_A 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGGNRL-KQPPECME 266 (323)
T ss_dssp ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred ccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHhcCCCC-CCCCccCH
Confidence 3322 223456789999998864 58999999999999999999 99999874 445556666655443 23445688
Q ss_pred HHHHHHHHhhc-CcCCCCC-------HHHHhcCccccCCCCCCCC
Q 010768 150 EARRFVGKCLE-NVSKRLP-------AKELLLDPFLASDAGEPLL 186 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRps-------a~ElL~hpf~~~~~~~~l~ 186 (502)
.+.+||.+||. +|.+||+ +++++.|||+......|+.
T Consensus 267 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 267 EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 99999999999 9999999 7788899999887665543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=265.03 Aligned_cols=177 Identities=21% Similarity=0.400 Sum_probs=123.7
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++.....
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 688999999998764 6999999999999999999999999 9999999999999753 35699999999987643
Q ss_pred CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHH---HHHHHHcCC--CCCCccccCCHH
Q 010768 77 QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ---IYKKVTSGK--LPGAFHRIQDAE 150 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~---i~~~i~~~~--~p~~~~~~~s~~ 150 (502)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+..+. .+.......++.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence 2334567899999999885 4588999999999999999999999976332211 122222222 222333456899
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 9999999999 99999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=267.53 Aligned_cols=171 Identities=29% Similarity=0.403 Sum_probs=128.1
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.............
T Consensus 113 ~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~ 187 (371)
T 2xrw_A 113 DANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYV 187 (371)
T ss_dssp SEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC--------------
T ss_pred CCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecccccccccccCCce
Confidence 468888886 46999999999999999999999999 9999999999999987 799999999998765544455678
Q ss_pred CCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-CCC-------------------C
Q 010768 84 GTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-LPG-------------------A 142 (502)
Q Consensus 84 GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~-~p~-------------------~ 142 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+..+.... .+. .
T Consensus 188 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (371)
T 2xrw_A 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266 (371)
T ss_dssp --CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred ecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence 9999999998764 5899999999999999999999999875443 3333333221 100 0
Q ss_pred c---------c-----------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 143 F---------H-----------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 143 ~---------~-----------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+ + ...+..+++||.+||. ||.+|||++|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0 0 0114678999999999 99999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=261.89 Aligned_cols=175 Identities=28% Similarity=0.457 Sum_probs=135.7
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCC-----CCcEEEEecCCceeccC
Q 010768 4 SGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGH-----LGQVKIGDLGLAAILRG 75 (502)
Q Consensus 4 gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~-----~g~vKL~DFGlA~~~~~ 75 (502)
+|+|.+++.+. ..+++..++.++.||+.||+|||++ | |+||||||+|||++.+ .+.+||+|||++.....
T Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence 89999999874 4599999999999999999999998 9 9999999999999632 24799999999987643
Q ss_pred CCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC-----hHHHHHHHHc--CCCCC------
Q 010768 76 SQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-----PAQIYKKVTS--GKLPG------ 141 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~-----~~~i~~~i~~--~~~p~------ 141 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .......+.. +..|.
T Consensus 191 --~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 268 (373)
T 1q8y_A 191 --HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268 (373)
T ss_dssp --CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred --CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhcc
Confidence 2344579999999998864 589999999999999999999999975321 1111111111 11110
Q ss_pred --------------------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 --------------------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 --------------------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+....+..+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred chhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 1112235678999999999 9999999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=254.03 Aligned_cols=175 Identities=32% Similarity=0.577 Sum_probs=149.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.+|+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeecccceecCcccccc
Confidence 6789999999865 67999999999999999999999999 9999999999999887 799999999998765432 23
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..+..+ ......+..+.+||.+|
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCC-CCCSSCCHHHHHHHHHH
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCCC-CCccccCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999977 4455555555555443 34556689999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
|. +|.+||++.++++||||....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 99 999999999999999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=252.59 Aligned_cols=174 Identities=32% Similarity=0.512 Sum_probs=138.5
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--- 76 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 172 (303)
T 1zy4_A 96 YCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDI 172 (303)
T ss_dssp CCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCCCSCTTC----
T ss_pred cCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEEEeeCcchhhcccccch
Confidence 578999999998654 5889999999999999999999999 9999999999999887 79999999999765321
Q ss_pred ------------CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC--CC
Q 010768 77 ------------QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK--LP 140 (502)
Q Consensus 77 ------------~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~--~p 140 (502)
.......||+.|+|||++.+ .++.++|||||||++|+|++ ||........+...+.... .+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 1zy4_A 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP 249 (303)
T ss_dssp ---------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCC
T ss_pred hccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccC
Confidence 12234578999999998864 58999999999999999998 6654334445555555433 34
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
..+....+..+++||.+||. ||.+||++.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 44555667889999999999 99999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=268.67 Aligned_cols=178 Identities=30% Similarity=0.418 Sum_probs=130.3
Q ss_pred CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe---CCCCcEEEEecCCc
Q 010768 3 TSGTLREYRKKY---------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---GHLGQVKIGDLGLA 70 (502)
Q Consensus 3 ~gGsL~~~L~k~---------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld---~~~g~vKL~DFGlA 70 (502)
.+|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||. ...+.+||+|||++
T Consensus 102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 356888888632 24999999999999999999999999 99999999999993 22379999999999
Q ss_pred eeccCC----CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCC---------hHHHHHHHH
Q 010768 71 AILRGS----QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSN---------PAQIYKKVT 135 (502)
Q Consensus 71 ~~~~~~----~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~---------~~~i~~~i~ 135 (502)
...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 876432 22345689999999998864 489999999999999999999999975332 122222221
Q ss_pred cCCCCC--Ccc---------------------------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 136 SGKLPG--AFH---------------------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 136 ~~~~p~--~~~---------------------------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
....|. .+. ...++.+.+||.+||. ||.+|||++|+|+||||+.
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 111110 000 0126688999999999 9999999999999999987
Q ss_pred CCC
Q 010768 180 DAG 182 (502)
Q Consensus 180 ~~~ 182 (502)
...
T Consensus 340 ~~~ 342 (405)
T 3rgf_A 340 DPL 342 (405)
T ss_dssp SSC
T ss_pred CCC
Confidence 543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=256.48 Aligned_cols=169 Identities=23% Similarity=0.433 Sum_probs=141.6
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 2 ~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++...+.+||+|||++...... ....
T Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~ 197 (312)
T 2iwi_A 121 LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTD 197 (312)
T ss_dssp SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCC
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccc
Confidence 678999999999889999999999999999999999999 9999999999999944489999999999876543 3345
Q ss_pred ccCCCcccCcccccc-cC-CcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 82 VIGTPEFMAPELYEE-DY-NELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 82 ~~GT~~Y~APEvl~~-~~-s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
..||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||... ..+..... .+....+..+.+||.+||
T Consensus 198 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~--~~~~~~~~~~~~li~~~l 268 (312)
T 2iwi_A 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QEILEAEL--HFPAHVSPDCCALIRRCL 268 (312)
T ss_dssp CCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHTCC--CCCTTSCHHHHHHHHHHT
T ss_pred cCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HHHhhhcc--CCcccCCHHHHHHHHHHc
Confidence 679999999998764 34 45899999999999999999999652 12222222 234556889999999999
Q ss_pred c-CcCCCCCHHHHhcCccccCCCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
. +|.+||++.|+++||||+....
T Consensus 269 ~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 269 APKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CSSTTTSCCHHHHHHSTTTCC---
T ss_pred cCChhhCcCHHHHhcChhhcCchh
Confidence 9 9999999999999999987544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=267.39 Aligned_cols=173 Identities=29% Similarity=0.394 Sum_probs=126.9
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
.+++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.... .....
T Consensus 116 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~ 189 (367)
T 2fst_X 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTAD--EMTGY 189 (367)
T ss_dssp CCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC----------------
T ss_pred cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeeccccccccc--cCCCc
Confidence 37899999876 67999999999999999999999999 9999999999999987 7999999999976543 23456
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC--------------------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL-------------------- 139 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~-------------------- 139 (502)
+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.....++...+.. +..
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence 89999999998764 5899999999999999999999999885443333222211 100
Q ss_pred ---CC-C---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 140 ---PG-A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 140 ---p~-~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+. . .....++.+.+||.+||. ||.+|||+.|+|.||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 0 012347889999999999 999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=262.23 Aligned_cols=174 Identities=25% Similarity=0.357 Sum_probs=131.5
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccc
Q 010768 4 SGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82 (502)
Q Consensus 4 gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~ 82 (502)
+|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++............
T Consensus 117 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 193 (362)
T 3pg1_A 117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHY 193 (362)
T ss_dssp SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCTTC-------------
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCEEEEecCccccccccccccee
Confidence 37888888765 46999999999999999999999999 9999999999999887 79999999999866555555567
Q ss_pred cCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--------------------
Q 010768 83 IGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-------------------- 140 (502)
Q Consensus 83 ~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-------------------- 140 (502)
.||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (362)
T 3pg1_A 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273 (362)
T ss_dssp --CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTC
T ss_pred cccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhh
Confidence 89999999998764 58999999999999999999999998744333322222111000
Q ss_pred -----C----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 -----G----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 -----~----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. ......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 274 LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 0112347889999999999 99999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=254.20 Aligned_cols=178 Identities=28% Similarity=0.443 Sum_probs=147.2
Q ss_pred CCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKY----TRVDIRAVKNWARQILRGIAYLHGHD---PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~----~~Lse~~i~~i~~QIl~aL~yLHs~g---~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ .+|+||||||+|||++.+ +.+||+|||++...
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARIL 166 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCHHHHC
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCchheee
Confidence 67899999999764 34999999999999999999999976 349999999999999987 79999999999765
Q ss_pred cCCCC-cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 74 RGSQH-AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 74 ~~~~~-~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .....+...+..+..+. .+...+..+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l 244 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYRYSDEL 244 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC-CCTTSCHHH
T ss_pred ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhccccc-CCcccCHHH
Confidence 43221 234578999999998864 589999999999999999999999977 45666777777776543 344568999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.++|.+||. +|.+||++.++|+|+|+....
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999 999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-30 Score=261.23 Aligned_cols=174 Identities=27% Similarity=0.404 Sum_probs=140.1
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC----C
Q 010768 3 TSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ----H 78 (502)
Q Consensus 3 ~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~----~ 78 (502)
.+|+|.++++. +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 112 ~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 187 (364)
T 3qyz_A 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGF 187 (364)
T ss_dssp CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCT
T ss_pred cCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCcceEecCCCCCcccc
Confidence 34799999976 56999999999999999999999999 9999999999999987 799999999998764322 1
Q ss_pred cccccCCCcccCccccc-c-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC----------------
Q 010768 79 AHSVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP---------------- 140 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p---------------- 140 (502)
....+||+.|+|||++. + .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 188 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 267 (364)
T 3qyz_A 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267 (364)
T ss_dssp TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 34568999999999764 3 48999999999999999999999998754443333222110000
Q ss_pred -------C-----CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 -------G-----AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 -------~-----~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. ......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 0112357889999999999 99999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=257.56 Aligned_cols=175 Identities=25% Similarity=0.363 Sum_probs=138.7
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC------
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ------ 77 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~------ 77 (502)
+|+|.+++.. +.+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 97 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~ 172 (353)
T 2b9h_A 97 QTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEP 172 (353)
T ss_dssp SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECC---------
T ss_pred CccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEecccccccccccccccCc
Confidence 4799999987 57999999999999999999999999 9999999999999887 799999999998764321
Q ss_pred -----CcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---------
Q 010768 78 -----HAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--------- 141 (502)
Q Consensus 78 -----~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--------- 141 (502)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+.........+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T 2b9h_A 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252 (353)
T ss_dssp -------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCC
T ss_pred cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccc
Confidence 122357899999999764 4589999999999999999999999987543333222111100000
Q ss_pred --------------------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 142 --------------------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 142 --------------------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
......++.+.+||.+||. ||.+||++.|+|+||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0112457899999999999 9999999999999999986543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=253.76 Aligned_cols=174 Identities=27% Similarity=0.494 Sum_probs=136.5
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccc
Q 010768 4 SGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHS 81 (502)
Q Consensus 4 gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~ 81 (502)
++.+..++.. .+.+++..++.++.||+.||.|||++ | |+||||||+|||++.+ +.+||+|||++...........
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC-----------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchhccCCccccc
Confidence 4556666554 57799999999999999999999985 8 9999999999999887 7999999999987655444556
Q ss_pred ccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc-cccCCHHHHHH
Q 010768 82 VIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF-HRIQDAEARRF 154 (502)
Q Consensus 82 ~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s~~l~~L 154 (502)
..||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+... ....++.+.+|
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 263 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence 67999999999873 358899999999999999999999998866666777776665543222 23468999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|.+||. +|.+||++.++++||||+..
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 264 VKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 999999 99999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=254.23 Aligned_cols=176 Identities=26% Similarity=0.388 Sum_probs=139.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+. |+|.+++.+ +++++..++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||++......
T Consensus 103 ~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 178 (320)
T 2i6l_A 103 YME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178 (320)
T ss_dssp CCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC-------
T ss_pred ccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccc
Confidence 344 799999865 67999999999999999999999999 9999999999999865579999999999865422
Q ss_pred CCcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCC-CC-------------
Q 010768 77 QHAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK-LP------------- 140 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~-~p------------- 140 (502)
.......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.... .....+.... ..
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (320)
T 2i6l_A 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESIPVVHEEDRQELLSVIP 257 (320)
T ss_dssp -CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHSCCCCHHHHHHHHTTSC
T ss_pred cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCchhhhhhhhhcCc
Confidence 2234456899999999774 45899999999999999999999999875433 3333332211 00
Q ss_pred --------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 141 --------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 141 --------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.......+..+++||.+||. ||.+||++.++|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 258 VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 00112458899999999999 999999999999999998643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=260.91 Aligned_cols=154 Identities=23% Similarity=0.373 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC---CcccccCCCcccCccc
Q 010768 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPEL 93 (502)
Q Consensus 17 Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APEv 93 (502)
+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence 999999999999999999999999 9999999999999877 799999999998653322 2234568899999998
Q ss_pred cc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHH
Q 010768 94 YE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE 170 (502)
Q Consensus 94 l~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~E 170 (502)
+. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+
T Consensus 267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 75 568999999999999999998 999998876666666666665543 3445578999999999999 9999999999
Q ss_pred HhcC
Q 010768 171 LLLD 174 (502)
Q Consensus 171 lL~h 174 (502)
++.|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=260.96 Aligned_cols=168 Identities=26% Similarity=0.412 Sum_probs=142.7
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 168 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kl 244 (370)
T 2psq_A 168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 244 (370)
T ss_dssp CCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEE
T ss_pred cCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEECCC-CCEEE
Confidence 688999999998754 4899999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++...... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..
T Consensus 245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~ 323 (370)
T 2psq_A 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR 323 (370)
T ss_dssp CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCC
T ss_pred ccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCC
Confidence 9999998764432 223446788999999876 459999999999999999999 9999987 455566666766654
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+ ..+...+..+.+||.+||. +|.+||++.|+++
T Consensus 324 ~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 324 M-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3 3344568899999999999 9999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-30 Score=253.33 Aligned_cols=174 Identities=26% Similarity=0.429 Sum_probs=138.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCccccccccccc
Confidence 6889999999999899999999999999999999999999 9999999999999987 799999999997654322 2
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC---ccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~~l~~L 154 (502)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+... ............+.. .....++.+.++
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-VSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-HHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 334679999999998864 588999999999999999999999987444 333333444443322 334568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
|.+||. +|.+||+..+.+.+.|..
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999 999999666666666654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.11 Aligned_cols=170 Identities=15% Similarity=0.240 Sum_probs=137.4
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC----CcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL----GQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~----g~vKL~DFGlA~~~~~ 75 (502)
|+ +|+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+. +.+||+|||++.....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 45 999999998764 5999999999999999999999999 99999999999997652 2399999999987654
Q ss_pred CCC--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCCCC---
Q 010768 76 SQH--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKLPG--- 141 (502)
Q Consensus 76 ~~~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~p~--- 141 (502)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ........+.....+.
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 321 345679999999998864 58999999999999999999999997743 3344444443322111
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
......++.+.+||.+||. +|.+||++.++++
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1223458899999999999 9999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=258.06 Aligned_cols=175 Identities=26% Similarity=0.439 Sum_probs=122.7
Q ss_pred CCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 4 SGTLREYRKK-----YTRVDIRAVKNWARQILRGIAYLHGH-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 4 gGsL~~~L~k-----~~~Lse~~i~~i~~QIl~aL~yLHs~-g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
.|+|.+++.. ...+++..++.++.||+.||.|||++ | |+||||||+|||++.+ +.+||+|||++.......
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEECCCSSSCC-----
T ss_pred CCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEccCCCceeccccc
Confidence 3588888864 57799999999999999999999998 8 9999999999999987 799999999998765544
Q ss_pred CcccccCCCcccCccccc-----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC---CccccCCH
Q 010768 78 HAHSVIGTPEFMAPELYE-----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG---AFHRIQDA 149 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~ 149 (502)
......||+.|+|||++. ..++.++|||||||++|+|++|..||............+..+..+. ......++
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCH
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCH
Confidence 444557999999999873 3589999999999999999999999976443323333333332221 22235689
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+.+||.+||. +|.+||++.++++||||....
T Consensus 261 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999 999999999999999997643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=245.71 Aligned_cols=170 Identities=25% Similarity=0.417 Sum_probs=142.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc-----EEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----VKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~-----vKL~DFGlA~~~~ 74 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||++|++|+||||||+|||++.+ +. +||+|||++....
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~Dfg~~~~~~ 180 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVADFGLSQQSV 180 (287)
T ss_dssp CCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEECCCTTCBCCS
T ss_pred ecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeCCCCcccccc
Confidence 67899999998765 46999999999999999999999998789999999999999865 44 9999999997543
Q ss_pred CCCCcccccCCCcccCccccc---ccCCcccchhhhhHHHHHHhhccCCCCCCCChH-HHHHHHHcCCCCCCccccCCHH
Q 010768 75 GSQHAHSVIGTPEFMAPELYE---EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA-QIYKKVTSGKLPGAFHRIQDAE 150 (502)
Q Consensus 75 ~~~~~~~~~GT~~Y~APEvl~---~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~-~i~~~i~~~~~p~~~~~~~s~~ 150 (502)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....+.........+...++.
T Consensus 181 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T 4f0f_A 181 H--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258 (287)
T ss_dssp S--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred c--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHH
Confidence 2 344567999999999883 347899999999999999999999998754333 3344455555555566677899
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+.+||.+||. +|.+||++.++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999 9999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=260.10 Aligned_cols=170 Identities=30% Similarity=0.435 Sum_probs=134.1
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..... ......
T Consensus 130 ~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~--~~~~~~ 202 (371)
T 4exu_A 130 QTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYV 202 (371)
T ss_dssp CEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC----------CTT
T ss_pred cccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccccccc--CcCCcc
Confidence 468888874 35999999999999999999999999 9999999999999987 7999999999976543 234567
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--------------------
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-------------------- 141 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------- 141 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.....+.
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (371)
T 4exu_A 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282 (371)
T ss_dssp CCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSC
T ss_pred cCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccC
Confidence 8999999998764 589999999999999999999999987543333333222111110
Q ss_pred --------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 142 --------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 142 --------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0112357899999999999 99999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=249.92 Aligned_cols=170 Identities=32% Similarity=0.552 Sum_probs=137.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC---C
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---S 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~---~ 76 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceecccccccccc
Confidence 67899999999654 56999999999999999999999999 9999999999999987 7999999999976532 2
Q ss_pred CCcccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc---cccCCH
Q 010768 77 QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF---HRIQDA 149 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~---~~~~s~ 149 (502)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+...+..+..+..+ ....++
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence 2234567999999999874 357889999999999999999999999888888888888777654433 335678
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.+||.+||. +|.+||++.+++.
T Consensus 257 ~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999 9999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=242.22 Aligned_cols=167 Identities=20% Similarity=0.333 Sum_probs=139.6
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||++|++|+||||||+|||++.+ +.++|+|||++....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~---- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQ---- 164 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTS----
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeeec----
Confidence 678999999998865 4999999999999999999999988889999999999999987 789999998875432
Q ss_pred cccccCCCcccCccccccc----CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~~----~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.. .......+.........+...++.+.++
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHVSKL 243 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 2345789999999988643 3347999999999999999999998754 4444444444444445566679999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.++++
T Consensus 244 i~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=254.98 Aligned_cols=169 Identities=24% Similarity=0.384 Sum_probs=136.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH----------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~----------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
|+.+|+|.+++++ ..+++..++.++.||+.||+|||++ | |+||||||+|||++.+ +.+||+|||++
T Consensus 103 ~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~~kL~DFg~a 178 (322)
T 3soc_A 103 FHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LTACIADFGLA 178 (322)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-CeEEEccCCcc
Confidence 6889999999977 4599999999999999999999998 8 9999999999999887 79999999999
Q ss_pred eeccCCCC---cccccCCCcccCcccccc------cCCcccchhhhhHHHHHHhhccCCCCCCC---------------C
Q 010768 71 AILRGSQH---AHSVIGTPEFMAPELYEE------DYNELVDIYSFGMCVLEMLTSEYPYSECS---------------N 126 (502)
Q Consensus 71 ~~~~~~~~---~~~~~GT~~Y~APEvl~~------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---------------~ 126 (502)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 87654322 334679999999998864 46778999999999999999999996532 2
Q ss_pred hHHHHHHHHcCCCCCCcccc-----CCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 127 PAQIYKKVTSGKLPGAFHRI-----QDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 127 ~~~i~~~i~~~~~p~~~~~~-----~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...+...+............ .++.+.+||.+||. ||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33344444443333222221 23569999999999 9999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=249.20 Aligned_cols=169 Identities=24% Similarity=0.388 Sum_probs=142.5
Q ss_pred CCCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe
Q 010768 1 MFTSGTLREYRKKYTR------------------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~------------------------Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld 56 (502)
|+.+|+|.+++.+... +++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~ 184 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA 184 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEc
Confidence 6789999999987644 899999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecCCceeccCCCC---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHH
Q 010768 57 GHLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131 (502)
Q Consensus 57 ~~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~ 131 (502)
.+ +.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .....+.
T Consensus 185 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~ 262 (314)
T 2ivs_A 185 EG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPPERLF 262 (314)
T ss_dssp TT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHH
T ss_pred CC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence 87 7999999999987643322 233457889999998764 58999999999999999999 9999977 4455666
Q ss_pred HHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 132 ~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
..+..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 263 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 263 NLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 666665543 3445668999999999999 99999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=246.22 Aligned_cols=170 Identities=29% Similarity=0.474 Sum_probs=145.3
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 177 (284)
T 2a19_B 101 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGK 177 (284)
T ss_dssp CCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEESSCCSC
T ss_pred ccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-CCEEECcchhheecccccc
Confidence 67899999999765 67999999999999999999999999 9999999999999987 7999999999988766555
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.. .......+..+.. ....+..+++||.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~li~~ 250 (284)
T 2a19_B 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII----SDIFDKKEKTLLQK 250 (284)
T ss_dssp CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCC----CTTSCHHHHHHHHH
T ss_pred ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhcccc----cccCCHHHHHHHHH
Confidence 556779999999998864 589999999999999999999988743 2344455555443 34568899999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccCC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
||. +|.+||++.|++.+.+....
T Consensus 251 ~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 251 LLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HccCChhhCcCHHHHHHHHHHHhh
Confidence 999 99999999999999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=254.79 Aligned_cols=172 Identities=23% Similarity=0.304 Sum_probs=144.1
Q ss_pred CCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC
Q 010768 1 MFTSGTLREYRKKYT-----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~ 57 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||+|||++| |+||||||+|||++.
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH 207 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcC
Confidence 678999999998753 3899999999999999999999999 999999999999998
Q ss_pred CCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHH
Q 010768 58 HLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYK 132 (502)
Q Consensus 58 ~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~ 132 (502)
+ +.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+......+..
T Consensus 208 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 286 (344)
T 1rjb_A 208 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286 (344)
T ss_dssp T-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred C-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHH
Confidence 7 7999999999986643322 23456788999999875 568999999999999999998 9999988666666666
Q ss_pred HHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 133 ~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
.+..+.. ...+...++.+.+||.+||. +|.+||++.+++.+-.
T Consensus 287 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 287 LIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 6655533 33445568999999999999 9999999999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=243.47 Aligned_cols=169 Identities=22% Similarity=0.386 Sum_probs=141.6
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence 678999999998764 4999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred -cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .........+..+... ..+...++.+.++|
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 238 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLASDTIYQIM 238 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcChHHHHHHH
Confidence 223446778999998865 58999999999999999999 9999977 4455555556555433 33455688999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999 99999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=257.72 Aligned_cols=169 Identities=27% Similarity=0.417 Sum_probs=144.4
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 156 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL 232 (382)
T 3tt0_A 156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI 232 (382)
T ss_dssp CCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEE
T ss_pred ecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEcCC-CcEEE
Confidence 678999999998764 4999999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++....... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ ....++.+.+..+..
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~ 311 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR 311 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCC
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 9999998664322 2334457889999998764 58999999999999999999 9999977 566677777776654
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...++.+.+||.+||. +|.+||++.+++++
T Consensus 312 ~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 312 MD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43 345568999999999999 99999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=248.44 Aligned_cols=169 Identities=29% Similarity=0.430 Sum_probs=133.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLH--------s~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.+|+|.++++. ..+++..++.++.||+.||+||| +++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 87 ~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 87 YHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQCCIADLGLAVM 162 (301)
T ss_dssp CCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred hccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CCEEEeeCCCeee
Confidence 6789999999954 57999999999999999999999 888 9999999999999987 7999999999987
Q ss_pred ccCCCC-----cccccCCCcccCccccccc-------CCcccchhhhhHHHHHHhhc----------cCCCCCCC----C
Q 010768 73 LRGSQH-----AHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTS----------EYPYSECS----N 126 (502)
Q Consensus 73 ~~~~~~-----~~~~~GT~~Y~APEvl~~~-------~s~ksDIwSLG~iLyeLLtG----------~~Pf~~~~----~ 126 (502)
...... .....||+.|+|||++.+. ++.++|||||||++|+|++| ..||.... .
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 644322 2334799999999988643 45789999999999999999 88886532 2
Q ss_pred hHHHHHHHHcCCCCCCcc-----ccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 127 PAQIYKKVTSGKLPGAFH-----RIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 127 ~~~i~~~i~~~~~p~~~~-----~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...+...+.........+ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 233333333322222221 1235789999999999 9999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=252.89 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=134.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH---------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~---------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
|+.+|+|.++++.. .+++..++.++.||+.||.|||++ | |+||||||+|||++.+ +.+||+|||++.
T Consensus 93 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~kL~DFG~a~ 168 (336)
T 3g2f_A 93 YYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-GTCVISDFGLSM 168 (336)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-SCEEECCCTTCE
T ss_pred cCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-CcEEEeecccee
Confidence 68899999999775 459999999999999999999999 8 9999999999999987 799999999998
Q ss_pred eccCCC---------CcccccCCCcccCcccccc--------cCCcccchhhhhHHHHHHhhccCCCCCCC---------
Q 010768 72 ILRGSQ---------HAHSVIGTPEFMAPELYEE--------DYNELVDIYSFGMCVLEMLTSEYPYSECS--------- 125 (502)
Q Consensus 72 ~~~~~~---------~~~~~~GT~~Y~APEvl~~--------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--------- 125 (502)
.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 764321 1234579999999998864 36778999999999999999977653211
Q ss_pred --------ChHHHHHHHHcCCCCCCcccc------CCHHHHHHHHHhhc-CcCCCCCHHHH------hcCccccCCCC
Q 010768 126 --------NPAQIYKKVTSGKLPGAFHRI------QDAEARRFVGKCLE-NVSKRLPAKEL------LLDPFLASDAG 182 (502)
Q Consensus 126 --------~~~~i~~~i~~~~~p~~~~~~------~s~~l~~LI~kcL~-dP~kRpsa~El------L~hpf~~~~~~ 182 (502)
....+...+........++.. .++.+.+||.+||. +|.+|||+.|+ +.++|.++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 111222222222222222221 24579999999999 99999999999 55788776544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=248.22 Aligned_cols=170 Identities=19% Similarity=0.310 Sum_probs=135.5
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe--CCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld--~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+ +|+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++ ...+.+||+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 45 8999999984 467999999999999999999999999 99999999999995 233799999999998765432
Q ss_pred C--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCC---CCc
Q 010768 78 H--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLP---GAF 143 (502)
Q Consensus 78 ~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p---~~~ 143 (502)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ..+.+..+...... ...
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 2 245679999999998865 589999999999999999999999976322 11222222222111 112
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
....++.+.+||.+||. +|.+||++.++++
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 24457899999999999 9999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=260.38 Aligned_cols=169 Identities=19% Similarity=0.271 Sum_probs=134.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe--CCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld--~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+ ||+|.+++... +.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+ +.+||+|||+++.+....
T Consensus 133 ~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~-~~~kl~DFG~a~~~~~~~ 208 (364)
T 3op5_A 133 RF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNP-DQVYLVDYGLAYRYCPEG 208 (364)
T ss_dssp CE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCT-TCEEECCCTTCEESSGGG
T ss_pred CC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCC-CeEEEEECCcceecccCC
Confidence 46 89999999876 67999999999999999999999999 99999999999998 55 799999999998754321
Q ss_pred C--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC---CCCC----
Q 010768 78 H--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG---KLPG---- 141 (502)
Q Consensus 78 ~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~---~~p~---- 141 (502)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.............. ..+.
T Consensus 209 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T 3op5_A 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288 (364)
T ss_dssp CCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHH
T ss_pred cccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHH
Confidence 1 134569999999998875 49999999999999999999999998633322222111111 1100
Q ss_pred -CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 -AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 -~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
......++.+.+||..||. +|.+||++.+|+.
T Consensus 289 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 289 CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 0113457899999999999 9999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=243.58 Aligned_cols=171 Identities=28% Similarity=0.438 Sum_probs=136.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceecccccCcEEEeCC-------CCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDP-PVIHRDLKCDNIFVNGH-------LGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~-~IIHRDLKPeNILld~~-------~g~vKL~DFGlA~~ 72 (502)
|+.+|+|.+++. .+++++..++.++.||+.||.|||++|. +|+||||||+|||++.. .+.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 678999999985 4689999999999999999999999883 38899999999999852 36899999999986
Q ss_pred ccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 73 LRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 73 ~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. ........+.........+...++.+
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (271)
T 3dtc_A 166 WHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTCPEPF 243 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred ccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcccCHHH
Confidence 54432 235579999999998864 5899999999999999999999999874 44445555555555555666778999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.++|.+||. +|.+||++.|++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999 99999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=254.14 Aligned_cols=169 Identities=27% Similarity=0.454 Sum_probs=141.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. +.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp CCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTHHHHHTTTCC-
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEccCcceeEccCCccc
Confidence 67899999999874 67999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+... ..+...+..+.++
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 251 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI 251 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHHHHH
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence 22345688999999876 458999999999999999999 9999977 4445556666655433 3345568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhcC
Q 010768 155 VGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~h 174 (502)
|.+||. +|.+||++.+++.+
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999 99999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=251.47 Aligned_cols=168 Identities=20% Similarity=0.349 Sum_probs=139.9
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.||+|.++++.. +.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECC----C
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCcccccccCccc
Confidence 68899999999765 67999999999999999999999999 9999999999999887 7999999999987644321
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+..+ ..+...++.+.+
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 285 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPHALHQ 285 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCHHHHH
Confidence 22334677899999886 458999999999999999999 9999977 4556666666665433 334556899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
||.+||. +|.+||++.+++.
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 9999999 9999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=255.77 Aligned_cols=166 Identities=26% Similarity=0.411 Sum_probs=133.4
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.++++. ...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceeccccccc
Confidence 6889999999988 567999999999999999999999999 9999999999999987 79999999999876432211
Q ss_pred ---------------ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH----HHHHHHcCCC
Q 010768 80 ---------------HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ----IYKKVTSGKL 139 (502)
Q Consensus 80 ---------------~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~----i~~~i~~~~~ 139 (502)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||........ .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY- 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-
Confidence 15679999999998865 589999999999999999999999865321100 011111111
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+...++.+.++|.+||. +|.+||++.++++
T Consensus 244 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 244 ---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 123456789999999999 9999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=252.47 Aligned_cols=169 Identities=24% Similarity=0.351 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC-CeEEE
Confidence 678999999998764 6999999999999999999999999 9999999999999877 79999
Q ss_pred EecCCceeccCCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .....+...+..+..+ .
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~-~ 261 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E 261 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCC-C
T ss_pred cccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCCCC-C
Confidence 99999975433233344567889999998864 48999999999999999998 9999977 4556667776665433 2
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+...++.+.+||.+||. +|.+||++.+++.+
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 344568999999999999 99999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=252.69 Aligned_cols=168 Identities=21% Similarity=0.319 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe
Q 010768 1 MFTSGTLREYRKKY------------------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56 (502)
Q Consensus 1 y~~gGsL~~~L~k~------------------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld 56 (502)
|+.+|+|.+++.+. ..+++.+++.++.||+.||.|||++| |+||||||+|||++
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG 208 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEC
Confidence 68899999999874 56999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHH
Q 010768 57 GHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIY 131 (502)
Q Consensus 57 ~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~ 131 (502)
.+ +.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+.
T Consensus 209 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~ 286 (343)
T 1luf_A 209 EN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVI 286 (343)
T ss_dssp GG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHH
T ss_pred CC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-CChHHHH
Confidence 87 799999999997653221 223456789999999876 569999999999999999999 9999977 4566667
Q ss_pred HHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 132 ~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+..+..+. .+...++.+.+||.+||. +|.+||++.+++.
T Consensus 287 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 287 YYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCcCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766543 345568899999999999 9999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=247.98 Aligned_cols=169 Identities=24% Similarity=0.392 Sum_probs=142.8
Q ss_pred CCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcE
Q 010768 1 MFTSGTLREYRKKYT------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62 (502)
Q Consensus 1 y~~gGsL~~~L~k~~------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~v 62 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETT-TEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCC-CCE
Confidence 578999999998764 4999999999999999999999999 9999999999999987 799
Q ss_pred EEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcC
Q 010768 63 KIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137 (502)
Q Consensus 63 KL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~ 137 (502)
||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+..........+..+
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 264 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence 9999999987654322 23345788999999775 568999999999999999999 999998866666666666555
Q ss_pred CCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+ ..+...+..+.++|.+||. +|.+||++.++++
T Consensus 265 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 265 FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333 3345568999999999999 9999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=250.55 Aligned_cols=170 Identities=23% Similarity=0.367 Sum_probs=144.6
Q ss_pred CCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYTR----------------VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~----------------Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl 189 (316)
T 2xir_A 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI 189 (316)
T ss_dssp CCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEE
T ss_pred cCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEE
Confidence 6789999999987654 899999999999999999999999 9999999999999877 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+...+..+..
T Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 269 (316)
T 2xir_A 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269 (316)
T ss_dssp CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred CCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc
Confidence 99999986543322 23456789999999875 468999999999999999998 99999887666666666666544
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+ ..+...++.+.++|.+||. +|.+||++.+++.|
T Consensus 270 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 270 M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 3344568999999999999 99999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=246.24 Aligned_cols=168 Identities=24% Similarity=0.438 Sum_probs=131.3
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-------------
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECccccccccCccccc
Confidence 678999999998764 6999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+...+..+..+ ..+...++.+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 250 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPPTLYSLM 250 (281)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 23345678999999886 568999999999999999997 99999874 344555566655443 34456689999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.+++.
T Consensus 251 ~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 251 TKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 99999 9999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=243.90 Aligned_cols=169 Identities=21% Similarity=0.419 Sum_probs=142.8
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence 68899999999764 55999999999999999999999999 9999999999999877 799999999997653321
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.++|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 240 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIM 240 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHHHH
Confidence 223445678899999886 569999999999999999999 9999977 5566666676665433 34455689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++++
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999 99999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=259.25 Aligned_cols=175 Identities=21% Similarity=0.344 Sum_probs=146.7
Q ss_pred CCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~ 71 (502)
|+.||+|.+++...+ .+++..++.|+.||+.||+|||++| |+||||||+|||++.+ ...+||+|||+++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 688999999998753 4999999999999999999999999 9999999999999854 2369999999997
Q ss_pred eccC---CCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 72 ILRG---SQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 72 ~~~~---~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
.... ........||+.|+|||++. +.++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+..
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~~-~~~~ 310 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMD-PPKN 310 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCCC-CCTT
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcc
Confidence 5422 12234567899999999875 569999999999999999998 9999977 55667777777665433 3445
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+..+.+||.+||. +|.+||++.+++++.++..
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 68899999999999 9999999999999887754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=246.72 Aligned_cols=169 Identities=20% Similarity=0.318 Sum_probs=135.2
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE---eCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl---d~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||+ +.+ +.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEecCccceeccCc
Confidence 45 9999999985 467999999999999999999999999 9999999999999 454 79999999999876543
Q ss_pred CC--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh--HHHHHHHHcCCCCC---C
Q 010768 77 QH--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP--AQIYKKVTSGKLPG---A 142 (502)
Q Consensus 77 ~~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~--~~i~~~i~~~~~p~---~ 142 (502)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ......+.....+. .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 22 235679999999998864 5899999999999999999999999764321 12222222221111 1
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....++.+.+||.+||. +|.+||++.++++
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 223457899999999999 9999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=255.04 Aligned_cols=169 Identities=25% Similarity=0.412 Sum_probs=140.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+. +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCSGGGGSCCCTTC
T ss_pred eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCCcccccCccccc
Confidence 68899999999875 57999999999999999999999999 9999999999999887 799999999998764332
Q ss_pred -CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+. ....+...+..+..+ ..+...+..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 249 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQPQICTIDVYMV 249 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCCTTBCTTTTHH
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCCCcCcHHHHHH
Confidence 223456788999999886 569999999999999999999 99999874 445555666655433 2334457789999
Q ss_pred HHHhhc-CcCCCCCHHHHhcC
Q 010768 155 VGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~h 174 (502)
|.+||. +|.+||++.+++++
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999 99999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=253.63 Aligned_cols=170 Identities=30% Similarity=0.423 Sum_probs=132.9
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|+|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..... ......
T Consensus 112 ~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~--~~~~~~ 184 (353)
T 3coi_A 112 QTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADA--EMTGYV 184 (353)
T ss_dssp SEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCTTC----------C
T ss_pred cCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeecccccCCCC--Cccccc
Confidence 3677777643 5999999999999999999999999 9999999999999987 7999999999976533 234567
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CC--------------------C-
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GK--------------------L- 139 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~--------------------~- 139 (502)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +. .
T Consensus 185 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T 3coi_A 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264 (353)
T ss_dssp CSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSC
T ss_pred cCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCc
Confidence 8999999998764 5899999999999999999999999874433322222111 00 0
Q ss_pred ---C---CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 140 ---P---GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 140 ---p---~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. .......++.+.+||.+||. ||.+||++.++|.||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 01123458899999999999 99999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-30 Score=259.18 Aligned_cols=170 Identities=18% Similarity=0.257 Sum_probs=135.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC-CcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~-g~vKL~DFGlA~~~~~~~-- 77 (502)
|+ ||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+. +.+||+|||+++.+....
T Consensus 133 ~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~ 209 (345)
T 2v62_A 133 RL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209 (345)
T ss_dssp CE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC
T ss_pred cc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccccc
Confidence 46 8999999988889999999999999999999999999 99999999999998761 399999999998763221
Q ss_pred ------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHH--HcCCCCCCc----
Q 010768 78 ------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKV--TSGKLPGAF---- 143 (502)
Q Consensus 78 ------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i--~~~~~p~~~---- 143 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+.... .....+...
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (345)
T 2v62_A 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWA 289 (345)
T ss_dssp CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHS
T ss_pred ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhc
Confidence 1245579999999998875 48999999999999999999999995532 222222111 111222111
Q ss_pred -cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 -HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 -~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
....++.+.+||.+||. +|.+||++.++++
T Consensus 290 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 290 PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11567899999999999 9999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=249.30 Aligned_cols=169 Identities=25% Similarity=0.402 Sum_probs=142.4
Q ss_pred CCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKY----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
|+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~-~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC-CeEEECcCccc
Confidence 67899999999763 45799999999999999999999999 9999999999999987 79999999999
Q ss_pred eeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 71 AILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 71 ~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ ....++...+..+..+. ...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 263 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD-KPD 263 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC-CCT
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcCC-CCC
Confidence 7654322 123345789999999886 458999999999999999999 8999977 45666677776665543 334
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
..+..+.+||.+||. +|.+||++.+++.+
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 568899999999999 99999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=244.80 Aligned_cols=168 Identities=23% Similarity=0.380 Sum_probs=142.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCcceeeccCCCcc
Confidence 6789999999999889999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred --cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .....+...+..+..+. .+...++.+.++
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 252 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDL 252 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHH
Confidence 122346788999998864 58899999999999999999 9999987 45566677777665443 345668999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 253 i~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=244.31 Aligned_cols=169 Identities=20% Similarity=0.393 Sum_probs=142.5
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence 6789999999987 567999999999999999999999999 9999999999999987 799999999997653321
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .........+..+... ..+...++.+.+||
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 254 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTIM 254 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCHHHHHHH
Confidence 122345678899999886 568999999999999999998 9999977 4555666666665432 34455689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++.+
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999 99999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=251.16 Aligned_cols=168 Identities=17% Similarity=0.260 Sum_probs=136.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc-----EEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ-----VKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~-----vKL~DFGlA~~~~ 74 (502)
|+ +|+|.+++... +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +. +||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEcccceeee
Confidence 46 99999999874 67999999999999999999999999 9999999999999876 45 9999999998764
Q ss_pred CCCC--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCC--CChHHHHHHHHcCCCCCCc
Q 010768 75 GSQH--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSEC--SNPAQIYKKVTSGKLPGAF 143 (502)
Q Consensus 75 ~~~~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~--~~~~~i~~~i~~~~~p~~~ 143 (502)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ....+.+..+.....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 4322 245689999999998865 5899999999999999999999999864 2334445554433221111
Q ss_pred ---cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 ---HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 ---~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
... .+.+.+||.+||. +|.+||++.++++
T Consensus 242 ~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 EVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 112 2389999999999 9999999988875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=243.07 Aligned_cols=169 Identities=23% Similarity=0.326 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCE
T ss_pred cccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEccccccccccccccc
Confidence 57899999999874 56999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred ---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+...+...+.............+..+.+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 256 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYN 256 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCcCcCHHHHH
Confidence 223457889999998864 58899999999999999999 9999987 45566666666555444455567899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.+++.
T Consensus 257 li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 257 VMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 9999999 9999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=267.54 Aligned_cols=164 Identities=17% Similarity=0.187 Sum_probs=134.0
Q ss_pred CCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC
Q 010768 3 TSGTLREYRKK-------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75 (502)
Q Consensus 3 ~gGsL~~~L~k-------~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~ 75 (502)
.+|+|.++++. .+.+++..++.++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++....
T Consensus 187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA 263 (413)
T ss_dssp CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCGGGCEETTE
T ss_pred hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecC-CeEEEEeccceeecCC
Confidence 56889998852 234888899999999999999999999 9999999999999987 7899999999986543
Q ss_pred CCCcccccCCCcccCcccc----------cc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCcc
Q 010768 76 SQHAHSVIGTPEFMAPELY----------EE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFH 144 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl----------~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~ 144 (502)
. ....+| +.|+|||++ .+ .++.++|||||||++|+|++|+.||.... .......+... .
T Consensus 264 ~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~~~------~ 333 (413)
T 3dzo_A 264 S--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA-ALGGSEWIFRS------C 333 (413)
T ss_dssp E--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG-GGSCSGGGGSS------C
T ss_pred c--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc-hhhhHHHHHhh------c
Confidence 2 455678 999999987 32 37889999999999999999999997632 21112222111 1
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
...++.+++||.+||. +|.+||++.++++||||+.
T Consensus 334 ~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 334 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 2457899999999999 9999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=250.18 Aligned_cols=168 Identities=27% Similarity=0.456 Sum_probs=135.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. +.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp CCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTC----------
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEEccCcceeEccCcccc
Confidence 57899999999874 56999999999999999999999999 9999999999999887 7999999999987643222
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+... ..+...+..+.+|
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 251 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMI 251 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence 23345688999999876 458999999999999999999 9999977 4445556666555433 3345568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.|++.
T Consensus 252 i~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 999999 9999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-29 Score=242.96 Aligned_cols=169 Identities=22% Similarity=0.421 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCCCccccccccc
Confidence 67899999999765 45999999999999999999999999 9999999999999987 799999999997654322
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......+++.|+|||++. ..++.++||||||+++|+|++ |..||..... ......+..+..+ ..+...++.+.++|
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li 247 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPDLCPPVLYTLM 247 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCTTCCHHHHHHH
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 123345788999999886 468999999999999999998 9999976433 3444555554433 23445689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++.+
T Consensus 248 ~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHH
Confidence 99999 99999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=243.62 Aligned_cols=171 Identities=20% Similarity=0.323 Sum_probs=144.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccceeeeccCcce
Confidence 67899999999754 56999999999999999999999999 9999999999999987 7999999999987643322
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++.+.+
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 244 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELYA 244 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCCcCHHHHH
Confidence 22345688999999886 458999999999999999998 99999874 445566666666543 334566899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcCcc
Q 010768 154 FVGKCLE-NVSKRLPAKELLLDPF 176 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~hpf 176 (502)
+|.+||. +|.+||++.+++.+.+
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999 9999999999997654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=244.65 Aligned_cols=168 Identities=26% Similarity=0.458 Sum_probs=133.0
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHh---CCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHG---HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs---~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.||+|.+++..... +++..++.|+.||+.||+|||+ +| |+||||||+|||++.+...+||+|||++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 6889999999987653 7899999999999999999999 67 99999999999999873348999999997654
Q ss_pred CCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC-hHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 75 GSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN-PAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 75 ~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...+...+..+..+ ......+..+.
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 234 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHH
T ss_pred cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHH
Confidence 32 234569999999998865 589999999999999999999999976433 33344445555443 33455688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++|.+||. +|.+||++.++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 99999999 9999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=246.10 Aligned_cols=169 Identities=20% Similarity=0.320 Sum_probs=135.1
Q ss_pred CCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKK------YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k------~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
|+.+|+|.+++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~ 198 (313)
T 3brb_A 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLSKKIY 198 (313)
T ss_dssp CCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT-SCEEECSCSCC----
T ss_pred cccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEEeecCcceecc
Confidence 6789999999953 356999999999999999999999999 9999999999999987 799999999997654
Q ss_pred CCC---CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 75 GSQ---HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 75 ~~~---~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++
T Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 276 (313)
T 3brb_A 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHGHRL-KQPEDCLD 276 (313)
T ss_dssp ------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCBTTCCH
T ss_pred cccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcCCCC-CCCccccH
Confidence 322 1233457889999998864 58999999999999999999 89999774 445556666665543 33455688
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+.+||.+||. +|.+||++.+++.+
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=247.43 Aligned_cols=169 Identities=27% Similarity=0.415 Sum_probs=143.1
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL 198 (334)
T 2pvf_A 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198 (334)
T ss_dssp CCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEE
T ss_pred CCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEcCC-CCEEE
Confidence 678999999998754 3899999999999999999999999 9999999999999887 79999
Q ss_pred EecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+..
T Consensus 199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~ 277 (334)
T 2pvf_A 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHR 277 (334)
T ss_dssp CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCC
T ss_pred ccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHHHHhcCCC
Confidence 99999987654322 23345788999999875 458999999999999999999 9999977 456667777766654
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...+..+.+||.+||. +|.+||++.+++.+
T Consensus 278 ~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 278 MD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32 344568899999999999 99999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=251.81 Aligned_cols=169 Identities=21% Similarity=0.315 Sum_probs=137.4
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC--cEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG--QVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g--~vKL~DFGlA~~~~~~ 76 (502)
|+ +|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ + .+||+|||++..+...
T Consensus 139 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 139 SL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp CC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETT-EEEEEEECCGGGCBCSSGG
T ss_pred CC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCC-CCceEEEecCcceeeccCC
Confidence 56 99999999986 78999999999999999999999999 9999999999999987 5 8999999999765422
Q ss_pred C--------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHH--cCCCCCCc-
Q 010768 77 Q--------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVT--SGKLPGAF- 143 (502)
Q Consensus 77 ~--------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~--~~~~p~~~- 143 (502)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..... ....+...
T Consensus 215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (352)
T 2jii_A 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG 294 (352)
T ss_dssp GCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC
T ss_pred CccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh
Confidence 1 1234579999999998875 68999999999999999999999998754 3443333322 11111111
Q ss_pred ----cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 ----HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 ----~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
....++.+.+||.+||. +|.+||++.++++
T Consensus 295 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 12358999999999999 9999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=263.12 Aligned_cols=174 Identities=28% Similarity=0.350 Sum_probs=131.1
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC----CCcEEEEecCCceeccCC--
Q 010768 4 SGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH----LGQVKIGDLGLAAILRGS-- 76 (502)
Q Consensus 4 gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~----~g~vKL~DFGlA~~~~~~-- 76 (502)
+|+|.+++.... .+.+..++.|+.||+.||.|||++| |+||||||+|||++.+ ...+||+|||+++.....
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 579999998764 4666678899999999999999999 9999999999999532 136889999999876433
Q ss_pred --CCcccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCC-CccccCC
Q 010768 77 --QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQD 148 (502)
Q Consensus 77 --~~~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s 148 (502)
.......||+.|+|||++. ..++.++|||||||++|+|++ |..||.... .......+....... ......+
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 257 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQANILLGACSLDCLHPEKHED 257 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHHHHHTTCCCCTTSCTTCHHH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHHHHHhccCCccccCcccccc
Confidence 2234567999999999885 347789999999999999999 999996533 222222222222211 1122235
Q ss_pred HHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 149 ~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
..+++||.+||. ||.+||++.++|+||||...
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 668999999999 99999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=245.75 Aligned_cols=170 Identities=28% Similarity=0.479 Sum_probs=132.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH--------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~--------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.+|+|.+++++. .+++..++.++.||+.||.|||++ | |+||||||+|||++.+ +.+||+|||++..
T Consensus 116 ~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 116 YHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKN-GTCCIADLGLAVK 191 (337)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred ccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCC-CCEEEEeCCCcee
Confidence 68899999999764 799999999999999999999998 7 9999999999999987 7999999999976
Q ss_pred ccCCCC-----cccccCCCcccCccccccc-CCc------ccchhhhhHHHHHHhhc----------cCCCCCCC----C
Q 010768 73 LRGSQH-----AHSVIGTPEFMAPELYEED-YNE------LVDIYSFGMCVLEMLTS----------EYPYSECS----N 126 (502)
Q Consensus 73 ~~~~~~-----~~~~~GT~~Y~APEvl~~~-~s~------ksDIwSLG~iLyeLLtG----------~~Pf~~~~----~ 126 (502)
...... .....||+.|+|||++.+. +.. ++|||||||++|+|++| ..||.... .
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 543222 2345799999999988654 333 38999999999999999 67775422 2
Q ss_pred hHHHHHHHHcCCCCCCccc-----cCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 127 PAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 127 ~~~i~~~i~~~~~p~~~~~-----~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
...+...+........++. ..++.+.+||.+||. +|.+||++.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2333333333333222222 335679999999999 99999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=240.32 Aligned_cols=169 Identities=21% Similarity=0.335 Sum_probs=141.0
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--- 76 (502)
|+.+|+|.+++.. ...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCcccccCCccc
Confidence 5789999999987 456999999999999999999999999 9999999999999887 79999999999755332
Q ss_pred --CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 77 --QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 77 --~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.......+++.|+|||++.+ .++.++|||||||++|+|++|..|+....+...+...+..+..+ ..+...++.+.+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 259 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPDSLYQ 259 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchHHHHH
Confidence 12234567889999998865 58999999999999999999666655556666666666665543 334556889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
||.+||. +|.+|||+.+++.
T Consensus 260 li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 9999999 9999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=245.91 Aligned_cols=168 Identities=23% Similarity=0.403 Sum_probs=139.6
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC----
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---- 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~---- 75 (502)
|+.||+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ + +.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecCCcccccccccc
Confidence 678999999998765 6999999999999999999999999 99999999999998 3 6899999999865421
Q ss_pred --CCCcccccCCCcccCcccccc----------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCc
Q 010768 76 --SQHAHSVIGTPEFMAPELYEE----------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAF 143 (502)
Q Consensus 76 --~~~~~~~~GT~~Y~APEvl~~----------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~ 143 (502)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+...+..+..+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCC
Confidence 122234568999999998753 378899999999999999999999977 4556666777777666555
Q ss_pred cccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 144 HRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 144 ~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
....+..+.++|.+||. +|.+||++.+++.
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 55668899999999999 9999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=238.11 Aligned_cols=169 Identities=21% Similarity=0.419 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence 57899999999875 56999999999999999999999999 9999999999999877 799999999997653321
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.++|
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 238 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIM 238 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHHHH
Confidence 123345788999999886 568999999999999999999 8999977 4556666667665433 33455689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+||++.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999 99999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=259.34 Aligned_cols=174 Identities=26% Similarity=0.380 Sum_probs=128.9
Q ss_pred CCCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC------------CCc
Q 010768 1 MFTSGTLREYRKKYTRV-------DIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH------------LGQ 61 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~L-------se~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~------------~g~ 61 (502)
|| +|+|.+++...... ++..++.++.||+.||+|||++| |+||||||+|||++.. .+.
T Consensus 90 ~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 45 57999999876543 23345789999999999999999 9999999999999753 248
Q ss_pred EEEEecCCceeccCCCC-----cccccCCCcccCccccc--------ccCCcccchhhhhHHHHHHhh-ccCCCCCCCCh
Q 010768 62 VKIGDLGLAAILRGSQH-----AHSVIGTPEFMAPELYE--------EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNP 127 (502)
Q Consensus 62 vKL~DFGlA~~~~~~~~-----~~~~~GT~~Y~APEvl~--------~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~ 127 (502)
+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 23457999999999875 348899999999999999999 99999764333
Q ss_pred HHHHHHHHcCCCCC-Cc----cccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 128 AQIYKKVTSGKLPG-AF----HRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 128 ~~i~~~i~~~~~p~-~~----~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. ..+..+.... .. ....++.+.+||.+||. +|.+||++.++++||||...
T Consensus 247 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 2 2233332211 11 11235789999999999 99999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-29 Score=243.51 Aligned_cols=165 Identities=18% Similarity=0.307 Sum_probs=133.4
Q ss_pred CCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCc--------EEEEecCCce
Q 010768 1 MFTSGTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ--------VKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~-Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~--------vKL~DFGlA~ 71 (502)
|+.||+|.+++.+.+. +++..++.|+.||+.||.|||++| |+||||||+|||++.+ +. +||+|||++.
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl~Dfg~~~ 169 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPFIKLSDPGISI 169 (289)
T ss_dssp CCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCEEEECCCCSCT
T ss_pred CCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-CcccccccceeeeccCcccc
Confidence 6889999999988755 999999999999999999999999 9999999999999876 44 9999999986
Q ss_pred eccCCCCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCH
Q 010768 72 ILRGSQHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDA 149 (502)
Q Consensus 72 ~~~~~~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~ 149 (502)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+................. ..+...++
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 243 (289)
T 4fvq_A 170 TVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH---QLPAPKAA 243 (289)
T ss_dssp TTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCCSSC
T ss_pred cccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC---CCCCCCCH
Confidence 5432 234568999999998864 589999999999999999996555444344444444433321 22233467
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+.+||.+||. +|.+||++.+++++
T Consensus 244 ~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 244 ELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999 99999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=243.56 Aligned_cols=169 Identities=26% Similarity=0.398 Sum_probs=132.7
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+.+ .+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 170 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEF 170 (295)
T ss_dssp CCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCSCC--------
T ss_pred eCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccCcccccccCCcce
Confidence 678999999998764 4999999999999999999999999 9999999999999987 7999999999987643321
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh---------------HHHHHHHHcCCC
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---------------AQIYKKVTSGKL 139 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---------------~~i~~~i~~~~~ 139 (502)
.....+++.|+|||++. ..++.++||||||+++|+|++|..||...... ..+...+..+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 3ugc_A 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250 (295)
T ss_dssp -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc
Confidence 22345677899999876 56899999999999999999999998542100 012223333322
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 251 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 251 -LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23345668999999999999 9999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=246.98 Aligned_cols=169 Identities=24% Similarity=0.386 Sum_probs=119.8
Q ss_pred CCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 3 TSGTLREYRKK---YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 3 ~gGsL~~~L~k---~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
.+|+|.+++.. .+.+++..++.|+.||+.||.|||++|++|+||||||+|||++.+ +.+||+|||++........
T Consensus 116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~ 194 (337)
T 3ll6_A 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDY 194 (337)
T ss_dssp CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCTTCBCCSSCC--
T ss_pred cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCccceeccccCcc
Confidence 35899999875 467999999999999999999999988789999999999999987 7999999999987643221
Q ss_pred ------------cccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC
Q 010768 79 ------------AHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 79 ------------~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+..+.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~ 269 (337)
T 3ll6_A 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----RIVNGKYSIP 269 (337)
T ss_dssp -----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCC
T ss_pred cccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----HhhcCcccCC
Confidence 11456899999999872 35889999999999999999999999763221 1222223333
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.....+..+.+||.+||. +|.+||++.|++++-+-
T Consensus 270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 344556789999999999 99999999999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=238.86 Aligned_cols=168 Identities=23% Similarity=0.388 Sum_probs=141.4
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence 578999999997543 6999999999999999999999999 9999999999999877 7999999999987654321
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+ .....+...+..+..+ ..+...++.+.++
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 242 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCPEELYQL 242 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccccHHHHHH
Confidence 23345688999999886 558999999999999999999 9999987 4555666666665433 3345568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+++.
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 999999 9999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=249.06 Aligned_cols=169 Identities=22% Similarity=0.372 Sum_probs=141.3
Q ss_pred CCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEe
Q 010768 1 MFTSGTLREYRKKY--------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66 (502)
Q Consensus 1 y~~gGsL~~~L~k~--------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~D 66 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG-HVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGG-GEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCC-CeEEECc
Confidence 67899999999753 45899999999999999999999999 9999999999999987 7999999
Q ss_pred cCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCC
Q 010768 67 LGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPG 141 (502)
Q Consensus 67 FGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 141 (502)
||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+...+..+.. .
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~ 286 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-M 286 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC-C
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC-C
Confidence 999986543221 23345788999999875 568999999999999999998 99999886666666555555433 2
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...++.+.++|.+||. +|.+||++.+++.
T Consensus 287 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3445568999999999999 9999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.85 Aligned_cols=169 Identities=20% Similarity=0.269 Sum_probs=129.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ--H 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~--~ 78 (502)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....... .
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCcccccccccc
Confidence 5789999999999889999999999999999999999999 9999999999999987 799999999997654322 2
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC-CCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~ 156 (502)
.....|++.|+|||++. ..++.++||||||+++|+|++|..||... ....+...+..... +.......++.+.++|.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 23557999999999886 45899999999999999999999999773 33334444433322 22334556889999999
Q ss_pred Hhhc-CcCCCC-CHHHHhc
Q 010768 157 KCLE-NVSKRL-PAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRp-sa~ElL~ 173 (502)
+||. +|.+|| ++.+++.
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHH
T ss_pred HhccCCHHHHHHhHHHHHH
Confidence 9999 999999 7777764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=241.04 Aligned_cols=170 Identities=29% Similarity=0.469 Sum_probs=133.9
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccceeeecCC
Confidence 6789999999975 466999999999999999999999999 9999999999999987 79999999999765432
Q ss_pred C-CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 77 Q-HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 77 ~-~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||.+.. +...+...+..+..+.......++.+.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 2 234457899999999876 458999999999999999999999997643 4456667777776665555667899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
||.+||. ||.+||++.+++.
T Consensus 270 li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 9999999 9999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=245.31 Aligned_cols=174 Identities=24% Similarity=0.387 Sum_probs=134.9
Q ss_pred CCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGH---DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----~Lse~~i~~i~~QIl~aL~yLHs~---g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||+|||++ | |+||||||+|||++.+ +.+||+|||++...
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAVVGDFGLAKLM 184 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEEECCCSSCEEC
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEEeccCcccccc
Confidence 678999999998653 399999999999999999999999 8 9999999999999987 79999999999876
Q ss_pred cCCC--CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCC----CChHHHHHHHHc---C-CCC--
Q 010768 74 RGSQ--HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSEC----SNPAQIYKKVTS---G-KLP-- 140 (502)
Q Consensus 74 ~~~~--~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~----~~~~~i~~~i~~---~-~~p-- 140 (502)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|..||... .........+.. . ...
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 4322 233456999999999885 56899999999999999999999999520 111111111111 1 110
Q ss_pred ------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 141 ------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 141 ------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
.......+..+.++|.+||. +|.+|||+.+++++-.-
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11111224678999999999 99999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=240.80 Aligned_cols=168 Identities=22% Similarity=0.374 Sum_probs=136.9
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEECcccccccccccchh
Confidence 67899999999864 56999999999999999999999999 9999999999999887 799999999997654322
Q ss_pred ---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 78 ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 78 ---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
......||+.|+|||++. ..++.++||||||+++|+|++ |.+||.. .+...+...+..+..+ ..+...+..+.
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 262 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPDPLY 262 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCHHHH
Confidence 123446788999999886 468999999999999999999 5666655 4444455555555443 33445688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhc
Q 010768 153 RFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
++|.+||. +|.+||++.++++
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 9999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=252.85 Aligned_cols=168 Identities=20% Similarity=0.336 Sum_probs=139.8
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|+|.+++++.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceecCCCcee
Confidence 688999999998754 6999999999999999999999999 9999999999999887 79999999999865432111
Q ss_pred ---ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 80 ---HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 80 ---~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+. ...++...+..+... ..+...++.+.+|
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 347 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRL-PCPELCPDAVFRL 347 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 1123467899999886 568999999999999999998 99999874 455566666665443 3345568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+|||+.+++.
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 999999 9999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=247.35 Aligned_cols=170 Identities=22% Similarity=0.257 Sum_probs=134.4
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEecCcchhcccc
Confidence 6789999999986 467999999999999999999999999 9999999999999887 79999999998764321
Q ss_pred CC----------cccccCCCcccCcccccc----cCCcccchhhhhHHHHHHhhccCCCCCCC-ChHHHHHHHHcCCCCC
Q 010768 77 QH----------AHSVIGTPEFMAPELYEE----DYNELVDIYSFGMCVLEMLTSEYPYSECS-NPAQIYKKVTSGKLPG 141 (502)
Q Consensus 77 ~~----------~~~~~GT~~Y~APEvl~~----~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-~~~~i~~~i~~~~~p~ 141 (502)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+...+.. ....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 266 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSI 266 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--C
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCCC
Confidence 11 123457999999998863 26899999999999999999999995310 00111222222 2222
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
......+..+.+||.+||. +|.+||++.+++.+
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 3334568899999999999 99999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=257.41 Aligned_cols=166 Identities=19% Similarity=0.366 Sum_probs=139.1
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++++.+. +++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--
Confidence 6889999999987654 799999999999999999999999 9999999999999987 79999999999865332
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.. ..++...+..+..+ ..+...++.+.+||.
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKM-DAPDGCPPAVYDVMK 420 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-TTTHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHH
Confidence 22346789999999886 469999999999999999998 999998744 34555666666443 344567899999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. +|.+||++.+++.
T Consensus 421 ~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 421 NCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 9999 9999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=240.10 Aligned_cols=166 Identities=19% Similarity=0.362 Sum_probs=134.2
Q ss_pred CCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTR--VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~--Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeecccccccccc--
Confidence 5788999999987644 899999999999999999999999 9999999999999987 79999999999765432
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....+++.|+|||++. ..++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...++.+.++|.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYEVMK 248 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCC-CCCTTCCHHHHHHHH
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCC-CCcccCCHHHHHHHH
Confidence 23346789999999886 458999999999999999998 99999774 445556666555433 344566899999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. +|.+||++.++++
T Consensus 249 ~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 249 NCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhcCChhhCCCHHHHHH
Confidence 9999 9999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=240.21 Aligned_cols=169 Identities=27% Similarity=0.431 Sum_probs=137.7
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+ ...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 106 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 182 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEY 182 (302)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCCE
T ss_pred eCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEECcccccccccCCCcc
Confidence 6789999999954 467999999999999999999999999 9999999999999887 7999999999987654322
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCC--------------CCChHHHHHHHHcCCCC
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSE--------------CSNPAQIYKKVTSGKLP 140 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~--------------~~~~~~i~~~i~~~~~p 140 (502)
.....||+.|+|||++. ..++.++|||||||++|+|++|..|+.. ......+...+..+...
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC
Confidence 23456888899999876 4588999999999999999999887632 11222334444444332
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...++.+.+||.+||. +|.+||++.++++
T Consensus 263 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 263 -PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3445568999999999999 9999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=246.07 Aligned_cols=175 Identities=21% Similarity=0.347 Sum_probs=145.4
Q ss_pred CCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCce
Q 010768 1 MFTSGTLREYRKKYT-------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAA 71 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~ 71 (502)
|+.||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ ...+||+|||++.
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 578999999998763 4999999999999999999999999 9999999999999843 2479999999987
Q ss_pred eccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCcccc
Q 010768 72 ILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRI 146 (502)
Q Consensus 72 ~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~ 146 (502)
...... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.. .....+...+..+..+. ....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 269 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMD-PPKN 269 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCCC-CCTT
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCCC-CCCC
Confidence 543322 223456899999999875 568999999999999999998 9999977 45566666676665433 3445
Q ss_pred CCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 147 QDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 147 ~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+..+.+||.+||. +|.+||++.+++++.|+..
T Consensus 270 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 68899999999999 9999999999999988754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=246.64 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=138.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~ 183 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDY 183 (327)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGGGCEECCTTCSE
T ss_pred ecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEcccccceecccCCcc
Confidence 67899999999874 56999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred ---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC--------------hHHHHHHHHcCCCC
Q 010768 79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--------------PAQIYKKVTSGKLP 140 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--------------~~~i~~~i~~~~~p 140 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+...+..+..
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 262 (327)
T 3lxl_A 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR- 262 (327)
T ss_dssp EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC-
T ss_pred ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC-
Confidence 234567888999998864 589999999999999999999999854211 1233334444433
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
...+...++.+.+||.+||. +|.+||++.++++
T Consensus 263 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23455678999999999999 9999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=243.76 Aligned_cols=169 Identities=22% Similarity=0.377 Sum_probs=136.2
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCCcchhhcccccc
Confidence 67899999999875 67999999999999999999999999 9999999999999987 7999999999987643221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..+. .+...+..+.+
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 281 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMDCPSAIYQ 281 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCBHHHHH
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-CcccCCHHHHH
Confidence 12234678899999886 468999999999999999999 9999977 45566667776664432 33456889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+|.+||. +|.+||++.+++.+
T Consensus 282 li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 282 LMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999 99999999998863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=244.48 Aligned_cols=170 Identities=27% Similarity=0.417 Sum_probs=137.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH--------GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLH--------s~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
|+.+|+|.+++.+ ..+++..++.++.||+.||.||| +++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 121 ~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 121 YHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIADLGLAVR 196 (342)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred ecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCEEEEECCCcee
Confidence 6789999999987 46999999999999999999999 778 9999999999999887 7999999999987
Q ss_pred ccCCC-----CcccccCCCcccCccccccc-------CCcccchhhhhHHHHHHhhc----------cCCCCCCC----C
Q 010768 73 LRGSQ-----HAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTS----------EYPYSECS----N 126 (502)
Q Consensus 73 ~~~~~-----~~~~~~GT~~Y~APEvl~~~-------~s~ksDIwSLG~iLyeLLtG----------~~Pf~~~~----~ 126 (502)
..... ......||+.|+|||++.+. ++.++|||||||++|+|++| ..||.... .
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 65433 23455799999999988653 33689999999999999999 78886532 3
Q ss_pred hHHHHHHHHcCCCCCCccc-----cCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 127 PAQIYKKVTSGKLPGAFHR-----IQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 127 ~~~i~~~i~~~~~p~~~~~-----~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
...+.+.+........++. .....+.+||.+||. +|.+||++.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3455555554444333222 223578999999999 99999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=252.21 Aligned_cols=169 Identities=21% Similarity=0.362 Sum_probs=131.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
|+.+|+|.+++++. ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++......
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeeccccccccccccc
Confidence 68899999999865 45899999999999999999999999 9999999999999987 799999999998653321
Q ss_pred ---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 78 ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 78 ---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
......+|+.|+|||++. ..++.++|||||||++|+|++ |.+||.... ..++...+..+..+ ..+...+..+.
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~-~~p~~~~~~l~ 326 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRL-LQPEYCPDPLY 326 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 122345788999999886 568999999999999999999 778887643 33444555555443 23445688999
Q ss_pred HHHHHhhc-CcCCCCCHHHHhcC
Q 010768 153 RFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 153 ~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
++|.+||. +|.+||++.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999 99999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=239.02 Aligned_cols=168 Identities=24% Similarity=0.369 Sum_probs=140.6
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence 57899999999874 44999999999999999999999999 9999999999999877 7999999999976543322
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+.....+ ..+...++.+.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 244 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYEL 244 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCHHHHHH
Confidence 23345688999999886 568999999999999999999 9999977 4445556555554333 3445568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.++++
T Consensus 245 i~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHH
Confidence 999999 9999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=241.65 Aligned_cols=170 Identities=25% Similarity=0.377 Sum_probs=136.5
Q ss_pred CCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKK---YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k---~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeeccccccccccc
Confidence 5789999999974 356999999999999999999999999 9999999999999887 799999999998764322
Q ss_pred C---cccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCCh---HHHHHHHHcCCC---------CCC
Q 010768 78 H---AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNP---AQIYKKVTSGKL---------PGA 142 (502)
Q Consensus 78 ~---~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~---~~i~~~i~~~~~---------p~~ 142 (502)
. .....||+.|+|||++.+.++.++||||||+++|+|++|..||...... ..+...+..... ...
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 1 2345799999999999888999999999999999999999999764332 122233222211 011
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.....+..+.++|.+||. +|.+||++.+++.
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122235678999999999 9999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=256.59 Aligned_cols=168 Identities=21% Similarity=0.397 Sum_probs=141.1
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++++. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce
Confidence 68899999999854 36899999999999999999999999 9999999999999987 799999999998654321
Q ss_pred -CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
......+++.|+|||++. +.++.++|||||||++|+|++ |+.||.+. ...++...+..+.... .+...++.+.+|
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEELYNI 417 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTSCHHHHHH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHH
Confidence 122334678899999886 569999999999999999999 99999874 4556666666664432 344568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+|+.
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 999999 9999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=249.67 Aligned_cols=168 Identities=21% Similarity=0.381 Sum_probs=130.1
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCccccccccCCcc
Confidence 688999999998764 6999999999999999999999999 9999999999999887 7999999999987643221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+++.|+|||++. ..++.++|||||||++|+|++ |+.||.. .....+...+..+... ......+..+.+
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 281 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRL-PPPMDCPAALYQ 281 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEEC-CCCTTCBHHHHH
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHHHH
Confidence 11234577899999886 569999999999999999998 9999977 4555666666655332 223456889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+|.+||. +|.+||++.+++.
T Consensus 282 li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHH
Confidence 9999999 9999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=252.16 Aligned_cols=164 Identities=20% Similarity=0.241 Sum_probs=129.6
Q ss_pred CCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC-----------CCCcEEE
Q 010768 1 MFTSGTLREYRKK-----YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-----------HLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k-----~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~-----------~~g~vKL 64 (502)
||.||+|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+. + +.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~-~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLS-AGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------C-TTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcccccccc-CCEEE
Confidence 6899999999984 456999999999999999999999999 999999999999987 4 79999
Q ss_pred EecCCceecc---CCCCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC
Q 010768 65 GDLGLAAILR---GSQHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP 140 (502)
Q Consensus 65 ~DFGlA~~~~---~~~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p 140 (502)
+|||+++.+. ........+||+.|+|||++.+ .++.++|||||||++|+|+||+.||........ ......+
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~ 300 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----KPEGLFR 300 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----EECSCCT
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----eechhcc
Confidence 9999997653 2233456789999999998875 489999999999999999999999954221100 0001111
Q ss_pred CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 141 GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 141 ~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
....++.+.+++.+||. +|.+|++..+.|.+
T Consensus 301 ---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 301 ---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 11236778999999999 99988765554443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-29 Score=249.54 Aligned_cols=172 Identities=23% Similarity=0.318 Sum_probs=134.8
Q ss_pred CCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYT----RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 678999999997653 5999999999999999999999999 9999999999999887 79999999999865322
Q ss_pred ---CCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh-----HHH-HHHHHcCCCCC-----
Q 010768 77 ---QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP-----AQI-YKKVTSGKLPG----- 141 (502)
Q Consensus 77 ---~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~-----~~i-~~~i~~~~~p~----- 141 (502)
.......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ... ......+.+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 1223456899999999875 56999999999999999999999999753221 111 11122222211
Q ss_pred ---CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCc
Q 010768 142 ---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175 (502)
Q Consensus 142 ---~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hp 175 (502)
......+..+.++|.+||. +|.+||++.+++.+.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1122235678999999999 999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.15 Aligned_cols=170 Identities=23% Similarity=0.403 Sum_probs=138.5
Q ss_pred CCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEE----eCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKKYTR---VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV----NGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~---Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILl----d~~~g~vKL~DFGlA~~~ 73 (502)
||.||+|.+++.+... +++..++.|+.||+.||+|||++| |+||||||+|||+ +.+ +.+||+|||++...
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEEecCCCceEc
Confidence 6889999999986533 999999999999999999999999 9999999999998 444 57999999999887
Q ss_pred cCCCCcccccCCCcccCccccc---------ccCCcccchhhhhHHHHHHhhccCCCCCC---CChHHHHHHHHcCCCCC
Q 010768 74 RGSQHAHSVIGTPEFMAPELYE---------EDYNELVDIYSFGMCVLEMLTSEYPYSEC---SNPAQIYKKVTSGKLPG 141 (502)
Q Consensus 74 ~~~~~~~~~~GT~~Y~APEvl~---------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~---~~~~~i~~~i~~~~~p~ 141 (502)
..........||+.|+|||++. ..++.++|||||||++|+|++|+.||... .....+...+..+..+.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 6655556678999999999875 35788999999999999999999999642 23344455555544321
Q ss_pred C-----------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 A-----------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~-----------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
. +....+..+.++|.+||. ||.+||++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 1 112235678999999999 9999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=238.73 Aligned_cols=159 Identities=21% Similarity=0.371 Sum_probs=125.9
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~ 76 (502)
|+.||+|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 172 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG- 172 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccccccccc-
Confidence 678999999998864 6999999999999999999999999 9999999999999873 37899999999865421
Q ss_pred CCcccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHH----HHcCCC--CCCccccCCHH
Q 010768 77 QHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKK----VTSGKL--PGAFHRIQDAE 150 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~----i~~~~~--p~~~~~~~s~~ 150 (502)
..++.++|||||||++|+|++|..||...... ..... +..+.. +.......++.
T Consensus 173 -------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (299)
T 3m2w_A 173 -------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEFPNPEWSEVSEE 232 (299)
T ss_dssp -------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred -------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHhhccccCCchhcccCCHH
Confidence 34778999999999999999999999763221 11111 111111 11111346889
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+.+||.+||. +|.+||++.|+|+||||+....
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 9999999999 9999999999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=257.10 Aligned_cols=169 Identities=21% Similarity=0.336 Sum_probs=136.8
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe---CCCCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---GHLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld---~~~g~vKL~DFGlA~~~~~~ 76 (502)
|+ +|+|.+++.. .+.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+ +.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCC-CeEEEEeCCcceeccCC
Confidence 45 9999999986 467999999999999999999999999 99999999999994 44 79999999999876543
Q ss_pred CC--------cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCCC---C
Q 010768 77 QH--------AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPG---A 142 (502)
Q Consensus 77 ~~--------~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p~---~ 142 (502)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ..+.+..+....... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 22 125679999999998764 589999999999999999999999987432 333343333322211 1
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+....+.++.+||.+||. +|.+||++.+|++
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 224457899999999999 9999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=265.98 Aligned_cols=168 Identities=22% Similarity=0.368 Sum_probs=141.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++.+.....
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-----
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCccccccCcccc
Confidence 6889999999999999999999999999999999999999 9999999999999987 7999999999987643221
Q ss_pred --cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+|+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+ ....++...+..+..+ ..+...++.+.+|
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 604 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL 604 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 223456789999998864 69999999999999999998 9999987 4556677777776554 3344568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+|+.
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 999999 9999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=241.41 Aligned_cols=168 Identities=27% Similarity=0.409 Sum_probs=136.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.+|+|.+++.+. .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 116 ~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp CCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECCTTCSEE
T ss_pred cccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCcccccccccccccc
Confidence 67899999999775 4999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred --cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCCh--------------HHHHHHHHcCCCCC
Q 010768 79 --AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNP--------------AQIYKKVTSGKLPG 141 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~--------------~~i~~~i~~~~~p~ 141 (502)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ..+...+..+. ..
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 270 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE-RL 270 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-CC
T ss_pred ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-CC
Confidence 234567888999998864 5889999999999999999999998642110 11223333333 23
Q ss_pred CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 142 AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 142 ~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3455678999999999999 9999999999984
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=255.45 Aligned_cols=168 Identities=23% Similarity=0.365 Sum_probs=140.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++++. ..+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence 68899999999874 45999999999999999999999999 9999999999999877 7999999999987643221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+. ...++...+..+... ..+...++.+.+|
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEKVYEL 451 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 22334678899999886 568999999999999999999 99999874 445566666655433 3345668999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 999999 9999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=252.66 Aligned_cols=168 Identities=22% Similarity=0.354 Sum_probs=136.9
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+.+|+|.+++++. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence 68899999999753 56999999999999999999999999 9999999999999877 7999999999987643221
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ ....++...+..+... ..+...++.+.+|
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 413 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDL 413 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHH
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 22345678999999875 569999999999999999999 9999987 4555666777666443 2344568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+|||+.+++.
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 999999 9999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=238.87 Aligned_cols=169 Identities=27% Similarity=0.408 Sum_probs=136.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 125 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~~~~~~ 201 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEY 201 (326)
T ss_dssp CCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCSSCSE
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCcchhhccccccc
Confidence 57899999999886 45999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred ---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC-----------C----hHHHHHHHHcCCC
Q 010768 79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS-----------N----PAQIYKKVTSGKL 139 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~-----------~----~~~i~~~i~~~~~ 139 (502)
.....++..|+|||++.+ .++.++|||||||++|+|++|..||.... . ...+...+..+..
T Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (326)
T 2w1i_A 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281 (326)
T ss_dssp EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC
Confidence 223456788999998864 58899999999999999999998875310 0 0112233333332
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+ ..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 282 ~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 282 L-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp C-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 3345568999999999999 9999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=260.26 Aligned_cols=173 Identities=19% Similarity=0.329 Sum_probs=140.7
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+++.+.....
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCce
Confidence 68999999999754 55999999999999999999999999 9999999999999987 7999999999986543221
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....+++.|+|||++. +.++.++|||||||++|||++ |+.||.+.. ..++...+..+..+ ..+...++.+.+
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~ 570 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYA 570 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence 12234568999999886 569999999999999999998 999998854 45667777776543 334456899999
Q ss_pred HHHHhhc-CcCCCCCHHHHh---cCcccc
Q 010768 154 FVGKCLE-NVSKRLPAKELL---LDPFLA 178 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL---~hpf~~ 178 (502)
||.+||. +|.+||++.+++ .+.|+.
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999 999999999985 444443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=264.88 Aligned_cols=177 Identities=28% Similarity=0.400 Sum_probs=140.7
Q ss_pred CCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC--CcEEEEecCCceeccC
Q 010768 1 MFTSGTLREYRKKYT---RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRG 75 (502)
Q Consensus 1 y~~gGsL~~~L~k~~---~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~--g~vKL~DFGlA~~~~~ 75 (502)
||.||+|.+++.... .+++..++.|+.||+.||+|||++| |+||||||+|||++.+. ..+||+|||++.....
T Consensus 99 y~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp CCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred eCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 678999999998764 5999999999999999999999999 99999999999998652 2489999999988766
Q ss_pred CCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHH-------------cCC---
Q 010768 76 SQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT-------------SGK--- 138 (502)
Q Consensus 76 ~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~-------------~~~--- 138 (502)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.....+..+...+. .+.
T Consensus 177 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~ 256 (676)
T 3qa8_A 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256 (676)
T ss_dssp CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCC
T ss_pred ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccc
Confidence 55556678999999999886 4689999999999999999999999976432222111000 010
Q ss_pred -----CCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 139 -----LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 139 -----~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+.......++.+.+||.+||. ||.+||++.+++.||||+.
T Consensus 257 ~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 257 SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0111223356889999999999 9999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=254.38 Aligned_cols=168 Identities=22% Similarity=0.356 Sum_probs=140.8
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
|+.+|+|.+++++. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce
Confidence 68899999999753 56999999999999999999999999 9999999999999877 799999999997654321
Q ss_pred -CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
......++..|+|||++. +.++.++|||||||++|+|++ |..||.+ ....++...+..+... ..+...+..+.+|
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 496 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDL 496 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 122345678999999775 569999999999999999999 9999987 4555666777666443 2344568899999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.+|+.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 999999 9999999999885
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=257.28 Aligned_cols=168 Identities=24% Similarity=0.433 Sum_probs=139.5
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.++++..+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++........
T Consensus 471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC----
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCCeecCCCcce
Confidence 688999999998654 6999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .....+...+..+..+. .+...++.+.+||
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 625 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPTLYSLM 625 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCCC-CCTTCCHHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCC-CCccccHHHHHHH
Confidence 22345678999999886 469999999999999999997 9999987 45556666666665433 3445689999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. +|.+||++.+++.
T Consensus 626 ~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 99999 9999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-28 Score=244.03 Aligned_cols=165 Identities=19% Similarity=0.189 Sum_probs=130.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceecccccCcEEEeCCCC-------------------
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLG------------------- 60 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLH-s~g~~IIHRDLKPeNILld~~~g------------------- 60 (502)
||.+|+|.+.+.+ +.+++..++.|+.||+.||+||| ++| ||||||||+|||++.+ +
T Consensus 143 ~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~ 218 (336)
T 2vuw_A 143 FEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCG 218 (336)
T ss_dssp EECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTT
T ss_pred ecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCC
Confidence 4678877666644 67999999999999999999999 899 9999999999999876 4
Q ss_pred -cEEEEecCCceeccCCCCcccccCCCcccCcccccccCCcccchhhhhHH-HHHHhhccCCCCCCCChHHHHHHHHcC-
Q 010768 61 -QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMC-VLEMLTSEYPYSECSNPAQIYKKVTSG- 137 (502)
Q Consensus 61 -~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~i-LyeLLtG~~Pf~~~~~~~~i~~~i~~~- 137 (502)
.+||+|||+|+..... ..+||+.|+|||++.+..+.++||||||++ .+++++|..||.+......+...+...
T Consensus 219 ~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~ 294 (336)
T 2vuw_A 219 LQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM 294 (336)
T ss_dssp EEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC
T ss_pred ceEEEeeccccEecCCC----cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh
Confidence 8999999999876542 458999999999998877999999998776 778889999985421112233333321
Q ss_pred CCC----CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHh-cCcccc
Q 010768 138 KLP----GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL-LDPFLA 178 (502)
Q Consensus 138 ~~p----~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL-~hpf~~ 178 (502)
... .......++.+++||.+||. + |+.|+| +||||+
T Consensus 295 ~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 295 TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 111 11223357889999999999 5 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=254.34 Aligned_cols=159 Identities=20% Similarity=0.311 Sum_probs=130.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.. .+++..++.|+.||+.||.|||++| ||||||||+|||++.+ .+||+|||+++..... .
T Consensus 165 ~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~---~ 235 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF---G 235 (681)
T ss_dssp CCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--CEEECCCTTCEETTCC---S
T ss_pred eCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--cEEEEecccchhcccC---C
Confidence 6889999998766 7999999999999999999999999 9999999999999874 8999999999876543 4
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+.++.++|||||||++|+|++|..||.+... ...+. ......++.+.+||.+||
T Consensus 236 ~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV----------DGLPEDDPVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp CCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC----------SSCCTTCHHHHHCHHHHHHHHHHT
T ss_pred ccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc----------ccccccccccccCHHHHHHHhhhc
Confidence 5679999999999987789999999999999999999988865210 01111 111123578999999999
Q ss_pred c-CcCCCCCHHHHhcCcccc
Q 010768 160 E-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~ 178 (502)
. +|.+||+..+++.++|+.
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHH
Confidence 9 999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-23 Score=207.45 Aligned_cols=142 Identities=16% Similarity=0.149 Sum_probs=110.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++++. ....++..|+.||+.||+|||++| |+||||||+|||++.+ +.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~~------------ 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA------------ 174 (286)
T ss_dssp CCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSCC------------
T ss_pred ecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEecc------------
Confidence 68899999999553 466788999999999999999999 9999999999999987 799987443
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH--HHHHcCCCCC--CccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY--KKVTSGKLPG--AFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~--~~i~~~~~p~--~~~~~~s~~l~~LI~ 156 (502)
|++| ++.++|||||||++|+|++|+.||.+......+. .+...+..+. ......++.+++||.
T Consensus 175 -------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 175 -------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp -------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred -------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence 3333 7889999999999999999999998743221110 0001111111 123456889999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. ||.+| |+.|+++
T Consensus 242 ~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 242 RSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHCTTSSCC-CHHHHHH
T ss_pred HHcccCCccC-CHHHHHH
Confidence 9999 99999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-23 Score=228.84 Aligned_cols=115 Identities=14% Similarity=0.127 Sum_probs=85.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
|++||+|.++|++.+++++.+ |+.||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+..... ...
T Consensus 323 yv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 323 KLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp CCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCS
T ss_pred cCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCCCCCccc
Confidence 799999999999999998764 6899999999999999 9999999999999987 89999999999876543 345
Q ss_pred ccccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCC
Q 010768 80 HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPY 121 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf 121 (502)
.+.+||+.|||||++.+.+..++|+|++|+++++|.++..++
T Consensus 397 ~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred cCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 667899999999999999999999999999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-16 Score=174.17 Aligned_cols=109 Identities=21% Similarity=0.295 Sum_probs=94.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
|+.||+|.+++.+ ++.|+.||+.||+|||++| |+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence 6889999999977 6789999999999999999 999999999999987 899999999988754321
Q ss_pred ------cccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCC
Q 010768 79 ------AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYS 122 (502)
Q Consensus 79 ------~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~ 122 (502)
.....||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 235689999999999874 48889999999999988888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=6.2e-13 Score=132.47 Aligned_cols=72 Identities=19% Similarity=0.199 Sum_probs=60.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+ +. ......++.||+.||.|||++| |+||||||+|||++ + +.+||+|||++..
T Consensus 181 ~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~vkl~DFG~a~~-------- 241 (282)
T 1zar_A 181 LIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIIDFPQSVE-------- 241 (282)
T ss_dssp CCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECCCTTCEE--------
T ss_pred ecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-CcEEEEECCCCeE--------
Confidence 678899988 42 1335679999999999999999 99999999999999 5 8999999999863
Q ss_pred cccCCCcccCccccc
Q 010768 81 SVIGTPEFMAPELYE 95 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~ 95 (502)
+..++|||++.
T Consensus 242 ----~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----VGEEGWREILE 252 (282)
T ss_dssp ----TTSTTHHHHHH
T ss_pred ----CCCCCHHHHHH
Confidence 34578899774
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.72 E-value=6.4e-12 Score=104.64 Aligned_cols=64 Identities=27% Similarity=0.361 Sum_probs=59.5
Q ss_pred CCceEEEEEEEcC---CCCee---eeecCCCCCcccHHHHHHHHHhccCCCCCCHHHHHHHHHHHHHhhC
Q 010768 231 DDTIFLKVQITDK---DGQAR---NIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEISSLV 294 (502)
Q Consensus 231 ~~~i~L~l~i~d~---~g~~r---~i~f~f~~~~Dt~~~Va~EMV~~~~i~~~d~~~ia~~I~~~i~~l~ 294 (502)
...++|+||+.|+ .|+.| +|+|+|++.+|++.+||+|||++++|.++|...||+||+..|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 3589999999999 48888 9999999999999999999999999999999999999999987764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=8.9e-10 Score=107.75 Aligned_cols=60 Identities=25% Similarity=0.314 Sum_probs=51.5
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLH-GHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 6 sL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLH-s~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
+|.++... .++..+..++.||+.||.||| ++| ||||||||+|||++. .++|+|||+|...
T Consensus 159 ~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 159 TLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp BHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred cHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 77776543 235578899999999999999 999 999999999999986 7999999999764
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=7.2e-08 Score=79.52 Aligned_cols=59 Identities=17% Similarity=0.259 Sum_probs=57.1
Q ss_pred ceEEEEEEEcCCCCeeeeecCCCCCcccHHHHHHHHHhccCCCCCCHHHHHHHHHHHHH
Q 010768 233 TIFLKVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELEITDWEPLEIAEMIEQEIS 291 (502)
Q Consensus 233 ~i~L~l~i~d~~g~~r~i~f~f~~~~Dt~~~Va~EMV~~~~i~~~d~~~ia~~I~~~i~ 291 (502)
.+.|.||++|...+...|.|.|-..+||+.+||+|||..+.|+..|...+|.+|++.|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 57899999999999999999999999999999999999999999999999999999997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.7e-07 Score=98.08 Aligned_cols=64 Identities=16% Similarity=0.177 Sum_probs=50.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCC----------cEEEEecCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG----------QVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g----------~vKL~DFGlA 70 (502)
|+.|++|..+. .......++.||+.+|.|||.+| ||||||||.|||++.+ + .+.|+||+-+
T Consensus 192 ~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-gd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 192 LVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-KDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp CCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-ECSSCTTSEEEEEEECCCTTC
T ss_pred ecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-CCcccccccccceEEEEeCCc
Confidence 45666665432 22345678999999999999999 9999999999999865 3 3899999987
Q ss_pred eec
Q 010768 71 AIL 73 (502)
Q Consensus 71 ~~~ 73 (502)
...
T Consensus 263 V~~ 265 (397)
T 4gyi_A 263 VSM 265 (397)
T ss_dssp EET
T ss_pred ccC
Confidence 543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.65 E-value=2.2e-05 Score=77.81 Aligned_cols=77 Identities=22% Similarity=0.222 Sum_probs=49.9
Q ss_pred CceecccccCcEEEeCC-CCcEEEEecCCceeccCCCCcccccCCCcc---cCccccc---ccCC------------ccc
Q 010768 42 PVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQHAHSVIGTPEF---MAPELYE---EDYN------------ELV 102 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y---~APEvl~---~~~s------------~ks 102 (502)
.++|+|++|.||+++.+ .+.+.|+||+.+....... .......+ ..|+.+. ..|. ...
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~ 268 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKE 268 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHH
Confidence 37999999999999974 3567899999987542211 11111111 2333221 1121 125
Q ss_pred chhhhhHHHHHHhhccCCC
Q 010768 103 DIYSFGMCVLEMLTSEYPY 121 (502)
Q Consensus 103 DIwSLG~iLyeLLtG~~Pf 121 (502)
+.|++|.++|.+.+|..+|
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 8999999999999998876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0029 Score=60.94 Aligned_cols=120 Identities=17% Similarity=0.130 Sum_probs=79.3
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 6 TLREYRKKY-TRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 6 sL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
+|.+.|+.+ .+++++++|.++.|.+.+|.-+-. .. -..+=+.|..|++..+ |.|-+.+ ..+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence 688999754 679999999999999999877621 11 1122344788999887 7776653 1110 1
Q ss_pred CCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 84 GTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 84 GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
....+.|||......+.+.=|||||+++|..+-=.. +...+...++.+..||..|..
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL--------------------~e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGL--------------------KENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTC--------------------CTTEEECCCHHHHHHHHHHTT
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCC--------------------CcccchhhCHHHHHHHHHHHh
Confidence 233567888776566788899999999999885222 223455668899999999876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00023 Score=68.32 Aligned_cols=66 Identities=23% Similarity=0.143 Sum_probs=48.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHD---------------------------------------- 40 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g---------------------------------------- 40 (502)
|+.|.+|.+.+. +......++.++..+|..||+..
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 467778776521 12234577899999999999810
Q ss_pred -----------------CCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 41 -----------------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 41 -----------------~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+.++|+|++|.||++++. +.+.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 238999999999999864 4557999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00048 Score=69.58 Aligned_cols=57 Identities=18% Similarity=0.228 Sum_probs=47.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------------
Q 010768 16 RVDIRAVKNWARQILRGIAYLHGH-------------------------------------------------------- 39 (502)
Q Consensus 16 ~Lse~~i~~i~~QIl~aL~yLHs~-------------------------------------------------------- 39 (502)
.++..+...++.+++..|..||+.
T Consensus 135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 214 (359)
T 3dxp_A 135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD 214 (359)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence 467888899999999999999973
Q ss_pred CCCceecccccCcEEEeCCCCc-EEEEecCCcee
Q 010768 40 DPPVIHRDLKCDNIFVNGHLGQ-VKIGDLGLAAI 72 (502)
Q Consensus 40 g~~IIHRDLKPeNILld~~~g~-vKL~DFGlA~~ 72 (502)
.+.++|+|++|.|||++.+... +.|+||+.+..
T Consensus 215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1349999999999999876323 68999999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0012 Score=62.45 Aligned_cols=29 Identities=28% Similarity=0.229 Sum_probs=24.8
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|+|++|.||+++++ +.+.|+||+.+..
T Consensus 186 l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 186 VTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred EECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 9999999999999875 4567999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.025 Score=55.58 Aligned_cols=45 Identities=22% Similarity=0.259 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHh-----------CCCCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 27 RQILRGIAYLHG-----------HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 27 ~QIl~aL~yLHs-----------~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++..++.+|+. ....++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 344456666653 22349999999999999765 5899999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=93.87 E-value=0.077 Score=52.43 Aligned_cols=32 Identities=38% Similarity=0.366 Sum_probs=25.4
Q ss_pred CceecccccCcEEEeC---CCCcEEEEecCCceec
Q 010768 42 PVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAIL 73 (502)
Q Consensus 42 ~IIHRDLKPeNILld~---~~g~vKL~DFGlA~~~ 73 (502)
.++|+|++|.||+++. +...+.|+||+.+..-
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3799999999999987 3233589999988653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.29 E-value=0.11 Score=53.63 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=25.5
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|++|.|||++.+ + ++|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~-~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQD-S-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence 49999999999999876 3 99999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.15 E-value=0.52 Score=46.18 Aligned_cols=28 Identities=25% Similarity=0.158 Sum_probs=24.2
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 489999999999998 3 799999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=87.60 E-value=0.24 Score=47.05 Aligned_cols=29 Identities=28% Similarity=0.400 Sum_probs=24.7
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|+|+.+.|||+++. +.+-|+||+.+..
T Consensus 195 l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 7999999999999875 4566999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=87.56 E-value=0.33 Score=48.33 Aligned_cols=31 Identities=19% Similarity=0.375 Sum_probs=25.5
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
+.++|+|+.|.|||+++. +.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~-~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDF-QPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETT-EEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCC-cEEEEEccccccc
Confidence 349999999999999853 4578999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.15 E-value=0.29 Score=47.87 Aligned_cols=30 Identities=37% Similarity=0.396 Sum_probs=24.9
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+++.|||++++ +.+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 49999999999999875 3457999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=85.43 E-value=0.77 Score=45.23 Aligned_cols=32 Identities=25% Similarity=0.331 Sum_probs=26.7
Q ss_pred CceecccccCcEEEeCC---CCcEEEEecCCceec
Q 010768 42 PVIHRDLKCDNIFVNGH---LGQVKIGDLGLAAIL 73 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~---~g~vKL~DFGlA~~~ 73 (502)
.++|||+.+.||+++.+ .+.+.|+||+.+..-
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999863 147899999988653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=83.81 E-value=1 Score=45.10 Aligned_cols=29 Identities=21% Similarity=0.345 Sum_probs=24.4
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+++.|||++++ .+.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCCC
Confidence 48999999999999764 589999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=81.69 E-value=0.87 Score=45.52 Aligned_cols=30 Identities=20% Similarity=0.340 Sum_probs=26.2
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 49999999999999865 5799999988765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=81.49 E-value=1.3 Score=44.91 Aligned_cols=29 Identities=34% Similarity=0.513 Sum_probs=24.8
Q ss_pred CCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 41 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 41 ~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
..++|+|+.+.|||++.+ .++|+||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~--~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH--ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS--CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC--CeEEEeCcccc
Confidence 349999999999999865 58999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 502 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-27 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-21 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 95/174 (54%), Positives = 125/174 (71%), Gaps = 2/174 (1%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
GTL+ Y K++ + I+ +++W RQIL+G+ +LH PP+IHRDLKCDNIF+ G G VKI
Sbjct: 97 GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSEC 124
GDLGLA + R S A +VIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM TSEYPYSEC
Sbjct: 157 GDLGLATLKRASF-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 215
Query: 125 SNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
N AQIY++VTSG P +F ++ E + + C+ N +R K+LL F
Sbjct: 216 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 4e-39
Identities = 45/179 (25%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
GT+ +K ++ D + + ++ ++Y H VIHRD+K +N+ + G++KI
Sbjct: 91 GTVYRELQKLSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSA-GELKI 147
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSE 123
D G + S+ ++ GT +++ PE+ E ++E VD++S G+ E L + P+ E
Sbjct: 148 ADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-E 205
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
+ + YK+++ + F AR + + L+ N S+R +E+L P++ +++
Sbjct: 206 ANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-37
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 13/183 (7%)
Query: 5 GTLREYRKKYTR----VDIRAVKNWARQILRGIAYLH---GHDPPVIHRDLKCDNIFVNG 57
G L K T+ +D V Q+ + H V+HRDLK N+F++G
Sbjct: 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149
Query: 58 HLGQVKIGDLGLAAIL-RGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEML 115
VK+GD GLA IL + A + +GTP +M+PE YNE DI+S G + E+
Sbjct: 150 K-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 116 TSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
P+ + ++ K+ GK +R E + + L R +E+L +
Sbjct: 209 ALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDELNEIITRMLNLKDYHRPSVEEILEN 266
Query: 175 PFL 177
P +
Sbjct: 267 PLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-37
Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 15/180 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
+L + T+ ++ + + ARQ +G+ YLH +IHRDLK +NIF++ VK
Sbjct: 88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHED-LTVK 144
Query: 64 IGDLGLAAIL---RGSQHAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLT 116
IGD GLA + GS + G+ +MAPE+ Y+ D+Y+FG+ + E++T
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLPAKELL 172
+ PYS +N QI V G L +++ +R + +CL+ +R ++L
Sbjct: 205 GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 59/191 (30%), Positives = 94/191 (49%), Gaps = 14/191 (7%)
Query: 5 GTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G + + R + ++ +Q L + YLH + +IHRDLK NI G +K
Sbjct: 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIK 150
Query: 64 IGDLGLAAIL-RGSQHAHSVIGTPEFMAPELY------EEDYNELVDIYSFGMCVLEMLT 116
+ D G++A R Q S IGTP +MAPE+ + Y+ D++S G+ ++EM
Sbjct: 151 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174
E P+ E NP ++ K+ + P A + + F+ KCLE NV R +LL
Sbjct: 211 IEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269
Query: 175 PFLASDAGEPL 185
PF+ D+ +P+
Sbjct: 270 PFVTVDSNKPI 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-35
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 9/179 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + + + + + Q++ G+ YLHG + HRD+K +N+ ++ +KI
Sbjct: 88 GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKI 144
Query: 65 GDLGLAAILRG---SQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEY 119
D GLA + R + + + GT ++APEL E + E VD++S G+ + ML E
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
P+ + S+ Q Y K + D+ + K L N S R+ ++ D +
Sbjct: 205 PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 7/191 (3%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + + T +D + R+ L+ + +LH + VIHRD+K DNI + G VK+
Sbjct: 102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMD-GSVKL 157
Query: 65 GDLGLAAILRGSQ-HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
D G A + Q +++GTP +MAPE + + Y VDI+S G+ +EM+ E PY
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181
+ +Y T+G A R F+ +CL+ +V KR AKELL FL
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
Query: 182 GEPLLIPKVPS 192
L P + +
Sbjct: 278 PLSSLTPLIAA 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 1e-34
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
+ + L+G+AYLH H +IHRD+K NI ++ G VK+
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKL 156
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEED----YNELVDIYSFGMCVLEMLTSEYP 120
GD G A+I+ A+S +GTP +MAPE+ Y+ VD++S G+ +E+ + P
Sbjct: 157 GDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
+ + +Y + + P R FV CL+ R ++ LL F+
Sbjct: 214 LFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
Query: 180 DAGEPLLIPKVPSFQN 195
+ +++ + ++
Sbjct: 273 ERPPTVIMDLIQRTKD 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (324), Expect = 2e-34
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y + + + + R +L I LH + ++HRDLK +NI ++ +K+
Sbjct: 95 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKL 151
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-------EDYNELVDIYSFGMCVLEMLTS 117
D G + L + V GTP ++APE+ E Y + VD++S G+ + +L
Sbjct: 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLD 174
P+ + + + SG D + V + L KR A+E L
Sbjct: 212 SPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270
Query: 175 PFL 177
PF
Sbjct: 271 PFF 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 47/237 (19%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G+L + KK R+ + + + +++G+ YL ++HRD+K NI VN G++K+
Sbjct: 89 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKL 146
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS- 122
D G++ L S A+S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 147 CDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 123 ----------------------------------------ECSNPAQIYKKVTSGKLPGA 142
++ + + P
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPK-VPSFQNLN 197
+ E + FV KCL N ++R K+L++ F+ E + + S LN
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 127 bits (319), Expect = 3e-33
Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 10/196 (5%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL-GQV 62
G L E ++ ++ + RQ+ +G+ ++H ++ +H DLK +NI ++
Sbjct: 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL 165
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
K+ D GL A L Q GT EF APE+ E + D++S G+ +L+ P+
Sbjct: 166 KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
N + + V S + + F+ K L + + R+ + L P+L
Sbjct: 226 GG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL- 283
Query: 179 SDAGEPLLIPKVPSFQ 194
+ P ++PS +
Sbjct: 284 TPGNAPGRDSQIPSSR 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 125 bits (315), Expect = 1e-32
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 11/194 (5%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQV 62
G L + + ++ V N+ RQ G+ ++H H ++H D+K +NI V
Sbjct: 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSV 168
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPY 121
KI D GLA L + T EF APE+ + E D+++ G+ +L+ P+
Sbjct: 169 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
+ + + + V EA+ F+ L+ KRL + L P+L
Sbjct: 229 AG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287
Query: 179 SDAGEPLLIPKVPS 192
D L ++PS
Sbjct: 288 GD--HSNLTSRIPS 299
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 1e-32
Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 9/191 (4%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--GQV 62
G L + + R Q+L + YLH D ++HRDLK +N+ ++
Sbjct: 92 GELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKI 149
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
I D GL+ + + GTP ++AP L ++ Y++ VD +S G+ +L P+
Sbjct: 150 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFLA 178
+ N A++++++ + D A+ F+ +E + KR ++ L P++A
Sbjct: 210 YD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
Query: 179 SDAGEPLLIPK 189
D I +
Sbjct: 269 GDTALDKNIHQ 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-32
Identities = 41/202 (20%), Positives = 83/202 (41%), Gaps = 11/202 (5%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV-NGHLGQV 62
+ E ++ R + ++ Q+ + +LH H + H D++ +NI +
Sbjct: 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTI 143
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPY 121
KI + G A L+ + + PE+ APE+++ D + D++S G V +L+ P+
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQD--AEARRFVGKCLE-NVSKRLPAKELLLDPFL- 177
QI + + + + ++ EA FV + L R+ A E L P+L
Sbjct: 204 -LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
Query: 178 -ASDAGEPLLIPKVPSFQNLNP 198
+ +I + + +
Sbjct: 263 QKIERVSTKVIRTLKHRRYYHT 284
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-31
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y +K D + + +I+ + YLH +IHRDLK +NI +N ++I
Sbjct: 93 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNED-MHIQI 149
Query: 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
D G A +L A+S +GT ++++PE L E+ + D+++ G + +++ P
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKE------LLL 173
+ N I++K+ + F +AR V K L + +KRL +E L
Sbjct: 210 F-RAGNEYLIFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
Query: 174 DPFLASDAGEPLL---IPKVPS 192
PF S E L PK+ +
Sbjct: 267 HPFFESVTWENLHQQTPPKLTA 288
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-29
Identities = 37/200 (18%), Positives = 87/200 (43%), Gaps = 20/200 (10%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
L ++ + + +++ Q+L + + H V+HRD+K +NI ++ + G
Sbjct: 91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRG 148
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
++K+ D G A+L+ + + GT + PE + ++S G+ + +M+ +
Sbjct: 149 ELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
P+ + G++ F + +E + + CL S R +E+ P++
Sbjct: 208 IPFEHDEE-------IIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 178 ASDAGEPLLIPKVPSFQNLN 197
+L+P+ + +L+
Sbjct: 259 QD-----VLLPQETAEIHLH 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 38/191 (19%), Positives = 72/191 (37%), Gaps = 13/191 (6%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL--G 60
G L + R + I I YLH + + HRD+K +N+
Sbjct: 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 151
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
+K+ D G A + TP ++APE+ E Y++ D++S G+ + +L
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
Query: 120 PYSECSNPA---QIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173
P+ A + ++ G+ P E + + L+ ++R+ E +
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
Query: 174 DPFLASDAGEP 184
P++ P
Sbjct: 272 HPWIMQSTKVP 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 45/220 (20%), Positives = 78/220 (35%), Gaps = 31/220 (14%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
R Y + + + VK + Q+ R +AY+H + HRD+K N+ ++ +K+
Sbjct: 108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLC 165
Query: 66 DLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
D G A L + S I + + APEL DY +D++S G + E+L + +
Sbjct: 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 124 CSNPAQIYK--------------------------KVTSGKLPGAFHRIQDAEARRFVGK 157
S Q+ + ++ + F EA +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 158 CLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNL 196
LE + RL E F + +P L
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPAL 325
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 44/199 (22%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
G L + + + + +I+ + + H V++RD+K +N+ ++ G
Sbjct: 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALE--YLHSRDVVYRDIKLENLMLDKD-G 142
Query: 61 QVKIGDLGLAAILRGS-QHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE 118
+KI D GL + GTPE++APE+ E DY VD + G+ + EM+
Sbjct: 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELL 172
P+ + ++++ + ++ F R EA+ + L+ + +RL AKE++
Sbjct: 203 LPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 173 LDPFLASDAGEPLLIPKVP 191
F S + ++ K+
Sbjct: 260 EHRFFLSINWQDVVQKKLL 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-28
Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 9/173 (5%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L +Y R + + + G+AYL + VIHRDL N V + +K
Sbjct: 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGEN-QVIK 141
Query: 64 IGDLGLAAILRGSQ--HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+ D G+ + Q + ++ +PE Y+ D++SFG+ + E+ +
Sbjct: 142 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
E + +++ + +++G R+ + + C E R LL
Sbjct: 202 PYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV---NGHLGQ 61
G L ++ + + + +QIL G+ + H + H DLK +NI + N +
Sbjct: 98 GELFDFLAEKESLTEEEATEFLKQILNGVY--YLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 62 VKIGDLGLAAILRGSQHAHSVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYP 120
+KI D GLA + ++ GTPEF+APE+ + D++S G+ +L+ P
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 121 YSECSNPAQIYKKVTSGK--LPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ + V++ + A A+ F+ + L + KR+ ++ L P++
Sbjct: 216 F-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
Query: 178 ASDAGEPLLIPKV--PSFQ 194
+ L P F+
Sbjct: 275 KPKDTQQALSSAWSHPQFE 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-27
Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 10/179 (5%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ + + + + A QI G+AY+ +HRDL+ NI V + K+ D
Sbjct: 100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGEN-LVCKVAD 156
Query: 67 LGLAAILRGSQH--AHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSE 123
GLA ++ +++ ++ APE + D++SFG+ + E+ T
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
Query: 124 CSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LDPFLAS 179
++ +V G + +C +R + L L+ + S
Sbjct: 217 GMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-27
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + + + D+ +A +I+ G+ +LH +++RDLK DNI ++ G +KI
Sbjct: 88 GDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKI 144
Query: 65 GDLGLAAILR-GSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
D G+ G ++ GTP+++APE L + YN VD +SFG+ + EML + P+
Sbjct: 145 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF- 203
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAK-ELLLDPFLASD 180
+ +++ + + R + EA+ + K KRL + ++ P
Sbjct: 204 HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
Query: 181 AGEPLLIPKVP 191
E L ++
Sbjct: 262 NWEELERKEID 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 8e-27
Identities = 36/176 (20%), Positives = 68/176 (38%), Gaps = 10/176 (5%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
++ I + + A QI G+A++ IHRDL+ NI V+ KI D GL
Sbjct: 99 KTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDT-LSCKIADFGL 155
Query: 70 AAILRGSQHAH--SVIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN 126
A ++ +++ ++ AP + + D++SFG+ + E++T
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215
Query: 127 PAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL--LDPFLAS 179
++ + + G E + + C E R L L+ F +
Sbjct: 216 NPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 8e-27
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 10/205 (4%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
M L R+ + + + NW QI +G+ YL ++HRDL N+ V
Sbjct: 92 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTP-Q 148
Query: 61 QVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
VKI D GLA +L + HA ++MA E + Y D++S+G+ V E++T
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDP 175
+ ++I + G+ I + + KC + R +EL+++
Sbjct: 209 FGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
Query: 176 -FLASDAGEPLLIPKVPSFQNLNPN 199
+A D L+I +P
Sbjct: 268 SKMARDPQRYLVIQGDERMHLPSPT 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (269), Expect = 9e-27
Identities = 50/192 (26%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
L +K R K +A ++ + YLH +I+RDLK +NI ++ + G +KI D
Sbjct: 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKN-GHIKITD 147
Query: 67 LGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECS 125
G A + +++ GTP+++APE + + YN+ +D +SFG+ + EML P+ + S
Sbjct: 148 FGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-S 204
Query: 126 NPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELLLDPFLAS 179
N + Y+K+ + +L F + + + + + + ++S+RL +++ P+
Sbjct: 205 NTMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
Query: 180 DAGEPLLIPKVP 191
E LL +
Sbjct: 263 VVWEKLLSRNIE 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 10/172 (5%)
Query: 5 GTLREY--RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62
G+L +Y + + + + ++ + + YL G+ +HRDL N+ V+
Sbjct: 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSED-NVA 142
Query: 63 KIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
K+ D GL S + ++ APE L E+ ++ D++SFG+ + E+ +
Sbjct: 143 KVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+ +V G A + C + + R +L
Sbjct: 201 YPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 59/196 (30%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
+ V +K+ Q+LRG+ +LH H V+HRDLK NI V GQ+K+ D GL
Sbjct: 106 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGL 162
Query: 70 AAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
A I SV+ T + APE L + Y VD++S G EM + + S+
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
Query: 129 QIYKKVTSGKLPG-------------AFHRIQ-----------DAEARRFVGKCLE-NVS 163
Q+ K + LPG AFH D + + KCL N +
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282
Query: 164 KRLPAKELLLDPFLAS 179
KR+ A L P+
Sbjct: 283 KRISAYSALSHPYFQD 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 34/174 (19%), Positives = 66/174 (37%), Gaps = 10/174 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L +Y ++ V + + Q+ G+ YL +HRDL N+ + KI
Sbjct: 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQ-HYAKI 148
Query: 65 GDLGLAAILRGSQHAHS----VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
D GL+ LR ++ + ++ APE + ++ D++SFG+ + E +
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+++ + G+ G E + C +V R +
Sbjct: 209 KPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (268), Expect = 3e-26
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 31/277 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
G L + ++ ++ +A +I+ G+ ++H + V++RDLK NI ++ H G V+I
Sbjct: 92 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH-GHVRI 148
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYS 122
DLGLA + H+ +GT +MAPE+ ++ Y+ D +S G + ++L P+
Sbjct: 149 SDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRL-----PAKELLLDPF 176
+ + + + E R + L+ +V++RL A+E+ PF
Sbjct: 208 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267
Query: 177 LASDAGEPLLIPKVPSFQNLNPNGAVTELVPQFAVDSDRRKSTDMTITGTMNPEDDTIFL 236
S + + + K P P + D G+ + ED
Sbjct: 268 FRSLDWQMVFLQKYP---------------PPLIPPRGEVNAADAFDIGSFDEEDTK--- 309
Query: 237 KVQITDKDGQARNIYFPYDIFNDTATEVALEMVKELE 273
+++ D D Q FP I EVA + +
Sbjct: 310 GIKLLDSD-QELYRNFPLTISERWQQEVAETVFDTIN 345
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 9/177 (5%)
Query: 1 MFTSGTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL 59
+ T G LR + + +D+ ++ +A Q+ +AYL +HRD+ N+ V+ +
Sbjct: 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSN- 144
Query: 60 GQVKIGDLGLAAILRGSQHAHS--VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
VK+GD GL+ + S + + ++MAPE + + D++ FG+C+ E+L
Sbjct: 145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+ + ++ +G+ + KC + S+R EL
Sbjct: 205 HGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 37/174 (21%), Positives = 66/174 (37%), Gaps = 6/174 (3%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ T + + + + ++A + RG+ YL IHRDL NI V +
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN-Y 164
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
KI D GL+ +MA E L Y D++S+G+ + E+++
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
A++Y+K+ G D E + +C +R ++L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 103 bits (257), Expect = 2e-25
Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 10/180 (5%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
TLR+ + + + + + H + +IHRD+K NI ++ VK+
Sbjct: 96 VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISAT-NAVKV 152
Query: 65 GDLGLAAILRGSQ----HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEY 119
D G+A + S +VIGT ++++PE + + D+YS G + E+LT E
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
Query: 120 PYSECSNPAQIYKKVTSGKL-PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFL 177
P++ S + Y+ V + P A H A+ V K L N R + +
Sbjct: 213 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 32/175 (18%), Positives = 61/175 (34%), Gaps = 11/175 (6%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L ++ K + + V Q+ G+ YL +HRDL N+ + K
Sbjct: 93 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNR-HYAK 149
Query: 64 IGDLGLAAILRGSQHAH----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
I D GL+ L + + ++ APE + ++ D++S+G+ + E L+
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+ ++ + GK E + C R +
Sbjct: 210 QKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 10/177 (5%)
Query: 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
+ + E + + + +A Q+ +G+ +L +HRDL N+ V
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KV 202
Query: 62 VKIGDLGLAAILRGSQHAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
VKI D GLA + + + ++MAPE L+E Y D++S+G+ + E+ +
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 118 -EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
PY A YK + +G E + C + KR L
Sbjct: 263 GVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-25
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 9/173 (5%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G L Y R+ R + + + + + YL +HRDL N VN G VK
Sbjct: 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQ-GVVK 140
Query: 64 IGDLGLAAILRGSQHAHS--VIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYP 120
+ D GL+ + ++ S + PE+ ++ DI++FG+ + E+ +
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200
Query: 121 YSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
E ++ + + G + + + C E +R K LL
Sbjct: 201 PYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 7e-25
Identities = 33/171 (19%), Positives = 61/171 (35%), Gaps = 9/171 (5%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
R + ARQ+ G+AYL +HRDL N V + VKI D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIAD 183
Query: 67 LGLAAILRGSQHAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYS 122
GL+ + + + + +M PE ++ Y D++++G+ + E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 123 ECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL 172
++ V G + A E + C + + R +
Sbjct: 244 YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 8e-25
Identities = 32/186 (17%), Positives = 68/186 (36%), Gaps = 15/186 (8%)
Query: 5 GTLREY-RKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L + R+ + + + R I G+ YL +HRDL NI VN + K
Sbjct: 112 GSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSN-LVCK 168
Query: 64 IGDLGLAAILRGSQHAHSV------IGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT 116
+ D GL+ L + + APE + + D++S+G+ + E+++
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--L 173
+ + + + + C + + + R +++ L
Sbjct: 229 YGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 174 DPFLAS 179
D + +
Sbjct: 288 DKMIRN 293
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 1e-24
Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
G + + ++ R + +A QI+ YLH D +I+RDLK +N+ ++ G
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-G 178
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEY 119
+++ D G A R ++ GTPE +APE + + YN+ VD ++ G+ + EM
Sbjct: 179 YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 120 PYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP-----AKELLL 173
P+ P QIY+K+ SGK+ F ++ + + L+ +++KR ++
Sbjct: 237 PF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 174 DPFLASDAGEPLLIPKVP 191
+ A+ + KV
Sbjct: 294 HKWFATTDWIAIYQRKVE 311
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 15/202 (7%)
Query: 5 GTLREYRKKYTR-VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G LR + + T ++ + + Q+ +G+ +HRDL N ++ VK
Sbjct: 114 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEK-FTVK 170
Query: 64 IGDLGLAAILRGSQHAH-----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTS 117
+ D GLA + + ++MA E L + + D++SFG+ + E++T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 118 EYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LD 174
P N I + G+ D + KC R EL+ +
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRIS 289
Query: 175 PFLASDAGEPLLIPKVPSFQNL 196
++ GE + ++ N+
Sbjct: 290 AIFSTFIGEH-YVHVNATYVNV 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 40/213 (18%), Positives = 76/213 (35%), Gaps = 40/213 (18%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
+ + +K + +L G+ Y+H ++HRD+K N+ + G +K+
Sbjct: 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD-GVLKL 158
Query: 65 GDLGLAAILRGSQ-----HAHSVIGTPEFMAPE--LYEEDYNELVDIYSFGMCVLEMLTS 117
D GLA ++ + + T + PE L E DY +D++ G + EM T
Sbjct: 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
Query: 118 EYPYSECSNPAQIYK--------------KVTSGKLPGAFHRIQ---------------D 148
+ Q+ V + +L ++ D
Sbjct: 219 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278
Query: 149 AEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180
A + K L + ++R+ + + L F SD
Sbjct: 279 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 5e-24
Identities = 35/181 (19%), Positives = 71/181 (39%), Gaps = 12/181 (6%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ R+K + + R I G+ Y + +HRDL NI VN + K+ D
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKY--LANMNYVHRDLAARNILVNSN-LVCKVSD 153
Query: 67 LGLAAILRGSQHAHSVI----GTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
GL+ +L A + APE + + D++SFG+ + E++T
Sbjct: 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL-ENVSKRLPAKELL--LDPFLA 178
+ ++ K + G + + + +C + ++R +++ LD +
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
Query: 179 S 179
+
Sbjct: 273 A 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 6e-24
Identities = 39/175 (22%), Positives = 61/175 (34%), Gaps = 10/175 (5%)
Query: 5 GTLREYR-KKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVK 63
G+L + K + + +A Q+ G+ YL IHRDL N+ + VK
Sbjct: 95 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATR-DLVK 151
Query: 64 IGDLGLAAILRGSQHAH----SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSE 118
IGD GL L + + + APE L ++ D + FG+ + EM T
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 119 YPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
N +QI K+ + + +C R L
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 2e-23
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 11/180 (6%)
Query: 6 TLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIG 65
+ ++ + + + A Q+ RG+ YL IHRDL N+ V +KI
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTED-NVMKIA 177
Query: 66 DLGLAAILRGSQ---HAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPY 121
D GLA + + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 122 SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--LDPFLA 178
+++K + G + E + C S+R K+L+ LD +A
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.0 bits (243), Expect = 4e-23
Identities = 38/213 (17%), Positives = 78/213 (36%), Gaps = 43/213 (20%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
++ + T DIR + +IL+ + Y H ++HRD+K N+ ++ ++++
Sbjct: 117 TDFKQLYQTLTDYDIR---FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRL 171
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYS 122
D GLA Q + + + F PEL + Y+ +D++S G + M+ + P+
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 123 ECSNPAQIYKKVT-----------------------------------SGKLPGAFHRIQ 147
+ ++ + +
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291
Query: 148 DAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179
EA F+ K L + RL A+E + P+ +
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 4e-23
Identities = 48/200 (24%), Positives = 80/200 (40%), Gaps = 33/200 (16%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
T + + +K++ Q+L+G+A+ H H V+HRDLK N+ +N G +K+ D GL
Sbjct: 92 DASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTE-GAIKLADFGL 148
Query: 70 AAIL-RGSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSN 126
A + + T + APE+ Y+ VDI+S G EM+T + S
Sbjct: 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 127 PAQIYKKVTSGKLPGAFHRIQ--------------------------DAEARRFVGKCLE 160
Q+++ + P D + R + + L
Sbjct: 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268
Query: 161 -NVSKRLPAKELLLDPFLAS 179
+ +KR+ AK L PF
Sbjct: 269 YDPNKRISAKAALAHPFFQD 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 5e-23
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
G L + + R V+ + +I+ + +LH +I+RD+K +NI ++ + G
Sbjct: 110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSN-G 166
Query: 61 QVKIGDLGLAAILRG--SQHAHSVIGTPEFMAPELY---EEDYNELVDIYSFGMCVLEML 115
V + D GL+ ++ A+ GT E+MAP++ + +++ VD +S G+ + E+L
Sbjct: 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226
Query: 116 TSEYPY---SECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLP---- 167
T P+ E ++ A+I +++ + P + + A A+ + + L + KRL
Sbjct: 227 TGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
Query: 168 -AKELLLDPFLASDAGEPLLIPKVP 191
A E+ F + L KVP
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 5e-23
Identities = 42/214 (19%), Positives = 78/214 (36%), Gaps = 33/214 (15%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGD 66
+ + +K + L+G+ YLH H ++HRDLK +N+ ++ + G +K+ D
Sbjct: 87 EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDEN-GVLKLAD 143
Query: 67 LGLAAILRGSQHAHS-VIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSE 123
GLA A++ + T + APEL Y VD+++ G + E+L
Sbjct: 144 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
Query: 124 CSNPAQIYK-------------------------KVTSGKLPGAFHRIQDAEARRFVGKC 158
S+ Q+ + K G + +
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263
Query: 159 LE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVP 191
N R+ A + L + ++ G P ++P
Sbjct: 264 FLFNPCARITATQALKMKYFSNRPG-PTPGCQLP 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 6e-23
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLH------GHDPPVIHRDLKCDNIFVNGH 58
G+L +Y +Y V + + A G+A+LH P + HRDLK NI V +
Sbjct: 86 GSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
Query: 59 LGQVKIGDLGLAAILRGSQH-----AHSVIGTPEFMAPELYEE-------DYNELVDIYS 106
G I DLGLA + + +GT +MAPE+ ++ + + DIY+
Sbjct: 145 -GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 107 FGMCVLEMLTSEYPYSECS--------------NPAQIYKKVTSGKL-PGAFHRIQDAEA 151
G+ E+ + ++ K V KL P +R Q EA
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263
Query: 152 ----RRFVGKCL-ENVSKRLPAKELL 172
+ + +C N + RL A +
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.3 bits (239), Expect = 6e-23
Identities = 34/167 (20%), Positives = 61/167 (36%), Gaps = 8/167 (4%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
V + A QI + YL IHRDL N V + VK+ D GL
Sbjct: 105 RECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGEN-HLVKVADFGL 161
Query: 70 AAILRGSQHAHS--VIGTPEFMAP-ELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSN 126
+ ++ G + ++ AP L ++ D+++FG+ + E+ T +
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221
Query: 127 PAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+Q+Y+ + + + C + N S R E+
Sbjct: 222 LSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 33/207 (15%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ ++ K++ Q+L GIAY H D V+HRDLK N+ +N G
Sbjct: 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINRE-G 137
Query: 61 QVKIGDLGLAAILR-GSQHAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTS 117
++KI D GLA + I T + AP++ Y+ +DI+S G EM+
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 118 EYPYSECSNPAQIYK--------------------------KVTSGKLPGAFHRIQDAEA 151
+ S Q+ + V +F + D
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257
Query: 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177
+ K L+ + ++R+ AK+ L +
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 12/188 (6%)
Query: 2 FTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQ 61
F + + + + ++ Q+ +G+ +L IHRDL NI ++
Sbjct: 116 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NV 172
Query: 62 VKIGDLGLAAILRGSQ---HAHSVIGTPEFMA-PELYEEDYNELVDIYSFGMCVLEMLT- 116
VKI D GLA + ++MA +++ Y D++SFG+ + E+ +
Sbjct: 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL--L 173
PY + +++ G A E + + C S+R EL+ L
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 174 DPFLASDA 181
L ++A
Sbjct: 292 GNLLQANA 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 95.3 bits (236), Expect = 2e-22
Identities = 32/192 (16%), Positives = 70/192 (36%), Gaps = 22/192 (11%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFV--NGHLGQV 62
+ + ++ V A Q++ I Y+H + IHRD+K DN + V
Sbjct: 88 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLV 145
Query: 63 KIGDLGLAAILRGSQ--------HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLE 113
I D GLA R ++ ++ GT + + + + + D+ S G ++
Sbjct: 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 205
Query: 114 MLT--SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE-NVSKRLP 167
+ + + Q Y++++ K+ + +E ++ C +
Sbjct: 206 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265
Query: 168 A---KELLLDPF 176
++L + F
Sbjct: 266 YSYLRQLFRNLF 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 8e-22
Identities = 34/162 (20%), Positives = 68/162 (41%), Gaps = 8/162 (4%)
Query: 16 RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 75
+D+ + +++ Q+ +G+A+L + IHRDL NI + KI D GLA ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKN 197
Query: 76 SQHAHS---VIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY 131
+ ++MAPE ++ Y D++S+G+ + E+ + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
K+ AE + C + + KR K+++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 3e-21
Identities = 49/234 (20%), Positives = 82/234 (35%), Gaps = 39/234 (16%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
G K + + + QILRG+ Y+H V+HRDLK N+ +N
Sbjct: 90 THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTT-C 146
Query: 61 QVKIGDLGLAAILRGSQHAH----SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEM 114
+KI D GLA + + T + APE+ + Y + +DI+S G + EM
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206
Query: 115 LTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQ--------------------------- 147
L++ + Q+ + P
Sbjct: 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 266
Query: 148 -DAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAGEPLLIPKVPSFQNLNPN 199
D++A + K L N KR+ ++ L P+L +P P + +
Sbjct: 267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY-DPSDEPIAEAPFKFDME 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-21
Identities = 37/177 (20%), Positives = 68/177 (38%), Gaps = 9/177 (5%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
+ + + + A +I G+AYL+ + +HRDL N V
Sbjct: 114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-F 170
Query: 61 QVKIGDLGLAAILRGSQHAH---SVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLT 116
VKIGD G+ + + + + +M+PE L + + D++SFG+ + E+ T
Sbjct: 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 230
Query: 117 SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172
+ + Q+ + V G L D + C + N R E++
Sbjct: 231 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 90.3 bits (223), Expect = 1e-20
Identities = 23/178 (12%), Positives = 61/178 (34%), Gaps = 20/178 (11%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN---- 56
+ + ++ V A+Q+L + +H +++RD+K DN +
Sbjct: 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNS 139
Query: 57 GHLGQVKIGDLGLAAILRGS--------QHAHSVIGTPEFMAPELYE-EDYNELVDIYSF 107
+ + + D G+ R + ++ GT +M+ + + + D+ +
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199
Query: 108 GMCVLEMLTSE--YPYSECSNPAQIYKKVTSGKLPGAFHRIQD---AEARRFVGKCLE 160
G + L + + + Q Y+++ K + E +++
Sbjct: 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN 257
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.9 bits (219), Expect = 3e-20
Identities = 37/188 (19%), Positives = 77/188 (40%), Gaps = 34/188 (18%)
Query: 22 VKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSQHAH 80
VK++ Q+L+G+ + H V+HRDLK N+ +N + G++K+ + GLA +
Sbjct: 103 VKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYS 159
Query: 81 SVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGK 138
+ + T + P++ + Y+ +D++S G E+ + P ++ K++
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 139 LPGAFHRIQ---------------------------DAEARRFVGKCLE-NVSKRLPAKE 170
+ +A R + L+ N +R+ A+E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 171 LLLDPFLA 178
L P+ +
Sbjct: 280 ALQHPYFS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 2e-19
Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 39/229 (17%)
Query: 5 GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64
GT K+ ++ ++ Q+L+G+ Y+H HRDLK N+ VN ++KI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNED-CELKI 162
Query: 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSEYPYS 122
D GLA + T + APE+ Y + VDI+S G + EM+T + +
Sbjct: 163 LDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 123 ECSNPAQIYKKV-TSGKLPGAFHRIQ---------------------------DAEARRF 154
+ Q+ + + +G P F + A
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 155 VGKCLE-NVSKRLPAKELLLDPFLAS---DAGEPLLIPKVPSFQNLNPN 199
+ K L + +R+ A E L P+ S EP + SF +++
Sbjct: 281 LEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 2e-18
Identities = 50/229 (21%), Positives = 80/229 (34%), Gaps = 47/229 (20%)
Query: 10 YRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 69
+ +D + Q+L GI +LH IHRDLK NI V +KI D GL
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGL 165
Query: 70 AAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPA 128
A S + T + APE + Y E VDI+S G + EM+ + +
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
Query: 129 QIYKKVTSGKLP---------------------------------------GAFHRIQDA 149
Q K + P ++++ +
Sbjct: 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285
Query: 150 EARRFVGKCLE-NVSKRLPAKELLLDPFLASD---AGEPLLIPKVPSFQ 194
+AR + K L + +KR+ + L P++ A P++ Q
Sbjct: 286 QARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 334
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 2e-17
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 39/229 (17%)
Query: 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLG 60
G K ++ V+ QILRG+ Y+H D +IHRDLK N+ VN
Sbjct: 102 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-C 158
Query: 61 QVKIGDLGLAAILRGSQHAHSVIGTPEFMAPELY--EEDYNELVDIYSFGMCVLEMLTSE 118
++KI D GLA + T + APE+ YN+ VDI+S G + E+LT
Sbjct: 159 ELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 119 YPYSECSN--------------PAQIYKKVTSGKLPGAFHRIQ--------------DAE 150
+ + A++ KK++S + +
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLA---SDAGEPLLIPKVPSFQN 195
A + K L + KR+ A + L + A EP+ P SF++
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFES 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.1 bits (183), Expect = 2e-15
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 56/242 (23%)
Query: 7 LREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN-----GHLGQ 61
+ ++ + + VK ++Q+L G+ Y+H +IH D+K +N+ + +L Q
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQ 170
Query: 62 VKIGDLGLAAILRGSQHAHSVIGTPEFMAPE-LYEEDYNELVDIYSFGMCVLEMLTSEYP 120
+KI DLG A +H + I T E+ +PE L + DI+S + E++T ++
Sbjct: 171 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
Query: 121 YSECS------------------------------------NPAQIYKKVTSGKLPG--- 141
+ N + + ++ K
Sbjct: 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 288
Query: 142 ------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG-EPLLIPKVPSF 193
F + + E F+ L+ + KR A L+ P+L G E + +P +
Sbjct: 289 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348
Query: 194 QN 195
+
Sbjct: 349 GS 350
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.9 bits (126), Expect = 1e-08
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 17/97 (17%)
Query: 23 KNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSV 82
IL +A + ++H DL N+ V+ + I D +
Sbjct: 106 DEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE--GIWIIDFPQS---VEVGEEGW- 157
Query: 83 IGTPEFMAPEL------YEEDYNELVDIYSFGMCVLE 113
E + ++ + Y DI S +L+
Sbjct: 158 ---REILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 502 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.98 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.98 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.25 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 86.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 85.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.38 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=335.73 Aligned_cols=177 Identities=54% Similarity=1.038 Sum_probs=163.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++++||||||||+|||++.+.+.+||+|||+|+.... ....
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~ 171 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAK 171 (270)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBE
T ss_pred CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccC
Confidence 789999999999999999999999999999999999999888999999999999986557999999999976433 3445
Q ss_pred cccCCCcccCcccccccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhhc
Q 010768 81 SVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCLE 160 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~ 160 (502)
+.+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+..+...+++.+..+..+..+....++++++||.+||.
T Consensus 172 ~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251 (270)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHcc
Confidence 67899999999999999999999999999999999999999988888899999998888777788889999999999999
Q ss_pred -CcCCCCCHHHHhcCcccc
Q 010768 161 -NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 161 -dP~kRpsa~ElL~hpf~~ 178 (502)
||.+|||++|+|+||||+
T Consensus 252 ~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 252 QNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SSGGGSCCHHHHHTSGGGC
T ss_pred CCHhHCcCHHHHhCCcccC
Confidence 999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=321.65 Aligned_cols=173 Identities=25% Similarity=0.504 Sum_probs=155.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|...... ...
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~-~~~ 162 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-RRT 162 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC-CCE
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCCC-ccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 79999999999876543 345
Q ss_pred cccCCCcccCccccccc-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEED-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
...||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+ .+..++++.+..+.. .++...++++++||.+||
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLL 239 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHT
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHc
Confidence 67899999999998754 89999999999999999999999976 567778888877665 345567999999999999
Q ss_pred c-CcCCCCCHHHHhcCccccCC
Q 010768 160 E-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 160 ~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. ||.+|||++|+|+||||+..
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCCc
Confidence 9 99999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=323.12 Aligned_cols=176 Identities=26% Similarity=0.426 Sum_probs=152.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---~ 77 (502)
||.||+|.+++.+.+.+++.+++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+..... .
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeeccCCccc
Confidence 7899999999998889999999999999999999999999 9999999999999987 79999999999876432 2
Q ss_pred CcccccCCCcccCccccccc--CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEED--YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~~--~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....+||+.|||||++.+. ++.++|||||||++|+|++|++||.........+..+.............++.+++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 24567899999999988653 4678999999999999999999998766655666666655554444556789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.+||. ||.+|||++|+|+||||+.
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999 9999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-39 Score=320.58 Aligned_cols=176 Identities=34% Similarity=0.555 Sum_probs=153.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||.||+|.+++.+ +.+++.+++.|++||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+... ...
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhheeeccccccc
Confidence 7899999998876 57999999999999999999999999 9999999999999887 79999999999876543 344
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+...+..+......+...++.+++||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 56789999999998875 58999999999999999999999998855555555555555544455666799999999999
Q ss_pred hc-CcCCCCCHHHHhcCccccCC
Q 010768 159 LE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 159 L~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
|. ||.+|||+.|+|+||||+..
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhcCHhhCCC
Confidence 99 99999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=318.89 Aligned_cols=180 Identities=30% Similarity=0.502 Sum_probs=156.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---C
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---Q 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---~ 77 (502)
||.||+|.+++...+.+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCCccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 79999999999876432 2
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+...+++++..+.. .++...++.+++||.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVE 242 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 3345689999999998865 599999999999999999999999987 567778888887765 344567899999999
Q ss_pred Hhhc-CcCCCCCHHH------HhcCccccCCCCCCCC
Q 010768 157 KCLE-NVSKRLPAKE------LLLDPFLASDAGEPLL 186 (502)
Q Consensus 157 kcL~-dP~kRpsa~E------lL~hpf~~~~~~~~l~ 186 (502)
+||. ||.+|||++| +++||||+.-.+..+.
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 9999 9999999988 5789999987776544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-38 Score=316.93 Aligned_cols=177 Identities=24% Similarity=0.441 Sum_probs=142.5
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC--CCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~--~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+.+.+++.+++.|+.||+.||+|||++| ||||||||+|||+.. +.+.+||+|||+++.......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 7899999999999999999999999999999999999999 999999999999963 347899999999987766556
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI 155 (502)
..+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .....+...+..+..+. ......++.+++||
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 667889999999998875 599999999999999999999999987 55667777777765532 33455789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. ||.+|||++|+|+||||++.
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999 99999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=319.79 Aligned_cols=176 Identities=26% Similarity=0.483 Sum_probs=158.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccC-CCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~-~~~~ 79 (502)
||.||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++.+ |.+||+|||+|+.... ....
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCCB
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccCCccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 8999999999987543 3445
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+ .+..++++.+..+.. .++...++++++||.+|
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHhh
Confidence 67889999999999874 599999999999999999999999987 667788888888765 34566799999999999
Q ss_pred hc-CcCCCCC-----HHHHhcCccccCCCC
Q 010768 159 LE-NVSKRLP-----AKELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRps-----a~ElL~hpf~~~~~~ 182 (502)
|. ||.+|++ +.|+++||||+...+
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCH
Confidence 99 9999994 999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=315.17 Aligned_cols=177 Identities=32% Similarity=0.532 Sum_probs=150.3
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CC
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~ 78 (502)
||.||+|.+++.+ .+.+++.+++.|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+|+..... ..
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechhhhccCCCccc
Confidence 7899999999875 456999999999999999999999999 9999999999999987 79999999999765332 22
Q ss_pred cccccCCCcccCccccc------ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC-CCccccCCHHH
Q 010768 79 AHSVIGTPEFMAPELYE------EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-GAFHRIQDAEA 151 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~------~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l 151 (502)
..+..||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+. +..++...+..+..+ ...+...++++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34578999999999873 34889999999999999999999999874 445555666665443 23445678999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
++||.+||+ ||.+|||+.|+|+||||+...
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999 999999999999999997643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=311.01 Aligned_cols=174 Identities=29% Similarity=0.460 Sum_probs=141.5
Q ss_pred CCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceecccccCcEEEeCCCCcEEEEecCCceec
Q 010768 1 MFTSGTLREYRKK----YTRVDIRAVKNWARQILRGIAYLHGHD---PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 73 (502)
Q Consensus 1 y~~gGsL~~~L~k----~~~Lse~~i~~i~~QIl~aL~yLHs~g---~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~ 73 (502)
||.||+|.+++.+ .+.+++..++.|+.||+.||+|||++| .+||||||||+|||++.+ +.+||+|||+|+.+
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~~~ 164 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARIL 164 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHHHC
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccceeec
Confidence 7899999999864 467999999999999999999999864 249999999999999987 79999999999876
Q ss_pred cCC-CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 74 RGS-QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 74 ~~~-~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
... ......+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..++...+..+..+. ++...++++
T Consensus 165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~s~~l 242 (269)
T d2java1 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYRYSDEL 242 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHH
T ss_pred ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHH
Confidence 543 23456789999999998864 599999999999999999999999977 56777888888877653 345568999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccc
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFL 177 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~ 177 (502)
++||.+||. ||.+|||+.|+|+|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999 99999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-38 Score=314.56 Aligned_cols=173 Identities=28% Similarity=0.469 Sum_probs=153.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|..++...+++++.+++.|+.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeecccccccCC---CC
Confidence 7889999999888899999999999999999999999999 9999999999999987 7999999999986543 34
Q ss_pred cccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
...||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +..+....+..+..+.......++.+++||.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 568999999999874 35899999999999999999999999874 4555666666666666666677999999999
Q ss_pred Hhhc-CcCCCCCHHHHhcCccccCC
Q 010768 157 KCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
+||. ||.+|||++|+|+||||...
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999 99999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=317.55 Aligned_cols=177 Identities=28% Similarity=0.518 Sum_probs=144.8
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
||.||+|.+++.+.+.+++..++.++.||+.||+|||+ +| |+||||||+||||+.+ +.+||+|||+|+.... ...
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH-HTC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCccccCC-Ccc
Confidence 78999999999999999999999999999999999997 58 9999999999999887 7999999999987643 233
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH-----------------------------
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ----------------------------- 129 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~----------------------------- 129 (502)
.+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||........
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 56789999999998875 699999999999999999999999976432211
Q ss_pred ------------HHHHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 130 ------------IYKKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 130 ------------i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
....+.....+.......+.++++||.+||. ||.+|||++|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 1111122222222333468899999999999 999999999999999998644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=309.24 Aligned_cols=181 Identities=24% Similarity=0.415 Sum_probs=156.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCC---CcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~---g~vKL~DFGlA~~~~~~~ 77 (502)
||.||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+|||++.+. ..+||+|||++.......
T Consensus 94 ~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~ 171 (293)
T d1jksa_ 94 LVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171 (293)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred cCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence 7899999999999899999999999999999999999999 99999999999998652 259999999999887666
Q ss_pred CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRF 154 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~L 154 (502)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+.+..+..+.... ......++.+++|
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence 6677889999999999875 599999999999999999999999987 56677777777765532 2334568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCccccCCCCCC
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLASDAGEP 184 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~~~~~~~ 184 (502)
|.+||. ||.+|||++|+|+||||+...+..
T Consensus 251 i~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 999999 999999999999999998755433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-37 Score=314.37 Aligned_cols=175 Identities=27% Similarity=0.512 Sum_probs=156.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+|||++.+ +.+||+|||+|+.+... ..
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~--~~ 196 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BC
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeecccc--cc
Confidence 6899999999999999999999999999999999999999 9999999999999987 79999999999887543 34
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
+..||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+... ++...++.+.+||.+||
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHHHS
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHHh
Confidence 6789999999998875 499999999999999999999999977 5677788888877653 34567899999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
. ||.+|+ +++++++||||+...+.
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred hhCHHhccccccccHHHHHcCccccCCCHH
Confidence 9 999995 89999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-37 Score=319.14 Aligned_cols=178 Identities=26% Similarity=0.446 Sum_probs=151.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|.+++.+...+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.+... ...
T Consensus 88 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~~-~~~ 163 (364)
T d1omwa3 88 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 163 (364)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEECSSS-CCC
T ss_pred ecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeecCCC-ccc
Confidence 7899999999999999999999999999999999999999 9999999999999887 79999999999876543 345
Q ss_pred cccCCCcccCccccc-c-cCCcccchhhhhHHHHHHhhccCCCCCCCC--hHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 81 SVIGTPEFMAPELYE-E-DYNELVDIYSFGMCVLEMLTSEYPYSECSN--PAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~-~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
..+||+.|+|||++. + .|+.++|||||||++|+|+||+.||.+... ...+.+.+.. .+..++...++.+++||.
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLE 241 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHHHHHHH
Confidence 678999999999885 3 489999999999999999999999976432 2233333222 233445567999999999
Q ss_pred Hhhc-CcCCCCC-----HHHHhcCccccCCCCCC
Q 010768 157 KCLE-NVSKRLP-----AKELLLDPFLASDAGEP 184 (502)
Q Consensus 157 kcL~-dP~kRps-----a~ElL~hpf~~~~~~~~ 184 (502)
+||. ||.+||| ++|+++||||++..+..
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 9999 9999999 79999999999876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.6e-37 Score=315.66 Aligned_cols=179 Identities=24% Similarity=0.393 Sum_probs=156.3
Q ss_pred CCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRK-KYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~-k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++. +.+++++.+++.|+.||+.||+|||++| ||||||||+|||++.+ .+.+||+|||+++.+.....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 789999999995 4567999999999999999999999999 9999999999999743 37899999999998877666
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..++...+..+... .......++.+++||
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 677899999999998875 589999999999999999999999986 5667777777766543 333345689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
.+||. ||.+|||++|+|+||||+....
T Consensus 261 ~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999 9999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-37 Score=308.97 Aligned_cols=175 Identities=29% Similarity=0.549 Sum_probs=156.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.||+|..++.....+++..++.|+.||+.||+|||++| ||||||||+||||+.+ |.+||+|||+|+.... ...
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--~~~ 159 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--VTY 159 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS--CBC
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEecc--ccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 7999999999988654 334
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHhh
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKCL 159 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL 159 (502)
+.+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..++...+..+.. .++...++.++++|.+||
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 6789999999999875 499999999999999999999999987 667777888877765 344567899999999999
Q ss_pred c-CcCCCC-----CHHHHhcCccccCCCCC
Q 010768 160 E-NVSKRL-----PAKELLLDPFLASDAGE 183 (502)
Q Consensus 160 ~-dP~kRp-----sa~ElL~hpf~~~~~~~ 183 (502)
. +|.+|+ +++++|+||||+.-.+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 9 999996 89999999999886554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-37 Score=302.71 Aligned_cols=175 Identities=26% Similarity=0.469 Sum_probs=155.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||+||+|.++++..+.+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++.+.......
T Consensus 91 ~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~ 167 (277)
T d1phka_ 91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLR 167 (277)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBC
T ss_pred cCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchheeEccCCCcee
Confidence 7899999999999999999999999999999999999999 9999999999999887 799999999999887666666
Q ss_pred cccCCCcccCcccccc-------cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC--CCCccccCCHHH
Q 010768 81 SVIGTPEFMAPELYEE-------DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL--PGAFHRIQDAEA 151 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-------~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l 151 (502)
...||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+ .+...+.+.+..+.. +.......++++
T Consensus 168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 246 (277)
T d1phka_ 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246 (277)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence 7889999999998742 378899999999999999999999987 556667777776654 233344679999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
++||.+||. +|.+||+++|+|+||||+.
T Consensus 247 ~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999 9999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.6e-37 Score=314.43 Aligned_cols=178 Identities=25% Similarity=0.396 Sum_probs=155.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC-CCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG-HLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~-~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+. .++++.+++.|+.||+.||+|||++| ||||||||+||||+. ..+.+||+|||+|..+.....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 78999999988765 46999999999999999999999999 999999999999973 347999999999998877666
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--CCccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP--GAFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+ .+...+...+..+..+ .......++++++||
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 677889999999998875 599999999999999999999999987 4556667777766543 334456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
.+||. ||.+|||+.|+|+||||+...
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999 999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-37 Score=309.22 Aligned_cols=176 Identities=26% Similarity=0.493 Sum_probs=156.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||+||+|.+++.+.+++++.+++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++..... ...
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCB
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhcccccccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 79999999999865432 334
Q ss_pred ccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHHh
Q 010768 80 HSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGKC 158 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kc 158 (502)
....||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++.++..+.. .++...++.+++||.+|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHh
Confidence 55789999999998865 699999999999999999999999987 567778888877654 44556799999999999
Q ss_pred hc-CcCCCCCHH-HHhcCccccCCCC
Q 010768 159 LE-NVSKRLPAK-ELLLDPFLASDAG 182 (502)
Q Consensus 159 L~-dP~kRpsa~-ElL~hpf~~~~~~ 182 (502)
|. ||.+||++. ++++||||+.-.+
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cccCCCCCcCHHHHHHhCchhccCCH
Confidence 99 999999995 8999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-37 Score=311.72 Aligned_cols=179 Identities=20% Similarity=0.363 Sum_probs=148.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~ 76 (502)
||.||+|.+++.+. .++++.+++.|+.||+.||+|||++| |+||||||+|||++.. .+.+||+|||+|+.....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCC
Confidence 79999999999875 46999999999999999999999999 9999999999999853 357999999999987766
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHH---HHHHHHcCCC--CCCccccCCHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQ---IYKKVTSGKL--PGAFHRIQDAE 150 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~---i~~~i~~~~~--p~~~~~~~s~~ 150 (502)
......+||+.|+|||++.+ .|+.++|||||||++|+|+||++||.+...... +...+..+.. |.......+++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 247 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHH
T ss_pred CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHH
Confidence 66677889999999999875 599999999999999999999999976433222 2222332322 22223346899
Q ss_pred HHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 151 ARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 151 l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
+++||.+||. ||.+|||+.|+|.||||+...
T Consensus 248 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 9999999999 999999999999999997543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=298.52 Aligned_cols=167 Identities=20% Similarity=0.392 Sum_probs=143.7
Q ss_pred CCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTS-GTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~g-GsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+ ++|.+++.+.+.+++.+++.|+.||+.||+|||++| ||||||||+|||++.+.+.+||+|||+|+.... ...
T Consensus 90 ~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~-~~~ 166 (273)
T d1xwsa_ 90 RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVY 166 (273)
T ss_dssp CCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCS-SCB
T ss_pred eccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccc-ccc
Confidence 4544 789999999899999999999999999999999999 999999999999997667999999999987544 334
Q ss_pred ccccCCCcccCcccccc-c-CCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHHH
Q 010768 80 HSVIGTPEFMAPELYEE-D-YNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVGK 157 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~-~-~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k 157 (502)
.+..||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.. ...+..+.. .++...++++++||.+
T Consensus 167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-------~~~i~~~~~--~~~~~~s~~~~~li~~ 237 (273)
T d1xwsa_ 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQV--FFRQRVSSECQHLIRW 237 (273)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS-------HHHHHHCCC--CCSSCCCHHHHHHHHH
T ss_pred cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC-------chHHhhccc--CCCCCCCHHHHHHHHH
Confidence 56789999999998864 3 46789999999999999999999976 223444443 3445678999999999
Q ss_pred hhc-CcCCCCCHHHHhcCccccC
Q 010768 158 CLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 158 cL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
||. ||.+|||++|+|+||||+.
T Consensus 238 ~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 238 CLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HccCCHhHCcCHHHHhcCHhhCC
Confidence 999 9999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=299.71 Aligned_cols=177 Identities=21% Similarity=0.326 Sum_probs=144.2
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~ 79 (502)
||.||++..++.....+++..++.|++||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence 6778888877777788999999999999999999999999 9999999999999987 79999999999876443 234
Q ss_pred ccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCC-----CC---------
Q 010768 80 HSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKL-----PG--------- 141 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~-----p~--------- 141 (502)
...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+....+.+ ..+.. +.. +.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l-~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH-HHHHHhcCCCChhhccchhccchhhh
Confidence 5678999999999875 34899999999999999999999999875444433 33321 100 00
Q ss_pred ------C----ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 142 ------A----FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 142 ------~----~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
. .....++.+++||.+||. ||.+|||+.|+|+||||+..+
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 012347899999999999 999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=294.57 Aligned_cols=171 Identities=30% Similarity=0.503 Sum_probs=145.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC---
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--- 76 (502)
||.||+|.+++... .++++..++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeeccccCCc
Confidence 78999999999765 56999999999999999999999999 9999999999999987 79999999999775432
Q ss_pred CCcccccCCCcccCccccc----ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC---ccccCCH
Q 010768 77 QHAHSVIGTPEFMAPELYE----EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---FHRIQDA 149 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~----~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~ 149 (502)
.......||+.|||||++. +.|+.++|||||||++|||+||+.||.+......+...+..+..++. .....++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 2334568999999999885 24899999999999999999999999987777788877777765443 3345688
Q ss_pred HHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 150 EARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 150 ~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+++||.+||. +|.+|||+.|++.+
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999 99999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=294.55 Aligned_cols=176 Identities=31% Similarity=0.442 Sum_probs=143.3
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
|+.+|.+...... ...+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++........
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~dfg~~~~~~~~~~~ 172 (305)
T d1blxa_ 96 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMAL 172 (305)
T ss_dssp CCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGG
T ss_pred eccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecchhhhhhhcccccC
Confidence 4666666555443 356999999999999999999999999 9999999999999987 79999999999876655556
Q ss_pred ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CCC-----------------
Q 010768 80 HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP----------------- 140 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~p----------------- 140 (502)
....||+.|+|||++. ..|+.++||||+||++|+|++|++||.+... ......+... ..+
T Consensus 173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 251 (305)
T d1blxa_ 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251 (305)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchhcccccccchhhhhc
Confidence 6788999999999875 5699999999999999999999999987543 3333333210 000
Q ss_pred -------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 -------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 -------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
..+....++.+++||.+||. ||.+|||+.|+|+||||+.-
T Consensus 252 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01223457899999999999 99999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-36 Score=301.24 Aligned_cols=177 Identities=22% Similarity=0.372 Sum_probs=154.7
Q ss_pred CCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC-CCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~-~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.||+|.+++.+.+ .+++.+++.|+.||+.||+|||++| |+||||||+|||++.+ ...+||+|||++........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 789999999998765 7999999999999999999999999 9999999999999753 35899999999998766666
Q ss_pred cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC--CccccCCHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG--AFHRIQDAEARRFV 155 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.... ......++++++||
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 667789999999998764 589999999999999999999999987 56677777787766532 22335689999999
Q ss_pred HHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+||. ||.+|||+.|+|+||||+..
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999 99999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=290.19 Aligned_cols=172 Identities=22% Similarity=0.381 Sum_probs=147.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC--
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH-- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~-- 78 (502)
||++|+|.+++.+...+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhcccccccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+..+. .+...++.+++|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHH
Confidence 23356899999999875 569999999999999999998 8999987 45677788888776553 345678999999
Q ss_pred HHHhhc-CcCCCCCHHHH---hcCccc
Q 010768 155 VGKCLE-NVSKRLPAKEL---LLDPFL 177 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~El---L~hpf~ 177 (502)
|.+||. +|.+|||++++ |+|+|+
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999 99999999998 456665
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-35 Score=297.05 Aligned_cols=170 Identities=24% Similarity=0.322 Sum_probs=145.2
Q ss_pred CCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC
Q 010768 1 MFTSGTLREYRKKYT-----------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG 57 (502)
Q Consensus 1 y~~gGsL~~~L~k~~-----------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~ 57 (502)
||+||+|.++|++.. .+++..++.|+.||+.||+|||+++ ||||||||+|||++.
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH 199 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhcccccc
Confidence 789999999997653 4899999999999999999999999 999999999999998
Q ss_pred CCCcEEEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHH
Q 010768 58 HLGQVKIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYK 132 (502)
Q Consensus 58 ~~g~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~ 132 (502)
+ +.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+......+.+
T Consensus 200 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 200 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp T-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred C-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7 7999999999987644332 23566899999999775 669999999999999999998 8999988666666666
Q ss_pred HHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 133 KVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 133 ~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+..+.. ...+...++.+++||.+||+ +|.+|||++||++|
T Consensus 279 ~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 279 LIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6655543 34455678999999999999 99999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-35 Score=289.54 Aligned_cols=170 Identities=23% Similarity=0.356 Sum_probs=140.3
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
||.+|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||
T Consensus 99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~-~~~Kl 175 (299)
T d1ywna1 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKI 175 (299)
T ss_dssp CCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEE
T ss_pred ecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCC-CcEEE
Confidence 78999999999754 24899999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhc-cCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTS-EYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG-~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||+|| .+||.+......+.+.+..+..
T Consensus 176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~ 255 (299)
T d1ywna1 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255 (299)
T ss_dssp CC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred ccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999998654322 234567999999999886 4599999999999999999986 5688877667777777777765
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
+. .+...++.+++||.+||. ||.+|||+.|+++|
T Consensus 256 ~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 256 MR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 53 445668999999999999 99999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-34 Score=291.47 Aligned_cols=179 Identities=26% Similarity=0.391 Sum_probs=143.1
Q ss_pred CCCCCCHH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC
Q 010768 1 MFTSGTLR---EYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ 77 (502)
Q Consensus 1 y~~gGsL~---~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~ 77 (502)
||.+|.+. .+......+++.+++.|++||+.||+|||++| ||||||||+|||++.+...+||+|||++.......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 45554322 23345667999999999999999999999999 99999999999999875589999999999877666
Q ss_pred CcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-C-----------------
Q 010768 78 HAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-G----------------- 137 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~----------------- 137 (502)
...+.+||+.|+|||++. ..|+.++||||+||++|+|++|+.||........+...+.. +
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 667789999999999764 35899999999999999999999999875544443332211 0
Q ss_pred CCCC--------CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCC
Q 010768 138 KLPG--------AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDA 181 (502)
Q Consensus 138 ~~p~--------~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~ 181 (502)
..+. ......++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1110 1122358899999999999 999999999999999998643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=284.25 Aligned_cols=175 Identities=22% Similarity=0.336 Sum_probs=149.2
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
||.+|+|.+++... .++++..++.|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence 78999999987543 36999999999999999999999999 9999999999999987 799999999998875432
Q ss_pred -CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++. +.++.++|||||||++|||+||..|+.......++...+..+..+. .+...++.+.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHHHHH
Confidence 234467899999999886 5699999999999999999996666555577778888888775543 3456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhc--CccccC
Q 010768 156 GKCLE-NVSKRLPAKELLL--DPFLAS 179 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~--hpf~~~ 179 (502)
.+||+ +|.+|||+.++++ ++||..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999 9999999999987 788753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-34 Score=283.44 Aligned_cols=175 Identities=25% Similarity=0.384 Sum_probs=138.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
||.||+|.+++...+.+++.+++.|+.||+.||+|||++| ||||||||+|||++.+ +.++|+|||.+......
T Consensus 92 ~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~~~~~~ 168 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSV 168 (277)
T ss_dssp CCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEECC------
T ss_pred CCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhhhccccccc
Confidence 7899999999999999999999999999999999999999 9999999999999987 79999999998765332
Q ss_pred CCcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCC-CccccCCHHHHHH
Q 010768 77 QHAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPG-AFHRIQDAEARRF 154 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~L 154 (502)
......+||+.|+|||++.+ .|+.++|||||||++|+|+||++||.+........+.+.....+. ......++.+++|
T Consensus 169 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~l 248 (277)
T d1o6ya_ 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAV 248 (277)
T ss_dssp ----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHH
T ss_pred cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 23345689999999998875 599999999999999999999999987444444444444444332 3345578999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCcccc
Q 010768 155 VGKCLE-NVSKRLPAKELLLDPFLA 178 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hpf~~ 178 (502)
|.+||. ||.+||+..+.|.|+|++
T Consensus 249 i~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 249 VLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999 999999544455567664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-34 Score=285.59 Aligned_cols=177 Identities=19% Similarity=0.365 Sum_probs=145.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.+|+|..+. +.+++..++.+++||+.||+|||++| ||||||||+|||++.+.+.+||+|||+|..........
T Consensus 113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 68899987763 56999999999999999999999999 99999999999999775679999999999877666667
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-------------CCC------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-------------GKL------ 139 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-------------~~~------ 139 (502)
..+||+.|+|||++.+ .++.++||||+||++|+|++|..||............+.. ...
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 7889999999998754 4899999999999999999999999775544332222110 000
Q ss_pred ----------------CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCCCC
Q 010768 140 ----------------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASDAG 182 (502)
Q Consensus 140 ----------------p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~~~ 182 (502)
+.......++++++||.+||. ||.+|||++|+|+||||+...+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 011223457899999999999 9999999999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-34 Score=284.58 Aligned_cols=173 Identities=20% Similarity=0.346 Sum_probs=148.6
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||+||+|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhcccccccc
Confidence 78999999998654 67999999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred ---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.. ..++...+..+..+.. +...++++.+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~~-p~~~~~~l~~ 243 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMEC-PPECPPELYA 243 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCCC-CTTCCHHHHH
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCC-CCcCCHHHHH
Confidence 23456899999999886 569999999999999999998 999998854 5667778887776543 4567899999
Q ss_pred HHHHhhc-CcCCCCCHHHH---hcCcccc
Q 010768 154 FVGKCLE-NVSKRLPAKEL---LLDPFLA 178 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~El---L~hpf~~ 178 (502)
||.+||. +|.+||++.++ |+++|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999 99999999887 6678774
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-34 Score=284.04 Aligned_cols=169 Identities=19% Similarity=0.348 Sum_probs=135.4
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCc
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~ 79 (502)
||.+|+|.+++.+. +.+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+++.+......
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccceEccCCCCc
Confidence 78999999999875 56999999999999999999999999 9999999999999987 79999999999876443221
Q ss_pred ------ccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHH
Q 010768 80 ------HSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEA 151 (502)
Q Consensus 80 ------~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l 151 (502)
....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..+. .+...++.+
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l 262 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDCPSAL 262 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCCHHH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHH
Confidence 2245789999999886 569999999999999999998 8999987 45667777777765543 344568999
Q ss_pred HHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 152 RRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 152 ~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||.+||. +|.+|||+.|+++.
T Consensus 263 ~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 263 HQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999 99999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-34 Score=278.78 Aligned_cols=170 Identities=20% Similarity=0.363 Sum_probs=135.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||.+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence 78999999998765 56899999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....||+.|+|||++. +.|+.++|||||||++|||+|+..|+.......++...+..+..+ ..+...++.+.+||.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 236 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHH
Confidence 23467899999999887 469999999999999999999544444446777788888777554 344567899999999
Q ss_pred Hhhc-CcCCCCCHHHHhcC
Q 010768 157 KCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~h 174 (502)
+||. +|.+|||++|++++
T Consensus 237 ~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 9999 99999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-34 Score=282.63 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=138.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.++.|..+.+..+.+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||.+....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceecccCcccc
Confidence 4566666777677788999999999999999999999999 9999999999999987 799999999998764432 23
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCCC----------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKLP---------------- 140 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~p---------------- 140 (502)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.+.... +..+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 45679999999998753 4799999999999999999999999875444433332211 1000
Q ss_pred ---------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 141 ---------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 141 ---------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
.......++.+++||.+||. ||++|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01123357899999999999 9999999999999999973
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=287.43 Aligned_cols=176 Identities=27% Similarity=0.397 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.||+|.++++. +++++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||++......
T Consensus 91 ~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 91 HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBC
T ss_pred eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccCceeeccCCCccc
Confidence 4679999999976 47999999999999999999999999 9999999999999987 79999999999875432
Q ss_pred CCcccccCCCcccCccccc--ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCC--------------
Q 010768 77 QHAHSVIGTPEFMAPELYE--EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLP-------------- 140 (502)
Q Consensus 77 ~~~~~~~GT~~Y~APEvl~--~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p-------------- 140 (502)
......+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+..........+.....+
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence 1234567999999999874 347899999999999999999999998754333332222111000
Q ss_pred -----------CC---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 -----------GA---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 -----------~~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.. .....++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 112347889999999999 99999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=284.69 Aligned_cols=179 Identities=25% Similarity=0.400 Sum_probs=149.4
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC--CC
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--QH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~--~~ 78 (502)
|+.||+|.+++...+.+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+++.+... ..
T Consensus 110 ~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~~~~~~~~ 186 (322)
T d1vzoa_ 110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETER 186 (322)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGG
T ss_pred cccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchhhhccccccc
Confidence 6899999999999999999999999999999999999999 9999999999999987 79999999999876432 23
Q ss_pred cccccCCCcccCcccccc---cCCcccchhhhhHHHHHHhhccCCCCCCC---ChHHHHHHHHcCCCCCCccccCCHHHH
Q 010768 79 AHSVIGTPEFMAPELYEE---DYNELVDIYSFGMCVLEMLTSEYPYSECS---NPAQIYKKVTSGKLPGAFHRIQDAEAR 152 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~~---~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~ 152 (502)
..+..|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.. ....+.+....... .++...++.+.
T Consensus 187 ~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~~ 264 (322)
T d1vzoa_ 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK 264 (322)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCCHHHH
Confidence 456789999999998753 37889999999999999999999997642 33344444444433 33456799999
Q ss_pred HHHHHhhc-CcCCCC-----CHHHHhcCccccCCCCCC
Q 010768 153 RFVGKCLE-NVSKRL-----PAKELLLDPFLASDAGEP 184 (502)
Q Consensus 153 ~LI~kcL~-dP~kRp-----sa~ElL~hpf~~~~~~~~ 184 (502)
+||.+||. ||.+|| +++|+|+||||+.-.+..
T Consensus 265 ~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 99999999 999999 589999999998755433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=279.99 Aligned_cols=174 Identities=28% Similarity=0.466 Sum_probs=139.0
Q ss_pred CCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC-CCcc
Q 010768 4 SGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-QHAH 80 (502)
Q Consensus 4 gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~-~~~~ 80 (502)
+|.+.+++.. .+.+++..++.|+.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSBCTT
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccCCcccce
Confidence 4555555543 456999999999999999999999999 9999999999999987 79999999999876443 3445
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCC----------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGA---------------- 142 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~---------------- 142 (502)
...||+.|+|||++.. .++.++|||||||++|+|++|+.||.+......+.+.+.....+..
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 6689999999997653 3688999999999999999999999886555544443322111000
Q ss_pred ----------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 143 ----------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 143 ----------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.....++.+++||.+||. ||.+|||+.|+|+||||+.-
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 011346889999999999 99999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-33 Score=279.64 Aligned_cols=169 Identities=22% Similarity=0.325 Sum_probs=145.5
Q ss_pred CCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKY--TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~--~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
||.+|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence 78999999999764 56899999999999999999999999 9999999999999987 7999999999987654322
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..++.+.+..+..+ ..+...++.+++||
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 249 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKVYELM 249 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHHHHHH
Confidence 23345899999999875 569999999999999999999877776667788888877776544 34456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhc
Q 010768 156 GKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~ 173 (502)
.+||. ||.+|||+.|+++
T Consensus 250 ~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 99999 9999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=280.82 Aligned_cols=176 Identities=21% Similarity=0.369 Sum_probs=139.7
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCC----
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---- 76 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~---- 76 (502)
|+.+|++..+......+++..++.+++||+.||.|||++| ||||||||+|||++.+ +.+||+|||+++.+...
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~dfg~~~~~~~~~~~~ 174 (318)
T d3blha1 98 FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQ 174 (318)
T ss_dssp CCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECCC-----
T ss_pred ccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEeeecceeeecccccccc
Confidence 4566666666666788999999999999999999999999 9999999999999987 79999999999866432
Q ss_pred -CCcccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc--CCCC-CCcc------
Q 010768 77 -QHAHSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS--GKLP-GAFH------ 144 (502)
Q Consensus 77 -~~~~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~--~~~p-~~~~------ 144 (502)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+. +.......+.. +..+ ....
T Consensus 175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCChhhccccchhh
Confidence 22344679999999998753 5899999999999999999999999774 33333333222 1111 1000
Q ss_pred ---------------------ccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 145 ---------------------RIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 145 ---------------------~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
...++.+.+||.+||. ||.+|||+.|+|.||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 1136778899999999 99999999999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-33 Score=272.82 Aligned_cols=176 Identities=22% Similarity=0.336 Sum_probs=146.9
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-Cc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-HA 79 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-~~ 79 (502)
|+.|++|..++...+.+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||.+....... ..
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccCCCccc
Confidence 5778999999999999999999999999999999999999 9999999999999987 799999999998765433 33
Q ss_pred ccccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCC------------------
Q 010768 80 HSVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKL------------------ 139 (502)
Q Consensus 80 ~~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~------------------ 139 (502)
....+++.|+|||++.+ .++.++|||||||++|+|++|..||....+..+...++.....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 44567889999998764 3789999999999999999999998776776666665542110
Q ss_pred ---------CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccC
Q 010768 140 ---------PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLAS 179 (502)
Q Consensus 140 ---------p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~ 179 (502)
........++.+.+||.+||+ ||.+|||++|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 011122347899999999999 9999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.2e-33 Score=275.19 Aligned_cols=169 Identities=24% Similarity=0.433 Sum_probs=135.5
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
||.+|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||+++.+ +.+||+|||+++......
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-------------
T ss_pred eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhheeccCCcce
Confidence 68999999998654 56999999999999999999999999 9999999999999987 799999999998764332
Q ss_pred CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 ~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+ .+..++...+..+..+. .+...++.+++||
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li 242 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPTLYSLM 242 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCCHHHHHHH
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHH
Confidence 234456899999999886 569999999999999999998 8999977 45667777888776553 4456789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. ||.+|||+.||+++
T Consensus 243 ~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 243 TKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999 99999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=274.34 Aligned_cols=176 Identities=20% Similarity=0.307 Sum_probs=145.2
Q ss_pred CCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC-
Q 010768 1 MFTSGTLREYRKK--YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k--~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~- 77 (502)
||.+|+|..++.. .+.+++.+++.++.||+.||+|||++| |+||||||+||||+.+ +.+||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhccCCCc
Confidence 7899999999854 467999999999999999999999999 9999999999999887 799999999998764332
Q ss_pred -CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 78 -HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 78 -~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
......||+.|+|||++. +.++.++|||||||++|||++|..||.......++...+..+..+. .+...++.+++||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHHHH
Confidence 233467899999999875 5699999999999999999997767666677788888887765543 4556789999999
Q ss_pred HHhhc-CcCCCCCHHHHhc--CccccCC
Q 010768 156 GKCLE-NVSKRLPAKELLL--DPFLASD 180 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~--hpf~~~~ 180 (502)
.+||+ +|.+||++.+|+. ++||...
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999 9999999999987 7888654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=273.10 Aligned_cols=169 Identities=20% Similarity=0.311 Sum_probs=139.0
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCC--
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQ-- 77 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~-- 77 (502)
||.+|+|.+++.+. +.+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+++.+....
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEcccchhhcccCCCcc
Confidence 68899999988765 67999999999999999999999999 9999999999999987 799999999998764322
Q ss_pred --CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 78 --HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 78 --~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
......||+.|+|||++. +.++.++|||||||++|||++|..|+.......++.+.+..+..+. .+...+..+.+|
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~l 245 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIYQL 245 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHHHHHH
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHHHHHH
Confidence 123356899999999876 5699999999999999999997666666677888888888876554 344568999999
Q ss_pred HHHhhc-CcCCCCCHHHHhc
Q 010768 155 VGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~ 173 (502)
|.+||. +|.+||++.||++
T Consensus 246 i~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 246 MMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCcCCHhHCcCHHHHHH
Confidence 999999 9999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.7e-32 Score=278.28 Aligned_cols=171 Identities=27% Similarity=0.383 Sum_probs=139.0
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCccccc
Q 010768 4 SGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVI 83 (502)
Q Consensus 4 gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~ 83 (502)
|++|..+++ .+++++..++.+++||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.... .....+
T Consensus 106 ~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~~--~~~~~~ 179 (346)
T d1cm8a_ 106 GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADS--EMTGYV 179 (346)
T ss_dssp SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECCS--SCCSSC
T ss_pred cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccccceeccCC--cccccc
Confidence 667777765 468999999999999999999999999 9999999999999987 7999999999987643 345678
Q ss_pred CCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHc-CCC---------------------
Q 010768 84 GTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTS-GKL--------------------- 139 (502)
Q Consensus 84 GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~-~~~--------------------- 139 (502)
||+.|+|||++.+ .++.++||||+||++|+|++|++||.+......+...... +..
T Consensus 180 ~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (346)
T d1cm8a_ 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259 (346)
T ss_dssp SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred ccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCC
Confidence 9999999998753 4789999999999999999999999875433333222111 000
Q ss_pred ---CC---CccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 140 ---PG---AFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 140 ---p~---~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.. ......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 1122357899999999999 99999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=270.25 Aligned_cols=169 Identities=20% Similarity=0.393 Sum_probs=146.4
Q ss_pred CCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++.. ...+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccCCCce
Confidence 6889999999765 467999999999999999999999999 9999999999999987 7999999999986644322
Q ss_pred -cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHH
Q 010768 79 -AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFV 155 (502)
Q Consensus 79 -~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI 155 (502)
.....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+...++.+++||
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHHHHHH
Confidence 23467899999999886 569999999999999999998 89999874 567778888877554 34567789999999
Q ss_pred HHhhc-CcCCCCCHHHHhcC
Q 010768 156 GKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 156 ~kcL~-dP~kRpsa~ElL~h 174 (502)
.+||. +|.+|||+.++|.|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999 99999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.1e-33 Score=278.37 Aligned_cols=170 Identities=26% Similarity=0.441 Sum_probs=143.2
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
|+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+++.......
T Consensus 91 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 91 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp CCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHHHHTTTTCC-
T ss_pred eccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccceeccccccc
Confidence 57899999988765 67999999999999999999999999 9999999999999987 7999999999987644322
Q ss_pred --cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHH
Q 010768 79 --AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRF 154 (502)
Q Consensus 79 --~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~L 154 (502)
.....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ ....++...+..+..+. .+...++.+.+|
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~l 245 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICTIDVYMI 245 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBCHHHHHH
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHH
Confidence 23456899999999775 569999999999999999998 8889876 45566777777776543 345668999999
Q ss_pred HHHhhc-CcCCCCCHHHHhcCc
Q 010768 155 VGKCLE-NVSKRLPAKELLLDP 175 (502)
Q Consensus 155 I~kcL~-dP~kRpsa~ElL~hp 175 (502)
|.+||. +|.+|||+.|++.|.
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHHH
Confidence 999999 999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-32 Score=278.09 Aligned_cols=173 Identities=29% Similarity=0.383 Sum_probs=137.6
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
|+.||+|.+++.. +++++.+++.+++||+.||+|||++| |+||||||+|||++.+ +.+|++|||++.... ....
T Consensus 103 ~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~--~~~~ 176 (348)
T d2gfsa1 103 HLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTD--DEMT 176 (348)
T ss_dssp ECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----CCT--GGGS
T ss_pred eecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhcccC--cccc
Confidence 4789999999855 57999999999999999999999999 9999999999999987 799999999997643 3345
Q ss_pred cccCCCcccCcccccc--cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcC-CCC-----------------
Q 010768 81 SVIGTPEFMAPELYEE--DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSG-KLP----------------- 140 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~--~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~-~~p----------------- 140 (502)
+..||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.. .......+... ..+
T Consensus 177 ~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 5678999999997654 37899999999999999999999998743 33333333211 000
Q ss_pred -------C-C---ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 -------G-A---FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 -------~-~---~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
. . .....++.+++||.+||. ||.+|||++|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 0 012357899999999999 99999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-32 Score=271.65 Aligned_cols=168 Identities=27% Similarity=0.406 Sum_probs=145.8
Q ss_pred CCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKYT----------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~~----------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
||.+|+|.+++.... .+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||
T Consensus 100 ~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~-~~~kl 176 (299)
T d1fgka_ 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKI 176 (299)
T ss_dssp CCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEE
T ss_pred ccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCC-CCeEe
Confidence 789999999997653 4899999999999999999999999 9999999999999988 79999
Q ss_pred EecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCC
Q 010768 65 GDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKL 139 (502)
Q Consensus 65 ~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~ 139 (502)
+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|+|++ |.+||.+ ....++++.+..+..
T Consensus 177 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~i~~~~~ 255 (299)
T d1fgka_ 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR 255 (299)
T ss_dssp CSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCC
T ss_pred ccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 9999998764432 234467899999999775 679999999999999999998 7888866 667788888887765
Q ss_pred CCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 140 PGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 140 p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
+. .+...++.+++||.+||+ +|.+|||+.||++
T Consensus 256 ~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 256 MD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 53 455678999999999999 9999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=275.10 Aligned_cols=169 Identities=24% Similarity=0.354 Sum_probs=144.8
Q ss_pred CCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEE
Q 010768 1 MFTSGTLREYRKKY----------------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKI 64 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL 64 (502)
|+.||+|.++|.+. ..+++..++.++.||+.||.|||+++ ||||||||+|||++.+ +.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~-~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC-CceEE
Confidence 78999999999764 56999999999999999999999999 9999999999999987 79999
Q ss_pred EecCCceeccCCCCcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhcc-CCCCCCCChHHHHHHHHcCCCCCC
Q 010768 65 GDLGLAAILRGSQHAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIYKKVTSGKLPGA 142 (502)
Q Consensus 65 ~DFGlA~~~~~~~~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~-~Pf~~~~~~~~i~~~i~~~~~p~~ 142 (502)
+|||+++............||+.|+|||.+. +.|+.++|||||||++|||++|. +||.+ .+..+++..+..+..+.
T Consensus 169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~~~~- 246 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE- 246 (309)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCCC-
T ss_pred ccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCCCC-
Confidence 9999998765444445667999999999885 56999999999999999999976 45654 67888888888876654
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcC
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~h 174 (502)
.+...++.+++||.+||. +|++|||+.|++.+
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 345568999999999999 99999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.6e-32 Score=271.51 Aligned_cols=168 Identities=21% Similarity=0.323 Sum_probs=142.2
Q ss_pred CCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEe
Q 010768 1 MFTSGTLREYRKKYT------------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVN 56 (502)
Q Consensus 1 y~~gGsL~~~L~k~~------------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld 56 (502)
|+.+|+|.+++.... .+++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld 174 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG 174 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEEC
Confidence 688999999997543 3899999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecCCceeccCCC---CcccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhcc-CCCCCCCChHHHH
Q 010768 57 GHLGQVKIGDLGLAAILRGSQ---HAHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIY 131 (502)
Q Consensus 57 ~~~g~vKL~DFGlA~~~~~~~---~~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~-~Pf~~~~~~~~i~ 131 (502)
.+ +.+||+|||+++...... ...+..||+.|+|||++. ..|+.++|||||||++|||++|. +||.+ .+..++.
T Consensus 175 ~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~~e~~ 252 (301)
T d1lufa_ 175 EN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVI 252 (301)
T ss_dssp GG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHH
T ss_pred CC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CCHHHHH
Confidence 87 799999999998654322 233567899999999886 46999999999999999999986 56665 6777888
Q ss_pred HHHHcCCCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 132 KKVTSGKLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 132 ~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+..+..+.. +...++.+.+||.+||+ +|.+|||+.||++
T Consensus 253 ~~v~~~~~~~~-p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 253 YYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCC-CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888876543 44568899999999999 9999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-32 Score=268.40 Aligned_cols=169 Identities=23% Similarity=0.326 Sum_probs=141.3
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 91 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCE
T ss_pred eecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhhcccCCCc
Confidence 68999999988654 56999999999999999999999999 9999999999999987 6999999999998654322
Q ss_pred ---cccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ---AHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ---~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....|++.|+|||++.+ .++.++|||||||++|||+| |..||.+ .+..++...+.........+...++.+++
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 246 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYN 246 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHHH
T ss_pred ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccHHHHH
Confidence 223457889999998864 58999999999999999998 8999987 55666666776655444455667899999
Q ss_pred HHHHhhc-CcCCCCCHHHHhc
Q 010768 154 FVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~ 173 (502)
||.+||. ||.+|||+.||++
T Consensus 247 li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 247 VMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 9999999 9999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=263.90 Aligned_cols=166 Identities=19% Similarity=0.358 Sum_probs=137.7
Q ss_pred CCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC
Q 010768 1 MFTSGTLREYRKKYT--RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~~--~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~ 78 (502)
|+++|+|.+++.+.+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecCCC--
Confidence 789999999997643 4999999999999999999999999 9999999999999987 79999999999865432
Q ss_pred cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHHHHH
Q 010768 79 AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARRFVG 156 (502)
Q Consensus 79 ~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~ 156 (502)
.....+|+.|+|||++. +.++.++|||||||++|||+| |++||.. ....++...+..+..+.. +...++.+++||.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMDA-PDGCPPAVYEVMK 234 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCCC-CTTCCHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHH
Confidence 34457899999999875 569999999999999999998 7888766 566778888887766544 4556899999999
Q ss_pred Hhhc-CcCCCCCHHHHhc
Q 010768 157 KCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 157 kcL~-dP~kRpsa~ElL~ 173 (502)
+||. ||.+|||+.++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcccCHhHCcCHHHHHH
Confidence 9999 9999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=273.72 Aligned_cols=174 Identities=28% Similarity=0.362 Sum_probs=127.0
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAH 80 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~ 80 (502)
||.+| |.+.+ ...+++..++.+++||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.........
T Consensus 103 y~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~~~ 176 (355)
T d2b1pa1 103 LMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMT 176 (355)
T ss_dssp CCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC-----------
T ss_pred ccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhhccccccccc
Confidence 45544 44444 357999999999999999999999999 9999999999999987 799999999998776666667
Q ss_pred cccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHH---------------------cCC
Q 010768 81 SVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVT---------------------SGK 138 (502)
Q Consensus 81 ~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~---------------------~~~ 138 (502)
..+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+........+.+. ...
T Consensus 177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (355)
T d2b1pa1 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256 (355)
T ss_dssp ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTS
T ss_pred cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcC
Confidence 7789999999998864 589999999999999999999999987443322222111 111
Q ss_pred CCCC------------------ccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 139 LPGA------------------FHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 139 ~p~~------------------~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
.+.. .....++.+++||.+||. ||++||||+|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 001135678999999999 99999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-31 Score=265.85 Aligned_cols=169 Identities=24% Similarity=0.392 Sum_probs=142.7
Q ss_pred CCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcE
Q 010768 1 MFTSGTLREYRKKYT------------------RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQV 62 (502)
Q Consensus 1 y~~gGsL~~~L~k~~------------------~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~v 62 (502)
||.+|+|.+++.+.. .+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~-~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETT-TEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccccc-Ccc
Confidence 789999999998654 5999999999999999999999999 9999999999999987 799
Q ss_pred EEEecCCceeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhh-ccCCCCCCCChHHHHHHHHcC
Q 010768 63 KIGDLGLAAILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLT-SEYPYSECSNPAQIYKKVTSG 137 (502)
Q Consensus 63 KL~DFGlA~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLt-G~~Pf~~~~~~~~i~~~i~~~ 137 (502)
||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||........+.+.+..+
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999987654322 23467899999999876 568999999999999999998 666676655555666666655
Q ss_pred CCCCCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 138 KLPGAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 138 ~~p~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..+ ..+...++.+.+||.+||. ||.+|||+.+|++
T Consensus 265 ~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 265 FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 443 3445678999999999999 9999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-31 Score=264.80 Aligned_cols=170 Identities=21% Similarity=0.316 Sum_probs=142.1
Q ss_pred CCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCC-
Q 010768 1 MFTSGTLREYRKKY-TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQH- 78 (502)
Q Consensus 1 y~~gGsL~~~L~k~-~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~- 78 (502)
||.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEecccchhhccccccc
Confidence 78999999999855 45889999999999999999999999 9999999999999987 7999999999987643321
Q ss_pred ----cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCChHHHHHHHHcCCCCCCccccCCHHHHH
Q 010768 79 ----AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPGAFHRIQDAEARR 153 (502)
Q Consensus 79 ----~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~ 153 (502)
.....||+.|+|||.+. +.++.++|||||||++|||+||..||.......++...+..+..+. .+...++.+.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcHHHHH
Confidence 22356899999999875 6799999999999999999998888877666677778888876654 34566889999
Q ss_pred HHHHhhc-CcCCCCCHHHHhcC
Q 010768 154 FVGKCLE-NVSKRLPAKELLLD 174 (502)
Q Consensus 154 LI~kcL~-dP~kRpsa~ElL~h 174 (502)
||.+||. +|.+||++.|++++
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999 99999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=260.29 Aligned_cols=168 Identities=24% Similarity=0.390 Sum_probs=143.1
Q ss_pred CCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCc
Q 010768 1 MFTSGTLREYRKKY----------TRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 70 (502)
Q Consensus 1 y~~gGsL~~~L~k~----------~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA 70 (502)
||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~-~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-ceEEEeecccc
Confidence 68999999998643 34799999999999999999999999 9999999999999987 79999999999
Q ss_pred eeccCCCC---cccccCCCcccCccccc-ccCCcccchhhhhHHHHHHhhcc-CCCCCCCChHHHHHHHHcCCCCCCccc
Q 010768 71 AILRGSQH---AHSVIGTPEFMAPELYE-EDYNELVDIYSFGMCVLEMLTSE-YPYSECSNPAQIYKKVTSGKLPGAFHR 145 (502)
Q Consensus 71 ~~~~~~~~---~~~~~GT~~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~ 145 (502)
+....... .....||+.|+|||.+. +.++.++|||||||++|||+||. .||.+ .+..+++..+..+..+.. +.
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~~-p~ 258 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLDK-PD 258 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCCC-CT
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCCC-cc
Confidence 86643222 23456899999999876 56899999999999999999985 66765 677788888888776543 34
Q ss_pred cCCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 146 IQDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 146 ~~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
..++.+.++|.+||+ +|.+|||+.+|++
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 568899999999999 9999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-30 Score=258.51 Aligned_cols=171 Identities=27% Similarity=0.391 Sum_probs=133.3
Q ss_pred CCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceecccccCcEEEeCCCCcEEEEecCCceecc
Q 010768 1 MFTSGTLREYRKKYTRVDIRAVKNWARQILRGIAYLHGH------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 74 (502)
Q Consensus 1 y~~gGsL~~~L~k~~~Lse~~i~~i~~QIl~aL~yLHs~------g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~ 74 (502)
||.+|+|.+++++. .+++..++.++.|++.||+|||+. .++||||||||+||||+.+ +.+||+|||+++...
T Consensus 82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEE
T ss_pred cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCcccccc
Confidence 78999999999875 699999999999999999999974 1239999999999999987 799999999998765
Q ss_pred CCC-----CcccccCCCcccCccccccc-------CCcccchhhhhHHHHHHhhccCCCCCC--------------CChH
Q 010768 75 GSQ-----HAHSVIGTPEFMAPELYEED-------YNELVDIYSFGMCVLEMLTSEYPYSEC--------------SNPA 128 (502)
Q Consensus 75 ~~~-----~~~~~~GT~~Y~APEvl~~~-------~s~ksDIwSLG~iLyeLLtG~~Pf~~~--------------~~~~ 128 (502)
... .....+||+.|+|||++.+. ++.++|||||||++|||+||..||... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 432 23456899999999988643 677899999999999999998776321 2334
Q ss_pred HHHHHHHcCCCCCCcccc-----CCHHHHHHHHHhhc-CcCCCCCHHHHhc
Q 010768 129 QIYKKVTSGKLPGAFHRI-----QDAEARRFVGKCLE-NVSKRLPAKELLL 173 (502)
Q Consensus 129 ~i~~~i~~~~~p~~~~~~-----~s~~l~~LI~kcL~-dP~kRpsa~ElL~ 173 (502)
.+.+.+..+...+.++.. ....+.+|+.+||. ||.+|||+.||++
T Consensus 240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 444444444442222221 12458899999999 9999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=7.4e-30 Score=253.42 Aligned_cols=176 Identities=18% Similarity=0.275 Sum_probs=134.6
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCC--CCcEEEEecCCceeccCCC-
Q 010768 2 FTSGTLREYRKK-YTRVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSQ- 77 (502)
Q Consensus 2 ~~gGsL~~~L~k-~~~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~--~g~vKL~DFGlA~~~~~~~- 77 (502)
+.+|+|..++.. .+.+++..++.++.||+.||+|||++| ||||||||+|||++.. ...+||+|||+|+.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 347777777655 467999999999999999999999999 9999999999998642 3579999999998765422
Q ss_pred -------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCCChHHHH--HHHHcCC---CCCCcc
Q 010768 78 -------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECSNPAQIY--KKVTSGK---LPGAFH 144 (502)
Q Consensus 78 -------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~~~i~--~~i~~~~---~p~~~~ 144 (502)
.....+||+.|+|||++.+ .++.++|||||||++|||+||..||.......... ....... ......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 2245689999999998875 49999999999999999999999997643322211 1111111 111223
Q ss_pred ccCCHHHHHHHHHhhc-CcCCCCCHH---HHhcCccccC
Q 010768 145 RIQDAEARRFVGKCLE-NVSKRLPAK---ELLLDPFLAS 179 (502)
Q Consensus 145 ~~~s~~l~~LI~kcL~-dP~kRpsa~---ElL~hpf~~~ 179 (502)
...++++.+||.+||. +|.+||++. ++|+++|.+.
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 4568899999999999 999999986 4577777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=7.7e-29 Score=246.45 Aligned_cols=169 Identities=15% Similarity=0.246 Sum_probs=134.4
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeC----CCCcEEEEecCCceeccCC
Q 010768 2 FTSGTLREYRKKYT-RVDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNG----HLGQVKIGDLGLAAILRGS 76 (502)
Q Consensus 2 ~~gGsL~~~L~k~~-~Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~----~~g~vKL~DFGlA~~~~~~ 76 (502)
+.+|+|.+++...+ .+++..+..++.|++.||+|||++| ||||||||+|||++. ..+.+||+|||+|+.....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 34899999998764 6999999999999999999999999 999999999999974 2368999999999876432
Q ss_pred C--------CcccccCCCcccCcccccc-cCCcccchhhhhHHHHHHhhccCCCCCCC--ChHHHHHHHHcCCC---CCC
Q 010768 77 Q--------HAHSVIGTPEFMAPELYEE-DYNELVDIYSFGMCVLEMLTSEYPYSECS--NPAQIYKKVTSGKL---PGA 142 (502)
Q Consensus 77 ~--------~~~~~~GT~~Y~APEvl~~-~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~--~~~~i~~~i~~~~~---p~~ 142 (502)
. .....+||+.|||||++.+ .++.++|||||||++|+|++|..||.+.. .....+..+..... +..
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 1 2345679999999998875 49999999999999999999999997543 23333333332211 111
Q ss_pred ccccCCHHHHHHHHHhhc-CcCCCCCHHHHh
Q 010768 143 FHRIQDAEARRFVGKCLE-NVSKRLPAKELL 172 (502)
Q Consensus 143 ~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL 172 (502)
.....++++.+|+..|+. +|.+||+.+.+.
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 223457899999999999 999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=9e-29 Score=250.56 Aligned_cols=164 Identities=27% Similarity=0.422 Sum_probs=124.9
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceecccccCcEEEeCCC-----CcEEEEecCCceeccCCCCcccccCCC
Q 010768 13 KYTRVDIRAVKNWARQILRGIAYLHG-HDPPVIHRDLKCDNIFVNGHL-----GQVKIGDLGLAAILRGSQHAHSVIGTP 86 (502)
Q Consensus 13 k~~~Lse~~i~~i~~QIl~aL~yLHs-~g~~IIHRDLKPeNILld~~~-----g~vKL~DFGlA~~~~~~~~~~~~~GT~ 86 (502)
....+++..++.++.||+.||+|||+ +| |+||||||+||||+.+. ..+||+|||.+..... .....+||+
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~ 193 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTR 193 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCG
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccc
Confidence 34679999999999999999999997 78 99999999999997542 1499999999986543 335678999
Q ss_pred cccCccccc-ccCCcccchhhhhHHHHHHhhccCCCCCCCCh------HHHHHHHH-cCCCC------------------
Q 010768 87 EFMAPELYE-EDYNELVDIYSFGMCVLEMLTSEYPYSECSNP------AQIYKKVT-SGKLP------------------ 140 (502)
Q Consensus 87 ~Y~APEvl~-~~~s~ksDIwSLG~iLyeLLtG~~Pf~~~~~~------~~i~~~i~-~~~~p------------------ 140 (502)
.|+|||++. ..++.++||||+||++++|++|+.||...... ..+...+. -+..+
T Consensus 194 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~ 273 (362)
T d1q8ya_ 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273 (362)
T ss_dssp GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred cccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccch
Confidence 999999776 56999999999999999999999999653211 11111110 01000
Q ss_pred --------------------CCccccCCHHHHHHHHHhhc-CcCCCCCHHHHhcCccccCC
Q 010768 141 --------------------GAFHRIQDAEARRFVGKCLE-NVSKRLPAKELLLDPFLASD 180 (502)
Q Consensus 141 --------------------~~~~~~~s~~l~~LI~kcL~-dP~kRpsa~ElL~hpf~~~~ 180 (502)
..+....++.+++||.+||. ||.+|||++|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 00111235778999999999 99999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.26 E-value=2.8e-13 Score=124.56 Aligned_cols=84 Identities=19% Similarity=0.204 Sum_probs=63.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCceecccccCcEEEeCCCCcEEEEecCCceeccCCCCcccccCCCcccC------
Q 010768 17 VDIRAVKNWARQILRGIAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQHAHSVIGTPEFMA------ 90 (502)
Q Consensus 17 Lse~~i~~i~~QIl~aL~yLHs~g~~IIHRDLKPeNILld~~~g~vKL~DFGlA~~~~~~~~~~~~~GT~~Y~A------ 90 (502)
++...+..++.||+.+|.|||++| |+||||||+|||++.+ .++|+|||.|......... .|..
T Consensus 100 l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~ 168 (191)
T d1zara2 100 VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGWR-------EILERDVRNI 168 (191)
T ss_dssp CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEECCCTTCEETTSTTHH-------HHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEEECCCcccCCCCCcH-------HHHHHHHHHH
Confidence 556677889999999999999999 9999999999999864 6999999999765432111 1111
Q ss_pred cccccccCCcccchhhhhHHH
Q 010768 91 PELYEEDYNELVDIYSFGMCV 111 (502)
Q Consensus 91 PEvl~~~~s~ksDIwSLG~iL 111 (502)
.+.+...|+.++|+||+.--+
T Consensus 169 ~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 169 ITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHHHHHHCCCCCHHHHHHHH
T ss_pred HHHHcCCCCCcccHHHHHHHH
Confidence 123456789999999975433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.56 E-value=0.081 Score=49.61 Aligned_cols=47 Identities=30% Similarity=0.276 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHHHHhCC--CCceecccccCcEEEeCCCCcEEEEecCCce
Q 010768 24 NWARQILRGIAYLHGHD--PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 71 (502)
Q Consensus 24 ~i~~QIl~aL~yLHs~g--~~IIHRDLKPeNILld~~~g~vKL~DFGlA~ 71 (502)
..+..+...+.-.+..+ .++||+|+.++||+++++ ...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccc-cceeEecccccc
Confidence 33444444444444321 249999999999999986 455799999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.25 E-value=0.18 Score=47.74 Aligned_cols=28 Identities=25% Similarity=0.150 Sum_probs=22.8
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC---ceEEechhccc
Confidence 48999999999999743 45899998753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=86.35 E-value=0.15 Score=46.00 Aligned_cols=29 Identities=34% Similarity=0.346 Sum_probs=24.2
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCC-ceEEEeechhccc
Confidence 7999999999999875 4456999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=85.91 E-value=0.15 Score=45.77 Aligned_cols=29 Identities=28% Similarity=0.229 Sum_probs=24.5
Q ss_pred ceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 43 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 43 IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence 7999999999999875 4567999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.38 E-value=0.42 Score=46.57 Aligned_cols=29 Identities=34% Similarity=0.511 Sum_probs=25.1
Q ss_pred CceecccccCcEEEeCCCCcEEEEecCCcee
Q 010768 42 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 72 (502)
Q Consensus 42 ~IIHRDLKPeNILld~~~g~vKL~DFGlA~~ 72 (502)
.++|+|+.|.|||++++ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 49999999999999875 589999988753
|